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1.1 PROTEIN-PROTEIN INTERACTIONS: ROLE AND PROPERTIES 
Protein-protein interactions (PPIs) are central to the tuning and regulation of 
the most important biological processes,1,2 because they play a key role in cell 
proliferation, growth, differentiation, signal transduction and apoptosis.3–6 Thus, it 
is not surprising that PPIs are also involved in many disease states, such as cancer, 
neurodegeneration, and viral and bacterial infections.7–9 Therefore, the modulation 
of PPIs has a great therapeutic potential and, in the last decades, much effort has 
been paid to the design and development of molecules targeting PPIs known to be 
involved in pathologic states.1,3,7,10–14 
However, interfering with PPIs represents a challenging task, because of the 
poor experience gained so far in this field and the intrinsic complexity of the target. 
This requires innovation of the methodological approaches used for “classical” 
targets, such as enzymes or receptors.2  
Indeed, the structural properties of PPIs differ from those of protein-ligand 
binding, and this represents the biggest problem when trying to modulate PPIs. 
First of all, the protein-protein interfaces are usually much larger than the binding 
sites of classical targets. While the ligand-receptor contact areas are usually of 
about 300-1000Ǻ2,15 protein-protein interfaces are usually of 1500-3000 Ǻ2 in size, 
or even larger, as in the case of those G-proteins and components of the signal 
transduction pathway.16–19 Furthermore, the interfaces involved in PPIs are usually 
flat and lacking of the grooves, pockets or indentations found at the binding site of 
classical targets,2,7,20 and the interactions between two proteins generally involve 
not contiguous amino acids (AAs). 
Nevertheless, since a huge amount of PPIs occurs in cells, structural and 
composition differences of the regions involved in the interaction are necessary to 
have the specificity needed for the formation of the right complex in the crowded 
cellular environment.11,21,22 This observation, together with promising 
5 
 
results,2,7,8,11,14,23–27 gives hope for finding molecules able to target protein-protein 
interfaces and, thus, modulate PPIs.7 
Indeed, although protein-protein interfaces are large, they are not energetically 
homogeneous,28 and generally specific interface portions, called hot regions, 
mainly contribute to PPIs.22,29 According to the O-ring theory,30 in these regions it 
is possible to identify a core and a rim, where this latter contains more accessible 
residues sheltering the core AAs from solvent molecules (Figure 1.1). The core 
residues, known as hot spots, are those accounting for most of the binding energy 
and, if replaced by an alanine, they lead to a change in the binding free energy 
(ΔGbind) ≥ 2 kcal/mol.31 Hot spots located in the same hot region cooperate in 
stabilizing the complex,22,32 while the energetic contributions of two or more 
regions are additive, suggesting the independency of hot regions.33 
 
Figure 1.1 . Hot spots and O-rings at the protein–protein interface. a) Orthogonal views of the 
human growth hormone binding protein (GHBP)–growth hormone (GH) complex (PDB ID: 
3HHR), with the proteins depicted as atom spheres coloured either purple (GH) or grey (GHBP) 
except for the hot spot (red) and rim (yellow) residues. b) The complex is shown opening to expose 
the interacting surface.34 
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Moreover, within hot regions and, most of all, hot spots, there is a strong 
geometric and energetic complementarity between the proteins involved in the PPI. 
This complementarity can be enhanced by water mediated interactions,35,36 where 
structural water molecules are involved in bridging H-bonds between the two 
proteins and/or create interfacial dry cores, thus maximizing the interactions 
between hot spots protected by the rim AAs and water.37 
Systematic analysis of known hot spots revealed that their composition is not 
random38 and that tryptophan, tyrosine, arginine and, at minor extent, isoleucine are 
the most frequently occurring and the most conserved AAs.28 Conversely, leucine, 
serine, threonine and valine are rarely identified as hot spots.30,39  
Indeed, both tryptophan and tyrosine have a bulky aromatic side chain, which 
can take part in π interactions and protect fragile H-bonds from water,40 and they 
are also able to take part in H-bonds. Moreover, the substitution of tryptophan with 
an alanine creates a large cavity, causing a destabilization of the PPI, while 
tyrosine, because of its ability of being involved in H-bonds, has a three times 
higher probability of being a hot spot than phenylalanine.30 On the other side, 
arginine can be responsible of the formation of both salt bridges and H-bonds. 
Therefore, although protein-protein interfaces show a high amount of 
hydrophobic residues, the hydrophobic effect cannot be the only driving force in 
protein-protein association and the importance of electrostatic interactions is not 
negligible.41,42 Indeed, the hydrophobicity degree of protein-protein interfaces is in 
between the one observed for a protein core and the one of a solvent exposed 
protein surface, and the composition of hot spots reflects this situation.38 
The presence of hot spots, where the binding energy is focused, makes the 
identification of compounds with a relatively low molecular weight more feasible 
than it would be if the binding energy was equally distributed over the interface. 





1.2 DRUGGABILITY OF PPIS 
Druggability is defined as the likelihood of identifying a selective, low 
molecular weight compound with high affinity to the target.43 It is not an absolute 
property of the target and, in addition, there is not yet a unified way to determine 
the druggability of PPIs. However, Chène proposed a useful decision tree to 
establish if a certain PPI can be considered druggable or not.11  
First of all, the difficulty in targeting a PPI is related to its half-life: 
permanent complexes, whose subunits remain associated, or obligate complexes, 
whose monomers do not exist in the non-associated form in the cellular 
environment, have a more difficult modulation than transient and non-obligate 
complexes. Furthermore, an a priori knowledge about the presence of cavities, the 
interfacial hydrophobicity degree, the size and complementarity of the interface 
helps in targeting PPIs.  
The shape of the interface is another factor to take in account, since the less 
flat the protein interface, the more stable the complex, because one of the partner 
is more buried. Therefore, transient and hetero-complexes, which are the most 
attractive for drug discovery, have more planar interfaces.18 However, the presence 
of some cavities at the interface is desirable, because they can accommodate 
molecules and allow specific targeting. Moreover, the hydrophobicity at the 
interface should be intermediate, allowing the development of molecules with an 
acceptable trade-off between optimal binding and good pharmacokinetic 
properties. 
Furthermore, it is important to consider the conformational changes 
eventually occurring upon binding, since when this phenomenon is observed is 
more difficult to modulate PPIs. 
Another important aspect that affects the druggability of a PPI is the 
presence of helical motifs at the interface. Indeed, because of their frequent 
occurrence in both protein core and exposed regions, superficial helices are often 
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responsible of molecular recognition, and the 62% of PPIs reported in databases 
have helical interfaces.44,45 
 
Figure 1.2. X-ray structure of MDM2 (magenta) in complex with the transactivation domain of 
p53 (turquoise) (PDB ID: 1YCR).46 
Helical interfaces can be divided into three main categories, which are 
differently druggable. In detail, to the first class belong proteins whose interface 
consists in a cleft where a helix can bind and a minimum of two close AAs 
strongly contribute to the interaction, as happens for the complex between MDM2 
and p53 (Figure 1.2).7,11,46 This situation offers better chances for the design of 
small molecule able to modulate these PPIs. To the second category belong 
extended interfaces where the interaction is due to multiple strong contacts 
between two to five turn helices and a high number of residues. The third category 
is made of proteins showing both of the described features and quite weak 
interactions. 
All these aspects have to be taken in account when assessing the 
druggability of a PPI and designing its potential modulators.  
1.3 ROLE OF WATER IN PPIS 
The importance of water in PPIs has been often underestimated, since the 
mainstream idea was that protein adhesion was the main actor, while water 
represented only a spectator in the protein aggregation phenomena. However, as 
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mentioned before, protein-protein interfaces are enriched in polar and charged 
residues,41 and water molecules are often trapped at the interface and are able to 
satisfy the H-bond network by bridging polar protein-protein interactions which 
are either too distant of energetically unfavored (Figure 1.3).47 Therefore, water 
molecules affect the structure, stability, dynamics and function of biomolecules. 
 
Figure 1.3. Cytochrome C-Cytochrome C peroxidase complex (PDB ID: 2PCC).48 Protein-protein 
interface is highlighted and colored depending on lipophilicity (magenta: hydrophilic, green: 
lipophilic). Interfacial water molecules are depicted as CPK. 
Moreover, it has been demonstrated that long-range water-mediated forces, 
quantified by the hydration free energy, are fundamental for the aggregation of 
proteins which are approaching each other from a large distance to within a contact 
distance, as happens in the cellular environment.49 Nonetheless, water interacting 
with rim residues allows the formation of dry nuclei at the interface, which 
enhance the interactions between hot spots,37 thanks to the hydrophobic effect 
induced by water. 
In a study conducted on 179 high-resolution (< 2.30 Ǻ) X-ray structures of 
protein-protein complexes50 it has been showed that of the 4741 interfacial water 
molecules, 21% were bridging interactions between both proteins and 53% were 
involved in favorable interactions with only one protein, while the remaining 26% 
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of water molecules were not interacting with either protein. However, about the 
half of them showed a solvent accessible surface area (SASA) ≤ 10 Å2, suggesting 
that they are buried within the protein-protein interface, often creating 
hydrophobic bubbles. This kind of water molecules seems fundamental for the 
mediation and/or lubrication of PPIs,18 and cannot be neglected when simulating 
PPIs. 
Therefore, as water has been exploited as a component for the design of 
modulators of classical targets, it can be useful also in the case of PPIs. 
1.4 MODULATION OF PPIS 
The modulation of PPIs can be achieved by either stabilization or inhibition of 
the interaction (Figure 1.4), with the latter being the most explored approach.7,10,51 
 
Figure 1.4. Regulatory control mechanisms for the association state of interacting proteins. 
Adapted from Thiel et al.52 
Furthermore, for both the approaches the modulation can be obtained by 
either a direct or an allosteric mode of action. When aiming at PPI inhibition by 
following the former mode, the modulator should directly bind at the interfacial 
surface of one of the proteins involved in the PPI, preventing the binding of the 
interaction partner, as observed in the case of the complex Rac1 - Tiam1, whose 
formation is inhibited by the binding of an inhibitor, such as NSC23766, to Rac1.53 
Conversely, when the stabilization of the PPI has to be obtained, the 
modulator binds at the interfacial surface making contacts with both partners and 
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increasing the mutual binding affinity. In this case, the stabilizing molecule can 
bind first to one of the interacting proteins, making the interaction surface more 
adapt to the other protein, as in the case of FKBP binding molecules FK506 and 
rapamycin.52 Conversely, the stabilizing molecule can bind to the rim of an already 
formed protein-protein interface and increase the binding affinity of the two 
protein partners, as in the case of forskolin binding the C1a and C2a subdomains of 
adenylyl cyclase, resulting in an increase of the cAMP levels in many tissues.54 
On the contrary, the allosteric modulation is achieved for both inhibition and 
stabilization of PPIs by binding to a region of one protein partner not directly 
involved in the PPI, as in the case of paclitaxel, which, binding to a hydrophobic 
pocket of polymerized tubulin located only on the β subunit, stabilizes the 
microtubule structures.55 
Simultaneously, the modulation of PPIs can be achieved through classical 
small molecules, which, not necessarily mimicking the secondary structure at the 
interface, bind to the protein receptor acting as simple functional mimetics.56,57 
These compounds are not versatile, because they are designed for the modulation 
of a specific target and they can be unlikely exploited for other PPIs. 
Conversely, it is possible to obtain the modulation through molecules able to 
mimic the surface by non-sequential hot spot residues.58 In this case, it is possible 
to develop non-peptide scaffolds, known as proteomimetics, witch match the 
topography of the original secondary structure, usually a helix,44,45 by spatially 
orienting their substituents in a way that allows the interaction with the hot spots. 
For example, the aryl core of 3,2′,2′′-terphenyl derivatives (Figure 1.5c) are able to 
assume a staggered conformation which projects the ortho substituents to mimic 
the positions of the i,i+4 and i+7 residues of a helix (Figure 1.5a,b). Some of these 
derivatives proved to inhibit the calmodulin/phosphodiesterase, the Bcl-xL/Bak 




Figure 1.5. a) Representation of an α-helix whose i, i+4 and i+7 residues are highlighted on a 
single face. b) X-ray structure of a terphenyl derivative. c) 3,2',2''-terphenyl - the first α-helix 
mimetic. Adapted from Azzarito.58  
The last and more interesting approach to modulate PPIs is the use of peptide-
based molecules. This is particularly useful when targeting helical interfaces, 
which are the most frequently occurring and structurally stable.45 Peptides provide 
a high degree of selectivity and specificity toward the target and a low toxicity.62–
64
 However, synthetic peptides are considered therapeutically undesirable because 
of their poor bioavailability and their sensitivity to proteolytic degradation.65 
Furthermore, synthetic peptides in solution often adopt random conformations, far 
from those observed in their parent proteins, which have to be maintained to assure 
the correct interaction with the target protein interface.58 Therefore, many 
approaches aimed to solve one or both these problems have been developed. 
Among these, the most exploited ones consist in the nucleation of the helix 
formation and/or in the stabilization of the helical conformation (Figure 1.6). 
Figure 1.6. Scheme illustrating different approaches for helix stabilization. 
In this framework, frequently applied methods are the covalent cyclization, 
i.e. disulfide or lactam bridges,66,67 the H-bond surrogate (HBS) method,68 the 
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hydrocarbon stapling69,70 or the use of non natural AAs (nnAAs), such as β-AAs71 
or Cα-tetrasubstituted AAs (CTAAs).72,73 
1.5 COMPUTATIONAL APPROACHES IN PPIS MODULATION 
The exploitation of computational methods has revealed to be extremely 
helpful for the design of PPIs modulators.74 Different methods can be applied to 
each step, from the analysis of the protein-protein interface to the modulators 
optimization and the estimation of the binding affinity. 
For example, although crystallographic structures provide important 
information about the protein-protein interfaces, different computational methods 
can be used for the identification of possible binding pockets present at the 
interface. Some of these methods rely on geometry- or energy-based algorithms,75 
while other techniques are based on structure and sequence comparison76,77 or on 
the analysis of the dynamics of proteins through extensive molecular dynamics 
(MD) simulations.78,79 
Furthermore, a fundamental step when designing any kind of PPIs modulators 
is the detection of hot spots. Obviously, this can be done through experimental 
methods, which, however, are laborious and expensive. Therefore, there is a high 
demand of computational approaches aimed to this. Among the available methods, 
the most straightforward is the in silico alanine scanning, where selected AAs are 
mutated to alanine and the effect of the mutation in terms of relative binding free 
energy are evaluated. Then, a relative binding (free) energy is computed for the 
wild-type complex and for the complexes carrying the mutations to alanine, often 
using simple physical models or empirical scoring functions.80 The computational 
alanine scanning can be performed on a single complex structure or on an 
ensemble of conformations obtained from MD simulations, with this approach 
performing better than the former because the single structure may be not 
representative if the proteins are flexible. 
Another widely used method to establish the contribution of single AAs to the 
ΔGbind is the Molecular Mechanics Generalized Born/Poisson Boltzmann Surface 
14 
 
Area (MMGB/PBSA), which allow a per-residue decomposition of the ΔGbind.81 In 
both methods endpoint free energy calculations are performed to predict the total 
ΔGbind on an ensemble of states extracted from MD simulations. They also allow 
the decomposition of the ΔGbind into pairwise contributions, which are useful to 
detect important interactions between pairs of AAs. 
Because of the already mentioned differences between PPIs and classical 
targets, different approaches for the rational design of molecules targeting PPIs 
have to be developed.82 The modulation via small molecules is quite difficult, 
although some successful results have been obtained. Indeed, an extensively 
developed database of starting structure is still needed and the current chemical 
libraries lack of a sufficient diversity to reflect PPI drugs. Furthermore, the protein 
interface might be too flat and without relevant crevices where a small molecule 
can bind.  
Nevertheless, in the case of the design of small molecules, the fragment based 
ligand design can be applicable, since it allows the introduction of a high degree of 
chemical diversity and because only the interaction with the hot spots is required.7 
Conversely, when designing a peptide or peptidomimetic PPI modulator, the 
hot spot identification is likely to evidence the required peptide function that the 
modulator needs. However, as previously underscored, in order to obtain a correct 
spatial orientation of the substituents, it is fundamental to assess the conformation 
that the modulator will assume in the biological environment. This can be achieved 
through computational methods such as long classical MD or enhanced sampling 
MD, which allow the exploration of the whole conformational space and, possibly, 
the identification of the most energetically stable conformation of the molecule 
under study.  
Furthermore, computational studies using different and complementary 
approaches can help in the generalization of either the structural features required 




The estimation of some kind of parameter as a measure of the ligand binding 
affinity is a fundamental step in drug discovery and the application of 
computational methods at different degree of accuracy and speed can represent a 
useful tool for this process. These methods can involve the use of scoring function 
and, therefore, limit the estimation to a single conformation state, or they can be 
based on the analysis of MD simulations, which provide a statistically meaningful 
ensemble of conformations for thermodynamic calculations at an acceptable 
computational cost. Among these latter methods, the most popular are the 
previously mentioned MMPB/GBSA, the linear interaction energy (LIE),83 the 
thermodynamic integration (TI),84 and the free energy perturbation (FEP).85 
However, because of their good balance between efficiency and accuracy, 
MMPB/GBSA methods are getting used more and more for the computation of 
binding energies. 
As just evidenced in this section, computational methods can be usefully 
exploited to target PPIs, although they have to be adapted to those used for 




2 PROJECT OVERVIEW 
Among all the research topics concerning the modulation of PPIs, my PhD 
project has been focused on the optimization of computational methods and 
protocols for the design of modulators of PPIs, with a particular interest on peptide 
modulators. 
It has to be underlined that my work has been mainly methodological and it 
aimed to provide basic knowledge and computational tools for the design of well-
structured peptides72,86–88 and for the prediction of binding energies with a good 
correlation with experimental data.89,90 
Therefore, I initially evaluated the ability of some of the modern force fields 
coupled to different implicit solvent models of reproducing and, thus, predicting 
the main peptide secondary structure motifs, such as helices, β-sheets and random 
coils.88 Indeed, as previously underscored, the a priori knowledge of which 
conformation a peptide designed as PPI modulator will more likely assume in the 
biological environment is fundamental to verify the correct spatial orientation of 
the side chains for the interaction with the protein target and to assure the 
interaction with the target protein interface.58 Therefore, I selected and submitted 
to Replica Exchange Molecular Dynamics (REMD) simulations eight peptides: 
two helical, three β-hairpins and three intrinsically disordered peptides (IDPs).88  
As evidenced in the previous chapter, helical protein-protein interfaces are 
frequently occurring in nature44,45 and different approaches to stabilize the helical 
secondary structure in synthetic peptides have been developed.58 Among these, the 
insertion of CTAAs in the peptide sequence can lead to peptides inherently stable 
to proteases and peptidases91, and folding into well-ordered helices.58,73,87 
Furthermore, this approach together with the synthesis of chiral CTAAs (cCTAAs) 
is of high interest in my research group.73,87,92,93 Therefore, taking in account the 
information gained from the previous study,88 I applied theoretical methods to 
identify some intuitive descriptors that can be applied to predict how a given 
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cCTAA can affect the peptide folding, as well as to compare different cCTAAs in 
terms of stabilization efficacy.72 
Moreover, since the ability of a cCTAA to influence the helical screw sense 
of a peptide might depend on its Cα stereochemistry,93–96 and because in nature the 
right-handed (P) helix is found more frequently than the left-handed (M) helix,97,98 
I extended the previous study by investigating the cCTAAs features which are 
most responsible of the helical screw sense selectivity.86 
In this context, by collaborating with Prof. Jonathan Clayden at the University 
of Manchester, I also studied the mechanisms involved in the helical screw sense 
inversion, whose knowledge can be exploited either for signal transmission in the 
cellular environment, as aimed by Prof. Clayden’s group,99 or for a conformation-
controlled modulation of PPIs.100 
Successively, because many efficient and reliable computational approaches 
for determining the protein-protein interface and identifying hot spots were already 
available,28,101 I preferred to focus on the development and optimization of a 
MMGBSA based protocol for the estimation of relative binding energies of PPIs 
involving complexes providing a good correlation with experimental data. This 
approach, named Nwat-MMGBSA consists in considering the effect of water on 
the binding affinity by including a selected number of water molecules (Nwat) 
which are the closest to the ligand or to selected residues frame by frame during 
the MD simulation time, as part of the receptor in the MMGBSA analysis. 
Therefore, I initially applied this approach to the simplest situation, represented by 
classical protein-ligand systems with known experimental activities.89  
Once assessed the reliability and validity of the Nwat-MM-GBSA method, I 
applied it to PPI systems. In detail, I initially performed a methodological 
investigation on a dataset of hetero-dimeric PPIs with known experimental ΔGbind. 
Aiming to identify the most critical variables affecting the correlation of predicted 
and experimental energies, I tested two different recent AMBER force fields (e.g. 
ff99SBildn and ff14SB), two implicit solvent models (e.g. GB-OBC(II) and GB-
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Neck2) and two explicit solvent models (e.g. TIP3P and TIP4PEW) on 12 ns 
simulations, which were analyzed through Nwat-MMGBSA at the fourth and at 
the last ns with different ways to select the protein-protein interface. Consequently, 
I applied the best protocol to five PPI systems consisting in one of the two 
interacting proteins inhibited by small molecules or peptidomimetics with known 
activities. 
After a brief chapter summarizing the bases of the computational methods 
applied throughout the project, each part will be discussed in a dedicated chapter, 
which will be organized as follows: a) an introduction to the study, aimed to 
contextualize it within the project and to summarize it; b) a results and discussion 





3.1 MOLECULAR DYNAMICS (MD) 
Molecular Dynamics (MD) is a computational method used to study the time 
dependent behavior of proteins and other macromolecules, providing atomistic 
information on the fluctuations and conformational changes of biosystems. This 
method is extensively applied for the investigation of structure, dynamics and 
thermodynamics of biological molecules and their complexes. 
MD method is based on the Newton’s second law, also known as equation of 
motion, expressed as 𝐹𝑖 = 𝑚𝑖𝑎𝑖, where Fi is the force, usually depending on the 
temperature, exerted on a particle i having mass m and acceleration a, which can 
also be expressed as 𝑑
2𝑟𝑖
𝑑𝑡2
, with ri being the vector of the Cartesian atomic 
coordinates. 
Therefore, from the knowledge of the force acting on each atom it is possible 
to determine the acceleration of each atom of the simulated system. The 
integration of the equation of motion on small time intervals through different 
algorithms yields a trajectory describing how atomic positions, velocities and 
accelerations vary with time.  
The force acting on a particle, Fi, can also be expressed as the gradient of the 
potential energy of the system (V): 𝐹𝑖 = −∇𝑖𝑉, which, combined with the 






Thus, starting from known initial coordinates, usually derived from 
experiments such as NMR or X-ray analyses, initial distribution of velocities and 
forces applied on the system, it is possible to generate the trajectory of the system 
as a function of the simulation time. Moreover, it allows to relate the derivative of 
the potential energy to the changes in position as a function of time.  
At the light of this, the potential energy function is fundamental for 
performing MD simulations and, being a function of the atomic positions r, takes 
in account for both the interactions between bonded atoms and those between 
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atoms which are not directly bound. Commonly, the potential energy function is 
represented in its basic form as the following Hamiltonian: 
𝑉(𝑅)⃗⃗⃗⃗ = ∑ 𝑘𝑑𝑏𝑜𝑛𝑑𝑠 (𝑑 − 𝑑0)
2 + ∑ 𝑘𝜃𝑎𝑛𝑔𝑙𝑒 (𝜃 − 𝜃0)
2 + ∑ 𝑘𝜑(1 +𝑑𝑖ℎ𝑒𝑑𝑟𝑎𝑙𝑠
















which collects the “bonded” energy terms, such as the stretching energy associated 
to the bond length, the bending energy associated to the angles variations, the 
torsion energy which derives from the torsion of dihedral angles, and the “non-
bonded” energy terms comprising van der Waals and electrostatic forces.102 
Being a Molecular Mechanics (MM) method, MD relies on the Born-
Oppenheimer (BO) approximation, which allows to consider the potential energy 
as a function of the nuclear coordinates only. The BO approximation is based on 
the assumption that, since the nuclei are much heavier than electrons, the atoms 
can be described as spheres with a certain radius, mass and a point charge, which 
simulates the effect of merging electrons and nuclei, located in the center of the 
sphere. 
The Hamiltonian and the related parameters, comprising atomic radii and 
point charges, are contained in a force field. Several force fields are available, 
differing in parameterization methods and/or in the form of the energy functions. 
Moreover, within a force field family (i.e. the Amber force field), few differences 
can also be observed, usually related to torsion angle parameters. 
Since MD simulations aim to reproduce what happens in the biological 
environment, the solvent, usually water, has to be considered during the 
simulation. This can be done by using either implicit or explicit solvent models. In 
the former, the solvent is considered as a continuous medium with a certain 
dielectric constant. In explicit models water molecules are included during the 
simulation, making the simulation more realistic, although increasing the 
computational time.  
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In addition, for the reproduction of the experimental conditions, it is possible 
to use different thermodynamic ensembles, where the total number of particles (N) 
is kept constant together with a) volume (V) and total energy (E), known as 
microcanonical ensemble (NVE), b) volume and temperature (T), known as 
canonical ensemble (NVT) or c) pressure (P) and temperature, known as 
isothermal-isobaric ensemble (NPT).  
However, when dealing with MD simulations, it is important to bear in mind 
that many approximations are introduced during the calculations, mainly related to 
the use of the force field and to the solvent model used. Furthermore, the feasible 
simulation time is only up to nano- or, maximum, microseconds, therefore the 
simulation of, for example, conformational changes occurring in a millisecond 
scale still represents a challenge. 
3.2 REPLICA EXCHANGE MOLECULAR DYNAMICS (REMD) 
Peptide folding simulations through classical all atoms MD need an extremely 
long computational time to converge, because simulated peptides tend to get 
trapped in local energy minima, from which it is hard to escape at the simulation 
temperature (usually 300 K). 
Therefore, Sugita and Okamoto developed the REMD method, which belongs 
to the class of enhanced sampling MD. 103 REMD performs simulations based on 
essentially known non-Boltzmann probability weight factors, realizing a random 
walk in the temperature space. This random walk induces a random walk in the 
energy space, which allows the simulation to escape from local minima energy 
states. 
Concretely, many MD simulations of a system, named replica, are performed 
at different temperatures starting from the same system coordinates. During the 





Figure 3.1. REMD simulation method scheme. 
The number of replicas and the temperature interval (usually between 200 and 
700 K) are chosen depending on the size of the system. At low temperatures the 
sampled conformations are stable but unlikely escaping from the local energy 
minima; conversely, at high temperatures it’s easier to escape from these minima, 
but the sampled geometries are not stable, since classical force-fields are not 
designed to operate at high temperatures. Therefore, moving a geometry obtained 
at high temperatures to a simulation at low temperature allows to benefit of both 
simulation conditions.  
Successively, the trajectory at the temperature of interest (around 300 K) is 
extracted and analyzed, in order to obtain information about the conformational 
changes of the system under study. 
3.3 POTENTIAL OF MEAN FORCE (PMF) 
For investigating some biological events, such as peptide/protein folding or 
the conformational changes to which a protein undergoes upon its activation or 
inactivation, it can be helpful to study how the free energy profile changes as a 
function of one or more inter- or intramolecular coordinate, such as atom distances 
or torsion angles. The free energy surface along the defined coordinate is known as 




Figure 3.2. From the free energy surface to the free energy as a function of a reaction coordinate. 
Therefore, the PMF 𝜔(𝜒) along the coordinate χ is defined from the average 
distribution function 〈𝜌(𝜒)〉 through this relationship: 




Where 𝜔(𝜒∗) and 〈𝜌(𝜒∗)〉 are arbitrary reference values. 〈𝜌(𝜒)〉 is obtained 
from a Boltzmann weighted average. This quantity cannot be obtained by a 
classical MD simulation, because of the poor sampling of high energy 
configurations, but it can be computed from REMD simulations. 
3.4 QUANTUM THEORY OF ATOM IN MOLECULES (QTAIM) 
QTAIM method105 has been developed by Richard Bader in the early 1960s 
and represents a model of molecular and condensed matter electronic systems (i.e. 
crystals) where atoms and bonds are expressions of the electron density 
distribution function. In particular, the nucleus acts as a point attractor immersed 
in a cloud of negative charge, the electronic density 𝜌(𝑟𝑐), which describes how 
the electronic charge is distributed throughout the space. The electronic density is 
a maximum at the position of each nucleus and decays quickly away from these 
position (Figure 3.3). 
 
Figure 3.3. The electron density in the plane containing the two carbon and four hydrogen nuclei 
of the ethene molecule. 
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However, to extrapolate information about the electronic density it is 
fundamental to consider the field obtained by following the trajectories traced out 
by the gradient vectors of the density. The gradient of 𝜌(𝑟𝑐) is a vector pointing 
toward the maximum increase in the density, thus, since the density has a 
maximum at the position of each nucleus, the traced trajectories terminate at each 
nucleus. These trajectories allows the definition of the atomic basins, which are the 
space regions traversed by trajectories and terminating at a given nucleus, as 
showed in Figure 3.4. 
Nuclei correspond to a kind of critical points (CP), where a CP is a point in 
the space where the first derivative of the density (∇𝜌(𝑟𝑐) is null. To CPs is 
associated a set of trajectories starting at infinity and terminating at CP (Figure 
3.4), which define an interatomic surface separating the basins of two neighboring 
atoms. A unique pair of trajectories originates at each CP and terminates, one each, 
at the neighboring nucleus. This pair defines a line through the space along which 
the 𝜌(𝑟𝑐) is a maximum. This line, called bond path, indicates that an interaction 
between the two atoms occur. Therefore, the related CP, which is the point with 
the lowest electronic density along the bond path, is called bond critical point. 
 
Figure 3.4. Trajectories that terminate at the nuclei (N), including the bond path and the bond 
critical point (CP). Each trajectory is arbitrarily terminated at the surface of a small circle centered 
on the nucleus. 
CPs are classified by two values: their rank and their signature. The former is 
the number of non-zero curvatures of the electron density at the CP, which are 
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always 3 if the system is at an equilibrium charge distribution state. The latter is 
the algebraic sum of the signs of the curvatures and it is equal to -3 if the CP is a 
local maximum (i.e. the nucleus), -1 if it is a bond critical point, because it is a 
minimum on the plane perpendicular to the bond path and a maximum along it. 
The 𝜌(𝑟𝑐) at the bond CP defines the strength of the chemical bond, while the 
sum of the three curvatures of the density at the CP (∇2𝜌(𝑟𝑐)) is < 0 if the 
interaction between the two atoms is covalent, > 0 if it’s electrostatic. A third 
parameter, called ellipticity (ε), measures the stability of the interaction, because it 
indicates the extent to which density is preferentially accumulated in a given plane 
containing the bond path. If ε = 0, the bond is cylindrically symmetrical and stable. 
Therefore, QTAIM can be exploited for the characterization of covalent and 
noncovalent interactions within a molecules in terms of strength (𝜌(𝑟𝑐)), nature 
(∇2𝜌(𝑟𝑐)) and stability (ε).106 
3.5 PARTIAL NUDGED ELASTIC BAND (PNEB) 
Many MD based approach for the study of conformational changes occurring 
along a defined path have been developed, however most of them are 
computationally expensive and require a prior definition of a reaction coordinate 
along which biasing the simulation. This represents a limit for systems involving 
many degrees of freedom. 
A possible alternative is to use chain-of-states methods, where two images are 
used as initial and final seeds, and additional images are generated between them 
and optimized. 
Among these methods, the nudged elastic band (NEB)107,108 allows the 
definition of a minimum energy path of a conformational transition given only 
initial and the final structures and uses multiple simulations of the system, called 
images, to map the conformational change. Indeed, these images are pulled into an 
interpolating path between the two endpoint conformations, then the initial path is 
optimized, by, for example, simulation annealing, to minimize the energy pathway 
and the minimum potential energy path is obtained. The images are connected to 
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their neighbor images by virtual springs, which are needed to force the images to 
stay at an average separation between their partner images along the path.  
In the plain elastic band method spring forces could interfere with the energy 
of each image, because too rigid spring constants cause an image overestimation of 
the energy in the saddle points, determining corner cutting and unresolved saddle 
point structures. Conversely, for weak spring constants, the forces acting on the 
images are too prominent, thus the images slide down the path back to the minima. 
NEB solves this problem by using a tangent vector to the path for decoupling 
the force to a perpendicular component, described by the force field, and a parallel 
component, described by the springs, which are only needed to keep the images 
evenly spaced along the path. Therefore, the force described by the force field is 
only applied perpendicular to the path tangent and, thus, it is projected out from 
each image and not along the path between images. 
Beyond the endpoint structures, which are not submitted to NEB, additional 
images can be chosen as seeds for the initial path, but they are not exempt from 
NEB force calculation. 
Recently, a partial nudged elastic band (PNEB)109 implementation has been 
introduced, allowing the NEB method to be applied to a desired subset of the 
system, whereas the non-NEB part acts as a standard MD simulation. With this 
implementation NEB can be used in large systems where a local transition is 
desired, or in explicitly solvated systems. 
3.6 MOLECULAR MECHANICS POISSON-BOLTZMANN/GENERALIZED 
BORN SURFACE AREA (MMPB/GBSA) 
The drug design process often benefits of computational methods for the 
prediction of binding energies.110,111 Many of these methods are MD-based, 
because MD provides statistically meaningful conformational ensembles for 
thermodynamic calculations in an acceptable computational time. Among the MD-
based methods, Molecular Mechanics Poisson-Boltzmann/Generalized Born 
Surface Area (MMPB/GBSA)112,113 is one of the most popular for drug 
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design/discovery purposes, because of its balance between reliability and 
computational cost.114 
MMPBSA and MMGBSA methods combine molecular mechanics (MM) 
energies, polar and nonpolar solvation contributes, and an entropy term to 
approximate the binding free energy of a ligand to a receptor. More in detail, with 
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Where ∆𝐺𝑏𝑖𝑛𝑑,𝑣𝑎𝑐𝑢𝑢𝑚0  results from the calculation of the average energy of 
interaction between receptor and ligand and by evaluating the entropic contribute, 
usually with normal-mode analysis. Conversely, the solvated free energies of 
complex, receptor and ligand are calculated through the linearized Poisson-
Boltzmann (PB) equation115 or the Generalized Born (GB)116,117 model, as showed 
by eq. 2. PB or GB equations solutions provide the electrostatic contribute (∆𝐺𝑒𝑙) 
to the solvation free energy, which is calculated as the sum of ∆𝐺𝑒𝑙 and a 
nonelectrostatic contribute (∆𝐺𝑛𝑜𝑛𝑒𝑙) considered proportional to the solvent 
accessible surface area (SA).112 
In both the approaches, the solvent is treated implicitly and considered as a 
continuous medium with a certain dielectric constant 𝜖𝑠𝑜𝑙𝑣, which is 80 for water, 
and a low dielectric constant 𝜖𝑖𝑛 is assigned to the solute (usually 𝜖𝑖𝑛 = 1 for 
proteins).  
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where A and n are constants and 𝑟𝑖𝑗𝑛 is the distance between atoms i and j. 
When performing MMPB/GBSA calculations, a fixed number of frames of the 
explicit solvent MD trajectory of the complex is analyzed in order to obtain the 
average of the interaction energies between receptor and ligand, taking each free 
energy component of eq. 1 from the single MD trajectory of the complex. 
However, because of the use of an implicit solvent model, the standard 
MMPB/GBSA approach does not consider the effect on the binding free energy of 
water molecules present at the binding site or at the protein-protein interface, 
which can mediate H-bonds between the receptor and the ligand or between the 
two protein partners, or stabilize the complex.118,119 
A way to overcome this limit is represented by the application of the Nwat-













Part 1:  
Designing well-structured helical peptides 





4 PROTOCOL OPTIMIZATION FOR PEPTIDE FOLDING PREDICTION 
4.1 INTRODUCTION 
As previously evidenced, PPIs occur through the interaction of protein 
domains with a well-defined secondary structure. Therefore, when designing 
peptide modulators of PPIs it is important to verify if they fold in the correct 
conformation. Several efforts has been thus devoted to the design of 
peptidomimetics121 or peptide drugs,122 as well as to the development of 
computational methods for the prediction of the secondary structure of 
peptides73,93,123–125 or mini-proteins.126–129 Indeed, we lately assisted to an 
improvement in computer hardwares130–132 and to the development of enhanced 
sampling methods,103,133,134 aiming to overcome the limit represented by the long 
and CPU intensive simulations needed to extensively sample the conformational 
space of peptides. Among the enhanced sampling techniques, REMD has been 
successfully applied for the prediction of folding behavior of many peptides. 
73,87,93,103
  
However, a limit to the accuracy of REMD simulations in predicting peptide 
secondary structures might be represented by the choice of the molecular 
mechanics force field. The existing force fields have been mostly derived from 
quantum mechanics calculations or from experiments and, recently, new force 
fields were obtained through refinement of old ones in order to improve their 
accuracy.135,136 Therefore, a plethora of force fields differing only in a few 
parameters associated to specific torsion angles is currently available. 
Nevertheless, except for some studies,137–141 the comparison of force fields 
accuracy in predicting peptide folding behavior has been focused on a limited 
number of test systems.142–152 Furthermore, with some exceptions,137,153,154 current 
force fields have been validated by focusing on α-helix and β-hairpin secondary 
structures, with less attention being paid to intrinsically disordered peptides 
(IDPs),137,138,148,149,155 and principally performing the simulations  in explicit 
solvent.140,142–144,146–149,153,156–158 Concerning this latter aspect, REMD simulation 
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time dramatically increases in explicit solvent conditions, thus a large CPU power 
is needed when simulating long peptides or a large number of systems. Therefore, 
in drug discovery the use of an implicit solvent model may be advantageous, as 
long as the secondary structure prediction accuracy is maintained.159–162 
Moreover, although challenging, the accurate modelling of disordered states 
of proteins and peptides is fundamental, since IDPs are involved in important 
biological processes, such as signaling and regulation,163,164 and their 
conformational flexibility can be crucial in mediating PPIs.165,166 
At the light of these considerations, we used REMD simulations to test the 
ability of some AMBER force fields, namely ff96,167 ff99SB,141 ff99SBildn,136 
ff99SBildn-φ,168 ff12SB169 and ff14SB170, and implicit solvation models, namely 
GB-HCT,171 GB-OBC(II)172 and GB-Neck2,173 to reproduce the folding behavior 
of 8 peptides. Among these, the QK VEGF modulator (H1)174 and the Ac-Ala-
Aib-Ala-Aib-Ala-NHMe peptide (H2)175 are known to be helical; the C-terminus 
of protein G (B1, PDB code 2GB1),176 the trpzip2 trypthophan zipper (B2, PDB 
code 1LE1)177 and the N-terminus of ubiquitin (B3, PDB code 1UBQ)178 fold into 
β-hairpins, while Polybia-MPII (ID1),179 the TRTK-12 CapZ peptide (ID2)180 and 
the C-terminus of p53 (ID3)181,182 are IDPs (Table 4.1).  
Table 4.1. Peptides considered for the protocol optimization. 
Peptide Sequence Secondary 
Structure 
Experimental Data 
H1 Ac-KLTWQELYQLKYKGI-NH2 Helix  CD (water, 20 °C, pH 7.1)  
H2 Ac-Ala-Aib-Ala-Aib-Ala-NHMe 310-Helix  X-ray 
B1 GEWTYDDATKTFTVTE β-hairpin NMR (H2O/10% D2O, pH 6.3)  
B2 SWTWENGKWTWK β-hairpin NMR (H2O/8% D2O, pH 5.5)  
B3 QIFVKTLTGKTITLE β-hairpin X-ray 
ID1 INWLKLGKMVIDAL-NH2 IDP CD (water, 25 °C 
ID2 TRTKIDWNKILS IDP NMR (H2O/10% D2O, pH 7.2)  
ID3 Ac-STSRHKKLMTKTE IDP NMR (D2O, 37°C)  
32 
 
In particular, the two latter peptides adopt an α-helical secondary structure 
when bound to S100B protein, while they are IDP in the unbound state,180,181,183 
thus representing an interesting test for the considered force fields and implicit 
solvent models. We decided to study only two helical peptides, because modern 
force fields generally overpopulate the α-region,140 thus we chose to stress more on 
β-hairpin and IDP predictions. 
This study was aimed to identify which is the most reliable combination of 
force field and implicit solvent model for the reproduction of a certain secondary 
structure and to evaluate if a protocol for the prediction of an unknown secondary 
structure can be defined. 
4.2 RESULTS AND DISCUSSION 
 
Figure 4.1. Native structures of peptides H2, B1-B3. 
Helical Peptides. As previously underscored, although the latest force fields 
were specifically developed to provide a better balance between the helical and the 
other conformations by adding specific torsional parameters,136,141,167,169 it has 
been reported that most modern force fields are still biased toward the helical 
structure.140 Therefore, this observation together with the strong helicity of peptide 
H1 explain why all the combinations used for the simulations on peptide H1 led to 
a helical conformation. Indeed, the principal cluster obtained from the analysis of 
the REMD simulations had in all cases a helical representative structure and a 
population (pop%) higher than 50% (Figure 4.2). The only exceptions were 
represented by the combination ff99SBildn-φ/GB-HCT, which gave a helical 
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population of 46.4% and ff99SBildn-φ/GB-Neck2, whose corresponding 
representative structure is only partially folded into a helix. The best results, in 
terms of both helicity of the representative structure of the most populated cluster 
and its pop%, were obtained for the simulations performed using the combinations 
ff96/GB-OBC(II), ff99SB/GB-HCT, ff12SB/GB-Neck2 and ff14SB/GB-OBC(II) 
(Figure 4.2).  
These observations were confirmed by the total DSSP average helical content 
(htot%, Table 4.2), which were all above 60%, except for the analysis of the 
ff99SB/GB-HCT trajectory. In this case, the low htot% (39.9%) was compensated 
by the presence of a significant amount of turn-like structures (26.1%) which are 
however clustered with helical geometries, thus explaining the high pop% obtained 
for the principal cluster. This suggests that the H1 helix is predicted as less stable 
by this combination. Indeed, helical H-bonds occupancies are lower than those 
observed for the other well-performing combinations (Annex 4.A). Moreover, 
DSSP analysis for ff12SB/GB-OBC(II) also provided a htot% (67.9%) as high as 
that obtained for the ff12SB/GB-Neck2 combination, although the population of 
the principal cluster was lower. However, the representative structure of the 
second cluster (Figure 4.3) is still helical at the N-terminus, thus explaining the 




Figure 4.2. Representative structure and populated of the most population cluster from 
the 300.37 K trajectory extracted from REMD simulations of peptide H1. 
 
Figure 4.3. Representative structure and populated of the second cluster from the 
300.37 K trajectory extracted from REMD simulations of peptide H1. 
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Furthermore, both cluster and DSSP analyses showed that the REMD simulations with ff96/GB-
HCT and ff96/GB-Neck2 predicted a significant amount of β-hairpin (Figure 4.3 and Table 4.2), which 
is not consistent with experimental findings.174 
Table 4.2. DSSP analysis of 300.37 K trajectory extracted from REMD simulations of peptide H1. Data are reported as 
averaged percentages. 
Force field/implicit solvent model Para Anti 3-10 Alpha Pi Turn Bend other 
ff96/GB-HCT 1.37 5.78 0.17 34.79 2.01 11.08 11.22 33.56 
ff96/GB-OBC(II) 0.01 0.34 0.08 63.03 0.37 6.16 2.59 27.41 
ff96/GB-Neck2 0.04 8.26 0.05 40.65 0.04 6.73 4.82 39.42 
ff99SB/GB-HCT 0.30 0.16 7.38 32.56 0.49 26.06 6.84 26.21 
ff99SB/GB-OBC(II) 0.01 0.07 6.17 38.50 0.28 20.30 6.39 28.28 
ff99SB/GB-Neck2 0.00 0.03 5.26 39.82 0.22 18.46 5.77 30.44 
ff99SBildn/GB-HCT 0.03 0.13 9.89 26.55 0.33 29.76 7.34 25.97 
ff99SBildn/GB-OBC(II) 0.02 0.34 9.39 26.63 0.21 26.58 7.32 29.51 
ff99SBildn/GB-Neck2 0.01 0.09 8.46 33.84 0.20 19.64 6.74 31.00 
ff99SBildn-φ/GB-HCT 0.01 0.01 8.25 34.39 0.29 27.57 5.30 24.18 
ff99SBildn-φ/GB-OBC(II) 0.01 0.02 7.01 40.96 0.06 21.59 5.17 25.17 
ff99SBildn-φ/GB-Neck2 1.36 0.04 7.51 33.97 0.18 22.55 5.88 28.51 
ff12SB/GB-HCT 0.01 0.00 4.68 52.18 0.14 17.74 2.52 22.73 
ff12SB/GB-OBC(II) 0.01 0.00 1.52 66.39 0.00 12.33 1.14 18.61 
ff12SB/GB-Neck2 0.00 0.00 2.43 63.82 0.03 11.84 1.29 20.59 
ff42SB/GB-HCT 0.03 0.00 6.85 49.10 0.05 21.66 2.99 19.33 
ff42SB/GB-OBC(II) 0.00 0.01 5.34 56.32 0.03 17.51 2.78 18.02 
ff42SB/GB-Neck2 0.00 0.02 6.08 53.42 0.03 16.87 2.50 21.08 
When considering peptide H2, which is shorter and contains the helix stabilizer α-aminoisobutyric 
acid (Aib),184–186 ff96 fails in predicting the helical secondary structure, independently from the 
implicit solvent model. Indeed, in all cases the representative structures of the two most populated 
clusters showed a RMSD from the native-like structure (Figure 4.1) of 2.9 Å or more (Figures 4.4 and 
4.5). These results were confirmed by both the DSSP and H-bond analyses: the former gave htot% < 
10% (Table 4.3) and the latter could not detect H-bonds with ff96/GB-Neck2, and only a weakly 
occupied Aib6→Ala2 H-bond with GB-HCT or GB-OBC(II) (Annex 4.B). 
On the other hand, most of the other representative structures of the principal cluster well 
reproduced the crystallographic structure, although with relatively low pop% (about 40-50%; Figure 
4.4), except for those resulting from the analysis of ff12SB/GB-OBC(II) and ff14SB/GB-HCT 
simulations. However, both DSSP and H-bonds analyses showed that ff12SB and ff14SB with any 
implicit solvent model overestimate the α-helical content at the expense of the 310-helix, while this 





Figure 4.4. Representative structure and population of the most populated cluster from 
the 308.5 K trajectory extracted from REMD simulations of peptide H2. 
 
Figure 4.5. Representative structure and population of the second cluster from the 
308.5 K trajectory extracted from REMD simulations of peptide H2. 
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Table 4.3. DSSP analysis of 308 K trajectory extracted from REMD simulations of peptide H2. Data are reported as 
averaged percentages. 
Force field/implicit solvent model Para Anti 3-10 Alpha Pi Turn Bend other 
ff96/GB-HCT 0.01 0.22 2.60 3.86 0.00 20.86 6.55 65.89 
ff96/GB-OBC(II) 0.01 0.12 2.16 6.88 0.00 18.48 6.23 66.13 
ff96/GB-Neck2 0.00 0.06 0.80 0.56 0.00 11.20 7.63 79.75 
ff99SB/GB-HCT 0.00 0.00 32.42 6.11 0.00 38.11 2.14 21.21 
ff99SB/GB-OBC(II) 0.00 0.00 33.91 5.53 0.00 37.57 2.23 20.75 
ff99SB/GB-Neck2 0.00 0.00 35.97 3.39 0.00 34.15 2.78 23.71 
ff99SBildn/GB-HCT 0.00 0.00 34.20 5.27 0.00 39.10 1.86 19.57 
ff99SBildn/GB-OBC(II) 0.00 0.00 36.25 6.69 0.00 34.66 2.08 20.32 
ff99SBildn/GB-Neck2 0.00 0.01 36.88 2.28 0.00 36.31 2.47 22.06 
ff99SBildn-φ/GB-HCT 0.00 0.00 34.86 5.96 0.00 38.68 1.66 18.84 
ff99SBildn-φ/GB-OBC(II) 0.00 0.00 36.00 6.79 0.00 38.15 1.49 17.57 
ff99SBildn-φ/GB-Neck2 0.00 0.00 37.25 3.34 0.00 35.04 2.11 22.27 
ff12SB/GB-HCT 0.00 0.00 22.87 20.85 0.00 31.52 1.08 23.68 
ff12SB/GB-OBC(II) 0.00 0.00 23.63 17.68 0.00 32.79 1.26 24.64 
ff12SB/GB-Neck2 0.00 0.00 27.70 8.57 0.00 32.35 1.79 29.59 
ff42SB/GB-HCT 0.00 0.00 21.66 18.20 0.00 33.28 1.27 25.58 
ff42SB/GB-OBC(II) 0.00 0.00 24.07 20.35 0.00 31.41 1.05 23.12 
ff42SB/GB-Neck2 0.00 0.00 25.71 8.69 0.00 33.96 1.97 29.67 
Therefore, the structure of medium-to-long natural peptides having a native helical geometry is 
well reproduced by all force field/GB model combinations used. Conversely, short helical peptides 
containing non natural amino acids are well simulated by using any of the ff99SB/ildn/ildn-φ force 
fields coupled with GB-OBC(II) or GB-Neck2 models, since the above combinations provide a 
significant amount of native-like conformations and, at the same time, discriminate well between α- 
and 310-helix, in line with previously reported results.73,93,187 
β-Hairpins Peptides. Because of the helical propensities of modern force fields140,141,188,189 and 
problems in correctly estimating salt bridges given by the implicit solvent models,137,150,151,190,191 the 
prediction of β-hairpins can be more challenging than that of helices. Therefore, it is not surprising that 
most of the REMD simulations performed on peptide B1 failed in predicting the native-like β-hairpin 
conformation,176 as observed from cluster (Figure 4.6), DSSP (Table 4.4) and H-bond (Annex 4.C) 
analyses.  
In detail, DSSP analysis showed that the best, although far from the ideal, results were obtained 
with the ff96/GB-Neck2 simulation, with an anti-parallel β-sheet content of 12.8% and an irrelevant 
htot% (< 1%; Table 4.4). Moreover, none of the H-bonds present in the native-like structure were 
detected by the H-bond analysis, while those actually found where characterized by low occupancies 
(Annex 4.C). An RMSD of 3.6 Å from the native conformation was found for the representative 
structure of the most populated cluster, which is the lowest found among all the simulations of this 
peptide (Figure 4.6) and lower than that reported in the literature for similar studies.137  
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Acceptable results were obtained for ff96/GB-HCT combination, where the second most 
populated cluster had a relevant pop% (39.5%) and a representative structure with a RMSD from the 
native-like peptide of 2.7 Å (Figure 4.7). However, DSSP analysis gave an average anti-parallel β-
sheet content of only 9.7% and a high α-helical content (Table 4.4), which is consistent with results 
from H-bond analysis (Annex 4.C). 
All the other force field/GB model combinations led to worse results, favoring the α/310-helix or 
disordered conformations. The bias toward the helix conformation was particularly strong for the 
simulation with ff14SB coupled to any of the GB models (Table 4.4), suggesting that the use of this 
force field with implicit solvation should be avoided when simulating the folding of β-hairpin peptides. 
Table 4.4. DSSP analysis of 300.37 K trajectory extracted from REMD simulations of peptide B1. Data are reported as 
averaged percentages. 
Force field/implicit solvent model Para Anti 3-10 Alpha Pi Turn Bend other 
ff96/GB-HCT 0.59 9.68 0.15 23.19 0.52 8.78 13.43 43.66 
ff96/GB-OBC(II) 0.55 0.75 0.13 25.58 0.05 7.70 7.99 57.25 
ff96/GB-Neck2 0.01 12.75 0.08 0.33 0.00 10.78 10.77 65.28 
ff99SB/GB-HCT 0.00 0.37 12.90 15.44 0.07 25.38 13.60 32.24 
ff99SB/GB-OBC(II) 0.14 4.01 11.27 12.77 0.02 19.68 12.12 40.00 
ff99SB/GB-Neck2 0.02 0.01 12.38 20.34 0.04 21.46 8.50 37.27 
ff99SBildn/GB-HCT 0.02 2.31 10.57 8.43 0.05 23.67 17.00 37.95 
ff99SBildn/GB-OBC(II) 0.05 0.06 8.53 10.97 0.02 21.73 12.40 46.24 
ff99SBildn/GB-Neck2 0.06 0.18 12.48 11.08 0.02 22.64 9.73 43.82 
ff99SBildn-φ/GB-HCT 0.00 0.05 13.96 12.68 0.03 25.26 14.95 33.08 
ff99SBildn-φ/GB-OBC(II) 0.01 0.00 13.00 13.61 0.02 20.58 11.94 40.84 
ff99SBildn-φ/GB-Neck2 0.00 0.13 14.16 16.07 0.03 22.04 8.75 38.83 
ff12SB/GB-HCT 0.02 0.23 14.34 14.00 0.08 28.84 9.33 33.15 
ff12SB/GB-OBC(II) 0.00 0.04 15.33 13.67 0.09 24.09 7.98 38.80 
ff12SB/GB-Neck2 0.01 0.01 17.38 15.22 0.07 22.13 8.07 37.11 
Ff14SB/GB-HCT 0.00 0.01 5.13 52.67 0.01 10.97 5.28 25.92 
Ff14SB/GB-OBC(II) 0.01 0.00 4.89 45.76 0.00 8.00 4.60 36.75 





Figure 4.6. Representative structure and populated of the most populated cluster from 
the 300.37 K trajectory extracted from REMD simulations of peptide B1. 
 
Figure 4.7. Representative structure and populated of the second cluster from the 
300.37 K trajectory extracted from REMD simulations of peptide B1 
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Our results apparently disagree with those obtained by Shell and coworkers,137 who found that the 
ff96/GB-OBC(II) combination was able to reproduce the native structure of B1. However, their 
REMD simulations were run by using the native structure as the starting conformation and a 10 ns 
length for each replica, with analyses performed on the last ns. Furthermore, NMR studies in water 
showed that the hairpin population of B1 was about 40%.176 Moreover, it has been reported that 
continuum solvent models favors non-native B1 structures, since they push the charged side chains to 
form salt bridges, instead of being fully solvated, thus overwhelming the hydrophobic interactions 
needed to form the β-hairpin.137,151 In detail, the salt bridge between Lys10 and Asp6 brings the latter 
residue, which is near to the β-hairpin turn, in close contact to Lys10, causing the expulsion of Tyr5 
and Phe12 side chains from the hydrophobic core.151 An H-bond between Asp6 and Lys10 with a 
significant occupancy was found in all the simulations except those with GB-Neck2 (Annex 4.C), 
suggesting that this model allows a better description of ion pairing. However, a force field-dependent 
effect altering the salt-bridge populations, as already hypothesized,143 or introducing a conformational 
bias toward helices cannot be excluded. Indeed, ff14SB/GB-Neck2 model gave no salt bridges, but 
still predicted a helical conformation (Table 4.4 and Annex 4.C). We also studied the folding behavior 
of peptide B2, which has been proved to be a stable monomeric β-hairpin by NMR experiments in 
water177. In this case also, most of the force field/GB model combinations failed in predicting the 
native structure. Indeed, except for ff96 coupled to GB-HCT or GB-OBC(II), the representative 
structures of the principal cluster (pop% > 50%) showed a RMSD from the native structure of about 5 
Å or more (Figure 4.8). These results were confirmed by DSSP and H-bond analyses (Table 4.5 and 
Annex 4.D), which evidenced the presence of a reasonable amount of average anti-parallel β-sheet 
content and a negligible helical content for ff96/GB-HCT or GB-OBC(II), while with GB-Neck2 only 
disordered conformations were found. For all the other simulations, it can still be noticed a bias toward 
the helical conformation (htot% > 20%), with a maximum observed for ff14SB with any GB model 
(Table 4.5). However, H-bond analysis evidenced i+3→i or i+4→i H-bonds with occupancies < 30%, 
showing that the preference for the helical secondary structure, although present (Annex 4.D), is less 
marked for this system compared to B1, and probably limited to a force field effect. Indeed, no 
persistent ionic interactions were observed in B2 simulations except those with ff12SB, ff14SB 
coupled to any GB model and, to a minor extent, the one with ff96/GB-HCT (Annex 4.D), where a salt 
bridge between Lys8 and Glu5 was sampled. However, while the two former methods predicted a high 




Figure 4.8. Representative structure and populated of the most populated cluster from 
the 300.37 K trajectory extracted from REMD simulations of peptide B2. 
 
Figure 4.9. Representative structure and populated of the second cluster from the 
300.37 K trajectory extracted from REMD simulations of peptide B2 
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Table 4.5. DSSP analysis of 300.37 K trajectory extracted from REMD simulations of peptide B2. Data are reported as 
averaged percentages. 
Force field/implicit solvent model Para Anti 3-10 Alpha Pi Turn Bend other 
ff96/GB-HCT 1.96 14.08 0.12 4.00 0.22 14.42 17.44 47.76 
ff96/GB-OBC(II) 1.83 10.35 0.11 1.49 0.04 7.40 15.67 63.13 
ff96/GB-Neck2 0.53 3.54 0.06 0.47 0.00 3.21 12.26 79.93 
ff99SB/GB-HCT 0.22 0.36 7.66 13.18 0.14 25.39 13.98 39.08 
ff99SB/GB-OBC(II) 0.18 0.65 9.64 4.26 0.01 19.80 15.90 49.56 
ff99SB/GB-Neck2 0.44 0.40 9.80 8.13 0.01 18.52 13.60 49.11 
ff99SBildn/GB-HCT 0.05 0.41 8.37 15.39 0.16 25.49 12.04 38.09 
ff99SBildn/GB-OBC(II) 0.07 1.19 9.65 7.43 0.05 18.17 17.57 45.87 
ff99SBildn/GB-Neck2 0.24 1.43 10.03 6.97 0.02 19.94 12.28 49.08 
ff99SBildn-φ/GB-HCT 0.06 0.43 10.95 13.90 0.13 26.89 10.97 36.68 
ff99SBildn-φ/GB-OBC(II) 0.00 0.15 14.46 7.21 0.03 20.17 11.70 46.28 
ff99SBildn-φ/GB-Neck2 0.11 0.29 13.83 9.32 0.02 20.21 11.15 45.06 
ff12SB/GB-HCT 0.03 0.03 0.32 13.24 15.79 0.02 24.12 46.43 
ff12SB/GB-OBC(II) 0.02 0.04 14.72 7.68 0.01 20.68 8.16 48.69 
ff12SB/GB-Neck2 0.12 0.60 16.34 6.61 0.02 18.76 8.99 48.57 
ff42SB/GB-HCT 0.02 0.80 14.90 20.48 0.04 20.87 5.62 37.28 
ff42SB/GB-OBC(II) 0.04 0.06 18.07 11.15 0.01 16.43 7.43 46.82 
ff42SB/GB-Neck2 0.01 0.03 17.01 16.87 0.01 13.03 6.30 46.75 
As an additional example of a β-hairpin, we performed REMD simulations on peptide B3, which 
is the N-terminal sequence of ubiquitin.178 Consistently with what observed for B2 and, to a minor 
extent, B1, the best results were obtained with ff96 force field coupled with GB-HCT, although the 
other GB models also gave acceptable performances. In detail, cluster analysis performed on the 
ff96/GB-HCT simulation resulted in a principal cluster with an excellent pop% (92.7%) and a 
representative structure which deviates from the native structure of only 0.95 Ǻ (Figure 4.10). Similar, 
although slightly worse, results were obtained with ff96 and either GB-OBC(II) or GB-Neck2. 
Coherently, DSSP analysis showed that the simulations performed with ff96 had an antiparallel β-sheet 
content of about 20-30%, with the highest and lowest percentages obtained for GB-HCT and GB-
OBC(II), respectively, and an irrelevant htot% (< 2%) (Table 4.6). H-bond analysis of ff96/GB-HCT 
and GB-OBC(II) trajectories evidenced the presence of 5 out of the 6 native H-bonds involving the 
peptide backbone, although with poor occupancies, while none of the native H-bonds was found with 
GB-Neck2 (Annex 4.E). However, it has to be underscored that helical H-bonds were poorly sampled 
as well, while some H-bonds, principally involving Leu14 and Phe3 or Lys5 and Ile12, were 
identified, particularly by using ff96/GB-Neck2 (Annex 4.E). This is indicative of the presence of β-
hairpin-like conformations with the turn between the two β-strands being shifted toward the N-




Figure 4.10. Representative structure and populated of the most populated cluster from 
the 300.37 K trajectory extracted from REMD simulations of peptide B3. 
 
Figure 4.11. Representative structure and populated of the second cluster from the 
300.37 K trajectory extracted from REMD simulations of peptide B3. 
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Contrary to what observed for peptides B1 and B2, ff99SBildn/GB-Neck2 and ff99SB/GB-Neck2 
were also able to reasonably predict a native-like conformation for peptide B3. Indeed, the principal 
cluster (pop% = 38.4%) obtained by the former method and the second cluster (pop% = 42.2%) 
obtained by the latter had a representative structure with rather low RMSDs from the native structure 
(1.01 and 2.45 Ǻ, respectively; Figures 4.10 and 4.11). Furthermore, these force field/GB model 
combinations gave an average antiparallel β-sheet content of about 20%, although a certain amount of 
helix was at the same time found (htot% > 10%; Table S13), coherently with results from H-bond 
analysis (Annex 4.E). 
 
Figure 4.12. Representative structure of the top cluster of the 300.37 K ff96/GB-Neck2 trajectory of peptide B3 (magenta) 
and native structure of peptide B3 (green). 
Table 4.6. DSSP analysis of 300.37 K trajectory extracted from REMD simulations of peptide B3. Data are reported as 
averaged percentages. 
Force field/implicit solvent model Para Anti 3-10 Alpha Pi Turn Bend other 
ff96/GB-HCT 1.01 36.86 0.04 1.98 0.30 7.59 16.73 35.49 
ff96/GB-OBC(II) 0.18 20.64 0.03 0.85 0.04 6.95 19.12 52.18 
ff96/GB-Neck2 0.17 31.43 0.02 0.01 0.00 2.74 15.96 49.68 
ff99SB/GB-HCT 0.01 4.91 6.19 16.71 0.07 26.31 9.19 36.61 
ff99SB/GB-OBC(II) 0.25 11.54 3.38 8.06 0.04 21.15 12.11 43.46 
ff99SB/GB-Neck2 0.04 24.79 5.76 8.41 0.07 17.34 6.49 37.09 
ff99SBildn/GB-HCT 0.06 0.49 8.84 15.43 0.05 27.35 9.20 38.58 
ff99SBildn/GB-OBC(II) 0.04 2.85 4.71 12.12 0.16 21.25 10.75 48.11 
ff99SBildn/GB-Neck2 0.11 20.55 6.21 6.38 0.04 16.59 8.70 41.42 
ff99SBildn-φ/GB-HCT 0.01 1.71 9.79 17.70 0.01 24.64 7.65 38.49 
ff99SBildn-φ/GB-OBC(II) 0.38 1.88 5.40 11.55 0.09 22.12 10.25 48.33 
ff99SBildn-φ/GB-Neck2 0.38 9.26 10.68 12.89 0.04 17.13 8.14 41.48 
ff12SB/GB-HCT 0.01 0.10 11.12 19.09 0.08 20.51 9.23 39.86 
ff12SB/GB-OBC(II) 0.71 1.00 11.44 13.33 0.05 21.45 9.36 42.67 
ff12SB/GB-Neck2 1.37 0.09 16.62 12.16 0.08 20.28 9.45 39.96 
ff42SB/GB-HCT 0.00 0.12 8.21 30.67 0.00 19.71 4.72 36.57 
ff42SB/GB-OBC(II) 0.02 0.18 6.73 33.89 0.02 14.02 5.27 39.86 
ff42SB/GB-Neck2 0.04 0.01 5.23 53.78 0.00 9.64 2.56 28.73 
Except for ff99SB/GB-OBC(II), which also behaved fairly, the other combinations showed a 
preference for the helical conformation, as evidenced by cluster, DSSP and H-bond analyses. This 
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might be due to the combined effect of the force field biases and salt bridges overestimation by the 
implicit solvent model, with ff14SB being the most helical and GB-HCT the most salt bridge 
stabilizer. Indeed, salt bridges between Lys5 or Lys10 and Glu15 were sampled in all simulations 
performed with GB-HCT, except those based on the ff96 force field (Annex 4.E), thus leading to 
misfolded conformations (Figure 4.13).  
 
Figure 4.13. Misfolded conformation of peptide B3 extracted from the 300.37 K trajectory performed with ff14SB and 
GB-HCT. The salt bridge is highlighted with the red arrow. 
At the light of this, we can conclude that the choice of a proper combination of force field and 
solvent model for the prediction of β-hairpins is not trivial and strictly dependent on the system to be 
simulated. Indeed, ff96 force field always gave the best results, but with different GB models (GB-
Neck2, GB-HCT or -OBC(II) and GB-HCT for B1, B2 and B3, respectively). Moreover, while ff12SB 
and ff14SB are clearly not suited for the simulation of β-hairpin peptides in implicit solvent, ff99SB or 
ff99SBildn might represent an alternative to ff96, especially if combined with GB-Neck2.  
Intrinsically Disordered Peptides. As previously underscored, the discrimination of disordered 
from well-structured peptide states is of fundamental interest, because of the role of IDPs in biological 
events.153,154,163–166 Moreover, testing the force field/GB model combinations on IDPs allows a better 
evaluation of their eventual biases toward a particular secondary structure. 
Indeed, when considering ID1, ff96/GB-HCT, GB-OBC(II) and, to minor extent, GB-Neck2 
combinations favored a β-hairpin secondary structure. Cluster analysis performed on the corresponding 
300.37 K trajectories gave a highly populated top cluster whose representative structure is a β-hairpin-
like geometry (Figure 4.14). Moreover, DSSP analysis showed a high amount of β-sheet content, only 
marginally compensated by other secondary structures (Table 4.7) and the radius of gyration profiles 
showed peaks suggesting the presence of compact structures (Figure 4.16). 
Although less intense, the same peaks were observed for ff12SB and ff14SB, which showed a 
helical bias in this case also. Indeed, the representative structure of the most populated cluster (pop% > 
70%) obtained from the analysis of the related trajectories (Figure 4.14) was helical. DSSP analysis 
also gave levels of helical propensity significantly higher than the average percentages of other 
structures (htot% > 40%; Table 4.7). 
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Similar observations can be done for ff99SB and ff99SBildn-φ coupled with GB-HCT or GB-
OBC(II), and for ff99SBildn coupled with GB-OBC(II), although htot% was lower than that observed 
for ff12SB and ff14SB force fields (Table 4.7) and the representative structure of the main clusters 
were not perfectly helical (Figure 4.14). Conversely, ff99SB/GB-Neck2 and ff99SBildn/GB-HCT or 
GB-Neck2 gave a representative structure of the most populated cluster which was helical only at the 
C-terminus, while a β-hairpin was obtained as the representative conformation of the second cluster 
(Figure 4.15), in agreement with the average secondary structure amount obtained by DSSP analysis 
(Table 4.7). The ff99SBildn-φ/GB-Neck2 simulation gave similar results, although a geometry with a 
high helical content was obtained as the representative structure of the principal cluster (Figure 4.14). 
Moreover, H-bond analysis found H-bonds corresponding to both turn- and β-sheet-like conformations 
with moderately low occupancies (Annex 4.F), thus explaining the broader distribution of the radius of 
gyrations profiles (Figure 4.16). 
Therefore, although a trajectory without a detectable amount of defined secondary structures was 
never obtained for ID1, the ff99SB series of force fields provided an acceptable description of a 
disordered conformation. In particular, when using the GB-Neck2 model, the trajectory analyses 
showed a similar amount of helical and β-hairpin content, which can be interpreted as a warning of 
structural instability and a suggestion that the system under study is an IDP. Conversely, ff96, ff12SB 
and ff14SB combined to any GB model not seem to be suited to simulate unstructured peptides. 
The analyses performed on ID2 and ID3 trajectories gave similar results, although some 
differences need to be underlined. First of all, the ff96/GB-OBC(II) combination unexpectedly turned 
out to have a helical preference, very evident for ID2 (Figures 4.17 and 4.18, Table 4.8) and weak for 
ID3 (Figures 4.19 and 4.10, Table 4.9).  
On the contrary, ff96/GB-Neck2 was the best combination in predicting the disordered 
conformation of both ID2 and ID3, as showed by DSSP analysis, where no preferential secondary 
structure was found, by the radius of gyration profile, which had a rather broad distribution (Figure 
4.16), and by the absence of persistent H-bonds (Annexes 4.G and 4.H). The ff99SB, ff99SBildn and 
ff99SBildn-φ force fields coupled with GB-Neck2 also represent an acceptable choice when 




Figure 4.14. Representative structure and populated of the most populated cluster from 
the 300.37 K trajectory extracted from REMD simulations of peptide ID1. 
 
Figure 4.15. Representative structure and populated of the second cluster from the 




Figure 4.16. Frequency of radii if gyrations for the 300.37 K trajectories extracted from the REMD simulations of A) ID1, 
B) ID2, and C) ID3. 
Table 4.7. DSSP analysis of 300.37 K trajectory extracted from REMD simulations of peptide ID1. Data are reported as 
averaged percentages. 
Force field/implicit solvent model Para Anti 3-10 Alpha Pi Turn Bend other 
ff96/GB-HCT 0.42 43.05 0.05 1.11 0.03 11.24 13.61 30.49 
ff96/GB-OBC(II) 0.67 35.28 0.06 2.46 0.30 7.65 13.76 39.82 
ff96/GB-Neck2 0.73 26.89 0.10 1.45 0.01 8.42 12.12 50.28 
ff99SB/GB-HCT 1.18 0.63 6.34 17.99 0.20 30.36 10.25 33.04 
ff99SB/GB-OBC(II) 0.12 0.17 9.77 24.33 0.07 22.87 7.63 35.04 
ff99SB/GB-Neck2 0.11 10.78 8.36 16.91 0.07 20.14 7.68 35.95 
ff99SBildn/GB-HCT 0.42 11.59 5.85 9.42 0.07 27.39 10.44 34.82 
ff99SBildn/GB-OBC(II) 0.68 1.93 10.04 12.02 0.09 23.67 11.10 40.46 
ff99SBildn/GB-Neck2 1.60 5.62 9.76 9.84 0.08 23.48 9.04 40.57 
ff99SBildn-φ/GB-HCT 0.72 1.02 9.55 13.15 0.14 30.67 10.73 34.03 
ff99SBildn-φ/GB-OBC(II) 0.52 2.27 11.39 17.04 0.03 24.15 7.99 36.61 
ff99SBildn-φ/GB-Neck2 0.07 11.39 8.37 8.60 0.03 19.83 10.23 41.48 
ff12SB/GB-HCT 0.05 1.68 6.26 37.97 0.16 23.04 4.34 26.50 
ff12SB/GB-OBC(II) 0.01 0.01 7.10 46.67 0.04 16.32 3.20 26.63 
ff12SB/GB-Neck2 0.01 0.09 9.65 35.31 0.05 18.42 4.99 31.47 
ff42SB/GB-HCT 0.05 0.37 6.97 30.77 0.20 22.70 7.09 31.86 
ff42SB/GB-OBC(II) 0.00 0.01 7.33 43.28 0.06 16.63 3.96 28.72 






Table 4.8. DSSP analysis of 300.37 K trajectory extracted from REMD simulations of peptide ID2. Data are reported as 
averaged percentages. 
Force field/implicit solvent model Para Anti 3-10 Alpha Pi Turn Bend other 
ff96/GB-HCT 0.05 18.77 0.42 6.40 0.03 9.03 23.63 41.67 
ff96/GB-OBC(II) 0.00 0.28 0.13 43.13 0.00 2.28 4.43 49.75 
ff96/GB-Neck2 0.00 1.13 0.21 0.59 0.00 1.34 11.18 85.56 
ff99SB/GB-HCT 0.42 1.64 8.35 7.98 0.00 23.49 17.50 40.62 
ff99SB/GB-OBC(II) 0.00 0.13 4.36 25.73 0.02 19.78 8.47 41.51 
ff99SB/GB-Neck2 0.00 0.21 9.02 10.72 0.01 15.69 8.64 55.71 
ff99SBildn/GB-HCT 0.03 8.29 3.77 8.42 0.02 21.19 18.27 40.02 
ff99SBildn/GB-OBC(II) 0.00 0.33 5.72 5.87 0.01 12.21 20.30 55.56 
ff99SBildn/GB-Neck2 0.53 1.47 7.07 9.99 0.04 13.51 9.14 58.26 
ff99SBildn-φ/GB-HCT 0.09 7.36 7.82 10.56 0.01 20.96 15.27 37.93 
ff99SBildn-φ/GB-OBC(II) 0.00 0.13 7.05 14.39 0.04 14.75 15.03 48.62 
ff99SBildn-φ/GB-Neck2 0.15 0.12 7.13 8.49 0.04 13.05 10.92 60.11 
ff12SB/GB-HCT 0.00 0.89 6.02 19.99 0.01 18.04 13.08 41.97 
ff12SB/GB-OBC(II) 0.04 0.02 5.66 31.32 0.01 10.20 6.70 46.04 
ff12SB/GB-Neck2 0.12 0.53 9.35 23.53 0.04 14.57 5.67 46.20 
ff42SB/GB-HCT 0.03 0.03 7.05 22.56 0.04 24.33 9.24 36.72 
ff42SB/GB-OBC(II) 0.00 0.74 4.83 28.89 0.01 15.63 5.48 44.42 
ff42SB/GB-Neck2 0.02 0.04 6.16 41.49 0.04 9.97 2.49 39.79 
Table 4.9. DSSP analysis of 300.37 K trajectory extracted from REMD simulations of peptide ID3. Data are reported as 
averaged percentages. 
Force field/implicit solvent model Para Anti 3-10 Alpha Pi Turn Bend other 
ff96/GB-HCT 0.36 9.18 0.23 14.26 0.58 8.58 28.11 38.72 
ff96/GB-OBC(II) 0.17 2.37 0.10 5.66 0.06 10.17 21.76 59.71 
ff96/GB-Neck2 0.08 3.21 0.19 4.46 0.01 2.51 10.70 78.84 
ff99SB/GB-HCT 0.89 0.59 9.34 16.06 0.20 26.08 14.10 32.73 
ff99SB/GB-OBC(II) 0.04 0.04 9.83 11.08 0.10 21.26 18.04 39.60 
ff99SB/GB-Neck2 0.16 4.17 8.70 8.06 0.07 18.74 12.26 47.84 
ff99SBildn/GB-HCT 1.79 0.63 7.94 19.66 0.29 26.03 12.86 30.80 
ff99SBildn/GB-OBC(II) 0.00 0.97 8.04 9.20 0.18 20.08 19.81 41.72 
ff99SBildn/GB-Neck2 0.74 1.00 10.34 4.90 0.02 19.52 14.11 49.37 
ff99SBildn-φ/GB-HCT 1.74 0.36 6.69 16.67 0.17 26.01 13.26 35.08 
ff99SBildn-φ/GB-OBC(II) 0.03 0.45 7.52 13.60 0.13 24.55 14.94 38.77 
ff99SBildn-φ/GB-Neck2 0.21 1.65 8.62 5.97 0.05 17.92 15.08 50.52 
ff12SB/GB-HCT 0.13 0.11 5.65 46.71 0.01 15.39 5.21 26.78 
ff12SB/GB-OBC(II) 0.06 1.49 6.99 20.77 0.00 26.65 9.94 34.09 
ff12SB/GB-Neck2 0.30 0.05 10.21 34.93 0.01 16.73 8.95 28.82 
ff42SB/GB-HCT 0.06 0.81 10.36 28.24 0.02 21.32 9.65 29.54 
ff42SB/GB-OBC(II) 0.00 0.04 8.30 19.53 0.09 21.02 15.05 35.98 




Figure 4.17. Representative structure and populated of the most populated cluster from 
the 300.37 K trajectory extracted from REMD simulations of peptide ID2. 
 
Figure 4.18. Representative structure and populated of the second cluster from the 




Figure 4.19. Representative structure and populated of the most populated cluster from 
the 300.37 K trajectory extracted from REMD simulations of peptide ID3. 
 
Figure 4.20. Representative structure and populated of the second cluster from the 
300.37 K trajectory extracted from REMD simulations of peptide ID3 
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4.3 MATERIALS AND METHODS 
REMD simulations. REMD simulations were performed on the selected peptides built with the 
tLEaP module of AMBER 14192 starting from both an extended conformation (φ = ψ = ω = 180°) and 
a misfolded conformation (i.e. β-hairpin for H1 and H2, α-helix for B1-B3 and ID1-ID3), for 
convergence test. The parameters of Aib were obtained from the RED database. For simulations with 
GB-HCT, GB-OBC(II) and GB-Neck2 (igb = 1, 5 and 8, respectively) the bondi, mbondi2 and 
mbondi3 sets of radii were used, respectively. The number of replicas, which were 12 for peptide H2, 
20 for the others, and the temperature ranges were selected through the T-REMD server. Each 
simulation was run with steps of 50 ns until convergence considering all the mentioned combinations 
of force field and solvent model. The trajectories at 308.5 K of the REMD simulations on peptide H2 
and at 300.37 K of all the other simulations were extracted and the analysis were performed on 25 ns 
time intervals to check the convergence. The convergence was checked in terms of frequency of 
RMSD, DSSP analysis, H-bonds occupancies and conformation of the representative structures of the 
two most populated clusters. 
Cluster analyses were conducted with cpptraj sampling one every two frames using the average-
linkage algorithm and the pairwise mass-weighted Root Mean Square Displacement (RMSD) on 
backbone heavy atoms as a metric and requesting five clusters.  
Secondary structure analyses were performed on the basis of DSSP with cpptraj. H-bonds were 
computed with VMD 1.9.1 by setting a donor-acceptor distance threshold of 4.0 Ǻ and an angle cutoff 
of 30° and considering only H-bonds with an occupancy ≥ 5%. Radii of gyration (RoG) of ID1-ID3 




5 MECHANISM OF HELIX SECONDARY STRUCTURE STABILIZATION BY CCTAAS 
5.1 INTRODUCTION 
As previously underlined, the high occurrence of helical motifs at protein-protein interfaces44,45 
leads to the necessity of stabilizing a defined secondary structure, in this case the helix, when 
designing peptide-based PPIs modulators.58 Indeed, it is fundamental to guarantee the correct 
orientation of peptide side chains to allow the interaction with the target protein, resulting in high 
selectivity and specificity.62–64 As already mentioned, a way to stabilize the helix peptide conformation 
is represented by the insertion of CTAAs in the sequence, which can also increase the resistance to 
proteases and peptidases.91 Among the CTAAs, the achiral α-aminoisobutyric acid (Aib) together with 
one of its higher homologues Cα,α-diethylglycine and cyclic derivatives (i.e. 1-aminocyclopropane-1-
carboxylic acid and 1-aminocyclopentane-1-carboxylic acid) are the most studied184–186,193–197 and their 
helical propensity has been attributed to a limitation of the peptide backbone conformational 
freedom.64,193,198,199 However, chiral CTAAs (cCTAAs) have also been synthetized and exploited,93,200–
204
 and configuration at Cα has been observed to affect both the helical stabilization and the screw 
sense preference.93,205–211  
Therefore, the choice of a given cCTAA has to be made depending on both the desired features of 
the cCTAA side chain (i.e. hydrophobicity, acidity, H-bond capability and so on), and the folding 
preference of the cCTAA. At the light of this, it would be important to have intuitive descriptors that 
can be used to predict how a cCTAA can drive the peptide folding or for the comparison of different 
cCTAAs in terms of stabilization efficacy. 
With this aim, using REMD simulations and QTAIM analyses, we investigated the 
conformational behaviour of selected cCTAAs (Figure 5.1) when inserted in the Ac-L-Ala-cCTAA-L-
Ala-Aib-L-Ala-NHMe sequence, a model peptide which have been already used in similar studies.92,126  
 
Figure 5.1. Selection of cCTAAs used for this study. 
We found that the inclusion of cCTAAs in the chosen peptide model limits the backbone freedom 
thanks to at least two complementary mechanisms: 1) steric hindrance mainly located in the (+x,+y,-z) 
sector of the right-handed 3D Cartesian space (Figure 5.2), where the +z → -z axis coincides with the 
N → C helical axis and the cCTAA Cα lies on the +y axis, and 2) the presence of additional 




Figure 5.2. 3D Cartesian space used for the representation of helical peptides containing cCTAAs. The ideal right-handed 
helix of Ac-L-Ala-(1R,2R,4R)-V-L-Ala-Aib-L-Ala-NHMe is shown. 
5.2 RESULTS AND DISCUSSION 
Cluster, DSSP and H-bond analysis (Tables 5.1 and 5.2) performed on the 300 K REMD 
trajectories of peptides 1-15 show that all the peptides, except 8 and 12, mainly fold into a P-helix, as 
indicated by the average population of helical geometries (poph%) obtained from the cluster analysis, 
the DSSP helical content (h%) and the occupancies of i+3→i H-bonds. 
Concerning peptide 8, containing (S)-I, circular dichroism (DC) in MeOH and NMR experiments 
in CD3CN solution already showed that this peptide do not fold into an ordered secondary structure.93 
Conversely, peptide 12, containing (1R,2S,4S)-IV, is the only one having a M-helix as the most 
populated cluster, although a minor amount of M-helix is observable also for peptides 15, 1 and 5 
(cCTAA = Aib, (R)-I and (1S,2R,4R)-IV, respectively). 
Table 5.1. Average Helical Population from Cluster Analysis (poph%) and Average DSSP Helical Content (h%) Obtained 
from the REMD Trajectories of Ac-L-Ala-CTAA-L-Ala-Aib-L-Ala-NHMe Peptides 1-15.a Differences Between Peptides 
Containing CTAAs of Opposite Stereochemistry (Δpoph% and Δh%) are also reported. 
# (R)-cCTAAsb poph% h% # (S)-cCTAAb poph% h% Δpoph% Δh% 
1 (R)-I 43.2±3.3 46.7±1.0 8 (S)-I n.a.c 23.1±1.2 0.5 23.5 
2 (R)-II 85.1±0.9 85.8±0.6 9 (S)-II 76.6±3.1 68.1±1.7 8.5 17.7 
3 (1R,2R,4R)-IIIad 73.3±2.0 80.0±0.2 10 (1S,2S,4S)-IIIad 72.2±1.7 73.6±1.8 1.1 6.4 
4 (1S,2R,4S)-IIIbd 79.7±1.5 82.0±0.7 11 (1R,2S,4R)-IIIbd 90.4±1.8 90.5±0.4 -20.3 -8.5 
5 (1S,2R,4R)-IV 61.9±2.6 56.5±1.4 12 (1R,2S,4S)-IV 30.6±2.7e 35.8±1.1 31.3 20.7 
6 (1R,2R,4R)-V 82.5±1.6 82.9±0.5 13 (1S,2S,4S)-V 84.8±2.1 69.0±0.8 -2.3 +13.9 
7 (R)-VI 83.1±2.4 84.1±1.3 14 (S)-VI 81.6±1.8 73.5±1.1 1.5 10.6 
aThe poph% and h% values obtained from the REMD trajectory of the reference Ac-Ala-Aib-Ala-Aib-AlaNHMe achiral 
peptide 15 are 51.3±4.9 and 51.8±1.2, respectively. bThe stereochemical descriptor refers to the Cα configuration. cThe 
55 
 
representative geometry of the most populated cluster does not correspond to a helix. dExperimental IIIa:IIIb ratio = 
7:1.198,201 eThe representative geometry of the most populated cluster corresponds to a M-helix. 
Table 5.2. H-bond Analysis of REMD Trajectories of Ac-L-Ala-CTAA-L-Ala-Aib-L-Ala-NHMe peptides 1-15 (donor: N-
H; acceptor: C=O).a  
# CTAA donor acceptor occ%  # CTAA donor acceptor occ% 
1 (R)-I Aib4 Ala1 39.00  8 (S)-I Aib4 Ala Aib4 
  Ala5 I 12.94    Ala5 I Ala5 
  Ala5 Ala1 7.11       
2 (R)-II Aib4 Ala1 69.72  9 (S)-II Aib4 Ala1 62.91 
  Ala5 II 57.57    Ala5 II 52.06 
3 (1R,2R,4R)-IIIa Aib4 Ala1 64.15  10 (1S,2S,4S)-IIIa Aib4 Ala1 60.07 
  Ala5 IIIa 47.11    Ala5 IIIa 51.79 
4 (1S,2R,4S)-IIIb Aib4 Ala1 63.84   11 (1R,2S,4R)-IIIb Aib4 Ala1 72.81 
  Ala5 IIIb 58.91    Ala5 IIIb  65.69 
5 (1S,2R,4R)-IV Aib4 Ala1 41.55  12 (1R,2S,4S)-IV Aib4 Ala1 31.89 
  Ala5 IV 25.30    Ala5 IV 38.40 
  Ala5 Ala1 11.20       
6 (1R,2R,4R)-V Aib4 Ala1 65.78  13 (1S,2S,4S)-V Aib4 Ala1 62.08 
  Ala5 V 55.69    Ala5 V 60.69 
7 (R)-VI Aib4 Ala1  70.17  14 (S)-VI Aib4 Ala1 72.60 
  Ala5 VI 60.13    Ala5 VI 54.16 
aThe reference H-bonds occ% obtained from the REMD trajectory of the Ac-Ala-Aib-Ala-Aib-AlaNHMe achiral peptide 
15 are 4→1 45.01%, 5→2 26.55% and 5→1 6.82%. 
Furthermore, from the analyses performed on the 300 K REMD trajectories it can be observed 
that the cCTAAs with the highest ability of helix stabilization are (1R,2S,4R)-IIIb, (R)-II, (R)-VI and 
(1R,2R,4R)-V which, once included in the peptide model, give poph% and h% above 80%.  
It has to be underlined that the stereochemistry at Cα, or better the spatial orientation of the 
substituents at Cα, influences at different extents the ability of each cCTAA to stabilize the helical 
conformation and, therefore, in all the examples a “eutomer”, i.e. the enantiomer having the highest 
stabilization effect, and a “distomer”, i.e. the enantiomer having the poorest stabilization effect, can be 
found. Obviously, the behavior as eutomer or distomer depends on the stereochemistry of the other 
residues in the peptide chain, because L-Ala can affect the peptide conformation. These differences are 
highlighted by the Δpop% and Δh% reported in table 4.1 and are particularly relevant for IV. 
At the light of this, the following discussion is focused on the peptides containing the “eutomers” 
cCTAAs (R)-I, (R)-II, (1R,2R,4R)-IIIa, (1S,2R,4R)-IV, (1R,2R,4R)-V, (R)-VI, (1R,2S,4R)-IIIb. 
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Furthermore, simulations of peptide 1, 5 and 15 (cCTAA = (R)-I, (1S,2R,4R)-IV and Aib, 
respectively) also sampled α-helices, although poorly, as showed by low occupancy i+4→i H-bonds 
(Table 5.2). 
These results were confirmed by 2D-PMF as a function of φ1-ψ2 and φ2-ψ3 dihedral pairs (Figures 
5.3 and 5.4), directly involving the cCTAA and the cCTAA + 1 residues, which show the statistical 
accessibility of these dihedrals pairs in the REMD trajectory. 
In these profiles it can be generally observed the presence of a global minimum corresponding to 
the P-helix, which has wider wells for 2D-PMF(φ2,ψ3), and a local one corresponding to the M-helix, 
with (1R,2R,4R)-V and (1R,2S,4R)-IIIb being the most selective toward the P-helix. Indeed, 2D-PMF 
profiles of peptides 1, 3, 5 and 15 (cCTAA = (R)-I, (1R,2R,4R)-IIIa, (1S,2R,4R)-IV and Aib, 
respectively) showed an additional minima corresponding to β-strands or polyproline helices (Figures 
5.3 and 5.4), while peptide 2 (cCTAA = (R)-II) had an additional minimum in 2D-PMF(φ1,ψ2) in a 
region which is not corresponding to any well-defined secondary structure (-130° ≤ φ1 ≤ -180°; -60° ≤ 
ψ2 ≤ +30°). The 2D-PMF(φ1,ψ2) of peptide 7 (cCTAA = (R)-VI), on the other hand, only showed the 
minima corresponding to the P- and M-helices, but with an apparently lower ΔE if compared to 




Figure 5.3. 2D-PMF profiles (kcal/mol) as a function of φ1-ψ2 dihedral pair obtained 
from REMD simulations of peptides 1-3, 5-7, 11 and 15 containing (R)-I, (R)-II, 
(1R,2R,4R)-IIIa, (1S,2R,4R)-IV, (1R,2R,4R)-V, (R)-VI, (1R,2S,4R)-IIIb and Aib, 
respectively. 
 
Figure 5.4. 2D-PMF profiles (kcal/mol) as a function of φ2-ψ3 dihedral pair obtained 
from REMD simulations of peptides 1-3, 5-7, 11 and 15 containing (R)-I, (R)-II, 





Figure 5.5. PMF profiles (kcal/mol) obtained from REMD simulations of peptides 1-3, 5-7, 11 and 15 containing (R)-I, 
(R)-II, (1R,2R,4R)-IIIa, (1S,2R,4R)-IV, (1R,2R,4R)-V, (R)-VI, (1R,2S,4R)-IIIb and Aib, respectively. Dihedrals associated 
with PMF higher than 6 kcal/mol were not sampled at the 260-335 K range temperature. 
 
Figure 5.6. PMF profiles descriptors. 
A more detailed description of the ΔE associated to the rotation of single dihedrals (e.g. φ1, ψ2, φ2, 
ψ3) is obtained from monodimensional PMF (Figure 5.5). Concerning PMF(φ1) and PMF(φ2) profiles, 
it can be observed that the energy difference between the two helical minima (Figure 5.6, ΔEM) is 
somehow correlated with the h% and the poph% (Table 5.1), which are here used as a measure of the 
helix stabilization ability of the cCTAAs. However, the energy barrier between the minima (Figure 
5.6, ΔEM‡) is quite high, suggesting that the interconversion from P- to M-helix and vice versa is 
unlikely to occur at the simulation time and temperature. This high ΔEM‡ is not observed for the 
PMF(ψ2) and PMF(ψ3), where both ΔEM and ΔEM‡ seem to reflect the h% and the poph%. Moreover, for 
peptides containing Aib, (R)-I and (1S,2R,4R)-IV the barrier for the conversion between helix and β-
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strand can be overcome, suggesting a lower ability in stabilizing the helix secondary structure if 
compared to other cCTAAs here studied. 
In addition, to investigate if the relative helical tendency of cCTAAs is influenced by the presence 
of Aib in the peptide chain, we also simulated the behavior of Ac-L-Ala2-cCTAA-L-Ala2-NHMe 
peptide models, where cCTAA = (R)-I or (1R,2R,4R)-V, which are the worst and the best performing 
cCTAAs, respectively. Table 5.3 shows that both cCTAAs maintain their helical stabilizing ability 
and, most of all, their hierarchy in terms of helical propensity. 
Table 5.3. DSSP Helix Content (h%)a and H-bond analyses of 100 ns REMD Trajectories of Ac-L-Ala2-cCTAA-L-Ala2-
NHMe Pentapeptides 16-17. 
    H-Bond  
# cCTAA h% donor acceptor occ% 
16 (R)-I 42.9±1.4 Ala4 Ala1 32.04 
   Ala5 Ala2 35.85 
   Ala5 Ala1 7.09 
17 (1R,2R,4R)-V 81.9±0.4 Ala4 Ala1 38.81 
   Ala5 Ala2 60.32 
   Ala5 Ala1 5.61 
a Calculated as the sum of 310- and α-helix content of CTAA, averaged with respect to the 25-50, 50-75, 75-100 ns time 
intervals.
 
Although these results give valuable insights about the folding preferences of peptides containing 
cCTAAs, they could not provide an explanation of the mechanisms behind the helix stabilization. It is 
known that cCTAAs’ additional alkyl group at Cα limits the φ1 conformational freedom, although this 
cannot explain the differences in the helix stabilizing ability among sterically similar cCTAAs, such as 
IV and V. The helical conformational preferences of some natural AAs have been suggested to depend 
on side chain entropic and steric factors,212,213 together with the ability to strengthen the helical H-bond 
network.214–218 Consistently, cCTAAs might affect the helical conformation stability by similar 
mechanisms.  
Therefore, for a preliminary investigation of the structure-“activity” relationships of the 
considered cCTAAs, where the “activity” corresponds to the ability in helical conformation 
stabilization/induction, we evaluated the role played by steric hindrance through a 3D quantitative 
structure-property relationship (QSPR) analysis using the PHASE software.219 This is a frequently 
applied medicinal chemistry tool for the derivation of predictive 3D-pharmacophore models, starting 
from a set of compounds with known activity data.220 
We preliminary discarded from this analysis peptides 8 and 12, because a P-helix conformation 
was not found by cluster analysis; then the ideal models of P-helix conformations of peptides 1-7, 9-
11, and 13-15 have been aligned and submitted to a QSPR analysis using the h% values obtained from 
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DSSP as the “activity” field. The obtained results were visualized with a 3D plot, where blue and red 
cubes represent the regions where hydrophobic substituents positively or negatively affect the helical 
content, respectively (Figure 5.7). 
 
Figure 5.7. 3D QSPR plot obtained from PHASE analysis of ideal P-helices of peptides 1-7, 9-11, and 13-15. Blue and red 
cubes correspond to regions where hydrophobic substituents positively and negatively affect the helix content, respectively. 
Peptides 1 (purple), 6 (green) and 11 (orange) are showed as reference. 
It can be observed that a positive effect on the helix stabilization is exerted by the presence of 
hydrophobic substituents in the (+x, +y, ± z) sectors of the Cartesian space, although this is more 
evident for the (+x, +y, -z) sector, probably because the considered peptide models have the cCTAA in 
position 2, thus closer to the N-terminus. Indeed, steric hindrance in this latter sector limits the 
rotational freedom of ψ2, as showed by PMF (Figure 5.5). For example, the best performing cCTAA is 
(1R,2S,4R)-IIIb, which has its aryl group in this sector, while its enantiomer has a lower helix 
stabilizing ability, since its aryl group is located in the (-x, +y, -z) sector. 
Furthermore, (1R,2R,4R)-IIIa, whose side chain points toward the (-x, +y, +z) sector, has both h% 
and poph% lower than those of (1R,2S,4R)-IIIb, together with reduced ΔEM and ΔEM‡ in the PMF 
profiles (Figure 5.5), although its performance is still good. Since the QSPR plot (Figure 5.7) shows 
that steric hindrance in the (-x, +y, +z) sector has limited effects on the helical stability, the lower helix 
stabilizing ability of (1R,2R,4R)-IIIa could be attributed to its reduced steric hindrance in the (+x, +y, 
-z) sector. 
 
Figure 5.8. Modified cCTAAs. 
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In order to prove the validity of the results obtained by the preliminary QSPR analysis, we 
investigated the folding behavior of hypothetical (thus never synthesized) cCTAAs (Figure 5.8), 
structurally related to the actual cCTAAs studied here (Figure 5.1).  
First of all, we evaluated how poph% and h% were affected by the inclusion in the peptide model of 
a modified cCTAA, called (1R,2R,4R)-IIIawr (Figure 5.8), where the aromatic ring of the 
benzoxanorbornene group of (1R,2R,4R)-IIIa was deleted. As expected, the poph% and h% for this 
peptide were equivalent to those of peptide 3 (Tables 5.1 and 5.4). Furthermore, PMF profiles as a 
function of the considered single dihedrals are comparable, except for a slight difference (0.5 kcal/mol) 
in ΔEM in PMF(φ1) and PMF (ψ2) (Figure 5.9). 
Table 5.4. Average helical population (poph%) from cluster analysis, average DSSP helical content (h%) and H-bonds 
occupancies (occ%)obtained from the analysis of the REMD trajectories (308 K) of the Ac-L-Ala-cCTAA-L- Ala-Aib-L-
Ala-NHMe peptides containing modified CTAAs. 
    H-Bond  
cCTAA poph% h% donor acceptor occ% 
(1R,2S,4R)-Vb 84.1 ± 1.7 83.6 ± 0.2 
Aib4 Ala1 66.12 
Ala5 cCTAA 58.1 
(1R,2S,4R)-IIIbwr 84.0 ± 2.4 86.2 ± 0.6 
Aib4 Ala1 69.5 
Ala5 cCTAA 57.3 
(1R,2R,4R)-IIIawr 71.6 ± 1.8 79.1 ± 0.3 
Aib4 Ala1 63.0 
Ala5 cCTAA 44.2 
(1R,2S,4R)-IIIbmb 90.6 ± 1.5 88.8 ± 0.4 
Aib4 Ala1 71.1 
Ala5 cCTAA 66.0 
(1R,2R,4R)-IIIamb 84.2 ± 1.3 83.8 ± 0.3 
Aib4 Ala1 67.4 
Ala5 cCTAA 57.8 
(1R,2S,4R)-Vbdm 91.4 ± 1.3 90.2 ± 0.4 
Aib4 Ala1 71.4 
Ala5 cCTAA 66.2 
(1R,2R,4R)-Vdm 84.5 ± 2.1 83.5 ± 0.9 
Aib4 Ala1 65.9 





Figure 5.9. Comparison of PMF profiles, as a function of φ1, ψ2, φ2 and ψ3 dihedrals, of peptides containing (1R,2R,4R)-
IIIa (black) and (1R,2R,4R)-IIIawr (red). 
 
Figure 5.10. Comparison of PMF profiles, as a function of φ1, ψ2, φ2 and ψ3 dihedrals, of peptides containing (1R,2S,4R)-
IIIb (black) and (1R,2S,4R)-IIIbwr (red). 
The cCTAA (1R,2S,4R)-IIIb was similarly modified, obtaining (1R,2S,4R)-IIIbwr (Figure 5.8). 
This latter residue, once inserted in the peptide model, gave poph% and h% only 6 and 4% lower, 
respectively, than those obtained for peptide 11 (Table 5.4). Moreover, their PMF(φ1), PMF(ψ2) and 
PMF(ψ3) only slightly differ in terms of both ΔEM and ΔEM‡ (Figure 5.10). The differences in helical 
stabilization ability of these two cCTAAs resulted lower than expected, considering their large 
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difference in size, but it can be observed that the H-C=C-H bridge of (1R,2S,4R)-IIIbwr is still located 
in the (+x, +y, -z) sector and the oxo-bridge points toward the (+x, +y, +z) area (Figure 5.11A). 
 
Figure 5.11. A) Superimposed right-handed 310-helices of peptides 3 ((1R,2R,4R,)-IIIa; pink) and Ala-(1R,2S,4R)-IIIbwr-
Ala-Aib-Ala (ochre). B) Superimposed right-handed 310-helices of peptides 11 ((1R,2S,4R)-IIIb; orange) and Ala-
(1R,2S,4R)-Vbdm-Ala-Aib-Ala (purple). 
Successively, we evaluated the role of the oxo or methylene bridge through the comparison of the 
folding behaviors of model peptides containing (1R,2S,4R)-Vb (Figure 5.8), which is the non-isolated 
regioisomer of (1R,2R,4R)-V,221 and (1R,2S,4R)-IIIbwr. Only minor differences can be observed in 
cluster and DSSP analyses (Δpoph% = 1.4 and Δh% = 2.6 in favor of (1R,2S,4R)-IIIbwr) (Table 4.4). 
Consistently, monodimensional PMF profiles were similar, except for an increased ΔEM‡ in PMF(φ1) 
for (1R,2S,4R)-Vb (Figure 5.12), indicating that a P→M helix conversion is disfavored. 
As a further proof, we replaced the oxygen of the oxo-bridge in (1R,2S,4R)-IIIb with a methylene 
group, obtaining (1R,2S,4R)-IIIbmb (Figure 5.8). As expected, we could not observe any significant 
difference in the cluster, DSSP and PMF analyses (Tables 5.1, 5.4 and Figure 5.13), driving to the 
conclusion that the oxo-bridge in the III does not play an important role in the helix stabilization. 
 
Figure 5.12. Comparison of PMF profiles, as a function of φ1, ψ2, φ2 and ψ3 dihedrals, of peptides containing (1R,2S,4R)-




Figure 5.13. Comparison of PMF profiles, as a function of φ1, ψ2, φ2 and ψ3 dihedrals, of peptides containing (1R,2S,4R)-
IIIb (black) and (1R,2S,4R)-IIIbmb (red). 
Subsequently, we evaluated if the positive effect on the helix stabilization of the aryl group of the 
IIIb can be attributed to an electronic effect, due its aromatic nature, or to a simple steric effect. 
Therefore, we compared the folding behavior of peptide 11 (cCTAA = (1R,2S,4R)-IIIb) with that of a 
model peptide containing the hypothetical cCTAA (1R,2S,4R)-Vbdm, bearing a methyl group at C5 
and C6 (Figure 5.8). Cluster and DSSP analyses showed an improvement of about 7% in both poph% 
and h% of (1R,2S,4R)-Vbdm compared to (1R,2S,4R)-Vb, with the former having a behavior 
equivalent to that of (1R,2S,4R)-IIIb. Furthermore, the PMF profiles of (1R,2S,4R)-Vbdm and 
(1R,2S,4R)-IIIb are closely related, although those of (1R,2S,4R)-Vbdm show a more limited 
conformational freedom (Figure 5.14), which can be attributed to the higher steric hindrance parallel to 
the z axis (Figure 5.11B). 
A rather high helical amount, with poph% and h% only 5% lower than those of peptide 11 (cCTTA 
= (1R,2S,4R)-IIIb), was observed for peptide 7, containing (R)-VI. From Figure 5.15A and C it can be 
noticed that only the saturated ring of the tetrahydrocarbazole moiety of (R)-VI is located in the (+x, 
+y, -z) sector, with the remaining part of its side chain lying in the (-x, +y, -z) area. In addition, PMF 
profiles of peptide 7 reproduce those of peptide 11, although lower ΔEM and ΔEM‡ together with an 
increased population in the β-strand region can be observed (Figure 5.14). Consistently, the folding 
behavior of peptide 4, whose poph% and h% are about 10% lower than those of peptide 11, can be 





Figure 5.14. Comparison of PMF profiles, as a function of φ1, ψ2, φ2 and ψ3 dihedrals, of peptides containing (1R,2S,4R)-
IIIb (black), (1R,2S,4R)-Vb (red) and (1R,2S,4R)-Vbdm (green). 
 
Figure 5.15. Front (A, B) and top (C, D) views of superimposed right-handed 310-helices of peptides 7 ((R)-VI; green), 11 
((1R,2S,4R,)-IIIb; orange) and 4 ((1S,2R,4S)-IIIb;magenta). 
Steric hindrance by itself, however, is not enough to explain why structurally unrelated cCTAAs, 
such as (R)-VI, (R)-II and (1R,2R,4R)-V (h% = 84.1, 85.8, and 82.9, respectively) behave similarly, 
and why related cCTAAs, such as (1S,2R,4R)-IV and (1R,2R,4R)-V have significantly different 




Figure 5.15. Superimposed right-handed 310-helices of peptides 2 ((R)-II; cyan), 6 ((1R,2R,4R)-V; blue) and 7 ((R)-VI; 
green) in the Cartesian space. 
Indeed, (R)-VI, (R)-II and (1R,2R,4R)-V have their bulky groups lying in different regions of the 
Cartesian space (Figure 5.16), with only (R)-VI side chain being partially located in the (+x, +y, -z) 
sector. Conversely, the side chain of (1R,2R,4R)-V is lying in the (-x, +y, +z) sector, which should not 
affect the helix stabilization, whereas the indane moiety of (R)-II is located on the +y axis. 
Therefore, other mechanism might be affecting the helix stabilization. Since differences in the H-
bond networks were found to affect helix stability in natural peptides,214,222 we employed QTAIM 
calculations to evidence and evaluate the differences in H-bonding, considering both classical and 
weak H-bonds, in the peptides studied here. 
For all the peptides, focusing on the P-helix conformation, the BCP network comprises the helical 
i +3 → i N-H···O=C BCPs with 𝜌(𝑟𝑐) in the range of classical H-bonds (0.002 – 0.022 au),223,224 a 
positive Laplacian, indicating an electrostatic interaction, and a low ε, proving the stability of H-bonds. 
Furthermore, Cβ-H···O=C i +3 → i BCPs, observed also in natural peptides,214,222 with 𝜌(𝑟𝑐) of 0.003 
– 0.009 au were detected. In addition, in both helical and extended conformations (Table 5.11), it can 
be observed the presence of an additional Aib4 → Ala3 Cβ-H···O=C BCP (Figure 4.1 6) with a 𝜌(𝑟𝑐) = 
0.011 – 0.012 au, a quite high value for a C-H···O interaction involving a hydrogen bound to a sp 3 
carbon. 
Some of the considered peptides, in the P-helical conformation, have peculiar BCP networks 
which can explain well the particular behaviors of (R)-II, (1R,2R,4R)-V and (R)-VI (Tables 5.5, 5.6 
and 5.10). For example, peptide 7 (cCTAA = (R)-VI) has only the BCP network typical of helical 
secondary structures (Table 5.5), with a ∑𝜌(𝑟𝑐) = 0.1002 au. Conversely, peptide 6 (cCTAA = 
(1R,2R,4R)-V) has an additional intra-residue C-H∙∙∙O=C BCP involving the methylene C7-H and the 
backbone carbonyl group of the cCTAA with a 𝜌(𝑟𝑐) = 0.0135 au, corresponding to a strong H-bond 




Figure 5.17. (A) Ball and stick representation and (B) QTAIM molecular graph of the optimized right-handed 310-helical 
conformation of Ac-Ala-(1R,2R,4R)-V-Ala-Aib-Ala-NHMe. The red arrow indicates the intra-residue C-H∙∙∙O. 
This H-bond constrains the ψ2 dihedral to a value corresponding to a P-helix, thus providing an 
additional stabilization to the helical secondary structure of peptide 6. This particular C-H∙∙∙O=C H-
bond can also be observed in the X-ray structure of an Ala-Aib pentapeptide containing at position 2 a 
β-benzylsulfanylnorbornene cCTAA.87,225  
In addition, a ∆∑𝜌(𝑟𝑐) = 0.0153 au, which can be compared to the electronic density of a single 
H-bond, can be observed between peptide 6 and 7 indicating that the strong helical stabilizing ability 
of (1R,2R,4R)-V is due to a strengthening of the H-bond network. Indeed, it has been showed that 
∆∑𝜌(𝑟𝑐) of about 0.0020 au is enough to explain differences in the helical stabilization exerted by 
natural AAs.226 
Table 5.5. Types and properties of BCPs for the Ala-(R)-VI-Ala-Aib-Ala peptide 7 in the P- 310-helical conformation. All 
parameters are reported in a.u. 
N-H∙∙∙O BCP ρ(rc) λ1 λ2 λ3 𝛁𝟐𝛒(𝐫𝐜) ε 
Ala3∙∙∙ACE 0.0187 -0.0217 -0.0205 0.1000 0.0578 0.0585 
Aib4∙∙∙Ala1 0.0198 -0.0233 -0.0219 0.1076 0.0624 0.0639 
Ala5∙∙∙VI 0.0196 -0.0229 -0.0217 0.1062 0.0616 0.0553 
NME∙∙∙Ala3 0.0217 -0.0264 -0.0248 0.1193 0.0681 0.0645 
Σρ(rc) at N-H∙∙∙O 0.0798 




      
Ala3∙∙∙ACE 0.0048 -0.0030 -0.0022 0.0242 0.0190 0.3636 
Aib4∙∙∙Ala3 0.0113 -0.0097 -0.0058 0.0562 0.0407 0.6724 
Ala5∙∙∙VI 0.0043 -0.0032 -0.0022 0.0227 0.0173 0.4545 
Σρ(rc) at C-H∙∙∙O 0.0204 
   
0.0770 
 
Σρ(rc) tot 0.1002 




Table 5.6. Types and properties of BCPs for peptides 5 and 6 in the P-310-helical conformation. All the parameters are 
reported in a.u. 
peptide 5;  
(1S,2R,4R)-IV 
 peptide 6;  
(1R,2R,4R)-V 
 




Ala3∙∙∙Ac 0.0176 0.0542 0.0579 Ala3∙∙∙Ac 0.0174 0.0536 0.0535 
Aib4∙∙∙Ala1 0.0181 0.0562 0.0619 Aib4∙∙∙Ala1 0.0191 0.0598 0.0622 
Ala5∙∙∙IV 0.0190 0.0593 0.0580 Ala5∙∙∙V 0.0193 0.0602 0.0566 
NHMe∙∙∙Ala3 0.0191 0.0594 0.0616 NHMe∙∙∙Ala3 0.0195 0.0606 0.0599 
Σρ(rc) at N-H∙∙∙O 0.0738   0.0753  
Cβ-H∙∙∙O BCP  Cβ-H∙∙∙O BCP  
Ala3∙∙∙Ac 0.0045 0.0178 0.3684 Ala3∙∙∙Ac 0.0045 0.0179 0.3684 
Aib4∙∙∙Ala1 0.0055 0.0218 0.7647 Aib4∙∙∙Ala1 0.0056 0.0223 0.7222 
Aib4∙∙∙Ala3 0.0117 0.0419 0.5373 Aib4∙∙∙Ala3 0.0119 0.0425 0.5000 
IV∙∙∙IV* 0.0126 0.0449 0.4868 V∙∙∙V* 0.0135 0.0476 0.3298 
Ala5∙∙∙IV 0.0046 0.0181 0.3600 Ala5∙∙∙V 0.0047 0.0184 0.3077 
Σρ(rc) at C-H∙∙∙O 0.0389   0.0402  
Σρ(rc) tot 0.1127   0.1155  
*The donor group is C5-H. 
Differences in the strength of the BCP networks can also explain why (1R,2R,4R)-IIIa has a 
worse performance than (1R,2R,4R)-V (Table 5.1), although their side chains occupy the same area of 
the Cartesian space. Indeed, the C-H∙∙∙O=C BCP found in peptide 6 cannot be observed in peptide 3 
and its ∑𝜌(𝑟𝑐) is 0.0131 au less than that of peptide 6 (Table 5.7). Analogous considerations are valid 
for the comparison of the behaviors of peptide 6 and that containing the hypotetical cCTAA 
(1R,2R,4R)-IIIawr (Tables 5.6 and 5.8).  
Table 5.7. Types and properties of BCPs for the Ala-(1R,2R,4R)-IIIa-Ala-Aib-Ala peptide 3 in the P- 310-helical 
conformation. All parameters are reported in a.u. 
N-H∙∙∙O BCPs ρ(rc) λ1 λ2 λ3 𝛁𝟐𝛒(𝐫𝐜) ε 
Ala3∙∙∙ACE 0.0213 -0.0257 -0.0242 0.1160 0.0661 0.0620 
Aib4∙∙∙Ala1 0.0179 -0.0204 -0.0192 0.0951 0.0555 0.0625 
Ala5∙∙∙IIIa 0.0212 -0.0254 -0.0239 0.1167 0.0674 0.0628 
NME∙∙∙Ala3 0.0212 -0.0255 -0.0240 0.1160 0.0665 0.0625 
Σρ(rc) at N-H∙∙∙O 0.0816      
Cβ-H∙∙∙O BCP       
Ala3∙∙∙ACE 0.0051 -0.0026 -0.0017 0.0245 0.0202 0.5294 
Aib4∙∙∙Ala3 0.0111 -0.0094 -0.0056 0.0549 0.0399 0.6786 
Ala5∙∙∙IIIa 0.0046 -0.0034 -0.0023 0.0238 0.0181 0.4783 
Σρ(rc) at C-H∙∙∙O 0.0208      
Σρ(rc) tot 0.1024      
 
Table 5.8. Types and properties of BCPs for the Ala-(1R,2R,4R)-IIIawr-Ala-Aib-Ala peptide in the P-310-helical 
conformation. All parameters are reported in a.u. 
N-H∙∙∙O BCPs ρ(rc) λ1 λ2 λ3 𝛁𝟐𝛒(𝐫𝐜) ε 
Ala3∙∙∙ACE 0.0147 -0.0147 -0.0133 0.0775 0.0495 0.1053 
Ala5∙∙∙Ala1 0.0122 -0.0127 -0.0119 0.0686 0.0440 0.0672 
Ala5∙∙∙IIIawr 0.0030 -0.0014 -0.0011 0.0152 0.0127 0.2727 
NME∙∙∙Ala3 0.0208 -0.0250 -0.0234 0.1131 0.0647 0.0684 
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Aib4∙∙∙ACE 0.0181 -0.0205 -0.0197 0.0999 0.0597 0.0406 
Σρ(rc) at N-H∙∙∙O 0.0688      
Cβ-H∙∙∙O BCP       
Ala3∙∙∙ACE 0.0059 -0.0048 -0.0040 0.0301 0.0213 0.2000 
Aib4∙∙∙Ala1 0.0086 -0.0076 -0.0072 0.0433 0.0285 0.0556 
Aib4∙∙∙Ala3 0.0110 -0.0091 -0.0051 0.0541 0.0399 0.7843 
Ala5∙∙∙IIIawr 0.0025 -0.0016 -0.0012 0.0119 0.0091 0.3333 
Σρ(rc) at C-H∙∙∙O 0.0280      
backbone N∙∙∙O BCPs       
Aib4∙∙∙Ala1 0.0076 -0.0047 -0.0029 0.0318 0.0242 0.6207 
Σρ(rc) tot 0.1044      
In addition, the substitution of the oxygen at position 7 of the (1R,2R,4R)-IIIa benzoxanorbornene 
core by a methylene group (Figure 5.8) seems not to affect helix stability. Indeed, QTAIM analysis of 
the P-helix conformation of the peptide containing (1R,2R,4R)-IIIamb, gave a ∑𝜌(𝑟𝑐) equivalent to 
that of peptide 6 (Tables 5.6 and 5.9) and an intra-residue C-H∙∙∙O=C BCP, involving the cCTAA, with 
a 𝜌(𝑟𝑐) = 0.0137 au. Therefore, this cCTAA resulted to be as strong as (1R,2R,4R)-V in stabilizing the 
helical secondary structure (Tables 5.1 and 5.4). 
Table 5.9. Types and properties of BCPs for the Ala-(1R,2R,4R)-IIIamb-Ala-Aib-Ala peptide in the P-310-helical 
conformation. All parameters are reported in au. 
N-H∙∙∙O BCPs ρ(rc) λ1 λ2 λ3 𝛁𝟐𝛒(𝐫𝐜) ε 
Ala3∙∙∙ACE 0.0198 -0.0233 -0.0220 0.1065 0.0612 0.0591 
Aib4∙∙∙Ala1 0.0191 -0.0221 -0.0208 0.1023 0.0594 0.0625 
Ala5∙∙∙IIIamb 0.0174 -0.0197 -0.0186 0.0927 0.0544 0.0591 
NME∙∙∙Ala3 0.0200 -0.0237 -0.0224 0.1084 0.0623 0.0580 
Σρ(rc) at N-H∙∙∙O 0.0763      
Cβ-H∙∙∙O BCP       
Ala3∙∙∙ACE 0.0048 -0.0028 -0.0020 0.0241 0.0193 0.4000 
Aib4∙∙∙Ala1 0.0057 -0.0033 -0.0018 0.0281 0.0230 0.8333 
Aib4∙∙∙Ala3 0.0116 -0.0101 -0.0064 0.0580 0.0415 0.5781 
IIIamb∙∙∙IIIamb* 0.0137 -0.0128 -0.0093 0.0708 0.0487 0.3763 
Ala5∙∙∙ONBmb2 0.0045 -0.0033 -0.0024 0.0234 0.0177 0.3750 
Σρ(rc) at C-H∙∙∙O 0.0403      
Σρ(rc) tot 0.1166      
*The donor group is C5-H. 
QTAIM analysis performed on peptide 2 (cCTAA = (R)-II) resulted in a ∑𝜌(𝑟𝑐) = 0.1150 au and 
showed a peculiar and strong (𝜌(𝑟𝑐) = 0.0110 au) i+ 1 → i C-H∙∙∙O=C BCP between C7-H of the 
cCTAA aromatic ring and the carbonyl group of Ala1 (Table 5.10). Therefore, (R)-II exerts its helical 
stabilizing effect through the combination of its steric hindrance and this additional C-H∙∙∙O=C H-
bond, although neither of the two features are fully satisfied. Indeed, the steric hindrance of this 
cCTAA is mainly located in the (+x, +y, 0) sector while the 𝜌(𝑟𝑐) of the just described BCP is slightly 
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lower than that observed for (1R,2R,4R)-V. In addition, the PMF(φ1) and PMF(ψ2) profiles of peptides 
6 and 7 (cCTAAs = (1R,2R,4R)-V and (R)-II, respectively) are different, probably because of the 
ability of (1R,2R,4R)-V to form an intra-cCTAA interaction, while (R)-II is involved in a C-H∙∙∙O=C 
interaction with Ala1, resulting in a wider conformational freedom of the cCTAA backbone. 
Table 5.10. Types and properties of BCPs for the Ala-(R)-II-Ala-Aib-Ala peptide 2 in the P-310-helical conformation. All 
parameters are reported in au. 
N-H∙∙∙O BCP ρ(rc) λ1 λ2 λ3 𝛁𝟐𝛒(𝐫𝐜) ε 
Ala3∙∙∙ACE 0.0197 -0.0233 -0.0219 0.1062 0.0610 0.0639 
Aib4∙∙∙Ala1 0.0207 -0.0246 -0.0232 0.1142 0.0664 0.0603 
Ala5∙∙∙II 0.0210 -0.0251 -0.0237 0.1153 0.0665 0.0591 
NME∙∙∙Ala3 0.0210 -0.0253 -0.0239 0.1152 0.0660 0.0586 
Σρ(rc) at N-H∙∙∙O 0.0824      
Cβ-H∙∙∙O BCP       
Aib4∙∙∙Ala1 0.0052 -0.0022 -0.0012 0.0245 0.0211 0.8333 
Aib4∙∙∙Ala3 0.0114 -0.0099 -0.0062 0.0569 0.0408 0.5968 
Ala5∙∙∙II 0.0049 -0.0036 -0.0027 0.0258 0.0195 0.3333 
(Cring-H)II∙∙∙Ala1 0.0111 -0.0103 -0.0093 0.0588 0.0392 0.1075 
Σρ(rc) at C-H∙∙∙O 0.0326      
Σρ(rc) tot 0.1150      
 
The explanation of the differences in the helix stabilizing ability between the structurally related 
(1S,2R,4R)-IV and (1R,2R,4R)-V required the analysis of additional conformations. Indeed, peptide 5 
(cCTAA = (1S,2R,4R)-IV) has a poph% and h% about 20% lower than peptide 6 (cCTAA = (1R,2R,4R)-
V) and peptide 12, containing the (1R,2S,4S)-IV enantiomer, folds into a M-helix, while peptide 13, 
containing (1S,2S,4S)-V, folds into a P-helix (Table 5.1). 
PMF(φ1) and PMF(ψ2) profiles of peptide 5 have ΔEM and ΔEM‡ (Figure 5.6) of about 1 and 1.5 
kcal/mol lower than those of peptide 6, while PMF(φ2) and PMF(ψ3) profiles of peptide 5 show a 
reduction in both ΔEM and ΔEM‡ between the minima corresponding to helical conformations and in 
the ΔE‡ between the helical and the extended conformations (Figure 5.5) and the ψ3 is accessible for 
the whole ±180° interval.  
At the light of this, the lower helix stabilization ability of (1S,2R,4R)-IV can be ascribed to a 
reduced stabilization of the P-helix and/or to an increased stabilization of the extended conformation, 
compared to the related (1R,2R,4R)-V. 
Table 5.11. Types and properties (a.u.) of BCPs for peptides 5 and 6 in the extended conformation. 
peptide 5; 
(1S,2R,4R)-IV  
peptide 6;  
(1R,2R,4R)-V  
N-H∙∙∙O BCPs ρ(rc) 𝛁𝟐𝝆(𝒓𝒄) ε N-H∙∙∙O BCPs ρ(rc) 𝛁𝟐𝝆(𝒓𝒄) ε 
Ala1∙∙∙Ala1 0.0215 0.0914 0.9231 Ala1∙∙∙Ala1 0.0215 0.0912 0.8992 
Ala3∙∙∙Ala3 0.0226 0.0928 0.7113 Ala3∙∙∙Ala3 0.0221 0.0918 0.7879 
Aib4∙∙∙Aib4 0.0273 0.1047 0.3115 Aib4∙∙∙Aib4 0.0276 0.0788 0.3012 
Ala5∙∙∙Ala5 0.0225 0.0921 0.6993 Ala5∙∙∙Ala5 0.0223 0.0919 0.7299 
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IV (Cα)∙∙∙Ala1 0.0173 0.0588 0.1548 V (Cα)∙∙∙Ala1 0.0198 0.0655 0.0950 
IV (C5)∙∙∙Ala1 0.0092 0.0331 0.1905 
    
Aib4(Cβ)∙∙∙Ala3 0.0119 0.0421 0.3210 Aib4(Cβ)∙∙∙Ala3 0.0122 0.0430 0.2727 
Aib4(Cβ)∙∙∙Ala4 0.0121 0.0426 0.3059 Aib4(Cβ)∙∙∙Ala4 0.0116 0.0411 0.3377 
Σρ(rc) at C-H∙∙∙O 0.0505 
 
   0.0436 
 
 
Σρ(rc) tot 0.1444 
 




QTAIM analyses on the P-helix of peptides 5 and 6 resulted in qualitatively similar BCPs (Table 
5.6), however the BCP network of the latter peptide turned out to be of about 0.0030 au stronger than 
that of peptide 5, which has been already considered significant to explain the different helix 
stabilization propensities of natural AAs).214 On the other hand, QTAIM analyses performed on the 
extended conformations of the same peptides (Table 5.11) showed a ∆∑𝜌(𝑟𝑐) = 0.0073 au in favor of 
peptide 5, because its BCP network is characterized by the presence of an additional C-H∙∙∙O=C 
interaction between C5-H and Ala1, which is lacking in the extended conformation of peptide 6 
(Figure 5.18). Consequently, the extended conformation of peptide 5 is relatively more stable than that 
of peptide 6.  
 
Figure 5.18. QTAIM molecular graph of the optimized extended conformation of Ac-Ala-(1S,2R,4R)-IV-Ala-Aib-Ala-
NHMe (A) and Ac-Ala-(1R,2R,4R)-V-Ala-Aib-Ala-NHMe (B). The red arrow indicates the additional C-H∙∙∙O observed 
for the norbornane CTAA -(1S,2R,4R)-IV. 
It has to be underlined that, although the ∑𝜌(𝑟𝑐) are higher for the extended conformations than 
for the P-helices, the BCPs of the extended structures have also higher ε, indicating a lower stability of 
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these interactions if compared to those of the helical conformations and a preference for the helix in 
both cases. 
QTAIM analysis can also explain why (1R,2S,4S)-IV stabilizes the M-helix, while (1S,2S,4S)-V, 
like its enantiomer, stabilizes the P-helix.123 Indeed, peptide 12 (cCTAA = (1R,2S,4S)-IV) has a 
∆∑𝜌(𝑟𝑐) between M- and P-helix of 0.0035 au in favor of the M-helix (Table 4.12). Moreover, the M-
helix conformation has a strong BCP network, although the number of BCP is lower than that of the P-
helix. On the contrary, peptide 13 (cCTAA = (1S,2S,4S)-V) BCP network indicates that the P-helix is 
favored of 0.0059 au compared to the M-helix (Table 5.13). 
Table 5.12. Types and properties of BCPs for the Ala-(1R,2S,4S)-IV-Ala-Aib-Ala peptide 12 in the P- and M- 310-helical 
conformation. All parameters are reported in au. 
peptide 12,  
P-helix 
   peptide 12,  
M-helix 
   
N-H∙∙∙O BCP ρ(rc) 𝛁𝟐𝛒(𝐫𝐜) ε N-H∙∙∙O BCP ρ(rc) 𝛁𝟐𝛒(𝐫𝐜) ε 
Ala3∙∙∙ACE 0.0200 0.0621 0.0580 Ala3∙∙∙ACE 0.0231 0.0736 0.0672 
Aib4∙∙∙Ala1 0.0179 0.0551 0.0628 Aib4∙∙∙Ala1 0.0179 0.0558 0.0567 
Ala5∙∙∙IV 0.0191 0.0598 0.0622 Ala5∙∙∙IV 0.0223 0.0715 0.0664 
NME∙∙∙Ala3 0.0207 0.0647 0.0601 NME∙∙∙Ala3 0.0227 0.0726 0.0646 
Σρ(rc) at N-H∙∙∙O 0.0777   Σρ(rc) at N-H∙∙∙O 0.0860   
Cβ-H∙∙∙O BCP    Cβ-H∙∙∙O BCP    
Ala3∙∙∙ACE 0.0050 0.0197 0.3636 Aib4∙∙∙Ala3 0.0109 0.0395 0.9362 
Aib4∙∙∙Ala1 0.0054 0.0213 0.8125 IV∙∙∙IV* 0.0128 0.0453 0.4557 
Aib4∙∙∙Ala3 0.0120 0.0428 0.4930 Ala5∙∙∙Aib4 0.0107 0.0389 0.8958 
IV∙∙∙IV* 0.0123 0.0435 0.1875     
Ala5∙∙∙IV 0.0045 0.0177 0.3750     
Σρ(rc) at C-H∙∙∙O 0.0392   Σρ(rc) at C-H∙∙∙O 0.0344   
Σρ(rc) tot 0.1169   Σρ(rc) tot 0.1204   
*The donor group is C5-H, the acceptor is C=O 
Table 5.13. Types and properties of BCPs for the Ala-(1S,2S,4S)-V-Ala-Aib-Ala peptide 13 in the P- and M-310-helical 
conformation. All parameters are reported in au. 
Peptide 13, 
P-helix 
   Peptide 13, 
M-helix 
   
N-H∙∙∙O BCP ρ(rc) 𝛁𝟐𝛒(𝐫𝐜) ε N-H∙∙∙O BCP ρ(rc) 𝛁𝟐𝛒(𝐫𝐜) ε 
Ala3∙∙∙ACE 0.0197 0.0610 0.0594 Ala3∙∙∙ACE 0.0225 0.0715 0.0615 
Aib4∙∙∙Ala1 0.0189 0.0587 0.0580 Aib4∙∙∙Ala1 0.0193 0.0603 0.0610 
Ala5∙∙∙V 0.0181 0.0562 0.0564 Ala5∙∙∙V 0.0220 0.0702 0.0677 
NME∙∙∙Ala3 0.0207 0.0646 0.0598 NME∙∙∙Ala3 0.0229 0.0735 0.0639 
Σρ(rc) at N-H∙∙∙O 0.0774   Σρ(rc) at N-H∙∙∙O 0.0867   
Cβ-H∙∙∙O BCP    Cβ-H∙∙∙O BCP    
Ala3∙∙∙ACE 0.0050 0.0196 0.3478 V∙∙∙V* 0.0140 0.0489 0.3069 
Aib4∙∙∙Ala1 0.0054 0.0217 0.8125 Ala5∙∙∙Aib4 0.0107 0.0388 0.8958 
Aib4∙∙∙Ala3 0.0121 0.0432 0.5000     
V∙∙∙V* 0.0129 0.0436 0.1818     
Ala5∙∙∙V 0.0045 0.0178 0.3200     
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Σρ(rc) at C-H∙∙∙O 0.0399   Σρ(rc) at C-H∙∙∙O 0.0247   
Σρ(rc) tot 0.1173   Σρ(rc) tot 0.1114   
*The donor group is C5-H. 
Summarizing, two complementary mechanisms can contribute to the helix stabilization by 
reducing the backbone conformational freedom: the first depends on the steric hindrance exerted by 
the cCTAA in an area parallel to the peptide helix axis and downstream of the cCTAA itself, whereas 
the second consists in the strengthening of the helical H-bond network thanks to peculiar C-H··· O=C 
interactions. Therefore, this knowledge can be exploited to design peptides folding into stable helices, 
although the choice has to be accompanied by the knowledge of the structural requirements for the 
cCTAA side chain. 
5.3 MATERIALS AND METHODS 
REMD simulations. CTAAs were designed using MOE,227 capped respectively with an acetyl 
(Ac) and a NHMe group at the N- and C-termini and submitted to a “Low Mode” conformational 
search (MMFF94x force field, Born solvation, iteration limit = 40000, MM iteration limit = 2500, 
rejection limit = 500). The two lowest energy conformations having φ and ψ dihedrals matching a 
right- or a left-handed helix (φ = ±60°, ψ = ±45°) were selected to derive partial charges with the 
R.E.D.IV software.228 Each geometry was optimized at the HF/6-31G(d) level and two different spatial 
orientations were used to derive orientation- and conformation-independent RESP-A1 charges. Charge 
restraints of −0.4157, 0.2719, 0.5973 and −0.5679 were imposed to the backbone nitrogen, hydrogen, 
carbonyl carbon and oxygen, respectively, as observed for standard AAs in the AMBER ff99SB force 
field.141 
REMD simulations were carried out on each Ac-L-Ala-CTAA-L-Ala-Aib-L-Ala-NHMe peptide 
by starting from an extended conformation (ψ=φ=ω= 180°). 12 replicas were run at temperatures from 
260.00 to 658.94 K, using the ff99SB/GB-OBC(II)172 force field and solvent model combination with 
a simulation time of 250 ns per replica, for a total of 3 μs of simulation for each peptide. REMD 
simulations were conducted with the pmemd module of the Amber12 suite. The trajectories were 
extracted at 308.53 K, unless stated otherwise. The simulation convergence was assessed on the basis 
of cluster analyses performed at 50-100, 100-150, 150-200 and 200-250 ns time intervals. We 
considered a simulation converged when the standard deviation of the main cluster population (σpop%), 
averaged with respect to the different intervals, was below 5%. Cluster analyses were performed with 
ptraj by using the average-linkage algorithm and by sampling one every four frames.192 The pairwise 
mass-weighted root mean squared displacement (RMSD) on Cα was used as a metric and a total of 
five clusters were requested on the basis of pseudo-F statistics and SSR/SST ratio.229 Secondary 
structure analyses were performed by DSSP230 on the 50-250 ns trajectories every Δt = 50 ns, 
coherently with cluster analyses, using the ptraj “secstruct” command. H-bonds were analyzed with 
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VMD 1.9.1231 over the whole 250 ns trajectory, with a donor−acceptor distance threshold of 4.0 Å and 
an angle cutoff of 30°. Only H-bonds with an occupancy (occ%) greater than 5% were considered. 
Mono and bidimensional (2D) Potentials of Mean Force (PMF) were obtained with Amber 
software coupled with the Weighted Histogram Analysis Method (WHAM) and WHAM-2d,232 
respectively. PMF were calculated over the 250 ns trajectory by setting a histogram limit of ±180°, 100 
bins and a tolerance of 0.01. Selected dihedrals (φ1, φ2, ψ2 and ψ3, accordingly to Figure 4.2) were 
obtained from the REMD trajectories at 260, 283, 308 and 335 K. 
QTAIM calculations. Selected geometries were fully optimized with Gaussian09233 at the 
MPWB95/6-31+G(d,p) level,234 a method that had proved reliable in previous studies from our 
group,235 with the CPCM solvation model for water.236 Vibrational analyses were performed at the 
same level to confirm optimized geometries as a minimum (no imaginary frequencies observed) 
(Annex 5.A). QTAIM calculations were performed with AIM2000 on the obtained wave functions.237 
The maximum number of Newton iterations and the step-size were set to 400 and 0.5, respectively, 
while other parameters were left as default. N-H∙∙∙O, C-H∙∙∙O and backbone N∙∙∙O BCPs were analyzed 
and 𝜌(𝑟𝑐), the sign of the Laplacian, and ellipticity (ε) were used to characterize the BCP network in 





6 ORIGIN OF HELIX SCREW SENSE SELECTIVITY BY CCTAAS IN AIB-BASED PEPTIDES 
6.1 INTRODUCTION 
It has just been underlined that enantiomers of cCTAAs can differently affect the stabilization of 
the helical secondary structure. These differences can be poor, as in the case of (1R,2R,4R)-IIIa and its 
enantiomer (1S,2S,4S)-IIIa (Table 5.1), or dramatic, as observed for the (1S,2R,4R)-IV and 
(1R,2S,4S)-IV enantiomers, where the former stabilizes the P-helix and the latter the M-helix in the 
(L)-Ala-Aib pentapeptide model.  
The knowledge of the mentioned different behaviors can be exploited for the design of peptides 
with a desired handedness. Indeed, in some cases it has been observed that the inclusion of even one 
chiral α-AA can be sufficient to favor one screw sense in an otherwise achiral peptide.94,207,209,210,238  
In literature several examples are reported where helices containing cCTAAs with a R 
configuration at Cα have a P-conformation, whereas cCTAAs with S configuration at Cα stabilize M-
helices,93,175,211,239,240 although some exceptions have been found.241–244  
Therefore, it is important to clarify the rationale behind the screw sense selectivity, defined as the 
capability to preferentially stabilize a P- or a M-helix in a peptide. Thus, the same methods used for the 
investigation on helix stabilization (e.g. REMD simulations, PMF and QTAIM analysis) have been 
applied to study the helical screw sense selectivity following the inclusion of selected cCTAAs (Figure 
6.1) in Ac-Aib2-cCTAA-Aib2-NHMe peptide models. This dataset does not include I, because it turned 
out to be a poor helical stabilizer, while other cCTAAs with a norbornane core substituted at C3 (e.g. 
VII and VIII) have been considered, because of the peculiarities observed for IV and V in the 
previous study.72 
 
Figure 6.1. Selected cCTAAs used for the investigation of helical screw sense selectivity. 
Our investigation was focused on the enantiomers found to be selective for the P-helix, because 
this screw sense is the most frequently observed in nature.97,98 
We found that the helical screw sense selectivity toward the P-helix is enhanced by cCTAA steric 
hindrance in the (+x, +y, -z) and (-x, +y, +z) sectors of a right-handed 3D-Cartesian space (Figure 6.2), 
where the P-helix has the same position as in the previous study: the +z → -z axis correspond to the N 
→ C helical axis and the Cα of the cCTAA lies on the +y axis (0, +y, 0). Analogous considerations are 




Figure 6.2. Representative geometry of the most populated cluster obtained from the analysis of the 308 K REMD 
trajectory of Ac-Aib2-(1R,2R,4R)-IIIa-Aib2-NHMe included in the 3D-Cartesian space used for the description. 
Moreover, additional intramolecular C-H··· O=C and backbone N···O interactions, 72,214,222 
together with an overall stabilization or destabilization of noncovalent interactions within a defined 
conformer, can affect the helical screw sense selectivity exerted by cCTAAs. Taking the cue from the 
helical excess (h.e.) evaluated from NMR studies in fast and slow exchange régimes,245 the percentage 
h.e. was here evaluated as the ratio (P% - M%)/(P% + M%), where P% and M% are the P- and the M-
helical populations from cluster analysis of REMD simulations. In this way, a quantitative comparison 
of the screw sense preferences of the selected peptides was provided.86 
In the following discussion, all the considered peptides are identified by an Arabic number 
preceded by R or S according to the Cα cCTAA stereochemistry. All the cCTAAs are indicated with 
their full stereochemical notation followed by the cCTAA name as showed in Figure 6.1. 
6.2 RESULTS AND DISCUSSION 
Table 6.1. Average P-helical (P%) and M-helical (M%) populationsa, average global helical content (H%) and helical 
excess (h.e., %) obtained from cluster analyses of the 308 K REMD trajectories of Ac-Aib2-cCTAA-Aib2-NHMe peptides 
with a preference for the P-helix (R-1, R-2, S-3, R-4, R-5, S-6, R-7, R-8, S-9, S-10) and 11b. 
# cCTAAc P% ± SD M% ± SD H% ± SD h.e. ± SD 
R-1 (R)-II 59.3±1.3 27.5±0.8 86.8±1.5 36.6±1.9 
R-2 (1R,2R,4R)-IIIad 88.7±1.2 1.2±0.4 89.9±1.3 97.3±2.0 
S-3 (1R,2S,4R)-IIIbd 81.0±2.1 13.7±2.9 94.7±3.6 71.1±3.8 
R-4 (1S,2R,4R)-IV 83.2±0.9 4.7±0.3 87.9±0.9 89.3±1.4 
R-5 (1R,2R,4R)-V 76.6±3.0 12.8±2.4 89.4±3.8 71.4±5.3 
S-6 (S)-VI 76.7±3.1 15.2±3.3 91.9±4.5 66.9±4.9 
R-7 (1S,2R,3S,4R)-VIIa 60.1±2.6 n.a 60.1±2.6 100.0±6.1 
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R-8 (1S,2R,3R,4R)-VIIb 78.4±2.0 9.9±1.4 83.3±2.4 77.6±3.5 
S-9 (1S,2S,3S,4R)-VIIIa 45.8±3.1 0.4±0.2  46.2±3.1 98.3±6.7 
S-10 (1S,2S,3R,4R)-VIIIb 85.2±0.9 3.7±0.7 88.9±1.1 91.7±1.3 
aAveraged with respect to the 50-100, 100-150. 150-200, 200-250 ns time intervals. bFor Ac-Aib5-NHMe peptide 11 P% 
= 47.7 ± 3.1, M% = 43.3 ± 3.5, H% = 91.0 ± 4.7 and h.e. < 5%. cThe stereochemical descriptors refers to the Cα 
configuration. dExperimental IIIa:IIIb ratio = 7:1.198,246  
Table 6.2. Average P-helical (P%) and M-helical (M%) populationsa, average global helical content (H%) and helical 
excess (h.e., %) obtained from cluster analyses of the 308 K REMD trajectories of Ac-Aib2-cCTAA-Aib2-NHMe peptides 
with a preference for the M-helix (S-1, S-2, R-3, S-4, S-5, R-6, S-7, S-8, R-9, R-10). 
# CTAAsb P% ± SD M% ± SD H% ± SD h.e.% ± SD 
S-1 (S)-II 27.0±1.6 60.2±2.1 87.2±2.6 -38.1±3.0 
S-2 (1S,2S,4S)-IIIad 1.2±0.2 87.0±2.0 88.2±2.0 -97.3±2.3 
R-3 (1S,2R,4S)-IIIbd 13.5±1.1 81.7±1.9 95.2±2.2 -71.6±2.8 
S-4 (1R,2S,4S)-IV 5.3±0.7 80.7±1.1 86.0±1.3 -87.7±1.5 
S-5 (1S,2S,4S)-V 12.1±1.6 76.5±1.7 88.6±2.3 -72.7±2.6 
R-6 (R)-VI 15.9±3.4 75.8±3.6 91.7±5.0 -65.3±6.4 
S-7 (1R,2S,3R,4S)-VIIa n.a 59.3±1.2 59.3±1.2 -100.0±2.0 
S-8 (1R,2S,3S,4S)-VIIb 12.8±2.3 75.9±1.5 88.7±2.7 -71.1±3.1 
R-9 (1R,2R,3R,4S)-VIIIa 0.2±0.06 41.4±2.0 41.6±2.0 -99.0±6.8 
R-10 (1R,2R,3S,4S)-VIIIb 3.2±0.6 86.0±1.6 89.2±1.7 -92.8±2.6 
aAveraged with respect to the 50-100, 100-150. 150-200, 200-250 ns time intervals. bThe stereochemical descriptors 
refers to the Cα configuration. dExperimental IIIa:IIIb ratio = 7:1.198,246  
Cluster analysis of the 308 K REMD trajectories showed in all cases the presence of both P- and 
M-310-helices (Tables 6.1 and 6.2), except for peptides R-7 and S-7 (cCTAA = (1S,2R,3S,4R)-VIIa 
and (1R,2S,3R,4S)-VIIa, respectively), and R-9 and S-9 (cCTAA = (1R,2R,3R,4S)-VIIIa and 
(1S,2S,3S,4R)-VIIIa, respectively). Only the P-conformation was significantly sampled for R-7 and S-
9 and only the M-helix was observed for S-7 and R-9. This uncommon behavior resulted in a complete 
selectivity for one of the two helical screw senses (h.e. ~ 100%), but P% of peptides R-7 and S-9 and 
M% of peptides S-7 and R-9 were quite low if compared to those observed for the other peptides, a 
poor total helical amount (H%) was obtained (Tables 6.1 and 6.2). For the other peptides, H% was 
greater than 80%, confirming the good-to-excellent helical stabilizing properties of cCTAAs.72 
For peptides reported in Table 6.1 (e.g. R-1, R-2, S-3, R-4, R-5, S-6, R-7, R-8, S-9, S-10) the 
representative structure of the most populated cluster was a P-helix, whereas, as expected, their 
stereoisomers (e.g. S-1, S-2, R-3, S-4, S-5, R-6, S-7, S-8, R-9, R-10; Table 6.2) had the opposite 
behavior. It is obvious that screw sense preference and Cα stereochemistry are somehow related, 
however the obtained data do not indicate any correlation between the absolute configuration of Cα 
and screw sense preference. Although, it has to be noted that opposite configurations, attributed on the 
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basis of a variation in formal Cahn – Ingold – Prelog priorities, do not always reflect a change in the 
spatial orientation of the physicochemical properties of Cα substituents. Thus, for example, peptides 
R-7 and S-9 have similar screw sense preferences but opposite Cα configurations. However, it can be 
observed that the norbornane cores of the two cCTAAs are perfectly superimposable, and the same is 
valid for R-8 and S-10. 
Therefore, focusing on P-helix inducers, except for peptides R-7 and S-9, whose particular 
behavior has already been introduced, cluster analyses indicate that peptides R-2, S-10, and R-4 
(cCTAAs = (1R,2R,4R)-IIIa, (1S,2S,3R,4R)-VIIIb, and (1S,2R,4R)-IV, respectively) are the most 
selective toward the P-helix (h.e. = 97.3 ± 2.0, 91.7 ± 1.3, and 89.3 ± 1.4%, respectively). Conversely, 
the lowest selectivity was observed for peptide R-1 (h.e. = 36.6 ± 1.9%), containing (R)-II, which, 
however, was a good helix stabilizer (Table 5.1),72 suggesting that screw sense selectivity and helix 
stabilization exerted by cCTAAs might follow different mechanisms. As happened in the previous 
study, the structurally related cCTAAs (1S,2R,4R)-IV and (1R,2R,4R)-V showed highly different 
helical screw sense preferences, whose causes will be clarified in the following discussion. 
2D-PMF as a function of φ2-ψ3 and φ3-ψ4 dihedrals pairs (Figures 6.3 and 6.4), which involve the 
cCTAA and cCTAA+1 residues, confirmed the results of cluster analysis and show the effect of the 
presence of the cCTAA on both the upstream and downstream dihedrals. In these profiles, it can be 
always observed the presence of a global and a local minimum. In most of the cases, the former 
corresponds to the P-helix, while the latter corresponds to the M-helix. As expected, the 2D-PMF 
profiles of the Aib pentamer (peptide 11) presented 2 isoenergetic minima, whereas a low ΔEM (the 
energy difference between the minima, Figure 5.6) was observed for peptide R-1 in both the profiles, 
and only in PMF(φ3-ψ4) profiles for peptides R-7 and S-9. On the other side, PMF(φ3-ψ4) profiles of 
these two peptides have the highest energy M-helix minimum with the narrowest well among those 
analyzed, and an additional minimum corresponding to a γ-turn (φ = +75°, ψ = -64°)247 is observable. 
These results are consistent with the absence, for peptides R-7 and S-9, of a significant M-helix 
population which is replaced by a well populated cluster (39.6 ± 2.6% and 53.5 ± 3.2 %, respectively) 
whose representative structure has a P screw sense upstream and a M screw sense downstream of the 
cCTAA (Figure 6.5). Therefore, it seems that both (1S,2R,3S,4R)-VIIa and (1S,2S,3S,4R)-VIIIa are 
able to stabilize the P-helix toward the N-terminus, but they do not seem to induce any screw sense 




Figure 6.3. PMF profiles (kcal/mol) as a function of φ2-ψ3 dihedral pairs obtained from REMD simulations of peptides R-
1, R-2, S-3, R-4, R-5, S-6, R-7, R-8, S-9, S-10 and 11 containing (R)-II, (1R,2R,4R)-IIIa, (1R,2S,4R)-IIIb, (1S,2R,4R)-IV, 
(1R,2R,4R)-V, (S)-VI, (1S,2R,3S,4R)-VIIa, (1S,2R,3R,4R)-VIIb, (1S,2S,3S,4R)-VIIIa, (1S,2S,3R,4R)-VIIIb and Aib, 
respectively. 
 
Figure 6.4. PMF profiles (kcal/mol) as a function of φ3-ψ4 dihedral pairs obtained from REMD simulations of peptides R-
1, R-2, S-3, R-4, R-5, S-6, R-7, R-8, S-9, S-10 and 11 containing (R)-II, (1R,2R,4R)-IIIa, (1R,2S,4R)-IIIb, (1S,2R,4R)-IV, 





Figure 6.5. Front (A and B) and top (C and D) views of representative structures of the second most populated cluster of 
peptides R-7 (A and C) and S-9 (B and D), containing (1S,2R,3S,4R)-VIIa and (1S,2S,3S,4R)-VIIIa highlighted in green. 
This is confirmed by cluster analyses performed on REMD trajectories of Ac-cCTAAs-Aib5-
NHMe peptides (Table 6.3). Indeed, when cCTAA = (1S,2R,3S,4R)-VIIa and (1S,2S,3S,4R)-VIIIa 
(peptides R-25 and S-27), h.e. (6.5 ± 4.8 and -7.7 ± 2.4%, respectively) were only marginally different 
from those obtained for the achiral peptide 11 (Table 6.1), proving that these cCTAAs lose their screw 
sense selectivity if moved from the third position to the N-terminus of the peptide chain. 
Table 6.3. Average P-helical (P%) and M-helical (M%) populations, average global helical content (H%) and helical 
excess (h.e., %) obtained from cluster analyses of the 308 K REMD trajectories of Ac-cCTAA-Aib5-NHMe Peptides. 
# cCTAA P% ± SD M% ± SD H% ± SD h.e. ± SD 
R-19 (R)-II 61.1±3.8 30.0±4.1 91.1±5.6 34.1±6.5 
R-20 (1R,2R,4R)-IIIa 62.2±5.8 28.9±5.6 91.1±8.1 36.6±9.4 
S-21 (1R,2S,4R)-IIIb 70.8±3.5 18.3±3.2 89.1±4.7 58.9±6.2 
R-22 (1S,2R,4R)-IV 67.6±5.7 25.7±2.3 93.3±6.1 44.9±7.2 
R-23 (1R,2R,4R)-V 57.9±1.7 32.7±1.8 90.7±2.5 27.8±2.8 
S-24 (S)-VI 56.3±3.6 34.9±3.6 91.2±5.1 23.5±5.7 
R-25 (1S,2R,3S,4R)-VIIa 48.6±3.4 42.7±2.7 91.3±4.3 6.5±4.8 
R-26 (1S,2R,3R,4R)-VIIb 76.0±5.7 18.4±2.2 94.4±6.1 61.0±7.6 
S-27 (1S,2S,3S,4R)-VIIIa 42.4±1.5 49.5±1.6  91.9±2.2 -7.7±2.4 




It should also be noticed that the other cCTAAs still maintain a certain ability of inducing the P-
helix, however the h.e. of all the Ac-cCTAA-Aib5-NHMe models are reduced. This decrease can be 
attributed to both the loss of the upstream stabilization effect and to a reduced “spatial memory” of the 
cCTAA after 3 – 5 Aib residues along the peptide chain. 
As noticed in the previous work, PMF(φ2-ψ3) and PMF(φ3-ψ4) profiles of peptide 11 showed local 
minima corresponding to β-strands or polyproline-like conformations, whereas for peptides R-4 
(cCTAA = (1S,2R,4R)-IV), R-7 (cCTAA = (1S,2R,3S,4R)-VIIa), R-8 (cCTAA = (1S,2R,3R,4R)-
VIIb), S-9 (cCTAA = (1S,2S,3S,4R)-VIIIa), and S-10 (cCTAA = (1S,2S,3R,4R)-VIIIb) those 
conformations were only observed in PMF(φ3-ψ4). Moreover, as observed while studying the helix 
stabilization mechanism, the PMF(φ2-ψ3) profile of peptide R-1 (cCTAA = (R)-II) has an additional 
minimum at (-130° ≤ φ2 ≤ -180°; -60° ≤ ψ3 ≤ +30°). 
Additional information concerning the rotational energy profile of the single considered dihedrals 
can be obtained by monodimensional PMF (Figure 6.6). 
 
Figure 6.6. PMF profiles from the analyses of trajectories at 260, 283, 308 and 335 K of peptides containing Aib and the 
cCTAAs selective towards the P-helix. Dihedrals associated with PMF higher than 8 kcal/mol were not sampled at the 
selected temperatures. 
In details, PMF(φ2) and PMF(ψ3) have a ΔEM which correlates to h.e., suggesting that φ2 and ψ3 
coordinates are relevant in the P → M interconversion. Moreover, the achiral peptide 11 has a ΔEM = 0 
kcal/mol, while peptides R-7 and S-9 (h.e. ~ 100%) have the highest ΔEM observed for both PMF(φ2) 
(about 3.5 and 3.0 kcal/mol for R-7 and S-9, respectively), and PMF(ψ3) (abut 4.0 and 3.5 kcal/mol for 
R-7 and S-9, respectively). As observed in the previous study, the interconversion barrier ΔEM‡ in 
PMF(φ2) profiles is relatively difficult to overcome at the considered temperatures in all cases, except 
for R-1, S-3 and 11. This suggests that the cCTAAs included in these latter peptides, namely (R)-II, 
(1R,2S,4R)-IIIb and Aib, respectively, have a lower ability in stabilizing the P-helix upstream of the 
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cCTAA itself. Conversely, ΔEM‡ in PMF(ψ3) profiles are low enough to allow the interconversion 
between P- and M-helices for all the considered peptides, although a peculiar trend cannot be clearly 
identified. 
The ΔEM of PMF(φ3) and PMF(ψ4) profiles are lower than those observed for PMF(φ2) and 
PMF(ψ3), although the correlation with h.e. is maintained. R-7 and S-9 are an exception, since their 
cCTAAs lose their P-screw sense selectivity on the downstream dihedrals, as also showed by 2D-PMF 
(Figure 6.4) and REMD simulations performed on Ac-cCTAA-Aib5-NHMe peptide models (Table 
6.3). In addition, peptides 11, R-4, S-6, R-7, R-8, and S-10 (cCTAAs = Aib, (1S,2R,4R)-IV, (S)-VI, 
(1S,2R,3S,4R)-VIIa, (1S,2R,3R,4R)-VIIb, and (1S,2S,3R,4R)-VIIIb, respectively) have PMF(φ3) 
profiles with easily surmountable ΔEM‡, indicating that their cCTAAs exert their P-screw sense 
selectivity mainly upstream of the cCTAA itself (Figure 6.6). 
As previously stated in Chapter 5, PMF analysis provided highlighting information on the helical 
screw sense preferences of the selected cCTAAs, in particular those related to the cCTAAs effects on 
the upstream and downstream dihedrals. However, they do not provide a clear explanation of the 
mechanisms involved in the helical screw sense selectivity.  
Recently, no better specified steric hindrance and geometrical factors have been invoked as a 
possible explanation of screw sense selectivity exerted by cCTAAs,248 however further investigations 
in this directions are required. Therefore, consistent with what done for the study of the helix 
secondary structure stabilization, the effect of steric factors has been preliminarily evaluated through a 
3D QSPR analysis with PHASE,219 by superposing the ideal P-310-helices of peptides R-1, R-2, S-3, 
R-4, R-5, S-6, R-7, R-8, S-9, S-10 and 11 and setting the h.e. as the “activity”. A 3D plot where blue 
and red cubes indicate areas where steric hindrance has a positive and negative effect on the h.e., 
respectively, was obtained (Figure 6.7). 
 
Figure 6.7. Front and top view of 3D plot of QSPR areas obtained through PHASE analysis of peptides R-1, R-2, S-3, R-4, 
R-5, S-6, R-7, R-8, S-9, S-10 and 11. Blue and red cubes represent areas where a steric hindrance has a positive or negative 
effect on the h.e., respectively. Peptides R-1 (orange), R-2 (green) and S-3 (magenta) are shown as a reference. 
From Figure 6.7 it can be observed that hydrophobic substituents in the (-x, +y, +z), (+x, +y, -z) 
and, to minor extent, (+x, +y, +z) sectors of the Cartesian space positively contribute to the P-screw 
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sense selectivity exerted by the cCTAA. Conversely, steric hindrance in the (-x, +y, -z) sector reduces 
the h.e. Indeed, the side chains of the highly performing cCTAAs (h.e. > 60%) are located in the (-x, 
+y, +z) or (+x, +y, -z) sectors, whereas for the least selective cCTAA, namely (R)-II, is predominantly 
located in the (-x, +y, -z) area.  
Following the same procedure previously described (see Chapter 5), hypothetical cCTAAs with 
ad-hoc structural modifications were investigated to confirm or rebut 3D QSPR suggestions (Figure 
6.8). 
 
Figure 6.8. Structurally modified cCTAAs used for the study of mechanisms of helical screw sense 
preferences. 
Therefore, to verify the importance of steric hindrance in the (-x, +y, +z) sector, the excellent 
performing (1R,2R,4R)-IIIa, whose side chain lies on that sector, was modified by deleting its 
aromatic ring, thus obtaining (1R,2R,4R)-IIIawr (Figure 6.8). When included in the Ac-Aib2-cCTAA-
Aib2-NHMe peptide model (peptide R-12), this cCTAA gave a reduction of about 17% in the h.e. 
compared to its parental cCTAA (Table 6.4). PMF profiles as a function of φ2, ψ3, φ3 and ψ4 dihedrals 
became comparable to those of peptide R-5, whose cCTAA ((1R,2R,4R)-V) is structurally related to 
(1R,2R,4R)-IIIawr, except for the methylene bridge instead of the oxo-bridge (Figure 6.9). 
As a counterproof, (1R,2R,4R)-V was modified by adding an aromatic ring, 1R,2R,4R)-Var 
(Figure 6.8), thus increasing its steric hindrance in the (-x, +y, +z) sector. As expected, h.e. increased 
of about 15%, compared to peptide R-5, reaching a h.e. (96.0 ± 3.2%) which is equivalent to that of 
peptide R-2 (cCTAA = (1R,2R,4R)-IIIa). The respective PMF also overlapped (Figure 6.9). 
Table 6.4. Average P-helix (P%) and M-helix (M%) populations, average global helical content (H%) and helical excess 
(h.e.) obtained from cluster analyses performed on the 308 K REMD trajectories of Ac-Aib2-cCTAA-Aib2-NHMe peptides 
12-18. 
# modified CTAA P% ± SD M% ± SD H% ± SD h.e. ± SD 
R-12 (1R,2R,4R)-IIIawr 77.7±3.2 8.7 ±2.1 86.4±3.8 79.9±5.7 
R-13 (1R,2R,4R)-Var 88.7±2.0 1.8 ±0.5 90.5±2.1 96.0±3.2 
R-14 (1R,2R,4R)-Vdm 87.6±1.3 1.0 ±0.4 88.6±1.4 97.7±2.1 
S-15 (1R,2S,4R)-V 87.3±2.1 7.0 ±1.2 94.3±2.4 85.2±3.4 
S-16 (1R,2S,4R)-Vdm 97.0±0.5 2.0 ±0.3 99.0±0.6 96.0±0.8 
S-17 (1R,2S,4R)-IIIbwr 73.6±2.9 20.0 ±1.9 93.6±3.5 57.3±4.3 





Figure 6.9. Comparison of PMF profiles, as a function of φ2, ψ3, φ3 and ψ4 dihedrals, of peptides containing (1R,2R,4R)-
IIIa, (1R,2R,4R)-V, (1R,2R,4R)-IIIawr, (1R,2R,4R)-Var and (1R,2R,4R)-Vdm cCTAAs. 
In order to understand if the positive effect on the helical screw sense selectivity of (1R,2R,4R)-
IIIa and (1R,2R,4R)-Var is ascribable to an electronic effect of the aromatic ring or to its steric 
hindrance, a derivative of (1R,2R,4R)-V, with two methyl groups at C5 and C6, named (1R,2R,4R)-
Vdm (Figure 6.8), was designed. Both the h.e. (Table 6.4) and PMF profiles (Figure 6.9) of the 
corresponding peptide R-14 were comparable to those of peptides R-2 and R-13 (cCTAAs = 
(1R,2R,4R)-IIIa and (1R,2R,4R)-Var, respectively), proving that the contribution to the helical screw 
sense selectivity is principally given by steric hindrance in the (-x, +y, +z) sector. 
An analogous approach was followed to evaluate the role of steric hindrance in the (+x, +y, -z) 
sector. Therefore, the aromatic ring of (1R,2S,4R)-IIIb was deleted, obtaining (1R,2S,4R)-IIIbwr 
(Figure 6.8), which, once included in the peptide model S-17, reduced the h.e. of about 14% compared 
to S-3, which contains the parental cCTAA (Tables 5.2 and 5.4). Conversely, the PMF profiles showed 
only slight differences (Figure 6.9), although a decrease in both ΔEM and ΔEM‡ was observable in all 
the considered PMF profiles for peptide S-17, suggesting that the deletion of the aromatic ring equally 
affects the upstream and downstream dihedrals. 
The stereoisomer (1R,2S,4R)-V (never isolated experimentally) was also studied. Its model 
peptide S-15 unexpectedly gave a h.e. about 14% and 30% higher than that of peptides S-3 (cCTAAs = 
(1R,2S,4R)-IIIb) and S-17 (cCTAAs = (1R,2S,4R)-IIIbwr), respectively (Tables 5.1 and 5.4). 
PMF(ψ3) and PMF(φ3) confirmed these results, because ΔEM and ΔEM‡ computed for S-15 were 0.5-
1.0 kcal/mol higher than those of peptides S-3 and S-17, whereas PMF(ψ4) and PMF(φ2) profiles were 
85 
 
equivalent to those of peptide S-3 (cCTAA = (1R,2S,4R)-IIIb) (Figure 6.10). This indicates that the 
methylene bridge of the norbornene core might play some role in favoring the P-helix. 
 
Figure 6.10. Comparison of PMF profiles, as a function of φ2, ψ3, φ3 and ψ4 dihedrals, of peptides containing (1R,2S,4R)-
IIIb, (1R,2S,4R)-IIIbwr, (1R,2S,4R)-V, (1R,2S,4R)-IIIbmb and (1R,2S,4R)-Vdm cCTAAs. 
Therefore, we analyzed the screw sense preferences of peptide S-18, containing (1R,2S,4R)-
IIIbmb which is derived from (1R,2S,4R)-IIIb by substituted the oxo-bridge with a methylene bridge 
(Figure 6.7). As previously observed, analysis of S-18gave an increased h.e. (93.9 ± 0.9 %) (Tables 5.1 
and 5.4) and PMF profiles showing ΔEM and ΔEM‡ higher than those obtained for peptide S-3 
containing the parent cCTAA (Figure 6.10). 
In this case also, we evaluated if the positive effect on h.e. was due to a steric hindrance or to 
electronic properties of the aromatic ring. Therefore, we studied the behavior of peptide S-16, 
containing (1R,2S,4R)-Vdm which is derived from (1R,2S,4R)-V (Figure 6.7) by addition of two 
methyl groups at C5 and C6. Peptides S-16 and S-18 gave comparable results in terms of h.e. (Table 
6.4) and PMF profiles (Figure 6.10), confirming the positive effect on h.e. is simply due to steric 
hindrance in the (+x, +y, -z) sector. 
The relative importance of steric hindrance in (-x, +y, +z) or (+x, +y, -z) sectors have been 
investigated as well. (1R,2R,4R)-IIIa, whose side chain is located in the (-x, +y, +z) sector, has a h.e. 
25% higher than that of (1R,2S,4R)-IIIb, which, instead, mainly lies in the (+x, +y, -z) sector. 
However, the deletion of the aromatic ring in both cCTAAs led to an equal reduction of the h.e. 
obtained for the corresponding R-12 and S-17 peptides (Table 6.4). 
However, steric hindrance by itself cannot explain the different levels of P-screw sense selectivity 
obtained for structurally related cCTAAs, such as (1R,2R,4R)-IV and (1R,2R,4R)-V or (1R,2R,4R)-V 
and (1R,2R,4R)-IIIawr pairs (Tables 5.1 and 5.4). 
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Since the role of classical and weak H-bonds has been proved as relevant for the stabilization of 
peptide secondary structures,72,214,222 QTAIM analyses were performed in this case also to investigate 
whether differences in H-bond networks of both P- and M-helices could explain the unexpected 
differences in h.e. (Table 6.5). 
Table 6.5. Useful Quantities Derived from QTAIM Calculations  
Symbol Expression Description 
𝜌𝑃 ∑𝜌(𝑟𝑐)𝑃 
BCP total density for a given peptide in P 
conformation 
𝜌𝑀 ∑𝜌(𝑟𝑐)𝑀 
BCP total density for a given peptide in M 
conformation 
∆𝜌𝑃−𝑀 ∑𝜌(𝑟𝑐)𝑃 − ∑𝜌(𝑟𝑐)𝑀 






Difference of BCP total densities between 






Difference of BCP total densities between 
peptides “A” and “B” in M conformation 
∆𝜌𝐴−𝐵 ∆𝐴−𝐵𝜌𝑃 − ∆𝐴−𝐵𝜌𝑀 Difference between two above differences 
In this case also, the BCP network consisted of i + 3 → i N – H··· O=C BCPs with 𝜌(𝑟𝑐) values 
typical for classical H-bonds (0.002 – 0.022 au)223,224 or slightly higher, a positive Laplacian, 
indicating that the nature of the interaction is electrostatic, and a low ε, which indicates stable BCPs. In 
addition, i + 3 → i C – H··· O=C BCPs with 𝜌(𝑟𝑐) higher than those observed in natural peptides214,222 
were found. Moreover, consistent to what reported for some natural peptides,214 N··· O BCP involving 
the backbone of cCTAA and Aib (𝜌(𝑟𝑐) ≈ 0.0120 au) was detected within the P-helix of peptides R-2, 
R-4, R-5, R-7, R-8, and S-10 and within the M-helix of peptide R-1. An analogous interaction, but 
involving Aib4 and Aib2, was found for peptides R-7 and S-9 in the M and P conformations, 
respectively. Additional i + 1 → i (with i ≠ cCTAA) Cβ – H··· O=C BCPs (𝜌(𝑟𝑐) = from 0.0102 to 
0.0126 au) were present between Aib5 and Aib4 in all peptides, and between Aib2 and Aib1 only in 
the P-helix of peptides R-2, R-4, R-5, R-7, R-8, and S-10 and in the M-helix of peptide R-1 (Figure 
6.11). Furthermore, peculiar BCPs involving the cCTAAs were detected in all cases and will be 




Figure 6.11. (A and C) Ball-and-stick representation and (B and D) QTAIM molecular graph of the optimized P- (top) and 
M- (bottom) 310-helix of Ac-Aib2-(1S,2R,4R)-IV-Aib2-NHMe peptide 
As previously observed, R-4 and R-5 peptides (cCTAAs = (1S,2R,4R)-IV and (1R,2R,4R)-V, 
respectively) had significantly different h.e., although their cCTAAs are structurally similar. QTAIM 
analyses performed on their P-helices (Tables 5.6 and 5.7) gave similar BCP total densities (∆4−5𝜌𝑃 = 
0.0004 au), although peptide R-4 had an additional C – H··· O=C BCP between the C5 of (1S,2R,4R)-
IV and the carbonyl oxygen of the acetyl cap (𝜌(𝑟𝑐) = 0.0037 au). Conversely, the same analysis 
performed on the M-helices provided qualitatively equivalent BCP networks, but a higher difference in 
BCP total density for peptide R-5 (∆4−5𝜌𝑀 = -0.0027 au). In addition, the differences in electronic 
densities between P- and M-helices ∆𝜌𝑃−𝑀 of peptides R-4 and R-5 were of 0.0182 and 0.0151 au, 
respectively, with a ΔΔρ of 0.0031 au. At the light of this, it can be concluded that the P-screw sense 
selectivity exerted by (1S,2R,4R)-IV and (1R,2R,4R)-V is increased by rather strong C – H··· O=C 
interactions involving the cCTAA, and the higher h.e. showed by peptide R-4 is ascribable to a lower 
stabilization of noncovalent interactions in the M-helix compared to peptide R-5. Indeed, a ∆𝜌𝑀 of 
about 0.0030 au was considered sufficient to explain differences in helical stability observed in natural 
peptides.214,222 
Table 6.6. Types and properties of BCPs of the Ac-Aib2-(1S,2R,4R)-IV-Aib2-NHMe peptide R-4 in the P- and M-helix 
conformation. All parameters are reported in au. 
Peptide R-4, 
P-helix    
Peptide R-4, 
M-helix    
N-H∙∙∙O BCP ρ(rc) 𝛁𝟐𝛒(𝐫𝐜) ε N-H∙∙∙O BCP ρ(rc) 𝛁𝟐𝛒(𝐫𝐜) ε 
IV∙∙∙Ac 0.0203 0.0636 0.0580 IV∙∙∙ACE 0.0170 0.0531 0.0795 
Aib4∙∙∙Aib1 0.0197 0.0620 0.0502 Aib4∙∙∙Aib1 0.0213 0.0676 0.0583 
Aib5···Aib2 0.0185 0.0580 0.0603 Aib5···Aib2 0.0161 0.0502 0.0473 
NMe∙∙∙IV 0.0215 0.0687 0.0612 NMe∙∙∙IV 0.0220 0.0704 0.0677 
Σρ(rc) at NH∙∙∙O 0.0800 
  




   
Cβ-H∙∙∙O BCP    
IV(C3-H)∙∙∙Ac 0.0101 0.0370 0.0833 IV(C6-H)∙∙∙Ac 0.0080 0.0281 0.1034 
IV(C5-H)∙∙∙Ac 0.0037 0.0135 0.6250 Aib5∙∙∙Aib2 0.0055 0.0217 0.5714 
Aib2∙∙∙Aib1 0.0104 0.0379 0.8085 IV(C7-H∙∙∙IV 0.0136 0.0461 0.1574 
Aib5∙∙∙Aib2 0.0055 0.0220 0.5238 Aib4∙∙∙IV 0.0118 0.0427 0.8704 
IV(C7-H)∙∙∙IV 0.0114 0.0412 0.8269 Aib5∙∙∙Aib4 0.0123 0.0436 0.4474 
Aib5∙∙Aib4 0.0126 0.0445 0.4304 
  
  
Σρ(rc) at C-H∙∙∙O 0.0537 
  




    
IV∙∙∙Aib1 0.0121 0.0385 0.9394     




Σρ(rc) tot 0.1458 
  
Σρ(rc) tot 0.1276   
 
Table 6.7. Types and properties of BCPs of the Ac-Aib2-(1R,2R,4R)-V-Aib2-NHMe peptide R-5 in the P- and M-helix 
conformation. All parameters are reported in au. 
peptide R-5, 
P-helix 
   
peptide R-5, 
M-helix 
   
N-H∙∙∙O BCP 𝝆(𝒓𝒄) 𝛁𝟐𝝆(𝒓𝒄) ε N-H∙∙∙O BCP 𝝆(𝒓𝒄) 𝛁𝟐𝝆(𝒓𝒄) ε 
V∙∙∙ACE 0.0199 0.0620 0.0548 V∙∙∙ACE 0.0176 0.0551 0.0707 
Aib4∙∙∙Aib1 0.0197 -0.0343 0.0455 Aib4∙∙∙Aib1 0.0216 0.0688 0.0571 
Aib5···Aib2  0.0195 0.0612 0.0660 Aib5···Aib2  0.0168 0.0521 0.0565 
NMe∙∙∙V 0.0217 0.0697 0.0605 NMe∙∙∙V 0.0219 0.0699 0.0640 
∑𝝆(𝒓𝒄)  at N-H∙∙∙O 0.0808   ∑𝝆(𝒓𝒄)  at N-H∙∙∙O 0.0779   
Cβ-H∙∙∙O BCP    Cβ-H∙∙∙O BCP    
V(C3-H)∙∙∙Ac 0.0100 0.0369 0.0941 V(C6-H)∙∙∙Ac 0.0091 0.0324 0.1370 
Aib2∙∙∙Aib1 0.0102 0.0374 0.9070 Aib5∙∙∙Aib2 0.0055 0.0218 0.5238 
Aib5∙∙∙Aib2 0.0055 0.0220 0.5238 V(C7-H)∙∙∙V 0.0138 0.0462 0.1441 
V(C7-H)∙∙∙V 0.0139 0.0488 0.3333 Aib4∙∙∙V 0.0116 0.0422 0.9038 
Aib5∙∙Aib4 0.0126 0.0448 0.4250 Aib5∙∙∙Aib4 0.0124 0.0439 0.4231 
∑𝝆(𝒓𝒄) at C-H∙∙∙O 0.0522   ∑𝝆(𝒓𝒄) at C-H∙∙∙O 0.0524   
N∙∙∙O CPs        
V∙∙∙Aib1 0.0124 0.0394 0.8611 
    
∑𝝆(𝒓𝒄) at N∙∙∙O 0.0124       
∑𝝆(𝒓𝒄) tot 0.1454   ∑𝝆(𝒓𝒄) tot 0.1303   
 
Similarly to what observed for peptide R-4, peptide R-2 in the P conformation showed a very 
strong noncovalent interactions network (Table 6.8), although not directly involving (1R,2R,4R)-IIIa. 
At the same time, the steric hindrance of this cCTAA in the (-x, +y, +z) sector is larger than that of 
(1S,2R,4R)-IV; therefore, the complete fulfilment of steric requirements together with the 
strengthening of noncovalent interactions selectively in the P-helical conformation made (1R,2R,4R)-
IIIa one of the best performing cCTAAs in terms of screw sense selectivity. 
Indeed, (1R,2R,4R)-IIIa also exerted a screw sense selectivity higher than that of its Cα epimer 
(1R,2S,4R)-IIIb (Table 6.1, Δh.e. ~ 26%), although steric hindrance in (-x, +y, +z) or in (+x, +y, -z) 
was found to equally affect the h.e. Conversely, QTAIM analysis performed on both R-2 and S-3 
peptides (cCTAAs = (1R,2R,4R)-IIIa and (1R,2S,4R)-IIIb, respectively) showed that this latter peptide 
had a significantly lower 𝜌𝑃 (∆2−3𝜌𝑃 = 0.0165 au) and a higher 𝜌𝑀 (∆2−3𝜌𝑀 = -0.0121 au) than 
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peptide R-2, although they have qualitatively similar BCP networks (Tables 5.8 and 5.9). In other 
words, the decrease in h.e. of peptide S-3 is explained by observing that this peptide in the P-
conformation has a less stable noncovalent interaction network than peptide R-2, whereas the stability 
of its interactions is higher in the M-conformation.  
It is important to underline that, although peptide S-3 showed a 𝜌𝑀 higher than 𝜌𝑃, DFT 
calculations performed at the CPCM-mPW1B95/6-31+G(d,p) level gave a ∆𝐸𝑃−𝑀 = -2.8 kcal/mol. 
This result suggests that the P-conformation of peptide S-3 is anyway more stable than its M-
conformation, probably because of the cCTAA side chain steric hindrance correctly located in the (+x, 
+y, -z) sector (Annex 6.A). 
Table 6.8. Types and properties of BCPs of the Ac-Aib2-(1R,2R,4R)-IIIa-Aib2-NHMe peptide R-2 in the P- and M-helix 
conformation. All parameters are reported in au. 
peptide R-2, 
P-helix 
   
peptide R-2, 
M-helix 
   
N-H∙∙∙O BCP 𝝆(𝒓𝒄) 𝛁𝟐𝝆(𝒓𝒄) ε N-H∙∙∙O BCP 𝝆(𝒓𝒄) 𝛁𝟐𝝆(𝒓𝒄) ε 
III∙∙∙Ac 0.0223 0.0703 0.0630 III∙∙∙Ac 0.0138 0.0445 0.0815 
Aib4∙∙∙Aib1 0.0216 0.0679 0.0484 Aib4∙∙∙Aib1 0.0202 0.0642 0.0580 
Aib5···Aib2 0.0159 0.0495 0.0545 Aib5···Aib2 0.0163 0.0508 0.0526 
NMe∙∙∙III 0.0234 0.0754 0.0623 NMe∙∙∙III 0.0205 0.0650 0.0652 
∑𝝆(𝒓𝒄) at N-H∙∙∙O 0.0832   ∑𝝆(𝒓𝒄)  at N-H∙∙∙O 0.0708   
Cβ-H∙∙∙O BCP    Cβ-H∙∙∙O BCP    
III(C3-H)∙∙∙Ac 0.0104 0.0370 0.1111 III(Car-H)∙∙∙Ac 0.0113 0.0376 0.1515 
Aib2∙∙∙Aib1 0.0112 0.0401 0.5410 Aib4∙∙∙Aib1 0.0067 0.0267 0.6667 
Aib4∙∙∙Aib1 0.0056 0.0226 1.0000 Aib5∙∙∙Aib2 0.0055 0.0218 0.6842 
Aib5∙∙∙Aib2 0.0051 0.0204 0.7059 Aib4∙∙∙III 0.0126 0.0453 0.6471 
Aib5∙∙Aib4 0.0119 0.0423 0.4789 Aib5∙∙∙Aib4 0.0122 0.0434 0.4533 
∑𝝆(𝒓𝒄) at C-H∙∙∙O 0.0442   ∑𝝆(𝒓𝒄) at C-H∙∙∙O 0.0483   
N∙∙∙O BCP        
III∙∙∙Aib1 0.0113 0.0351 0.2564 
    
∑𝝆(𝒓𝒄) at N∙∙∙O 0.0113       
∑𝝆(𝒓𝒄) tot 0.1387   ∑𝝆(𝒓𝒄) tot 0.1191   
 
Table 6.9. Types and properties of BCPs of the Ac-Aib2-(1R,2S,4R)-IIIb-Aib2-NHMe peptide S-
3 in the P- and M-helix conformation. All parameters are reported in au. 
peptide S-3, 
P-helix 
   
peptide S-3, 
M-helix 
   
N-H∙∙∙O BCP 𝝆(𝒓𝒄) 𝛁𝟐𝝆(𝒓𝒄) ε N-H∙∙∙O BCP 𝝆(𝒓𝒄) 𝛁𝟐𝝆(𝒓𝒄) ε 
III∙∙∙Ac 0.0213 0.0673 0.0583 III∙∙∙Ac 0.0212 0.0666 0.0546 
Aib4∙∙∙Aib1 0.0187 0.0594 0.0588 Aib4∙∙∙Aib1 0.0193 0.0608 0.0519 
Aib5···Aib2 0.0178 0.0555 0.0582 Aib5···Aib2 0.0178 0.0558 0.0635 
NMe∙∙∙III 0.0214 0.0680 0.0617 NMe∙∙∙III 0.0212 0.0672 0.0625 
∑𝝆(𝒓𝒄)  at N-H∙∙∙O 0.0792   ∑𝝆(𝒓𝒄) at N-H∙∙∙O 0.0795   
Cβ-H∙∙∙O BCP    Cβ-H∙∙∙O BCP    
C1H(III)∙∙∙Ac 0.0087 0.0335 0.0857 C3H(III)∙∙∙Ac 0.0103 0.0376 0.1011 
Aib4∙∙∙Aib1 0.0051 0.0204 0.7692 Aib5∙∙∙Aib2 0.0052 0.0206 0.5882 
Aib5∙∙∙Aib2 0.0057 0.0228 0.5909 C6(III)∙∙∙III 0.0134 0.0448 0.5156 
Aib4∙∙∙III 0.0109 0.0396 0.9348 Aib4∙∙∙III 0.0108 0.0392 0.8936 
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Aib5∙∙Aib4 0.0126 0.0445 0.4304 Aib5∙∙∙Aib4 0.0120 0.0424 0.4722 
∑𝝆(𝒓𝒄) at C-H∙∙∙O 0.0430   ∑𝝆(𝒓𝒄) at C-H∙∙∙O 0.0517   
∑𝝆(𝒓𝒄) tot 0.1222   ∑𝝆(𝒓𝒄) tot 0.1312   
 
Analogous considerations can be made when comparing peptide S-15 (cCTAA = (1R,2S,4R)-V) 
and S-3, whose Δh.e. ~ 14% (Table 6.1 and 5.4) is justified by a ∆15−3𝜌𝑃 = 0.0052 au and ∆15−3𝜌𝑀 = -
0.0034 au (Tables 5.9 and 5.10).  
Table 6.10. Types and properties of BCPs of the Ac-Aib2-(1R,2S,4R)-V-Aib2-NHMe peptide S-15 in the P- and M-helix 
conformation. All parameters are reported in au. 
peptide S-15, 
P-helix 
   
peptide S-15, 
M-helix 
   
N-H∙∙∙O BCP 𝝆(𝒓𝒄) 𝛁𝟐𝝆(𝒓𝒄) ε N-H∙∙∙O BCP 𝝆(𝒓𝒄) 𝛁𝟐𝝆(𝒓𝒄) ε 
V∙∙∙ACE 0.0213 0.0672 0.0625 V∙∙∙ACE 0.0201 0.0628 0.0588 
Aib4∙∙∙Aib1 0.0185 0.0577 0.0448 Aib4∙∙∙Aib1 0.0197 0.0620 0.0502 
Aib5···Aib2 0.0195 0.0608 0.0613 Aib5···Aib2 0.0200 0.0631 0.0636 
NMe∙∙∙V 0.0216 0.0688 0.0610 NMe∙∙∙V 0.0227 0.0735 0.0568 
∑𝝆(𝒓𝒄) at N-H∙∙∙O 0.0809   ∑𝝆(𝒓𝒄) at N-H∙∙∙O 0.0825   
Cβ-H∙∙∙O BCP    Cβ-H∙∙∙O BCP    
C1H(V)∙∙∙Ac 0.0068 0.0270 0.1628 C3H(V)∙∙∙Ac 0.0104 0.0381 0.0909 
Aib2∙∙∙Aib1 0.0104 0.0378 0.7872 Aib5∙∙∙Aib2 0.0057 0.0230 0.4783 
Aib5∙∙∙Aib2 0.0058 0.0234 0.5909 Aib5∙∙∙Aib4 0.0127 0.0449 0.4198 
Aib4∙∙∙V 0.0109 0.0395 0.9565 C6H(V)∙∙∙Nme 0.0010 0.0036 0.7500 
Aib5∙∙Aib4 0.0126 0.0445 0.4304 C6(V)∙∙∙V 0.0155 0.0537 0.3012 
∑𝝆(𝒓𝒄) at C-H∙∙∙O 0.0465   ∑𝝆(𝒓𝒄) at C-H∙∙∙O 0.0453   
∑𝝆(𝒓𝒄) tot 0.1274   ∑𝝆(𝒓𝒄) tot 0.1278   
 
Conversely, the difference of about 22% in helical screw sense selectivity observed between 
peptides S-18 (cCTAA = (1R,2S,4R)-IIIbmb) and S-3 is difficult to explain. Indeed, the higher h.e. of 
peptide S-18 is only supported by a slight increase in cCTAA steric hindrance in the (+x, +y, +z) in the 
P-conformation and by a limited weakening of the covalent interactions in the M-helix (∆3−18𝜌𝑀 = 
0.0020 au; Tables 5.9 and 5.11). However, in this case also, DFT calculations supported the results of 
REMD simulations, since for both peptides S-18 and S-3 the obtained ∆𝐸𝑃−𝑀 were of -3.6 kcal/mol 
and -2.8 kcal/mol, respectively (Annex 6.A). Therefore, it seems that some other factors, not detected 
by QTAIM analysis, might play a role in this particular example. 
Table 6.11. Types and properties of BCPs of the Ac-Aib2-(1R,2S,4R)-IIIbmb-Aib2-NHMe peptide S-18 in the P- and M-
helix conformation. All parameters are reported in au. 
peptide S-18, 
P-helix 
   
peptide S-18, 
M-helix 
   
N-H∙∙∙O CPs 𝝆(𝒓𝒄) 𝛁𝟐𝝆(𝒓𝒄) ε N-H∙∙∙O CPs 𝝆(𝒓𝒄) 𝛁𝟐𝝆(𝒓𝒄) ε 
IIIbmb∙∙∙Ac 0.0214 0.0674 0.0622 IIIbmb∙∙∙ACE 0.0206 0.0644 0.0570 
Aib4∙∙∙Aib1 0.0194 0.0614 0.0514 Aib4∙∙∙Aib1 0.0198 0.0622 0.0502 
Aib5···Aib2 0.0178 0.0555 0.0579 Aib5···Aib2 0.0183 0.0576 0.0558 
NMe∙∙∙IIIbmb 0.0225 0.0725 0.0615 NMe∙∙∙IIIbmb 0.0220 0.0705 0.0635 
∑𝝆(𝒓𝒄) at N-H∙∙∙O 0.0811   ∑𝝆(𝒓𝒄) at N-H∙∙∙O 0.0807   
Cβ-H∙∙∙O CP    Cβ-H∙∙∙O CP    
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C1H(IIIbmb)∙∙∙Ac 0.0069 0.0274 0.1304 C3H(IIIbmb)∙∙∙Ac 0.0104 0.0377 0.0899 
Aib2∙∙∙Aib1 0.0103 0.0376 0.9762 Aib2∙∙∙Aib1 0.0104 0.0378 0.9302 
Aib4∙∙∙Aib1 0.0053 0.0211 1.0000 Aib5∙∙∙Aib2 0.0053 0.0210 0.5556 
Aib5∙∙∙Aib2 0.0057 0.0225 0.5217 C6(IIIbmb)∙∙∙IIIbmb 0.0104 0.0474 0.5303 
Aib5∙∙Aib4 0.0126 0.0445 0.4125 Aib5∙∙∙Aib4 0.0120 0.0426 0.4722 
∑𝝆(𝒓𝒄) at C-H∙∙∙O 0.0408   ∑𝝆(𝒓𝒄) at C-H∙∙∙O 0.0485   
∑𝝆(𝒓𝒄) tot 0.1219   ∑𝝆(𝒓𝒄) tot 0.1292   
 
On the contrary, QTAIM analysis well explained why peptide R-12 (cCTAA = (1R,2R,4R)-
IIIawr) had a h.e. of about 8% higher than that of peptide R-5 (cCTAA = (1R,2R,4R)-V). Indeed, 
although these cCTAAs has structurally similar side chains, similarly located in the Cartesian space, 
the ∆𝜌𝑃−𝑀 of peptide R-12 is 0.0082 au higher than that of peptide R-5 (Tables 5.7 and 5.12). 
Table 6.12. Types and properties of BCPs of the Ac-Aib2-(1R,2R,4R)-IIIawr-Aib2-NHMe peptide R-12 in the P- and M-
helix conformation. All parameters are reported in au. 
peptide R-12, 
P-helix 
   
peptide R-12, 
M-helix 
   
N-H∙∙∙O BCP 𝝆(𝒓𝒄) 𝛁𝟐𝝆(𝒓𝒄) ε N-H∙∙∙O BCP 𝝆(𝒓𝒄) 𝛁𝟐𝝆(𝒓𝒄) ε 
IIIawr∙∙∙ACE 0.0218 0.0688 0.0607 IIIawr∙∙∙ACE 0.0190 0.0590 0.0735 
Aib4∙∙∙Aib1 0.0197 0.0621 0.0500 Aib4∙∙∙Aib1 0.0221 0.0706 0.0553 
Aib5···Aib2 0.0178 0.0559 0.0688 Aib5···Aib2 0.0163 0.0508 0.0588 
NMe∙∙∙IIIawr 0.0215 0.0688 0.0615 NMe∙∙∙IIIawr 0.0221 0.0708 0.0632 
∑𝝆(𝒓𝒄)  at N-H∙∙∙O 0.0808   ∑𝝆(𝒓𝒄)  at N-H∙∙∙O 0.0795   
Cβ-H∙∙∙O BCP    Cβ-H∙∙∙O BCP    
C3H(IIIawr)∙∙∙Ac 0.0098 0.0358 0.1084 C5H(IIIawr)∙∙∙Ac 0.0107 0.0374 0.1319 
Aib2∙∙∙Aib1 0.0106 0.0386 0.7400 Aib5∙∙∙Aib2 0.0053 0.0213 0.4762 
Aib5∙∙∙Aib2 0.0054 0.0217 0.5238 Aib5∙∙∙Aib4 0.0124 0.0438 0.4416 
Aib5∙∙Aib4 0.0125 0.0445 0.4487 
 
   
∑𝝆(𝒓𝒄) at C-H∙∙∙O 0.0383   ∑𝝆(𝒓𝒄) at C-H∙∙∙O 0.0284   
N∙∙∙O CPs        
IIIawr∙∙∙Aib1 0.0121 0.0386 0.9091     
∑𝝆(𝒓𝒄) at N∙∙∙O 0.0121       
∑𝝆(𝒓𝒄) tot 0.1312   ∑𝝆(𝒓𝒄) tot 0.1079   
 
Peptide S-6 (cCTAA = (S)-VI) had an h.e. comparable to that of S-3 and R-5, although its side 
chain is not well located in either (-x, +y, +z) or (+x, +y, -z). However, the good h.e. can be attributed 
to the strong noncovalent interaction network, involving the cCTAA, of peptide S-6 in the P 
conformation, together with a poor interaction network observed in the M-conformation, where the 
cCTAA is only marginally involved (Table 6.13). 
Table 6.13. Types and properties of BCPs of the Ac-Aib2-(S)-VI-Aib2-NHMe peptide S-6 in the P- and M-helix 
conformation. All parameters are reported in au. 
peptide S-6, 
P-helix 
   
peptide S-6, 
M-helix 
   
N-H∙∙∙O BCP 𝝆(𝒓𝒄) 𝛁𝟐𝝆(𝒓𝒄) ε N-H∙∙∙O BCP 𝝆(𝒓𝒄) 𝛁𝟐𝝆(𝒓𝒄) ε 
VI∙∙∙ACE 0.0190 0.0601 0.0637 VI∙∙∙ACE 0.0172 0.0539 0.0734 
Aib4∙∙∙Aib1 0.0196 0.0616 0.0553 Aib4∙∙∙Aib1 0.0205 0.0649 0.0614 
Aib5···Aib2  0.0172 0.0536 0.0492 Aib5···Aib2  0.0178 0.0554 0.0415 
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NMe∙∙∙VI 0.0216 0.0684 0.0650 NMe∙∙∙VI 0.0201 0.0629 0.0628 
∑𝝆(𝒓𝒄)  at N-H∙∙∙O 0.0774   ∑𝝆(𝒓𝒄)  at N-H∙∙∙O 0.0756   
Cβ-H∙∙∙O BCP    Cβ-H∙∙∙O BCP    
VI(C-H)∙∙∙Ac 0.0075 0.0296 0.0926 VI(C-H)∙∙∙Ac 0.0107 0.0350 0.0521 
VI(CH2)∙∙Aib1(CH3) 0.0037 0.0129 0.3125 Aib5∙∙∙Aib2 0.0050 0.0200 0.6000 
Aib5∙∙∙Aib2 0.0051 0.0203 0.5882 VI∙∙∙Aib2 0.0142 0.0493 0.2718 
VI∙∙∙Aib2 0.0127 0.0452 0.5417 Aib4∙∙∙VI 0.0120 0.0431 0.6308 
Aib4∙∙∙VI 0.0111 0.0402 0.8600 
  
  
Aib5∙∙Aib4 0.0123 0.0436 0.4286 
   
 
∑𝝆(𝒓𝒄) at C-H∙∙∙O 0.0524   ∑𝝆(𝒓𝒄) at C-H∙∙∙O 0.0544   
∑𝝆(𝒓𝒄) tot 0.1298   ∑𝝆(𝒓𝒄) tot 0.1300   
 
When comparing peptides R-8 (cCTAA = (1S,2R,3R,4R)-VIIb) and S-10 (cCTAA = 
(1S,2S,3R,4R)-VIIIb), it can be noticed that the former peptide has a h.e. of about 13% lower than that 
of S-10. This difference cannot be ascribed to differences in steric hindrance between the two 
cCTAAs, which is equivalent; however, QTAIM calculations gave a ∆𝜌𝑃−𝑀 of 0.0032 and 0.0127 au 
for peptides R-8 and S-10, respectively (Tables 5.14 and 5.15), indicating that the difference in helical 
screw sense selectivity of these cCTAAs is only depending on their electronic properties. 
Table 6.14. Types and properties of BCPs of the Ac-Aib2-(1S,2R,3R,4R)-VIIb-Aib2-NHMe peptide R-8 in the P- and M-
helix conformation. All parameters are reported in au. 
peptide R-8, 
P-helix 
   
peptide R-8, 
M-helix 
   
N-H∙∙∙X BCP 𝝆(𝒓𝒄) 𝛁𝟐𝝆(𝒓𝒄) ε N-H∙∙∙O BCP 𝝆(𝒓𝒄) 𝛁𝟐𝝆(𝒓𝒄) ε 
VIIb∙∙∙ACE 0.0126 0.0399 0.0424 VIIb∙∙∙ACE 0.0133 0.0426 0.0952 
Aib4∙∙∙Aib1 0.0152 0.0477 0.0318 Aib4∙∙∙Aib1 0.0209 0.0670 0.0596 
Aib5···Aib2  0.0190 0.0594 0.0637 Aib5···Aib2  0.0195 0.0626 0.0607 
NMe∙∙∙VIIb 0.0214 0.0680 0.0571 NMe∙∙∙VIIb 0.0219 0.0706 0.0595 
VIIb(SH)∙∙∙Ac 0.0201 0.0657 0.0931 
  
  
∑𝝆(𝒓𝒄)  at N-H∙∙∙O 0.0883   ∑𝝆(𝒓𝒄)  at N-H∙∙∙O 0.0756   
Cβ-H∙∙∙X BCP    Cβ-H∙∙∙O BCP    
Aib1∙∙VIIb(SH) 0.0047 0.0162 0.3174 VIIb(C6-H)∙∙∙Ac 0.0087 0.0309 0.1094 
Aib2∙∙∙Aib1 0.0108 0.0385 0.5893 VIIb(C3-H)∙∙VIIb 0.0200 0.0791 0.7838 
Aib5∙∙∙Aib2 0.0057 0.0227 0.5217 VIIb(C7-H)∙∙∙VIIb 0.0138 0.0484 0.2979 
Aib5∙∙Aib4 0.0126 0.0447 0.4375 Aib5∙∙∙Aib4 0.0124 0.0439 0.4359 
∑𝝆(𝒓𝒄)  at C-H∙∙∙O 0.0338   ∑𝝆(𝒓𝒄) at C-H∙∙∙O 0.0549   
N∙∙∙O CPs        
VIIb∙∙∙Aib1 0.0116 0.0363 0.3191     
∑𝝆(𝒓𝒄) at N∙∙∙O 0.0116       
∑𝝆(𝒓𝒄) tot 0.1337   ∑𝝆(𝒓𝒄) tot 0.1305   
 
Table 6.15. Types and properties of BCPs of the Ac-Aib2-(1S,2S,3R,4R)-VIIIb-Aib2-NHMe peptide S-10 in the P- and M-
helix conformation. All parameters are reported in au. 
peptide S-10, 
P-helix 
   
peptide S-10, 
M-helix 
   
N-H∙∙∙O BCP 𝝆(𝒓𝒄) 𝛁𝟐𝝆(𝒓𝒄) ε N-H∙∙∙O BCP 𝝆(𝒓𝒄) 𝛁𝟐𝝆(𝒓𝒄) ε 
VIIIb∙∙∙ACE 0.0157 0.0476 0.0385 VIIIb∙∙∙ACE 0.0174 0.0546 0.0773 
Aib4∙∙∙Aib1 0.0164 0.0512 0.0345 Aib4∙∙∙Aib1 0.0214 0.0682 0.0576 
Aib5···Aib2 0.0194 0.0608 0.0664 Aib5···Aib2 0.0144 0.0455 0.0548 
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NMe∙∙∙VIIIb 0.0213 0.0676 0.0576 NMe∙∙∙VIIIb 0.0218 0.0694 0.0688 
VIIIb(OH)∙∙Ac 0.0252 0.0930 0.0811 VIIIb(OH)∙∙∙Aib2 0.0222 0.0743 0.0513 
∑𝝆(𝒓𝒄)  at N-H∙∙∙O 0.0980   ∑𝝆(𝒓𝒄)  at N-H∙∙∙O 0.0972   
Cβ-H∙∙∙O BCP    Cβ-H∙∙∙O BCP    
Aib1∙∙∙Ac 0.0105 0.0382 0.7826 VIIIb(C6-H)∙∙∙Ac 0.0081 0.0286 0.1034 
VIIIb(C4-H)∙∙∙Ac 0.0081 0.0278 0.2241 VIIIb(C7-H)∙∙∙VIb 0.0147 0.0498 0.1405 
Aib2∙∙∙Aib1 0.0110 0.0392 0.5000 Aib4∙∙∙VIIIb 0.0122 0.0439 0.6984 
Aib5∙∙∙Aib2 0.0053 0.0213 0.5882 Aib5∙∙∙Aib4 0.0121 0.0428 0.4459 
Aib5∙∙Aib4 0.0124 0.0440 0.4605 
  
  
∑𝝆(𝒓𝒄) at C-H∙∙∙O 0.0473   ∑𝝆(𝒓𝒄)  at C-H∙∙∙O 0.0471   
N∙∙∙O BCP        
VIIIb∙∙∙Aib1 0.0118 0.0371 0.3043     
∑𝝆(𝒓𝒄) at N∙∙∙O 0.0118       
∑𝝆(𝒓𝒄)  tot 0.1571   ∑𝝆(𝒓𝒄) tot 0.1443   
 
Summarizing, REMD simulations together with QTAIM calculations on Ac-Aib2-cCTAA-Aib2-
NHMe model peptides showed that the P-helical screw sense selectivity is due to steric hindrance 
exerted by the the cCTAA parallel to the peptide helix axis, without particular preferences for the 
region downstream and upstream of the cCTAA itself. However, when the side chain is located in the 
upstream semiaxis, it also has to point toward the opposite direction of the helical screw sense (i.e. the 
(-x, +y, +z) sector of the Cartesian space indicated in Figure 6.2). On the contrary, if the side chain is 
located in the downstream semiaxis, its encumbrance needs to follow the helical screw sense direction 
(i.e. the (+x, +y, -z) sector). In addition, quite strong noncovalent interactions consisting of classical N 
– H··· O=C H-bonds and weak C – H··· O=C interactions can improve the helical screw sense 
selectivity exerted by cCTAAs. 
At the light of this, (1S,2R,4R)-IV turned out to be a modest helical stabilizer,72 but an excellent 
P-helix inducer. Indeed, this CTAA develops its steric hindrance in the upstream direction and is able 
to strengthen the peptide noncovalent interaction network only in the P-helix configuration. 
Conversely, (1R,2R,4R)-V resulted an excellent helical stabilizer, but a relatively poor P-helix inducer. 
Therefore, the design of a peptide including one or more cCTAAs and with well-defined helical 
secondary structure requires to seek a reasonable compromise between structural features of the 
cCTAA, needed to allow the binding efficiently to the protein target, and those required to obtain a 
stable helix and with a defined screw sense. 
6.3 MATERIAL AND METHODS 
REMD Simulations. Force-field parameters for Aib, II, IIIa, IIIb, IV, V and VI were taken 
from previous work (Annex 5.B),72 while VIIa, VIIb, VIIIa and VIIIb cCTAAs were parameterized 
by following the same protocol adopted before.72 
The pmemd module of the Amber14 suite192 was used to perform REMD simulations of Ac-Aib2-
cCTAA-Aib2-NHMe peptides, starting from extended conformations (φ = ψ = ω = 180°) and applying 
the protocol previously described.72 Briefly, the combination of AMBER ff99SB force field141 and 
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OBC(II) (igb = 5) solvent model172 was chosen, and 12 replicas of 250 ns each were run spanning a 
temperature range from 260.00 to 658.94 K, for a total of 3 μs simulation for each peptide. 
The trajectories extracted at 308.53 K were submitted to cluster analyses with cpptraj192 at 50-
100, 100-150, 150-200, 200-250 ns time intervals using the previously reported protocol.72 Here, the 
simulation was considered converged when the standard deviations of the cluster populations 
corresponding to P- and M-helices (σP% and σM%, respectively) were less than 5% among all intervals. 
We also verified that simulations conducted on peptides containing enantiomeric CTAAs gave equal 
and opposite h.e., within the threshold of 5%. As expected, peptide 11 which contains only Aib, also 
gave h.e. below 5%. 
Mono and bidimensional potentials of mean force (PMF) were computed using the weighted 
histogram analysis method (WHAM and WHAM-2d)232 on the φ2, ψ3, φ3 and ψ4 dihedrals obtained 
from the whole 250 ns trajectories at 260, 283, 308 and 335 K extracted from the REMD simulations. 
The histogram limit was set to ±180° over 100 bins with a tolerance of 0.01. 
QTAIM Calculations. Gaussian 09233 was used to optimize the P- and M-helices of selected 
peptides using the mPW1B95/6-31+G(d,p) level of theory234 and the CPCM solvent model for 
water,236 a combination successfully used by our group in similar instances.72,249 The same level of 
theory was used to confirm, by vibrational analyses, that the optimized geometries were true minima. 
The obtained wave functions were submitted to QTAIM calculations with the AIM2000 software250 by 
setting the same parameters used previously.72 In this case also, N-H··· O, C-H··· O and backbone 
N··· O bond critical points (BCPs) were evaluated in terms of strength, type and stability by calculating 
their electronic density 𝜌(𝑟𝑐), the sign of the Laplacian ∇2(𝑟𝑐) and their ellipticity ε; BCPs with ε > 1 




7 MECHANISMS OF HELICAL SCREW SENSE INVERSION 
7.1 INTRODUCTION 
Beyond the knowledge of the mechanisms involved in the helix secondary structure stabilization72 
and in the helical screw sense selectivity86 exerted by cCTAAs, understanding how the interconversion 
between P- and M-helices occurs represents an important, although challenging, goal. 
Indeed, many events in biological systems involve the coupling of selective molecular recognition 
to a conformational response,100,251 leading to modulation of function in peptides, proteins or nucleic 
acids.99 
In PPIs modulation, the switch from an inactive to an active conformation of a peptide modulator 
can represent an advantage if it allows a control of its kinetics and site of action.252 For example, the 
possibility of regulating PPI inhibitors activity with light was investigated by introducing photo-
sensitive cross-linkers in the peptide chain.253–255 
Since the secondary structure motif is fundamental in protein-protein recognition, one of the two 
helical screw senses can represent the inactive conformation (or a prodrug, in the case of switchable 
peptides), because the AAs side chains are differently oriented in space. Therefore, a detailed 
knowledge on how the helical screw sense inversion occurs can be helpful for the design of screw 
sense switchable PPI modulator. 
At the light of this, in collaboration with Professor Jonathan Clayden’s group at the University of 
Manchester, the mechanisms involved in this process have been studied.  
Clayden’s group synthesized Cbz-(S)-αMeVal2-Aib5-(S)-αMeVal2-NHMe (peptide 1) and Cbz-
(S)-αMeVal2-Aib5-(R)-αMeVal2-NHMe (2) peptides. As expected, the former peptide, containing only 
(S)-αMeVal, had a X-ray structure corresponding to a P-310-helix conformation (Figure 7.1A), since it 
has been proved that (S)-αMeVal induces a P conformation once inserted in an otherwise achiral 
helical peptide.96 Conversely, peptide 2, bearing (S)-αMeVal at the N-termini and (R)-αMeVal at the 
C-termini, gave a X-ray structure corresponding to a P-310-helix from the N-terminus to Aib5 and to a 
M-helix from Aib5 to the C-terminus (Figure 7.1B). However, these peptides and their relative 
crystallographic structures could not provide satisfactory information about either the mechanism 
involved in the helical screw sense inversion or the energy barriers associated to the migration of the 
screw sense inversione along the peptide chain.  
Therefore, REMD simulations were performed to obtain statistically relevant conformations of the 
two peptides. PMF analysis was then applied to evaluate the energy barriers associated to the 
migration of the reverse along the peptide chain. Furthermore, PNEB simulations were carried out on 
achiral Aib-containing peptides with the aim of describing qualitatively the mechanism behind the 





Figure 7.1. X-ray structures of Cbz-(S)-αMeVal2-Aib5-(S)-αMeVal2-NHMe peptide 1 (A) and Cbz-(S)-αMeVal2-Aib5-(R)-
αMeVal2-NHMe peptide 2 (B). 
7.2 RESULTS AND DISCUSSION 
The results of cluster analyses performed on the 297.31 K implicit solvent trajectories of peptides 
1 and 2, reported in Tables 6.1, showed that in both cases the REMD simulations were able to 
reproduce the crystallographic data (Figure 7.2). Indeed, the most populated clusters of peptides 1 and 
2 (90.1% and 69.3%, respectively) have a RMSD from the backbone of the correspondent X-ray 
structures of 1.4 Å and 1.0 Å, respectively, and the structures are superimposable to the 
crystallographic ones (Figure 7.2). As expected, peptide 1 is a complete right-handed 310-helix, 
whereas peptide 2 corresponds to a right-handed 310-helix from the N-terminus to Aib5 and to a left-
handed 310-helix from Aib5 to the C-terminus. 
 
Figure 7.2. A) Superposition of X-ray structure (green) and representative structure of the most populated cluster 
(magenta) of peptide 1 from the analysis of the 297.31 K REMD trajectory. B) Superposition of X-ray structure (green) and 




Moreover, the most stable H-bonds (occupancies > 50%), which are those identifiable in the X-
ray structures also (Figure 7.1 and Table 7.3), involve i+3 and i residues, indicating the presence of a 
310-helix or a β-turn. It has to be noted that the occupancies of the H-bonds between (R)-αMeVal8 and 
Aib5 and between (R)-αMeVal9 and Aib6 of peptide 2 are about 20% lower than those between (S)-
αMeVal8 and Aib5 and between (S)-αMeVal9 and Aib6 of peptide 1. This can be explained by the 
reduced stability of the screw sense preference of peptide 2, due to the competition between the (S)- 
and (R)-αMeVal residues located at the N- and C-terminus, respectively. This is also demonstrated by 
considering the difference between the two percentages of the most populated clusters: while REMD 
simulation of peptide 1 mostly resulted in a unique preferential conformation, corresponding to the 
right-handed 310-helix, REMD performed on peptide 2 gave additional minor clusters with helical 




Table 7.1. Cluster analyses of the final 50 ns of the 297.31 K REMD trajectories of peptide 1 and 2. 
1 pop% φ0 ψ1 φ1 ψ2 φ2 ψ3 φ3 ψ4 φ4 ψ5 φ5 ψ6 φ6 ψ7 φ7 ψ8 φ8 ψ9 RMSD 
X-ray  -55.0 -37.5 -52.1 -34.2 -49.8 -39.5 -53.0 -40.6 -57.2 -40.0 -57.6 -32.8 -60.2 -20.9 -44.0 -49.9 -58.3 -38.5  
c0 90.1 -62.9 -13.7 -61.5 -23.3 -34.8 -32.0 -46.3 -31.0 -48.3 -24.8 -50.8 -15.4 -52.3 -35.7 -42.5 -24.9 -61.7 -17.3 1.4 Å 
c1 8.6 -64.4 -0.9 -64.1 -8.4 45.9 24.3 49.7 27.8 53.7 18.8 46.9 34.1 56.0 26.3 -68.5 -3.8 -57.9 -30.4 2.3 Å 
c2 1.2 -53.8 -33.1 -65.8 -14.0 51.7 38.1 53.0 26.8 47.1 29.3 44.9 38.1 43.6 23.0 48.2 17.5 -50.7 -30.1 2.3 Å 
c3 0.1 -50.2 -29.2 -44.1 -39.8 -51.6 -25.2 -45.2 -37.5 -51.3 -33.8 -39.6 -36.5 -48.7 -26.6 60.5 20.4 51.4 11.2 2.1 Å 
c4 0.0 -54.6 -24.0 -56.3 -21.7 -47.0 -35.2 -52.9 -8.8 37.3 44.1 62.5 25.4 -46.4 157.4 -52.6 -19.6 -59.2 -1.8 3.3 Å 
2                     
X-ray  -55.3 -37.7 -46.5 -33.6 -55.2 -27.4 -51.0 -27.6 -61.6 -19.4 -48.4 -39.9 49.5 42.8 51.6 34.2 56.5 36.6  
c0 69.3 -41.2 -25.1 -52.6 -35.4 -51.7 -25.4 -54.1 -17.1 -52.4 -39.0 -40.2 -19.9 56.0 11.3 65.3 9.6 50.4 28.9 1.0 Å 
c1 26.7 -49.7 -21.7 -51.1 -34.7 -39.5 -29.8 -51.6 -11.8 -56.4 -33.0 -37.6 -33.2 -54.7 -19.0 49.4 26.2 55.7 11.2 2.0 Å 
c2 3.7 -54.5 -30.0 -67.1 -19.0 -47.7 -45.4 -62.8 -7.5 -53.1 -16.4 -47.2 -33.9 -56.5 -19.3 -41.1 -39.3 58.0 23.5 1.9 Å 
c3 0.3 -39.3 -24.4 -50.9 -7.3 -51.9 -4.9 47.1 26.0 56.2 28.7 43.4 47.3 49.7 26.7 -68.9 -42.2 -59.7 -13.2 2.6 Å 
c4 0.0 -74.8 3.5 -57.9 -18.7 -40.5 -35.7 -46.9 -23.7 -60.6 -15.6 -46.0 -10.3 51.1 -153.9 39.5 27.5 50.5 10.5 2.6 Å 
  
Table 7.2. Cluster analysis of the final 60 ns of the 303.60 K REMD trajectory of peptide 2 in explicit methanol. 
 pop% φ0 ψ1 φ1 ψ2 φ2 ψ3 φ3 ψ4 φ4 ψ5 φ5 ψ6 φ6 ψ7 φ7 ψ8 φ8 ψ9 RMSD 
X-ray  -55.3 -37.7 -46.5 -33.6 -55.2 -27.4 -51.0 -27.6 -61.6 -19.4 -48.4 -39.9 49.5 42.8 51.6 34.2 56.5 36.6  
c0 53.5 -71.1 -18.3 -45.6 -13.0 -52.9 -13.3 -53.9 -21.5 -50.5 -31.2 50.6 18.6 48.4 31.8 51.8 7.2 53.2 16.7 2.1 Å 
c1 12.7 62.9 23.6 39.3 21.5 54.6 35.5 44.8 29.0 42.1 40.1 55.5 13.5 56.3 0.9 60.8 13.8 48.1 6.1 2.1 Å 
c2 10.0 -44.6 -31.8 -52.3 -19.4 -45.5 -18.5 -44.6 -26.3 -47.7 -19.4 -56.6 -16.2 47.7 27.3 48.7 35.7 59.8 12.7 0.9 Å 
c3 8.9 -51.2 -18.7 -52.5 -24.2 -30.7 -55.5 -37.9 -32.1 -50.6 -31.7 -43.1 -18.7 -47.4 -8.1 52.4 17.2 58.3 26.3 2.0 Å 
c4 7.9 -68.9 9.4 -55.8 -18.6 -51.2 -33.4 62.1 9.2 37.1 29.4 48.5 19.9 49.8 7.7 36.9 20.2 71.9 18.2 2.0 Å 
c5 3.1 -49.8 -22.4 -60.0 -20.7 -55.0 -28.6 -56.0 -26.4 -56.6 -19.5 -47.5 -43.1 -48.7 -19.8 53.1 17.8 75.3 8.9 2.2 Å 
c6 1.8 -63.9 -17.9 -57.2 -8.7 -52.7 -15.4 -44.8 -29.1 -53.1 -23.3 -35.6 -30.8 -65.2 -16.3 -44.8 0.5 48.3 25.5 2.1 Å 
c7 1.4 -53.6 -20.0 -56.2 -40.0 -44.8 -22.5 -64.2 -24.2 -46.2 -10.9 -62.6 -19.3 -51.8 -22.3 -50.6 -14.7 72.8 9.7 1.9 Å 
c8 0.4 -47.8 -32.8 -71.1 1.6 -21.2 -49.3 -44.5 -26.7 -46.4 -17.9 -51.2 -18.7 -61.7 -4.2 -56.5 11.0 52.0 8.7 2.3 Å 
c9 0.2 -51.8 -14.8 -58.0 -10.8 -47.2 -14.3 -47.1 -27.6 -46.6 -28.9 -43.6 -29.2 -40.7 -36.9 -49.6 -28.1 -40.4 -40.3 1.7 Å 
c10 0.1 -56.0 -16.3 -44.3 -22.7 -62.0 -31.2 -31.5 -30.2 -42.9 -30.4 -71.2 11.3 -42.1 -47.9 53.4 -4.0 129.3 -3.1 2.0 Å 
c11 0.0 40.3 39.2 50.9 25.8 52.1 29.4 40.0 30.7 55.3 18.2 46.3 25.5 40.2 41.9 65.1 14.0 110.1 10.7 2.0 Å 
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c12 0.0 -33.9 -40.3 -42.7 -29.9 -60.0 -23.7 -55.1 8.8 -51.4 -31.8 46.6 26.0 48.3 27.1 24.9 35.2 71.4 19.8 2.5 Å 
c13 0.0 -53.5 -20.2 -61.4 -27.9 -46.0 -14.1 -49.9 -27.6 -56.3 -21.5 -70.3 -5.2 -42.4 -25.0 59.4 -8.0 71.3 12.0 1.9 Å 
c14 0.0 -43.6 -22.3 -59.4 -13.3 -37.5 -49.3 -49.2 -30.0 -71.5 -18.6 -64.0 -10.7 -50.4 -34.0 -61.4 13.0 56.4 9.1 1.9 Å 
 
Table 7.3. H-bond analyses of 297.31 K implicit solvent REMD trajectories of peptides 1 and 2 (Donor, N-H; Acceptor, C=O). 
peptide 1    peptide 2   
donor acceptor occupancy  donor acceptor occupancy 
Aib4 (S)-αMeVal1 90.24%  Aib4 (S)-αMeVal1 88.43% 
Aib5 (S)-αMeVal2 93.05%  Aib5 (S)-αMeVal2 86.74% 
Aib6 Aib3 92.92%  Aib6 Aib3 86.11% 
Aib7 Aib4 92.74%  Aib7 Aib4 86.95% 
Aib7 Aib5 6.52%  Aib7 Aib5 8.42% 
(S)-αMeVal8 Aib5 73.44%  (R)-αMeVal8 Aib5 56.07% 
(S)-αMeVal8 Aib6 7.46%  (R)-αMeVal8 Aib6 10.50% 
(S)-αMeVal9 Aib6 77.69%  (R)-αMeVal9 Aib6 59.00% 






Furthermore, in the representative structure of the most populated cluster of 
peptide 2, the carbonyl group of Aib5 and the amino group of (R)-αMeVal8 are not 
involved in any H-bond, as also observed in the X-ray structure. However, from H-
bond analysis we noticed the presence of both i+3→i and i+2→i H-bonds involving 
Aib5 and (R)-αMeVal8, underscoring the presence of β- and γ-turns, respectively. 
Moreover, even if the H-bonds corresponding to γ-turns are also present in the 
simulation performed on peptide 1, their occupancies are higher for peptide 2 (Table 
7.3). The low occupancy (around 10%) of these H-bonds means that γ-turns are only 
transient and the differences showed analyzing the REMD trajectories of the two 
peptides suggest that γ-turns occur more frequently where the competition between 
the two helical screw senses is more pronounced. Thus, we can hypothesize that γ-
turns can play an active role in the inversion of the helical screw sense. The presence 
of γ-turns with poor occupancies in the trajectory of peptide 1 can be attributed to the 
mild effect of the achiral residues, which, in principle, can equally assume both the P- 
and the M-conformations. Indeed, for peptide 1, the i+2→i H-bond with the highest 
occupancy is the one involving (S)-αMeVal8 and Aib6, which is the Aib residue less 
effected by the presence of the (S)-αMeVal at the N-terminus. 
The different behavior of the two peptides is confirmed by monodimensional 
PMF profiles as a function of φ and ψ dihedrals (Figure 7.3). Indeed, for both peptides 
we only observed the presence of two minima corresponding to the P- and M-helical 
conformations. However, only the PMF profiles as a function of φ1, φ2, ψ2 and ψ3 
dihedrals, which are those where the CαS enantiomer is involved, are identical in the 
two peptides, showing a global and a local minimum corresponding to the P-helix and 
M-helix, repsectively. PMF profiles of peptide 1 always resulted in a preference for 
the right-handed helical conformation; conversely, for peptide 2 the PMF as a function 
of φ3-5 and ψ4-6 showed a progressive reduction in the energy difference between the 
two minima (Figure 5.6, ΔEM), which culminated in an inversion of the screw sense 





Figure 7.3. PMF as a function of φ (A) and ψ (B) dihedrals for peptide 1 and PMF as a function of φ 
(C) and ψ (D) dihedrals for peptide 2. 
In details, concerning peptide 1, ΔEM for PMF(φ0) is of about 2.5 kcal/mol in 
favor of the P-helix at the considered temperatures; then, it drops of about 1 kcal/mol 
from PMF(φ1) to PMF(φ2), together with a further decrease of less than 0.5 kcal/mol 
from PMF(φ2) to PMF(φ3). The ΔEM value for PMF(φ4-5) remained constant, while 
ΔEM for PMF(φ7-8) increased again up to 2.5 kcal/mol, always favoring the P-helix.  
The same behavior is observable for PMF on ψ dihedrals, although in this case 
the energy barrier between the two minima (ΔEM‡) can be overcome at the analyzed 
temperatures, as previously observed.72,86 In this case, ΔEM‡ decreased progressively 
from a maximum of 3 kcal/mol reached for PMF(ψ2) to 1.5 kcal/mol showed by 
PMF(ψ6) and then increased again to 2.5 kcal/mol for PMF(ψ8). It should be noticed 
that PMF(ψ9) showed a unique minimum corresponding to the P-helix, suggesting that 
the effect of (S)-αMeVal is particularly strong on this dihedral. 
On the contrary, PMF profiles for peptide 2 as a function of φ dihedrals showed a 
progressive ΔEM decrease from a maximum of 2.5 kcal/mol in favor of the P-helical 
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conformation, observed for PMF(φ1), to a minimum of less of 0.5 kcal/mol for 
PMF(φ5). Successively, PMF as a function of φ6-8, showed again an increase of ΔEM 
up to 2.5 kcal/mol, but favoring the M-helix. PMF profiles as a function of ψ dihedrals 
gave the same trend, although, in this case also, the ΔEM‡ resulted surmountable. 
Moreover, as happened for peptide 1, PMF (ψ9) showed only one minimum, which 
however corresponded to the M-helical conformation. 
In order to verify if the solvent can significantly affect the results of the 
simulation,256,257 we performed a REMD simulation of peptide 2 in explicit methanol. 
The choice of carrying out the simulation just on this peptide was due to the fact that 
the screw sense inversion occurs only in peptide 2, which is the one having 
enantiomers cCTAAs at the N- and C-termini. Moreover, REMD simulations in 
explicit solvent resulted extremely time consuming on the available hardware. 
The simulation carried out in explicit MeOH led to slightly different results. 
Indeed, in the representative structure of the most populated cluster (53.5%) the 
helical screw sense inversion from P- to M-helix is observed at Aib4, and the RMSD 
from the crystallographic structure is of 2.06 Å (Figure 7.4A and Table 7.2). 
Nonetheless, the representative structure of cluster c2 (10.0%) had a conformation 
which is superimposable to the X-ray structure and with a RMSD of 0.90 Å (Figure 
7.4B and Table 7.2), and, considering the representative structures of the other minor 
clusters, the inversion of the helical screw sense can involve any peptide residue. 
Moreover, in some minor clusters (e.g. c6, c8, c12-14, see Table 7.2 and Figure 7.5) 
the presence of γ-turns at different points along the chain is clearly observable. It can 
also be noticed that γ-turns are located where the helical switch takes place, giving a 
further proof to the hypothesis that i+2→i H-bonds are involved in the helical screw 
sense inversion mechanism. 
This can also be confirmed by the H-bond analysis of the intramolecular 
interactions (Table 7.4). Indeed, in the simulation of peptide 2 conducted in implicit 
solvent i+2→i H-bonds were only observed between Aib7 and Aib5, αMeVal8 and 
Aib6 and between αMeVal9 and Aib7 (Table 7.3), i.e. where the helical screw sense 
inversion can occur, as showed by cluster analysis and PMF (Table 7.1 and Figure 7.3, 
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respectively). Conversely, in the case of the explicit MeOH simulation, γ-turns can 
involve any peptide residue and, as expected, the reverse can occur at different points 
all along peptide 2, as showed in Figure 7.5. However, it should be underscored that 
also in explicit solvent the i+2→i H-bonds having the highest occupancies are those 
between Aib7 and Aib5, (R)-αMeVal8 and Aib6 and (R)-αMeVal9 and Aib7, proving 
the consistency between the two simulations and confirming that the inversion of the 
helical screw sense preferentially takes place at this point of the peptide chain. 
Although, it is clear that methanol some way affects the process, by stabilizing the γ-
turns and allowing the reverse from right- to left-handed helix and vice versa to occur 
anywhere along the peptide chain. 
 
Figure 7.4. A) Representative structure of the most populated cluster of REMD trajectory in explicit 
solvent at 303.60 K. B) Superposition of crystallographic structure of peptide 2 (green) and the 




Figure 7.5. Representative structures of clusters C6 (top) and C12 (bottom) of REMD trajectory in 
explicit methanol at 303.60 K. The γ-turn is highlighted in green. 
Indeed, it’s not surprising that (S)-αMeVal1, (S)-αMeVal2, (R)-αMeVal8 and 
(R)-αMeVal9 are the residues most frequently involved in H-bonds with solvent 
molecules, since their backbone -NH and -C=O groups can’t be involved in intra-
peptide H-bonds. However, also the backbone atoms of the central residues are also 
able to interact with the solvent (Table 7.4). Thus, methanol seems to contribute to the 
stabilization of the chain reversal by establishing H-bonds with the residues involved 
in the helical screw sense inversion, whose amine and carbonyl groups would 
otherwise be free as observed for the simulation in implicit solvent. 
The stabilizing effect of methanol can also be verified by observing the PMF as a 
function of φ and ψ dihedrals (Figure 7.6). Indeed, if compared to those obtained in 
implicit solvent (Figure 7.3), the PMF(φ) profiles show a global reduction of both 
ΔEM and ΔEM‡, except for PMF(φ8) profile, whose ΔEM is slightly higher in explicit 
solvent than in the implicit solvent simulation. In addition, ΔEM‡ from PMF(φ2-5) can 
be overcome at the analyzed temperatures, ΔEM from PMF(φ4) is zeroed while from 
PMF(φ5) the M- helix results slightly favored. The same trend can be observed for 
PMF as a function of ψ dihedrals: ΔEM are reduced of about 0.5-1.0 kcal/mol, all the 
ΔEM‡ are lower than 2.0 kcal/mol compared to those obtained from implicit solvent 
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REMD, and the inversion of the screw sense preference occurs at ψ5, although for this 
dihedral the ΔEM is close to zero.  
Table 7.4. H-bond analysis of explicit solvent REMD trajectory of peptide 2. 
donor acceptor occ%  donor acceptor frac%§ donor acceptor frac%§ 
Aib4 αMeVal1 82.8  αMeVal1 MeOH 70.4  MeOH αMeVal9 71.5 
Aib3 αMeVal1 7.4  αMeVal2 MeOH 41.5  MeOH αMeVal8 61.0 
Aib5 αMeVal2 81.4  Aib6 MeOH 11.9  MeOH Aib7 41.7 
Aib4 αMeVal2 5.9  Aib5 MeOH 11.4  MeOH Aib3 34.5 
Aib6 Aib3 79.5  Aib7 MeOH 9.85  MeOH Aib4 31.5 
Aib5 Aib3 6.1  Aib4 MeOH 7.09  MeOH Aib5 29.8 
Aib7 Aib4 81.8  αMeVal8 MeOH 3.79  MeOH αMeVal2 26.7 
Aib6 Aib4 5.5  Aib3 MeOH 3.6  MeOH αMeVal1 24.7 
αMeVal8 Aib5 73.43  αMeVal9 MeOH 0.83  MeOH Aib6 22.45 
Aib7 Aib5 8.93         
αMeVal9 Aib6 75.51         
αMeVal8 Aib6 14.83         
αMeVal9 Aib7 11.41         
§ The frac% doesn’t represent a real occupancy, since for any given frame more than one solvent 
molecule can bind to the same place. 
 
Figure 7.6. PMF as a function of φ (left) and ψ (right) dihedrals for peptide 2. 
To further verify the involvement of γ-turns in the screw sense inversion 
mechanism, we qualitatively studied the process leading from a P- to a M-helix by 
PNEB simulations on Ac-Aibn-NH2 peptides, with n = 4, 6, 8 and 20. Different 
peptide lengths were used to assess the independency of the simulations from the 
number of amino acid residues considered. Moreover, these peptides were chosen 
because they equally exist in both the right- and the left-handed conformations, which 
can be therefore selected as initial and final images for the simulations (Figure 7.7A 
and 7.7H, respectively).  
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The following discussion is mainly focused on the PNEB simulations performed 
on the hexapeptide, although it is valid for all the peptide considered here. Indeed, the 
Ac-Aib6-NH2 is sufficiently long to be taken as a model for the whole process, but at 
the same time is easier to handle than its higher homologues due to its lower number 
of degrees of freedom. The octa- and eicosapeptide have been taken in account to 
extend the obtained results to longer peptides, while the tetrapeptide has been useful to 
gain the details of the switch from β- to β’-turn, which represents one of the main 
steps in the helical inversion. 
First of all, a defined propagation direction of the helical inversion is not 
detectable: the process always starts with the break of one or two internal H-bonds. 
Apparently, this starting point could seem unrealistic, since the internal H-bonds are 
stronger than the terminal ones. However, with PNEB simulations the minimum 
energy pathway from a state to another one is found;258 thus, although the break of 
terminal H-bonds is more likely occurring, their re-forming is equally probable 
without any significant conformational change. Conversely, the break of an internal 
H-bond can be the initial seed for the inversion, because the system evolution toward 
the other conformation is less hampered once this high energy H-bond is broken. 
After this initial step, in all cases we observe a relaxation of the peptide structure, 
which assumes a sigmoidal shape stabilized by β-turns (Figure 7.7B-D). 
Independently from the type of β-turn formed, this seems to be fundamental for the 
helical inversion, since it creates local C-shaped conformations favoring the 




Figure 7.7. Conformations extracted from the PNEB simulation of the Ac-Aib6-NH2 peptide (run 5) 
representing the main steps in the helical screw sense inversion. 
Indeed, the inversion of the screw sense takes place individually in each fragment 
identified by a β-turn and it involves the creation of γ-turns (Figure 7.7B, 6.7C and 
6.7F), which can be detected by the H-bond analysis performed on the trajectories 
extracted from the PNEB simulations (Table 7.5). From a visual inspection and from 
the measurement of the dihedrals (Figure 7.7C and 6.7F), the observed γ-turns 
represent the obligated intermediate step in between the switch from β to β’ type I 
turns, which, if repeatedly present in the peptide, lead to a right- and left-handed 310-
helix, respectively.  
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Table 7.5. H-bond analyses on PNEB simulations of Ac-Aibn-NH2 (n = 4, 6, 8 and 20). Donor (D) and acceptor (A) are NH and C=O groups, respectively. 
n = 4  run1 run2 run3 run4 run5 run6 run7 run8 run9 run10 
D  A  occ%  occ%  occ%  occ%  occ%  occ%  occ%  occ%  occ%  occ% 
NH2  Aib2 20.8 8.3 8.3 25.0 8.3 25.0 12.5 8.3 29.2 12.5 
Aib4  Aib1 100.0 100.0 100.0 100.0 95.8 95.8 95.8 95.8 100.0 95.8 
Aib3  Ac 29.2 37.5 37.5 12.5 37.5 33.3 25.0 33.3 29.2 25.0 
Aib4  Aib2 4.2 4.2 4.2 n.a 4.2 4.2 8.3 8.3 n.a 4.2 
NH2  Aib3 4.2 8.3 8.3 4.2 8.3 4.2 4.2 8.3 4.2 8.3 
Aib2  Ac 29.2 25.0 25.0 20.8 29.2 16.7 29.2 16.7 20.8 33.3 
Aib3  Aib1 8.3 33.3 33.3 4.2 4.2 4.2 8.3 8.3 20.8 8.3 
n = 6  run1 run2 run3 run4 run5 run6 run7 run8 run9 run10 
D  A  occ%  occ%  occ%  occ%  occ%  occ%  occ%  occ%  occ%  occ% 
Aib6  Aib3 30.56 30.56 36.11 38.89 11.11 16.67 8.33 16.67 8.33 13.89 
NH2  Aib4 100.00 100.00 97.22 13.89 100.00 75.00 100.00 100.00 83.33 100.00 
Aib4  Aib1 52.78 88.89 100.00 75.00 97.22 91.67 88.89 44.44 41.67 80.56 
Aib5  Aib2 44.44 33.33 25.00 19.44 22.22 13.89 36.11 30.56 13.89 33.33 
Aib3  Ac 25.00 13.89 44.44 50.00 44.44 44.44 63.89 66.67 44.44 52.78 
Aib2  Ac 16.67 11.11 8.33 19.44 25.00 8.33 8.33 16.67 44.44 30.56 
Aib3  Aib1 38.89 n.a 5.56 8.33 5.56 2.78 5.56 13.89 5.56 11.11 
Aib6  Aib4 5.56 2.78 5.56 11.11 2.78 5.56 8.33 5.56 n.a 2.78 
Aib4  Aib2 5.56 36.11 n.a 2.78 n.a 13.89 8.33 n.a n.a n.a 
Aib5  Aib3 27.78 44.44 22.22 11.11 19.44 25.00 16.67 19.44 19.44 30.56 
Aib4  Ac 11.11 n.a n.a n.a n.a n.a 11.11 30.56 5.56 n.a 
NH2  Aib5 n.a n.a n.a n.a n.a n.a n.a n.a 8.33 n.a 
n = 8  run1 run2 run3 run4 run5 run6 run7 run8 run9 run10 
D  A  occ%  occ%  occ%  occ%  occ%  occ%  occ%  occ%  occ%  occ% 
NH2  Aib6 50.0 77.1 8.3 54.2 12.5 43.8 50.0 77.1 45.8 83.3 
Aib7  Aib4 97.9 22.9 100.0 95.8 100.0 83.3 58.3 50.0 75.0 52.1 
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Aib5  Aib2 58.3 81.3 70.8 66.7 68.8 81.3 77.1 41.7 31.3 79.2 
Aib6  Aib3 20.8 54.2 31.3 16.7 27.1 14.6 27.1 54.2 20.8 16.7 
Aib4  Aib1 10.4 31.3 20.8 8.3 20.8 10.4 20.8 37.5 10.4 8.3 
Aib3  Ac 66.7 37.5 45.8 37.5 89.6 54.2 52.1 45.8 45.8 58.3 
Aib8  Aib5 50.0 33.3 14.6 8.3 22.9 8.3 22.9 68.8 8.3 14.6 
Aib5  Aib3 16.7 33.3 25.4 62.5 56.3 66.7 37.5 20.8 43.8 33.3 
Aib8  Aib6 4.2 4.2 45.8 8.3 10.4 14.6 4.2 16.7 6.3 8.3 
Aib7  Aib5 4.2 22.9 n.a n.a 4.2 37.5 4.2 n.a 2.1 n.a 
Aib2  Ac 20.8 25.0 4.2 18.8 4.2 14.6 16.7 10.4 10.4 18.8 
Aib3  Aib1 25.0 8.3 31.3 33.3 6.3 20.8 20.8 10.4 14.6 n.a 
NH2  Aib7 4.2 4.2 4.2 2.1 2.1 2.1 6.3 4.2 2.1 2.1 
Aib6  Aib4 n.a 10.4 6.3 4.2 31.3 25.0 6.3 8.3 29.2 18.8 
Aib6  Aib2 n.a 4.2 n.a n.a n.a n.a n.a n.a n.a n.a 
NH2  Aib5 n.a n.a n.a n.a n.a n.a n.a 16.7 n.a 6.3 
Aib4  Aib2 n.a n.a n.a n.a n.a n.a n.a 6.3 n.a n.a 
n = 20  run1 run2 run3 run4 run5 run6 run7 run8 run9 run10 
D  A  occ%  occ%  occ%  occ%  occ%  occ%  occ%  occ%  occ%  occ% 
Aib13  Aib10 99.0 100.0 63.5 53.1 85.4 81.3 95.8 96.9 55.2 100.0 
Aib15  Aib12 69.8 53.1 53.1 55.2 89.6 58.3 45.8 57.3 58.3 67.7 
Aib12  Aib9 71.9 25.0 64.6 35.4 37.5 52.1 69.8 42.7 67.7 69.8 
Aib10  Aib7 66.7 13.5 61.5 53.1 36.5 61.5 52.1 16.7 95.8 52.1 
Aib9  Aib6 20.8 7.3 49.0 35.4 64.6 57.3 44.8 13.5 80.2 0.1 
Aib7  Aib4 53.1 19.8 55.2 33.3 37.5 53.1 52.1 61.5 55.2 60.4 
Aib6  Aib3 17.7 16.7 33.3 33.3 51.0 63.5 15.6 35.4 67.7 27.1 
Aib5  Aib2 58.3 56.3 79.2 81.3 43.8 72.9 38.5 86.5 88.5 84.4 
Aib4  Aib1 17.7 11.5 24.0 10.4 94.8 57.3 19.8 29.2 40.6 26.0 
Aib3  Ac 64.6 26.0 55.2 62.5 46.9 63.5 76.0 65.6 84.4 67.7 
NH2  Aib18 89.6 60.4 57.3 18.8 60.4 79.2 72.9 83.3 88.5 43.8 
Aib20  Aib17 66.7 38.5 67.7 84.4 58.3 46.9 41.7 80.2 79.2 40.6 
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Aib19  Aib16 92.7 92.7 100.0 93.8 46.9 100.0 95.8 90.6 93.8 100.0 
Aib18  Aib15 77.1 54.2 56.3 45.8 59.4 54.2 64.6 40.6 40.6 64.6 
Aib17  Aib14 100.0 88.5 83.3 70.8 67.7 93.8 79.2 97.9 51.0 95.8 
Aib16  Aib13 67.7 49.0 28.1 62.5 57.3 57.3 47.9 17.7 55.2 52.1 
Aib14  Aib11 72.9 22.9 75.0 64.6 34.4 51.0 32.3 21.9 72.9 69.8 
Aib11  Aib8 99.0 100.0 63.5 53.1 85.4 81.3 95.8 96.9 55.2 100.0 
Aib8  Aib5 69.8 53.1 53.1 55.2 89.6 58.3 45.8 57.3 58.3 67.7 
Aib5  Aib3 71.9 25.0 64.6 35.4 37.5 52.1 69.8 42.7 67.7 69.8 
Aib9  Aib7 66.7 13.5 61.5 53.1 36.5 61.5 52.1 16.7 95.8 52.1 
Aib8  Aib6 20.8 7.3 49.0 35.4 64.6 57.3 44.8 13.5 80.2 0.1 
Aib11  Aib9 53.1 19.8 55.2 33.3 37.5 53.1 52.1 61.5 55.2 60.4 
Aib14  Aib12 17.7 16.7 33.3 33.3 51.0 63.5 15.6 35.4 67.7 27.1 
Aib20  Aib18 58.3 56.3 79.2 81.3 43.8 72.9 38.5 86.5 88.5 84.4 
Aib15  Aib13 17.7 11.5 24.0 10.4 94.8 57.3 19.8 29.2 40.6 26.0 
Aib13  Aib11 64.6 26.0 55.2 62.5 46.9 63.5 76.0 65.6 84.4 67.7 
Aib12  Aib10 89.6 60.4 57.3 18.8 60.4 79.2 72.9 83.3 88.5 43.8 
NH2  Aib19 66.7 38.5 67.7 84.4 58.3 46.9 41.7 80.2 79.2 40.6 
Aib18  Aib16 92.7 92.7 100.0 93.8 46.9 100.0 95.8 90.6 93.8 100.0 
Aib17  Aib15 77.1 54.2 56.3 45.8 59.4 54.2 64.6 40.6 40.6 64.6 
Aib6  Aib4 100.0 88.5 83.3 70.8 67.7 93.8 79.2 97.9 51.0 95.8 
Aib2  Ac 67.7 49.0 28.1 62.5 57.3 57.3 47.9 17.7 55.2 52.1 
Aib16  Aib14 72.9 22.9 75.0 64.6 34.4 51.0 32.3 21.9 72.9 69.8 
Aib3  Aib1 99.0 100.0 63.5 53.1 85.4 81.3 95.8 96.9 55.2 100.0 
Aib7  Aib5 69.8 53.1 53.1 55.2 89.6 58.3 45.8 57.3 58.3 67.7 
Aib10  Aib8 71.9 25.0 64.6 35.4 37.5 52.1 69.8 42.7 67.7 69.8 
Aib19  Aib17 66.7 13.5 61.5 53.1 36.5 61.5 52.1 16.7 95.8 52.1 
Aib4  Aib2 20.8 7.3 49.0 35.4 64.6 57.3 44.8 13.5 80.2 0.1 
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As can be noticed from most of the trajectories extracted from the PNEB 
simulations, the i+2→i H-bonds are frequently found in peptide 2 with β-turns (Figure 
7.7C and 6.7F), but are transient since their presence increases the conformational 
energy, as showed by the relative energy plot associated to the helical inversion of the 
Ac-Aib4-NH2 peptide (Figure 7.8). In the simulations of the tetrapeptide the global 
maximum corresponds to a conformation where the carbonyl group of Aib1 is 
involved in H-bonds with the NH of both Aib3 and Aib4, while the local maxima or 
other high energetic conformations show the presence of γ-turns at either the N- or the 
C-terminus. For longer peptides these observations are less significant, because the 
energies extrapolated from the PNEB simulations are associated to the whole 
conformation of each image and the effect of γ-turns can be reduced by the presence 
of other stabilizing interactions or enhanced if there are other steric clashes.  
 
Figure 7.8. Total energies in kcal/mol extracted from the PNEB simulation (run 2) of Ac-Aib4-NH2 
peptide with relevant conformations. 
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Summarizing, the application of computational techniques gave further insights 
for the study of both the conformational equilibria and the energetics in peptides 
containing chiral amino acids at the N- and C-termini. In particular, REMD 
simulations showed that, while peptide 1 is unequivocally a stable P-310-helix, in 
peptide 2 the presence of enantiomeric αMeVal at the two termini produces a 
competition for the global helical screw sense: the CαS-enantiomer imposes the P-
helix, while the CαR-enantiomer induces the M conformation. From the PMF profiles 
as a function of φ and ψ dihedrals, obtained from the REMD simulations of peptide 2, 
we can see that the switch from one screw sense to the other is more probable when 
the ΔEM‡ and ΔEM are lower than 1 kcal/mol, both in implicit and explicit solvent. In 
principle, the helical inversion can occur at any point along the peptide chain, 
however it is more frequently observed at Aib6 or Aib7, the residues just above the 
two chiral ones. Moreover, it is clear that methanol reduces the energetic barrier 
between the P- and the M-helix, since it might stabilize high energy conformations by 
creating H-bonds with the backbone atoms. 
Furthermore, PNEB simulations allowed to clarify how the inversion from one 
helical screw sense to the other takes place and, thus, to qualitatively prove the 
hypothesis that γ-turns are intermediates in the screw sense inversion. Indeed, we 
found that this process does not show any recurring propagation direction, but, on the 
contrary, it implies the break of internal H-bonds, leading to a sigmoidal conformation 
characterized by the presence of multiple β-turns of any type. These turns create local 
conformations where the switch from β- to β’-turn independently occurs. An obligated 
step at this point is the formation of transient γ-turns, which are required in order to 
switch from negative to positive dihedral values and vice versa. 
In conclusion, in this part of the project we developed some basic knowledge that 
might be useful for the design of well-structured helical peptide, containing cCTAAs 
as helical stabilizers, and with a defined helical screw sense. At the same time, we 
investigated the mechanisms behind the helical screw sense inversion, which might be 
exploited to design switchable helical peptide that can be activated to PPI modulators 
by inducing a conformational change. 
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7.3 MATERIALS AND METHODS 
REMD Simulations. Aib, (R)- and (S)-αMeVal amino acids and the Cbz 
protecting group were designed using MOE.227. The formers were capped with an 
acetyl (Ac) and a NHMe group at the N- and C-termini, respectively, while the latter 
was only capped by NHMe at the C-termini. They were then submitted to a “Low 
Mode” conformational search by setting MMFF94x as force field, Born solvation 
model, iteration limit = 40000, MM iteration limit = 2500, and rejection limit = 500. 
For each molecule, the two conformations showing the lowest energy and, in the case 
of the three amino acids, with the φ and ψ dihedrals corresponding to the right- and 
left-handed helical ones (φ = ±60° and ψ = ±45°) were chosen for partial charges 
derivation performed by the R.E.D.IV software228. For this step, the selected 
geometries were optimized at the HF/6-31G(d) level of theory and the RESP-A1 
charges were derived using two different spatial orientations, in order to have an 
orientation- and conformation-independent charges. Moreover, the charges 
ofbackbone nitrogen, hydrogen, carbonyl carbon and oxygen were fixed at the same 
values reported in the AMBER ff99SBildn-φ force field168 for standard amino acids 
(e.g. -0.4157, 0.2719, 0.5973 and -0.5679, respectively). 
Cbz-(S)-αMeVal2-Aib5-(S)-αMeVal2-NHMe (peptide 1) and Cbz-(S)-αMeVal2-
Aib5-(R)-αMeVal2-NHMe (peptide 2) peptides were built by imposing an extended 
conformation (φ = ψ = ω = 180°). REMD simulations in implicit solvent of the two 
peptides were performed using the AMBER ff99SBildn-φ force field coupled with the 
implicit solvent model GB-Neck2 (igb = 8),173 combination that proved to give the 
best results in predicting peptides secondary structures.88 16 replica, spanning 
temperatures between 260.00 K and 690.08 K with a 0.5 probability exchange, were 
run for 100 ns each, for a total of 1.6 µs of simulation for each peptide, using the 
pmemd module of the Amber14 package.259 Unless stated otherwise, the trajectories at 
297.31 K were extracted and analyzed on the 50-100 ns time interval.  
For the REMD simulations in explicit methanol, the Cbz-(S)-αMeVal2-Aib5-(R)-
αMeVal2-NHMe peptide in the extended conformation was solvated with an 
octahedral box of 1290 MeOH molecules (closeness = 8.0 Å) and preliminarily 
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submitted to minimization and equilibrations cycles. Initially 5000 cycles of 
hydrogens minimization (1000 cycles of steepest descent and 4000 cycles of 
conjugated gradient), followed by 5000 cycles of solvent minimization (2000 cycles 
of steepest descent and 3000 cycles of conjugated gradient) were carried out. Then, 
the solvent box was equilibrated at 300 K by 1ns of NVT equilibration and 1ns of 
NPT equilibration using the Langevin thermostat with a frequency collision of 2.0. 
This step was followed by 5000 cycles (2500 of steepest descent and 2500 of 
conjugated gradient) of solvent and sidechains minimization and by 5000 cycles (2500 
of steepest descent and 2500 of conjugated gradient) of total minimization. The last 
step consisted in 100 ps of NVT and 100 ps of NPT equilibration of the whole system. 
The REMD simulation of the equilibrated system was carried out with the AMBER 
ff99SBildn-φ force field and by performing 40 replica of 120 ns each (4.8 µs totally) 
between 290.00 K and 511.61 with an exchange probability of 0.20. The trajectory at 
303.60 K was extracted, the solvent was stripped out and the simulation convergence 
was checked every 10 ns by assuring that the conformations obtained during the 10 ns 
time intervals were similar on the base of the Root Mean Square Deviation (RMSD) 
(Annex 7.A). 
Cluster analyses were performed with cpptraj (Amber14)259 using the average-
linkage algorithm and the pairwise mass-weighted RMSD on the Cα of residues 7-11, 
in order to identify where the screw sense inversion occurs. For the simulations 
conducted in implicit solvent the 50-100 ns time interval was analyzed by sampling 
one every four frames and by requesting 5 clusters on the basis of pseudo-F statistics 
and SSR/SST ratio.260 As regards the REMD in explicit solvent, since convergence 
was reached after 50 ns, the last 60 ns were submitted to cluster analysis, sampling 
one every four frames and requesting 15 clusters. 
H-bonds occupancies during the simulations were computed with VMD 1.9.1231 
over the whole trajectories for the simulations in implicit solvent and on the last 60 ns 
for that in explicit methanol, with a donor-acceptor distance limit of 4.0 Å and an 
angle cutoff of 60°. This very low angle acceptance threshold was chosen in order to 
be able to identify the presence of γ-turns, since it has been showed that the hydrogen 
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bond in γ-turns is highly bent261 and the N-H-O angle can reach values of 110-130°. 
Only H-bonds with an occupancy greater than 5% were considered. The H-bond 
analysis between peptide 2 and methanol molecules was performed with Amber14 
cpptraj, using successively the backbone carbonyl oxygen atoms as acceptor atoms 
and setting methanol molecules as solvent donor, then the methanol residues were 
considered as solvent acceptor and the backbone amidic hydrogens were considered as 
donor atoms. In this case the distance cutoff was set to 4.0 Å and the minimum angle 
accepted was fixed at 150°, as for standard H-bonds. 
Potential of Mean Force (PMF) as a function of φ and ψ dihedrals were computed 
with Amber software coupled with the Weighted Histogram Analysis Method 
(WHAM)262 over the whole implicit solvent trajectories and over the last 60 ns for the 
explicit methanol simulation by setting a histogram limit of ±180°, 100 bins and a 
tolerance of 0.01. Temperatures between 260.00 K and 317.73 K were considered. A 
threshold of 6 kcal/mol has been fixed for the non-accessible conformations. 
NEB simulations. Minimized structures of ideal M- and M-310-helices of Ac-
Aibn-NH2 peptides (n = 4, 6, 8 and 20) were used as initial and final conformations, 
respectively, for the Partial Nudged Elastic Band (PNEB) simulation of the transition 
pathway between right- and left-handed helices. The AMBER ff99SBildn-φ force field 
coupled with the GB-Neck2 solvent model was used. For n = 4, 6, 8 and 20, 24, 36, 48 
and 96 images, respectively, where chosen and the simulations were repeated 10 times 
for each peptide to test the reproducibility of the minimum energy pathway. The NEB 
forces were applied only to the backbone nitrogen, Cα and carbonyl carbon atoms, 
while the RMS fitted the system on all the atoms. The system was initially heated 
from 0 K to 300 K in 20 ps, using a spring constant of 10 kcal·mol-1·Å-2 and the 
Langevin thermostat with a collision rate of 1000 ps-1. In the next 100 ps the system 
was submitted to a MD at 300 K with a spring constant of 50 kcal·mol-1·Å-2. 
Successively, the system was heated from 300 K to 700K and subsequently cooled 
back to 300 K over 750 ps. The cooling to 0 K to remove kinetic energy was 
performed in 120 ps and quenched MD was run over 200 ps. The final pathway was 
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extracted and analyzed. The reproducibility of the simulations was checked by 
comparing the behavior of φ and ψ dihedrals.109,263,264 
H-bond analyses were conducted on the extracted trajectory with VMD 1.9.1 
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8 NWAT-MMGBSA: A MMGBSA-BASED APPROACH TO IMPROVE THE 
CORRELATION BETWEEN PREDICTED BINDING ENERGIES AND 
EXPERIMENTAL ACTIVITIES  
As previously underlined, the prediction of the activity of a designed molecule 
toward a defined target represents a fundamental, although challenging, goal of the 
drug discovery process. The combination of MD simulations and MMPB/GBSA 
calculations has been frequently used to compute binding free energies in classical 
protein-ligand,27 DNA-ligand,265 or PPIs.266 However, the correlation between 
MMPB/GBSA predicted binding energies and biological activity was often protocol-
dependent. Indeed, in literature extensive studies on the sensitivity of MMPB/GBSA 
results to protocol changes can be found.114,267,268 
In this context, much attention has been paid to tune the solvation term in its 
electrostatic component, with a particular interest on the parameters common to both 
PB and GB equations (eq. 3 and 4).90 In this framework, studies on the effects of a 
variation if the internal dielectric constant 𝜖𝑖𝑛 on the correlation between experiments 
and predicted binding energies showed that this parameter highly affects the 
calculation. Moreover, an universal value for this constant, i.e. suitable for all the 
protein systems, cannot be found and this choice necessarily depends on an analysis of 
the properties of the binding pocket.267–270 Therefore, if a good dataset of known 
ligands with known activity data is not available, the variation of 𝜖𝑖𝑛 should seldom be 
done. 
Another approach to increase the correlation between experimental activities and 
MMPB/GBSA predicted binding energies consists in the inclusion of selected explicit 
water molecules in the calculation. This approached stemmed from the previously 
underlined observation that water can play a relevant role in both receptor-ligand and 
protein-protein interactions, because it can takes part in water-mediated H-bonds or it 
can stabilize the complex through transient H-bonds.90,120,271 
The selection of the water molecules to be included in the calculation can be done 
in different ways. The most intuitive consists in including the solvent molecules that 
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are known to mediate receptor-ligand binding or PPI from crystallographic data.272,273 
However, this approach can lead to detrimental results,274 because, during the MD 
simulation water molecules can rapidly exchange their positions. Therefore, although 
a water mediated H-bond can be detected during the whole simulation time, the water 
residue involved in it can be not always the same. 
To overcome this issue, a possible approach, that proved to increase the 
correlation between experimental and predicted data, is represented by the inclusion of 
water molecules identified from MD trajectory analysis through H-bond analysis,275 
B-factor analysis119 or water density/occupancy analysis,276 or by selecting those 
water residues which are, frame by frame, the closest to the ligand or to the residues 
involved in the PPI.89 
Although all these approaches have the advantage of their generalizability and 
reproducibility, because the selected water residues are those which pass a defined 
numerical threshold, the last one is the easiest to automatize, thanks to the cpptraj 
“closest” command192 (Figure 8.1). This command allows the user to process the 
explicit solvent MD trajectory to save a new trajectory, containing only a fixed 
number of the closest water molecules (Nwat) to a residue or atom mask during the 
whole simulation time, which can be directly used for the MMPB/GBSA calculation 
(see Annex 10.A and 11.F).  
 
Figure 8.1. Nwat-MMPB/GBSA approach scheme. 
Therefore, we decided to initially test this approach on classical receptor-ligand 
complexes, for which experimental activities were available, in order to verify its 
reliability and its benefit compared to the standard MMPB/GBSA method (Chapter 9). 
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Then, we optimized the protocol for the binding affinity prediction in PPIs (Chapter 
10), because these systems, as observed in Chapter 1, are structurally different from 
classical receptor-ligand systems.  
Finally, at the light of the good obtained results, we automatized the process by 
writing a script that performs the setup, calculations and analysis and evaluated the 
optimized protocol for the prediction of activities of a set of small molecules or 




9 APPLICATION OF NWAT-MMGBSA TO CLASSICAL RECEPTOR-
LIGAND COMPLEXES 
9.1 INTRODUCTION 
Bearing in mind that water can contribute to the binding free energy of receptor-
ligand complexes and that it is often found at protein binding sites,119,271,275,277 we 
initially applied the Nwat-MMPB/GBSA approach to four different protein systems, 
namely topoisomerase I-DNA, α-thrombin, penicillopepsin and avidin complexes, to 
evaluate both the reliability and robustness of the protocol. 
In particular, the topoisomerase I-DNA system was selected because it is known 
that water plays an important role in mediating H-bond interactions between the 
topoisomerase I and camptothecin (CPT)-like inhibitors,278 α-thrombin and 
penicillopepsin complexes were chosen because previously reported MMPB/GBSA 
results were poorly correlated with experiments, when using the default 𝜖𝑖𝑛.267 
Conversely, the avidin system was considered because of the high correlation 
coefficient obtained with the standard dielectric constant, in order to observe if the 
Nwat-MMPB/GBSA protocol was detrimental for systems where water does not seem 
to play a role in the receptor ligand interaction.267,268,279 
Therefore, we considered the complexes of topoisomerase I – DNA and 9 CPT 
derivatives with known IC50 (Figure 9.1), 7 α-thrombin–ligand and 7 penicillopepsin–
igand and 7 avidin–ligand complexes with known ΔGbind (Figure 9.2, 9.3, and 9.4, 
respectively). 
Each system will be discussed independently, in order to provide a clear 
explanation about the reproducibility, reliability and robustness of the Nwat-
MMGBSA approach, evaluated in terms of squared Pearson’s correlation coefficient 
(r2) between computed binding energies and available experimental data. Although, 
additional investigations have been performed on the topoisomerase I – DNA system, 
because of the known importance of water in the interaction between topoisomerase 




Figure 9.1. Considered topoisomerase I ligands at the protonation state used for the analyses; 
experimental IC50s are also reported.280 
 





Figure 9.3. Considered penicillopepsin ligands; experimental free energies of binding (ΔGbind) are also 
reported.267  
 





Figure 9.5. Crystallographic structure of the topoisomerase I – DNA – topotecan (TTC) complex (PDB 
code: 1K4T). Crystallographic waters interacting with both the protein and the ligand are highlighted. 
9.2 RESULTS AND DISCUSSION 
Topoisomerase I - DNA. H-bond analyses performed on TTC and SN38 
complexes confirmed the previously underlined observation that even hydrogen-
bound waters can rearrange, and a specific residue is replace by a neighboring one. 
Indeed, for example, the C3=O of TTC takes part in a H-bond with water for the 73% 
of the simulation time, although 5 different water residues determine this occupancy, 
namely WAT1638 (37.4%), WAT20971 (25.6%), WAT28324 (4.3%), WAT22562 
(3.2%), and WAT20947 (2.5%). Analogous considerations can be done for all the 
TTC atoms able to take part in H-bonds, namely, C14=O, N6, O2, and C9 – OH 
(Table 9.1). This latter interacts with 10 different water residues for about the 20% of 
the simulation time. The simulation of the SN38 complex led to consistent results, 
although in this case SN38 interacted with about 20 water molecules during the 
simulation time (Table 9.2). 
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Table 9.1. H-bonds between TTC and water during the last ns of MD simulation. D, A and Occ are the 
donor atom, the acceptor atom and the occupancy, respectively. 
D A Occ  D A Occ 
WAT20971-O TTC-O=C3 25.6%  TTC-OH(C9) WAT3805-O 2.0% 
WAT16448-O TTC-OH(C9) 1.4%  TTC-OH(C4) WAT30530-O 0.1% 
WAT25062-O TTC-O=C14 2.0%  TTC-OH(C9) WAT10204-O 1.3% 
WAT22562-O TTC-O=C3 3.2%  WAT25062-O TTC-OH(C9) 4.7% 
WAT25062-O TTC-N13 0.4%  WAT20998-O TTC-O=C14 0.1% 
WAT28324-O TTC-O=C3 4.3%  WAT12379-O TTC-OH(C9) 1.0% 
WAT20971-O TTC-O2 3.6%  TTC-OH(C9) WAT18473-O 0.4% 
WAT28324-O TTC-O2 0.2%  WAT3805-O   TTC-OH(C9) 0.1% 
WAT20947-O TTC-O=C3 2.5%  WAT24732-O TTC-OH(C9) 0.6% 
WAT16384-O TTC-O=C3 37.4%  WAT10910-O TTC-O=C14 2.0% 
WAT3278-O   TTC-OH(C9) 0.2%  WAT10910-O TTC-N13 0.4% 
TTC-OH(C9) WAT16448-O 0.2%  WAT24111-O TTC-N6 0.3% 
WAT20947-O TTC-O2 0.1%  TTC-OH(C9) WAT8209-O 7.3% 
TTC-OH(C9) WAT12379-O 0.6%  WAT24111-O TTC-OH(C9) 2.0% 
WAT10204-O TTC-OH(C9) 7.8%  WAT10910-O TTC-N6 0.5% 
WAT16384-O TTC-O2 3.9%  WAT10910-O TTC-OH(C9) 0.2% 
WAT16025-O TTC-OH(C9) 2.2%     
 
Table 9.2. H-bonds between SN38 and water during the last ns of MD simulation. D, A and Occ are the 
donor atom, the acceptor atom and the occupancy, respectively. 
D A Occ  D A Occ 
SN38-OH(C9) WAT9324-O 35.7%  WAT10865-O SN38-OH(C9) 1.0% 
WAT14674-O SN38-O=C3 66.8%  WAT9324-O   SN38-OH(C9) 1.4% 
WAT9756-O   SN38-O=C14 18.4%  SN38-OH(C9) WAT20864-O 0.2% 
WAT16826-O SN38-OH(C9) 0.5%  WAT14633-O SN38-O=C3 0.1% 
WAT14674-O SN38-O2 4.1%  WAT14422-O SN38-O=C3 0.2% 
WAT21099-O SN38-OH(C9) 1.4%  WAT10627-O SN38-OH(C9) 14.7% 
WAT9756-O   SN38-N13 0.3%  SN38-OH(C4) WAT14422-O 0.1% 
WAT19706-O SN38-O=C3 0.3%  WAT21173-O SN38-O=C14 8.0% 
SN38-OH(C9) WAT17717-O 2.9%  SN38-OH(C9) WAT5781-O 4.3% 
WAT11350-O SN38-OH(C9) 0.6%  SN38-OH(C9) WAT10627-O 2.2% 
WAT20864-O SN38-OH(C9) 1.3%  WAT6006-O   SN38-OH(C9) 0.4% 
WAT28324-O SN38-O=C14 0.2%  SN38-OH(C9) WAT16853-O 5.6% 
WAT5781-O   SN38-OH(C9) 3.8%  SN38-OH(C9) WAT9756-O 1.1% 
WAT22614-O SN38-O=C14 38.3%  WAT26026-O SN38-OH(C9) 0.1% 
WAT22614-O SN38-N13 0.4%  WAT14422-O SN38-OH(C4) 0.1% 
WAT16853-O SN38-OH(C9) 4.4%  WAT6651-O   SN38-OH(C9) 0.2% 
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These results are not in conflict with the X-ray data, because crystallographic 
residues are identified as a mean electron density, which can be determined by 
different water molecules which concur to occupy the same position.281 Indeed, the 
grid analysis performed for water oxygen atoms showed that the high-water-density 
regions match with crystallographic water molecules of the X-ray structure (Figures 
9.5 and 9.6). 
Therefore, standard MMPBSA and MMGBSA (Nwat = 0) calculations and 
Nwat-MMPBSA and MMGBSA analyses with Nwat = 10, 20, 30, 40, and 50 were 
performed and the results were correlated to − log10(𝐼𝐶50) (Figures 9.8 and 9.9). 
 
Figure 9.6. Water density plots obtained by grid analysis (ptraj; grid box = 50x50x50 Å, mesh = 0.5 Å; 
visualization with VMD specifying an isovalue = 45) of topoisomerase-DNA-TTC complex. 
 





Figure 9.8. Correlations between MMGBSA predicted binding energies and experimental –log10(IC50) 




Figure 9.9. Correlations between MMPBSA predicted binding energies and experimental –log10(IC50) 
for topoisomerase – DNA complexes. 
Figures 9.7, 9.8 and 9.9 show that the Nwat-MMPBSA and Nwat-MMGBSA 
protocols gave for any Nwat better correlations with experiments than the standard 
MMPBSA and MMGBSA, being the best results those obtained with Nwat = 20 for 
both PB and GB (r2 = 0.51 and 0.87, respectively). In detail, the correlation sharply 
increases with Nwat switching from 10 to 20, while it slowly decreases with 30 or 
more water molecules, although maintaining an acceptable correlation. 
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Therefore, it seems that the inclusion of only 10 water molecules around the 
ligand is not sufficient to take in account all the explicit interactions between the 
solute and the solvent. Conversely, in this case the use of Nwat > 20 turned out to be 
slightly detrimental, probably because of the background noises due to the inclusion 
of a number of solvent molecules larger than needed. 
From Figures 9.8 and 9.9, it can be noticed that the improvement in the r2 is 
mainly due to a better description of a single ligand, TTC. An explanation of this is 
given by the comparison of the H-bond analyses performed on the Nwat = 10 and 20 
trajectories for TTC and SN38, with this latter weakly affecting the r2 (Tables 9.3, 9.4, 
9.5). The H-bonds with an occupancy greater than 5% detected for the SN38 
trajectories remained constant at the increase of Nwat, whereas for TTC an increase of 
H-bonds were observed when shifting from Nwat = 10 to Nwat = 20. These results 
provide an explanation to the fact the best r2 was obtained with Nwat = 20, and 
suggest that a better correlation can be obtained by considering not only those few 
water molecules making stable water-mediated H-bonds between the ligand and the 
receptor, but also those waters involved in transient interactions, but that still 
contribute to the determination of a water buffer between the ligand and the binding 
site residues. 
Table 9.3. H-bonds between TTC and water of the Nwat= 10 trajectory (occupancy ≥ 5%). 
Donor Atom Acceptor Atom  Occ  Donor Atom Acceptor Atom  Occ 
TTC-N28 WAT611-O   11.8%  WAT616-O   TTC-O18 9.3% 
WAT616-O   TTC-N10 8.3%  WAT620-O   TTC-N10 5.5% 
WAT618-O   TTC-O23 8.8%  WAT615-O   TTC-O18 6.9% 
WAT613-O   TTC-O26 12.9%  WAT617-O   TTC-O26 7.4% 
TTC-O26 WAT611-O   60.2%  WAT619-O   TTC-O26 7.2% 
WAT618-O   TTC-O18 12.2%  TTC-N28 WAT612-O   10.4% 
WAT614-O   TTC-O26 10.2%  WAT619-O   TTC-O18 12.1% 
WAT616-O   TTC-O26 7.9%  TTC-O26 WAT612-O   10.3% 
WAT613-O   TTC-N10 5.4%  WAT618-O   TTC-N10 8.1% 
WAT619-O   TTC-O23 7.4%  WAT620-O   TTC-O23 6.3% 
WAT620-O   TTC-O26 9.0%  WAT615-O   TTC-N10 6.5% 
WAT619-O   TTC-N10 6.8%  WAT614-O   TTC-N10 7.5% 
WAT620-O   TTC-O18 11.5%  WAT612-O   TTC-O26 7.5% 
WAT617-O   TTC-O18 10.5%  WAT617-O   TTC-N10 9.1% 
WAT615-O   TTC-O26 9.6%  WAT618-O   TTC-O26 6.5% 
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Table 9.4. H-bonds between TTC and water of the Nwat = 20 trajectory (occupancy ≥ 5%). 
Donor Atom Acceptor Atom  Occ  Donor Atom Acceptor Atom  Occ 
TTC-N28 WAT611-O   11.8%  WAT620-O   TTC-N10 5.5% 
WAT616-O   TTC-N10 8.3%  WAT624-O   TTC-O23 6.0% 
WAT618-O   TTC-O23 8.8%  WAT623-O   TTC-O23 8.3% 
WAT613-O   TTC-O26 12.9%  WAT624-O   TTC-O18 6.5% 
TTC-O26 WAT611-O   60.2%  WAT624-O   TTC-O26 6.9% 
WAT618-O   TTC-O18 12.2%  WAT621-O   TTC-O18 9.8% 
WAT614-O   TTC-O26 10.2%  WAT622-O   TTC-O26 9.2% 
WAT616-O   TTC-O26 7.9%  WAT615-O   TTC-O18 6.9% 
WAT613-O   TTC-N10 5.4%  WAT617-O   TTC-O26 7.4% 
WAT619-O   TTC-O23 7.4%  WAT619-O   TTC-O26 7.2% 
WAT620-O   TTC-O26 9.0%  TTC-N28 WAT612-O   10.4% 
WAT623-O   TTC-O26 6.4%  WAT619-O   TTC-O18 12.1% 
WAT626-O   TTC-O26 5.9%  TTC-O26 WAT612-O   10.3% 
WAT619-O   TTC-N10 6.8%  WAT618-O   TTC-N10 8.1% 
WAT617-O   TTC-O18 10.5%  WAT620-O   TTC-O23 6.3% 
WAT620-O   TTC-O18 11.5%  WAT615-O   TTC-N10 6.5% 
WAT615-O   TTC-O26 9.6%  WAT614-O   TTC-N10 7.5% 
WAT616-O   TTC-O18 9.3%  WAT622-O   TTC-O18 7.8% 
WAT621-O   TTC-O23 9.6%  WAT612-O   TTC-O26 7.5% 
WAT627-O   TTC-O26 5.7%  WAT625-O   TTC-O26 5.1% 
WAT621-O   TTC-O26 8.3%  WAT617-O   TTC-N10 9.1% 
WAT622-O   TTC-O23 6.4%  WAT618-O   TTC-O26 6.5% 
WAT623-O   TTC-O18 7.9%     
Table 9.5. H-bonds between SN38 and water of the Nwat
 
= 10 (left) and 20 (right) trajectories 
(occupancy ≥ 5%). 
Nwat = 10    Nwat = 20   
Donor Atom Acceptor Atom  Occ  Donor Atom Acceptor Atom  Occ 
SN38-OH(C9)  WAT611-O   82.4%  SN38-OH(C9)  WAT611-O   82.4% 
WAT617-O  SN38-O=C3 7.0%  WAT617-O  SN38-O=C3 7.0% 
WAT612-O  SN38-O=C14 8.0%  WAT612-O  SN38-O=C14 8.0% 
WAT615-O  SN38-O=C3 12.0%  WAT615-O  SN38-O=C3 12.0% 
WAT613-O  SN38-O=C3 8.3%  WAT613-O  SN38-O=C3 8.3% 
WAT619-O  SN38-OH(C9) 7.3%  WAT619-O  SN38-OH(C9) 7.3% 
WAT616-O  SN38-OH(C9) 7.6%  WAT616-O  SN38-OH(C9) 7.6% 
WAT612-O  SN38-O=C3 6.0%  WAT612-O  SN38-O=C3 6.0% 
WAT613-O  SN38-OH(C9) 7.2%  WAT613-O  SN38-OH(C9) 7.2% 
WAT615-O  SN38-OH(C9) 8.4%  WAT615-O  SN38-OH(C9) 8.4% 
WAT618-O  SN38-O=C14 6.3%  WAT618-O  SN38-O=C14 6.3% 
WAT616-O  SN38-O=C3 7.6%  WAT616-O  SN38-O=C3 7.6% 
WAT613-O  SN38-O=C14 10.5%  WAT613-O  SN38-O=C14 10.5% 
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WAT615-O  SN38-O=C14 9.2%  WAT615-O  SN38-O=C14 9.2% 
WAT614-O  SN38-O=C3 10.5%  WAT614-O  SN38-O=C3 10.5% 
WAT618-O  SN38-O=C3 5.1%  WAT618-O  SN38-O=C3 5.1% 
WAT614-O  SN38-OH(C9) 6.9%  WAT614-O  SN38-OH(C9) 6.9% 
WAT618-O  SN38-OH(C9) 8.4%  WAT618-O  SN38-OH(C9) 8.4% 
WAT614-O  SN38-O=C14 10.5%  WAT614-O  SN38-O=C14 10.5% 
WAT617-O  SN38-OH(C9) 8.1%  WAT617-O  SN38-OH(C9) 8.1% 
WAT616-O  SN38-O=C14 8.6%  WAT616-O  SN38-O=C14 8.6% 
WAT617-O  SN38-O=C14 6.8%  WAT617-O  SN38-O=C14 6.8% 
The Nwat-MMPB/GBSA approach also allows a better estimation of the activity 
of the fluorinated derivative 12. The analysis of IC50 suggests that substitutions at the 
C12 of the C-ring decreases the activity of CPT derivatives (compounds 7, 8, 12, 20 
and 22), with a more pronounced detrimental effect observed when the C12 
substituent is an H-bond acceptor. In addition, although the 12α and 12β epimers had 
the same IC50,280 the standard MMPB/GBSA calculation (Nwat = 0) overestimated the 
activity of 12α, while the application of the Nwat-MMPB/GBSA approach gave 
converged binding energies, thanks to a better estimation of 12α. This is explained by 
observing that, during the MD simulation, 12α F atom is more exposed to the solvent 
than the F atom of 12β, as showed by the water density plots obtained from grid 
analysis on the trajectories (Figure 9.10). 
 
Figure 9.10. Water density plots obtained by grid analysis (ptraj; grid box = 50x50x50 Å, mesh = 0.5 
Å; visualization with VMD, isovalue = 45) of topoisomerase-DNA-12α (A) and 12β (B) complexes. 
It has to be underlined that the GB method gave better results than PB, in 
agreement with that observed by other authors.267,279,282 Therefore, GB seems to be 
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better suited for drug design/discovery purposes, especially considering its 
significantly lower computational cost compared to PB (in the present study, GB 
required 1/6 of the computational time needed by PB). 
At the light of this, although both MMPBSA and MMGBSA analyses were 
performed (see Annex 9.A for MMPBSA results), the discussion of the remaining 
systems will be focused on the latter method. 
α-Thrombin. Standard MMGBSA calculations (Nwat = 0) on this system 
already gave acceptable correlation between computed binding energies and 
experimental binding free energies (r2 = 0.67, rs = 0.82). The application of the Nwat-
MMGBSA approach (Nwat = 10, 20, 30, 40, 50, 60 and 70) gave different results 
from those observed for the topoisomerase – DNA systems. Indeed, the inclusion of 
only 10 water molecules caused the decrease of the r2 (Figures 9.10 and 9.12), 
suggesting that a small hydration shell around the ligand introduces noise and it does 
not improve the treatment of solute-solvent interactions. However, with higher Nwat 
the r2 increases, up to 0.78 (Nwat = 50). To check the calculation convergence, the 
analyses with Nwat = 60 and 70 were also performed, showing a negligible increase in 
the correlation (r2 = 0.83). 
Therefore, for the α-thrombin system the improvement in the correlation between 
computed and experimental ∆𝐺𝑏𝑖𝑛𝑑 was less significant than that observed in the 
previous example, and it could only be noticed with the inclusion of a rather large 
hydration shell (Nwat = 50 – 70). At the light of this, it can be hypothesized that in 
this case water plays a less relevant role in mediating receptor-ligand binding. Indeed, 
H-bond analyses performed on the MID and BT2 trajectories showed the presence of 
H-bond with negligible occupancies (between 0.10 and 3.70%, Table 9.6) and the 
water density around the ligand showed by grid analysis (Figure 9.11) was poor 
compared to that observed for topoisomerase (Figure 9.10). 
Therefore, in this case, the mild r2 improvement given by the application of the 
Nwat-MMGBSA approach is probably ascribable to a contribution given to the 




Figure 9.10. Trend of r2 as a function of Nwat for α-thrombin system. 
 
Figure 9.11. Water density plots obtained by grid analysis (ptraj; grid box = 50x50x50 Å, mesh = 0.5 








Table 9.6. H-bonds between MID/BT2 and water during the last ns of MD simulation. 
MID    BT2   
Donor Atom Acceptor Atom Occupancy  Donor Atom Acceptor Atom Occupancy 
WAT5573-O MID-O=S11 2.2%  WAT863-O BT2-O1 0.4% 
WAT5573-O MID-S11   0.2%  BT2-N34 WAT1148-O 0.2% 
WAT8805-O MID-N26 0.2%  WAT1148-O BT2-O3 0.1% 
WAT9812-O MID-N12    0.9%  BT2-N10 WAT863-O 0.5% 
WAT9812-O MID-O=S11 2.6%  WAT8353-O BT2-S16 0.2% 
WAT9812-O MID-S11   1.5%  BT2-N34 WAT8533-O 0.9% 
WAT924-O MID-O=S11 3.7%  WAT4716-O BT2-O1 0.2% 
WAT924-O MID-S11  0.5%  BT2-N10 WAT4716-O 0.2% 
MID-N15 WAT9812-O 0.2%  WAT3398-O BT2-O1 0.2% 
WAT3348-O MID-O=S11 0.3%  BT2-N10 WAT4423-O 0.3% 
WAT3348-O MID-S11   0.1%  WAT2725-O BT2-O1 0.1% 
WAT8182-O MID-O=S11 1.2%  WAT4687-O BT2-S16 0.5% 
WAT8182-O MID-S11   0.7%  BT2-N34 WAT7785-O 0.6% 
WAT8182-O MID-N12   0.1%  WAT7785-O BT2-N34 0.1% 
WAT10308-O MID-O=S11 1.1%     
WAT10308-O MID-S11  0.3%     
WAT11327-O MID-O=S11 0.2%     
Penicillopepsin. For penicillopepsin, the standard MMGBSA calculations (Nwat 
= 0) gave a modest correlation between predicted and experimental ∆𝐺𝑏𝑖𝑛𝑑 (r2 = 0.46, 
rs = 0.68). Conversely, the Nwat-MMGBSA approach, with Nwat = from 10 to 70, 
gave a significant improvement of r2 value (Figures 9.13 and 9.15).  
For this system, the r2 constantly improved with increasing Nwat, although a 
sharp hike was observed for Nwat = 20-30 (r2 = 0.70), followed by the convergence to 
a plateau value of 0.79 (Nwat = 70). The positive effect on correlation between 
predicted and experimental ∆𝐺𝑏𝑖𝑛𝑑 can be explained by observing the presence of 
quite wide areas of high water density around the ligand highlighted by the grid 




Figure 9.13. Trend of r2 as a function of Nwat for penicillopepsin system. 
The estimation of the binding affinity of the APU ligand was the most affected by 
the application of the Nwat-MMGBSA approach (Figure 9.15), because its binding 
energy was highly underestimated by the standard protocol. Therefore, H-bond 
analyses were performed on the Nwat = 10 and 20 trajectories of APU and APT 
(Tables 9.7, 9.8 and 9.9), with this latter being a complex not affected by the explicit 
inclusion of water molecules in MMGBSA calculations. 
As previously observed for TTC (Tables 9.3 and 9.4), the number of H-bonds 
between APU and water molecules increased from 41 to 70 when passing from Nwat 
= 10 to Nwat = 20 (Tables 9.7 and 9.8), while the APT complex simulation had only 6 
H-bonds between APT and water with Nwat = 20, compared to Nwat = 10 (Table 
9.9). 
 
Figure 9.14. Water density plots obtained by grid analysis (ptraj; grid box = 50x50x50 Å, mesh = 0.5 
Å; visualization with VMD, isovalue = 45) of APT-penicillopepsin complex. 
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It has to be noted that in this case MMPBSA gave better r2 than MMGBSA 
(Annex 9.A), however positive ∆𝐺𝑏𝑖𝑛𝑑 have been obtained with the former method. 
Table 9.7. H-bonds between APU and water of the Nwat
 
= 10 trajectory (occupancy ≥ 5%). 
Donor Atom Acceptor Atom Occ Donor Atom Acceptor Atom Occ 
WAT334-O   IVA-O=C5 8.8%   WAT333-O   STA-O29 11.3% 
WAT335-O   VAL326-O=C16 7.3%   WAT333-O   IVA-O=C5 6.8% 
WAT330-O   STA-O29 9.5%   WAT337-O   VAL326-O=C16 8.0% 
WAT329-O   STA-O29 5.6%   WAT329-O   STA-O=C28   5.3% 
WAT332-O   STA-O29 12.0%   WAT330-O   IVA-O=C5 5.6% 
VAL325-N6 WAT328-O   35.7%   VAL325-N613 WAT329-O   17.4% 
WAT333-O   VAL326-O=C16 8.1%   WAT335-O   IVA-O=C5 7.1% 
WAT331-O   STA-O29 11.0%   WAT329-O   VAL326-O=C16 5.6% 
WAT337-O   STA-O29 12.4%   WAT336-O   STA-O=C28   17.0% 
WAT336-O   STA-O29 13.5%   WAT334-O   STA-O=C28   15.5% 
WAT337-O   STA-O=C28  14.0%   WAT337-O   IVA-O=C5 6.6% 
WAT331-O   STA-O=C28   13.6%   WAT331-O   IVA-O=C5 5.9% 
WAT336-O   IVA-O=C5 6.9%   WAT332-O   VAL326-O=C16 7.1% 
WAT334-O   VAL326-O=C16 5.7%   WAT336-O   VAL326-O=C16 6.5% 
WAT335-O   STA-O=C28   16.7%   VAL325-N66 WAT329-O   11.3% 
WAT330-O   STA-O=C28   8.2%   STA-OH-C23   WAT328-O   34.0% 
WAT332-O   STA-O =C28  16.7%   STA-OH-C23   WAT329-O   6.7% 
WAT335-O   STA-O29 12.8%   VAL325-N66 WAT330-O   7.0% 
WAT334-O   STA-O29 13.3%   STA-N21 WAT328-O   26.1% 
WAT331-O   VAL326-O=C16 6.9%   STA-N21 WAT329-O   5.9% 
WAT333-O   STA-O=C28   18.7%      
 
Table 9.8. H-bonds between APU and water of the Nwat
 
= 20 trajectory (occupancy ≥ 5%). 
Donor Atom Acceptor Atom Occ Donor Atom Acceptor Atom Occ 
WAT342-O  IVA-O=C5 7.4%  WAT340-O  STA-O=C28  11.1% 
WAT334-O  IVA-O=C5 8.8%  WAT344-O  IVA-O=C5 5.0% 
WAT335-O  VAL326-O=C16 7.3%  WAT337-O  VAL326-O=C16 8.0% 
WAT330-O  STA-O29 9.5%  WAT329-O  STA-O=C28   5.3% 
WAT343-O  STA-O=C28   8.8%  WAT330-O  IVA-O=C5 5.6% 
WAT329-O  STA-O29 5.6%  WAT338-O  STA-O29 10.7% 
WAT338-O  STA-O=C28   13.0%  VAL326-N13  WAT329-O   17.4% 
WAT332-O  STA-O29 12.0%  WAT335-O  IVA-O=C5 7.1% 
VAL326-N13  WAT328-O   35.7%  WAT329-O  VAL326-O=C16 5.6% 
WAT333-O  VAL326-O=C16 8.1%  WAT336-O  STA-O=C28  17.0% 
WAT341-O  STA-O=C28  10.6%  WAT341-O  VAL326-O=C16 5.0% 
WAT331-O  STA-O29 11.0%  WAT342-O  STA-O29 6.5% 
WAT344-O  STA-O29 6.4%  WAT345-O  STA-O29 5.0% 
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WAT337-O  STA-O29 12.4%  WAT334-O  STA-O=C28   15.5% 
WAT336-O  STA-O29 13.5%  WAT337-O  IVA-O=C5 6.6% 
WAT337-O  STA-O=C28   14.0%  WAT342-O  STA-O=C28   9.1% 
WAT341-O  STA-O29   8.7%  WAT339-O  STA-O29 9.9% 
WAT331-O  STA-O=C28   13.6%  WAT341-O  IVA-O=C5 5.2% 
WAT336-O  IVA-O=C5 6.9%  WAT331-O  IVA-O=C5 5.9% 
WAT334-O  VAL326-O=C16 5.7%  WAT332-O  VAL326-O=C16 7.1% 
WAT343-O  STA-O29 6.0%  WAT345-O  STA-O=C28   6.1% 
WAT335-O  STA-O=C28   16.7%  WAT339-O  STA-O=C28   11.4% 
WAT339-O  IVA-O=C5 6.8%  WAT343-O  IVA-O=C5 5.6% 
WAT338-O  VAL326-O=C16 6.4%  WAT336-O  VAL326-O=C16 6.5% 
WAT335-O  STA-O29 12.8%  WAT340-O  STA-O29 7.5% 
WAT330-O  STA-O=C28   8.2%  WAT346-O  STA-O=C28   5.5% 
WAT332-O  STA-O=C28   16.7%  WAT340-O  VAL326-O=C16 5.7% 
WAT334-O  STA-O29 13.3%  WAT344-O  STA-O=C28   7.1% 
WAT338-O  IVA-O=C5 5.8%  WAT347-O  STA-O=C28   6.0% 
WAT331-O  VAL326-O=C16 6.9%  VAL325-N6  WAT329-O   11.3% 
WAT333-O  STA-O=C28   18.7%  STA-OH-C23  WAT328-O   34.0% 
WAT340-O  IVA-O=C5 5.6%  STA-OH-C23  WAT329-O   6.7% 
WAT339-O  VAL326-O=C16 6.4%  VAL325-N6  WAT330-O   7.0% 
WAT333-O  STA-O29 11.3%  STA-N21  WAT328-O   26.1% 
WAT333-O  IVA-O=C5 6.8%  STA-N21  WAT329-O   5.9% 
 
Table 9.9. H-bonds between APT and water of the Nwat
 
= 10 (left) and 20 (right) trajectories 
(occupancy ≥ 5%). 
Nwat = 10   Nwat = 20   
Donor Atom Acceptor Atom Occ Donor Atom Acceptor Atom Occ 
LTA-N28  WAT328-O   59.2% 
 
LTA-N28 WAT328-O   58.4% 
WAT336-O  IVA-O=C5 10.3% 
 
WAT336-O IVA-O=C5 11.7% 
LTA-N28  WAT329-O   49.3% 
 
LTA-N28 WAT329-O   48.1% 
WAT332-O  IVA-O=C5 5.1% 
 
WAT332-O IVA-O=C5 6.0% 
WAT333-O  IVA-O=C5 6.3% 
 
WAT340-O IVA-O=C5 8.7% 
WAT337-O  IVA-O=C5 12.0% 
 
WAT339-O IVA-O=C5 10.8% 
WAT335-O  IVA-O=C5 8.8% 
 
WAT333-O IVA-O=C5 6.8% 
LTA-N28  WAT331-O   7.9% 
 
WAT337-O IVA-O=C5 11.0% 
LTA-N28  WAT330-O   30.7% 
 
WAT335-O IVA-O=C5 10.6% 
LTA-OH-C23  WAT328-O   14.3% 
 
WAT343-O IVA-O=C5 5.4% 
WAT334-O  IVA-O=C5 6.2% 
 
WAT341-O IVA-O=C5 6.9% 
WAT330-O  VAL326-O=C16 10.9% 
 
LTA-N28 WAT331-O   7.3% 
VAL326-N13  WAT330-O   6.0% 
 
WAT334-O IVA-O=C5 7.8% 
WAT329-O  VAL326-O=C16 14.4% 
 
WAT342-O IVA-O=C5 6.6% 
WAT328-O  VAL326-O=C16 17.3% 
 
LTA-N28 WAT330-O   25.8% 
    
LTA-OH-C23 WAT328-O   14.3% 
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WAT338-O IVA-O=C5 10.0% 
    
WAT330-O VAL326-O=C16 9.5% 
    
VAL326-N13 WAT330-O   6.1% 
    
WAT329-O VAL326-O=C16 14.8% 
    










Avidin. This system was selected because it already gave good correlation with 
the standard MMGBSA approach.267,283 Thus, it was not surprising that the good r2 
value of 0.72 was obtained with Nwat = 0 and only minor improvements were given 
by using Nwat = 10-70 (Figures 9.16 and 9.17). 
The small increase in r2 obtained with the application of the Nwat-MMGBSA 
method may be attributed to transient interactions between the solute and the solvent. 
Moreover, the poor relevance of water in this system is also highlighted by the grid 
analysis of the complex between avidin and BTN2, which showed the absence of high 
water density around the ligand (Figure 9.18). In addition, no H-bonds with 
occupancies > 5% were found between water residues and the ligand for BTN1 and 
BTN2 trajectories (Table 9.10).  
 









Figure 9.18. Water density plots obtained by grid analysis (ptraj; grid box = 50x50x50 Å, mesh = 0.5 
Å; visualization with VMD, isovalue = 25) of avidin-BTN2 complex. 
Table 9.10. H-bonds between BTN1 (left) or BTN2 (right) and water during the last ns of MD 
simulation. 
BTN1   BTN2   
Donor Atom Acceptor Atom Occ Donor Atom Acceptor Atom Occ 
WAT6517-O BTN1-O=C12 2.7% WAT523-O BTN2-O-(C12) 0.5% 
WAT6517-O BTN1-O-(C12) 0.2% WAT12292-O BTN2-N4 0.1% 
WAT6498-O BTN1-O=C12 4.1% WAT12292-O BTN2-N1 0.1% 
WAT6498-O BTN1-O-(C12) 0.4%    
WAT13708-O BTN1-O=C12 0.1%    
WAT2867-O BTN1-O-(C12) 3.7%    
WAT2867-O BTN1-O=C12 0.1%    
 
At the light of the results of this study, it appears that the Nwat-MMGBSA approach 
represents a useful way to improve the correlation between MMPBG/GBSA predicted 
binding energies and experimental activities of the ligands, without significantly 
affecting the required computational time.  
Although the optimal Nwat was system-dependent, a Nwat = 30 could be considered 
as a default value in MMPB/GBSA calculations for classical receptor-ligand 
complexes. Indeed, also in those cases where water has not a significant role in 
protein-ligand interaction, the inclusion of a hydration shell made of 30 water 
molecules was not detrimental. 
It has also to be underlined that only the correlation between predicted binding 
energies and biological activities increases, while the estimation of absolute binding 
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free energy (which also imply the estimation of binding entropies) might be worsened 
by the presence of water. However, being relative binding energies the most relevant 
quantity in drug design/discovery, and being calculation time a particularly valuable 
resource, this approach might be particularly suited for medicinal chemistry 
applications. 
9.3 MATERIALS AND METHODS 
Preparation of Complexes. 
Topoisomerase. All models were derived from the 1K4T crystal structure.278 The 
considered system is made of human topoisomerase I B, 22 pairs of bases of double 
helix DNA and Topotecan (TTC) as the ligand (Figure 9.19A). The DNA filament 
composed by nucleotides 1-22 is cleaved between thymine 10 and guanidine 11, this 
latter replaced by its 5’-thio derivative (TGP) due to technical reasons related to X-ray 
resolution. Accordingly to the topoisomerase I cleaving mechanism,284 the dangling 3’ 
phosphate group of thymine 10 is covalently bound to the Tyr 723 residue. 
For those reasons, to prepare a suitable system for MD simulations, the TGP 
residue was replaced by guanosine monophosphate. A special attention has been given 
to the covalently bounded thymidine-phosphotyrosine system, for which the definition 
and charge parameterization of two non-standard residues (DTP and TYP for 
thymidine and phosphotyrosine, respectively) was mandatory. Conformation and 
orientation independent partial charges for non-standard residues were derived with 
the R.E.D. IV software,228 accordingly to the ff99SB force field (RESP-A1 charge 
model),141 using two conformations and four orientations for each structure. It’s 
necessary to underline that in the Amber ff99SB force field a total charge of −1.0, 
−0.3079 and −0.6921 is attributed to internal bases, 5’ bases ,and 3’ bases, 
respectively.141 Moreover, when considering the binary complex between DNA and 
topoisomerase, there is an intact DNA strand, with an integer total charge of −21.0, 
and two cleaved strands: one is free and has an integer charge of −11.0, the other one 
has a free 5’ end, while the 3’ end is covalently bound to TYP 723. Since an integer 
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charge is requested for the protein-DNA system, the charge of the TYP residue has 
been restrained to −0.6921 while DTP has been treated as an internal base. 
For DTP, an -OMe group has been used to cap the 5’ phosphate and the 
parameterization has been carried by restraining to −1.0 the final total charge of the 
uncapped DTP. Conversely, to parameterize the TYP residue three caps were added 
(Figure 9.20) and charge restraints were imposed as follow: a NH-methyl cap on C-
terminus with charge of 0.0, an acetyl cap on N-terminus with charge of 0.0 and, on 
the phosphate group, a methoxyl cap with a charge of −0.3079, as this cap simulates 
the covalently bounded DNA strand. The backbone N and C atoms were restrained to 
the same charge value as reported in the force field for the standard tyrosine.141 
Finally, bending parameters for angles involving CA-OS-P and C-OS-P atom types 
have been calculated from the QM optimized structure using the parmchk tool of the 
Amber 11 suite.285 Finally, the covalent bond between the phosphotyrosine and the 
thymidine residues has been created using the LEaP bond command (Figure 9.19B).  
 
Figure 9.19. A) complex between topoisomerase, DNA and topotecan (carbons colored in green); 
evidence on TYP and DTP residues (carbons colored in cyan). B) covalent bond between DTP and 
TYP. 
 
Figure 9.20. TYP residue; the caps (red) have been applied for the charge parameterization step. 
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The complex between DNA and topoisomerase has been finally processed by 
H++ server286 by choosing default settings, in order to establish the correct 
protonation state for each residue under physiological conditions. The resulting total 
charge of the DNA-topoisomerase complex was −12, HIS 22, 146, 167, 311, 376 and 
342 were protonated on the Nε, while HIS 66, 199, 206 and 315 were protonated on 
both Nε and Nδ. 
The ligand test set was made of camptothecin (CPT), topotecan (TTC) and other 
seven derivatives, for which an experimental IC50 value was available in the 
literature.280 For ligands characterized by an additional stereocenter at position 5, 
experimentally evaluated as racemates,29 both the α and β epimers were considered in 
MM-PB/GBSA calculation only for compound 12, as previously reported docking 
calculations evidenced a significant difference among predicted binding energies for 
this compound, while only the β epimer was considered for compounds 7, 8, 20 and 
22. Regarding this latter derivative, a keto-enol tautomerism might be possible 
through an intramolecular H-transfer between the C-5 ammonium and the amidic 
carbonyl (T1 and T2, Figure 9.20). Both tautomers were evaluated, but only the T2 
tautomer, which is stabilized by resonance, provided significant correlation with 































Figure 9.20. Tautomerism for derivative 22. 
Each derivative has then been docked with MOE227 (placement = Alpha Triangle, 
800000 minimum iterations and 5000000 maximum iterations; scoring = Affinity dG; 
the top 30 structures were subjected to force field refinement up to a gradient = 0.01 
and rescored with Affinity dG). A simple pharmacophore (Figure 9.21) consisting of 
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an H-bond acceptor feature centered on the lactone moiety (F1, radius of 2.8 Å) and 
an aromatic feature centered on the quinolone moiety (F2, radius of 2.5 Å) based on 
the crystal structure of topotecan was designed and used as a pharmacophore restraint 
in all dockings.  
 
 
Figure 9.21. Pharmacophore created from bounded TTC and used as a pharmacophore restraint while 
docking topoisomerase I ligands. F1 = H-bond acceptor; F2 = Aromatic. 
The top-ranked conformations were then used to build the complexes. Partial 
charges were then calculated by following the RESP-A1 model with R.E.D.IV, using 
two conformations and four orientations. 
α-thrombin and penicillopepsin. Since the crystallographic structures of the α-
thrombin and penicillopepsin complexes with all the considered ligands were 
available (PDB codes for α-thrombin: 1D3D, 1D3P, 1D3Q, 1D3T, 1DWB, 1DWC, 
1DWD; PDB codes for penicillopepsin: 1APU, 1APT, 1APV, 1APW, 2WEA, 2WEB, 
2WEC), no further action, save the protonation of the two proteins with the H++ 
server, was necessary to build starting geometries for MD simulations. A total charge 
of −2 was obtained for α-thrombin. HIS 72, 95, 116, 145 and 271 of 1DWB, 1DWC 
and 1DWD structures and HIS 71, 94 115, 144 and 263 of 1D3D, 1D3P, 1D3Q and 
1D3T were protonated at Nε. A total charge of −22 was obtained for penicillopepsin, 
where HIS 54, 98 and 159 were protonated at Nε. Partial charges for the α-thrombin 
ligands were derived as previously described for camptothecin derivatives.89 
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Penicillopepsin ligands APT, APU, APV and APW were considered as non-
natural tetrapeptides containing a divaline group substituted with isovaleric acid (IVA) 
at the N-terminus and with one of the non-standard residues LTA, STA, DFI or DFO 
at the C-terminus. Partial charges were thus derived for IVA (capped with a NH-
methyl group), and LTA, STA, DFI and DFO (all capped with acetyl groups) and 
corresponding force field libraries were generated. Conformations were generated 
through the low-mode molecular dynamics conformational search implemented in 
MOE by using default parameters and charges computed with R.E.D.IV as explained 
above. Conversely, charge parameterization for PP4, PP5 and PP6 ligands was done 
on the complete structures by restraining the atoms corresponding to the central valine 
residue to the same charge value as reported in the ff99SB force field for valine.287  
1.3 Avidin. Since the crystallographic structure of avidin-biotin (BTN1) was the 
only one available (1AVD),288 the starting geometries of the six biotin analogues 
(BTN2-BTN7) were manually generated on the basis of the avidin-biotin complex 
using MOE software. It has been shown that the neutral form of the guanidinium 
group in BTN2 and BTN5 is dominant when it is bound to the protein,289 therefore, 
the neutral form of the guanidinium group for these ligands was used in our 
simulations. Partial charges for the biotin analogues were derived as previously 
described for camptothecin derivatives.  
The protein structure was protonated through the H++ server, obtaining a total 
charge of +9 with HIS 48 and 172 being protonated at Nε.  
In all cases, QM geometry optimization and electrostatic potential calculation 
were performed at the HF/6-31G* level, accordingly to the ff99SB force field, by 
using the Gaussian09 software package.233  
Molecular dynamics 
MD simulations were carried out with the pmemd module of the Amber 11 
package285 using the ff99SB141 and gaff force fields. In each case, the system total 
charge was neutralized by adding the proper number of Na+/Cl- ions and solvent, a 
cubic box of TIP3P water, has been added up to a distance of 10 Å from the solute. 
The systems were then relaxed by minimizing hydrogens, ions and waters (1000 
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cycles of steepest descent and 5000 cycles of conjugated gradient). The solvent box 
was then equilibrated at 300 K by 45 ps of NVT and 45 ps of NPT simulation. This 
step was followed by a minimization involving side chains, water and ions and by a 
total minimization (2500 cycles of steepest descent and 5000 cycles of conjugated 
gradient) with restraints applied on backbone atoms (10.0 kcal/mol) and on ligands 
(5.0 kcal/mol). The systems were then heated up to 300 K in 6 steps of 20 ps each (ΔT 
50 K), where backbone and ligand restraints were reduced from 10.0 to 5.0 and from 
5.0 to 0.5 kcal/mol, respectively. Full equilibration was then performed in NVT 
ensemble (100 ps, with a restraint of 10.0 and 5.0 kcal/mol on the backbone and 
ligands, respectively) and in the NPT ensemble (4 steps of 100 ps each, reducing 
backbone and ligand restraints from 5.0 to 2.0 and from 0.5 to 0.2 kcal/mol, 
respectively, followed by a 1 ns NPT equilibration with backbone and ligand restraints 
of 1.0 and 0.1 kcal/mol, respectively). Finally, unrestrained production runs were 
performed at 300 K for 4 ns, a length considered adequate for similar calculations.267 
A cut-off for electrostatic of 8.0 Å, a time step of 0.002 ps and the SHAKE algorithm, 
constraining bonds involving hydrogens, were applied to all calculations. Root-mean-
square deviation (RMSD) analyses of receptor backbone and ligand atoms were made 
to assess the system stability. As regards avidin complexes, the analyses has been 
conducted on each of the two monomers, because the avidin sites are independent of 
each other.290  
In some cases (CPT, 7, 12β, BEN, MIT, PP4 and PP6), poor RMSD convergence 
was observed, so the NPT equilibration step was then extended to 2 ns.  
Both MM-PBSA and MM-GBSA analyses were performed by using the 
MMPBSA.py python script implemented in the Amber 11 package. Analyses were 
conducted on the 4th ns of production run trajectory by selecting 100 evenly spaced 
out snapshots. The atomic radii developed by Onufriev and coworkers (igb=5)172 was 
chosen for all GB calculation, and a salt molar concentration in solution was at 0.15 M 
in both GB and PB calculations (saltcon and istrng parameters, respectively). The 
default PB solver implemented in the sander module was used for PB calculation and, 
unless differently specified, default parameters were adopted.  
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The entropy term in the herein reported binding energy calculations was 
neglected, considering that the benefits of including this term are 
controversial119,267,269,283 and entropy estimations by normal mode analysis are rather 
consuming in terms of CPU time.  
When a ligand hydration shell had to be considered in MM-PB/GBSA analyses, 
corresponding trajectories were obtained using the ptraj keyword “closest”, which 
allows to retain only the requested number of those water molecules that, in each 
frame of the solvated MD trajectory, are the closest to the atoms specified in the mask 
(the ligand atoms, in our case). For performance reason, it has been found convenient 
to sample the requested snapshots with the ptraj “offset” keyword, and successively 
perform the “closest” analysis on the reduced trajectory. MM-PB/GBSA were then 
run by setting “strip_mdcrd=0” (avoid the stripping of water molecules) and 
“interval=1” (consider all frames in the MD trajectory) in the input file. The water 
molecules (10, 20, 30, 40, 50, 60 or 70, depending from the chosen Nwat) defining the 
ligand hydration shell were then included in both the complex and receptor files and 
considered as part of the receptor atoms. Indeed, we noticed that considering water 
molecules as part of the ligand atoms provided worse correlation and higher standard 
deviations to the computed ΔGbind. 
Unless differently specified, the square of Pearson’s correlation coefficient (r2) 
between computed binding energies and available experimental values such as the –
log10(IC50) (for topoisomerase) and ΔGbind (for α-thrombin, penicillopepsin and 
avidin) was used as an evaluation metric. 
As regards avidin complexes, MM-PB/GBSA analyses were performed on 
separate monomers and the results averaged.  
All H-bond analyses of ligand-water interactions were performed on the 4th ns of 
production run with VMD,231 requesting a donor-acceptor distance of 4.0Å, an angle 
cutoff of 30°. The same software has been used to visualize grid density maps, 
generated with a ptraj analysis of the whole production run by setting a cubic box 




10 TEST AND OPTIMIZATION OF NWAT-MMPB/GBSA METHOD ON 
PPIS 
10.1 INTRODUCTION 
As previously observed, water molecules are often found at protein-protein 
interfaces, and solvent can play a role in PPIs by bridging interactions between the 
protein partners o by stabilizing their interaction. 47,50 Therefore, the Nwat-
MMPB/GBSA approach could improve the correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑 
and predicted binding energies also for PPI systems. 
However, the Nwat-MMPB/GBSA protocol previously applied to classical 
receptor-ligand complexes might not be suitable for protein-protein complexes, 
because of their different structural properties, which have been highlighted in 
Chapter 1. Indeed, the large interaction surface15 might need the inclusion in the 
hydration shell of more than 30-50 water molecules, or the big PPI complexes might 
necessitate more than 4 ns of production run to achieve the best results in terms of r2. 
In addition, more recent force fields, or explicit and implicit solvation models might 
affect the prediction of the binding energies. Moreover, the selection of the protein-
protein interfacial residues, to which the hydration shell has to be centered, is 
nontrivial. 
At the light of this, 20 heterodimeric PPI complexes without ions and missing 
residues at the interface and with known experimental ∆𝐺𝑏𝑖𝑛𝑑 (Table 10.1)291 have 
been selected and submitted to explicit solvent MD and to the Nwat-MMPB/GBSA 
approach by using different simulation conditions, with the aim of both optimizing the 
Nwat-MMPB/GBSA method for PPIs and assessing the robustness of the method. In 
particular, for the MD simulations, we tested two different AMBER force fields, 
namely the ff14SB135 and the ff99SBildn136, two different explicit solvent models, 
namely TIP3P292 and TIP4P-Ew293, and 4 ns and12 ns MD simulation lengths. 
Concerning the Nwat-MMPB/GBSA protocol, we tested both the PB and GB 
methods, two implicit solvent models, namely GB-OBC(II)172 and GB-Neck2173, and 
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Nwat = 0 - 50. The effects of these parameters have been evaluated in terms of 
correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑 and computed binding energies. 
In addition, the interface residues have been selected through an automatic python 
script (Annex 10.A), which selects as interfacial residues those whose difference in 
SASA (dASA) from the complex to a single chain is greater than a given cutoff, 
whose effect on the r2 has also been tested by setting it to 0.50 and 0.75. 
Furthermore, we verified the effect of including all the interfacial residues or only 
the polar ones as the residues mask used for the selection of Nwat water molecules. 
All the considered variables are summarized in Table 10.2. 
Moreover, the whole process has been automatized through a tcsh script reported 
in Annex 10.A. 
Table 10.1. PDB ID and experimental ∆𝐺𝑏𝑖𝑛𝑑  of the selected PPI complexes. 
PDB ID Exp. ∆𝐺𝑏𝑖𝑛𝑑 (kcal/mol) PDB ID Exp. ∆𝐺𝑏𝑖𝑛𝑑 (kcal/mol) 
1ACB294 -13.05 1ZHI295 -9.08 
1AVX296 -12.50 2HLE297 -10.09 
1AY7298 -13.23 2HRK299 -10.98 
1BVN300 -15.06 2OOB301 -5.66 
1EMV302 -18.58 2OUL303 -11.96 
1FLE304 -12.28 2SIC305 -13.84 
1GLA306 -6.76 2SNI307 -15.96 
1KAC308 -10.68 2UUY309 -11.26 
1R0R310 -14.17 3BZD311 -9.57 
1YVB312 -11.17 3SGB313 -14.51 
Table 10.2. Protocol variables considered in the present study. 
MD  Nwat-MMPB/GBSA  
Force field ff14SB, ff99SBildn Method GB, PB 
Explicit solvent model TIP3P, TIP4P-Ew Nwat 0 - 50 
Simulation length 4 ns, 12 ns Implicit solvent model GB-OBC(II), GB-Neck2 
  dASA cutoff 0.50, 0.75 




10.2 RESULTS AND DISCUSSION 
The setup of an appropriate and automatic way to select the interfacial residues 
has been nontrivial, therefore this aspect will be explained as first. Indeed, the 
selection of interfacial residues is necessary to define the Nwat water molecules (0 – 
50) to be considered during the Nwat-MMPB/GBSA calculations.  
A straight approach to identify the interfacial residues consists in the selection of 
those residues whose dASA from the PPI complex to the single protein chain is 
greater than a cutoff, which, however, has to be determined. In addition, the relevance 
of selecting all interfacial residues or only the polar one, which most likely will be 
those majorly solvated, needed to be evaluated.  
In detail, the optimization of the protocol for the interfacial residues selection 
included the comparison of MMGBSA analysis of: 
 4th ns of ff99SBildn136 / TIP3P292 explicit solvent model MD simulations 
 4th ns of ff14SB135 / TIP3P292 explicit solvent model MD simulations 
by setting for MMGBSA calculations 
 GB-OBC(II)172 or GB-Neck2173 as implicit solvent model 
 Nwat = 0 – 50 (ΔNwat = 10) 
 dASA = 0.50 or 0.75 
 the selection of all or only the polar interfacial residues. 
The predicted binding energies have been then correlated to the experimental 
∆𝐺𝑏𝑖𝑛𝑑 (Figures 10.12 – 10.37) 
Surprisingly, independently from the simulation and analysis conditions, the 
correlation between experimental and predicted binding energies in terms of r2 was 





Figure 10.1. Variation of r2 in dependency of Nwat for Nwat-MMGBSA analysis performed on the 4th 
ns of the MD simulations. The MD simulation and Nwat-MMGBSA conditions are reported on the top 
of each plot. See figure 10.12 – 10.37 for details. 
This result is explained by observing that the water molecules included during the 
Nwat-MMGBSA analysis are the same (red oxygen water molecules in Figure 10.2), 
except for few residues (blue/yellow oxygen water molecules in Figure 10.2), with a 
cutoff of either 0.50 or 0.75 and with the selection of either all or only polar interfacial 
residues. This is probably due to the fact that water molecules are anyway mainly 
located in proximity of polar residues, thus the different parameters acting on the 
interfacial residues identification do not strongly affect the water molecule selection. 
Therefore the small and not statistically significant differences in the r2 that are 





Figure 10.2. Frame of the 2OUL complex MD simulation (ff14SB, TIP3P) submitted to Nwat-
MMGBSA (Nwat =20; GB-Neck2) after selecting a) all the residues with a dASA cutoff of 0.75 b) only 
polar residues with a dASA cutoff of 0.50 as residues to which the 20 water molecules are close during 
the simulation time. Water molecules with a red oxygen are those residues which have been selected 
with both the approaches; water molecules with yellow oxygen are those selected only by a); water 
molecules with blue oxygen are those selected only by b). 
It has to be underscored that cutoff values of 0.25, 0.10 and 0.05 have also been 
tested, but they led to the same selection obtained with a cutoff of 0.50. Analogously, 
a cutoff value of 1.0 or 0.75 provided the same selection. 
At the light of this, only the results obtained using a cutoff of 0.50 and selecting 
only polar residues will be discussed, whereas those obtained with a cutoff of 0.75 and 
selecting all the residues whose dASA satisfied this threshold were taken in account as 
countercheck. 
Successively, the performances of both PB and GB were tested despite the poor 
performances previously observed for PB methods.89 
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As expected, at all the considered conditions, MMPBSA gave worse correlation 
between experimental and predicted binding energies than MMGBSA (Figures 10.1 
and 10.3). The best r2 values (~ 0.20) were obtained with Nwat = 0, although positive 
binding energies were predicted, making the results unreliable (Figure 10.3). The 
inclusion of water molecules during the MMPBSA analysis partially solved this 
problem, but high standard deviations (> 20%) (Figures 10.18, 10.19, 10.20 and 
10.21) were observed together with poor or completely absent correlation between 
experimental and predicted data (0.26 < r2 < 0.0). 
In addition, one or few complexes, which, if discarded, significantly improved 
the correlation index, could not be found, although it can be observed that for some of 
them, such as 1YVB and 2SIC, the predicted binding energy is only slightly affected 
by the inclusion of explicit solvent molecules. The binding energy of other complexes, 
such as 1EMV, is highly overestimated when applying the Nwat-MMPBSA protocol. 
This opposite behavior showed by some complexes is the main responsible of the r2 
decrease given by MMPBSA calculations. 
 
Figure 10.3. Variation of r2 in dependency of Nwat for Nwat-MMPBSA analysis performed on the 4th 
and 12th ns of the MD simulations. The MD simulation and Nwat-MMPBSA conditions are reported on 
the top of the plot. See Figures 10.18 – 10.21 for details. 
Although it has been reported that the MMPBSA method gives better correlation 
with experiments when performed on longer simulations because of its high 
dependency from the analyzed conformations,268,314 a dependency of r2 from the 
simulation length could not be observed.  
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Furthermore, analogously to what stated for classical receptor-ligand 
complexes,89 the use of the PB method, beyond being detrimental, is also extremely 
time consuming, compared to the well performing GB method. Therefore, MMGBSA 
can represent a good choice for the correlation between experimental activities and 
predicted binding energies for PPIs. 
Focusing on MMGBSA results, it can be noticed that, a positive effect on the r2 
values is obtained at any simulation condition when increasing the Nwat from 0 to 20 
– 30, except for the analyses performed on the simulations where the TIP4P-Ew 
explicit solvent model was used (Figures 10.22 and 10.23). Indeed, in this case the 
correlation between experimental and predicted binding energies obtained with Nwat 
= 0 (r2 = 0.31, Figures 10.22 and 10.23) was equivalent to that obtained from MD 
simulations with TIP3P solvent model (0.30 < r2 < 0.45, Figure 10.1, and Figures 
10.13 – 10.14). Conversely, when Nwat ≠ 0, the MMGBSA results coming from the 
analysis of the TIP4P-Ew MD simulations did not correlate with experimental ∆𝐺𝑏𝑖𝑛𝑑 
and positive binding energies were predicted (Figures 10.22 and 10.23). This is 
necessarily due to the presence of an additional pseudoatom in the water molecules of 
the TIP4P-Ew model, namely EPW, which has only a point charge, but not a radius.293 
This atom has been introduced to mimic the free electron pair of the water molecule, 
but, clearly, it is also responsible of the failure of the MMGBSA calculations when 
water is explicitly included during the analysis. 
As previously observed for MMPBSA calculations, the correlations coefficient r2 
is not improved by longer MD simulations. Indeed, in the case of the MD simulations 
with ff14SB as force field, the MMGBSA analyses performed on the 4th ns gave r2 
values of about 20% higher than those obtained by analyzing the 12th ns (Figure 10.4 
and Figure 10.5). This difference can be mainly attributed to complexes 1AVX and 
2HLE, whose binding energy are overestimated when the 12th ns of the MD 
simulation is analyzed (Figure 10.5). The 2HLE misbehavior is due to the fact that 
during the 12th ns conformations with higher RMSD from the crystallographic 
structure are sampled, compared to those sampled during the 4th ns (Figure 10.6A), 
indeed it is an outlier with both Nwat = 0 and Nwat = 30. This is still true, but less 
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evident for 1AVX complex, whose predicted binding energy has, however, one of the 
highest standard deviations (> 10%) observed, suggesting that the conformations 
sampled for the MMGBSA calculation are significantly different. Nevertheless, 
although for this force field short simulations lead to good results in terms of r2, it has 
to be underlined that the trend of the r2 as a function of Nwat is equivalent, showing 
an increase of about 20-25% when passing from Nwat = 0 to Nwat = 20-30 followed 
by a slight decrease with higher Nwat. 
Conversely, the MMGBSA analyses performed on the ff99SBildn simulations did 
showed differences in r2 related to the analyzed time interval of about 10% and, 
therefore, statistically nonsignificant. Indeed, although 1AVX became an outlier on 
the analysis performed on the 12th ns (Figure 10.7) with this force field also, this is not 
due to difference in the RMSD from the crystallographic structure (Figure 10.8) as 
previously observed (Figure 10.6B), indeed, the r2 obtained with Nwat = 0 are 
equivalent, although poor. However, in this case, the misbehavior of 1AVX is 
compensated by a better correlation of all the other complexes, for which longer 
simulations are, therefore, useful. 
 
 
Figure 10.4. Variation of r2 in dependency of Nwat for Nwat-MMGBSA analysis performed on the 4th 
ns and 12th ns of the MD simulations. The MD simulation and Nwat-MMGBSA conditions are reported 




Figure 10.5. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑 and predicted binding energies obtained from 
the analysis MMGBSA analysis (cutoff = 0.50, polar interfacial residues, GB-Neck2) of the 4th (A, C) 
and 12th (B, D) ns of MD simulations (ff14SB, TIP3P). 
 
Figure 10.6. RMSD from the crystallographic structure of A) 2HLE, B) 1AVX and C) 2OOB 





Figure 10.7. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑 and predicted binding energies obtained from 
the analysis MMGBSA analysis (cutoff = 0.50, polar interfacial residues, GB-Neck2) of the 4th (A, C) 
and 12th (B, D) ns of MD simulations (ff99SBildn, TIP3P). 
The overestimation of the binding energy of 1AVX can be explained by 
comparing the occupancies of stable (occupancy > 20%) water-bridged H-bonds 
during the 4th and 12th ns of the simulations of 1AVX and 2SNI, chosen as a reference 
as its behavior is equivalent during both the time intervals (Tables 8.13 and 8.14). 
Indeed, for the former complex 6 additional water-mediated H-bonds are detected 
with a longer simulation, and the H-bond involving Ile30 and Asn31 is about 20% 
more stable (Table 10.3). Conversely, for 2SNI only 3 additional water-mediated 
interactions are detected by analyzing the 12th ns, and the occupancy are not 
significantly different (Table 10.4). 
Probably, for the correct treatment of the solute-solvent interactions in the 1AVX 
complex the consideration of other water-bridged H-bonds is needed. Indeed, the 
analysis of the 1AVX water-mediated interactions on the 4th ns of the ff14SB 
simulation showed a high number of these interactions with an occupancy of about 20 
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– 60%). However, compared to the ff99SBildn MD, in this simulation additional 
water-mediated interactions, such as the one between HIS40 and HIS294 (Figure 
10.9), are found. 
 
Figure 10.8. RMSD from the crystallographic structure of 1AVX complex computed on the 4th ns 
(black) and at the 12th ns (red) of the MD simulation (ff99SBildn, TIP3P). 
Table 10.3. Water-mediated H-bonds with occupancy > 20% detected from the analysis of the 4th and 
12th ns of the simulation of 1AVX (ff99SBildn, TIP3P). 
4th ns  12th ns  
Residues involved Occ% Residues involved Occ% 
 30:ILE  31:ASN 64.0  30:ILE  31:ASN 83.0 
 68:ALA  69:LYS 62.0  24:PHE  25:CYX 61.0 
 364:GLU  365:ASP 61.0  68:ALA  69:LYS 57.0 
 24:PHE  25:CYX 60.0  364:GLU  365:ASP 52.0 
 44:SER  224:ASP 55.0  235:GLU  288:ARG 46.0 
 16:VAL  28:SER 36.0  16:VAL  28:SER 44.0 
 175:GLY  177:SER 35.0  195:TYR  202:LYS  286:ARG 35.0 
 235:GLU  288:ARG 30.0  231:GLY  352:ASN 34.0 
 20:SER  47:GLN 29.0  80:THR  364:GLU 31.0 
 224:ASP  292:GLU 26.0  342:ARG  364:GLU 30.0 
 364:GLU  365:ASP  366:ASP 24.0  78:GLY  364:GLU 30.0 
 195:TYR  202:LYS  286:ARG 22.0  222:ALA  223:ASN 27.0 
 398:LYS  400:ASP 22.0  129:SER  131:TYR  236:ASN 27.0 
 342:ARG  364:GLU 22.0  125:LYS  174:GLN 27.0 
 231:GLY  352:ASN 21.0  364:GLU  365:ASP  366:ASP 26.0 
   365:ASP  366:ASP 26.0 
   346:VAL  347:SER 25.0 
   20:SER  47:GLN 24.0 
   347:SER  351:PHE 23.0 
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   79:ASN  364:GLU 23.0 
   20:SER  45:ARG 22.0 
 
Table 10.4. Water-mediated H-bonds with occupancy > 20% detected from the analysis of the 4th and 
12th ns of the simulation of 2SNI (ff99SBildn, TIP3P). 
4th ns  12th ns  
Residues involved Occ% Residues involved Occ% 
 155:ASN  221:SER 68.0  39:HIE  209:LEU 73.0 
 39:HIE  209:LEU 67.0  155:ASN  221:SER 69.0 
 318:ARG  321:ARG 64.0  323:ARG  337:ARG 68.0 
 323:ARG  337:ARG 61.0  218:ASN  316:GLU  317:TYR 58.0 
 99:ASP  101:SER 56.0  99:ASP  101:SER 55.0 
 316:GLU  321:ARG 53.0  71:THR  207:SER 55.0 
 95:VAL  96:LEU 50.0  298:ASP  299:LYS 44.0 
 325:PHE  334:GLU 49.0  197:ASP  198:VAL 42.0 
 62:ASN  314:THR 47.0  325:PHE  334:GLU 41.0 
 218:ASN  316:GLU  317:TYR 45.0  62:ASN  314:THR 38.0 
 197:ASP  198:VAL 43.0  316:GLU  339:GLY 35.0 
 71:THR  207:SER 39.0  334:GLU  337:ARG 35.0 
 334:GLU  337:ARG 36.0  60:ASP  63:SER 33.0 
 16:LEU  17:HIE 35.0  95:VAL  96:LEU 32.0 
 120:ASP  121:VAL 33.0  323:ARG  337:ARG  339:GLY 32.0 
 323:ARG  337:ARG  339:GLY 31.0  323:ARG  339:GLY 32.0 
 323:ARG  339:GLY 31.0  156:GLU  159:SER 29.0 
 99:ASP  323:ARG 29.0  317:TYR  338:VAL 27.0 
 333:ALA  334:GLU 25.0  156:GLU  164:THR 27.0 
 60:ASP  63:SER 22.0  104:TYR  311:THR 26.0 
 67:HIE  68:VAL 21.0  16:LEU  17:HIE 26.0 
 10:GLN  184:ASN 21.0  333:ALA  334:GLU 25.0 
   120:ASP  121:VAL 21.0 
   218:ASN  317:TYR 21.0 
   156:GLU  337:ARG 21.0 
 
Table 10.5. Water-mediated H-bonds with occupancy > 20% detected from the analysis of the 4th ns of 
the simulation of 1AVX (ff14SB, TIP3P). 
Residues involved Occ% 
 365:ASP  366:ASP 63.0 
 24:PHE  25:CYX 56.0 
 342:ARG  343:LEU 53.0 
 342:ARG  365:ASP 48.0 
 30:ILE  31:ASN 43.0 
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 235:GLU  288:ARG 40.0 
 63:GLN  97:ASN 39.0 
 40:HID  294:HIE 38.0 
 244:SER  249:PHE 37.0 
 364:GLU  367:LYS 35.0 
 68:ALA  69:LYS 35.0 
 222:ALA  223:ASN 31.0 
 364:GLU  366:ASP 29.0 
 155:GLN  156:ILE 26.0 
 131:TYR  235:GLU  236:ASN 26.0 
 80:THR  155:GLN 26.0 
 79:ASN  365:ASP 25.0 
 398:LYS  400:ASP 25.0 
 171:ASP  199:GLN  202:LYS 22.0 
 175:GLY  177:SER 22.0 
 28:SER  29:LEU 22.0 
 80:THR  82:ASP 22.0 
 131:TYR  236:ASN 21.0 
 
 
Figure 10.9. 1AVX complex. HIS40 and HIS294 are highlighted in green. 
The worse correlation of the 1AVX binding energy when analyzing the 12th MD 
ns was compensated by a better evaluation of all the other complexes in the case of the 
ff99SBildn simulations, because in this case the inclusion of 30 water molecules 
during the MMGBSA analysis worsened the problem showed by 1AVX. However, it 
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has to be underlined that the correlation between experimental and predicted binding 
energies improves of about 25% when increasing the Nwat value from 0 to 30, 
suggesting the overall robustness of the Nwat-MMGBSA approach. In addition, the 
use of short MD simulations is an advantage when this method is applied for drug 
design/discovery purposes. 
Concerning the effect of the force field for the MD simulations on the Nwat-
MMGBSA protocol, it can be observed that the best correlations between 
experimental and predicted binding energies are obtained with the ff14SB (Figure 
10.1), with or without explicit solvent molecules during the MMGBSA calculation. 
Indeed, the r2 obtained from the analysis of the simulations with this force field were 
higher than those obtained with the ff99SBildn force field, under equivalent analysis 
conditions. In detail, this difference is only marginal when Nwat = 0, while it becomes 
significant (Δr2 = 0.20 – 0.26) when considering Nwat ≠ 0 (Table 10.6). 
Table 10.6. Values of r2 obtained from the Nwat-MMGBSA analysis (GB-Neck2) of the 4th ns of the 
MD simulations performed with either ff14SB or ff99SBildn. 
Nwat r2 (ff14SB; 
cutoff = 0.50, polar) 
r2 (ff14SB; 
cutoff = 0.75, all) 
r2 (ff99SBildn; 
cutoff = 0.50, polar) 
r2 (ff99SBildn; 
cutoff = 0.75, all) 
0 0.45 0.45 0.32 0.32 
10 0.64 0.59 0.44 0.40 
20 0.77 0.71 0.55 0.48 
30 0.77 0.73 0.54 0.46 
40 0.68 0.68 0.47 0.42 
50 0.57 0.50 0.37 0.36 
 
However, it has to be noticed that with either ff14SB or ff99SBildn force fields 
the same trend in the correlation index can be observed, because under both conditions 
the r2 value improved of about 20% when increasing Nwat from 0 to 20-30, and, then, 
it slightly decreased with Nwat = 40 -50, indicating that the consideration of 20 – 30 
water molecules at the protein-protein interface has a positive effect when correlating 
MMGBSA binding energies with experiments (Figure 10.1).  
The slight difference observed in the correlation index when Nwat = 0 can be 
completely ascribed to the differences in the two considered force fields, which are 
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mainly related to parameters associated to side chains and backbone torsional angles 
and which make ff14SB the force field of election when simulating proteins and 
peptides in explicit solvent.135 Conversely, the differences observed with Nwat = 30, 
i.e. when the maximum r2 is reached, are only partially attributable to the force fields. 
Indeed, if the common outlier 1AVX is discarded, the analyses performed on the 
ff99SBildn simulations give predicted binding energies equivalent to those obtained 
from the ff14SB simulations. Moreover, the same correlation with experiments is 
obtained if the simulation time is prolonged to 12 ns (Figure 10.10), whereas 
MMGBSA analyses with Nwat = 0 are not significantly affected by this complex. This 
suggests that, as previously hypothesized, the ff99SBildn simulations require longer 
simulations to allow a correct positioning of water molecules around interacting side-
chains, and consequently a proper evaluation of solute-solvent interactions during the 
MMGBSA analysis. 
However, contrarily to what observed for ff99SBildn simulations, the MMGBSA 
analyses performed on the ff14SB simulations are not affected by either the simulation 
length or the consideration of particular complexes, such as 1AVX. In addition, at any 
simulation and analysis condition, this force field provided predicted energies well-to-
excellently correlating with experimental data, with the best being those obtained by 
including 20 – 30 water molecules during the MMGBSA calculations.  
Furthermore, Nwat-MMGBSA analysis were also conducted on 4ns ff14SB 
trajectory using the GB-OBC(II) solvent model, instead of the well performing GB-
Neck2, in order to check if the choice of implicit solvent model is critical in the 
adopted conditions. 
The use of this implicit solvent model turned out to have a positive effect when 
Nwat = 0, while it was detrimental when Nwat ≠ 0 (Table 10.7). Although, the best 
results are those obtained by setting Nwat = 10, and the inclusion of 20 water 
molecules provided equivalent results to those obtained with Nwat = 0. In addition, 
the excellent r2 value of 0.77 obtained by including 20 – 30 water molecules in the 
MMGBSA analysis with GB-Neck2 as implicit solvent model and performed on the 
166 
 
4th ns of the ff14SB simulations could not be reached when the GB-OBC(II) implicit 
solvent model was used. 
 
Figure 10.10. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted binding energies obtained from 
the analysis MMGBSA analysis (cutoff = 0.50, polar interfacial residues, GB-Neck2) of the 4th ns of 
the ff14SB (A, B) and ff99SBildn (C, D) MD simulations with Nwat = 0 (A, C) and Nwat = 30 (B, D) 




Table 10.7. Values of r2 obtained from the Nwat-MMGBSA analysis (GB-OBC(II)) of the 4th ns of the 
MD simulations performed with ff14SB. 
Nwat r2  
(cutoff = 0.50, polar) 
r2  
(cutoff = 0.75, all) 
0 0.60 0.60 
10 0.64 0.65 
20 0.54 0.60 
30 0.43 0.50 
40 0.32 0.42 
50 0.24 0.34 
Therefore, referring to the overall best conditions (e.g. 4ns, ff14SB, TIP3P MD 
simulations, dASA cutoff = 0.50, polar residues, GB-Neck2), the inclusion of 20 – 30 
water molecules during the MMGBSA calculations positively affected the correlation 
between experimental and predicted binding energies, because water-mediated 
interactions within one of the two interacting proteins or between the protein partners 
are taken in account during the analysis (Table 10.5, Figure 10.2 as an example). 
Although all the complexes benefit of this protocol (Figure 10.5), the inclusion of 20 – 
30 water molecules is particularly advantageous for some of them, such as 1YVB, 
2OUL, and 3BZD, while it weakly affected the calculations performed on other 
complexes, such as 1ZHI. In particular, the binding energy of 3BZD was 
underestimated, suggesting that water plays an important role in mediating H-bond 
between the two protein partners involved in the PPI. Indeed, water-mediated H-bond 
analysis (Table 10.8) together with the water density plot obtained from grid analysis 
(Figure 10.11) of the 4ns ff14SB MD simulation of 3BZD showed that many high 
water density areas are found at the protein-protein interface, compared to those 
observed for 1ZHI. Moreover, stable (occupancy > 20%) water-mediated H-bonds 
between the two protein partners are found (Table 10.8) when analyzing the MD 
simulation of 3BZD, while for 1ZHI, which is only slightly affected by the inclusion 
of explicit water, only few water-mediated interactions are found, and with lower 




Figure 10.11. Water density plots obtained by grid analysis of the 3BZD (left) and 1ZHI (right) 
complexes. 
Table 10.8. Water-mediated H-bonds with occupancy > 20% detected from the analysis of the 4th ns of 
the simulation of 3BZD and 1ZHI (ff14SB, TIP3P). The water-mediated H-bonds between the two 
protein partners are reported in bold. 
3BZD  1ZHI  
Residues involved Occ% Residues involved Occ% 
53:SER  55:GLU 75.0  233:THR  234:LEU 69.0 
 70:GLN  71:GLU  169:ASN 67.0  56:GLN  57:GLU 65.0 
 55:GLU  56:LYS  129:THR 65.0  153:ARG  154:ASP 64.0 
 55:GLU  313:ASP 61.0  131:ILE  132:ARG 45.0 
 289:GLU  290:THR 59.0  201:GLU  202:GLU 42.0 
 55:GLU  315:PHE 59.0  110:THR  111:ALA 36.0 
 45:ILE  46:HID 58.0  221:GLU  273:LYS 31.0 
 334:SER  335:VAL 53.0 
 48:GLY  217:ASP 29.0 
 137:TYR  138:ASP 45.0  221:GLU  271:PHE 27.0 
 70:GLN  211:TRP 44.0  101:ASN  104:ASN 26.0 
 24:GLN  67:ARG 41.0  56:GLN  189:GLN 26.0 
 55:GLU  129:THR 40.0  202:GLU  203:TYR 25.0 
 71:GLU  169:ASN 38.0  76:ARG  219:ALA  220:GLU 23.0 
 51:ALA  199:TYR  200:VAL  317:GLN 38.0  45:GLU  230:ARG 22.0 
 282:GLU  283:PHE 37.0 
 76:ARG  220:GLU 21.0 
 71:GLU  168:LYS  169:ASN 34.0  108:SER  109:GLU 21.0 
 216:THR  217:CYX 34.0  220:GLU  222:LYS 21.0 
 133:MET  134:LYS 32.0  150:ASP  152:GLU 21.0 
 71:GLU  168:LYS 31.0   
 59:ILE  61:ASP 31.0   
 249:THR  250:ILE 30.0   
 68:PRO  135:TYR 29.0   
 5:GLN  104:THR 27.0   
 150:VAL  151:ASP 26.0   
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 63:TYR  284:ASN 26.0   
 281:TYR  282:GLU 26.0   
 311:PRO  314:LYS 24.0   
 25:THR  26:ASN 24.0   
 69:SER  72:GLN 23.0   
 310:ALA  314:LYS 22.0   
 
Conversely, 1YVB and 2OUL binding energies were overestimated with Nwat = 
0, while with Nwat = 20 – 30 their predicted values well correlated with experimental 
∆𝐺𝑏𝑖𝑛𝑑.  
Contrarily to what observed for the complex where ∆𝐺𝑏𝑖𝑛𝑑 was underestimated, 
the overestimation is not explained by the lacking of consideration of water-mediated 
interactions between the two protein partners. Conversely, according to equation 1, it 
can be hypothesized that the contribute associated to one of the proteins in the 
complex is underestimated, possibly because the monomer is stabilized by H-bonds 
with the solvent. Indeed, water-mediated H-bond analysis performed on the 1YVB 
simulation showed that most of the water-mediated interactions only involve the 
falcipain 2 (chain A, residues 1-241), stabilizing it, whereas only few waters mediate 
the interactions between falcipain 2 and cystatin or intramolecular interactions only 
involving cystatin (chain B, residues 242-352) (Table 10.9). Analogous observations 
can be done for 2OUL, for which the water mediated interactions mainly involve 
falcipain 2 (chain A, residues 1-241), while few interactions are found within chagasin 
(chain B, residues 242-348) or between the two proteins (Table 10.10). 
Therefore, for overestimated complexes, the Nwat-MMGBSA approach with 
Nwat = 20 – 30 allows a better evaluation of the contribute associated to only one of 
the two protein partners, leading to a global improvement in the correlation with 
experimental ∆𝐺𝑏𝑖𝑛𝑑. 
Table 10.9. Water-mediated H-bonds with occupancy > 20% detected from the analysis of the 4th ns of 
the simulation of 1YVB (ff14SB, TIP3P).  
Residues involved Occ% Chains involved 
 46:SER  148:ILE  87.0 A 
 159:TYR  217:ASN  73.0 A 
 281:VAL  282:ARG  65.0 B 
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 149:SER  234:ASP  59.0 A 
 126:LYS  127:ASN  59.0 A 
 305:THR  306:THR  54.0 B 
 284:ILE  285:SER  52.0 B 
 153:SER  167:GLU  42.0 A 
 179:VAL  180:GLY  36.0 A 
 38:ASN  109:ASP  36.0 A 
 159:TYR  210:TRP  36.0 A 
 325:MET  326:ALA  35.0 B 
 347:LEU  348:GLU  35.0 B 
 39:CYX  106:TYR  34.0 A 
 154:ASP  155:ASP  31.0 A 
 43:TRP  82:GLY  31.0 A 
 233:THR  234:ASP  28.0 A 
 152:VAL  171:GLN  28.0 A 
 35:ASP  206:TRP  27.0 A 
 50:SER  147:SER  27.0 A 
 154:ASP  296:TYR  26.0 AB 
 44:ALA  45:PHE  26.0 A 
 154:ASP  255:GLU  23.0 AB 
 81:ASN  289:GLN  23.0 AB 
 159:TYR  211:GLY  22.0 A 
 170:ASP  171:GLN  22.0 A 
 85:ILE  234:ASP  21.0 A 
 160:LYS  161:GLU  20.0 A 
 242:ARG  243:LEU  20.0 B 
 341:LEU  343:GLN  20.0 B 
 
Table 10.10. Water-mediated H-bonds with occupancy > 20% detected from the analysis of the 4th ns 
of the simulation of 2OUL (ff14SB, TIP3P). 
Residues involved Occ% Chains involved 
 46:SER  148:ILE  86.0 A 
 159:TYR  217:ASN  75.0 A 
 339:GLU  340:ARG  57.0 B 
 149:SER  234:ASP  52.0 A 
 154:ASP  275:TYR  46.0 AB 
 179:VAL  180:GLY  42.0 A 
 154:ASP  309:GLU  41.0 AB 
 288:MET  289:PHE  36.0 B 
 154:ASP  272:PHE  34.0 AB 
 126:LYS  127:ASN  33.0 A 
 327:TYR  339:GLU  29.0 B 
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 43:TRP  82:GLY  29.0 A 
 50:SER  147:SER  27.0 A 
 6:GLU  7:VAL  26.0 A 
 329:ARG  332:THR  26.0 B 
 281:LYS  282:GLU  25.0 B 
 173:ASN  174:HIP  25.0 A 
 157:ALA  159:TYR  25.0 A 
 233:THR  234:ASP  23.0 A 
 300:SER  302:LEU  22.0 B 
 209:GLN  332:THR  21.0 AB 
 159:TYR  211:GLY  21.0 A 
 44:ALA  45:PHE  20.0 A 
 
The inclusion of a number of water molecules greater than 30 caused a decrease 
in the r2 values, probably because a large number of water molecules at the protein-
protein interfaces generates background noises counteracting the benefits of the 
explicit consideration of solute – solvent interactions, as previously observed for 
classical receptor – ligand complexes. 
Moreover, although protein-protein interfaces are wider than classical binding 
pockets, the number of explicit water to be included during the MMGBSA analysis to 
improve the correlation with experiments should not be over 50. This is probably due 
to the presence of a high number of hydrophobic residues at the protein-protein 
interface. Indeed, for all complexes, a maximum of 30 polar residues have been 
individuated at the interface. 
It has to be emphasized that, as observed in Chapter 9, the Nwat-MMGBSA 
approach improves the correlation between predicted and experimental data improved 
with the Nwat-MMGBSA approach, but it has not been tested on the prediction of the 
absolute binding free energies, since the entropic term is neglected. However, this 
protocol seems to be useful for drug discovery purposes, also because it can be easily 
automatized (Annex 10.A). 
Furthermore, the Nwat-MMGBSA method revealed to be quite robust to changes 
in the simulation protocol, except for the use of TIP4P-Ew explicit solvent mode. 
Although the best results have been obtained by analyzing 4 ns MD simulations 
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performed with the ff14SB force field and the TIP3P explicit solvent model, and with 
using the GB-Neck2 as implicit solvent model during the MMGBSA calculations. 
10.3 MATERIALS AND METHODS 
Structure preparation. Initially, crystallographic water molecules were removed 
from the PDB files of the PPI complexes. Consequently, the structure preparation 
tool of MOE227 has been used to cap with an acetyl and a methyl-amino group the N- 
and C-termini, respectively, of those protein chains having more than 3 missing 
residues, and to protonate all the considered complexes, in order to build the starting 
geometries for the MD simulations. 
MD simulations. MD simulations were performed with the pmemd module of 
Amber14 package,192 using either the ff99SBildn136 or the ff14SB135 force fields. In 
each complex, the total charge was neutralized by adding an adequate number of 
Na+/Cl- ions, and the systems were solvated with an octahedral box of either TIP3P292 
or TIP4P-Ew293 water added up to a distance of 10 Ǻ from the solute. The systems 
where then relaxed by minimizing hydrogens (1000 cycles of steepest descent and 
5000 cycles of conjugated gradient), ions and waters (2000 cycles of steepest descent 
and 5000 cycles of conjugated gradient). The solvent box was equilibrated at 300 K 
by 100 ps of NVT and 100 ps of NPT simulation using a Langevin thermostat with a 
collision frequency of 2.0 ps-1. Successively, a minimization of side chains, water and 
ions with backbone restraints of 25 kcal/mol and a total minimization with backbone 
restraints of 10 kcal/mol (2500 cycles of steepest descent and 5000 cycles of 
conjugated gradient) were performed. The systems were then heated up to 300 K in 6 
steps of 5 ps each (ΔT = 50 K), where backbone restraints were reduced from 10.0 
kcal/mol to 5 kcal/mol. Full equilibration was performed in the NVT ensemble (100 
ps, backbone restraints = 5.0 kcal/mol) and in the NPT ensemble (1 step of 200 ps, 
backbone restraints = 5 kcal/mol; 3 steps of 100 ps each, reducing the backbone 
restraints from 5.0 kcal/mol to 1.0 kcal/mol, and 1 step 1 ns with 1.0 kcal/mol of 
backbone restraints). Finally, unrestrained production runs were run at 300K for 4 to 




RMSD analyses of backbone atoms were made to assess the system stability. H-
bonds analysis of solute – solvent interaction (donor – acceptor distance = 4.0 Ǻ, 
angle = 150°) and grid analyses (cubic box 50 Ǻ ×50 Ǻ ×50 Ǻ, mesh = 0.5 Ǻ, 
centered on interfacial residues) were also performed with cpptraj. 
Nwat-MMPB/GBSA. Both MMPBSA and MMGBSA analyses were performed 
with the MMPBSA.py python script implemented in the Amber14 package. The 
analyses were conducted on either the 4th or the 12th ns of the production runs by 
selecting 100 evenly spaced out snapshots. Either the GB-Neck2 or the GB-OBC(II) 
implicit solvent models were chosen for the GB calculations, and a salt molar 
concentration in solution was set at 0.15 M. The PB solver implemented in the sander 
module was applied for PB calculations, using the default parameters. During the 
analyses the entropic term was neglected. 
When explicit water molecules were considered during the MMPB/GBSA 
calculations the same approach described in Chapter 8.1.3 was followed, although the 
water molecules were selected among those being closest to the interfacial residues. 
These residues were automatically selected with a pymol script (Annex 10.A) which, 
given two protein chains, considers as interfacial residues only those whose dASA 
from the complex to a single chain is greater than a defined cutoff, which in this study 
was set to either 0.75 or 0.50. Water molecules selection was made by either 
considering all interfacial residues or only the polar ones. 
The water molecules (10, 20, 30, 40 or 50, depending on the chosen Nwat) were 
considered as part of the protein considered as the receptor, always the first chain of 
the PDB file. 
The square of Pearson’s correlation coefficient (r2) between experimental ∆𝐺𝑏𝑖𝑛𝑑 




Figure 10.12. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.50, ALL interfacial residues, GB-Neck2) of the 4th ns of the ff14SB, 
TIP3P MD simulations. 
 
Figure 10.13. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.50, POLAR interfacial residues, GB-Neck2) of the 4th ns of the ff14SB, 




Figure 10.14. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.75, ALL interfacial residues, GB-Neck2) of the 4th ns of the ff14SB, 
TIP3P MD simulations. 
 
Figure 10.15. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.75, POLAR interfacial residues, GB-Neck2) of the 4th ns of the ff14SB, 




Figure 10.16. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.50, POLAR interfacial residues, GB-Neck2) of the 12th ns of the ff14SB, 
TIP3P MD simulations. 
 
Figure 10.17. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.75, ALL interfacial residues, GB-Neck2) of the 12th ns of the ff14SB, 




Figure 10.18. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMPBSA analysis (cutoff = 
0.50, POLAR interfacial residues) of the 4th ns of the ff14SB, TIP3P MD 
simulations. 
 
Figure 10.19. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMPBSA analysis (cutoff = 





Figure 10.20. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMPBSA analysis (cutoff = 
0.75, ALL interfacial residues) of the 4th ns of the ff14SB, TIP3P MD 
simulations. 
 
Figure 10.21. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMPBSA analysis (cutoff = 





Figure 10.22. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.50, POLAR interfacial residues, GB-Neck2) of the 4th ns of the ff14SB, 
TIP4P-Ew MD simulations. 
 
Figure 10.23. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.75, ALL interfacial residues, GB-Neck2) of the 4th ns of the ff14SB, 




Figure 10.24. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.50, POLAR interfacial residues, GB-OBC(II)) of the 4th ns of the ff14SB, 
TIP3P MD simulations. 
 
Figure 10.25. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.50, ALL interfacial residues, GB-OBC(II)) of the 4th ns of the ff14SB, 




Figure 10.26. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.75, ALL interfacial residues, GB-OBC(II)) of the 4th ns of the ff14SB, 
TIP3P MD simulations. 
 
Figure 10.27. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.75, POLAR interfacial residues, GB-OBC(II)) of the 4th ns of the ff14SB, 




Figure 10.28. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.50, POLAR interfacial residues, GB-Neck2) of the 4th ns of the 
ff99SBildn, TIP3P MD simulations. 
 
Figure 10.29. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.50, ALL interfacial residues, GB-Neck2) of the 4th ns of the ff99SBildn, 




Figure 10.30. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.50, POLAR interfacial residues, GB-Neck2) of the 12th ns of the 
ff99SBildn, TIP3P MD simulations. 
 
Figure 10.31. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.75, ALL interfacial residues, GB-Neck2) of the 4th ns of the ff99SBildn, 




Figure 10.32. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.75, POLAR interfacial residues, GB-Neck2) of the 4th ns of the 
ff99SBildn, TIP3P MD simulations. 
 
Figure 10.33. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.75, ALL interfacial residues, GB-Neck2) of the 12h ns of the ff99SBildn, 




Figure 10.34. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.50, ALL interfacial residues, GB-OBC(II)) of the 4th ns of the ff99SBildn, 
TIP3P MD simulations. 
 
Figure 10.35. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.50, POLAR interfacial residues, GB-OBC(II)) of the 4th ns of the 




Figure 10.36. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.75, ALL interfacial residues, GB-OBC(II)) of the 4th ns of the ff99SBildn, 
TIP3P MD simulations. 
 
Figure 10.37. Correlation between experimental ∆𝐺𝑏𝑖𝑛𝑑  and predicted 
binding energies obtained from the analysis MMGBSA analysis (cutoff = 
0.75, POLAR interfacial residues, GB-OBC(II)) of the 4th ns of the 
ff99SBildn, TIP3P MD simulations. 
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11 APPLICATION OF THE NWAT-MMGBSA PROTOCOL TO PPI-
INHIBITOR COMPLEXES 
11.1 INTRODUCTION 
In Chapter 10 the application of an automated Nwat-MMGBSA approach to the 
prediction of binding energies in PPI complexes has been described. In particular, the 
best protocol conditions in terms of correlation between MMGBSA predicted binding 
energies and experimental data for this particular kind of systems were found. 
Summarizing, the highest correlation in terms of r2 has been obtained by submitting 
the last of 4 ns of MD simulations, performed by using the ff14SB135 force field and 
the TIP3P292 explicit solvent model, to Nwat-MMGBSA calculations, where the GB-
Neck2173 was used as implicit solvent model and 20 – 30 water molecules were 
explicitly included during the analysis. 
Therefore, the optimized protocol had to be tested on systems where one of the 
two PPI protein partners is inhibited by a small molecule or a peptide-like ligand. 
Indeed, when the other protein partner is replaced by a decidedly smaller molecule, 
Nwat-MMGBSA results might be significantly affected. Indeed, in classical protein-
ligand systems the ligand is generally buried in the receptor; in PPI complexes, on the 
other hand, there is a wide contact surface and waters are generally placed in between. 
Conversely, in complexes made by a ligand bound to a protein surface, the Nwat-
MMGBSA procedure might lead to the selection of water molecules located on the 
solvent-exposed side. Since explicit water are considered as part of the receptor, this 
might be detrimental for the prediction of binding energy. 
At the light of this, we initially applied the optimized MD/Nwat-MMGBSA 
protocol to the previously studied penicillopepsin system (see Chapter 9), which is 
inhibited by peptide-like molecules with known experimental ∆𝐺𝑏𝑖𝑛𝑑, in order to 
compare this updated protocol to the initial one. Successively, three additional 
systems consisting of one protein usually involved in PPIs complexed with inhibitors 
with known experimental activities have been tested, namely the MDM2 protein, 
involved in the MDM2-p53 PPI, complexed with 10 inhibitors with known IC50 
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(Figure 11.15),315 the BCL-XL inhibited by 7 small molecules with known IC50 
(Figure 11.14),316 and XIAP-BIR2 in complex with 8 inhibitors with known IC50 
(Figure 11.16).317 In addition, HIV1-protease and 6 of its mutants complexed with 
amprenavir318 and two HIV1-protease mutants complexed with ritonavir319 (Figure 
11.17) with known ki were also considered (Table 11.9), in order to verify if the Nwat-
MMGBSA approach can be also applied to predict the activity of a particular ligand 
on different mutants of the same protein target. 
For these systems we verified if the explicit inclusion of water molecules during 
the MMGBSA analysis positively affected the correlation between predicted binding 
energy and available experimental activities in terms of r2, and we evaluated the 
optimal number of solvent residues to consider during the calculations. 
Furthermore, aiming to make this protocol fast enough to be applied for drug 
design/discovery purposes, we compared Nwat-MMGBSA calculations made on the 
first or on the fourth ns of production run. Calculations conducted on a classical HPC 
infrastructure, using 128 Xeon cores, were also compared with MD simulations run on 
a single GPU GTX card that, in terms of performance, equalled the 128 cores. To 
provide statistical significance, 3 independent simulations (using a random seed for 
the guess of initial forces) were conducted for each system on each hardware.  
11.2 RESULTS AND DISCUSSION 
Before discussing the results obtained by the application of the Nwat-MMGBSA 
protocol to the selected systems, it is important to underline that this study has been 
particularly challenging, because only few dataset of more than 5 PPIs modulators 
with known activity data and crystallized in complex with their target are reported in 
literature. In addition, the choice of the dataset had to be done carefully, selecting 
complexes covering a wide range of binding energies and, possibly, evaluated within 
the same set of experiments or at least from very robust and validated experiments. 
Indeed, bad correlations were often obtained by us, during preliminary evaluations, 
when selecting complexes reported in different publications and with binding energies 
determined through different experimental setups. Furthermore, when a dataset of PPI 
modulators is made of congeneric compounds, but where only one or few 
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crystallographic structures of the complexes are available, other complexes must be 
reconstructed by manually modifying the ligand, as done for the MDM2, the BCL-XL 
and the XIAP-BIR2 systems. 
Penicillopepsin. The results obtained from the application of the updated Nwat-
MMGBSA protocol on penicillopepsin system globally agreed with those previously 
discussed (see Chapter 9), and grid analysis showed in this case also the presence of 
many high water density areas (Figure 11.1B). Indeed, the inclusion of explicit water 
molecules during the MMGBSA calculations significantly increased the correlation 
between experimental and predicted binding energies, and the highest r2 obtained was 
of about 0.70, except for the analysis performed on the 4th of MD simulations run on 
CPU hardware (Figure 11.1A).  
 
Figure 11.1. A) Trend of r2 in dependency of Nwat for penicillopepsin. B) Water density plots obtained 
by grid analysis of penicillopepsin-APT complex (visualization with Chimera, step = 1 and level = 15). 
However, some differences have to be highlighted and additional observations 
can be extrapolated from these results. In particular, the average correlations obtained 
when Nwat = 0 are lower than that obtained with the previous protocol (r2 = 0.46, see 
Chapter 8.1), thus making the improvement given by the consideration of solute-
solvent interactions more significant. This can be due to the different setup used for 
the MD simulations (ff14SB force field instead of ff99SB, Langevin MD with 
restraints instead of constraints in equilibration steps, longer equilibration, see 
Material and Methods) and to the different method used to derive the point charges of 
penicillopepsin ligands (Figure 9.3), because in this case a fast and less accurate semi-
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empirical AM1-BCC method has been used instead of the accurate but time 
consuming ab initio RESP method. 
Although, when Nwat ≠ 0 the r2 values are not statistically different from those 
previously obtained, with this new protocol a plateau value is immediately reached 
with Nwat = 10 – 30. This might be due to a longer NPT equilibration (see Materials 
and Methods section) which can lead to a better positioning of water molecules 
around the ligands, allowing the formation of stable and relevant solute-solvent H-
bonds also with lower Nwat values. Indeed, in this case the prediction of the binding 
energy of all the complexes (and not only APU, as showed in Chapter 9) is equally 
affected by the inclusion of water molecules during the MMGBSA analysis (Figure 
11.2),. 
Table 11.1. Values of r2 as a function of Nwat obtained by the analysis of the first and fourth ns of MD 
simulations run on both GPU and CPU hardwares. Average values and standard deviations are also 
reported. 
GPU, 1 ns CPU, 1 ns 
Nwat r2 run1 r2 run2 r2 run3 Avg r2 ± SD r2 run1 r2 run2 r2 run3 Avg r2 ± SD 
0 0.38 0.22 0.10 0.23 ± 0.14 0.18 0.13 0.20 0.17 ± 0.04 
10 0.80 0.73 0.73 0.75 ± 0.04 0.57 0.86 0.81 0.75 ± 0.16 
20 0.80 0.71 0.73 0.75 ± 0.05 0.61 0.86 0.82 0.76 ± 0.13 
30 0.79 0.69 0.73 0.74 ± 0.05 0.69 0.85 0.82 0.79 ± 0.09 
40 0.78 0.65 0.70 0.71 ± 0.07 0.76 0.81 0.76 0.78 ±0.03 
50 0.76 0.63 0.65 0.68 ± 0.07 0.82 0.74 0.70 0.75 ± 0.06  
GPU, 4 ns CPU, 4 ns 
Nwat r2 run1 r2 run2 r2 run3 Avg r2 ± SD r2 run1 r2 run2 r2 run3 Avg r2 ±SD 
0 0.13 0.05 0.01 0.06 ± 0.06 0.23 -0.09 0.16 0.10 ± 0.17 
10 0.83 0.70 0.59 0.71 ± 0.12 0.59 0.48 0.45 0.51 ± 0.07 
20 0.73 0.68 0.69 0.70 ± 0.03 0.59 0.48 0.54 0.54 ± 0.06 
30 0.68 0.61 0.60 0.63 ± 0.04 0.61 0.41 0.53 0.52 ± 0.10 
40 0.70 0.53 0.52 0.58 ± 0.10 0.64 0.36 0.46 0.49 ± 0.14 




Figure 11.2. Correlation between experimental free energy of binding and predicted binding energies 
obtained for penicillopepsin by analyzing the first ns of one of the three MD simulations run on a GPU 
hardware. 
Moreover, the performances of GPU and CPU hardware are generally statistically 
equivalent, and the same is true for the analyses performed on either the first or the 4th 
ns of MD. The only exception is represented by the MMGBSA results obtained from 
the analysis of the 4th ns of the MD simulations run on a CPU hardware, which are 
worse in terms of r2 than the others at any Nwat (Figures 11.1 and 11.4). However, the 
analyses carried out on the 4th ns of GPU MD simulations also gave worse results than 
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those performed on the first ns of the MD simulations. This is mainly ascribable to the 
WEC complex, (Figure 11.4) whose binding energy is decidedly overestimated and 
has a high standard deviation (> 10%), not observed in the analysis on the first ns of 
GPU MD runs. The incorrect prediction of the binding energy of WEC when 
performing the MMGBSA calculation on the 4th ns of the CPU MD simulations can 
probably be attributed to problems in the MD simulations on this complex, which can 
be noticed, although at minor extent, also from Figure 11.2, where the correlations 
between experimental free energy of binding and predicted binding energies obtained 
for penicillopepsin by analyzing the first ns of one of the three MD simulations run on 
a GPU hardware are showed. The instability of the WEC complex is also proved by 
the RMSD of the backbone atoms from the crystallographic structure computed on the 
4th ns of a CPU MD simulation. Indeed, this RMSD is higher than that computed on 
the first ns of the same simulation, whereas the RMSD computed on a CPU simulation 
of APU, whose predicted binding energy well correlated with experiments, are 
superimposable (Figure 11.3). In addition, it should be noted that the WEC RMSD are 
more fluctuating, explaining the high standard deviations of the predicted binding 
energy for this complex. 
 
Figure 11.3. RMSD from the crystallographic structure of A) WEC and B) APU complexes computed 




Figure 11.4. Correlation between experimental free energy of binding and predicted binding energies 
obtained for penicillopepsin by analyzing the 4th ns of one of the three MD simulations run on a CPU 
hardware. 
Therefore, as observed in Chapter 10, multiple simulation runs, although shorter 
are recommended over a single and long simulation. Conversely, the nature of the 
hardware does not seem to significantly affect the results. 
MDM2. For the MDM2 system an acceptable correlation between predicted 
binding energies and − log10(𝐼𝐶50) could not be obtained by MMGBSA analyses 
with Nwat = 0, and the inclusion of up to 70 water molecules around the ligands 
194 
 
during the MMGBSA calculations slightly improved the r2 value, which reached ~ 
0.50 with Nwat = 70 (Figure 11.5A and Table 11.2). This increment in correlation of 
about 20 % can be explained by observing the water density plots obtained by grid 
analysis: for this system few and small areas of relevant water density are present 
around the inhibitors (Figure 11.5B), suggesting that the explicit consideration of 
solute-solvent interactions is advantageous, but not fundamental for the MDM2 
system. Therefore, as observed for other systems (see Chapter 9) the small, but 
statistically significant, increase in r2 might be due to the explicit inclusion of a few 
water molecules that, although not firmly bridging the ligand−receptor interactions, 
contribute in defining a water buffer between the ligands and the MDM2. This 
hypothesis explain why up to 70 water molecules are needed to have a significant 
increase of the correlation index. 
 
Figure 11.5. A) Trend of r2 in dependency of Nwat for MDM2. B) Water density plots obtained by grid 
analysis of MDM2-4JVE complex (visualization with Chimera, step = 1 and level = 15). 
Table 11.2. Values of r2 as a function of Nwat obtained by the analysis of the first and fourth ns of MD 
simulations run on both GPU and CPU hardwares for MDM2 system. Average values and standard 
deviations are also reported. 
GPU, 1 ns CPU, 1 ns 
Nwat r2 run1 r2 run2 r2 run3 Avg r2 ± SD r2 run1 r2 run2 r2 run3 Avg r2 ± SD 
0 0.10 0.16 0.16 0.14 ± 0.03 0.16 0.2 0.31 0.22 ± 0.08 
10 0.33 0.40 0.32 0.35 ± 0.04 0.41 0.42 0.38 0.40 ± 0.02 
20 0.33 0.35 0.25 0.31 ± 0.05 0.4 0.37 0.35 0.37 ± 0.03 
30 0.38 0.39 0.29 0.35 ± 0.06 0.44 0.42 0.37 0.41 ± 0.04 
40 0.43 0.44 0.34 0.40 ± 0.06 0.48 0.44 0.39 0.44 ± 0.05 
50 0.46 0.47 0.38 0.44 ± 0.05 0.51 0.46 0.41 0.46 ± 0.05 
60 0.47 0.49 0.41 0.46 ± 0.04 0.52 0.47 0.43 0.47 ± 0.05 
70 0.47 0.50 0.43 0.47 ± 0.04 0.53 0.48 0.44 0.48 ± 0.05 
GPU, 4 ns CPU, 4 ns 
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Nwat r2 run1 r2 run2 r2 run3 Avg r2 ± SD r2 run1 r2 run2 r2 run3 Avg r2 ±SD 
0 0.16 0.61 0.34 0.37 ± 0.23 0.18 0.22 0.44 0.28 ± 0.14 
10 0.32 0.41 0.36 0.36 ± 0.05 0.44 0.37 0.36 0.39 ± 0.04 
20 0.29 0.38 0.26 0.31 ± 0.06 0.48 0.33 0.35 0.39 ± 0.08 
30 0.37 0.39 0.26 0.34 ± 0.07 0.53 0.38 0.4 0.44 ± 0.08 
40 0.45 0.42 0.30 0.39 ± 0.08 0.53 0.45 0.43 0.47 ± 0.05 
50 0.49 0.44 0.32 0.42 ± 0.09 0.53 0.48 0.46 0.49 ± 0.04 
60 0.52 0.46 0.34 0.44 ± 0.09 0.53 0.50 0.47 0.50 ± 0.03 
70 0.53 0.47 0.36 0.45 ± 0.09 0.54 0.51 0.47 0.51 ± 0.04 
The difficulty in having a correlation between predicted binding energies and 
experimental activities above 50% might also be attributed to the fact that some of the 
considered MDM2 inhibitors (Figure 11.6 and 8.48) were tested as racemates but only 
the complex of a single enantiomer was available, and thus considered. 
Therefore, the poor correlation reached might also be due to the inhibitors data 
set, but, anyway, it is significantly improved when solute – solvent interactions are 
taken in account, although the role of water in mediating protein-ligand interactions is 
poor (Figure 11.5B). Moreover, it should be underlined that when Nwat ≠ 0 the 
standard deviation of r2 decreases, suggesting that the Nwat-MMGBSA approach 
improve the reproducibility of the results, the contribute of the MDM2 protein to the 
binding energy is better estimated in the presence of explicit water. 
Also in this case, simulations run on GPUs gave equivalent results to those run on 
CPUs, most of all when Nwat ≠ 0, making the GPU-based hardware a fast, cheap and 





Figure 11.6. Correlation between experimental free energy of binding and predicted binding energies 




BCL-XL. For the BCL-XL system a high correlation index (r2 ≈ 0.70) was 
obtained even with Nwat = 0, suggesting that water does not play a relevant role in 
mediating protein-ligand interactions or in stabilizing the complex. Indeed, including a 
hydration shell of 10 to 50 water molecules around the ligands when computing the 
binding energies did not minimally affect the correlation with − log10(𝐼𝐶50) (Figure 
11.7A and Table 11.3). As a further proof, grid analyses performed on the MD 
simulations showed the presence of decidedly small high water density areas, mainly 
located around protein loops and not at the protein -ligand boundary (Figure 11.7B).  
It is important to emphasize that, although water has not a particular importance 
in this system, the inclusion of explicit hydration shells is neither detrimental nor time 
consuming. This aspect is fundamental, because it allows to automatically and safely 
apply the Nwat-MMGBSA approach in drug design/discovery protocols. 
In addition, as previously observed for the other systems, it could not be found 
any significant difference between the MMGBSA results obtained from the analyses 
of the MD simulations performed on either GPUs or CPUs, indicating that the highly 
performing and innovative GPUs can be reliably used for MD simulations. 
 
Figure 11.7. A) Trend of r2 in dependency of Nwat for BCL-XL. B) Water density plots obtained by 
grid analysis of BCL-XL-3ZC4 (visualization with Chimera, step = 1 and level = 15). 
Table 11.3. Values of r2 as a function of Nwat obtained by the analysis of the first and fourth ns of 
BCL-XL MD simulations run on both GPU and CPU hardwares. Average values and standard 
deviations are also reported. 
GPU, 1 ns CPU, 1 ns 
Nwat r2 run1 r2 run2 r2 run3 Avg r2 ± SD r2 run1 r2 run2 r2 run3 Avg r2 ± SD 
0 0.75 0.73 0.79 0.76 ± 0.03 0.70 0.75 0.74 0.73 ± 0.03 
10 0.71 0.69 0.72 0.71 ± 0.02 0.75 0.72 0.65 0.71 ± 0.05 
20 0.67 0.68 0.69 0.68 ± 0.01 0.74 0.69 0.62 0.68 ± 0.06 
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30 0.67 0.71 0.69 0.69 ± 0.02 0.73 0.71 0.62 0.69 ± 0.06 
40 0.68 0.71 0.69 0.69 ± 0.02 0.69 0.70 0.61 0.67 ± 0.05 
50 0.69 0.69 0.69 0.69 ± 0.00 0.65 0.68 0.58 0.64 ± 0.05 
GPU, 4 ns CPU, 4 ns 
Nwat r2 run1 r2 run2 r2 run3 Avg r2 ± SD r2 run1 r2 run2 r2 run3 Avg r2 ±SD 
0 0.63 0.76 0.75 0.71 ± 0.07 0.62 0.7 0.76 0.66 ± 0.06 
10 0.65 0.75 0.74 0.71 ± 0.06 0.73 0.7 0.65 0.72 ± 0.02  
20 0.65 0.74 0.72 0.70 ± 0.05 0.71 0.66 0.64 0.69 ± 0.04 
30 0.65 0.73 0.71 0.70 ± 0.04 0.72 0.66 0.65 0.69 ± 0.04 
40 0.66 0.71 0.71 0.69 ± 0.03 0.71 0.66 0.66 0.69 ± 0.04 





Figure 11.8. Correlation between experimental free energy of binding and predicted binding energies 
obtained for BCL-XL with Nwat = 0 - 50 by analyzing the first ns of a MD simulation run on a HPC 
hardware. 
XIAP-BIR2. The study of XIAP-BIR2 system required the extension of the 
hydration shell around the ligand up to Nwat = 90, in order to verify the convergence 
in terms of r2. Indeed, this system behaved in a completely different way compared to 
the previously considered complexes. In detail, the correlation between predicted 
binding energies and − log10(𝐼𝐶50) was already high (0.64 < r2 < 0.72) without 
considering any explicit solvent model during the MMGBSA calculations (Nwat = 0). 
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Then, with Nwat = 10 – 30 a drastic decrease in the r2 values was observed (0.01 < r2 
< 0.13), followed by an improvement in correlation up to values 10% higher than 
those obtained with Nwat = 0 (0.74 < r2 < 0.84) with Nwat = 80 – 90 (Figures 8.42A 
and 8.43, and Table 11.4). 
 
Figure 11.9. A) Trend of r2 in dependency of Nwat for XIAP-BIR2. B) Water density plots obtained by 
grid analysis of XIAP-BIR2-21J (visualization with Chimera, step = 1 and level = 15). 
Table 11.4. Values of r2 as a function of Nwat obtained by the analysis of the first and fourth ns of MD 
simulations run on both GPU and CPU hardwares for MDM2 system. Average values and standard 
deviations are also reported. 
GPU, 1 ns CPU, 1 ns 
Nwat r2 run1 r2 run2 r2 run3 Avg r2 ± SD r2 run1 r2 run2 r2 run3 Avg r2 ± SD 
0 0.83 0.74 0.60 0.72 ± 0.12 0.60 0.81 0.61 0.67 ± 0.12 
10 0.18 0.03 0.09 0.10 ± 0.08 0.07 0.31 0.00 0.13 ± 0.16 
20 0.03 0.01 0.02 0.02 ±0.01 0.01 0.20 0.01 0.07 ± 0.11 
30 0.09 0.07 0.03 0.06 ± 0.03 0.03 0.24 0.00 0.09 ± 0.13 
40 0.23 0.46 0.22 0.30 ± 0.14 0.18 0.44 0.01 0.21 ± 0.22 
50 0.59 0.83 0.59 0.67 ± 0.14 0.50 0.71 0.16 0.46 ± 0.28 
60 0.75 0.84 0.73 0.77 ± 0.06 0.73 0.81 0.49 0.68 ± 0.17 
70 0.81 0.83 0.76 0.80 ± 0.04 0.81 0.84 0.62 0.76 ± 0.12 
80 0.83 0.83 0.77 0.81 ± 0.03 0.83 0.86 0.72 0.80 ± 0.07 
90 0.83 0.82 0.81 0.82 ± 0.01 0.87 0.85 0.77 0.83 ± 0.05 
GPU, 4 ns CPU, 4 ns 
Nwat r2 run1 r2 run2 r2 run3 Avg r2 ± SD r2 run1 r2 run2 r2 run3 Avg r2 ±SD 
0 0.68 0.67 0.58 0.64 ± 0.06 0.61 0.75 0.57 0.64 ± 0.09 
10 0.01 0.09 0.04 0.05 ± 0.04 0.00 0.03 0.01 0.01 ± 0.02 
20 0.00 0.02 0.01 0.01 ± 0.01 0.01 0.02 0.00 0.01 ± 0.01 
30 0.07 0.02 0.03 0.04 ± 0.03 0.00 0.07 0.00 0.02 ± 0.04 
40 0.36 0.09 0.31 0.25 ± 0.14 0.01 0.23 0.01 0.08 ± 0.13 
50 0.81 0.29 0.89 0.66 ± 0.33 0.16 0.51 0.19 0.29 ± 0.19 
60 0.90 0.49 0.96 0.78 ± 0.26 0.49 0.68 0.50 0.56 ± 0.11 
70 0.85 0.57 0.88 0.77 ± 0.17 0.62 0.69 0.69 0.67 ± 0.04 
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80 0.81 0.63 0.80 0.75 ± 0.10 0.72 0.73 0.77 0.74 ± 0.03 
90 0.76 0.66 0.76 0.73 ± 0.06 0.77 0.76 0.83 0.79 ± 0.04 
The decrease in r2 values when Nwat = 10 -30 can be mainly attribute to the C09 
complex. Indeed, for this complex the inclusion of small hydration shells around the 
ligands is detrimental, while it does not have any effect on the other complexes. This 
is probably due to the fact that, among the considered ligands, C09 is the only one 
with a secondary amine on the benzodiazepine ring (Figure 11.16), which can interact 
with water molecules (Figure 11.10). This additional interaction leads to an 
overestimation of the binding energy of the related complex when Nwat = 10 -30 is 
used, while with larger hydration shell it is not observed because additional water-
mediated H-bonds within the protein reduce the impact of the complex contribute in 
the binding energy computation (Table 11.5). 
 
Figure 11.10. XIAP-BI2-C09 complex with Nwat = 20. C09 is represented in green, while the water 
molecule involved in the interaction with C09(N7) is represented in ball and stick and circled in red. 
Therefore, if C09 was omitted from the dataset, results are similar to those 
obtained for the BCL-XL system. It should also be considered that the overestimation 
of the binding energy in the C09 complex was reduced when considering larger 
hydration shells, and that the use of the Nwat-MMGBSA approach with Nwat ≠ 0. 
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Table 11.5. Water-mediated H-bonds with occupancy > 20% detected from the analysis of a CPU MD 
simulation of the C09 complex.  
Nwat = 20  Nwat = 70  
Residues involved Occ% Residues involved Occ% 
65:ASP  70:GLU 39.0 65:ASP  70:GLU 68.0 
93:ARG  115:GLY 34.0 63:PRO  65:ASP 54.0 
17:ARG  39:GLY 33.0 60:ASN  62:GLU 35.0 
62:GLU  65:ASP 28.0 93:ARG  115:GLY 34.0 
60:ASN  62:GLU 27.0 17:ARG  39:GLY 33.0 
  62:GLU  65:ASP 33.0 





Figure 11.11. Correlation between experimental free energy of binding and predicted binding energies 




HIV1-protease. It is known that water is fundamental for the catalytic activity of 
this aspartic protease, where a water molecule, located between two aspartate residues, 
is activated through an acid-base mechanism and attacks the amidic carbonyl of the 
cleavage site.320 Thus, it is not surprising that for this system many and relatively wide 
areas of high water density between the protein and the ligand have been detected by 
grid analysis (Figure 11.12B).  
 
Figure 11.12. A) Trend of r2 in dependency of Nwat for HIV1-protease. B) Water density plots 
obtained by grid analysis of HIV1-protease-3NUO (visualization with Chimera, step = 1 and level = 
15). 
In addition, among the considered systems, the HIV1-protease is the most 
affected by solute-solvent interactions. Indeed, the inclusion of a hydration shell of 30 
– 70 molecules increased the correlation between predicted binding energies and ki of 
about 50 – 60 % compared to the r2 obtained with Nwat = 0 (Figure 11.11A and Table 
11.5). In all the performed runs, the inclusion of 10 – 20 water molecules during the 
MMGBSA analysis did not significantly affect the r2 (Table 11.6). This suggests that 
small hydration shells around the ligand are not enough to correctly treat the solute – 
solvent interactions, which, in this case, may differently involve the HIV1-protease 
mutants. Indeed, water-mediated H-bond analyses showed that only one or two stable 
(occupancy > 20%) water-mediated interactions involved the ligand, while in most of 
the cases water is needed to bridge interactions within the HIV1-protease. In addition, 
the water-mediated interactions between HIV1-protease and the ligand have the same 
occupancies with both Nwat = 10 and Nwat = 70, although the correlation with 
experiments is greater with Nwat = 70 than with Nwat =10. This is showed in Tables 
8.26 and 8.27, where 3NUO, which is highly affected by the inclusion of solvent 
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molecules during the MMGBSA analysis, and 3NDW, which well correlated with 
experiments also with Nwat = 0, are taken as example. It can be observed that the 
number of water-mediated H-bonds within the protein decidedly increases when 
passing from Nwat = 10 to Nwat = 70 for 3NUO, evidencing the importance of water 
in this system. Conversely, with Nwat = 10 and Nwat = 70 the water-mediated 
interactions detected in 3NDW are equivalent and significantly lower than those 
obtained by analysing the 3NUO trajectory. 
Table 11.6. Values of r2 as a function of Nwat obtained by the analysis of the first and fourth ns of MD 
simulations run on both GPU and CPU hardwares for HIV1-protease system. Average values and 
standard deviations are also reported. 
GPU, 1 ns CPU, 1 ns 
Nwat r2 run1 r2 run2 r2 run3 Avg r2 ± SD r2 run1 r2 run2 r2 run3 Avg r2 ± SD 
0 0.22 0.06 0.03 0.10 ± 0.10 0.48 0.36 0.01 0.28 ± 0.24 
10 0.08 0.03 0.12 0.08 ± 0.05 0.34 0.66 0.12 0.37 ± 0.27 
20 0.13 0.09 0.12 0.11 ± 0.02 0.39 0.70 0.23 0.44 ± 0.24 
30 0.52 0.60 0.68 0.60 ± 0.08 0.72 0.76 0.6 0.69 ± 0.08 
40 0.60 0.77 0.74 0.70 ± 0.09 0.73 0.75 0.69 0.72 ± 0.03 
50 0.62 0.80 0.74 0.72 ± 0.09 0.72 0.74 0.70 0.72 ± 0.02 
60 0.63 0.80 0.74 0.72 ± 0.09 0.71 0.73 0.71 0.72 ± 0.01 
70 0.63 0.80 0.74 0.72 ± 0.09 0.71 0.73 0.71 0.72 ± 0.01 
GPU, 4 ns CPU, 4 ns 
Nwat r2 run1 r2 run2 r2 run3 Avg r2 ± SD r2 run1 r2 run2 r2 run3 Avg r2 ±SD 
0 0.12 -0.02 0.00 0.03 ± 0.08 0.08 0.00 0.01 0.04 ± 0.06 
10 0.13 0.00 0.03 0.05 ± 0.07 0.52 0.39 0.10 0.46 ± 0.09 
20 0.19 0.01 0.02 0.07 ± 0.10 0.32 0.65 0.00 0.49 ± 0.23 
30 0.53 0.24 0.23 0.33 ± 0.17 0.62 0.90 0.52 0.76 ± 0.20 
40 0.65 0.50 0.40 0.52 ± 0.13 0.67 0.89 0.70 0.78 ± 0.16 
50 0.67 0.58 0.45 0.57 ± 0.11 0.66 0.87 0.72 0.77 ± 0.15 
60 0.66 0.60 0.47 0.58 ± 0.10 0.67 0.85 0.72 0.76 ± 0.13 




Figure 11.13. Correlation between experimental free energy of binding and predicted binding energies 




Table 11.7. Water-mediated H-bonds with occupancy > 20% detected from the analysis of a CPU MD 
simulation of 3NUO. The water-mediated H-bonds involving amprenavir are reported in bold. 
Nwat = 10  Nwat = 70  
Residues involved occ% Residues involved occ% 
31:ASP  203:AMP 58.0 31:ASP  203:AMP 58.0 
90:LEU  91:MET  54.0 129:GLY  131:ASP  56.0 
129:GLY  131:ASP  51.0 90:LEU  91:MET  54.0 
132:ASP  203:AMP 47.0 80:PRO  152:ILE  54.0 
191:LEU  192:MET  41.0 132:ASP  203:AMP 47.0 
  191:LEU  192:MET  41.0 
  27:THR  28:GLY  34.0 
  52:GLY  181:PRO  30.0 
  30:ASP  31:ASP  28.0 
  31:ASP  46:LYS  21.0 
  128:THR  129:GLY  20.0 
 
Table 11.8. Water-mediated H-bonds with occupancy > 20% detected from the analysis of a CPU MD 
simulation of 3NDW. The water-mediated H-bonds involving ritonavir are reported in bold. 
Nwat = 10   Nwat = 70  
Residues involved occ% Residues involved occ% 
191:LEU  192:LEU  73.0 26:ASP  127:ASP  86.0 
26:ASP  127:ASP  70.0 191:LEU  192:LEU  73.0 
132:ASP  203:RIT  54.0 132:ASP  203:RIT  54.0 
90:LEU  91:LEU  53.0 90:LEU  91:LEU  53.0 
176:THR  177:VAL  36.0 28:GLY  30:ASP  38.0 
  176:THR  177:VAL  36.0 
Moreover, when Nwat > 30 the standard deviations of r2 generally decreased, and 
this is particularly evident for the MMGBSA analyses performed on the 1st ns of CPU 
MD simulations. This observation is consistent with what previously noticed for the 
MDM2 and the XIAP-BIR2 systems. 
Therefore, this study confirmed the reliability and robustness of the Nwat-
MMGBSA approach, which gave reproducible results within different independent 
MD simulations and independently from the hardware on which the simulations run. 
Indeed, the standard deviation of the correlation index within 3 independent MD 
simulations was generally lower when the optimal Nwat was considered than when 
Nwat = 0. Furthermore, the inclusion of variably wide hydration shells around the 
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ligands improved or, at least, did not worsened the correlation between predicted 
binding energies and experimental activities, such as ∆𝐺𝑏𝑖𝑛𝑑, ki and IC50.  
Although, the definition of an optimal Nwat valid for all sytems is still an issue, 
generally Nwat = 50 – 60 gave good results, not significantly different from the best 
obtainable for each system. Therefore, in PPI systems larger hydration shells have to 
be considered during the MMGBSA calculations, compared to what observed for 
classical receptor-ligand or protein-protein complexes. Indeed, considering that 
explicit waters are considered as a part of the receptor, the selection of a limited 
number of water molecules around the ligand might lead to an overestimation of the 
binding energy when solvent-exposed hydrophilic groups are present on the ligand. 
These observations indicate that the Nwat-MMGBSA approach represents a 
promising protocol for drug design/discovery studies, also because short MD 
simulations (even 1 ns) and fast and cheap GPU cards can be safely used at this scope. 
Furthermore, the whole protocol, including ligands parametrization, MD simulations, 
MMGBSA calculations and additional trajectory analysis, has been automatized 
(Annex 11.F) and a “single-click” is necessary to go from PDB complexes to 
MMGBSA results. 
11.3 MATERIALS AND METHODS 
Preparation of complexes. For BCL-XL (Figure 11.14), MDM2 (Figure 11.15) 
and XIAP-BIR2 (Figure 11.16) ligands not all the crystallographic structures of the 
complexes were available. In detail a X-ray structure was available for BCL-XL 3ZK6, 
3ZLN, 3ZLO and 3ZLR complexes,316 for the MDM2 4JV7, 4JV9, 4JVE, 4JVR and 
4JWR,315 whereas for the XIAP-BIR2 system only the crystallographic structure of 
21J was available.317 Therefore, the starting geometries of the ligands without an X-





Figure 11.14. BCL-XL ligands with IC50 values. 
 
Figure 11.15. MDM2 ligands with IC50 values. 
 




Figure 11.17. HIV1-protease ligands. 
Table 11.9. HIV1-protease complexes with related mutations and ki values (APV= amprenavir, RTV = 
ritonavir). 
Complex Mutation Ligand ki (nM) 
3NU3 Wild type APV 0.150 
3NU4 V32I APV 1.500 
3NU5 I50V APV 4.500 
3NU6 I54M APV 0.500 
3NUJ I54V APV 0.410 
3NU9 I84V APV 0.900 
3NUO L90M APV  0.160 
3NDW Q7K RTV 0.055 
3NDX Q7K RTV 0.055 
Ligand partial charges were derived with the AM1-BCC method by the 
antechamber321 software of AMBER14 package. 
From the available crystallographic structures, crystallographic water molecules 
or crystal stabilizers have been manually removed, and the protonation states of the 
proteins were determined by MOE software through the Protonate 3D tool. 
MD simulations. MD simulations were performed with the pmemd module of 
Amber14 package,192 using the ff14SB135 and gaff322 force fields. In each complex, the 
total charge was neutralized by adding an adequate number of Na+/Cl- ions, and the 
systems were solvated with an octahedral box of TIP3P292 water added up to a 
distance of 10 Ǻ from the solute. The systems where then relaxed by minimizing 
hydrogens (1000 cycles of steepest descent and 5000 cycles of conjugated gradient), 
ions and waters (2000 cycles of steepest descent and 5000 cycles of conjugated 
gradient). The solvent box was equilibrated at 300 K by 100 ps of NVT and 100 ps of 
NPT simulation using a Langevin thermostat with a collision frequency of 2.0 ps-1. 
Successively, a minimization of side chains, water and ions with restraints on 
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backbone and ligand of 25 kcal/mol and a total minimization (2500 cycles of steepest 
descent and 5000 cycles of conjugated gradient) were performed. The systems were 
then heated up to 300 K in 6 steps of 5 ps each (ΔT = 50 K), where backbone and 
ligand restraints were reduced from 10.0 kcal/mol to 5 kcal/mol. Full equilibration 
was performed in the NVT ensemble (100 ps, ligand and backbone restraints = 5.0 
kcal/mol) and in the NPT ensemble (1 step of 200 ps, ligand and backbone restraints = 
5 kcal/mol; 3 steps of 100 ps each, reducing the ligand and backbone restraints from 
5.0 kcal/mol to 1.0 kcal/mol, and 1 step 1 ns with 1.0 kcal/mol of ligand and backbone 
restraints). Finally, unrestrained production runs were run at 300K for 4 ns. An 
electrostatic cutoff of 8.0 Ǻ, and the SHAKE algorithm were applied to all the 
calculations. Six independent simulations for each complex were run on GPU and on 
CPUs. 
When needed, RMSD analyses of backbone atoms were made to assess the 
system stability, and solute – solvent H-bonds (donor – acceptor distance = 4.0 Ǻ, 
angle = 150°) and grid (cubic box 50 Ǻ ×50 Ǻ ×50 Ǻ, mesh = 0.5 Ǻ, centered on 
interfacial residues) analyses were performed with cpptraj. 
Nwat-MMPB/GBSA. MMGBSA analyses were performed with the 
MMPBSA.py python script implemented in the Amber14 package. The analyses were 
conducted on either the 1st or the 4th ns of the production runs by selecting 100 evenly 
spaced out snapshots. The GB-Neck2 implicit solvent model was chosen for the GB 
calculations, and a salt molar concentration in solution was set at 0.15 M. During the 
analyses the entropic term was neglected. 
When explicit water molecules were considered during the MMPB/GBSA 
calculations the same approach described in Chapter 8.1.3 was followed.  
The water molecules (depending on the chosen Nwat) were considered as part of 
the protein considered as the receptor. 
The square of Pearson’s correlation coefficient (r2) between experimental ∆𝐺𝑏𝑖𝑛𝑑 
and computed binding energies was used as an evaluation metric. 
The whole process (from ligand parametrization to MMGBSA) has been 




In the wide field of PPIs, this PhD project has been focused on the optimization 
and application of computational methods for the design of PPIs modulators, with a 
particular interest toward peptide modulators targeting PPIs involving helical motifs. 
In this contest, the first part of the project has been aimed to define the rationales 
behind the helical secondary structure stabilization and the helical screw sense 
selectivity exerted by chiral Cα-tetrasubstituted amino acids (cCTAAs) through 
REMD simulations and QTAIM analyses, and the mechanisms responsible of the 
helical screw sense inversion through PNEB simulations.  
In detail, it has been found that the helical motif is stabilized by two 
complementary mechanisms: the first depends on the steric hindrance exerted by the 
cCTAA in an area parallel to the peptide helix axis and downstream of the cCTAA 
itself, whereas the second consists in the strengthening of the helical H-bond network 
thanks to peculiar C-H··· O=C interactions. Analogously, P-helical screw sense 
selectivity is ascribable to the cCTAA steric hindrance parallel to the peptide helix 
axis, without particular preferences for the region downstream and upstream of the 
cCTAA, together with quite strong noncovalent interactions, consisting of classical N 
– H···O=C H -bonds and weak C – H···O=C interactions.  Furthermore, PNEB 
simulations performed on achiral peptides of different lengths suggest that the helical 
screw sense inversion requires the formation of γ-turns, although a preferential screw 
sense inversion direction was not found.  
Therefore, the knowledge gained from these studies could be helpful in designing 
stable helical peptides, having a preferential screw sense and that can be in principle 
activated in situ by inducing a conformational switch from P to M helix or vice versa. 
Conversely, the second part of the project has been focused on the optimization 
of an MMGBSA based method, called Nwat-MMGBSA, aimed to improve the 
correlation between predicted binding energies of PPI complexes and experimental 
data. This approach, consisting in the inclusion, as part of the receptor, of hydration 
shells around the ligand during the MMGBSA calculations, was initially tested on 
213 
 
classical receptor-ligand complexes and, then, automatized, optimized and tested on 
PPI complexes.  
This approach turned out to be good for the evaluation of PPI modulators 
activities, from different points of view. First of all, when water played a significant 
role in mediating protein-ligand interactions, the application of Nwat-MMGBSA 
improved the correlation between predicted and experimental data. On the other hand, 
if the solvent does not explicitly participate to the interaction, it did not give 
detrimental results compared to those obtained with the standard approach. In 
addition, the protocol proved to be robust and reproducible, giving equivalent results 
by using different setups. Furthermore, although an optimal number of water 
molecules to include in the hydration shell could not be found, in the case of PPI 
interactions inhibited by small molecules the inclusion of 50 – 60 water molecules 
appears to be a good choice. A non-negligible advantage of this approach is 
represented by the possibility to automatize it, making it applicable for drug 
design/discovery purposes. 
Therefore, although further evaluations are needed, most of all on larger datasets, 
the knowledge coming from the combination of both parts of the project can be 
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ANNEXES 
ANNEX 4.A. Additional information for peptide H1. 
H-bond analysis of the 300.37 K trajectory extracted from REMD simulations of 
peptide H1. Data are related to H-bonds involving the backbone (donor backbone N-H, 
acceptor backbone C=O). 
ff96/ GB-HCT  ff96/ GB-OBC(II)  ff96/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
GLU7 LEU3 30.68  TYR13 TYR9 72.91  LYS12 LEU8 69.15 
LYS14 GLN10 35.35  LYS14 GLN10 62.96  GLN6 LYS14 8.80 
GLN6 LYS2 19.22  TYR9 TRP5 74.06  TRP5 LYS14 6.82 
GLY15 GLN10 10.03  LYS12 LEU8 79.69  ILE16 LEU3 7.87 
LEU11 GLU7 35.42  GLN10 GLN6 81.16  LEU8 LYS12 7.06 
LYS12 LEU8 42.26  LEU11 GLU7 78.83  LEU3 ILE16 6.62 
GLN10 GLN6 36.85  GLN6 LYS2 38.66  LYS14 GLN10 47.49 
TYR13 TYR9 40.04  LEU8 THR4 58.01  TYR13 TYR9 51.86 
LEU8 THR4 30.61  GLU7 LEU3 46.24  LEU11 GLU7 61.36 
TYR9 TRP5 52.09  GLY15 GLN10 11.79  LEU8 THR4 33.15 
GLU7 TYR13 5.14  GLY15 LEU11 17.47  GLN10 GLN6 37.37 
LYS14 TYR9 5.14  LYS14 TYR9 5.84  GLY15 GLN10 8.33 
GLY15 LYS2 6.16      TYR9 TRP5 36.06 
GLY15 LEU11 11.54      LEU11 LEU8 5.62 
THR4 LYS12 7.10      LYS14 GLN6 6.38 
LYS12 THR4 10.12      GLY15 LEU11 15.35 
        GLU7 LEU3 14.22 
        GLN6 LYS2 14.04 
           
ff99SB/ GB-HCT  ff99SB/ GB-OBC(II)  ff99SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
GLU7 LEU3 22.98  LYS12 TYR9 12.36  LEU11 GLU7 22.56 
TRP5 LYS2 16.62  LYS12 LEU8 26.07  TYR13 LEU8 6.93 
GLY15 LEU11 11.42  TYR13 GLN10 11.99  GLN6 LEU3 24.60 
TYR13 GLN10 21.61  GLU7 LEU3 25.44  LEU8 THR4 34.54 
LYS14 GLN10 22.98  LEU8 TRP5 10.24  GLU7 THR4 17.66 
ILE16 TYR13 8.64  LEU11 LEU8 11.39  TYR9 TRP5 41.27 
LYS12 TYR9 15.29  TYR9 TRP5 30.46  TYR13 TYR9 16.54 
TYR13 TYR9 15.47  GLU7 THR4 12.02  LYS12 LEU8 26.77 
GLN6 LEU3 29.56  GLN10 GLU7 13.97  LEU11 LEU8 16.33 
TYR9 GLN6 17.45  LEU8 THR4 26.93  TYR13 GLN10 12.92 
GLN10 GLN6 20.31  GLN6 LEU3 27.49  LYS12 GLN6 7.29 
LEU11 GLU7 18.10  LEU11 GLU7 28.66  LYS14 GLN10 16.24 
GLY15 LYS12 5.30  TYR13 TYR9 22.38  GLN10 GLU7 17.59 
LEU11 LEU8 11.85  GLN10 GLN6 29.96  TYR9 GLN6 6.87 
TYR9 TRP5 21.34  ILE16 TYR13 9.36  ILE16 TYR13 9.78 
GLN6 LYS2 10.67  GLN6 LYS2 16.80  GLN10 GLN6 25.78 
LEU8 THR4 20.39  TYR9 GLN6 12.38  GLU7 LEU3 32.97 
GLY15 GLN10 5.97  LYS14 LEU11 8.62  GLY15 LYS12 5.23 
LEU8 TRP5 13.85  TRP5 LYS2 13.60  TRP5 LYS2 13.75 
GLU7 THR4 14.49  LYS12 GLU7 5.30  LEU8 TRP5 10.41 
LYS12 LEU8 16.66  LYS14 GLN10 19.89  GLN6 LYS2 17.18 
LYS14 LEU11 12.50  GLY15 LEU11 8.62  TYR13 GLU7 8.13 
GLN10 GLU7 12.60      LYS12 GLU7 7.02 
LEU11 TRP5 5.94      LYS12 TYR9 7.43 
LYS12 GLU7 7.60      LYS14 LEU11 9.70 
        GLY15 LEU11 6.47 
        LEU11 GLN6 8.02 
        GLY15 GLN10 5.15 
ff99SBildn/ GB-HCT  ff99SBildn/ GB-OBC(II)  ff99SBildn/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
TYR9 TRP5 15.27  LEU11 LEU8 21.48  GLY15 LYS12 6.99 
LEU8 THR4 18.74  LYS12 TYR9 18.51  GLU7 THR4 25.32 
GLY15 TYR9 5.40  GLY15 LEU11 8.77  LEU8 THR4 36.82 
LEU11 GLU7 15.66  LEU8 THR4 21.04  LYS14 LEU11 8.86 
LYS12 LEU8 14.49  TYR13 TYR9 17.69  GLN6 LEU3 34.00 
LEU11 LEU8 21.86  LEU8 TRP5 17.71  TYR9 TRP5 29.49 
GLN6 LEU3 37.18  GLN6 LEU3 30.13  GLY15 LEU11 5.10 
GLU7 LEU3 20.73  GLU7 LEU3 20.83  TYR13 GLN10 9.60 
TYR13 TYR9 11.62  LYS12 LEU8 14.66  GLU7 LEU3 22.24 
LYS14 LEU11 17.22  GLU7 THR4 18.21  LEU11 GLU7 25.77 
GLN10 GLU7 12.51  LEU11 GLU7 17.49  GLN10 GLN6 19.86 
TYR9 GLN6 19.31  TYR13 GLN10 9.03  LYS12 LEU8 23.12 
LYS12 GLU7 9.52  ILE16 TYR13 9.83  LYS12 TYR9 17.29 
GLN10 GLN6 22.86  TYR9 GLN6 16.20  LYS14 GLN10 14.52 
GLU7 THR4 16.02  LYS14 LEU11 14.98  TYR13 TYR9 22.19 
LEU8 TRP5 13.02  GLN10 GLU7 16.43  LEU11 LEU8 22.94 
GLY15 LYS12 12.17  GLY15 LYS12 6.53  GLN6 LYS2 9.66 
ILE16 TYR13 15.62  GLN10 GLN6 18.56  TRP5 LYS2 8.90 
TYR13 GLN10 15.41  TYR9 TRP5 19.09  LEU8 TRP5 14.54 
LYS14 GLN10 14.26  LYS14 GLN10 12.88  ILE16 LEU11 6.79 
LYS12 TYR9 17.25  TRP5 LYS2 9.47  TYR9 GLN6 11.98 
TRP5 LYS2 7.18  GLN6 LYS2 5.93  GLN10 GLU7 17.57 
ILE16 LEU11 9.80  GLN10 TRP5 8.00  TYR13 LEU8 9.26 
        ILE16 TYR13 9.23 
        LEU11 GLN6 6.52 
ff99SBildn-φ/ GB-HCT  ff99SBildn-φ/ GB-OBC(II)  ff99SBildn-φ/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
TYR9 GLN6 12.90  GLU7 LEU3 24.54  LEU8 THR4 33.18 
LEU8 TRP5 13.93  LEU8 THR4 31.10  TYR9 TRP5 26.89 
GLN6 LEU3 29.06  TYR9 TRP5 35.99  LEU11 GLU7 32.41 
LEU11 LEU8 14.49  GLN10 GLN6 32.75  TYR13 LEU8 24.58 
GLN10 GLN6 14.38  TYR13 TYR9 27.26  GLN6 LEU3 38.89 
GLY15 LYS12 15.25  LYS12 LEU8 23.34  LEU8 TRP5 10.79 
TYR9 TRP5 25.57  GLY15 LEU11 7.99  GLU7 THR4 19.26 
GLU7 LEU3 25.20  ILE16 LEU11 11.05  GLN10 GLU7 16.05 
LEU8 THR4 27.07  GLN6 LEU3 28.29  LYS12 LEU8 29.35 
TYR13 GLN10 17.11  GLU7 THR4 17.03  GLY15 LYS12 7.93 
LEU11 TRP5 7.58  TRP5 LYS2 9.22  TYR13 TYR9 16.68 
GLU7 THR4 17.69  LEU11 LEU8 18.55  LEU11 GLN6 5.20 
LYS12 TYR9 15.37  LYS12 TYR9 19.48  TYR9 GLN6 15.10 
LYS14 GLN10 25.95  TYR13 GLN10 8.91  LYS14 LEU11 9.28 
GLY15 LEU11 11.03  LEU11 GLU7 25.45  GLN10 GLN6 23.66 
LYS14 LEU11 13.92  LYS14 GLN10 21.37  LYS14 GLN10 12.66 
TRP5 LYS2 9.74  GLY15 LYS12 9.98  GLY15 TYR9 8.20 
ILE16 TYR13 7.76  TYR9 GLN6 11.07  ILE16 LEU11 5.26 
LEU11 GLU7 8.57  GLN10 GLU7 10.13  GLU7 LEU3 24.76 
GLN10 GLU7 15.17  TYR13 LEU8 9.75  LEU11 LEU8 12.56 
LYS12 GLN6 9.94  LEU8 TRP5 13.77  TYR13 GLN10 7.87 
ILE16 LEU11 17.59  LYS14 LEU11 6.83  LYS12 TYR9 11.10 
GLN6 LYS2 10.04  GLN6 LYS2 11.70  ILE16 TYR13 15.13 
LEU11 GLN6 8.18  ILE16 TYR13 13.50  TRP5 LYS2 9.63 
TYR13 TYR9 14.03      LYS12 GLU7 5.74 
LYS12 LEU8 12.77      GLN6 LYS2 6.76 
ff12SB/ GB-HCT  ff12SB/ GB-OBC(II)  ff12SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LEU8 THR4 47.55  LYS12 LEU8 53.91  LYS14 GLN10 48.09 
LYS12 TYR9 11.65  TYR13 TYR9 56.36  GLN6 LYS2 31.64 
GLU7 LEU3 38.02  LEU11 GLU7 52.22  GLU7 LEU3 40.12 
LEU11 GLU7 30.38  LEU8 THR4 58.82  TYR13 TYR9 56.90 
LYS14 LEU11 17.08  GLN6 LYS2 37.39  ILE16 LEU11 16.50 
TYR9 TRP5 43.74  GLU7 LEU3 41.16  TYR9 TRP5 61.76 
GLN10 GLN6 40.38  GLY15 LEU11 17.33  GLN10 GLN6 52.59 
GLY15 LEU11 12.17  TYR9 TRP5 67.77  LEU8 THR4 50.20 
LYS12 LEU8 32.97  GLN10 GLN6 60.84  GLY15 LEU11 14.93 
ILE16 TYR13 14.52  TRP5 LYS2 8.24  TRP5 LYS2 12.14 
LYS14 GLN10 29.22  ILE16 LEU11 11.98  LYS12 LEU8 55.68 
ILE16 LEU11 9.62  GLY15 LYS12 10.33  LYS14 LEU11 8.79 
TYR13 TYR9 34.10  LYS14 GLN10 49.29  LEU11 GLU7 49.81 
GLN6 LYS2 14.85  TYR13 LEU8 8.92  GLN6 LEU3 17.97 
GLY15 LYS12 12.96  LYS12 TYR9 6.92  GLY15 GLN10 8.00 
TYR13 GLN10 13.11  GLN6 LEU3 10.00  GLY15 LYS12 11.02 
GLN6 LEU3 18.23  ILE16 TYR13 15.19  GLU7 THR4 12.02 
TRP5 LYS2 7.05  LYS14 LEU11 8.86  TYR13 LEU8 5.03 
LEU8 TRP5 5.96  GLU7 THR4 7.34  ILE16 TYR13 6.86 
TYR9 GLN6 6.37  ILE16 LYS12 6.11     
GLU7 THR4 11.64         
TYR13 LEU8 8.33         
LEU11 LEU8 7.89         
GLY15 GLN10 5.82         
ff14SB/ GB-HCT  ff14SB/ GB-OBC(II)  ff14SB/ GB-Neck2 
donor acceptor occ%  donor  acceptor  occ%  donor acceptor occ% 
GLU7 LEU3 27.81  LEU11  LEU8 11.69  GLY15 LYS12 13.39 
LEU8 TRP5 11.14  GLU7  LEU3 35.54  LYS14 GLN10 44.36 
TYR9 GLN6 13.52  GLN6  LYS2 27.76  ILE16 LEU11 24.73 
LYS12 TYR9 19.53  GLN10  GLN6 39.71  LYS12 LEU8 42.43 
GLN6 LEU3 18.33  GLY15  LYS12 12.20  LEU11 GLU7 49.22 
TRP5 LYS2 13.12  LEU8  THR4 42.76  TYR9 TRP5 45.40 
LYS14 LEU11 9.83  LYS12  LEU8 38.19  LEU8 THR4 45.80 
GLY15 LYS12 13.68  TYR9  TRP5 45.14  GLU7 THR4 18.44 
GLN6 LYS2 16.65  LEU11  GLU7 34.83  LEU8 TRP5 6.73 
ILE16 TYR13 8.75  TYR13  TYR9 39.13  GLN10 GLN6 36.49 
GLN10 GLU7 10.37  TRP5  LYS2 14.21  GLY15 LEU11 9.70 
LEU11 GLU7 16.67  GLY15  LEU11 12.44  TYR9 GLN6 8.67 
LYS12 LEU8 19.04  LYS14  GLN10 43.21  TYR13 TYR9 39.67 
GLU7 THR4 13.57  LEU8  TRP5 9.13  LYS12 TYR9 10.42 
GLN10 GLN6 27.30  LYS12  TYR9 14.65  TRP5 LYS2 18.89 
TYR9 TRP5 30.88  GLN10  GLU7 7.14  TYR13 GLN10 8.52 
TYR13 TYR9 20.73  ILE16  TYR13 15.05  GLN10 GLU7 10.41 
LYS14 GLN10 43.52  GLN6  LEU3 15.71  ILE16 TYR13 11.28 
ILE16 LEU11 18.87  ILE16  LEU11 16.27  TYR13 LEU8 10.18 
LEU8 THR4 35.01  TYR9  GLN6 9.25  LEU11 LEU8 8.74 
GLY15 LEU11 15.57  LYS14  LEU11 6.04  GLN6 LEU3 19.60 
TYR13 GLN10 18.57  TYR13  GLN10 9.88  GLN6 LYS2 19.12 
LEU11 LEU8 16.29  GLU7  THR4 11.12  GLU7 LEU3 21.69 
 
ANNEX 4.B. Additional information for peptide H2. 
H-bond analysis of the 300.37 K trajectory extracted from REMD simulations of 
peptide H2. Data are related to H-bonds involving the backbone (donor backbone N-H, 
acceptor backbone C=O). 
ff96/ GB-HCT  ff96/ GB-OBC(II)  ff96/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
AIB6 ALA2 8.19  AIB6 ALA2 10.63  / / / 
ff99SB/ GB-HCT  ff99SB/ GB-OBC(II)  ff99SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
AIB6 ALA2 7.76  AIB5 ALA2 41.21  AIB5 ALA2 42.53 
AIB5 ALA2 42.85  AIB6 ALA2 6.83  AIB6 AIB3 26.33 
AIB6 AIB3 23.96  AIB6 AIB3 22.44     
ff99SBildn/ GB-HCT  ff99SBildn/ GB-OBC(II)  ff99SBildn/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
AIB5 ALA2 45.61  AIB6 AIB3 25.32  AIB6 AIB3 25.43 
AIB6 AIB3 23.14  AIB5 ALA2 41.65  AIB5 ALA2 45.52 
AIB6 ALA2 6.86  AIB6 ALA2 7.79     
ff99SBildn-φ/ GB-HCT  ff99SBildn-φ/ GB-OBC(II)  ff99SBildn-φ/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
AIB5 ALA2 46.40  AIB5 ALA2 44.66  AIB5 ALA2 43.30 
AIB6 AIB3 22.33  AIB6 AIB3 21.97  AIB6 AIB3 26.37 
AIB6 ALA2 7.22  AIB6 ALA2 8.02     
ff12SB/ GB-HCT  ff12SB/ GB-OBC(II)  ff12SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
AIB6 ALA2 25.73  AIB5 ALA2 27.51  AIB6 ALA2 11.92 
AIB5 ALA2 29.29  AIB6 ALA2 21.62  AIB5 ALA2 36.17 
AIB6 AIB3 12.43  AIB6 AIB3 11.60  AIB6 AIB3 15.59 
ff14SB/ GB-HCT  ff14SB/ GB-OBC(II)  ff14SB/ GB-Neck2 
donor acceptor occ%  donor  acceptor  occ%  donor acceptor occ% 
AIB6  AIB3 11.80  AIB6  AIB3 11.67  AIB5  ALA2 32.69 
AIB5  ALA2 26.51  AIB5  ALA2 28.89  AIB6  AIB3 13.30 
AIB6  ALA2 22.78  AIB6  ALA2 23.78  AIB6  ALA2 12.22 
 
ANNEX 4.C. Additional information for peptide B1. 









H-bond analysis of the 300.37 K trajectory extracted from REMD simulations of 
peptide B1. Data are related to H-bonds involving the backbone (donor backbone N-H, 
acceptor backbone C=O). 
ff96/ GB-HCT  ff96/ GB-OBC(II)  ff96/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS10 ASP7 12.14  LYS10 ASP6 46.56  THR11 ASP7 36.04 
ASP6 PHE12 4.61  ALA8 THR4 27.15  LYS10 ASP7 21.76 
VAL14 LYS10 22.17  THR11 ASP7 61.57  THR15 GLY1 5.14 
PHE12 ALA8 38.33  THR9 TYR5 34.81  TRP3 THR13 6.16 
THR13 THR9 23.49  THR13 THR9 19.41  TRP3 VAL14 5.06 
THR11 ASP7 56.38  PHE12 ALA8 36.34  ASP7 LYS10 6.12 
THR4 THR13 9.14  VAL14 LYS10 12.55  VAL14 TRP3 6.14 
ASP6 THR11 5.87  LYS10 ASP7 7.42  TYR5 PHE12 6.39 
THR13 THR4 7.70  ASP7 TRP3 5.26  PHE12 TYR5 6.75 
ASP6 GLU2 7.45         
LYS10 ASP6 20.13         
THR9 TYR5 16.82         
THR15 THR11 6.39         
ASP7 TRP3 11.04         
ALA8 THR4 9.37         
THR15 GLU2 5.03         
ff99SB/ GB-HCT  ff99SB/ GB-OBC(II)  ff99SB/ GB-Neck2 
donor  acceptor  occ%  donor acceptor occ%  donor acceptor occ% 
THR15  PHE12 17.77  THR13 LYS10 13.53  ASP6 GLU2 27.34 
VAL14  THR11 18.74  LYS10 ASP7 25.19  THR9 TYR5 10.51 
VAL14  LYS10 8.46  ASP7 TRP3 14.60  ASP7 TRP3 27.42 
PHE12  THR9 26.65  VAL14 LYS10 5.56  PHE12 ALA8 12.19 
THR13  THR9 15.38  THR9 ASP6 27.50  ALA8 THR4 13.17 
TYR5  GLU2 31.89  ASP6 TRP3 10.96  LYS10 ASP6 16.65 
THR9  ASP6 16.85  THR13 THR9 10.06  THR11 ASP7 10.21 
THR4  GLY1 15.42  TYR5 GLU2 18.93  THR15 PHE12 12.81 
THR13  LYS10 25.41  ASP7 THR4 12.20  THR13 LYS10 19.02 
THR11  ALA8 19.47  PHE12 THR9 21.17  LYS10 ASP7 34.17 
LYS10  ASP7 29.18  THR15 PHE12 10.60  ALA8 TRP3 10.30 
ASP7  TRP3 19.00  ASP6 GLU2 11.36  TYR5 GLU2 35.91 
ASP6  TRP3 22.90  VAL14 THR11 11.60  VAL14 THR11 18.01 
GLU16  THR13 5.14  LYS10 ASP6 21.45  THR15 THR11 5.62 
ASP6  GLU2 15.50  ALA8 THR4 10.42  THR11 ALA8 17.65 
PHE12  ALA8 8.06  THR9 TYR5 8.01  PHE12 THR9 31.54 
THR11  ASP7 9.90  ALA8 TYR5 15.23  THR9 ASP6 24.00 
LYS10  ASP6 11.22  THR11 ALA8 12.42  ASP6 TRP3 14.85 
ALA8  TYR5 5.42  PHE12 ALA8 5.91  ASP7 THR4 6.50 
ALA8  THR4 8.74  ASP6 THR11 5.53  THR13 THR9 15.09 
THR9  TYR5 7.73  THR13 THR4 7.86  ALA8 TYR5 8.42 
    THR4 THR13 5.67  GLU16 THR13 6.80 
        VAL14 LYS10 8.71 
ff99SBildn/ GB-HCT  ff99SBildn/ GB-OBC(II)  ff99SBildn/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
THR15 PHE12 13.97  THR9 ASP6 29.14  LYS10 ASP7 29.50 
LYS10 ASP7 31.85  LYS10 ASP6 29.01  THR13 LYS10 26.68 
THR4 GLY1 5.38  PHE12 THR9 38.48  THR9 ASP6 30.76 
ASP6 GLU2 17.61  THR13 THR9 18.59  LYS10 ASP6 24.88 
ASP6 TRP3 5.30  VAL14 LYS10 14.68  PHE12 THR9 25.27 
VAL14 THR11 20.19  VAL14 THR11 13.12  VAL14 LYS10 11.14 
PHE12 THR9 25.65  ALA8 THR4 5.76  THR11 ALA8 12.48 
THR13 LYS10 27.93  THR13 LYS10 19.43  THR13 THR9 11.18 
TYR5 GLU2 24.09  TYR5 GLU2 8.68  THR15 PHE12 14.08 
THR11 ASP7 6.34  THR15 PHE12 10.00  TYR5 GLU2 22.73 
VAL14 LYS10 14.21  LYS10 ASP7 22.73  ASP6 GLU2 11.12 
THR11 ALA8 21.05  THR11 ASP7 5.57  ALA8 THR4 8.10 
THR9 ASP6 11.71  THR11 ALA8 12.58  VAL14 THR11 24.87 
PHE12 TRP3 7.06  ASP7 THR4 5.06  THR15 THR11 8.92 
TYR5 LYS10 8.17  ALA8 TYR5 5.81  GLU16 THR13 6.00 
ALA8 TYR5 10.55      PHE12 ALA8 6.38 
THR13 THR9 12.68      THR11 ASP7 9.08 
THR15 THR11 5.72      ALA8 TYR5 8.94 
LYS10 ASP6 7.22      ASP7 THR4 7.00 
ff99SBildn-φ/ GB-HCT  ff99SBildn-φ/ GB-OBC(II)  ff99SBildn-φ/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ASP6 GLU2 16.77  ASP6 TRP3 7.94  THR15 PHE12 18.14 
VAL14 THR11 20.58  TYR5 GLU2 17.10  VAL14 THR11 19.89 
LYS10 ASP7 30.45  PHE12 THR9 29.89  LYS10 ASP6 23.60 
THR11 ASP7 9.37  LYS10 ASP7 33.78  ASP7 THR4 7.72 
GLU16 THR13 7.91  THR9 ASP6 27.27  THR9 TYR5 7.91 
THR13 LYS10 25.90  ALA8 TYR5 12.91  GLU16 THR13 10.10 
THR9 ASP6 18.28  THR13 THR9 13.99  THR9 ASP6 29.09 
TYR5 GLU2 34.61  THR15 PHE12 18.42  ASP7 TRP3 12.03 
ASP6 TRP3 12.89  THR13 LYS10 20.88  ASP6 GLU2 14.49 
THR15 PHE12 24.69  THR11 ASP7 8.14  PHE12 THR9 34.11 
THR4 GLY1 16.78  ASP6 GLU2 7.10  LYS10 ASP7 31.36 
THR11 ALA8 19.71  LYS10 ASP6 17.28  THR13 LYS10 21.20 
THR15 THR11 6.68  VAL14 THR11 18.07  VAL14 LYS10 10.77 
PHE12 ALA8 7.05  ASP7 TRP3 10.31  TYR5 GLU2 29.14 
PHE12 THR9 26.28  THR11 ALA8 16.79  THR11 ALA8 17.28 
ASP7 TRP3 8.54  THR9 TYR5 6.87  THR11 ASP7 9.15 
ALA8 TYR5 5.69  ASP7 THR4 5.79  ALA8 TYR5 10.07 
VAL14 LYS10 9.90  VAL14 LYS10 9.55  THR13 THR9 16.22 
LYS10 ASP6 11.90  PHE12 ALA8 6.40  PHE12 ALA8 10.26 
THR13 THR9 16.21  GLU16 THR13 7.05  THR15 THR11 6.30 
THR9 TYR5 5.18  ALA8 THR4 9.92  ASP6 TRP3 9.89 
        ALA8 THR4 12.05 
ff12SB/ GB-HCT  ff12SB/ GB-OBC(II)  ff12SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
THR9 ASP6 18.23  THR11 ASP7 8.46  ASP7 THR4 17.67 
ASP6 GLU2 9.95  ALA8 TYR5 22.05  THR11 ASP7 15.60 
VAL14 THR11 21.08  THR9 ASP6 18.60  TYR5 GLU2 26.64 
VAL14 LYS10 5.83  ASP7 THR4 13.95  ASP6 GLU2 9.01 
PHE12 ALA8 5.51  TYR5 GLU2 22.81  PHE12 ALA8 10.55 
LYS10 ASP7 19.25  ASP6 TRP3 7.38  THR13 LYS10 20.41 
THR13 THR9 7.04  VAL14 THR9 7.35  ASP6 TRP3 14.58 
THR4 GLY1 19.18  PHE12 THR9 18.87  LYS10 ASP6 17.01 
LYS10 ASP6 24.34  THR13 THR9 10.50  THR9 ASP6 21.31 
TYR5 GLU2 27.13  GLU16 THR13 10.88  GLU16 THR13 14.00 
THR13 LYS10 21.79  THR11 ALA8 14.49  ALA8 TYR5 27.97 
THR11 ALA8 13.67  VAL14 THR11 20.93  LYS10 ASP7 31.42 
PHE12 THR9 22.95  THR13 LYS10 22.37  VAL14 THR11 16.75 
THR15 PHE12 19.85  LYS10 ASP6 12.18  THR15 THR11 5.46 
THR11 ASP7 16.85  VAL14 LYS10 10.44  THR11 ALA8 13.96 
GLU16 THR13 15.16  LYS10 ASP7 33.59  THR15 PHE12 19.75 
ALA8 THR4 6.24  PHE12 ALA8 5.53  ALA8 THR4 6.94 
PHE12 ASP7 6.46  ASP6 GLU2 8.98  VAL14 ALA8 6.06 
ASP7 THR4 10.3  ALA8 THR4 5.15  THR13 THR9 10.38 
THR9 TYR5 8.15  THR9 TYR5 10.62  VAL14 LYS10 9.63 
ALA8 TYR5 9.78  THR15 PHE12 17.57  ASP7 TRP3 6.08 
ASP6 TRP3 15.06  THR11 ASP6 9.79  THR9 TYR5 6.28 
    THR4 GLY1 5.94  PHE12 THR9 27.46 
ff14SB/ GB-HCT  ff14SB/ GB-OBC(II)  ff14SB/ GB-Neck2 
donor  acceptor  occ%  donor  acceptor  occ%  donor acceptor occ% 
LYS10  ASP6 61.51  THR15  PHE12 16.42  THR11 ASP7 65.05 
THR13  THR9 34.97  GLU16  THR13 6.11  VAL14 LYS10 49.96 
THR15  THR11 17.63  THR9  ASP6 7.74  PHE12 ALA8 76.46 
GLU16  PHE12 12.14  LYS10  ASP6 63.91  ALA8 THR4 48.73 
ASP7  TRP3 20.95  ASP7  THR4 5.95  ASP6 TRP3 8.74 
THR11  ASP7 43.84  THR11  ASP7 49.06  THR9 TYR5 60.72 
VAL14  LYS10 37.01  VAL14  THR11 11.63  TYR5 GLU2 21.19 
PHE12  ALA8 59.65  ALA8  THR4 33.81  LYS10 ASP6 74.91 
ALA8  THR4 22.55  THR9  TYR5 35.37  THR15 THR11 25.80 
ASP6  GLU2 20.91  VAL14  LYS10 37.05  GLU16 PHE12 19.19 
THR4  GLY1 21.06  PHE12  ALA8 56.17  GLU16 THR13 6.66 
ASP6  TRP3 13.90  THR15  THR11 16.99  THR13 THR9 36.07 
THR9  TYR5 32.95  THR13  THR9 31.25  ASP6 GLU2 16.97 
TYR5  GLU2 32.18  TYR5  GLU2 11.73  ASP7 TRP3 26.72 
VAL14  THR11 11.21  ASP7  TRP3 11.29  THR15 PHE12 9.40 
PHE12  THR9 6.73  THR4  GLY1 5.62  ASP7 THR4 5.19 
THR15  PHE12 13.51  ASP6  GLU2 7.23  VAL14 THR11 6.22 
THR13  LYS10 9.30  THR13  LYS10 10.21  THR13 LYS10 5.32 
THR11  ALA8 6.30  LYS10  ASP7 7.73     
GLU16  THR13 5.46  PHE12  THR9 11.14     
    GLU16  PHE12 7.30     
    THR11  ALA8 7.54     
 
Salt bridge analysis of the 300.37 K trajectory extracted from REMD simulations of 
peptide B1.  
ff96/ GB-HCT  ff96/ GB-OBC(II)  ff96/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS10 ASP6 44.89  LYS10 ASP6 41.46  LYS10 ASP6 18.17 
ff99SB/ GB-HCT  ff99SB/ GB-OBC(II)  ff99SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS10  ASP6 16.08  LYS10  ASP6 12.67  LYS10  ASP7 17.90 
LYS10  ASP7 15.68  LYS10  ASP7 22.35     
ff99SBildn/ GB-HCT  ff99SBildn/ GB-OBC(II)  ff99SBildn/ GB-Neck2 
LYS10  ASP6 23.49  LYS10  ASP6 15.11  LYS10  ASP7 5.44 
LYS10  ASP7 25.70  LYS10  ASP7 22.02     
ff99SBildn-φ/ GB-HCT  ff99SBildn-φ/ GB-OBC(II)  ff99SBildn-φ/ GB-Neck2 
LYS10  ASP6 15.16  LYS10  ASP6 8.59  LYS10  ASP7 14.65 
LYS10  ASP7 23.53  LYS10  ASP7 19.92     
ff12SB/ GB-HCT  ff12SB/ GB-OBC(II)  ff12SB/ GB-Neck2 
LYS10  ASP7 32.04  LYS10  ASP7 23.40  LYS10  ASP7 11.83 
ff14SB/ GB-HCT  ff14SB/ GB-OBC(II)  ff14SB/ GB-Neck2 
LYS10  ASP6 13.80  LYS10  ASP6 14.32  / / / 
LYS10  ASP7 37.66  LYS10  ASP7 18.34     
 
ANNEX 4.D. Additional information for peptide B2. 










H-bond analysis of the 300.37 K trajectory extracted from REMD simulations of 
peptide B2. Data are related to H-bonds involving the backbone (donor backbone N-H, 
acceptor backbone C=O). 
ff96/ GB-HCT  ff96/ GB-OBC(II)  ff96/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ASN6 TRP2 18.41  TRP9 GLU5 11.99  TRP11 TRP4 5.04 
LYS8 GLU5 5.60  GLY7 THR3 5.00     
LYS12 SER1 5.82  GLY7 TRP9 6.50     
TRP4 THR10 7.80  LYS12 TRP2 6.31     
GLY7 THR10 6.60  TRP4 THR10 7.46     
LYS12 TRP2 8.92  THR10 TRP4 5.94     
SER1 LYS12 5.96  ASN6 LYS8 5.24     
GLY7 THR3 8.26         
TRP4 GLY7 6.90         
GLY7 TRP9 8.10         
THR10 GLU5 5.61         
TRP9 GLU5 15.03         
TRP9 TRP2 6.56         
ff99SB/ GB-HCT  ff99SB/ GB-OBC(II)  ff99SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
TRP4 SER1 17.08  ASN6 TRP2 5.86  GLU5 TRP2 28.17 
GLU5 SER1 14.51  LYS12 TRP9 10.81  ASN6 THR3 20.73 
TRP9 ASN6 9.13  GLY7 TRP4 15.35  TRP9 ASN6 7.33 
TRP11 LYS8 13.73  TRP11 LYS8 20.85  THR10 GLY7 19.21 
ASN6 TRP2 19.79  LYS12 LYS8 5.74  LYS12 LYS8 7.41 
GLY7 TRP2 5.84  TRP9 ASN6 10.66  TRP11 GLY7 6.89 
TRP11 GLY7 9.92  TRP11 GLY7 6.07  TRP11 LYS8 15.03 
ASN6 THR3 12.81  GLU5 TRP2 18.32  LYS12 TRP9 5.66 
THR10 GLY7 14.04  ASN6 THR3 17.11  LYS8 GLU5 11.34 
GLY7 TRP4 11.36  THR10 GLY7 15.59  GLY7 TRP4 10.72 
GLY7 THR3 6.39  GLY7 THR3 4.95  GLY7 THR3 6.23 
LYS12 TRP9 17.59  LYS8 GLU5 16.40  ASN6 TRP2 14.07 
GLU5 TRP2 26.14      TRP9 GLU5 5.22 
LYS8 GLU5 17.28      TRP4 SER1 7.03 
        GLU5 SER1 6.33 
        GLY7 TRP2 6.02 
ff99SBildn/ GB-HCT  ff99SBildn/ GB-OBC(II)  ff99SBildn/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ASN6 TRP2 28.15  TRP9 LYS12 7.98  ASN6 THR3 25.72 
GLU5 SER1 13.99  TRP9 ASN6 9.11  GLU5 TRP2 26.50 
TRP4 SER1 16.70  GLU5 TRP2 14.29  TRP11 GLY7 7.82 
THR10 GLY7 13.48  ASN6 THR3 24.07  THR10 GLY7 14.07 
GLY7 TRP2 9.50  LYS12 TRP9 16.32  TRP9 ASN6 8.45 
LYS12 TRP9 21.77  THR10 GLY7 18.13  LYS12 TRP9 6.85 
GLU5 TRP2 26.90  GLY7 TRP4 19.64  GLY7 THR3 7.00 
TRP11 LYS8 14.67  TRP11 GLY7 8.89  LYS8 GLU5 12.81 
GLY7 THR3 6.40  GLY7 THR3 6.06  GLY7 TRP4 16.42 
LYS8 THR3 7.31  TRP11 LYS8 11.38  ASN6 TRP2 10.50 
GLY7 TRP4 15.15  GLU5 SER1 5.90  TRP9 GLU5 7.17 
ASN6 THR3 15.98  TRP4 SER1 6.62  TRP11 LYS8 13.82 
LYS8 GLU5 9.10  LYS8 GLU5 9.91     
TRP9 ASN6 11.27  ASN6 TRP2 7.58     
TRP11 GLY7 7.48         
ff99SBildn-φ/ GB-HCT  ff99SBildn-φ/ GB-OBC(II)  ff99SBildn-φ/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
GLU5 TRP2 26.25  GLU5 TRP2 18.05  THR10 GLY7 20.37 
ASN6 THR3 15.85  ASN6 TRP2 7.52  ASN6 TRP2 15.79 
TRP11 LYS8 25.99  THR10 GLY7 28.11  GLU5 SER1 5.68 
GLY7 TRP4 17.47  GLY7 TRP4 24.76  TRP4 SER1 7.19 
ASN6 TRP2 25.47  TRP11 GLY7 10.26  GLU5 TRP2 33.06 
THR10 GLY7 18.30  ASN6 THR3 32.01  TRP11 LYS8 19.92 
LYS8 THR3 7.92  TRP9 ASN6 7.58  GLY7 TRP4 21.76 
TRP9 ASN6 7.07  LYS8 GLU5 9.99  ASN6 THR3 26.52 
TRP4 SER1 18.04  TRP11 LYS8 25.03  TRP11 GLY7 7.09 
LYS12 TRP9 23.34  GLY7 THR3 9.26  GLY7 THR3 6.88 
GLY7 THR3 5.81  LYS12 LYS8 6.46  LYS8 THR3 6.45 
TRP11 GLY7 5.85  LYS12 TRP9 12.28  LYS12 LYS8 6.66 
LYS8 GLU5 11.27      LYS12 TRP9 10.18 
GLU5 SER1 15.79      LYS8 GLU5 8.90 
        TRP9 ASN6 8.49 
ff12SB/ GB-HCT  ff12SB/ GB-OBC(II)  ff12SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
GLY7 TRP4 19.84  TRP9 ASN6 8.06  ASN6 THR3 41.12 
ASN6 THR3 26.27  ASN6 THR3 45.80  GLY7 THR3 7.66 
LYS8 GLU5 17.47  GLY7 TRP4 29.01  TRP11 LYS8 17.13 
GLY7 THR3 14.29  THR10 GLY7 23.51  LYS12 LYS8 7.62 
TRP9 ASN6 8.50  LYS8 GLU5 18.12  THR10 GLY7 21.46 
ASN6 TRP2 19.96  GLY7 THR3 12.49  LYS12 TRP9 15.79 
THR10 GLY7 24.79  LYS12 TRP9 10.98  ASN6 TRP2 8.73 
TRP11 LYS8 24.73  LYS8 TRP4 7.16  GLY7 TRP4 30.96 
LYS12 LYS8 9.42  TRP11 GLY7 5.25  TRP9 ASN6 9.06 
LYS8 TRP4 7.46  TRP11 LYS8 18.66  GLU5 TRP2 13.03 
LYS12 TRP9 20.12      LYS8 GLU5 17.37 
GLU5 TRP2 11.59      TRP9 GLU5 6.12 
GLU5 SER1 9.47         
TRP4 SER1 12.42         
TRP11 GLY7 6.24         
ff14SB/ GB-HCT  ff14SB/ GB-OBC(II)  ff14SB/ GB-Neck2 
donor  acceptor  occ%  donor  acceptor  occ%  donor acceptor occ% 
GLY7  THR3 18.97  ASN6  THR3 44.07  THR10 GLY7 34.27 
LYS8  GLU5 21.05  GLY7  THR3 10.66  LYS12 TRP9 8.04 
TRP11  LYS8 26.53  LYS8  TRP4 10.33  GLY7 TRP4 26.08 
LYS12  TRP9 19.47  THR10  GLY7 28.70  TRP11 LYS8 24.07 
ASN6  TRP2 15.48  TRP11  LYS8 26.09  TRP9 GLU5 10.02 
TRP4  SER1 9.78  TRP11  GLY7 10.19  LYS8 TRP4 20.19 
TRP9  ASN6 16.81  GLY7  TRP4 28.61  ASN6 THR3 43.44 
LYS8  TRP4 17.76  LYS12  TRP9 12.95  LYS8 GLU5 15.34 
LYS12  LYS8 5.66  TRP9  ASN6 12.60  TRP9 ASN6 12.10 
ASN6  THR3 30.68  LYS8  GLU5 24.10  TRP11 GLY7 16.15 
THR10  GLY7 30.86  GLU5  TRP2 5.05  GLY7 THR3 16.12 
GLY7  TRP4 18.77  THR10  ASN6 5.22  GLU5 TRP2 6.59 
TRP11  GLY7 14.21  TRP9  GLU5 5.12  LYS12 LYS8 7.43 
GLU5  TRP2 9.64      THR10 ASN6 6.71 
GLU5  SER1 6.05         
THR10  ASN6 6.52         
 
Salt bridge analysis of the 300.37 K trajectory extracted from REMD simulations of 
peptide B2.  
ff96/ GB-HCT  ff96/ GB-OBC(II)  ff96/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS8 GLU5 12.12  / / /  / / / 
ff99SB/ GB-HCT  ff99SB/ GB-OBC(II)  ff99SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
/ / /  LYS8 GLU5 12.66  / / / 
ff99SBildn/ GB-HCT  ff99SBildn/ GB-OBC(II)  ff99SBildn/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
/ / /  / / /  / / / 
ff99SBildn-φ/ GB-HCT  ff99SBildn-φ/ GB-OBC(II)  ff99SBildn-φ/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
/ / /  / / /  / / / 
ff12SB/ GB-HCT  ff12SB/ GB-OBC(II)  ff12SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS8 GLU5 31.15  LYS8 GLU5 24.56  / / / 
ff14SB/ GB-HCT  ff14SB/ GB-OBC(II)  ff14SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS8  GLU5 43.31  LYS8  GLU5 34.18  LYS8  GLU5 18.29 
 
ANNEX 4.E. Additional information for peptide B3. 









THR8 THR6 (OH Side chain) 
 
H-bond analysis of the 300.37 K trajectory extracted from REMD simulations of 
peptide B3. Data are related to H-bonds involving the backbone (donor backbone N-H, 
acceptor backbone C=O). 
ff96/ GB-HCT  ff96/ GB-OBC(II)  ff96/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS10 LYS5 7.31  ILE2 LEU14 11.18  LEU14 PHE3 46.86 
THR8 VAL4 6.09  ILE12 VAL4 14.89  PHE3 LEU14 29.04 
GLY9 LYS5 5.22  LEU14 ILE2 13.07  ILE12 LYS5 48.36 
LEU14 ILE2 24.05  VAL4 ILE12 15.35  LYS5 ILE12 51.80 
VAL4 ILE12 26.27  LEU14 PHE3 9.33  LEU7 LYS10 21.74 
LEU14 PHE3 19.01  LYS5 ILE12 18.21  LYS10 LEU7 9.79 
LYS5 ILE12 23.20  ILE12 LYS5 14.44  LYS10 THR8 5.15 
ILE12 LYS5 21.42  LEU7 LYS10 7.22     
LEU7 LYS10 13.83  ILE12 PHE3 8.31     
PHE3 LEU14 7.61  THR8 VAL4 14.04     
ILE2 LEU14 23.81  GLY9 VAL4 7.02     
THR11 VAL4 9.64  PHE3 LEU14 5.89     
ILE12 VAL4 17.96  ILE12 THR6 8.22     
THR6 GLY9 8.94  THR6 ILE12 9.35     
ILE12 LEU7 5.94  THR6 LYS10 10.50     
GLN1 GLU15 5.05         
THR11 LYS5 5.41         
THR6 LYS10 9.58         
LYS5 THR11 6.46         
GLU15 PHE3 6.34         
ILE12 PHE3 6.44         
PHE3 ILE12 5.14         
ff99SB/ GB-HCT  ff99SB/ GB-OBC(II)  ff99SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS10 LYS5 20.55  LEU7 PHE3 10.18  LYS5 ILE12 31.02 
THR6 ILE2 12.92  THR13 LYS10 12.03  LEU7 LYS10 31.78 
LEU14 THR11 24.53  LEU14 THR11 12.17  ILE12 LYS5 32.13 
LEU7 PHE3 18.89  THR8 VAL4 19.20  LYS10 LEU7 32.07 
THR13 LYS10 24.85  ILE12 GLY9 6.66  LEU14 THR11 16.40 
LYS5 ILE2 20.97  THR8 LYS5 8.10  THR8 VAL4 18.35 
LEU7 VAL4 13.92  GLY9 LYS5 13.84  LEU7 PHE3 12.12 
THR8 VAL4 28.53  LYS5 THR11 13.48  GLY9 THR6 11.07 
THR6 PHE3 16.74  GLU15 ILE12 8.50  GLY9 LYS5 5.50 
GLY9 THR6 21.25  GLY9 THR6 19.01  LEU14 PHE3 25.34 
LEU14 LYS10 8.83  LEU14 LYS10 7.53  PHE3 LEU14 15.81 
VAL4 GLN1 7.57  LEU7 VAL4 17.91  THR8 LYS5 6.79 
THR8 LYS5 11.5  THR13 PHE3 8.78  THR6 PHE3 8.60 
VAL4 ILE12 7.94  THR6 LYS10 13.05  LEU7 VAL4 16.50 
LEU14 ILE2 7.18  ILE12 VAL4 16.57  ILE12 GLY9 7.78 
ILE2 LEU14 6.18  VAL4 ILE12 15.66  THR13 LYS10 14.32 
LYS5 LYS10 6.05  THR6 PHE3 7.71  GLU15 THR11 7.37 
    ILE2 LEU14 11.56  LEU14 LYS10 5.57 
    LEU14 ILE2 12.18     
ff99SBildn/ GB-HCT  ff99SBildn/ GB-OBC(II)  ff99SBildn/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LEU14 THR11 26.22  THR13 LYS10 9.86  LYS10 LEU7 17.49 
GLY9 THR6 18.85  LEU14 LYS10 12.18  LEU7 LYS10 11.50 
THR8 LYS5 17.06  THR6 PHE3 7.73  ILE12 LYS5 13.05 
THR6 ILE2 7.35  GLY9 LYS5 9.45  LEU14 PHE3 12.90 
THR8 VAL4 25.99  LEU14 THR11 19.27  PHE3 LEU14 10.54 
LEU7 VAL4 23.45  THR8 LYS5 7.43  LYS5 ILE12 13.64 
LYS10 LYS5 26.10  LEU7 VAL4 33.49  GLY9 THR6 19.54 
THR13 LYS10 25.77  LYS10 LEU7 5.46  ILE12 VAL4 17.23 
LEU14 LYS10 11.42  LEU7 PHE3 6.75  VAL4 ILE12 17.22 
LYS5 ILE2 23.88  THR8 VAL4 22.73  LEU14 ILE2 15.64 
THR6 PHE3 27.09  ILE12 GLY9 19.28  LEU14 THR11 18.80 
LEU7 PHE3 12.68  THR13 GLY9 14.31  THR6 LYS10 12.48 
ILE2 GLU15 11.06  GLY9 THR6 15.19  ILE12 GLY9 9.85 
    THR6 LYS10 5.34  THR8 VAL4 11.26 
        LEU7 PHE3 6.21 
        THR13 LYS10 10.83 
        ILE12 PHE3 5.08 
        LYS5 LYS10 6.99 
        GLY9 LYS5 7.11 
        ILE2 LEU14 5.98 
        THR8 LYS5 8.40 
        THR6 PHE3 7.72 
        LEU7 VAL4 18.32 
        GLU15 THR11 5.53 
ff99SBildn-φ/ GB-HCT  ff99SBildn-φ/ GB-OBC(II)  ff99SBildn-φ/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LEU14 THR11 39.79  LEU7 VAL4 31.18  THR8 VAL4 25.18 
LYS10 LYS5 20.60  THR8 VAL4 27.13  THR6 PHE3 15.09 
THR13 LYS10 24.98  GLY9 LYS5 12.18  LEU7 PHE3 16.30 
ILE2 GLU15 5.01  THR13 LYS10 8.14  LEU14 LYS10 7.80 
LYS5 ILE2 21.57  LEU14 LYS10 10.12  LYS5 ILE2 5.67 
THR6 PHE3 23.91  ILE12 GLY9 13.62  LYS10 LEU7 14.81 
THR8 VAL4 26.70  LEU7 PHE3 7.41  THR11 THR8 6.11 
LEU14 LYS10 9.98  THR8 LYS5 7.94  GLY9 THR6 18.20 
LEU7 VAL4 17.56  LEU14 THR11 25.91  ILE12 GLY9 17.53 
LYS5 LYS10 8.82  LYS10 LEU7 7.63  THR8 LYS5 13.01 
GLY9 THR6 26.21  ILE12 PHE3 6.02  GLY9 LYS5 8.52 
LEU7 PHE3 20.77  LYS5 LYS10 9.31  LEU7 VAL4 24.33 
THR6 ILE2 9.94  THR13 GLY9 6.76  ILE12 VAL4 5.66 
ILE12 PHE3 6.39  THR6 PHE3 9.97  LEU14 THR11 20.55 
THR8 LYS5 13.09  GLY9 THR6 12.08  GLU15 THR11 5.96 
VAL4 GLN1 6.54      THR13 GLY9 6.51 
        THR13 LYS10 18.88 
        LYS5 ILE12 6.02 
        ILE12 LYS5 5.96 
        LEU7 LYS10 5.27 
        LYS5 LYS10 4.97 
        ILE12 PHE3 5.00 
        LEU14 ILE2 5.20 
        VAL4 ILE12 6.18 
ff12SB/ GB-HCT  ff12SB/ GB-OBC(II)  ff12SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LEU7 PHE3 26.81  LYS5 ILE2 13.74  LYS10 LEU7 13.81 
LEU14 THR11 21.69  LEU14 THR11 27.00  LEU7 VAL4 31.45 
GLU15 ILE12 8.17  THR6 PHE3 16.46  THR6 PHE3 22.24 
THR8 VAL4 31.97  LYS10 LEU7 18.47  LYS5 ILE2 17.56 
LYS10 LYS5 9.26  LEU7 VAL4 25.32  THR8 LYS5 15.25 
THR6 ILE2 15.01  LEU14 GLY9 8.81  LEU7 PHE3 18.86 
GLY9 THR6 20.17  LEU7 PHE3 18.63  LEU14 THR11 30.89 
LYS10 LEU7 11.47  THR8 LYS5 9.61  GLU15 ILE12 12.50 
VAL4 GLN1 7.25  ILE12 GLY9 13.90  GLY9 VAL4 6.50 
LYS5 ILE2 34.94  GLY9 THR6 22.53  THR8 VAL4 20.09 
THR6 PHE3 29.63  THR6 LYS10 6.24  ILE12 GLY9 19.11 
LEU7 VAL4 19.67  THR13 LYS10 9.23  THR13 LYS10 17.72 
THR8 LYS5 9.46  THR8 VAL4 20.64  GLY9 THR6 13.97 
THR11 LYS5 24.54  GLY9 LYS5 7.72  GLU15 THR11 7.85 
THR13 LYS10 7.06  THR13 GLY9 10.02  GLY9 LYS5 9.77 
GLN1 GLU15 5.44  GLU15 ILE12 5.26  THR11 THR8 5.70 
        LEU14 GLY9 8.91 
        THR13 GLY9 9.64 
ff14SB/ GB-HCT  ff14SB/ GB-OBC(II)  ff14SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
VAL4 GLN1 6.32  LYS10 LEU7 5.22  GLU15 ILE12 5.81 
THR8 VAL4 40.00  THR6 PHE3 15.71  GLU15 THR11 6.10 
LYS5 ILE2 17.38  LEU7 VAL4 13.64  LEU14 THR11 14.45 
LEU7 PHE3 48.50  THR13 GLY9 26.23  GLY9 THR6 8.81 
GLY9 LYS5 6.69  GLY9 LYS5 21.21  THR13 LYS10 19.27 
LYS10 LYS5 23.79  LYS10 THR6 18.85  ILE12 GLY9 14.57 
LEU14 THR11 44.05  ILE12 THR8 12.76  THR11 THR8 8.29 
GLY9 THR6 23.99  LEU7 PHE3 50.64  LEU14 GLY9 10.28 
THR6 ILE2 26.21  LEU14 THR11 29.07  THR8 VAL4 68.67 
LYS5 GLN1 11.96  THR8 LYS5 7.86  LYS5 GLN1 26.58 
LEU7 VAL4 10.39  THR8 VAL4 44.06  LEU7 PHE3 76.23 
THR6 PHE3 17.32  THR11 LEU7 13.13  THR6 ILE2 28.77 
THR8 LYS5 9.69  LEU14 LYS10 10.54  ILE12 THR8 43.28 
THR13 LYS10 17.37  THR6 ILE2 6.30  LEU14 LYS10 13.33 
THR11 LYS5 8.21  GLY9 THR6 15.30  THR11 LEU7 29.01 
ILE12 GLY9 7.11  LYS10 LYS5 11.75  GLY9 LYS5 43.80 
    THR13 LYS10 8.09  THR13 GLY9 18.88 
    ILE12 GLY9 13.45  LYS10 THR6 42.83 
    THR11 THR8 5.18  GLU15 GLY9 9.39 
        THR6 PHE3 7.62 
 
Salt bridge analysis of the 300.37 K trajectory extracted from REMD simulations of 
peptide B3.  
ff96/ GB-HCT  ff96/ GB-OBC(II)  ff96/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
/ / /  LYS5 GLU15 6.74  / / / 
ff99SB/ GB-HCT  ff99SB/ GB-OBC(II)  ff99SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS5 GLU15 25.94  LYS5 GLU15 7.68  / / / 
LYS10 GLU15 19.52         
ff99SBildn/ GB-HCT  ff99SBildn/ GB-OBC(II)  ff99SBildn/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS5 GLU15 33.12  LYS5 GLU15 6.18  / / / 
LYS10 GLU15 15.62  LYS10 GLU15 9.19     
ff99SBildn-φ/ GB-HCT  ff99SBildn-φ/ GB-OBC(II)  ff99SBildn-φ/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS5 GLU15 26.24  LYS10 GLU15 8.6  / / / 
LYS10 GLU15 13.89         
ff12SB/ GB-HCT  ff12SB/ GB-OBC(II)  ff12SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS5 GLU15 36.48  LYS10 GLU15 12.05  LYS10 GLU15 5.67 
LYS10 GLU15 20.41         
ff14SB/ GB-HCT  ff14SB/ GB-OBC(II)  ff14SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS5 GLU15 36.53  LYS5 GLU15 19.52  / / / 
LYS10 GLU15 14.21  LYS10 GLU15 14.89     
 
ANNEX 4.F. Additional information for peptide ID1. 
H-bond analysis of the 300.37 K trajectory extracted from REMD simulations of 
peptide ID1. Data are related to H-bonds involving the backbone (donor backbone N-
H, acceptor backbone C=O). 
ff96/ GB-HCT  ff96/ GB-OBC(II)  ff96/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
TRP3 ILE11 8.38  LEU14 ASN2 6.34  VAL10 GLY7 8.91 
ILE11 TRP3 6.87  LEU4 ASP12 5.89  LEU4 ASP12 10.86 
LYS5 MET9 23.11  LEU6 ASN2 5.00  LEU14 ASN2 11.02 
MET9 LEU6 11.22  ILE11 LEU4 42.74  ASP12 LEU4 9.78 
ILE1 ALA13 23.00  GLY7 MET9 14.41  GLY7 VAL10 10.57 
LEU6 MET9 37.68  ALA13 ASN2 29.73  ILE11 LEU4 20.09 
ALA13 ILE1 7.89  LEU4 ILE11 36.47  LEU4 ILE11 16.10 
ALA13 ASN2 25.59  LEU6 MET9 29.77  LEU6 MET9 16.93 
ILE11 LEU4 43.83  MET9 LEU6 9.90  MET9 LEU6 9.03 
ASN2 ALA13 14.20  GLY7 VAL10 7.48  ALA13 ASN2 9.66 
LEU4 ILE11 31.24  VAL10 GLY7 3.52  ASN2 LEU14 6.19 
MET9 LYS5 17.87  ILE11 LYS5 5.73  MET9 LYS5 6.41 
GLY7 MET9 14.90  ALA13 TRP3 6.77  LYS5 ASP12 7.42 
ASN2 ILE11 15.11  LYS5 ILE11 7.68  ASP12 LYS5 6.56 
LEU4 MET9 6.63  ASP12 LEU4 5.34  LYS5 MET9 5.36 
ILE11 ASN2 18.62         
LYS8 LYS5 8.83         
ASP12 LEU4 8.90         
LEU4 ASP12 8.78         
ff99SB/ GB-HCT  ff99SB/ GB-OBC(II)  ff99SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
MET9 LEU6 7.81  ALA13 VAL10 17.10  GLY7 TRP3 14.44 
ASP12 MET9 26.69  LEU14 VAL10 15.93  VAL10 LEU6 8.06 
ALA13 VAL10 14.83  LYS8 LYS5 7.44  ILE11 LYS8 23.03 
LEU14 ILE11 21.91  MET9 LYS5 6.37  ASP12 LYS8 14.79 
GLY7 TRP3 16.60  LEU6 ASN2 27.31  LEU6 ASN2 18.81 
LYS5 ASN2 21.14  GLY7 TRP3 23.64  MET9 LYS5 7.08 
LYS8 LYS5 20.60  LEU6 TRP3 14.05  ALA13 MET9 23.65 
LEU6 ASN2 33.35  ALA13 MET9 25.59  ASP12 MET9 30.61 
ALA13 MET9 20.78  ASP12 MET9 33.36  LEU6 TRP3 11.74 
LEU14 VAL10 12.02  GLY7 LEU4 12.47  MET9 LEU6 18.13 
MET9 LYS5 12.86  LYS5 ASN2 16.18  LEU14 MET9 7.74 
MET9 LEU4 7.45  MET9 LEU6 13.03  ILE11 LEU4 14.09 
ILE11 LYS8 12.02  VAL10 LEU6 10.59  ASN2 LEU14 5.46 
LEU6 TRP3 10.56  LYS8 TRP3 12.97  LEU14 ASN2 10.76 
GLY7 LEU4 8.66  ILE11 LYS8 12.72  LEU4 ASP12 12.83 
VAL10 LYS5 10.31  LEU14 ILE11 21.62  LEU6 MET9 14.55 
ASP12 LYS8 7.26  VAL10 GLY7 12.02  ASP12 LEU4 9.79 
LYS8 TRP3 8.62  ILE11 GLY7 9.91  LYS5 ASN2 17.52 
    ASP12 LYS8 9.34  LEU14 ILE11 12.13 
    LYS8 LEU4 5.70  LYS8 LYS5 11.61 
        ALA13 VAL10 16.03 
        GLY7 LEU4 7.15 
        LEU14 VAL10 13.88 
        VAL10 GLY7 8.95 
        LYS8 TRP3 7.02 
ff99SBildn/ GB-HCT  ff99SBildn/ GB-OBC(II)  ff99SBildn/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ASN2 VAL10 16.95  MET9 LYS5 5.46  GLY7 LEU4 14.09 
VAL10 ASN2 18.12  LYS8 LYS5 6.46  LEU14 ILE11 19.19 
LEU14 ILE11 33.51  GLY7 TRP3 12.57  ILE11 GLY7 7.06 
GLY7 LEU4 20.79  GLY7 LEU4 15.09  VAL10 GLY7 11.70 
MET9 LYS5 9.19  LYS5 ASN2 17.94  ILE11 LYS8 17.24 
LEU6 TRP3 11.93  ALA13 MET9 11.10  LYS5 ASN2 26.54 
LYS8 LYS5 12.31  LEU14 ILE11 30.30  LEU6 TRP3 19.91 
ASP12 MET9 13.61  ILE11 LYS8 7.65  LEU14 VAL10 9.42 
LEU6 ASN2 16.02  ASP12 MET9 13.21  ALA13 VAL10 13.48 
ALA13 VAL10 13.23  LEU6 TRP3 18.01  MET9 LYS5 6.22 
LYS8 TRP3 10.27  VAL10 GLY7 9.14  GLY7 TRP3 14.49 
LYS5 ASN2 16.93  MET9 LEU6 11.42  LYS8 TRP3 8.95 
LEU4 MET9 7.00  LEU14 VAL10 11.86  LEU6 ASN2 11.50 
ILE11 ASN2 8.03  ASP12 LYS8 7.62  ALA13 MET9 9.58 
ASN2 ILE11 5.29  LEU6 ASN2 13.22  LYS8 LYS5 5.87 
MET9 LEU4 5.53  LYS8 TRP3 10.92  ASP12 LYS8 10.25 
LEU14 VAL10 7.81  ALA13 VAL10 20.43  MET9 LEU6 11.90 
LEU4 LYS8 13.99  ILE11 GLY7 7.18  VAL10 LEU6 8.68 
ALA13 MET9 8.82      ASP12 MET9 11.64 
GLY7 TRP3 10.86      ILE11 LEU6 7.25 
LYS8 LEU4 5.63      ILE11 LEU4 6.37 
LYS5 MET9 6.22      LEU6 MET9 5.90 
        LEU4 ILE11 5.05 
ff99SBildn-φ/ GB-HCT  ff99SBildn-φ/ GB-OBC(II)  ff99SBildn-φ/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ASP12 MET9 14.09  LEU14 ILE11 36.85  ALA13 ASN2 5.96 
LEU14 ILE11 31.75  LEU14 VAL10 11.11  ILE11 LEU4 13.26 
GLY7 TRP3 14.65  LEU6 TRP3 19.43  LEU6 MET9 11.57 
LEU6 TRP3 18.76  ALA13 VAL10 18.30  ILE11 LYS8 11.08 
LEU6 ASN2 22.26  LYS5 ASN2 21.35  ASP12 LYS8 7.01 
LYS8 LYS5 12.23  GLY7 TRP3 17.63  LYS5 ASN2 22.32 
MET9 LYS5 9.21  MET9 LEU6 11.92  LEU6 TRP3 18.22 
LEU14 VAL10 14.08  VAL10 LEU6 5.76  ILE11 GLY7 7.07 
LYS5 ASN2 22.60  ILE11 GLY7 10.12  LEU6 ASN2 10.26 
VAL10 LYS5 5.02  ASP12 MET9 11.94  GLY7 LEU4 9.54 
ALA13 VAL10 21.01  VAL10 GLY7 13.70  VAL10 GLY7 13.09 
MET9 LEU6 11.52  LEU6 ASN2 16.47  LYS8 LYS5 12.27 
ALA13 MET9 9.22  GLY7 LEU4 18.89  LEU14 VAL10 8.85 
GLY7 LEU4 18.20  LYS8 TRP3 10.10  LEU14 ILE11 16.32 
LYS8 TRP3 12.99  LYS8 LEU4 5.63  GLY7 TRP3 15.46 
ILE11 LYS8 6.39  ASP12 LYS8 13.17  MET9 LYS5 7.44 
MET9 LEU4 5.02  ILE11 LYS8 13.78  LYS5 MET9 5.26 
    ALA13 MET9 12.65  ILE11 TRP3 5.26 
    MET9 LYS5 6.52  ALA13 VAL10 12.49 
    LYS8 LYS5 6.81  ASP12 MET9 9.17 
        LEU4 ILE11 11.66 
        MET9 LEU6 12.95 
        ALA13 MET9 7.81 
ff12SB/ GB-HCT  ff12SB/ GB-OBC(II)  ff12SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LEU6 ASN2 42.56  LEU14 ILE11 40.72  LYS5 ASN2 28.08 
ALA13 MET9 15.45  LEU6 ASN2 38.36  LEU6 TRP3 16.06 
VAL10 LEU6 10.54  MET9 LYS5 21.85  GLY7 TRP3 36.74 
GLY7 TRP3 24.31  ILE11 GLY7 34.77  ALA13 VAL10 20.35 
LYS8 LYS5 8.88  ASP12 LYS8 58.20  ASP12 LYS8 39.36 
MET9 LYS5 18.84  LYS8 LEU4 22.76  VAL10 GLY7 21.89 
ILE11 LYS8 11.97  GLY7 TRP3 43.00  ILE11 GLY7 20.39 
ASP12 LYS8 44.35  ALA13 MET9 19.69  MET9 LEU6 9.31 
LEU14 ILE11 41.05  VAL10 LEU6 19.47  ILE11 LYS8 17.35 
LYS5 ASN2 18.63  LEU14 VAL10 14.85  ALA13 MET9 14.87 
MET9 LEU6 6.44  LEU6 TRP3 13.17  GLY7 LEU4 10.81 
LYS8 LEU4 15.99  ALA13 VAL10 18.93  LEU6 ASN2 38.55 
VAL10 GLY7 17.65  MET9 LEU6 9.49  VAL10 LEU6 19.84 
LYS8 TRP3 9.39  LYS8 LYS5 6.57  LEU14 ILE11 31.01 
ILE11 GLY7 16.82  ILE11 LYS8 9.14  LYS8 LYS5 9.14 
ALA13 VAL10 15.19  LYS5 ASN2 20.43  ASP12 MET9 7.38 
LEU14 VAL10 11.21  VAL10 GLY7 20.10  LEU14 VAL10 13.73 
GLY7 LEU4 11.78  GLY7 LEU4 9.08  LYS8 LEU4 12.07 
LEU6 TRP3 9.16  LYS8 TRP3 5.38  MET9 LYS5 20.02 
MET9 TRP3 6.33      LYS8 TRP3 6.65 
ASP12 MET9 5.36      LEU14 MET9 5.26 
ff14SB/ GB-HCT  ff14SB/ GB-OBC(II)  ff14SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ASP12 LYS8 28.86  ALA13 MET9 21.81  ILE11 GLY7 23.13 
MET9 TRP3 9.95  LEU14 ILE11 39.69  LEU14 ILE11 27.04 
VAL10 GLY7 10.80  VAL10 GLY7 19.66  MET9 LYS5 19.02 
LEU6 TRP3 8.40  ASP12 LYS8 53.28  ASP12 LYS8 38.54 
ASP12 MET9 5.68  ILE11 LYS8 11.59  LYS5 ASN2 30.79 
GLY7 LEU4 15.00  LEU6 ASN2 30.65  VAL10 LEU6 19.13 
LEU14 ILE11 35.31  LYS8 TRP3 7.74  LEU6 ASN2 35.63 
ALA13 VAL10 14.98  ILE11 GLY7 33.78  GLY7 LEU4 10.66 
LYS8 LEU4 8.77  GLY7 TRP3 30.73  VAL10 GLY7 19.71 
ILE11 GLY7 12.95  LYS5 ASN2 18.21  LEU14 VAL10 20.04 
TRP3 LYS8 7.38  LEU6 TRP3 13.61  ALA13 VAL10 18.33 
LYS8 LYS5 18.22  GLY7 LEU4 14.26  LEU6 TRP3 17.07 
VAL10 LEU4 5.20  LEU14 VAL10 17.40  ILE11 LYS8 15.90 
LYS5 ASN2 18.80  VAL10 LEU6 17.09  ALA13 MET9 17.56 
MET9 LYS5 10.39  MET9 LYS5 19.58  LYS8 LYS5 10.72 
LEU6 ASN2 37.38  LYS8 LEU4 19.72  GLY7 TRP3 33.49 
ALA13 MET9 13.13  ALA13 VAL10 13.12  ASP12 MET9 11.97 
LYS8 TRP3 9.17  LYS8 LYS5 5.25  MET9 LEU6 8.59 
LEU4 ILE1 5.50  MET9 LEU6 6.54  LYS8 LEU4 11.89 
LEU14 VAL10 11.26      LYS8 TRP3 5.73 
GLY7 TRP3 21.79         
MET9 LEU6 5.61         
VAL10 LEU6 6.34         
ILE11 LYS8 9.66         
 
Salt bridge analysis of the 300.37 K trajectory extracted from REMD simulations of 
peptide ID1.  
ff96/ GB-HCT  ff96/ GB-OBC(II)  ff96/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
/ / /  / / /  / / / 
ff99SB/ GB-HCT  ff99SB/ GB-OBC(II)  ff99SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS5 ASP12 17.98  LYS8 ASP12 11.16  / / / 
LYS8 ASP12 5.18         
ff99SBildn/ GB-HCT  ff99SBildn/ GB-OBC(II)  ff99SBildn/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS8 ASP12 11.31  / / /  / / / 
ff99SBildn-φ/ GB-HCT  ff99SBildn-φ/ GB-OBC(II)  ff99SBildn-φ/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS8 ASP12 15.08  / / /  / / / 
ff12SB/ GB-HCT  ff12SB/ GB-OBC(II)  ff12SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS8 ASP12 36.08  LYS8 ASP12 41.85  LYS8 ASP12 21.86 
ff14SB/ GB-HCT  ff14SB/ GB-OBC(II)  ff14SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS5 ASP12 14.22  LYS8 ASP12 30.55  LYS8 ASP12 14.88 
LYS8 ASP12 31.14         
 
ANNEX 4.G. Additional information for peptide ID2. 
H-bond analysis of the 300.37 K trajectory extracted from REMD simulations of 
peptide ID2. Data are related to H-bonds involving the backbone (donor backbone N-
H, acceptor backbone C=O). 
ff96/ GB-HCT  ff96/ GB-OBC(II)  ff96/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ILE5 LYS9 10.18  ASN8 LYS4 69.51  / / / 
LEU11 THR3 12.92  LYS9 ILE5 59.21     
THR3 LEU11 7.89  TRP7 THR3 82.16     
ASN8 LYS4 10.71  ILE10 ASP6 70.32     
TRP7 THR3 27.19         
ILE10 ASP6 10.74         
ARG2 LEU11 23.33         
ASP6 LYS9 14.45         
THR1 SER12 7.53         
ARG2 ILE10 25.62         
ILE10 ARG2 25.77         
LYS4 ASN8 19.50         
ILE5 ASN8 13.82         
LEU11 ARG2 12.29         
LYS9 ILE5 7.30         
ff99SB/ GB-HCT  ff99SB/ GB-OBC(II)  ff99SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LEU11 TRP7 17.41  ILE10 ASP6 16.92  ASN8 LYS4 23.10 
ILE5 ARG2 5.09  LEU11 TRP7 11.78  ASP6 THR3 35.17 
LEU11 ASN8 27.16  TRP7 THR3 37.96  LEU11 TRP7 16.65 
ASN8 ILE5 23.81  ASN8 LYS4 33.70  ILE10 TRP7 20.97 
THR1 SER12 9.92  LYS9 ASP6 24.93  ILE5 ARG2 6.53 
ILE10 TRP7 25.04  ASP6 THR3 25.33  ASN8 ILE5 10.98 
TRP7 LYS4 12.99  LEU11 ASN8 17.42  TRP7 THR3 14.91 
ASN8 LYS4 17.13  LYS9 ILE5 8.38  LYS9 ASP6 17.37 
LYS9 ILE5 7.97  TRP7 LYS4 13.99  TRP7 LYS4 16.74 
ASP6 THR3 11.10  ASN8 ILE5 13.13  LEU11 ASN8 14.79 
LYS9 ASP6 22.11  ILE10 TRP7 17.38     
SER12 ASN8 13.38  SER12 TRP7 6.60     
TRP7 THR3 6.58         
ff99SBildn/ GB-HCT  ff99SBildn/ GB-OBC(II)  ff99SBildn/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ARG2 LEU11 17.17  ASP6 ILE10 10.10  TRP7 LYS4 7.46 
LEU11 ARG2 16.45  ILE10 ASP6 18.55  ASN8 ILE5 16.89 
LYS4 LYS9 14.35  TRP7 THR3 7.29  ILE10 ASP6 17.00 
ASN8 ILE5 10.95  ASN8 ILE5 19.54  LEU11 ASP6 9.33 
LEU11 ASN8 5.62  LYS9 ASP6 23.58  LYS9 ASP6 31.93 
TRP7 LYS4 22.77  ASP6 THR3 6.59  LYS9 ILE5 6.13 
ILE10 TRP7 21.90  LEU11 TRP7 5.88  LEU11 TRP7 21.13 
LYS9 ILE5 7.10  ILE10 TRP7 6.78  LEU11 ASN8 7.70 
ASN8 LYS4 16.38  LYS9 ILE5 6.20     
LYS9 ASP6 12.42  LEU11 ASN8 10.00     
ILE10 ASP6 6.19  SER12 ASN8 5.13     
THR3 LYS9 6.58         
LEU11 THR1 7.16         
ASP6 THR3 6.76         
THR1 SER12 9.96         
TRP7 THR3 5.30         
LEU11 TRP7 21.77         
ff99SBildn-φ/ GB-HCT  ff99SBildn-φ/ GB-OBC(II)  ff99SBildn-φ/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ILE10 ARG2 6.02  ASN8 ILE5 30.13  LEU11 TRP7 21.76 
ARG2 ILE10 5.91  ILE10 ASP6 35.53  LYS9 ASP6 29.41 
LYS4 ASN8 5.22  LYS9 ASP6 37.01  ASN8 ILE5 11.87 
TRP7 LYS4 28.74  TRP7 LYS4 13.11  ILE10 ASP6 11.43 
LEU11 TRP7 17.37  LEU11 TRP7 10.58  ILE10 TRP7 16.17 
ILE10 ASP6 12.43  LYS9 ILE5 8.26  ASP6 ARG2 6.54 
ASN8 ILE5 24.20  ILE10 TRP7 9.66  LEU11 ASN8 9.06 
LYS9 ASP6 36.33  LEU11 ASN8 9.29  ILE5 ARG2 5.78 
THR1 SER12 10.72  ASN8 LYS4 5.62  TRP7 THR3 6.08 
LEU11 ASN8 16.05  TRP7 THR3 12.57     
SER12 TRP7 6.66         
LYS9 ILE5 9.46         
ILE10 TRP7 17.76         
ASN8 LYS4 8.72         
ARG2 LEU11 12.23         
LYS4 LYS9 9.94         
LEU11 ARG2 10.70         
ff12SB/ GB-HCT  ff12SB/ GB-OBC(II)  ff12SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ILE10 ASP6 16.96  TRP7 THR3 36.51  ILE10 TRP7 23.85 
ILE10 TRP7 22.52  LYS9 ILE5 27.80  LEU11 TRP7 43.71 
THR1 SER12 8.91  ILE10 ASP6 53.88  LYS9 ASP6 30.94 
LYS9 ILE5 17.93  LYS9 ASP6 22.29  ILE10 ASP6 14.09 
ASN8 ILE5 17.16  ASN8 ILE5 19.64  TRP7 THR3 10.17 
LEU11 ASN8 15.46  ASP6 THR3 7.31  SER12 ASN8 10.42 
TRP7 THR3 8.23  TRP7 LYS4 5.66  LYS9 ILE5 14.26 
ASN8 LYS4 24.45  ASN8 LYS4 33.84  ASN8 LYS4 21.29 
LYS9 ASP6 17.24  LEU11 ASN8 6.74  ASP6 ARG2 5.03 
SER12 LYS9 6.38  ILE10 TRP7 6.38  ILE5 ARG2 5.04 
TRP7 LYS4 21.22  LEU11 TRP7 11.46  SER12 LYS9 6.53 
SER12 ASN8 5.24      ASP6 THR3 11.26 
LEU11 TRP7 20.83      TRP7 LYS4 19.12 
ARG2 SER12 6.11      ASN8 ILE5 18.15 
THR3 SER12 5.86      LEU11 ASN8 8.71 
LYS4 THR1 6.73         
ASP6 ARG2 5.61         
ff14SB/ GB-HCT  ff14SB/ GB-OBC(II)  ff14SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ASN8 ILE5 19.37  TRP7 THR3 38.71  ASP6 THR3 18.59 
ILE10 TRP7 21.47  LEU11 TRP7 21.23  ASN8 LYS4 37.92 
ASN8 LYS4 24.05  ILE10 ASP6 39.88  LYS9 ASP6 25.27 
LEU11 ASN8 11.13  ASN8 LYS4 31.81  LEU11 TRP7 55.09 
LYS9 ILE5 8.15  LYS9 ASP6 26.37  ILE10 ASP6 23.25 
LEU11 TRP7 31.43  ASN8 ILE5 14.47  LYS9 ILE5 21.63 
LYS9 ASP6 29.97  TRP7 LYS4 7.23  TRP7 THR3 38.33 
TRP7 THR3 10.38  LYS9 ILE5 19.41  ILE10 TRP7 23.41 
ASP6 THR3 7.06  ASP6 ARG2 6.30  SER12 ASN8 13.73 
TRP7 LYS4 16.16  ASP6 THR3 7.65  ASN8 ILE5 13.31 
SER12 LYS9 7.12  ILE10 TRP7 12.64  SER12 LYS9 7.98 
ILE10 ASP6 18.42  ILE10 ILE5 7.14  TRP7 LYS4 14.48 
ILE5 THR3 13.93         
ASP6 ARG2 22.09         
SER12 ASN8 7.23         
ILE10 ILE5 8.90         
 
Salt bridge analysis of the 300.37 K trajectory extracted from REMD simulations of 
peptide ID2.  
ff96/ GB-HCT  ff96/ GB-OBC(II)  ff96/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ARG2 ASP6 36.67  ARG2 ASP6 102.37  / / / 
ff99SB/ GB-HCT  ff99SB/ GB-OBC(II)  ff99SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS9 ASP6 26.59  ARG2 ASP6 87.69  ARG2 ASP6 22.56 
ff99SBildn/ GB-HCT  ff99SBildn/ GB-OBC(II)  ff99SBildn/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
LYS4 ASP6 15.53  ARG2 ASP6 86.72  / / / 
LYS9 ASP6 17.66  LYS9 ASP6 5.06     
ff99SBildn-φ/ GB-HCT  ff99SBildn-φ/ GB-OBC(II)  ff99SBildn-φ/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ARG2 ASP6 50.02  ARG2 ASP6 117.45  / / / 
LYS4 ASP6 23.57         
LYS9 ASP6 10.48         
ff12SB/ GB-HCT  ff12SB/ GB-OBC(II)  ff12SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ARG2 ASP6 72.46  ARG2 ASP6 100.70  / / / 
LYS4 ASP6 5.39         
LYS9 ASP6 23.02         
ff14SB/ GB-HCT  ff14SB/ GB-OBC(II)  ff14SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ARG2 ASP6 89.71  ARG2 ASP6 82.41  / / / 
LYS9 ASP6 20.18         
 
ANNEX 4.H. Additional information for peptide ID2. 
H-bond analysis of the 300.37 K trajectory extracted from REMD simulations of 
peptide ID3. Data are related to H-bonds involving the backbone (donor backbone N-
H, acceptor backbone C=O). 















HIP6 12.20  HIP6 GLU14 10.56  LYS7 THR3 7.33 
LEU9 SER2 6.62  PHE11 LYS7 23.58  HIP6 SER2 7.57 
LYS8 PHE11 6.94  LYS7 GLU14 13.50     
GLU14 HIP6 10.50  GLU14 HIP6 10.39     
THR13 HIP6 6.21  MET1
0 
HIP6 5.10     
PHE11 LYS8 5.29  LYS7 THR3 7.29     
HIP6 GLU14 9.45  LYS8 SER4 7.17     
SER4 LYS7 7.72  LEU9 ARG5 7.46     
LYS12 LYS8 13.96  HIP6 SER2 7.50     
LYS7 GLU14 7.44  ARG5 ACE1 5.12     
LYS7 THR3 18.42  HIP6 LEU9 5.26     
LYS8 SER4 16.33         
LEU9 ARG5 17.08         
HIP6 SER2 18.33         
LYS12 ARG5 5.59         
PHE11 LYS7 13.75         















ARG5 6.05  LYS12 LYS8 6.14  HIP6 THR3 18.85 
ARG5 SER2 25.88  PHE11 LYS8 12.33  PHE11 LYS8 10.64 
LEU9 ARG5 21.22  ARG5 SER2 20.82  ARG5 SER2 24.93 
LYS8 SER4 16.28  LYS7 THR3 8.54  LYS7 SER4 10.03 
HIP6 SER2 17.54  HIP6 THR3 20.41  LYS7 THR3 8.34 
LEU9 HIP6 6.11  MET1
0 
LYS7 8.01  HIP6 SER2 10.25 
MET1
0 
HIP6 7.14  LYS7 SER4 19.67  LYS8 ARG5 5.74 
LYS7 THR3 12.02  LYS12 LEU9 7.49  LEU9 ARG5 8.17 
LYS12 LEU9 10.85  LYS8 ARG5 9.95  LYS12 LEU9 8.21 
LYS8 ARG5 15.56  LYS8 SER4 16.37  LYS8 SER4 7.38 
LYS7 SER4 18.08  LEU9 ARG5 9.80  MET1
0 
LYS7 6.06 
HIP6 THR3 21.53  HIP6 SER2 9.56     
MET1
0 
LYS7 11.10  MET1
0 
HIP6 6.06     
PHE11 LYS7 6.20         
PHE11 LYS8 9.31         
LYS12 LYS8 5.57         
LEU9 SER4 5.62         
THR13 MET10 5.74         













HIP6 THR3 15.64  ARG5 SER2 18.48  MET1
0 
LYS7 6.70 
LYS7 SER4 16.65  PHE11 ARG5 11.41  ARG5 SER2 27.00 
MET1
0 
LYS7 7.11  HIP6 SER2 5.97  HIP6 THR3 21.94 
ARG5 SER2 24.36  HIP6 THR3 13.96  HIP6 SER2 8.50 
LEU9 ARG5 32.00  LYS8 SER4 16.64  LYS12 LEU9 9.94 
LYS8 ARG5 19.69  LYS7 SER4 11.11  LYS7 SER4 9.94 
LYS12 LEU9 12.16  LEU9 SER4 8.97  LYS7 THR3 6.11 
HIP6 SER2 18.55  LYS7 THR3 7.74  LEU9 HIP6 5.72 
LYS8 SER4 21.43  GLU14 PHE11 8.90  LYS8 ARG5 6.03 
PHE11 ARG5 5.37  LEU9 ARG5 7.14  LEU9 ARG5 6.61 
LEU9 HIP6 8.36  LEU9 HIP6 11.34  PHE11 LYS8 7.35 
MET1
0 
HIP6 11.63  MET1
0 
LYS7 13.47     
MET1
0 
ARG5 10.46  LYS12 LEU9 12.09     
LYS7 THR3 11.86         
PHE11 LYS8 7.49         
LEU9 SER4 6.27         
PHE11 LYS7 9.63         
LYS12 LYS8 6.92         
GLU14 LYS8 5.08         













HIP6 THR3 12.69  LYS7 SER4 14.81  HIP6 THR3 21.43 
ARG5 SER2 18.39  LYS8 ARG5 5.39  LYS12 LEU9 9.42 
HIP6 GLU14 5.44  ARG5 SER2 19.48  LYS7 SER4 10.38 
LYS8 ARG5 13.11  LYS12 LEU9 17.73  MET1
0 
LYS7 5.24 
ARG5 GLU14 7.61  LEU9 ARG5 18.44  LYS8 ARG5 5.82 
LYS12 LEU9 9.30  THR13 LEU9 9.18  HIP6 SER2 9.46 
LEU9 ARG5 26.65  LYS8 SER4 18.12  ARG5 SER2 24.55 
LYS7 SER4 21.07  LYS7 THR3 8.79  LYS7 THR3 6.90 
LYS8 SER4 23.39  HIP6 SER2 9.22  LEU9 HIP6 5.04 
MET1
0 
HIP6 13.69  MET1
0 
LYS7 13.70  LYS8 SER4 6.13 
PHE11 LYS8 6.01  HIP6 THR3 15.22  LEU9 ARG5 5.33 
HIP6 SER2 14.28  PHE11 LYS8 5.62     
MET1
0 
LYS7 7.13  LEU9 SER4 5.90     
LYS7 THR3 7.22  LEU9 HIP6 9.70     
LEU9 HIP6 10.05  PHE11 ARG5 5.72     
MET1
0 
ARG5 9.48  PHE11 LYS7 8.55     
PHE11 ARG5 11.58  LYS7 GLU14 5.83     
LYS12 HIP6 9.55         


















HIP6 40.33  ARG5 SER2 22.87  LEU9 ARG5 50.29 
GLU14 LYS8 13.53  PHE11 LYS8 7.44  LYS8 SER4 38.23 
PHE11 LYS7 31.49  LYS12 LYS8 12.82  LYS7 THR3 32.22 
LYS7 THR3 29.21  LYS8 SER4 25.78  HIP6 SER2 30.96 
HIP6 SER2 29.39  LEU9 ARG5 49.56  ARG5 SER2 29.42 
LYS7 SER4 16.40  LYS7 SER4 9.99  HIP6 THR3 19.45 
LYS12 LYS8 26.66  MET1
0 
HIP6 14.20  PHE11 LYS7 10.45 
MET1
0 
LYS7 5.56  PHE11 LYS7 11.89  LEU9 HIP6 7.38 
HIP6 THR3 14.26  LYS7 THR3 17.67  PHE11 LYS8 7.84 
LEU9 ARG5 49.13  HIP6 GLU14 15.49  LYS12 MET10 5.83 
PHE11 LYS8 12.51  LYS12 LEU9 31.28  MET1
0 
LYS7 10.40 
THR13 LYS8 9.22  MET1
0 
LYS7 9.54  THR13 MET10 14.66 
ARG5 SER2 20.53  HIP6 SER2 10.93  GLU14 MET10 5.55 
LYS8 ARG5 8.69  LYS8 ARG5 14.57  LYS7 SER4 16.11 
LYS12 LEU9 6.05  SER4 LEU9 7.38  LYS8 ARG5 7.02 
        LYS12 LEU9 8.69 
        LYS12 LYS8 6.43 













HIP6 THR3 19.44  LYS8 SER4 37.49  LYS7 SER4 15.62 
LYS7 SER4 17.64  ARG5 SER2 27.67  ARG5 SER2 26.13 
LYS7 THR3 22.91  HIP6 THR3 20.23  HIP6 SER2 21.54 
LYS12 HIP6 7.93  THR13 MET10 11.03  LYS8 ARG5 10.52 
LEU9 ARG5 29.21  LYS7 SER4 13.52  LEU9 HIP6 9.86 
MET1
0 
HIP6 15.89  MET1
0 
LYS7 7.60  PHE11 LYS8 11.46 
LYS8 SER4 29.77  LYS8 ARG5 5.23  LYS7 THR3 24.13 
LYS12 LEU9 9.82  LEU9 ARG5 14.12  THR13 MET10 11.60 
THR13 MET10 16.21  LYS7 THR3 18.48  HIP6 THR3 24.56 
GLU14 PHE11 6.13  LEU9 HIP6 7.54  LYS12 LEU9 18.98 





LYS7 12.90  PHE11 LYS8 6.22  GLU14 MET10 5.80 
PHE11 LYS7 10.62  HIP6 SER2 9.16  GLU14 PHE11 5.52 
PHE11 LYS8 6.78  GLU14 PHE11 7.42  LYS12 LYS8 9.79 
LYS8 ARG5 11.38  MET1
0 
ARG5 6.22  THR13 LEU9 7.52 
LEU9 HIP6 10.88  LEU9 SER4 6.50  LYS8 SER4 28.69 
SER4 MET10 5.58  PHE11 ARG5 12.00  THR13 LYS8 5.59 
        MET1
0 
HIP6 19.31 
        LEU9 ARG5 29.52 
        PHE11 LYS7 22.55 
 
Salt bridge analysis of the 300.37 K trajectory extracted from REMD simulations of 
peptide ID3.  
ff96/ GB-HCT  ff96/ GB-OBC(II)  ff96/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ARG5 GLU14 65.51  ARG5 GLU14 35.78  / / / 
HIP6 GLU14 29.43  HIP6 GLU14 35.93     
LYS7 GLU14 15.29  LYS7 GLU14 6.59     
LYS8 GLU14 5.55         
LYS12 GLU14 18.81         
ff99SB/ GB-HCT  ff99SB/ GB-OBC(II)  ff99SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ARG5 GLU14 37.00  ARG5 GLU14 48.53  / / / 
HIP6 GLU14 8.09  HIP6 GLU14 6.64     
LYS12 GLU14 21.66  LYS12 GLU14 11.77     
ff99SBildn/ GB-HCT  ff99SBildn/ GB-OBC(II)  ff99SBildn/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ARG5 GLU14 42.41  ARG5 GLU14 60.05  / / / 
HIP6 GLU14 5.33  HIP6 GLU14 14.59     
LYS7 GLU14 5.06  LYS12 GLU14 5.25     
LYS8 GLU14 13.73         
LYS12 GLU14 28.53         
ff99SBildn-φ/ GB-HCT  ff99SBildn-φ/ GB-OBC(II)  ff99SBildn-φ/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ARG5 GLU14 35.82  ARG5 GLU14 56.98  / / / 
HIP6 GLU14 20.02  HIP6 GLU14 9.06     
LYS12 GLU14 25.21  LYS12 GLU14 14.71     
ff12SB/ GB-HCT  ff12SB/ GB-OBC(II)  ff12SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ARG5 GLU14 47.60  ARG5 GLU14 51.19  HIP6 GLU14 20.19 
HIP6 GLU14 6.02  LYS12 GLU14 9.82     
LYS8 GLU14 27.77         
LYS12 GLU14 28.10         
ff14SB/ GB-HCT  ff14SB/ GB-OBC(II)  ff14SB/ GB-Neck2 
donor acceptor occ%  donor acceptor occ%  donor acceptor occ% 
ARG5 GLU14 42.49  ARG5 GLU14 93.63  / / / 
HIP6 GLU14 8.69         
LYS7 GLU14 5.26         
LYS8 GLU14 11.09         
 
  
ANNEX 5.A. Additional information about QM 
calculations 
Cartesian coordinates (pdb format) and energies 
(a.u.) of all structures optimized at the MPW1B95/6-
31+G(d,p) level with the CPCM solvent model for 
water. 310R = right-handed 310 helix; 310L = left-
handed 310 helix; ext = extended. Vibrational 
analysis has been conducted at standard conditions 
(T = 298.15 K; P = 1 atm)
 
COMPND Ac-L-Ala-R-I-L-Ala-Aib-L-Ala-NHMe_310R  
REMARK Energy(ZPE)= -1735.026859 
REMARK #IF = 0 
ATOM      1  C   P01     1       5.632  -2.163  -1.911   
ATOM      2  H   P01     1       5.339  -1.678  -2.841   
ATOM      3  H   P01     1       6.582  -1.756  -1.572   
ATOM      4  H   P01     1       5.755  -3.227  -2.117   
ATOM      5  C   P01     1       4.531  -1.998  -0.910   
ATOM      6  O   P01     1       3.361  -2.299  -1.161   
ATOM      7  N   P01     1       4.865  -1.488   0.295   
ATOM      8  H   P01     1       5.834  -1.303   0.500   
ATOM      9  C   P01     1       3.908  -1.455   1.379   
ATOM     10  H   P01     1       3.482  -2.452   1.513   
ATOM     11  C   P01     1       4.579  -1.005   2.667   
ATOM     12  H   P01     1       5.012  -0.010   2.558   
ATOM     13  H   P01     1       3.848  -0.980   3.473   
ATOM     14  H   P01     1       5.367  -1.706   2.942   
ATOM     15  C   P01     1       2.709  -0.570   1.071   
ATOM     16  O   P01     1       1.625  -0.784   1.612   
ATOM     17  N   P01     1       2.898   0.439   0.203   
ATOM     18  H   P01     1       3.814   0.547  -0.205   
ATOM     19  C   P01     1       1.836   1.351  -0.189   
ATOM     20  C   P01     1       1.379   2.168   1.033   
ATOM     21  H   P01     1       2.256   2.343   1.662   
ATOM     22  H   P01     1       0.706   1.552   1.626   
ATOM     23  C   P01     1       0.685   3.486   0.745   
ATOM     24  H   P01     1       0.020   3.744   1.565   
ATOM     25  H   P01     1       0.102   3.464  -0.173   
ATOM     26  N   P01     1       1.657   4.622   0.640   
ATOM     27  H   P01     1       2.269   4.606   1.457   
ATOM     28  H   P01     1       1.140   5.499   0.714   
ATOM     29  C   P01     1       2.487   4.680  -0.601   
ATOM     30  H   P01     1       1.804   4.918  -1.415   
ATOM     31  H   P01     1       3.170   5.516  -0.467   
ATOM     32  C   P01     1       3.244   3.400  -0.893   
ATOM     33  H   P01     1       3.922   3.647  -1.711   
ATOM     34  H   P01     1       3.883   3.127  -0.049   
ATOM     35  C   P01     1       2.359   2.235  -1.333   
ATOM     36  H   P01     1       2.900   1.593  -2.030   
ATOM     37  H   P01     1       1.502   2.622  -1.889   
ATOM     38  C   P01     1       0.633   0.580  -0.748   
ATOM     39  O   P01     1      -0.485   1.100  -0.719   
ATOM     40  N   P01     1       0.853  -0.617  -1.302   
ATOM     41  H   P01     1       1.773  -1.048  -1.258   
ATOM     42  C   P01     1      -0.236  -1.353  -1.904   
ATOM     43  H   P01     1      -0.726  -0.712  -2.640   
ATOM     44  C   P01     1       0.284  -2.609  -2.584   
ATOM     45  H   P01     1       0.794  -3.257  -1.871   
ATOM     46  H   P01     1      -0.547  -3.154  -3.028   
ATOM     47  H   P01     1       0.987  -2.342  -3.374   
ATOM     48  C   P01     1      -1.344  -1.704  -0.913   
ATOM     49  O   P01     1      -2.473  -1.957  -1.342   
ATOM     50  N   P01     1      -1.033  -1.715   0.389   
ATOM     51  H   P01     1      -0.091  -1.463   0.672   
ATOM     52  C   P01     1      -2.004  -1.997   1.439   
ATOM     53  C   P01     1      -1.324  -1.732   2.782   
ATOM     54  H   P01     1      -0.492  -2.424   2.919   
ATOM     55  H   P01     1      -0.938  -0.713   2.835   
ATOM     56  H   P01     1      -2.039  -1.885   3.589   
ATOM     57  C   P01     1      -2.484  -3.441   1.369   
ATOM     58  H   P01     1      -3.196  -3.633   2.169   
ATOM     59  H   P01     1      -2.965  -3.644   0.414   
ATOM     60  H   P01     1      -1.628  -4.106   1.487   
ATOM     61  C   P01     1      -3.203  -1.038   1.350   
ATOM     62  O   P01     1      -4.293  -1.356   1.822   
ATOM     63  N   P01     1      -2.978   0.175   0.812   
ATOM     64  H   P01     1      -2.075   0.394   0.404   
ATOM     65  C   P01     1      -4.016   1.179   0.765   
ATOM     66  H   P01     1      -4.610   1.086   1.676   
ATOM     67  C   P01     1      -3.406   2.570   0.692   
ATOM     68  H   P01     1      -2.779   2.675  -0.194   
ATOM     69  H   P01     1      -4.199   3.314   0.649   
ATOM     70  H   P01     1      -2.795   2.757   1.575   
ATOM     71  C   P01     1      -5.010   0.983  -0.380   
ATOM     72  O   P01     1      -6.012   1.702  -0.444   
ATOM     73  N   P01     1      -4.733   0.038  -1.279   
ATOM     74  H   P01     1      -3.911  -0.541  -1.157   
ATOM     75  C   P01     1      -5.613  -0.222  -2.392   
ATOM     76  H   P01     1      -6.595  -0.552  -2.049   
ATOM     77  H   P01     1      -5.749   0.675  -2.997   
ATOM     78  H   P01     1      -5.173  -1.002  -3.008   
END 
 
COMPND Ac-L-Ala-R-II-L-Ala-Aib-L-Ala-NHMe_310R  
REMARK Energy(ZPE)= -1792.373533 
REMARK #IF = 0 
ATOM      1  C   P02     1       5.965  -1.967  -1.698   
ATOM      2  H   P02     1       5.647  -1.601  -2.675   
ATOM      3  H   P02     1       6.883  -1.462  -1.407   
ATOM      4  H   P02     1       6.157  -3.035  -1.792   
ATOM      5  C   P02     1       4.846  -1.766  -0.723   
ATOM      6  O   P02     1       3.728  -2.258  -0.894   
ATOM      7  N   P02     1       5.099  -0.998   0.358   
ATOM      8  H   P02     1       6.033  -0.654   0.513   
ATOM      9  C   P02     1       4.123  -0.868   1.419   
ATOM     10  H   P02     1       3.822  -1.864   1.753   
ATOM     11  C   P02     1       4.708  -0.089   2.586   
ATOM     12  H   P02     1       5.012   0.912   2.278   
ATOM     13  H   P02     1       3.966   0.001   3.377   
ATOM     14  H   P02     1       5.575  -0.612   2.989   
ATOM     15  C   P02     1       2.830  -0.223   0.940   
ATOM     16  O   P02     1       1.768  -0.466   1.514   
ATOM     17  N   P02     1       2.922   0.611  -0.106   
ATOM     18  H   P02     1       3.838   0.767  -0.500   
ATOM     19  C   P02     1       1.793   1.276  -0.723   
ATOM     20  C   P02     1       2.218   1.905  -2.072   
ATOM     21  H   P02     1       2.216   1.182  -2.888   
ATOM     22  H   P02     1       3.237   2.281  -1.954   
ATOM     23  C   P02     1       1.266   3.083  -2.277   
ATOM     24  H   P02     1       1.707   3.874  -2.884   
ATOM     25  H   P02     1       0.348   2.755  -2.774   
ATOM     26  C   P02     1       1.263   2.482   0.026   
ATOM     27  C   P02     1       1.068   2.643   1.390   
ATOM     28  H   P02     1       1.293   1.842   2.081   
ATOM     29  C   P02     1       0.577   3.860   1.853   
ATOM     30  H   P02     1       0.428   4.009   2.916   
ATOM     31  C   P02     1       0.276   4.888   0.963   
ATOM     32  H   P02     1      -0.103   5.830   1.338   
ATOM     33  C   P02     1       0.466   4.716  -0.406   
ATOM     34  H   P02     1       0.239   5.520  -1.096   
ATOM     35  C   P02     1       0.967   3.507  -0.869   
ATOM     36  C   P02     1       0.662   0.281  -1.022   
ATOM     37  O   P02     1      -0.504   0.670  -1.096   
ATOM     38  N   P02     1       0.997  -0.992  -1.282   
ATOM     39  H   P02     1       1.956  -1.315  -1.182   
ATOM     40  C   P02     1      -0.032  -1.939  -1.652   
ATOM     41  H   P02     1      -0.552  -1.571  -2.539   
ATOM     42  C   P02     1       0.577  -3.300  -1.947   
ATOM     43  H   P02     1       1.080  -3.705  -1.069   
ATOM     44  H   P02     1      -0.207  -3.992  -2.250   
ATOM     45  H   P02     1       1.300  -3.221  -2.758   
ATOM     46  C   P02     1      -1.124  -2.067  -0.595   
ATOM     47  O   P02     1      -2.252  -2.439  -0.933   
ATOM     48  N   P02     1      -0.795  -1.780   0.671   
ATOM     49  H   P02     1       0.140  -1.433   0.868   
ATOM     50  C   P02     1      -1.743  -1.856   1.776   
ATOM     51  C   P02     1      -1.064  -1.266   3.012   
ATOM     52  H   P02     1      -0.184  -1.857   3.269   
ATOM     53  H   P02     1      -0.749  -0.237   2.838   
ATOM     54  H   P02     1      -1.757  -1.290   3.852   
ATOM     55  C   P02     1      -2.156  -3.297   2.044   
ATOM     56  H   P02     1      -2.870  -3.328   2.865   
ATOM     57  H   P02     1      -2.617  -3.739   1.163   
ATOM     58  H   P02     1      -1.274  -3.877   2.316   
ATOM     59  C   P02     1      -2.987  -0.995   1.500   
ATOM     60  O   P02     1      -4.053  -1.244   2.060   
ATOM     61  N   P02     1      -2.828   0.074   0.699   
ATOM     62  H   P02     1      -1.950   0.225   0.211   
ATOM     63  C   P02     1      -3.919   0.985   0.446   
ATOM     64  H   P02     1      -4.470   1.119   1.379   
ATOM     65  C   P02     1      -3.388   2.329  -0.030   
ATOM     66  H   P02     1      -2.822   2.220  -0.955   
ATOM     67  H   P02     1      -4.220   3.008  -0.206   
ATOM     68  H   P02     1      -2.735   2.763   0.727   
ATOM     69  C   P02     1      -4.949   0.451  -0.550   
ATOM     70  O   P02     1      -6.010   1.062  -0.710   
ATOM     71  N   P02     1      -4.639  -0.655  -1.229   
ATOM     72  H   P02     1      -3.772  -1.143  -1.036   
ATOM     73  C   P02     1      -5.560  -1.221  -2.186   
ATOM     74  H   P02     1      -6.492  -1.523  -1.704   
ATOM     75  H   P02     1      -5.801  -0.498  -2.966   





REMARK Energy(ZPE)= -1905.640014 
REMARK #IF = 0 
ATOM      1  C   P03     1      -4.607   3.731  -1.872   
ATOM      2  H   P03     1      -4.216   3.552  -2.872   
ATOM      3  H   P03     1      -5.624   3.351  -1.806   
ATOM      4  H   P03     1      -4.621   4.809  -1.709   
ATOM      5  C   P03     1      -3.681   3.113  -0.870   
ATOM      6  O   P03     1      -2.462   3.309  -0.893   
ATOM      7  N   P03     1      -4.231   2.316   0.070   
ATOM      8  H   P03     1      -5.233   2.214   0.105   
ATOM      9  C   P03     1      -3.448   1.828   1.185   
ATOM     10  H   P03     1      -2.917   2.668   1.640   
ATOM     11  C   P03     1      -4.350   1.172   2.218   
ATOM     12  H   P03     1      -4.900   0.336   1.784   
ATOM     13  H   P03     1      -3.749   0.799   3.045   
ATOM     14  H   P03     1      -5.061   1.900   2.609   
ATOM     15  C   P03     1      -2.343   0.874   0.758   
ATOM     16  O   P03     1      -1.361   0.699   1.481   
ATOM     17  N   P03     1      -2.489   0.243  -0.418   
ATOM     18  H   P03     1      -3.337   0.392  -0.942   
ATOM     19  C   P03     1      -1.489  -0.665  -0.931   
ATOM     20  C   P03     1      -1.992  -1.390  -2.204   
ATOM     21  H   P03     1      -2.949  -1.004  -2.553   
ATOM     22  H   P03     1      -1.267  -1.304  -3.011   
ATOM     23  C   P03     1      -2.052  -2.854  -1.725   
ATOM     24  H   P03     1      -2.027  -3.599  -2.515   
ATOM     25  O   P03     1      -0.864  -2.911  -0.928   
ATOM     26  C   P03     1      -1.228  -1.906   0.011   
ATOM     27  H   P03     1      -0.454  -1.756   0.755   
ATOM     28  C   P03     1      -2.581  -2.386   0.460   
ATOM     29  C   P03     1      -3.124  -2.988  -0.675   
ATOM     30  C   P03     1      -4.404  -3.507  -0.667   
ATOM     31  H   P03     1      -4.836  -3.967  -1.547   
ATOM     32  C   P03     1      -5.125  -3.435   0.527   
ATOM     33  H   P03     1      -6.122  -3.855   0.574   
ATOM     34  C   P03     1      -4.580  -2.840   1.661   
ATOM     35  H   P03     1      -5.160  -2.803   2.575   
ATOM     36  C   P03     1      -3.296  -2.291   1.637   
ATOM     37  H   P03     1      -2.881  -1.810   2.515   
ATOM     38  C   P03     1      -0.166   0.061  -1.182   
ATOM     39  O   P03     1       0.887  -0.571  -1.284   
ATOM     40  N   P03     1      -0.188   1.399  -1.269   
ATOM     41  H   P03     1      -1.050   1.926  -1.167   
ATOM     42  C   P03     1       1.054   2.118  -1.442   
ATOM     43  H   P03     1       1.558   1.751  -2.339   
ATOM     44  C   P03     1       0.790   3.609  -1.573   
ATOM     45  H   P03     1       0.286   3.997  -0.687   
ATOM     46  H   P03     1       1.733   4.137  -1.705   
ATOM     47  H   P03     1       0.157   3.802  -2.438   
ATOM     48  C   P03     1       2.047   1.847  -0.314   
ATOM     49  O   P03     1       3.255   1.997  -0.522   
ATOM     50  N   P03     1       1.554   1.459   0.869   
ATOM     51  H   P03     1       0.553   1.321   0.967   
ATOM     52  C   P03     1       2.397   1.138   2.014   
ATOM     53  C   P03     1       1.501   0.512   3.083   
ATOM     54  H   P03     1       0.752   1.236   3.409   
ATOM     55  H   P03     1       0.984  -0.367   2.698   
ATOM     56  H   P03     1       2.105   0.224   3.942   
ATOM     57  C   P03     1       3.078   2.386   2.559   
ATOM     58  H   P03     1       3.706   2.122   3.408   
ATOM     59  H   P03     1       3.699   2.853   1.796   
ATOM     60  H   P03     1       2.317   3.096   2.885   
ATOM     61  C   P03     1       3.453   0.083   1.647   
ATOM     62  O   P03     1       4.506   0.011   2.279   
ATOM     63  N   P03     1       3.132  -0.798   0.681   
ATOM     64  H   P03     1       2.284  -0.679   0.135   
ATOM     65  C   P03     1       4.023  -1.881   0.335   
ATOM     66  H   P03     1       4.484  -2.239   1.257   
ATOM     67  C   P03     1       3.253  -3.016  -0.323   
ATOM     68  H   P03     1       2.770  -2.682  -1.241   
ATOM     69  H   P03     1       3.939  -3.826  -0.564   
ATOM     70  H   P03     1       2.487  -3.393   0.355   
ATOM     71  C   P03     1       5.193  -1.464  -0.557   
ATOM     72  O   P03     1       6.092  -2.276  -0.792   
ATOM     73  N   P03     1       5.180  -0.230  -1.065   
ATOM     74  H   P03     1       4.439   0.415  -0.817   
ATOM     75  C   P03     1       6.248   0.236  -1.917   
ATOM     76  H   P03     1       6.355  -0.407  -2.791   
ATOM     77  H   P03     1       6.016   1.246  -2.246   





REMARK Energy(ZPE)= -1905.640304 
REMARK #IF = 0 
ATOM      1  C   P04     1      -5.843  -1.372   2.206   
ATOM      2  H   P04     1      -5.492  -0.677   2.967   
ATOM      3  H   P04     1      -6.755  -0.986   1.756   
ATOM      4  H   P04     1      -6.064  -2.320   2.698   
ATOM      5  C   P04     1      -4.747  -1.598   1.212   
ATOM      6  O   P04     1      -3.605  -1.921   1.552   
ATOM      7  N   P04     1      -5.049  -1.422  -0.092   
ATOM      8  H   P04     1      -6.000  -1.217  -0.355   
ATOM      9  C   P04     1      -4.101  -1.773  -1.127   
ATOM     10  H   P04     1      -3.775  -2.805  -0.980   
ATOM     11  C   P04     1      -4.733  -1.624  -2.501   
ATOM     12  H   P04     1      -5.066  -0.600  -2.674   
ATOM     13  H   P04     1      -4.009  -1.889  -3.269   
ATOM     14  H   P04     1      -5.589  -2.293  -2.594   
ATOM     15  C   P04     1      -2.821  -0.954  -1.039   
ATOM     16  O   P04     1      -1.765  -1.401  -1.489   
ATOM     17  N   P04     1      -2.906   0.257  -0.468   
ATOM     18  H   P04     1      -3.815   0.592  -0.184   
ATOM     19  C   P04     1      -1.764   1.138  -0.349   
ATOM     20  C   P04     1      -1.329   1.708  -1.720   
ATOM     21  H   P04     1      -1.871   1.200  -2.515   
ATOM     22  H   P04     1      -0.260   1.606  -1.885   
ATOM     23  C   P04     1      -1.773   3.181  -1.596   
ATOM     24  H   P04     1      -2.030   3.678  -2.526   
ATOM     25  O   P04     1      -2.930   3.066  -0.746   
ATOM     26  C   P04     1      -2.269   2.445   0.354   
ATOM     27  H   P04     1      -2.951   2.268   1.183   
ATOM     28  C   P04     1      -1.112   3.374   0.590   
ATOM     29  C   P04     1      -0.802   3.868  -0.675   
ATOM     30  C   P04     1      -0.393   3.744   1.708   
ATOM     31  H   P04     1      -0.629   3.354   2.691   
ATOM     32  C   P04     1       0.250   4.743  -0.862   
ATOM     33  H   P04     1       0.506   5.122  -1.843   
ATOM     34  C   P04     1       0.655   4.650   1.531   
ATOM     35  H   P04     1       1.228   4.979   2.389   
ATOM     36  C   P04     1       0.972   5.138   0.267   
ATOM     37  H   P04     1       1.787   5.843   0.159   
ATOM     38  C   P04     1      -0.627   0.466   0.415   
ATOM     39  O   P04     1       0.540   0.826   0.253   
ATOM     40  N   P04     1      -0.958  -0.494   1.292   
ATOM     41  H   P04     1      -1.915  -0.827   1.369   
ATOM     42  C   P04     1       0.070  -1.147   2.070   
ATOM     43  H   P04     1       0.626  -0.392   2.630   
ATOM     44  C   P04     1      -0.553  -2.144   3.035   
ATOM     45  H   P04     1      -1.130  -2.897   2.498   
ATOM     46  H   P04     1       0.230  -2.638   3.608   
ATOM     47  H   P04     1      -1.217  -1.628   3.728   
ATOM     48  C   P04     1       1.129  -1.833   1.212   
ATOM     49  O   P04     1       2.251  -2.033   1.690   
ATOM     50  N   P04     1       0.791  -2.198  -0.031   
ATOM     51  H   P04     1      -0.132  -1.961  -0.384   
ATOM     52  C   P04     1       1.722  -2.847  -0.947   
ATOM     53  C   P04     1       1.050  -2.923  -2.318   
ATOM     54  H   P04     1       0.155  -3.542  -2.258   
ATOM     55  H   P04     1       0.764  -1.934  -2.676   
ATOM     56  H   P04     1       1.738  -3.374  -3.032   
ATOM     57  C   P04     1       2.079  -4.247  -0.464   
ATOM     58  H   P04     1       2.764  -4.716  -1.167   
ATOM     59  H   P04     1       2.551  -4.212   0.516   
ATOM     60  H   P04     1       1.169  -4.845  -0.401   
ATOM     61  C   P04     1       2.998  -2.007  -1.123   
ATOM     62  O   P04     1       4.053  -2.539  -1.465   
ATOM     63  N   P04     1       2.875  -0.676  -0.971   
ATOM     64  H   P04     1       2.000  -0.280  -0.642   
ATOM     65  C   P04     1       3.987   0.216  -1.197   
ATOM     66  H   P04     1       4.584  -0.199  -2.011   
ATOM     67  C   P04     1       3.489   1.600  -1.587   
ATOM     68  H   P04     1       2.855   2.023  -0.807   
ATOM     69  H   P04     1       4.340   2.261  -1.742   
ATOM     70  H   P04     1       2.913   1.544  -2.510   
ATOM     71  C   P04     1       4.951   0.322  -0.015   
ATOM     72  O   P04     1       5.992   0.975  -0.140   
ATOM     73  N   P04     1       4.615  -0.294   1.120   
ATOM     74  H   P04     1       3.764  -0.842   1.171   
ATOM     75  C   P04     1       5.476  -0.240   2.277   
ATOM     76  H   P04     1       6.445  -0.699   2.068   
ATOM     77  H   P04     1       5.649   0.792   2.584   





REMARK Energy(ZPE)= -1717.366164 
REMARK #IF = 0 
ATOM      1  C   P05     1       5.683  -2.068  -1.874  
ATOM      2  H   P05     1       5.385  -1.658  -2.838  
ATOM      3  H   P05     1       6.609  -1.596  -1.551  
ATOM      4  H   P05     1       5.856  -3.136  -2.007  
ATOM      5  C   P05     1       4.559  -1.885  -0.900  
ATOM      6  O   P05     1       3.408  -2.255  -1.147  
ATOM      7  N   P05     1       4.853  -1.279   0.271  
ATOM      8  H   P05     1       5.810  -1.036   0.471  
ATOM      9  C   P05     1       3.881  -1.204   1.339  
ATOM     10  H   P05     1       3.466  -2.200   1.514  
ATOM     11  C   P05     1       4.533  -0.690   2.614  
ATOM     12  H   P05     1       4.961   0.302   2.463  
ATOM     13  H   P05     1       3.791  -0.632   3.407  
ATOM     14  H   P05     1       5.324  -1.370   2.931  
ATOM     15  C   P05     1       2.675  -0.346   0.981  
ATOM     16  O   P05     1       1.608  -0.506   1.576  
ATOM     17  N   P05     1       2.836   0.570   0.016  
ATOM     18  H   P05     1       3.748   0.654  -0.407  
ATOM     19  C   P05     1       1.771   1.456  -0.414  
ATOM     20  C   P05     1       1.340   2.494   0.659  
ATOM     21  H   P05     1       0.610   2.092   1.359  
ATOM     22  C   P05     1       2.273   2.368  -1.575  
ATOM     23  H   P05     1       3.272   2.077  -1.909  
ATOM     24  H   P05     1       1.606   2.292  -2.435  
ATOM     25  C   P05     1       3.251   3.873   0.155  
ATOM     26  H   P05     1       3.417   4.914   0.439  
ATOM     27  H   P05     1       4.217   3.462  -0.146  
ATOM     28  C   P05     1       2.598   3.073   1.309  
ATOM     29  H   P05     1       3.256   2.315   1.732  
ATOM     30  H   P05     1       2.299   3.734   2.124  
ATOM     31  C   P05     1       2.214   3.771  -0.972  
ATOM     32  H   P05     1       2.286   4.559  -1.721  
ATOM     33  C   P05     1       0.898   3.684  -0.200  
ATOM     34  H   P05     1       0.039   3.464  -0.832  
ATOM     35  H   P05     1       0.693   4.569   0.406  
ATOM     36  C   P05     1       0.574   0.629  -0.883  
ATOM     37  O   P05     1      -0.568   1.096  -0.871  
ATOM     38  N   P05     1       0.817  -0.605  -1.353  
ATOM     39  H   P05     1       1.749  -1.002  -1.308  
ATOM     40  C   P05     1      -0.266  -1.406  -1.875  
ATOM     41  H   P05     1      -0.779  -0.840  -2.656  
ATOM     42  C   P05     1       0.266  -2.707  -2.453  
ATOM     43  H   P05     1       0.788  -3.289  -1.693  
ATOM     44  H   P05     1      -0.560  -3.298  -2.845  
ATOM     45  H   P05     1       0.960  -2.499  -3.267  
ATOM     46  C   P05     1      -1.354  -1.689  -0.843  
ATOM     47  O   P05     1      -2.493  -1.967  -1.231  
ATOM     48  N   P05     1      -1.015  -1.629   0.452  
ATOM     49  H   P05     1      -0.073  -1.341   0.702  
ATOM     50  C   P05     1      -1.962  -1.863   1.534  
ATOM     51  C   P05     1      -1.257  -1.530   2.849  
ATOM     52  H   P05     1      -0.413  -2.204   2.996  
ATOM     53  H   P05     1      -0.886  -0.505   2.851  
ATOM     54  H   P05     1      -1.954  -1.659   3.676  
ATOM     55  C   P05     1      -2.436  -3.311   1.546  
ATOM     56  H   P05     1      -3.135  -3.464   2.365  
ATOM     57  H   P05     1      -2.929  -3.566   0.610  
ATOM     58  H   P05     1      -1.575  -3.965   1.687  
ATOM     59  C   P05     1      -3.167  -0.913   1.427  
ATOM     60  O   P05     1      -4.245  -1.209   1.939  
ATOM     61  N   P05     1      -2.954   0.273   0.828  
ATOM     62  H   P05     1      -2.063   0.467   0.381  
ATOM     63  C   P05     1      -3.990   1.278   0.764  
ATOM     64  H   P05     1      -4.558   1.229   1.696  
ATOM     65  C   P05     1      -3.379   2.662   0.610  
ATOM     66  H   P05     1      -2.801   2.732  -0.313  
ATOM     67  H   P05     1      -4.169   3.409   0.584  
ATOM     68  H   P05     1      -2.718   2.876   1.449  
ATOM     69  C   P05     1      -5.016   1.034  -0.343  
ATOM     70  O   P05     1      -6.019   1.750  -0.413  
ATOM     71  N   P05     1      -4.760   0.051  -1.208  
ATOM     72  H   P05     1      -3.936  -0.522  -1.079  
ATOM     73  C   P05     1      -5.667  -0.257  -2.287  
ATOM     74  H   P05     1      -6.637  -0.580  -1.906  
ATOM     75  H   P05     1      -5.825   0.616  -2.921  
ATOM     76  H   P05     1      -5.238  -1.057  -2.884  
END 
 
COMPND Ac-L-Ala-SRR-IV-L-Ala-Aib-L-Ala-NHMe_ext  
REMARK Energy(ZPE)= -1717.338937 
REMARK #IF = 0 
ATOM      1  C   P05     1       9.672  -2.049  -1.040   
ATOM      2  H   P05     1      10.498  -2.246  -0.357   
ATOM      3  H   P05     1       9.707  -2.802  -1.827   
ATOM      4  H   P05     1       9.805  -1.064  -1.484   
ATOM      5  C   P05     1       8.378  -2.192  -0.289   
ATOM      6  O   P05     1       8.063  -3.249   0.265   
ATOM      7  N   P05     1       7.585  -1.108  -0.255   
ATOM      8  H   P05     1       7.836  -0.256  -0.735   
ATOM      9  C   P05     1       6.311  -1.102   0.416   
ATOM     10  H   P05     1       5.808  -2.049   0.203   
ATOM     11  C   P05     1       6.467  -0.949   1.928   
ATOM     12  H   P05     1       6.940   0.005   2.167   
ATOM     13  H   P05     1       5.502  -0.998   2.433   
ATOM     14  H   P05     1       7.093  -1.757   2.302   
ATOM     15  C   P05     1       5.503   0.057  -0.171   
ATOM     16  O   P05     1       6.071   0.966  -0.773   
ATOM     17  N   P05     1       4.186  -0.015   0.078   
ATOM     18  H   P05     1       3.893  -0.844   0.574   
ATOM     19  C   P05     1       3.096   0.885  -0.299   
ATOM     20  C   P05     1       2.806   1.984   0.746   
ATOM     21  H   P05     1       2.349   1.606   1.662   
ATOM     22  C   P05     1       3.318   1.722  -1.599   
ATOM     23  H   P05     1       4.302   1.554  -2.025   
ATOM     24  H   P05     1       2.573   1.436  -2.343   
ATOM     25  C   P05     1       4.289   3.604  -0.274   
ATOM     26  H   P05     1       4.237   4.676  -0.071   
ATOM     27  H   P05     1       5.245   3.394  -0.751   
ATOM     28  C   P05     1       4.085   2.784   1.021   
ATOM     29  H   P05     1       4.934   2.147   1.265   
ATOM     30  H   P05     1       3.916   3.435   1.880   
ATOM     31  C   P05     1       3.103   3.166  -1.138   
ATOM     32  H   P05     1       2.875   3.845  -1.960   
ATOM     33  C   P05     1       2.005   2.993  -0.087   
ATOM     34  H   P05     1       1.074   2.601  -0.500   
ATOM     35  H   P05     1       1.790   3.908   0.469   
ATOM     36  C   P05     1       1.921  -0.081  -0.567   
ATOM     37  O   P05     1       2.028  -0.942  -1.440   
ATOM     38  N   P05     1       0.817   0.052   0.175   
ATOM     39  H   P05     1       0.721   0.773   0.875   
ATOM     40  C   P05     1      -0.357  -0.760  -0.033   
ATOM     41  H   P05     1      -0.510  -0.875  -1.108   
ATOM     42  C   P05     1      -0.211  -2.140   0.604   
ATOM     43  H   P05     1      -0.087  -2.050   1.684   
ATOM     44  H   P05     1      -1.085  -2.758   0.401   
ATOM     45  H   P05     1       0.667  -2.632   0.187   
ATOM     46  C   P05     1      -1.528   0.004   0.580   
ATOM     47  O   P05     1      -1.325   0.891   1.412   
ATOM     48  N   P05     1      -2.737  -0.390   0.172   
ATOM     49  H   P05     1      -2.829  -1.103  -0.543   
ATOM     50  C   P05     1      -4.006   0.128   0.657   
ATOM     51  C   P05     1      -4.135   1.620   0.342   
ATOM     52  H   P05     1      -3.329   2.160   0.836   
ATOM     53  H   P05     1      -4.071   1.794  -0.733   
ATOM     54  H   P05     1      -5.085   2.014   0.702   
ATOM     55  C   P05     1      -4.156  -0.137   2.157   
ATOM     56  H   P05     1      -5.103   0.254   2.529   
ATOM     57  H   P05     1      -4.114  -1.206   2.366   
ATOM     58  H   P05     1      -3.348   0.362   2.689   
ATOM     59  C   P05     1      -5.068  -0.661  -0.127   
ATOM     60  O   P05     1      -4.751  -1.501  -0.972   
ATOM     61  N   P05     1      -6.340  -0.376   0.161   
ATOM     62  H   P05     1      -6.592   0.343   0.827   
ATOM     63  C   P05     1      -7.449  -1.000  -0.518   
ATOM     64  H   P05     1      -7.222  -1.042  -1.586   
ATOM     65  C   P05     1      -7.708  -2.415  -0.005   
ATOM     66  H   P05     1      -7.975  -2.394   1.052   
ATOM     67  H   P05     1      -8.517  -2.889  -0.561   
ATOM     68  H   P05     1      -6.805  -3.010  -0.131   
ATOM     69  C   P05     1      -8.660  -0.102  -0.289   
ATOM     70  O   P05     1      -8.656   0.757   0.594   
ATOM     71  N   P05     1      -9.717  -0.330  -1.072   
ATOM     72  H   P05     1      -9.652  -1.019  -1.802   
ATOM     73  C   P05     1     -10.947   0.417  -0.922   
ATOM     74  H   P05     1     -10.780   1.479  -1.104   
ATOM     75  H   P05     1     -11.671   0.042  -1.640   




REMARK Energy(ZPE)= -1716.159420 
REMARK #IF = 0 
ATOM      1  C   P06     1       5.720  -1.957  -1.869   
ATOM      2  H   P06     1       5.428  -1.512  -2.820   
ATOM      3  H   P06     1       6.645  -1.500  -1.526   
ATOM      4  H   P06     1       5.890  -3.020  -2.039   
ATOM      5  C   P06     1       4.591  -1.804  -0.896   
ATOM      6  O   P06     1       3.443  -2.176  -1.155   
ATOM      7  N   P06     1       4.877  -1.222   0.289   
ATOM      8  H   P06     1       5.832  -0.977   0.498   
ATOM      9  C   P06     1       3.897  -1.165   1.351   
ATOM     10  H   P06     1       3.494  -2.167   1.519   
ATOM     11  C   P06     1       4.534  -0.648   2.632   
ATOM     12  H   P06     1       4.946   0.352   2.489   
ATOM     13  H   P06     1       3.787  -0.606   3.422   
ATOM     14  H   P06     1       5.334  -1.316   2.950   
ATOM     15  C   P06     1       2.685  -0.321   0.987   
ATOM     16  O   P06     1       1.607  -0.511   1.553   
ATOM     17  N   P06     1       2.853   0.616   0.043   
ATOM     18  H   P06     1       3.779   0.750  -0.331   
ATOM     19  C   P06     1       1.791   1.509  -0.382   
ATOM     20  C   P06     1       1.373   2.542   0.723   
ATOM     21  H   P06     1       0.686   2.127   1.455   
ATOM     22  C   P06     1       2.301   2.440  -1.519   
ATOM     23  H   P06     1       3.307   2.169  -1.840   
ATOM     24  H   P06     1       1.649   2.380  -2.391   
ATOM     25  C   P06     1       3.186   3.875   0.273   
ATOM     26  H   P06     1       4.156   4.355   0.261   
ATOM     27  C   P06     1       2.679   3.100   1.237   
ATOM     28  H   P06     1       3.152   2.813   2.166   
ATOM     29  C   P06     1       2.218   3.851  -0.884   
ATOM     30  H   P06     1       2.308   4.657  -1.609   
ATOM     31  C   P06     1       0.890   3.717  -0.136   
ATOM     32  H   P06     1       0.050   3.464  -0.781   
ATOM     33  H   P06     1       0.656   4.593   0.470   
ATOM     34  C   P06     1       0.593   0.687  -0.860   
ATOM     35  O   P06     1      -0.552   1.142  -0.824   
ATOM     36  N   P06     1       0.845  -0.531  -1.364   
ATOM     37  H   P06     1       1.781  -0.920  -1.331   
ATOM     38  C   P06     1      -0.232  -1.327  -1.907   
ATOM     39  H   P06     1      -0.749  -0.745  -2.674   
ATOM     40  C   P06     1       0.312  -2.608  -2.517   
ATOM     41  H   P06     1       0.842  -3.202  -1.771   
ATOM     42  H   P06     1      -0.508  -3.198  -2.922   
ATOM     43  H   P06     1       1.003  -2.373  -3.326   
ATOM     44  C   P06     1      -1.319  -1.645  -0.884   
ATOM     45  O   P06     1      -2.457  -1.916  -1.281   
ATOM     46  N   P06     1      -0.980  -1.625   0.412   
ATOM     47  H   P06     1      -0.043  -1.334   0.673   
ATOM     48  C   P06     1      -1.930  -1.898   1.484   
ATOM     49  C   P06     1      -1.229  -1.610   2.812   
ATOM     50  H   P06     1      -0.384  -2.287   2.938   
ATOM     51  H   P06     1      -0.861  -0.584   2.850   
ATOM     52  H   P06     1      -1.928  -1.768   3.632   
ATOM     53  C   P06     1      -2.398  -3.347   1.444   
ATOM     54  H   P06     1      -3.098  -3.532   2.256   
ATOM     55  H   P06     1      -2.889  -3.571   0.499   
ATOM     56  H   P06     1      -1.535  -4.003   1.563   
ATOM     57  C   P06     1      -3.137  -0.950   1.407   
ATOM     58  O   P06     1      -4.212  -1.264   1.913   
ATOM     59  N   P06     1      -2.931   0.254   0.840   
ATOM     60  H   P06     1      -2.043   0.466   0.396   
ATOM     61  C   P06     1      -3.974   1.253   0.803   
ATOM     62  H   P06     1      -4.536   1.183   1.737   
ATOM     63  C   P06     1      -3.372   2.643   0.672   
ATOM     64  H   P06     1      -2.802   2.736  -0.254   
ATOM     65  H   P06     1      -4.166   3.387   0.668   
ATOM     66  H   P06     1      -2.704   2.844   1.510   
ATOM     67  C   P06     1      -5.004   1.024  -0.302   
ATOM     68  O   P06     1      -6.017   1.728  -0.347   
ATOM     69  N   P06     1      -4.742   0.067  -1.194   
ATOM     70  H   P06     1      -3.910  -0.501  -1.085   
ATOM     71  C   P06     1      -5.653  -0.225  -2.274   
ATOM     72  H   P06     1      -6.616  -0.570  -1.895   
ATOM     73  H   P06     1      -5.826   0.663  -2.884   
ATOM     74  H   P06     1      -5.218  -1.003  -2.896   
END 
 
COMPND Ac-L-Ala-RRR-V-L-Ala-Aib-L-Ala-NHMe_ext  
REMARK Energy(ZPE)= -1716.131699 
REMARK #IF = 0 
ATOM      1  C   P06     1       9.535  -2.371  -1.234   
ATOM      2  H   P06     1       9.465  -3.369  -1.667   
ATOM      3  H   P06     1       9.526  -1.633  -2.033   
ATOM      4  H   P06     1      10.484  -2.308  -0.702   
ATOM      5  C   P06     1       8.414  -2.190  -0.249   
ATOM      6  O   P06     1       8.265  -2.948   0.713   
ATOM      7  N   P06     1       7.585  -1.158  -0.476   
ATOM      8  H   P06     1       7.700  -0.555  -1.278   
ATOM      9  C   P06     1       6.462  -0.862   0.375   
ATOM     10  H   P06     1       5.974  -1.804   0.637   
ATOM     11  C   P06     1       6.893  -0.148   1.656   
ATOM     12  H   P06     1       7.353   0.812   1.420   
ATOM     13  H   P06     1       6.042   0.024   2.317   
ATOM     14  H   P06     1       7.618  -0.768   2.181   
ATOM     15  C   P06     1       5.504   0.017  -0.431   
ATOM     16  O   P06     1       5.914   0.626  -1.416   
ATOM     17  N   P06     1       4.261   0.052   0.079   
ATOM     18  H   P06     1       4.122  -0.550   0.877   
ATOM     19  C   P06     1       3.093   0.863  -0.249   
ATOM     20  C   P06     1       2.905   2.004   0.811   
ATOM     21  H   P06     1       2.524   1.659   1.772   
ATOM     22  C   P06     1       3.162   1.670  -1.579   
ATOM     23  H   P06     1       4.044   1.430  -2.160   
ATOM     24  H   P06     1       2.278   1.454  -2.182   
ATOM     25  C   P06     1       4.371   3.380  -0.293   
ATOM     26  H   P06     1       5.246   3.910  -0.644   
ATOM     27  C   P06     1       4.240   2.711   0.856   
ATOM     28  H   P06     1       4.983   2.575   1.630   
ATOM     29  C   P06     1       3.121   3.142  -1.101   
ATOM     30  H   P06     1       2.916   3.852  -1.899   
ATOM     31  C   P06     1       2.081   3.028   0.019   
ATOM     32  H   P06     1       1.116   2.661  -0.336   
ATOM     33  H   P06     1       1.943   3.955   0.574   
ATOM     34  C   P06     1       1.936  -0.145  -0.369   
ATOM     35  O   P06     1       2.050  -1.121  -1.108   
ATOM     36  N   P06     1       0.823   0.097   0.333   
ATOM     37  H   P06     1       0.725   0.901   0.936   
ATOM     38  C   P06     1      -0.352  -0.732   0.216   
ATOM     39  H   P06     1      -0.481  -0.994  -0.836   
ATOM     40  C   P06     1      -0.230  -2.014   1.038   
ATOM     41  H   P06     1      -0.124  -1.780   2.098   
ATOM     42  H   P06     1      -1.107  -2.646   0.905   
ATOM     43  H   P06     1       0.649  -2.566   0.708   
ATOM     44  C   P06     1      -1.533   0.112   0.688   
ATOM     45  O   P06     1      -1.347   1.113   1.383   
ATOM     46  N   P06     1      -2.733  -0.340   0.314   
ATOM     47  H   P06     1      -2.808  -1.161  -0.276   
ATOM     48  C   P06     1      -4.014   0.243   0.679   
ATOM     49  C   P06     1      -4.125   1.672   0.142   
ATOM     50  H   P06     1      -3.323   2.274   0.566   
ATOM     51  H   P06     1      -4.042   1.684  -0.945   
ATOM     52  H   P06     1      -5.077   2.123   0.424   
ATOM     53  C   P06     1      -4.211   0.204   2.196   
ATOM     54  H   P06     1      -5.173   0.636   2.474   
ATOM     55  H   P06     1      -4.169  -0.821   2.564   
ATOM     56  H   P06     1      -3.423   0.785   2.672   
ATOM     57  C   P06     1      -5.054  -0.664  -0.003   
ATOM     58  O   P06     1      -4.713  -1.653  -0.655   
ATOM     59  N   P06     1      -6.333  -0.319   0.160   
ATOM     60  H   P06     1      -6.609   0.520   0.653   
ATOM     61  C   P06     1      -7.414  -1.069  -0.433   
ATOM     62  H   P06     1      -7.128  -1.335  -1.454   
ATOM     63  C   P06     1      -7.713  -2.346   0.350   
ATOM     64  H   P06     1      -8.034  -2.106   1.365   
ATOM     65  H   P06     1      -8.496  -2.928  -0.136   
ATOM     66  H   P06     1      -6.811  -2.954   0.399   
ATOM     67  C   P06     1      -8.624  -0.144  -0.466   
ATOM     68  O   P06     1      -8.651   0.892   0.200   
ATOM     69  N   P06     1      -9.648  -0.545  -1.224   
ATOM     70  H   P06     1      -9.554  -1.382  -1.774   
ATOM     71  C   P06     1     -10.877   0.212  -1.305   
ATOM     72  H   P06     1     -10.702   1.194  -1.745   
ATOM     73  H   P06     1     -11.582  -0.335  -1.925   




REMARK Energy(ZPE)= -1963.151409 
REMARK #IF = 0 
ATOM      1  C   P07     1       6.589  -0.356   1.572   
ATOM      2  H   P07     1       6.165  -0.628   2.538   
ATOM      3  H   P07     1       7.207  -1.172   1.206   
ATOM      4  H   P07     1       7.212   0.526   1.721   
ATOM      5  C   P07     1       5.473   0.004   0.639   
ATOM      6  O   P07     1       4.641   0.873   0.915   
ATOM      7  N   P07     1       5.397  -0.678  -0.524   
ATOM      8  H   P07     1       6.120  -1.343  -0.752   
ATOM      9  C   P07     1       4.455  -0.299  -1.555   
ATOM     10  H   P07     1       4.552   0.773  -1.746   
ATOM     11  C   P07     1       4.725  -1.076  -2.833   
ATOM     12  H   P07     1       4.636  -2.151  -2.666   
ATOM     13  H   P07     1       4.009  -0.783  -3.599   
ATOM     14  H   P07     1       5.728  -0.859  -3.199   
ATOM     15  C   P07     1       3.006  -0.475  -1.120   
ATOM     16  O   P07     1       2.116   0.184  -1.660   
ATOM     17  N   P07     1       2.765  -1.355  -0.140   
ATOM     18  H   P07     1       3.547  -1.872   0.236   
ATOM     19  C   P07     1       1.440  -1.602   0.406   
ATOM     20  C   P07     1       0.557  -2.349  -0.607   
ATOM     21  H   P07     1       0.165  -1.631  -1.330   
ATOM     22  H   P07     1       1.210  -3.032  -1.161   
ATOM     23  C   P07     1      -0.548  -3.095   0.058   
ATOM     24  C   P07     1      -0.643  -3.268   1.409   
ATOM     25  C   P07     1       0.329  -2.750   2.402   
ATOM     26  H   P07     1      -0.067  -1.852   2.888   
ATOM     27  H   P07     1       0.517  -3.478   3.193   
ATOM     28  C   P07     1       1.637  -2.438   1.685   
ATOM     29  H   P07     1       2.320  -1.911   2.354   
ATOM     30  H   P07     1       2.118  -3.375   1.389   
ATOM     31  N   P07     1      -1.788  -3.962   1.711   
ATOM     32  H   P07     1      -2.075  -4.236   2.635   
ATOM     33  C   P07     1      -2.453  -4.259   0.549   
ATOM     34  C   P07     1      -3.646  -4.947   0.342   
ATOM     35  H   P07     1      -4.213  -5.352   1.171   
ATOM     36  C   P07     1      -4.083  -5.092  -0.965   
ATOM     37  H   P07     1      -5.008  -5.621  -1.159   
ATOM     38  C   P07     1      -3.350  -4.565  -2.041   
ATOM     39  H   P07     1      -3.723  -4.696  -3.050   
ATOM     40  C   P07     1      -2.163  -3.884  -1.831   
ATOM     41  H   P07     1      -1.605  -3.482  -2.668   
ATOM     42  C   P07     1      -1.696  -3.722  -0.521   
ATOM     43  C   P07     1       0.798  -0.267   0.808   
ATOM     44  O   P07     1      -0.423  -0.109   0.771   
ATOM     45  N   P07     1       1.619   0.692   1.267   
ATOM     46  H   P07     1       2.627   0.583   1.212   
ATOM     47  C   P07     1       1.078   1.930   1.780   
ATOM     48  H   P07     1       0.362   1.700   2.572   
ATOM     49  C   P07     1       2.193   2.802   2.337   
ATOM     50  H   P07     1       2.933   3.026   1.568   
ATOM     51  H   P07     1       1.775   3.734   2.712   
ATOM     52  H   P07     1       2.693   2.290   3.159   
ATOM     53  C   P07     1       0.261   2.707   0.754   
ATOM     54  O   P07     1      -0.577   3.524   1.151   
ATOM     55  N   P07     1       0.492   2.473  -0.542   
ATOM     56  H   P07     1       1.146   1.740  -0.803   
ATOM     57  C   P07     1      -0.257   3.131  -1.607   
ATOM     58  C   P07     1       0.110   2.450  -2.925   
ATOM     59  H   P07     1       1.173   2.588  -3.130   
ATOM     60  H   P07     1      -0.099   1.381  -2.890   
ATOM     61  H   P07     1      -0.461   2.899  -3.737   
ATOM     62  C   P07     1       0.081   4.614  -1.673   
ATOM     63  H   P07     1      -0.481   5.087  -2.477   
ATOM     64  H   P07     1      -0.163   5.111  -0.736   
ATOM     65  H   P07     1       1.147   4.727  -1.871   
ATOM     66  C   P07     1      -1.770   2.938  -1.413   
ATOM     67  O   P07     1      -2.568   3.752  -1.873   
ATOM     68  N   P07     1      -2.166   1.805  -0.803   
ATOM     69  H   P07     1      -1.481   1.178  -0.390   
ATOM     70  C   P07     1      -3.565   1.479  -0.659   
ATOM     71  H   P07     1      -4.083   1.861  -1.542   
ATOM     72  C   P07     1      -3.755  -0.027  -0.572   
ATOM     73  H   P07     1      -3.199  -0.444   0.270   
ATOM     74  H   P07     1      -4.811  -0.255  -0.441   
ATOM     75  H   P07     1      -3.402  -0.502  -1.487   
ATOM     76  C   P07     1      -4.247   2.167   0.523   
ATOM     77  O   P07     1      -5.463   2.027   0.688   
ATOM     78  N   P07     1      -3.486   2.897   1.342   
ATOM     79  H   P07     1      -2.496   3.009   1.152   
ATOM     80  C   P07     1      -4.060   3.591   2.469   
ATOM     81  H   P07     1      -4.809   4.314   2.143   
ATOM     82  H   P07     1      -4.541   2.890   3.153   
ATOM     83  H   P07     1      -3.267   4.114   2.996   
END 
 
COMPND Ac-L-Ala-RSS-IV-L-Ala-Aib-L-Ala-NHMe_310L  
REMARK Energy(ZPE)= -1717.360697 
REMARK #IF = 0 
ATOM      1  C   P12     1       5.660  -2.146   1.897   
ATOM      2  H   P12     1       5.339  -1.725   2.849   
ATOM      3  H   P12     1       5.743  -3.226   2.024   
ATOM      4  H   P12     1       6.636  -1.743   1.635   
ATOM      5  C   P12     1       4.607  -1.869   0.867   
ATOM      6  O   P12     1       3.425  -2.182   1.042   
ATOM      7  N   P12     1       5.002  -1.242  -0.259   
ATOM      8  H   P12     1       5.983  -1.056  -0.388   
ATOM      9  C   P12     1       4.122  -1.070  -1.403   
ATOM     10  H   P12     1       4.659  -0.419  -2.098   
ATOM     11  C   P12     1       3.802  -2.381  -2.100   
ATOM     12  H   P12     1       3.278  -3.055  -1.425   
ATOM     13  H   P12     1       3.172  -2.198  -2.968   
ATOM     14  H   P12     1       4.728  -2.851  -2.429   
ATOM     15  C   P12     1       2.853  -0.305  -1.030   
ATOM     16  O   P12     1       1.788  -0.515  -1.610   
ATOM     17  N   P12     1       2.982   0.633  -0.076   
ATOM     18  H   P12     1       3.891   0.761   0.340   
ATOM     19  C   P12     1       1.898   1.508   0.336   
ATOM     20  C   P12     1       1.428   2.496  -0.769   
ATOM     21  H   P12     1       0.691   2.056  -1.438   
ATOM     22  C   P12     1       2.400   2.475   1.452   
ATOM     23  H   P12     1       3.406   2.215   1.785   
ATOM     24  H   P12     1       1.743   2.424   2.322   
ATOM     25  C   P12     1       3.325   3.922  -0.356   
ATOM     26  H   P12     1       4.302   3.535  -0.058   
ATOM     27  H   P12     1       3.473   4.952  -0.683   
ATOM     28  C   P12     1       2.663   3.069  -1.466   
ATOM     29  H   P12     1       2.336   3.695  -2.298   
ATOM     30  H   P12     1       3.325   2.307  -1.874   
ATOM     31  C   P12     1       2.310   3.850   0.793   
ATOM     32  H   P12     1       2.383   4.670   1.508   
ATOM     33  C   P12     1       0.982   3.713   0.050   
ATOM     34  H   P12     1       0.752   4.569  -0.588   
ATOM     35  H   P12     1       0.139   3.506   0.707   
ATOM     36  C   P12     1       0.719   0.678   0.851   
ATOM     37  O   P12     1      -0.426   1.139   0.863   
ATOM     38  N   P12     1       0.996  -0.551   1.307   
ATOM     39  H   P12     1       1.938  -0.919   1.224   
ATOM     40  C   P12     1      -0.030  -1.429   1.827   
ATOM     41  H   P12     1       0.440  -2.411   1.921   
ATOM     42  C   P12     1      -0.538  -0.998   3.193   
ATOM     43  H   P12     1      -0.987  -0.007   3.138   
ATOM     44  H   P12     1      -1.286  -1.701   3.552   
ATOM     45  H   P12     1       0.294  -0.974   3.897   
ATOM     46  C   P12     1      -1.180  -1.620   0.837   
ATOM     47  O   P12     1      -2.313  -1.895   1.240   
ATOM     48  N   P12     1      -0.886  -1.515  -0.467   
ATOM     49  H   P12     1       0.052  -1.244  -0.745   
ATOM     50  C   P12     1      -1.885  -1.688  -1.514   
ATOM     51  C   P12     1      -2.327  -3.141  -1.614   
ATOM     52  H   P12     1      -1.464  -3.761  -1.860   
ATOM     53  H   P12     1      -2.755  -3.482  -0.673   
ATOM     54  H   P12     1      -3.077  -3.247  -2.396   
ATOM     55  C   P12     1      -1.256  -1.232  -2.830   
ATOM     56  H   P12     1      -1.984  -1.324  -3.635   
ATOM     57  H   P12     1      -0.923  -0.195  -2.770   
ATOM     58  H   P12     1      -0.395  -1.859  -3.066   
ATOM     59  C   P12     1      -3.105  -0.784  -1.260   
ATOM     60  O   P12     1      -4.220  -1.105  -1.665   
ATOM     61  N   P12     1      -2.861   0.388  -0.647   
ATOM     62  H   P12     1      -1.938   0.567  -0.266   
ATOM     63  C   P12     1      -3.897   1.368  -0.395   
ATOM     64  H   P12     1      -3.418   2.152   0.197   
ATOM     65  C   P12     1      -4.440   2.000  -1.667   
ATOM     66  H   P12     1      -4.904   1.248  -2.303   
ATOM     67  H   P12     1      -5.183   2.754  -1.416   
ATOM     68  H   P12     1      -3.625   2.474  -2.214   
ATOM     69  C   P12     1      -5.022   0.838   0.500   
ATOM     70  O   P12     1      -6.125   1.391   0.507   
ATOM     71  N   P12     1      -4.720  -0.173   1.319   
ATOM     72  H   P12     1      -3.832  -0.654   1.231   
ATOM     73  C   P12     1      -5.703  -0.709   2.230   
ATOM     74  H   P12     1      -6.092   0.075   2.881   
ATOM     75  H   P12     1      -6.544  -1.153   1.694   





REMARK Energy(ZPE)= -1717.366358 
REMARK #IF = 0 
ATOM      1  C   P12     1       5.620  -1.975  -1.963   
ATOM      2  H   P12     1       5.368  -1.391  -2.847   
ATOM      3  H   P12     1       6.576  -1.639  -1.567   
ATOM      4  H   P12     1       5.707  -3.018  -2.268   
ATOM      5  C   P12     1       4.501  -1.863  -0.972   
ATOM      6  O   P12     1       3.337  -2.154  -1.259   
ATOM      7  N   P12     1       4.813  -1.408   0.259   
ATOM      8  H   P12     1       5.778  -1.229   0.487   
ATOM      9  C   P12     1       3.839  -1.421   1.330   
ATOM     10  H   P12     1       3.400  -2.420   1.398   
ATOM     11  C   P12     1       4.503  -1.062   2.651   
ATOM     12  H   P12     1       4.951  -0.069   2.607   
ATOM     13  H   P12     1       3.762  -1.074   3.448   
ATOM     14  H   P12     1       5.278  -1.789   2.891   
ATOM     15  C   P12     1       2.656  -0.500   1.069   
ATOM     16  O   P12     1       1.582  -0.702   1.640   
ATOM     17  N   P12     1       2.843   0.518   0.219   
ATOM     18  H   P12     1       3.742   0.607  -0.227   
ATOM     19  C   P12     1       1.790   1.459  -0.107   
ATOM     20  C   P12     1       2.278   2.521  -1.133   
ATOM     21  H   P12     1       2.304   2.142  -2.155   
ATOM     22  C   P12     1       1.355   2.339   1.097   
ATOM     23  H   P12     1       1.894   2.049   1.999   
ATOM     24  H   P12     1       0.287   2.216   1.272   
ATOM     25  C   P12     1       3.196   3.942   0.594   
ATOM     26  H   P12     1       3.673   3.569   1.502   
ATOM     27  H   P12     1       3.466   4.994   0.490   
ATOM     28  C   P12     1       3.603   3.137  -0.662   
ATOM     29  H   P12     1       3.968   3.796  -1.451   
ATOM     30  H   P12     1       4.403   2.422  -0.469   
ATOM     31  C   P12     1       1.674   3.764   0.638   
ATOM     32  H   P12     1       1.153   4.529   1.214   
ATOM     33  C   P12     1       1.319   3.680  -0.848   
ATOM     34  H   P12     1       1.589   4.575  -1.412   
ATOM     35  H   P12     1       0.273   3.435  -1.026   
ATOM     36  C   P12     1       0.595   0.710  -0.710   
ATOM     37  O   P12     1      -0.541   1.189  -0.677   
ATOM     38  N   P12     1       0.831  -0.469  -1.310   
ATOM     39  H   P12     1       1.754  -0.894  -1.297   
ATOM     40  C   P12     1      -0.256  -1.188  -1.934   
ATOM     41  H   P12     1      -0.746  -0.532  -2.657   
ATOM     42  C   P12     1       0.263  -2.430  -2.640   
ATOM     43  H   P12     1       0.768  -3.095  -1.940   
ATOM     44  H   P12     1      -0.568  -2.962  -3.100   
ATOM     45  H   P12     1       0.970  -2.148  -3.421   
ATOM     46  C   P12     1      -1.363  -1.561  -0.954   
ATOM     47  O   P12     1      -2.498  -1.790  -1.385   
ATOM     48  N   P12     1      -1.048  -1.633   0.346   
ATOM     49  H   P12     1      -0.110  -1.378   0.640   
ATOM     50  C   P12     1      -2.023  -1.961   1.380   
ATOM     51  C   P12     1      -1.349  -1.769   2.738   
ATOM     52  H   P12     1      -0.520  -2.470   2.843   
ATOM     53  H   P12     1      -0.960  -0.756   2.848   
ATOM     54  H   P12     1      -2.070  -1.963   3.531   
ATOM     55  C   P12     1      -2.508  -3.398   1.235   
ATOM     56  H   P12     1      -3.225  -3.627   2.022   
ATOM     57  H   P12     1      -2.984  -3.551   0.269   
ATOM     58  H   P12     1      -1.655  -4.072   1.325   
ATOM     59  C   P12     1      -3.219  -0.996   1.337   
ATOM     60  O   P12     1      -4.309  -1.332   1.795   
ATOM     61  N   P12     1      -2.992   0.241   0.855   
ATOM     62  H   P12     1      -2.092   0.476   0.447   
ATOM     63  C   P12     1      -4.033   1.242   0.851   
ATOM     64  H   P12     1      -4.617   1.120   1.765   
ATOM     65  C   P12     1      -3.428   2.637   0.813   
ATOM     66  H   P12     1      -2.813   2.771  -0.077   
ATOM     67  H   P12     1      -4.224   3.379   0.802   
ATOM     68  H   P12     1      -2.806   2.800   1.693   
ATOM     69  C   P12     1      -5.039   1.077  -0.288   
ATOM     70  O   P12     1      -6.052   1.783  -0.311   
ATOM     71  N   P12     1      -4.759   0.176  -1.231   
ATOM     72  H   P12     1      -3.931  -0.402  -1.142   
ATOM     73  C   P12     1      -5.652  -0.048  -2.342   
ATOM     74  H   P12     1      -6.623  -0.411  -2.001   
ATOM     75  H   P12     1      -5.811   0.874  -2.902   
ATOM     76  H   P12     1      -5.208  -0.791  -3.000   
END 
 
COMPND Ac-L-Ala-SSS-V-L-Ala-Aib-L-Ala-NHMe_310L  
REMARK Energy(ZPE)= -1716.153965 
REMARK #IF = 0 
ATOM      1  C   P13     1       5.718  -2.002   1.912   
ATOM      2  H   P13     1       5.399  -1.556   2.853   
ATOM      3  H   P13     1       5.822  -3.075   2.073   
ATOM      4  H   P13     1       6.683  -1.591   1.625   
ATOM      5  C   P13     1       4.649  -1.777   0.886   
ATOM      6  O   P13     1       3.473  -2.095   1.088   
ATOM      7  N   P13     1       5.025  -1.190  -0.269   
ATOM      8  H   P13     1       6.003  -1.002  -0.417   
ATOM      9  C   P13     1       4.127  -1.062  -1.405   
ATOM     10  H   P13     1       4.649  -0.434  -2.130   
ATOM     11  C   P13     1       3.802  -2.399  -2.049   
ATOM     12  H   P13     1       3.296  -3.051  -1.338   
ATOM     13  H   P13     1       3.154  -2.251  -2.910   
ATOM     14  H   P13     1       4.724  -2.876  -2.378   
ATOM     15  C   P13     1       2.860  -0.292  -1.037   
ATOM     16  O   P13     1       1.787  -0.528  -1.590   
ATOM     17  N   P13     1       3.000   0.673  -0.113   
ATOM     18  H   P13     1       3.924   0.842   0.254   
ATOM     19  C   P13     1       1.924   1.562   0.288   
ATOM     20  C   P13     1       1.464   2.531  -0.860   
ATOM     21  H   P13     1       0.769   2.070  -1.556   
ATOM     22  C   P13     1       2.437   2.561   1.364   
ATOM     23  H   P13     1       3.453   2.324   1.681   
ATOM     24  H   P13     1       1.801   2.536   2.250   
ATOM     25  C   P13     1       3.263   3.914  -0.518   
ATOM     26  H   P13     1       4.225   4.409  -0.551   
ATOM     27  C   P13     1       2.750   3.083  -1.430   
ATOM     28  H   P13     1       3.211   2.755  -2.353   
ATOM     29  C   P13     1       2.319   3.935   0.658   
ATOM     30  H   P13     1       2.411   4.779   1.339   
ATOM     31  C   P13     1       0.979   3.741  -0.054   
ATOM     32  H   P13     1       0.719   4.580  -0.700   
ATOM     33  H   P13     1       0.157   3.508   0.621   
ATOM     34  C   P13     1       0.744   0.747   0.823   
ATOM     35  O   P13     1      -0.404   1.202   0.814   
ATOM     36  N   P13     1       1.024  -0.467   1.316   
ATOM     37  H   P13     1       1.969  -0.830   1.249   
ATOM     38  C   P13     1       0.002  -1.335   1.862   
ATOM     39  H   P13     1       0.480  -2.310   1.989   
ATOM     40  C   P13     1      -0.511  -0.863   3.212   
ATOM     41  H   P13     1      -0.978   0.117   3.123   
ATOM     42  H   P13     1      -1.244  -1.566   3.601   
ATOM     43  H   P13     1       0.322  -0.798   3.912   
ATOM     44  C   P13     1      -1.144  -1.570   0.877   
ATOM     45  O   P13     1      -2.273  -1.849   1.289   
ATOM     46  N   P13     1      -0.852  -1.496  -0.429   
ATOM     47  H   P13     1       0.083  -1.220  -0.715   
ATOM     48  C   P13     1      -1.850  -1.709  -1.470   
ATOM     49  C   P13     1      -2.272  -3.171  -1.532   
ATOM     50  H   P13     1      -1.400  -3.785  -1.756   
ATOM     51  H   P13     1      -2.701  -3.491  -0.584   
ATOM     52  H   P13     1      -3.016  -3.309  -2.315   
ATOM     53  C   P13     1      -1.228  -1.281  -2.799   
ATOM     54  H   P13     1      -1.961  -1.389  -3.598   
ATOM     55  H   P13     1      -0.894  -0.243  -2.762   
ATOM     56  H   P13     1      -0.369  -1.912  -3.028   
ATOM     57  C   P13     1      -3.080  -0.814  -1.239   
ATOM     58  O   P13     1      -4.191  -1.157  -1.638   
ATOM     59  N   P13     1      -2.850   0.375  -0.655   
ATOM     60  H   P13     1      -1.928   0.574  -0.280   
ATOM     61  C   P13     1      -3.898   1.348  -0.426   
ATOM     62  H   P13     1      -3.429   2.151   0.149   
ATOM     63  C   P13     1      -4.446   1.945  -1.713   
ATOM     64  H   P13     1      -4.898   1.173  -2.334   
ATOM     65  H   P13     1      -5.201   2.693  -1.479   
ATOM     66  H   P13     1      -3.637   2.419  -2.268   
ATOM     67  C   P13     1      -5.019   0.825   0.478   
ATOM     68  O   P13     1      -6.128   1.365   0.472   
ATOM     69  N   P13     1      -4.707  -0.167   1.318   
ATOM     70  H   P13     1      -3.813  -0.639   1.241   
ATOM     71  C   P13     1      -5.686  -0.698   2.236   
ATOM     72  H   P13     1      -6.522  -1.157   1.705   
ATOM     73  H   P13     1      -5.207  -1.450   2.857   
ATOM     74  H   P13     1      -6.082   0.091   2.876   
END 
 
COMPND Ac-L-Ala-SSS-V-L-Ala-Aib-L-Ala-NHMe_310R  
REMARK Energy(ZPE)= -1716.161003 
REMARK #IF = 0 
ATOM      1  C   P13     1      -5.640  -1.901   1.945   
ATOM      2  H   P13     1      -5.398  -1.284   2.810   
ATOM      3  H   P13     1      -6.601  -1.591   1.540   
ATOM      4  H   P13     1      -5.711  -2.934   2.284   
ATOM      5  C   P13     1      -4.522  -1.800   0.952   
ATOM      6  O   P13     1      -3.359  -2.094   1.240   
ATOM      7  N   P13     1      -4.833  -1.352  -0.282   
ATOM      8  H   P13     1      -5.798  -1.173  -0.512   
ATOM      9  C   P13     1      -3.856  -1.363  -1.349   
ATOM     10  H   P13     1      -3.424  -2.364  -1.426   
ATOM     11  C   P13     1      -4.509  -0.983  -2.668   
ATOM     12  H   P13     1      -4.949   0.014  -2.615   
ATOM     13  H   P13     1      -3.765  -0.992  -3.462   
ATOM     14  H   P13     1      -5.290  -1.700  -2.921   
ATOM     15  C   P13     1      -2.668  -0.455  -1.065   
ATOM     16  O   P13     1      -1.581  -0.673  -1.606   
ATOM     17  N   P13     1      -2.861   0.568  -0.224   
ATOM     18  H   P13     1      -3.789   0.721   0.142   
ATOM     19  C   P13     1      -1.811   1.512   0.099   
ATOM     20  C   P13     1      -2.330   2.571   1.145   
ATOM     21  H   P13     1      -2.381   2.184   2.161   
ATOM     22  C   P13     1      -1.400   2.406  -1.095   
ATOM     23  H   P13     1      -1.927   2.109  -2.001   
ATOM     24  H   P13     1      -0.328   2.330  -1.270   
ATOM     25  C   P13     1      -3.273   3.878  -0.488   
ATOM     26  H   P13     1      -3.943   4.356  -1.190   
ATOM     27  C   P13     1      -3.611   3.131   0.568   
ATOM     28  H   P13     1      -4.609   2.882   0.905   
ATOM     29  C   P13     1      -1.771   3.833  -0.616   
ATOM     30  H   P13     1      -1.315   4.627  -1.204   
ATOM     31  C   P13     1      -1.370   3.730   0.860   
ATOM     32  H   P13     1      -0.321   3.473   1.002   
ATOM     33  H   P13     1      -1.629   4.618   1.437   
ATOM     34  C   P13     1      -0.614   0.771   0.701   
ATOM     35  O   P13     1       0.522   1.249   0.660   
ATOM     36  N   P13     1      -0.854  -0.397   1.321   
ATOM     37  H   P13     1      -1.777  -0.822   1.306   
ATOM     38  C   P13     1       0.229  -1.110   1.956   
ATOM     39  H   P13     1       0.726  -0.442   2.663   
ATOM     40  C   P13     1      -0.297  -2.331   2.693   
ATOM     41  H   P13     1      -0.811  -3.008   2.010   
ATOM     42  H   P13     1       0.531  -2.860   3.161   
ATOM     43  H   P13     1      -0.998  -2.026   3.470   
ATOM     44  C   P13     1       1.332  -1.516   0.983   
ATOM     45  O   P13     1       2.464  -1.747   1.419   
ATOM     46  N   P13     1       1.014  -1.611  -0.315   
ATOM     47  H   P13     1       0.076  -1.353  -0.612   
ATOM     48  C   P13     1       1.983  -1.979  -1.341   
ATOM     49  C   P13     1       1.311  -1.817  -2.704   
ATOM     50  H   P13     1       0.472  -2.509  -2.788   
ATOM     51  H   P13     1       0.938  -0.802  -2.845   
ATOM     52  H   P13     1       2.030  -2.045  -3.490   
ATOM     53  C   P13     1       2.452  -3.417  -1.158   
ATOM     54  H   P13     1       3.169  -3.672  -1.936   
ATOM     55  H   P13     1       2.924  -3.551  -0.187   
ATOM     56  H   P13     1       1.593  -4.084  -1.234   
ATOM     57  C   P13     1       3.189  -1.026  -1.323   
ATOM     58  O   P13     1       4.275  -1.385  -1.776   
ATOM     59  N   P13     1       2.975   0.223  -0.871   
ATOM     60  H   P13     1       2.078   0.474  -0.469   
ATOM     61  C   P13     1       4.024   1.215  -0.889   
ATOM     62  H   P13     1       4.601   1.074  -1.806   
ATOM     63  C   P13     1       3.430   2.615  -0.868   
ATOM     64  H   P13     1       2.822   2.767   0.025   
ATOM     65  H   P13     1       4.231   3.351  -0.875   
ATOM     66  H   P13     1       2.803   2.770  -1.746   
ATOM     67  C   P13     1       5.037   1.060   0.244   
ATOM     68  O   P13     1       6.060   1.751   0.243   
ATOM     69  N   P13     1       4.753   0.184   1.210   
ATOM     70  H   P13     1       3.917  -0.386   1.142   
ATOM     71  C   P13     1       5.653  -0.026   2.317   
ATOM     72  H   P13     1       6.615  -0.411   1.975   
ATOM     73  H   P13     1       5.832   0.907   2.852   




REMARK Energy(ZPE)= -1562.672596 
REMARK #IF = 0 
ATOM      1  C   P15     1      -6.045  -0.765   1.967   
ATOM      2  H   P15     1      -5.728  -0.195   2.840   
ATOM      3  H   P15     1      -6.951  -0.325   1.558   
ATOM      4  H   P15     1      -6.259  -1.782   2.295   
ATOM      5  C   P15     1      -4.915  -0.810   0.983   
ATOM      6  O   P15     1      -3.791  -1.216   1.290   
ATOM      7  N   P15     1      -5.171  -0.370  -0.268   
ATOM      8  H   P15     1      -6.110  -0.096  -0.511   
ATOM      9  C   P15     1      -4.197  -0.522  -1.326   
ATOM     10  H   P15     1      -3.876  -1.566  -1.369   
ATOM     11  C   P15     1      -4.800  -0.116  -2.662   
ATOM     12  H   P15     1      -5.127   0.924  -2.646   
ATOM     13  H   P15     1      -4.059  -0.234  -3.450   
ATOM     14  H   P15     1      -5.654  -0.751  -2.897   
ATOM     15  C   P15     1      -2.918   0.260  -1.062   
ATOM     16  O   P15     1      -1.855  -0.107  -1.566   
ATOM     17  N   P15     1      -3.014   1.340  -0.274   
ATOM     18  H   P15     1      -3.923   1.576   0.095   
ATOM     19  C   P15     1      -1.880   2.190   0.061   
ATOM     20  C   P15     1      -2.328   3.148   1.165   
ATOM     21  H   P15     1      -3.127   3.792   0.795   
ATOM     22  H   P15     1      -2.687   2.603   2.039   
ATOM     23  H   P15     1      -1.493   3.779   1.465   
ATOM     24  C   P15     1      -1.397   2.968  -1.156   
ATOM     25  H   P15     1      -0.555   3.601  -0.881   
ATOM     26  H   P15     1      -1.082   2.291  -1.948   
ATOM     27  H   P15     1      -2.209   3.595  -1.522   
ATOM     28  C   P15     1      -0.738   1.339   0.633   
ATOM     29  O   P15     1       0.435   1.704   0.531   
ATOM     30  N   P15     1      -1.083   0.230   1.307   
ATOM     31  H   P15     1      -2.048  -0.083   1.313   
ATOM     32  C   P15     1      -0.080  -0.572   1.966   
ATOM     33  H   P15     1       0.519   0.077   2.609   
ATOM     34  C   P15     1      -0.734  -1.658   2.806   
ATOM     35  H   P15     1      -1.346  -2.315   2.188   
ATOM     36  H   P15     1       0.035  -2.252   3.298   
ATOM     37  H   P15     1      -1.369  -1.210   3.569   
ATOM     38  C   P15     1       0.933  -1.182   1.005   
ATOM     39  O   P15     1       2.025  -1.559   1.446   
ATOM     40  N   P15     1       0.595  -1.274  -0.286   
ATOM     41  H   P15     1      -0.305  -0.911  -0.590   
ATOM     42  C   P15     1       1.502  -1.798  -1.302   
ATOM     43  C   P15     1       0.863  -1.561  -2.670   
ATOM     44  H   P15     1      -0.064  -2.131  -2.748   
ATOM     45  H   P15     1       0.633  -0.507  -2.823   
ATOM     46  H   P15     1       1.544  -1.896  -3.450   
ATOM     47  C   P15     1       1.757  -3.286  -1.095   
ATOM     48  H   P15     1       2.433  -3.654  -1.864   
ATOM     49  H   P15     1       2.200  -3.471  -0.118   
ATOM     50  H   P15     1       0.810  -3.822  -1.166   
ATOM     51  C   P15     1       2.832  -1.029  -1.290   
ATOM     52  O   P15     1       3.862  -1.552  -1.711   
ATOM     53  N   P15     1       2.790   0.254  -0.884   
ATOM     54  H   P15     1       1.929   0.640  -0.509   
ATOM     55  C   P15     1       3.965   1.092  -0.916   
ATOM     56  H   P15     1       4.530   0.841  -1.816   
ATOM     57  C   P15     1       3.567   2.559  -0.957   
ATOM     58  H   P15     1       2.966   2.825  -0.086   
ATOM     59  H   P15     1       4.460   3.180  -0.968   
ATOM     60  H   P15     1       2.985   2.765  -1.855   
ATOM     61  C   P15     1       4.934   0.845   0.240   
ATOM     62  O   P15     1       6.037   1.400   0.234   
ATOM     63  N   P15     1       4.530   0.046   1.229   
ATOM     64  H   P15     1       3.631  -0.420   1.169   
ATOM     65  C   P15     1       5.386  -0.242   2.354   
ATOM     66  H   P15     1       6.280  -0.785   2.042   
ATOM     67  H   P15     1       5.703   0.680   2.843   





REMARK Energy(ZPE)= -1869.719615 
REMARK #IF = 0 
ATOM      1  C   P16     1       4.576  -3.704  -1.802   
ATOM      2  H   P16     1       4.284  -3.410  -2.809   
ATOM      3  H   P16     1       5.603  -3.396  -1.619   
ATOM      4  H   P16     1       4.515  -4.790  -1.743   
ATOM      5  C   P16     1       3.603  -3.120  -0.825   
ATOM      6  O   P16     1       2.384  -3.274  -0.939   
ATOM      7  N   P16     1       4.112  -2.398   0.196   
ATOM      8  H   P16     1       5.112  -2.332   0.301   
ATOM      9  C   P16     1       3.271  -1.936   1.278   
ATOM     10  H   P16     1       2.694  -2.779   1.665   
ATOM     11  C   P16     1       4.120  -1.342   2.391   
ATOM     12  H   P16     1       4.710  -0.500   2.027   
ATOM     13  H   P16     1       3.477  -0.990   3.195   
ATOM     14  H   P16     1       4.792  -2.100   2.794   
ATOM     15  C   P16     1       2.217  -0.936   0.819   
ATOM     16  O   P16     1       1.183  -0.787   1.472   
ATOM     17  N   P16     1       2.471  -0.252  -0.305   
ATOM     18  H   P16     1       3.363  -0.395  -0.754   
ATOM     19  C   P16     1       1.559   0.728  -0.858   
ATOM     20  C   P16     1       2.173   1.349  -2.148   
ATOM     21  H   P16     1       3.091   0.839  -2.442   
ATOM     22  H   P16     1       1.472   1.276  -2.981   
ATOM     23  C   P16     1       2.384   2.830  -1.771   
ATOM     24  H   P16     1       2.588   3.470  -2.627   
ATOM     25  C   P16     1       1.087   3.081  -0.993   
ATOM     26  H   P16     1       0.188   2.890  -1.578   
ATOM     27  H   P16     1       1.042   4.074  -0.543   
ATOM     28  C   P16     1       1.362   1.989   0.055   
ATOM     29  H   P16     1       0.629   1.836   0.843   
ATOM     30  C   P16     1       2.747   2.381   0.486   
ATOM     31  C   P16     1       3.390   2.884  -0.651   
ATOM     32  C   P16     1       4.716   3.277  -0.598   
ATOM     33  H   P16     1       5.224   3.662  -1.474   
ATOM     34  C   P16     1       5.386   3.181   0.624   
ATOM     35  H   P16     1       6.418   3.501   0.695   
ATOM     36  C   P16     1       4.743   2.685   1.754   
ATOM     37  H   P16     1       5.282   2.625   2.692   
ATOM     38  C   P16     1       3.412   2.266   1.692   
ATOM     39  H   P16     1       2.916   1.869   2.570   
ATOM     40  C   P16     1       0.206   0.078  -1.154   
ATOM     41  O   P16     1      -0.824   0.754  -1.203   
ATOM     42  N   P16     1       0.183  -1.245  -1.377   
ATOM     43  H   P16     1       1.023  -1.809  -1.287   
ATOM     44  C   P16     1      -1.070  -1.898  -1.678   
ATOM     45  H   P16     1      -1.528  -1.408  -2.541   
ATOM     46  C   P16     1      -0.843  -3.369  -1.987   
ATOM     47  H   P16     1      -0.379  -3.879  -1.142   
ATOM     48  H   P16     1      -1.794  -3.848  -2.210   
ATOM     49  H   P16     1      -0.190  -3.474  -2.853   
ATOM     50  C   P16     1      -2.104  -1.746  -0.567   
ATOM     51  O   P16     1      -3.303  -1.842  -0.845   
ATOM     52  N   P16     1      -1.656  -1.529   0.677   
ATOM     53  H   P16     1      -0.658  -1.407   0.831   
ATOM     54  C   P16     1      -2.541  -1.383   1.828   
ATOM     55  C   P16     1      -1.686  -0.977   3.029   
ATOM     56  H   P16     1      -0.976  -1.770   3.263   
ATOM     57  H   P16     1      -1.129  -0.062   2.828   
ATOM     58  H   P16     1      -2.330  -0.820   3.893   
ATOM     59  C   P16     1      -3.271  -2.686   2.126   
ATOM     60  H   P16     1      -3.918  -2.557   2.992   
ATOM     61  H   P16     1      -3.878  -2.997   1.278   
ATOM     62  H   P16     1      -2.538  -3.463   2.345   
ATOM     63  C   P16     1      -3.553  -0.249   1.604   
ATOM     64  O   P16     1      -4.621  -0.234   2.211   
ATOM     65  N   P16     1      -3.173   0.751   0.787   
ATOM     66  H   P16     1      -2.302   0.682   0.272   
ATOM     67  C   P16     1      -4.012   1.908   0.580   
ATOM     68  H   P16     1      -4.469   2.166   1.538   
ATOM     69  C   P16     1      -3.183   3.080   0.076   
ATOM     70  H   P16     1      -2.712   2.842  -0.878   
ATOM     71  H   P16     1      -3.824   3.949  -0.058   
ATOM     72  H   P16     1      -2.402   3.325   0.796   
ATOM     73  C   P16     1      -5.184   1.654  -0.366   
ATOM     74  O   P16     1      -6.059   2.515  -0.495   
ATOM     75  N   P16     1      -5.195   0.501  -1.038   
ATOM     76  H   P16     1      -4.471  -0.187  -0.866   
ATOM     77  C   P16     1      -6.265   0.179  -1.950   
ATOM     78  H   P16     1      -7.224   0.135  -1.431   
ATOM     79  H   P16     1      -6.342   0.929  -2.739   





REMARK Energy(ZPE)= -1752.081494 
REMARK #IF = 0 
ATOM      1  C   P17     1       4.129  -3.551  -0.805   
ATOM      2  H   P17     1       4.155  -3.228  -1.845   
ATOM      3  H   P17     1       5.130  -3.489  -0.383   
ATOM      4  H   P17     1       3.798  -4.589  -0.788   
ATOM      5  C   P17     1       3.128  -2.721  -0.065   
ATOM      6  O   P17     1       1.956  -2.613  -0.445   
ATOM      7  N   P17     1       3.550  -2.072   1.036   
ATOM      8  H   P17     1       4.491  -2.213   1.367   
ATOM      9  C   P17     1       2.607  -1.365   1.877   
ATOM     10  H   P17     1       1.806  -2.048   2.165   
ATOM     11  C   P17     1       3.299  -0.827   3.119   
ATOM     12  H   P17     1       4.098  -0.132   2.857   
ATOM     13  H   P17     1       2.578  -0.305   3.745   
ATOM     14  H   P17     1       3.722  -1.648   3.697   
ATOM     15  C   P17     1       1.911  -0.240   1.125   
ATOM     16  O   P17     1       0.756   0.082   1.397   
ATOM     17  N   P17     1       2.625   0.403   0.184   
ATOM     18  H   P17     1       3.584   0.135   0.026   
ATOM     19  C   P17     1       2.054   1.512  -0.548   
ATOM     20  C   P17     1       3.066   2.116  -1.551   
ATOM     21  H   P17     1       4.013   1.578  -1.567   
ATOM     22  H   P17     1       2.661   2.127  -2.562   
ATOM     23  C   P17     1       3.187   3.562  -1.012   
ATOM     24  H   P17     1       3.528   4.298  -1.733   
ATOM     25  O   P17     1       1.834   3.805  -0.627   
ATOM     26  C   P17     1       1.753   2.766   0.341   
ATOM     27  H   P17     1       0.785   2.748   0.826   
ATOM     28  C   P17     1       2.992   2.998   1.171   
ATOM     29  H   P17     1       3.122   2.713   2.205   
ATOM     30  C   P17     1       3.890   3.497   0.322   
ATOM     31  H   P17     1       4.933   3.719   0.492   
ATOM     32  C   P17     1       0.772   1.046  -1.254   
ATOM     33  O   P17     1      -0.232   1.746  -1.324   
ATOM     34  N   P17     1       0.850  -0.165  -1.838   
ATOM     35  H   P17     1       1.640  -0.763  -1.637   
ATOM     36  C   P17     1      -0.283  -0.722  -2.539   
ATOM     37  H   P17     1      -0.738   0.070  -3.134   
ATOM     38  C   P17     1       0.163  -1.869  -3.434   
ATOM     39  H   P17     1       0.643  -2.652  -2.845   
ATOM     40  H   P17     1      -0.695  -2.297  -3.951   
ATOM     41  H   P17     1       0.870  -1.506  -4.179   
ATOM     42  C   P17     1      -1.382  -1.185  -1.585   
ATOM     43  O   P17     1      -2.572  -0.996  -1.856   
ATOM     44  N   P17     1      -0.979  -1.813  -0.474   
ATOM     45  H   P17     1       0.016  -1.942  -0.318   
ATOM     46  C   P17     1      -1.915  -2.382   0.490   
ATOM     47  C   P17     1      -1.116  -2.821   1.715   
ATOM     48  H   P17     1      -0.396  -3.591   1.432   
ATOM     49  H   P17     1      -0.582  -1.977   2.151   
ATOM     50  H   P17     1      -1.789  -3.240   2.462   
ATOM     51  C   P17     1      -2.664  -3.565  -0.105   
ATOM     52  H   P17     1      -3.359  -3.971   0.627   
ATOM     53  H   P17     1      -3.225  -3.266  -0.988   
ATOM     54  H   P17     1      -1.946  -4.339  -0.381   
ATOM     55  C   P17     1      -2.905  -1.301   0.954   
ATOM     56  O   P17     1      -4.067  -1.573   1.243   
ATOM     57  N   P17     1      -2.395  -0.063   1.090   
ATOM     58  H   P17     1      -1.411   0.085   0.901   
ATOM     59  C   P17     1      -3.167   1.022   1.649   
ATOM     60  H   P17     1      -3.792   0.616   2.448   
ATOM     61  C   P17     1      -2.238   2.085   2.213   
ATOM     62  H   P17     1      -1.588   2.481   1.431   
ATOM     63  H   P17     1      -2.826   2.904   2.622   
ATOM     64  H   P17     1      -1.617   1.664   3.003   
ATOM     65  C   P17     1      -4.147   1.659   0.665   
ATOM     66  O   P17     1      -4.931   2.523   1.068   
ATOM     67  N   P17     1      -4.102   1.258  -0.606   
ATOM     68  H   P17     1      -3.479   0.506  -0.877   
ATOM     69  C   P17     1      -5.005   1.802  -1.592   
ATOM     70  H   P17     1      -6.044   1.601  -1.326   
ATOM     71  H   P17     1      -4.879   2.882  -1.678   





REMARK Energy(ZPE)= -1794.699892 
REMARK #IF = 0 
ATOM      1  C   P18     1      -5.205  -2.869   1.895   
ATOM      2  H   P18     1      -5.023  -2.364   2.842   
ATOM      3  H   P18     1      -6.184  -2.583   1.516   
ATOM      4  H   P18     1      -5.197  -3.943   2.085   
ATOM      5  C   P18     1      -4.088  -2.546   0.950   
ATOM      6  O   P18     1      -2.907  -2.764   1.232   
ATOM      7  N   P18     1      -4.423  -1.986  -0.232   
ATOM      8  H   P18     1      -5.398  -1.863  -0.457   
ATOM      9  C   P18     1      -3.443  -1.792  -1.278   
ATOM     10  H   P18     1      -2.871  -2.716  -1.396   
ATOM     11  C   P18     1      -4.130  -1.449  -2.589   
ATOM     12  H   P18     1      -4.743  -0.552  -2.490   
ATOM     13  H   P18     1      -3.383  -1.276  -3.362   
ATOM     14  H   P18     1      -4.766  -2.275  -2.905   
ATOM     15  C   P18     1      -2.385  -0.752  -0.925   
ATOM     16  O   P18     1      -1.311  -0.743  -1.531   
ATOM     17  N   P18     1      -2.667   0.106   0.062   
ATOM     18  H   P18     1      -3.583   0.060   0.480   
ATOM     19  C   P18     1      -1.713   1.072   0.578   
ATOM     20  C   P18     1      -1.415   2.258  -0.401   
ATOM     21  H   P18     1      -0.684   2.003  -1.167   
ATOM     22  C   P18     1      -2.327   1.814   1.801   
ATOM     23  H   P18     1      -3.300   1.401   2.074   
ATOM     24  H   P18     1      -1.678   1.730   2.674   
ATOM     25  C   P18     1      -3.369   3.333   0.152   
ATOM     26  C   P18     1      -4.748   3.873   0.275   
ATOM     27  H   P18     1      -4.734   4.926   0.569   
ATOM     28  H   P18     1      -5.308   3.340   1.050   
ATOM     29  H   P18     1      -5.306   3.789  -0.658   
ATOM     30  C   P18     1      -2.768   2.735  -0.890   
ATOM     31  C   P18     1      -3.272   2.472  -2.264   
ATOM     32  H   P18     1      -3.204   1.412  -2.519   
ATOM     33  H   P18     1      -2.667   3.004  -3.005   
ATOM     34  H   P18     1      -4.308   2.786  -2.389   
ATOM     35  C   P18     1      -2.399   3.279   1.315   
ATOM     36  H   P18     1      -2.587   3.990   2.118   
ATOM     37  C   P18     1      -1.061   3.376   0.584   
ATOM     38  H   P18     1      -0.199   3.147   1.210   
ATOM     39  H   P18     1      -0.923   4.332   0.078   
ATOM     40  C   P18     1      -0.420   0.353   0.976   
ATOM     41  O   P18     1       0.667   0.934   0.947   
ATOM     42  N   P18     1      -0.514  -0.920   1.393   
ATOM     43  H   P18     1      -1.400  -1.417   1.377   
ATOM     44  C   P18     1       0.667  -1.617   1.849   
ATOM     45  H   P18     1       1.129  -1.043   2.656   
ATOM     46  C   P18     1       0.305  -3.004   2.353   
ATOM     47  H   P18     1      -0.156  -3.600   1.565   
ATOM     48  H   P18     1       1.203  -3.512   2.700   
ATOM     49  H   P18     1      -0.396  -2.930   3.185   
ATOM     50  C   P18     1       1.754  -1.713   0.784   
ATOM     51  O   P18     1       2.928  -1.872   1.136   
ATOM     52  N   P18     1       1.379  -1.638  -0.499   
ATOM     53  H   P18     1       0.407  -1.435  -0.718   
ATOM     54  C   P18     1       2.323  -1.716  -1.607   
ATOM     55  C   P18     1       1.562  -1.403  -2.895   
ATOM     56  H   P18     1       0.774  -2.142  -3.048   
ATOM     57  H   P18     1       1.103  -0.415  -2.854   
ATOM     58  H   P18     1       2.248  -1.443  -3.739   
ATOM     59  C   P18     1       2.949  -3.102  -1.694   
ATOM     60  H   P18     1       3.665  -3.130  -2.514   
ATOM     61  H   P18     1       3.464  -3.354  -0.769   
ATOM     62  H   P18     1       2.165  -3.836  -1.880   
ATOM     63  C   P18     1       3.419  -0.647  -1.474   
ATOM     64  O   P18     1       4.510  -0.799  -2.020   
ATOM     65  N   P18     1       3.093   0.480  -0.814   
ATOM     66  H   P18     1       2.198   0.553  -0.338   
ATOM     67  C   P18     1       4.016   1.586  -0.718   
ATOM     68  H   P18     1       4.567   1.641  -1.659   
ATOM     69  C   P18     1       3.263   2.889  -0.490   
ATOM     70  H   P18     1       2.687   2.849   0.435   
ATOM     71  H   P18     1       3.971   3.712  -0.426   
ATOM     72  H   P18     1       2.577   3.075  -1.317   
ATOM     73  C   P18     1       5.084   1.404   0.359   
ATOM     74  O   P18     1       6.002   2.224   0.450   
ATOM     75  N   P18     1       4.962   0.357   1.176   
ATOM     76  H   P18     1       4.207  -0.304   1.036   
ATOM     77  C   P18     1       5.929   0.106   2.218   
ATOM     78  H   P18     1       6.918  -0.089   1.799   
ATOM     79  H   P18     1       6.008   0.965   2.885   





REMARK Energy(ZPE)= -1869.718581 
REMARK #IF = 0 
ATOM      1  C   P19     1       5.851   1.400   2.200   
ATOM      2  H   P19     1       5.535   0.674   2.948   
ATOM      3  H   P19     1       6.766   1.055   1.724   
ATOM      4  H   P19     1       6.051   2.341   2.714   
ATOM      5  C   P19     1       4.730   1.618   1.231   
ATOM      6  O   P19     1       3.587   1.903   1.599   
ATOM      7  N   P19     1       5.014   1.474  -0.081   
ATOM      8  H   P19     1       5.966   1.297  -0.362   
ATOM      9  C   P19     1       4.048   1.830  -1.098   
ATOM     10  H   P19     1       3.686   2.844  -0.907   
ATOM     11  C   P19     1       4.684   1.766  -2.478   
ATOM     12  H   P19     1       5.054   0.762  -2.694   
ATOM     13  H   P19     1       3.948   2.035  -3.233   
ATOM     14  H   P19     1       5.514   2.469  -2.542   
ATOM     15  C   P19     1       2.798   0.964  -1.052   
ATOM     16  O   P19     1       1.740   1.379  -1.529   
ATOM     17  N   P19     1       2.908  -0.246  -0.489   
ATOM     18  H   P19     1       3.805  -0.516  -0.112   
ATOM     19  C   P19     1       1.784  -1.159  -0.370   
ATOM     20  C   P19     1       1.346  -1.723  -1.748   
ATOM     21  H   P19     1       1.904  -1.219  -2.537   
ATOM     22  H   P19     1       0.282  -1.575  -1.919   
ATOM     23  C   P19     1       1.729  -3.220  -1.669   
ATOM     24  H   P19     1       1.812  -3.706  -2.639   
ATOM     25  C   P19     1       2.999  -3.147  -0.809   
ATOM     26  H   P19     1       3.796  -2.559  -1.268   
ATOM     27  H   P19     1       3.385  -4.127  -0.525   
ATOM     28  C   P19     1       2.299  -2.440   0.367   
ATOM     29  H   P19     1       2.886  -2.209   1.255   
ATOM     30  C   P19     1       1.133  -3.368   0.574   
ATOM     31  C   P19     1       0.784  -3.858  -0.688   
ATOM     32  C   P19     1       0.432  -3.739   1.706   
ATOM     33  H   P19     1       0.700  -3.356   2.684   
ATOM     34  C   P19     1      -0.283  -4.723  -0.840   
ATOM     35  H   P19     1      -0.565  -5.103  -1.816   
ATOM     36  C   P19     1      -0.630  -4.632   1.559   
ATOM     37  H   P19     1      -1.185  -4.955   2.432   
ATOM     38  C   P19     1      -0.985  -5.115   0.303   
ATOM     39  H   P19     1      -1.811  -5.809   0.212   
ATOM     40  C   P19     1       0.636  -0.489   0.386   
ATOM     41  O   P19     1      -0.532  -0.839   0.208   
ATOM     42  N   P19     1       0.957   0.461   1.279   
ATOM     43  H   P19     1       1.912   0.795   1.371   
ATOM     44  C   P19     1      -0.077   1.096   2.063   
ATOM     45  H   P19     1      -0.640   0.327   2.597   
ATOM     46  C   P19     1       0.536   2.064   3.064   
ATOM     47  H   P19     1       1.116   2.835   2.556   
ATOM     48  H   P19     1      -0.253   2.537   3.645   
ATOM     49  H   P19     1       1.196   1.528   3.746   
ATOM     50  C   P19     1      -1.127   1.808   1.217   
ATOM     51  O   P19     1      -2.248   2.009   1.698   
ATOM     52  N   P19     1      -0.788   2.192  -0.020   
ATOM     53  H   P19     1       0.128   1.948  -0.385   
ATOM     54  C   P19     1      -1.723   2.855  -0.922   
ATOM     55  C   P19     1      -1.060   2.949  -2.296   
ATOM     56  H   P19     1      -0.163   3.567  -2.233   
ATOM     57  H   P19     1      -0.776   1.964  -2.669   
ATOM     58  H   P19     1      -1.751   3.411  -3.000   
ATOM     59  C   P19     1      -2.075   4.249  -0.419   
ATOM     60  H   P19     1      -2.764   4.727  -1.113   
ATOM     61  H   P19     1      -2.541   4.203   0.562   
ATOM     62  H   P19     1      -1.164   4.845  -0.355   
ATOM     63  C   P19     1      -3.001   2.019  -1.102   
ATOM     64  O   P19     1      -4.057   2.556  -1.430   
ATOM     65  N   P19     1      -2.878   0.685  -0.970   
ATOM     66  H   P19     1      -2.002   0.282  -0.652   
ATOM     67  C   P19     1      -3.992  -0.203  -1.204   
ATOM     68  H   P19     1      -4.590   0.223  -2.013   
ATOM     69  C   P19     1      -3.495  -1.582  -1.611   
ATOM     70  H   P19     1      -2.863  -2.014  -0.835   
ATOM     71  H   P19     1      -4.345  -2.241  -1.776   
ATOM     72  H   P19     1      -2.916  -1.515  -2.532   
ATOM     73  C   P19     1      -4.952  -0.322  -0.021   
ATOM     74  O   P19     1      -5.996  -0.970  -0.153   
ATOM     75  N   P19     1      -4.611   0.276   1.121   
ATOM     76  H   P19     1      -3.759   0.823   1.176   
ATOM     77  C   P19     1      -5.467   0.208   2.281   
ATOM     78  H   P19     1      -6.433   0.677   2.086   
ATOM     79  H   P19     1      -5.646  -0.829   2.570   





REMARK Energy(ZPE)= -1752.084225 
REMARK #IF = 0 
ATOM      1  C   P20     1       5.716  -1.576  -2.025   
ATOM      2  H   P20     1       5.444  -0.910  -2.843   
ATOM      3  H   P20     1       6.667  -1.259  -1.604   
ATOM      4  H   P20     1       5.823  -2.579  -2.436   
ATOM      5  C   P20     1       4.602  -1.588  -1.023   
ATOM      6  O   P20     1       3.445  -1.890  -1.329   
ATOM      7  N   P20     1       4.906  -1.232   0.243   
ATOM      8  H   P20     1       5.867  -1.047   0.486   
ATOM      9  C   P20     1       3.932  -1.355   1.305   
ATOM     10  H   P20     1       3.535  -2.373   1.312   
ATOM     11  C   P20     1       4.570  -1.043   2.649   
ATOM     12  H   P20     1       4.975  -0.030   2.667   
ATOM     13  H   P20     1       3.827  -1.134   3.439   
ATOM     14  H   P20     1       5.376  -1.748   2.854   
ATOM     15  C   P20     1       2.714  -0.471   1.077   
ATOM     16  O   P20     1       1.628  -0.766   1.578   
ATOM     17  N   P20     1       2.886   0.624   0.324   
ATOM     18  H   P20     1       3.816   0.845  -0.001   
ATOM     19  C   P20     1       1.807   1.549   0.047   
ATOM     20  C   P20     1       1.432   2.390   1.287   
ATOM     21  H   P20     1       1.936   1.995   2.167   
ATOM     22  H   P20     1       0.359   2.413   1.459   
ATOM     23  C   P20     1       1.998   3.777   0.885   
ATOM     24  H   P20     1       2.298   4.422   1.704   
ATOM     25  O   P20     1       3.129   3.405   0.086   
ATOM     26  C   P20     1       2.396   2.672  -0.883   
ATOM     27  H   P20     1       3.038   2.297  -1.676   
ATOM     28  C   P20     1       1.289   3.623  -1.257   
ATOM     29  H   P20     1       0.761   3.630  -2.198   
ATOM     30  C   P20     1       1.056   4.333  -0.155   
ATOM     31  H   P20     1       0.282   5.063   0.028   
ATOM     32  C   P20     1       0.627   0.828  -0.596   
ATOM     33  O   P20     1      -0.520   1.266  -0.490   
ATOM     34  N   P20     1       0.900  -0.268  -1.322   
ATOM     35  H   P20     1       1.837  -0.662  -1.346   
ATOM     36  C   P20     1      -0.165  -0.960  -2.011   
ATOM     37  H   P20     1      -0.693  -0.246  -2.648   
ATOM     38  C   P20     1       0.397  -2.087  -2.863   
ATOM     39  H   P20     1       0.944  -2.804  -2.250   
ATOM     40  H   P20     1      -0.416  -2.602  -3.370   
ATOM     41  H   P20     1       1.077  -1.686  -3.614   
ATOM     42  C   P20     1      -1.239  -1.491  -1.070   
ATOM     43  O   P20     1      -2.369  -1.722  -1.513   
ATOM     44  N   P20     1      -0.906  -1.687   0.211   
ATOM     45  H   P20     1       0.024  -1.427   0.526   
ATOM     46  C   P20     1      -1.859  -2.166   1.205   
ATOM     47  C   P20     1      -1.194  -2.063   2.578   
ATOM     48  H   P20     1      -0.314  -2.706   2.612   
ATOM     49  H   P20     1      -0.880  -1.041   2.790   
ATOM     50  H   P20     1      -1.895  -2.388   3.346   
ATOM     51  C   P20     1      -2.264  -3.607   0.926   
ATOM     52  H   P20     1      -2.984  -3.938   1.673   
ATOM     53  H   P20     1      -2.716  -3.698  -0.060   
ATOM     54  H   P20     1      -1.380  -4.243   0.976   
ATOM     55  C   P20     1      -3.104  -1.265   1.243   
ATOM     56  O   P20     1      -4.184  -1.707   1.630   
ATOM     57  N   P20     1      -2.927   0.030   0.921   
ATOM     58  H   P20     1      -2.033   0.349   0.560   
ATOM     59  C   P20     1      -4.007   0.984   1.018   
ATOM     60  H   P20     1      -4.614   0.709   1.884   
ATOM     61  C   P20     1      -3.456   2.389   1.206   
ATOM     62  H   P20     1      -2.817   2.673   0.369   
ATOM     63  H   P20     1      -4.280   3.097   1.272   
ATOM     64  H   P20     1      -2.870   2.443   2.123   
ATOM     65  C   P20     1      -4.971   0.954  -0.167   
ATOM     66  O   P20     1      -5.991   1.651  -0.137   
ATOM     67  N   P20     1      -4.658   0.173  -1.202   
ATOM     68  H   P20     1      -3.828  -0.408  -1.167   
ATOM     69  C   P20     1      -5.521   0.083  -2.356   
ATOM     70  H   P20     1      -6.501  -0.314  -2.083   
ATOM     71  H   P20     1      -5.667   1.064  -2.808   





REMARK Energy(ZPE)= -1716.159907 
REMARK #IF = 0 
ATOM      1  C   P21     1      -5.743  -1.569   2.047   
ATOM      2  H   P21     1      -5.459  -0.940   2.891   
ATOM      3  H   P21     1      -6.684  -1.214   1.633   
ATOM      4  H   P21     1      -5.878  -2.583   2.421   
ATOM      5  C   P21     1      -4.624  -1.575   1.051   
ATOM      6  O   P21     1      -3.473  -1.896   1.358   
ATOM      7  N   P21     1      -4.919  -1.195  -0.210   
ATOM      8  H   P21     1      -5.877  -0.991  -0.451   
ATOM      9  C   P21     1      -3.951  -1.326  -1.278   
ATOM     10  H   P21     1      -3.553  -2.343  -1.275   
ATOM     11  C   P21     1      -4.603  -1.034  -2.621   
ATOM     12  H   P21     1      -5.013  -0.024  -2.646   
ATOM     13  H   P21     1      -3.865  -1.131  -3.415   
ATOM     14  H   P21     1      -5.407  -1.746  -2.810   
ATOM     15  C   P21     1      -2.730  -0.437  -1.081   
ATOM     16  O   P21     1      -1.663  -0.725  -1.628   
ATOM     17  N   P21     1      -2.879   0.647  -0.309   
ATOM     18  H   P21     1      -3.783   0.814   0.107   
ATOM     19  C   P21     1      -1.790   1.567  -0.024   
ATOM     20  C   P21     1      -1.355   2.375  -1.273   
ATOM     21  H   P21     1      -0.284   2.292  -1.443   
ATOM     22  H   P21     1      -1.884   2.002  -2.150   
ATOM     23  C   P21     1      -1.789   3.826  -0.930   
ATOM     24  H   P21     1      -1.863   4.478  -1.798   
ATOM     25  C   P21     1      -3.074   3.557  -0.143   
ATOM     26  H   P21     1      -3.830   3.022  -0.721   
ATOM     27  H   P21     1      -3.507   4.457   0.292   
ATOM     28  C   P21     1      -2.363   2.696   0.911   
ATOM     29  H   P21     1      -2.952   2.296   1.736   
ATOM     30  C   P21     1      -1.219   3.607   1.281   
ATOM     31  H   P21     1      -0.710   3.597   2.235   
ATOM     32  C   P21     1      -0.882   4.287   0.183   
ATOM     33  H   P21     1      -0.039   4.953   0.061   
ATOM     34  C   P21     1      -0.627   0.821   0.627   
ATOM     35  O   P21     1       0.529   1.241   0.540   
ATOM     36  N   P21     1      -0.911  -0.295   1.322   
ATOM     37  H   P21     1      -1.852  -0.676   1.347   
ATOM     38  C   P21     1       0.151  -1.016   1.985   
ATOM     39  H   P21     1       0.693  -0.325   2.635   
ATOM     40  C   P21     1      -0.413  -2.159   2.813   
ATOM     41  H   P21     1      -0.967  -2.860   2.188   
ATOM     42  H   P21     1       0.401  -2.690   3.303   
ATOM     43  H   P21     1      -1.085  -1.772   3.578   
ATOM     44  C   P21     1       1.213  -1.534   1.022   
ATOM     45  O   P21     1       2.340  -1.802   1.454   
ATOM     46  N   P21     1       0.876  -1.675  -0.266   
ATOM     47  H   P21     1      -0.050  -1.388  -0.570   
ATOM     48  C   P21     1       1.824  -2.124  -1.279   
ATOM     49  C   P21     1       1.170  -1.940  -2.648   
ATOM     50  H   P21     1       0.276  -2.561  -2.716   
ATOM     51  H   P21     1       0.880  -0.902  -2.811   
ATOM     52  H   P21     1       1.868  -2.244  -3.427   
ATOM     53  C   P21     1       2.200  -3.584  -1.067   
ATOM     54  H   P21     1       2.920  -3.893  -1.823   
ATOM     55  H   P21     1       2.640  -3.732  -0.082   
ATOM     56  H   P21     1       1.304  -4.199  -1.155   
ATOM     57  C   P21     1       3.086  -1.246  -1.267   
ATOM     58  O   P21     1       4.164  -1.691  -1.656   
ATOM     59  N   P21     1       2.925   0.041  -0.905   
ATOM     60  H   P21     1       2.032   0.360  -0.540   
ATOM     61  C   P21     1       4.017   0.984  -0.966   
ATOM     62  H   P21     1       4.626   0.729  -1.836   
ATOM     63  C   P21     1       3.486   2.402  -1.113   
ATOM     64  H   P21     1       2.842   2.666  -0.273   
ATOM     65  H   P21     1       4.318   3.101  -1.150   
ATOM     66  H   P21     1       2.909   2.492  -2.034   
ATOM     67  C   P21     1       4.973   0.904   0.224   
ATOM     68  O   P21     1       6.003   1.584   0.223   
ATOM     69  N   P21     1       4.635   0.099   1.233   
ATOM     70  H   P21     1       3.797  -0.468   1.166   
ATOM     71  C   P21     1       5.484  -0.044   2.391   
ATOM     72  H   P21     1       6.450  -0.474   2.121   
ATOM     73  H   P21     1       5.662   0.923   2.861   





REMARK Energy(ZPE)= -1794.702106 
REMARK #IF = 0 
ATOM      1  C   P22     1      -5.809  -1.557   2.039   
ATOM      2  H   P22     1      -5.538  -0.870   2.839   
ATOM      3  H   P22     1      -6.726  -1.217   1.564   
ATOM      4  H   P22     1      -5.984  -2.535   2.488   
ATOM      5  C   P22     1      -4.659  -1.672   1.087   
ATOM      6  O   P22     1      -3.517  -1.947   1.466   
ATOM      7  N   P22     1      -4.914  -1.447  -0.220   
ATOM      8  H   P22     1      -5.863  -1.278  -0.512   
ATOM      9  C   P22     1      -3.914  -1.707  -1.233   
ATOM     10  H   P22     1      -3.511  -2.711  -1.083   
ATOM     11  C   P22     1      -4.526  -1.602  -2.621   
ATOM     12  H   P22     1      -4.939  -0.607  -2.794   
ATOM     13  H   P22     1      -3.763  -1.797  -3.373   
ATOM     14  H   P22     1      -5.319  -2.340  -2.739   
ATOM     15  C   P22     1      -2.703  -0.791  -1.117   
ATOM     16  O   P22     1      -1.624  -1.132  -1.606   
ATOM     17  N   P22     1      -2.870   0.371  -0.475   
ATOM     18  H   P22     1      -3.780   0.573  -0.086   
ATOM     19  C   P22     1      -1.784   1.314  -0.258   
ATOM     20  C   P22     1      -1.332   2.004  -1.567   
ATOM     21  H   P22     1      -0.258   1.904  -1.717   
ATOM     22  H   P22     1      -1.849   1.554  -2.415   
ATOM     23  C   P22     1      -1.760   3.478  -1.351   
ATOM     24  H   P22     1      -1.812   4.059  -2.271   
ATOM     25  C   P22     1      -3.057   3.290  -0.566   
ATOM     26  H   P22     1      -3.813   2.713  -1.103   
ATOM     27  H   P22     1      -3.486   4.229  -0.215   
ATOM     28  C   P22     1      -2.361   2.523   0.565   
ATOM     29  H   P22     1      -2.961   2.198   1.416   
ATOM     30  C   P22     1      -1.216   3.458   0.883   
ATOM     31  C   P22     1      -0.854   4.034  -0.274   
ATOM     32  C   P22     1      -0.631   0.625   0.472   
ATOM     33  O   P22     1       0.532   1.012   0.344   
ATOM     34  C   P22     1      -0.601   3.550   2.234   
ATOM     35  H   P22     1       0.221   4.265   2.256   
ATOM     36  H   P22     1      -0.210   2.581   2.557   
ATOM     37  H   P22     1      -1.339   3.858   2.981   
ATOM     38  C   P22     1       0.303   4.915  -0.574   
ATOM     39  H   P22     1       1.003   4.410  -1.248   
ATOM     40  H   P22     1       0.851   5.196   0.326   
ATOM     41  H   P22     1      -0.016   5.830  -1.081   
ATOM     42  N   P22     1      -0.936  -0.397   1.292   
ATOM     43  H   P22     1      -1.881  -0.768   1.346   
ATOM     44  C   P22     1       0.110  -1.047   2.046   
ATOM     45  H   P22     1       0.631  -0.300   2.650   
ATOM     46  C   P22     1      -0.477  -2.117   2.953   
ATOM     47  H   P22     1      -1.018  -2.866   2.373   
ATOM     48  H   P22     1       0.322  -2.606   3.507   
ATOM     49  H   P22     1      -1.168  -1.666   3.665   
ATOM     50  C   P22     1       1.202  -1.645   1.167   
ATOM     51  O   P22     1       2.328  -1.821   1.645   
ATOM     52  N   P22     1       0.890  -1.972  -0.094   
ATOM     53  H   P22     1      -0.032  -1.742  -0.453   
ATOM     54  C   P22     1       1.855  -2.556  -1.018   
ATOM     55  C   P22     1       1.205  -2.608  -2.401   
ATOM     56  H   P22     1       0.321  -3.246  -2.371   
ATOM     57  H   P22     1       0.903  -1.615  -2.736   
ATOM     58  H   P22     1       1.912  -3.025  -3.117   
ATOM     59  C   P22     1       2.253  -3.958  -0.577   
ATOM     60  H   P22     1       2.966  -4.380  -1.284   
ATOM     61  H   P22     1       2.708  -3.942   0.411   
ATOM     62  H   P22     1       1.364  -4.589  -0.551   
ATOM     63  C   P22     1       3.101  -1.665  -1.146   
ATOM     64  O   P22     1       4.180  -2.144  -1.489   
ATOM     65  N   P22     1       2.925  -0.345  -0.951   
ATOM     66  H   P22     1       2.032   0.004  -0.615   
ATOM     67  C   P22     1       4.005   0.594  -1.132   
ATOM     68  H   P22     1       4.624   0.230  -1.955   
ATOM     69  C   P22     1       3.460   1.972  -1.476   
ATOM     70  H   P22     1       2.807   2.342  -0.684   
ATOM     71  H   P22     1       4.286   2.670  -1.601   
ATOM     72  H   P22     1       2.889   1.930  -2.404   
ATOM     73  C   P22     1       4.953   0.692   0.063   
ATOM     74  O   P22     1       5.968   1.389  -0.025   
ATOM     75  N   P22     1       4.633   0.016   1.168   
ATOM     76  H   P22     1       3.802  -0.564   1.190   
ATOM     77  C   P22     1       5.482   0.057   2.335   
ATOM     78  H   P22     1       6.493  -0.273   2.091   
ATOM     79  H   P22     1       5.543   1.068   2.740   
ATOM     80  H   P22     1       5.065  -0.603   3.092   
END 
ANNEX 6.A. Additional information about QM 
calculations  
Cartesian coordinates (pdb format) and energies 
(a.u.) of all structures optimized at MPW1B95/6-
31+G(d,p) level with the CPCM solvent model. 
P310 = right-handed 310-helix; M310 = left-handed 
310-helix. Vibrational analysis has been conducted at 
standard conditions (T = 298.15 K, P = 1 atm) 
COMPND Ac-Aib2-(R)-II-Aib2-NHMe-P310 
REMARK Energy(ZPE)= -1910.167821 
REMARK #IF = 0 
ATOM  1 C P01 1  6.2027  1.7476 -0.1735 
ATOM  2 H P01 1  5.7937  2.5883  0.3843 
ATOM  3 H P01 1  7.0755  1.3573  0.3456 
ATOM  4 H P01 1  6.5098  2.1159 -1.1529 
ATOM  5 C P01 1  5.1246  0.7239 -0.3682 
ATOM  6 O P01 1  4.0034  1.0290 -0.7836 
ATOM  7 N P01 1  5.4323 -0.5515 -0.0529 
ATOM  8 H P01 1  6.3789 -0.7592  0.2244 
ATOM  9 C P01 1  4.5592 -1.6802 -0.3582 
ATOM 10 C P01 1  5.1534 -2.9218  0.3069 
ATOM 11 H P01 1  6.1315 -3.1398 -0.1248 
ATOM 12 H P01 1  5.2654 -2.7827  1.3828 
ATOM 13 H P01 1  4.5062 -3.7798  0.1309 
ATOM 14 C P01 1  4.4389 -1.8873 -1.8620 
ATOM 15 H P01 1  3.7867 -2.7328 -2.0719 
ATOM 16 H P01 1  4.0259 -1.0019 -2.3422 
ATOM 17 H P01 1  5.4277 -2.0903 -2.2734 
ATOM 18 C P01 1  3.1703 -1.4534  0.2526 
ATOM 19 O P01 1  2.1569 -1.8923 -0.2908 
ATOM 20 N P01 1  3.1324 -0.8113  1.4309 
ATOM 21 H P01 1  4.0020 -0.4798  1.8208 
ATOM 22 C P01 1  1.9128 -0.6315  2.2056 
ATOM 23 C P01 1  2.2195  0.3477  3.3382 
ATOM 24 H P01 1  2.9728 -0.0791  4.0024 
ATOM 25 H P01 1  2.5859  1.2994  2.9511 
ATOM 26 H P01 1  1.3169  0.5302  3.9196 
ATOM 27 C P01 1  1.4251 -1.9608  2.7682 
ATOM 28 H P01 1  0.5178 -1.8102  3.3501 
ATOM 29 H P01 1  1.2118 -2.6647  1.9654 
ATOM 30 H P01 1  2.1983 -2.3778  3.4136 
ATOM 31 C P01 1  0.8147  0.0034  1.3434 
ATOM 32 O P01 1 -0.3728 -0.1977  1.6027 
ATOM 33 N P01 1  1.2049  0.8269  0.3588 
ATOM 34 H P01 1  2.1939  0.9059  0.1381 
ATOM 35 C P01 1  0.2596  1.5100 -0.5036 
ATOM 36 C P01 1  0.9862  2.1042 -1.7335 
ATOM 37 H P01 1  1.1432  1.3653 -2.5194 
ATOM 38 H P01 1  1.9651  2.4540 -1.4016 
ATOM 39 C P01 1  0.1309  3.2981 -2.1587 
ATOM 40 H P01 1  0.7124  4.0661 -2.6693 
ATOM 41 H P01 1 -0.6683  2.9841 -2.8364 
ATOM 42 C P01 1 -0.3774  2.7461  0.0982 
ATOM 43 C P01 1 -0.8434  2.9433  1.3900 
ATOM 44 H P01 1 -0.7861  2.1507  2.1251 
ATOM 45 C P01 1 -1.3867  4.1815  1.7215 
ATOM 46 H P01 1 -1.7479  4.3575  2.7272 
ATOM 47 C P01 1 -1.4671  5.1961  0.7706 
ATOM 48 H P01 1 -1.8893  6.1555  1.0437 
ATOM 49 C P01 1 -0.9983  4.9910 -0.5239 
ATOM 50 H P01 1 -1.0514  5.7864 -1.2581 
ATOM 51 C P01 1 -0.4481  3.7597 -0.8537 
ATOM 52 C P01 1 -0.8131  0.5433 -1.0370 
ATOM 53 O P01 1 -1.9459  0.9482 -1.3050 
ATOM 54 N P01 1 -0.4166 -0.7142 -1.2807 
ATOM 55 H P01 1  0.5120 -1.0106 -0.9916 
ATOM 56 C P01 1 -1.2818 -1.6967 -1.9225 
ATOM 57 C P01 1 -0.5897 -3.0567 -1.8381 
ATOM 58 H P01 1  0.3512 -3.0312 -2.3891 
ATOM 59 H P01 1 -0.3798 -3.3298 -0.8034 
ATOM 60 H P01 1 -1.2296 -3.8184 -2.2819 
ATOM 61 C P01 1 -1.5317 -1.3234 -3.3783 
ATOM 62 H P01 1 -2.1766 -2.0632 -3.8483 
ATOM 63 H P01 1 -2.0091 -0.3474 -3.4502 
ATOM 64 H P01 1 -0.5781 -1.2957 -3.9062 
ATOM 65 C P01 1 -2.6213 -1.8323 -1.1774 
ATOM 66 O P01 1 -3.6339 -2.1877 -1.7772 
ATOM 67 N P01 1 -2.5913 -1.6205  0.1508 
ATOM 68 H P01 1 -1.7433 -1.2510  0.5688 
ATOM 69 C P01 1 -3.7525 -1.7940  1.0136 
ATOM 70 C P01 1 -3.3485 -1.3597  2.4228 
ATOM 71 H P01 1 -2.5298 -1.9848  2.7831 
ATOM 72 H P01 1 -3.0200 -0.3202  2.4370 
ATOM 73 H P01 1 -4.1977 -1.4740  3.0952 
ATOM 74 C P01 1 -4.2082 -3.2479  1.0331 
ATOM 75 H P01 1 -5.0774 -3.3527  1.6797 
ATOM 76 H P01 1 -4.4699 -3.5871  0.0329 
ATOM 77 H P01 1 -3.4001 -3.8691  1.4211 
ATOM 78 C P01 1 -4.9123 -0.8775  0.5881 
ATOM 79 O P01 1 -6.0725 -1.1475  0.9090 
ATOM 80 N P01 1 -4.5870  0.2551 -0.0437 
ATOM 81 H P01 1 -3.6374  0.3970 -0.3672 
ATOM 82 C P01 1 -5.6018  1.2026 -0.4351 
ATOM 83 H P01 1 -6.1838  1.5217  0.4301 
ATOM 84 H P01 1 -5.1181  2.0703 -0.8765 
ATOM 85 H P01 1 -6.2899  0.7710 -1.1653 
COMPND Ac-Aib2-(R)-II-Aib2-NHMe-M310 
REMARK Energy(ZPE)= -1910.169435 
REMARK #IF = 0 
ATOM  1 C P01 1  6.1966  0.4517 -1.3243 
ATOM  2 H P01 1  5.8516  0.6934 -2.3288 
ATOM  3 H P01 1  6.5790  1.3686 -0.8756 
ATOM  4 H P01 1  7.0028 -0.2763 -1.3846 
ATOM  5 C P01 1  5.0284 -0.0231 -0.5128 
ATOM  6 O P01 1  3.9957  0.6420 -0.4067 
ATOM  7 N P01 1  5.1485 -1.2296  0.0811 
ATOM  8 H P01 1  6.0325 -1.7093  0.0132 
ATOM  9 C P01 1  4.1796 -1.7438  1.0437 
ATOM 10 C P01 1  4.1876 -0.9119  2.3196 
ATOM 11 H P01 1  5.1750 -0.9703  2.7777 
ATOM 12 H P01 1  3.9572  0.1296  2.1005 
ATOM 13 H P01 1  3.4463 -1.2939  3.0188 
ATOM 14 C P01 1  4.5501 -3.1951  1.3482 
ATOM 15 H P01 1  3.8263 -3.6226  2.0405 
ATOM 16 H P01 1  4.5676 -3.8000  0.4408 
ATOM 17 H P01 1  5.5340 -3.2347  1.8186 
ATOM 18 C P01 1  2.7709 -1.7497  0.4338 
ATOM 19 O P01 1  1.7757 -1.6152  1.1465 
ATOM 20 N P01 1  2.6974 -1.9689 -0.8879 
ATOM 21 H P01 1  3.5652 -2.0601 -1.3942 
ATOM 22 C P01 1  1.4561 -2.1192 -1.6328 
ATOM 23 C P01 1  0.7502 -3.4151 -1.2461 
ATOM 24 H P01 1  1.4066 -4.2556 -1.4720 
ATOM 25 H P01 1  0.5134 -3.4251 -0.1830 
ATOM 26 H P01 1 -0.1726 -3.5212 -1.8127 
ATOM 27 C P01 1  1.8067 -2.1290 -3.1201 
ATOM 28 H P01 1  0.8957 -2.2207 -3.7092 
ATOM 29 H P01 1  2.3234 -1.2138 -3.4124 
ATOM 30 H P01 1  2.4471 -2.9839 -3.3428 
ATOM 31 C P01 1  0.5153 -0.9314 -1.3974 
ATOM 32 O P01 1 -0.6938 -1.0553 -1.6073 
ATOM 33 N P01 1  1.0480  0.2342 -1.0014 
ATOM 34 H P01 1  2.0474  0.3162 -0.8317 
ATOM 35 C P01 1  0.1956  1.3847 -0.7736 
ATOM 36 C P01 1 -0.3527  2.0108 -2.0717 
ATOM 37 H P01 1 -1.3128  1.5817 -2.3485 
ATOM 38 H P01 1  0.3664  1.7822 -2.8599 
ATOM 39 C P01 1 -0.4063  3.5235 -1.8325 
ATOM 40 H P01 1 -0.1807  4.0982 -2.7321 
ATOM 41 H P01 1 -1.3989  3.8256 -1.4897 
ATOM 42 C P01 1  0.9478  2.5354 -0.1369 
ATOM 43 C P01 1  1.8101  2.4886  0.9488 
ATOM 44 H P01 1  2.0659  1.5425  1.4131 
ATOM 45 C P01 1  2.3550  3.6793  1.4163 
ATOM 46 H P01 1  3.0406  3.6666  2.2543 
ATOM 47 C P01 1  2.0237  4.8892  0.8092 
ATOM 48 H P01 1  2.4577  5.8097  1.1799 
ATOM 49 C P01 1  1.1404  4.9281 -0.2658 
ATOM 50 H P01 1  0.8825  5.8740 -0.7272 
ATOM 51 C P01 1  0.5960  3.7401 -0.7370 
ATOM 52 C P01 1 -0.9462  1.0343  0.1938 
ATOM 53 O P01 1 -2.0093  1.6574  0.1434 
ATOM 54 N P01 1 -0.6985  0.0929  1.1141 
ATOM 55 H P01 1  0.1808 -0.4183  1.0799 
ATOM 56 C P01 1 -1.6562 -0.2477  2.1594 
ATOM 57 C P01 1 -1.7923  0.8958  3.1567 
ATOM 58 H P01 1 -0.8234  1.0804  3.6215 
ATOM 59 H P01 1 -2.1287  1.8041  2.6591 
ATOM 60 H P01 1 -2.5144  0.6333  3.9274 
ATOM 61 C P01 1 -1.1534 -1.5070  2.8634 
ATOM 62 H P01 1 -1.8677 -1.8063  3.6293 
ATOM 63 H P01 1 -1.0262 -2.3291  2.1581 
ATOM 64 H P01 1 -0.1941 -1.3079  3.3425 
ATOM 65 C P01 1 -3.0332 -0.5857  1.5609 
ATOM 66 O P01 1 -4.0559 -0.4068  2.2191 
ATOM 67 N P01 1 -3.0380 -1.1488  0.3387 
ATOM 68 H P01 1 -2.1688 -1.1926 -0.1838 
ATOM 69 C P01 1 -4.2557 -1.5831 -0.3335 
ATOM 70 C P01 1 -4.9230 -2.7264  0.4210 
ATOM 71 H P01 1 -4.2330 -3.5694  0.4739 
ATOM 72 H P01 1 -5.1925 -2.4219  1.4303 
ATOM 73 H P01 1 -5.8237 -3.0368 -0.1052 
ATOM 74 C P01 1 -3.8633 -2.0465 -1.7367 
ATOM 75 H P01 1 -4.7554 -2.3541 -2.2806 
ATOM 76 H P01 1 -3.3647 -1.2493 -2.2890 
ATOM 77 H P01 1 -3.1836 -2.8974 -1.6702 
ATOM 78 C P01 1 -5.2465 -0.4200 -0.5185 
ATOM 79 O P01 1 -6.4490 -0.6453 -0.6785 
ATOM 80 N P01 1 -4.7298  0.8099 -0.6000 
ATOM 81 H P01 1 -3.7541  0.9686 -0.3729 
ATOM 82 C P01 1 -5.5783  1.9541 -0.8273 
ATOM 83 H P01 1 -6.1489  1.8344 -1.7488 
ATOM 84 H P01 1 -6.2858  2.0951 -0.0071 
ATOM 85 H P01 1 -4.9538  2.8400 -0.9104 
COMPND Ac-Aib2-(1R,2R,4R)-IIIa-Aib2-NHMe-P310 
REMARK Energy(ZPE)= -2023.432969 
REMARK #IF = 0 
ATOM 1  C P02 1  5.9583  0.4259 -0.8974 
ATOM 2  H P02 1  5.7072  1.3895 -0.4562 
ATOM 3  H P02 1  6.8349  0.0177 -0.3991 
ATOM 4  H P02 1  6.192   0.5934 -1.9488 
ATOM 5  C P02 1  4.7599 -0.4701 -0.8140 
ATOM 6  O P02 1  3.6584 -0.1267 -1.2548 
ATOM 7  N P02 1  4.9303 -1.665  -0.2143 
ATOM 8  H P02 1  5.8604 -1.9257  0.0748 
ATOM 9  C P02 1  3.9098 -2.7097 -0.2146 
ATOM 10 C P02 1  4.3892 -3.827   0.7107 
ATOM 11 H P02 1  5.3092 -4.2624  0.3175 
ATOM 12 H P02 1  4.577  -3.4554  1.7187 
ATOM 13 H P02 1  3.637  -4.6129  0.7618 
ATOM 14 C P02 1  3.6799 -3.242  -1.6226 
ATOM 15 H P02 1  2.9217 -4.0225 -1.6093 
ATOM 16 H P02 1  3.3483 -2.4457 -2.2872 
ATOM 17 H P02 1  4.6131 -3.6599 -2.0007 
ATOM 18 C P02 1  2.5951 -2.1615  0.3602 
ATOM 19 O P02 1  1.5083 -2.5602 -0.0566 
ATOM 20 N P02 1  2.7139 -1.2805  1.3675 
ATOM 21 H P02 1  3.6465 -1.0051  1.6369 
ATOM 22 C P02 1  1.5999 -0.735   2.1316 
ATOM 23 C P02 1  2.1765  0.2863  3.1102 
ATOM 24 H P02 1  2.8423 -0.2156  3.8140 
ATOM 25 H P02 1  2.7305  1.0677  2.5886 
ATOM 26 H P02 1  1.3676  0.7508  3.6722 
ATOM 27 C P02 1  0.8659 -1.8344  2.8938 
ATOM 28 H P02 1  0.0596 -1.3988  3.4801 
ATOM 29 H P02 1  0.4446 -2.5696  2.2103 
ATOM 30 H P02 1  1.5683 -2.3299  3.5641 
ATOM 31 C P02 1  0.6039  0.0041  1.2282 
ATOM 32 O P02 1 -0.5401  0.2331  1.6281 
ATOM 33 N P02 1  1.0268  0.4135  0.0226 
ATOM 34 H P02 1  1.9711  0.2019 -0.2879 
ATOM 35 C P02 1  0.1293  1.0878 -0.8903 
ATOM 36 C P02 1  0.8982  1.5953 -2.1363 
ATOM 37 H P02 1  1.9271  1.2412 -2.1552 
ATOM 38 H P02 1  0.3984  1.2846 -3.0526 
ATOM 39 C P02 1  0.7628  3.1223 -1.9835 
ATOM 40 H P02 1  0.9051  3.6929 -2.8965 
ATOM 41 O P02 1 -0.5915  3.2143 -1.5275 
ATOM 42 C P02 1 -0.4305  2.4532 -0.334 
ATOM 43 H P02 1 -1.363   2.3753  0.2126 
ATOM 44 C P02 1  0.7318  3.1538  0.3127 
ATOM 45 C P02 1  1.5188  3.5736 -0.7598 
ATOM 46 C P02 1  2.7177  4.2263 -0.5515 
ATOM 47 H P02 1  3.3405  4.5486 -1.3770 
ATOM 48 C P02 1  3.0994  4.4791  0.7690 
ATOM 49 H P02 1  4.0217  5.012   0.9647 
ATOM 50 C P02 1  2.3082  4.0664  1.8371 
ATOM 51 H P02 1  2.6255  4.2821  2.8499 
ATOM 52 C P02 1  1.1114  3.3800  1.6197 
ATOM 53 H P02 1  0.5039  3.0412  2.4508 
ATOM 54 C P02 1 -1.0491  0.1897 -1.2785 
ATOM 55 O P02 1 -2.0883  0.6821 -1.7236 
ATOM 56 N P02 1 -0.9026 -1.1292 -1.0999 
ATOM 57 H P02 1 -0.0285 -1.4972 -0.7346 
ATOM 58 C P02 1 -1.9724 -2.0743 -1.3956 
ATOM 59 C P02 1 -1.5747 -3.4244 -0.7993 
ATOM 60 H P02 1 -0.6666 -3.7902 -1.2795 
ATOM 61 H P02 1 -1.3883 -3.3411  0.2725 
ATOM 62 H P02 1 -2.3731 -4.1467 -0.9649 
ATOM 63 C P02 1 -2.1889 -2.2028 -2.8971 
ATOM 64 H P02 1 -2.9928 -2.9088 -3.0967 
ATOM 65 H P02 1 -2.4525 -1.2412 -3.3339 
ATOM 66 H P02 1 -1.2710 -2.5667 -3.3596 
ATOM 67 C P02 1 -3.2823 -1.6468 -0.709 
ATOM 68 O P02 1 -4.3686 -1.9358 -1.2054 
ATOM 69 N P02 1 -3.1636 -1.0279  0.4808 
ATOM 70 H P02 1 -2.2406 -0.7641  0.8076 
ATOM 71 C P02 1 -4.3061 -0.6341  1.2956 
ATOM 72 C P02 1 -3.7678  0.1598  2.4858 
ATOM 73 H P02 1 -3.1128 -0.4717  3.088 
ATOM 74 H P02 1 -3.1993  1.0293  2.154 
ATOM 75 H P02 1 -4.5983  0.4924  3.1073 
ATOM 76 C P02 1 -5.0729 -1.8537  1.7919 
ATOM 77 H P02 1 -5.9237 -1.5333  2.3904 
ATOM 78 H P02 1 -5.4359 -2.4512  0.958 
ATOM 79 H P02 1 -4.4128 -2.4647  2.4088 
ATOM 80 C P02 1 -5.2501  0.3094  0.5291 
ATOM 81 O P02 1 -6.4336  0.4113  0.8621 
ATOM 82 N P02 1 -4.7031  1.0733 -0.4215 
ATOM 83 H P02 1 -3.7603  0.8842 -0.7437 
ATOM 84 C P02 1 -5.5018  2.0225 -1.1578 
ATOM 85 H P02 1 -6.2750  1.5233 -1.7465 
ATOM 86 H P02 1 -5.9920  2.7201 -0.4782 
ATOM 87 H P02 1 -4.8519  2.5789 -1.8285 
 
COMPND Ac-Aib2-(1R,2R,4R)-IIIa-Aib2-NHMe-M310 
REMARK Energy(ZPE)= -2023.430125 
REMARK #IF = 0 
ATOM 1  C P02 1 -5.8049 -0.4134 -1.0589 
ATOM 2  H P02 1 -5.8860  0.0053 -2.0606 
ATOM 3  H P02 1 -6.6502 -1.0726 -0.8723 
ATOM 4  H P02 1 -5.8430  0.4126 -0.3470 
ATOM 5  C P02 1 -4.4792 -1.1034 -0.9253 
ATOM 6  O P02 1 -3.4217 -0.5729 -1.2750 
ATOM 7  N P02 1 -4.4886 -2.3263 -0.3565 
ATOM 8  H P02 1 -5.3754 -2.7567 -0.1467 
ATOM 9  C P02 1 -3.2928 -3.1552 -0.2741 
ATOM 10 C P02 1 -2.8508 -3.6166 -1.6563 
ATOM 11 H P02 1 -3.6516 -4.2022 -2.1081 
ATOM 12 H P02 1 -2.6264 -2.7626 -2.2933 
ATOM 13 H P02 1 -1.9592 -4.2357 -1.5773 
ATOM 14 C P02 1 -3.6133 -4.3567  0.6142 
ATOM 15 H P02 1 -2.7261 -4.9776  0.7304 
ATOM 16 H P02 1 -3.9533 -4.0433  1.6019 
ATOM 17 H P02 1 -4.3924 -4.9619  0.1483 
ATOM 18 C P02 1 -2.1648 -2.3674  0.4027 
ATOM 19 O P02 1 -0.9914 -2.5154  0.0639 
ATOM 20 N P02 1 -2.5144 -1.5697  1.4253 
ATOM 21 H P02 1 -3.4911 -1.4950  1.6675 
ATOM 22 C P02 1 -1.5320 -0.9343  2.2926 
ATOM 23 C P02 1 -0.8265 -1.9668  3.1603 
ATOM 24 H P02 1 -1.5644 -2.4736  3.7823 
ATOM 25 H P02 1 -0.3127 -2.7014  2.5422 
ATOM 26 H P02 1 -0.0942 -1.4799  3.8012 
ATOM 27 C P02 1 -2.2658  0.0889  3.1589 
ATOM 28 H P02 1 -1.5545  0.6134  3.7956 
ATOM 29 H P02 1 -2.7926  0.8211  2.5454 
ATOM 30 H P02 1 -2.9858 -0.4205  3.8013 
ATOM 31 C P02 1 -0.5054 -0.1650  1.4519 
ATOM 32 O P02 1  0.6742 -0.0952  1.7946 
ATOM 33 N P02 1 -0.9774  0.5161  0.3899 
ATOM 34 H P02 1 -1.9190  0.3363  0.0543 
ATOM 35 C P02 1 -0.1197  1.4341 -0.3265 
ATOM 36 C P02 1  0.4283  2.5914  0.5481 
ATOM 37 H P02 1  0.0801  2.5172  1.5757 
ATOM 38 H P02 1  1.5150  2.5956  0.5323 
ATOM 39 C P02 1 -0.1224  3.8297 -0.1827 
ATOM 40 H P02 1  0.4490  4.7449 -0.0607 
ATOM 41 O P02 1 -0.0920  3.3924 -1.5520 
ATOM 42 C P02 1 -0.9314  2.2579 -1.3949 
ATOM 43 H P02 1 -1.0948  1.7494 -2.3411 
ATOM 44 C P02 1 -2.1327  2.8651 -0.7087 
ATOM 45 C P02 1 -1.6031  3.8931  0.0704 
ATOM 46 C P02 1 -2.4108  4.6753  0.8712 
ATOM 47 H P02 1 -2.0029  5.4685  1.4856 
ATOM 48 C P02 1 -3.7853  4.4252  0.8492 
ATOM 49 H P02 1 -4.4489  5.0371  1.4474 
ATOM 50 C P02 1 -4.3155  3.4118  0.0570 
ATOM 51 H P02 1 -5.3866  3.2503  0.0457 
ATOM 52 C P02 1 -3.4889  2.6076 -0.7313 
ATOM 53 H P02 1 -3.8959  1.8118 -1.3393 
ATOM 54 C P02 1  1.0453  0.7076 -1.0145 
ATOM 55 O P02 1  2.0657  1.3192 -1.3384 
ATOM 56 N P02 1  0.9074 -0.6065 -1.2449 
ATOM 57 H P02 1  0.1020 -1.1072 -0.8826 
ATOM 58 C P02 1  1.9739 -1.3797 -1.8709 
ATOM 59 C P02 1  2.1524 -0.9802 -3.3300 
ATOM 60 H P02 1  1.2258 -1.1804 -3.8689 
ATOM 61 H P02 1  2.3965  0.0766 -3.4168 
ATOM 62 H P02 1  2.9564 -1.5633 -3.7747 
ATOM 63 C P02 1  1.6114 -2.8612 -1.7803 
ATOM 64 H P02 1  2.4030 -3.4518 -2.2398 
ATOM 65 H P02 1  1.4848 -3.1791 -0.7458 
ATOM 66 H P02 1  0.6801 -3.0500 -2.3156 
ATOM 67 C P02 1  3.2990 -1.2016 -1.1087 
ATOM 68 O P02 1  4.3729 -1.3394 -1.6906 
ATOM 69 N P02 1  3.2110 -0.9744  0.2160 
ATOM 70 H P02 1  2.3005 -0.8119  0.6328 
ATOM 71 C P02 1  4.3774 -0.8710  1.0835 
ATOM 72 C P02 1  5.1265 -2.1957  1.1569 
ATOM 73 H P02 1  4.4634 -2.9585  1.5667 
ATOM 74 H P02 1  5.4618 -2.5066  0.1695 
ATOM 75 H P02 1  5.9937 -2.0917  1.8065 
ATOM 76 C P02 1  3.8825 -0.4774  2.4755 
ATOM 77 H P02 1  4.7333 -0.3739  3.1476 
ATOM 78 H P02 1  3.3326  0.4638  2.4474 
ATOM 79 H P02 1  3.2201 -1.2511  2.8667 
ATOM 80 C P02 1  5.3252  0.2496  0.6221 
ATOM 81 O P02 1  6.5176  0.2272  0.9364 
ATOM 82 N P02 1  4.7725  1.2784 -0.0297 
ATOM 83 H P02 1  3.8186  1.2078 -0.3631 
ATOM 84 C P02 1  5.5713  2.4004 -0.4588 
ATOM 85 H P02 1  6.2893  2.1110 -1.2298 
ATOM 86 H P02 1  4.9118  3.1650 -0.8617 
ATOM 87 H P02 1  6.1262  2.8161  0.3821 
 
COMPND Ac-Aib2-(1S,2R,4R)-IV-Aib2-NHMe-P310 
REMARK Energy(ZPE)= -1835.160047 
REMARK #IF = 0 
ATOM  1 C P03 1  6.1757  1.3622  0.0064 
ATOM  2 H P03 1  5.8363  2.1385  0.6905 
ATOM  3 H P03 1  7.0240  0.8393  0.4430 
ATOM  4 H P03 1  6.4958  1.8484 -0.9154 
ATOM  5 C P03 1  5.0230  0.4574 -0.3096 
ATOM  6 O P03 1  3.9356  0.8975 -0.6932 
ATOM  7 N P03 1  5.2223 -0.8653 -0.1371 
ATOM  8 H P03 1  6.1447 -1.1778  0.1229 
ATOM  9 C P03 1  4.2671 -1.8803 -0.5720 
ATOM 10 C P03 1  4.7539 -3.2312 -0.0491 
ATOM 11 H P03 1  5.7163 -3.4774 -0.5004 
ATOM 12 H P03 1  4.8643 -3.2210  1.0359 
ATOM 13 H P03 1  4.0430 -4.0100 -0.3213 
ATOM 14 C P03 1  4.1538 -1.9046 -2.0905 
ATOM 15 H P03 1  3.4382 -2.6640 -2.3994 
ATOM 16 H P03 1  3.8216 -0.9391 -2.4687 
ATOM 17 H P03 1  5.1292 -2.1409 -2.5162 
ATOM 18 C P03 1  2.8892 -1.6148  0.0519 
ATOM 19 O P03 1  1.8564 -1.9140 -0.5461 
ATOM 20 N P03 1  2.8906 -1.1008  1.2925 
ATOM 21 H P03 1  3.7842 -0.8767  1.7038 
ATOM 22 C P03 1  1.6948 -0.8903  2.0976 
ATOM 23 C P03 1  2.1154 -0.1332  3.3568 
ATOM 24 H P03 1  2.8036 -0.7437  3.9437 
ATOM 25 H P03 1  2.6050  0.8100  3.1087 
ATOM 26 H P03 1  1.2388  0.0776  3.9672 
ATOM 27 C P03 1  1.0520 -2.2218  2.4708 
ATOM 28 H P03 1  0.1680 -2.0497  3.0817 
ATOM 29 H P03 1  0.7600 -2.7742  1.5789 
ATOM 30 H P03 1  1.7686 -2.8151  3.0390 
ATOM 31 C P03 1  0.6729 -0.0125  1.3621 
ATOM 32 O P03 1 -0.5157 -0.0446  1.6915 
ATOM 33 N P03 1  1.1225  0.8042  0.4008 
ATOM 34 H P03 1  2.1033  0.7845  0.1380 
ATOM 35 C P03 1  0.2240  1.6881 -0.3210 
ATOM 36 C P03 1 -0.3309  2.8576  0.5390 
ATOM 37 H P03 1 -1.2255  2.5812  1.0924 
ATOM 38 C P03 1  1.0090  2.4383 -1.4410 
ATOM 39 H P03 1  2.0165  2.0385 -1.5551 
ATOM 40 H P03 1  0.4928  2.3343 -2.3975 
ATOM 41 C P03 1  1.7740  4.0019  0.3358 
ATOM 42 H P03 1  2.0253  5.0398  0.5599 
ATOM 43 H P03 1  2.7111  3.4427  0.2736 
ATOM 44 C P03 1  0.8100  3.4117  1.3927 
ATOM 45 H P03 1  1.2778  2.6624  2.0302 
ATOM 46 H P03 1  0.4155  4.1940  2.0438 
ATOM 47 C P03 1  0.9732  3.8902 -0.9718 
ATOM 48 H P03 1  1.2754  4.5975 -1.7438 
ATOM 49 C P03 1 -0.4729  3.9864 -0.4884 
ATOM 50 H P03 1 -1.2021  3.7756 -1.2696 
ATOM 51 H P03 1 -0.7120  4.9403 -0.0126 
ATOM 52 C P03 1 -0.9179  0.8821 -0.9434 
ATOM 53 O P03 1 -2.0164  1.4033 -1.1556 
ATOM 54 N P03 1 -0.6549 -0.3867 -1.2933 
ATOM 55 H P03 1  0.2455 -0.7969 -1.0634 
ATOM 56 C P03 1 -1.6345 -1.2265 -1.9694 
ATOM 57 C P03 1 -1.0984 -2.6578 -1.9735 
ATOM 58 H P03 1 -0.1668 -2.7043 -2.5389 
ATOM 59 H P03 1 -0.9078 -3.0100 -0.9590 
ATOM 60 H P03 1 -1.8242 -3.3182 -2.4465 
ATOM 61 C P03 1 -1.8633 -0.7462 -3.3968 
ATOM 62 H P03 1 -2.5924 -1.3826 -3.8943 
ATOM 63 H P03 1 -2.2309  0.2785 -3.4043 
ATOM 64 H P03 1 -0.9199 -0.7923 -3.9417 
ATOM 65 C P03 1 -2.9682 -1.2534 -1.2038 
ATOM 66 O P03 1 -4.0247 -1.4456 -1.8029 
ATOM 67 N P03 1 -2.9000 -1.1474  0.1363 
ATOM 68 H P03 1 -2.0149 -0.9043  0.5696 
ATOM 69 C P03 1 -4.0706 -1.2521  0.9977 
ATOM 70 C P03 1 -3.6204 -0.9517  2.4276 
ATOM 71 H P03 1 -2.8806 -1.6874  2.7470 
ATOM 72 H P03 1 -3.1752  0.0408  2.5004 
ATOM 73 H P03 1 -4.4774 -1.0067  3.0977 
ATOM 74 C P03 1 -4.6760 -2.6484  0.9290 
ATOM 75 H P03 1 -5.5443 -2.7083  1.5824 
ATOM 76 H P03 1 -4.9829 -2.8874 -0.0871 
ATOM 77 H P03 1 -3.9325 -3.3752  1.2586 
ATOM 78 C P03 1 -5.1278 -0.1931  0.6396 
ATOM 79 O P03 1 -6.3150 -0.3692  0.9249 
ATOM 80 N P03 1 -4.6770  0.9494  0.1117 
ATOM 81 H P03 1 -3.7161  1.0113 -0.2045 
ATOM 82 C P03 1 -5.5813  2.0256 -0.2116 
ATOM 83 H P03 1 -6.1392  2.3383  0.6717 
ATOM 84 H P03 1 -5.0023  2.8685 -0.5805 
ATOM 85 H P03 1 -6.2999  1.7269 -0.9781 
 
COMPND Ac-Aib2-(1S,2R,4R)-IV-Aib2-NHMe-M310 
REMARK Energy(ZPE)= -1835.158057 
REMARK #IF = 0 
ATOM  1 C P03 1 -5.9940  1.3721 -0.6045 
ATOM  2 H P03 1 -5.6832  2.2258 -0.0038 
ATOM  3 H P03 1 -6.2018  1.7336 -1.6119 
ATOM  4 H P03 1 -6.9041  0.9471 -0.1867 
ATOM  5 C P03 1 -4.8606  0.3928 -0.6750 
ATOM  6 O P03 1 -3.7227  0.7337 -1.0072 
ATOM  7 N P03 1 -5.1338 -0.8854 -0.3401 
ATOM  8 H P03 1 -6.0877 -1.1392 -0.1357 
ATOM  9 C P03 1 -4.1704 -1.9637 -0.5294 
ATOM 10 C P03 1 -3.9187 -2.2209 -2.0086 
ATOM 11 H P03 1 -4.8533 -2.5214 -2.4824 
ATOM 12 H P03 1 -3.5410 -1.3242 -2.4969 
ATOM 13 H P03 1 -3.1858 -3.0164 -2.1298 
ATOM 14 C P03 1 -4.7311 -3.2159  0.1439 
ATOM 15 H P03 1 -4.0187 -4.0350  0.0548 
ATOM 16 H P03 1 -4.9352 -3.0434  1.2013 
ATOM 17 H P03 1 -5.6569 -3.5161 -0.3493 
ATOM 18 C P03 1 -2.8532 -1.6083  0.1731 
ATOM 19 O P03 1 -1.7667 -1.9326 -0.3045 
ATOM 20 N P03 1 -2.9587 -0.9921  1.3614 
ATOM 21 H P03 1 -3.8816 -0.7598  1.6971 
ATOM 22 C P03 1 -1.8246 -0.7578  2.2458 
ATOM 23 C P03 1 -1.2889 -2.0725  2.7976 
ATOM 24 H P03 1 -2.0806 -2.5735  3.3550 
ATOM 25 H P03 1 -0.9543 -2.7222  1.9903 
ATOM 26 H P03 1 -0.4491 -1.8847  3.4635 
ATOM 27 C P03 1 -2.3054  0.1442  3.3820 
ATOM 28 H P03 1 -1.4771  0.3657  4.0536 
ATOM 29 H P03 1 -2.7055  1.0832  2.9971 
ATOM 30 H P03 1 -3.0826 -0.3645  3.9549 
ATOM 31 C P03 1 -0.7089 -0.0001  1.5128 
ATOM 32 O P03 1  0.4695 -0.1513  1.8401 
ATOM 33 N P03 1 -1.0839  0.8900  0.5801 
ATOM 34 H P03 1 -2.0408  0.8867  0.2429 
ATOM 35 C P03 1 -0.1166  1.7611 -0.0623 
ATOM 36 C P03 1 -0.8199  2.7694 -1.0127 
ATOM 37 H P03 1 -1.1266  2.3204 -1.9576 
ATOM 38 C P03 1  0.6076  2.7134  0.9322 
ATOM 39 H P03 1  0.2659  2.5322  1.9516 
ATOM 40 H P03 1  1.6820  2.5402  0.8917 
ATOM 41 C P03 1 -1.2188  4.3883  0.7461 
ATOM 42 H P03 1 -1.4674  5.4394  0.5880 
ATOM 43 H P03 1 -1.4617  4.1447  1.7825 
ATOM 44 C P03 1 -1.9583  3.4804 -0.2645 
ATOM 45 H P03 1 -2.6723  2.8082  0.2057 
ATOM 46 H P03 1 -2.5203  4.0736 -0.9879 
ATOM 47 C P03 1  0.2543  4.1154  0.4292 
ATOM 48 H P03 1  0.9376  4.8859  0.7859 
ATOM 49 C P03 1  0.2126  3.8979 -1.0843 
ATOM 50 H P03 1  1.1689  3.5916 -1.5035 
ATOM 51 H P03 1 -0.1713  4.7611 -1.6322 
ATOM 52 C P03 1  0.9085  0.9332 -0.8523 
ATOM 53 O P03 1  2.0166  1.3990 -1.1382 
ATOM 54 N P03 1  0.5557 -0.3050 -1.2289 
ATOM 55 H P03 1 -0.3319 -0.6982 -0.9316 
ATOM 56 C P03 1  1.4633 -1.1629 -1.9809 
ATOM 57 C P03 1  1.6472 -0.6477 -3.4021 
ATOM 58 H P03 1  0.6820 -0.6537 -3.9093 
ATOM 59 H P03 1  2.0425  0.3662 -3.3979 
ATOM 60 H P03 1  2.3375 -1.2908 -3.9446 
ATOM 61 C P03 1  0.8709 -2.5716 -2.0073 
ATOM 62 H P03 1  1.5446 -3.2376 -2.5452 
ATOM 63 H P03 1  0.7188 -2.9560 -0.9986 
ATOM 64 H P03 1 -0.0923 -2.5608 -2.5184 
ATOM 65 C P03 1  2.8267 -1.2703 -1.2748 
ATOM 66 O P03 1  3.8503 -1.4821 -1.9217 
ATOM 67 N P03 1  2.8124 -1.2089  0.0702 
ATOM 68 H P03 1  1.9490 -0.9608  0.5413 
ATOM 69 C P03 1  4.0023 -1.3906  0.8913 
ATOM 70 C P03 1  4.5508 -2.8054  0.7538 
ATOM 71 H P03 1  3.7905 -3.5157  1.0808 
ATOM 72 H P03 1  4.8175 -3.0187 -0.2794 
ATOM 73 H P03 1  5.4355 -2.9200  1.3772 
ATOM 74 C P03 1  3.6019 -1.1271  2.3431 
ATOM 75 H P03 1  4.4754 -1.2285  2.9858 
ATOM 76 H P03 1  3.1849 -0.1264  2.4613 
ATOM 77 H P03 1  2.8505 -1.8524  2.6587 
ATOM 78 C P03 1  5.0923 -0.3613  0.5444 
ATOM 79 O P03 1  6.2748 -0.5897  0.8121 
ATOM 80 N P03 1  4.6794  0.8094  0.0485 
ATOM 81 H P03 1  3.7189  0.9141 -0.2584 
ATOM 82 C P03 1  5.6189  1.8599 -0.2586 
ATOM 83 H P03 1  6.2233  2.1006  0.6163 
ATOM 84 H P03 1  6.2935  1.5716 -1.0682 
ATOM 85 H P03 1  5.0652  2.7453 -0.5607 
 
COMPND Ac-Aib2-(1R,2R,4R)-IV-Aib2-NHMe-P310 
REMARK Energy(ZPE)= -1833.953184 
REMARK #IF = 0 
ATOM  1 C P04 1  6.1912  1.3959  0.1214 
ATOM  2 H P04 1  5.8528  2.1117  0.8694 
ATOM  3 H P04 1  7.0494  0.8496  0.5065 
ATOM  4 H P04 1  6.4947  1.9577 -0.7621 
ATOM  5 C P04 1  5.0429  0.5072 -0.2519 
ATOM  6 O P04 1  3.9609  0.9659 -0.6293 
ATOM  7 N P04 1  5.2389 -0.8220 -0.1353 
ATOM  8 H P04 1  6.1578 -1.1470  0.1222 
ATOM  9 C P04 1  4.2864 -1.8165 -0.6200 
ATOM 10 C P04 1  4.7679 -3.1891 -0.1514 
ATOM 11 H P04 1  5.7335 -3.4174 -0.6054 
ATOM 12 H P04 1  4.8698 -3.2257  0.9338 
ATOM 13 H P04 1  4.0582 -3.9545 -0.4621 
ATOM 14 C P04 1  4.1845 -1.7776  -2.139 
ATOM 15 H P04 1  3.4678 -2.5203 -2.4839 
ATOM 16 H P04 1  3.8587 -0.7960 -2.4793 
ATOM 17 H P04 1  5.1620 -2.0000 -2.5672 
ATOM 18 C P04 1  2.9040 -1.5770  0.0042 
ATOM 19 O P04 1  1.8755 -1.8465 -0.6148 
ATOM 20 N P04 1  2.8962 -1.1199  1.2671 
ATOM 21 H P04 1  3.7868 -0.9206  1.6974 
ATOM 22 C P04 1  1.6945 -0.9462  2.0723 
ATOM 23 C P04 1  2.1027 -0.2369  3.3627 
ATOM 24 H P04 1  2.7930 -0.8648  3.9285 
ATOM 25 H P04 1  2.5844  0.7195  3.1537 
ATOM 26 H P04 1  1.2210 -0.0586  3.9761 
ATOM 27 C P04 1  1.0539 -2.2936  2.3875 
ATOM 28 H P04 1  0.1691 -2.1492  3.0041 
ATOM 29 H P04 1  0.7632 -2.8077  1.4727 
ATOM 30 H P04 1  1.7710 -2.9095  2.9303 
ATOM 31 C P04 1  0.6756 -0.0443  1.3637 
ATOM 32 O P04 1 -0.5166 -0.0967  1.6780 
ATOM 33 N P04 1  1.1336  0.8124  0.4427 
ATOM 34 H P04 1  2.1198  0.8150  0.2026 
ATOM 35 C P04 1  0.2453  1.7236 -0.2549 
ATOM 36 C P04 1 -0.2807  2.8841  0.6579 
ATOM 37 H P04 1 -1.1156  2.5887  1.2870 
ATOM 38 C P04 1  1.0254  2.5040 -1.3528 
ATOM 39 H P04 1  2.0480  2.1423 -1.4473 
ATOM 40 H P04 1  0.5362  2.3957 -2.3224 
ATOM 41 C P04 1  1.6786  4.0597  0.4355 
ATOM 42 H P04 1  2.6693  4.4767  0.5612 
ATOM 43 C P04 1  0.9512  3.4143  1.3525 
ATOM 44 H P04 1  1.2305  3.1945  2.3742 
ATOM 45 C P04 1  0.9340  3.9748 -0.8733 
ATOM 46 H P04 1  1.2128  4.6979 -1.6373 
ATOM 47 C P04 1 -0.5127  3.9949 -0.3741 
ATOM 48 H P04 1 -1.2419  3.7265 -1.1374 
ATOM 49 H P04 1 -0.7845  4.9393  0.0993 
ATOM 50 C P04 1 -0.9096  0.9437 -0.8894 
ATOM 51 O P04 1 -2.0136  1.4682 -1.0578 
ATOM 52 N P04 1 -0.6468 -0.3080 -1.2978 
ATOM 53 H P04 1  0.2576 -0.7244 -1.0939 
ATOM 54 C P04 1 -1.6284 -1.1202 -2.0044 
ATOM 55 C P04 1 -1.0885 -2.5486 -2.0746 
ATOM 56 H P04 1 -0.1577 -2.5674 -2.6427 
ATOM 57 H P04 1 -0.8969 -2.9475 -1.0779 
ATOM 58 H P04 1 -1.8136 -3.1877 -2.5771 
ATOM 59 C P04 1 -1.8632 -0.5799 -3.4095 
ATOM 60 H P04 1 -2.5912 -1.1979 -3.9312 
ATOM 61 H P04 1 -2.2356  0.4425 -3.3749 
ATOM 62 H P04 1 -0.9214 -0.5982 -3.9585 
ATOM 63 C P04 1 -2.9600 -1.1870 -1.2378 
ATOM 64 O P04 1 -4.0156 -1.3617 -1.8438 
ATOM 65 N P04 1 -2.8903 -1.1360  0.1052 
ATOM 66 H P04 1 -2.0074 -0.8977  0.5460 
ATOM 67 C P04 1 -4.0596 -1.2824  0.9629 
ATOM 68 C P04 1 -3.6086 -1.0436  2.4041 
ATOM 69 H P04 1 -2.8662 -1.7903  2.6900 
ATOM 70 H P04 1 -3.1665 -0.0539  2.5203 
ATOM 71 H P04 1 -4.4650 -1.1311  3.0715 
ATOM 72 C P04 1 -4.6601 -2.6766  0.8346 
ATOM 73 H P04 1 -5.5293 -2.7650  1.4836 
ATOM 74 H P04 1 -4.9650 -2.8746 -0.1910 
ATOM 75 H P04 1 -3.9152 -3.4143  1.1353 
ATOM 76 C P04 1 -5.1224 -0.2135  0.6540 
ATOM 77 O P04 1 -6.3063 -0.4045  0.9436 
ATOM 78 N P04 1 -4.6792  0.9492  0.1654 
ATOM 79 H P04 1 -3.7205  1.0254 -0.1545 
ATOM 80 C P04 1 -5.5868  2.0365 -0.1075 
ATOM 81 H P04 1 -6.2932  1.7800 -0.9003 
ATOM 82 H P04 1 -6.1579  2.2928  0.7853 
ATOM 83 H P04 1 -5.0089  2.9033 -0.4184 
COMPND Ac-Aib2-(1R,2R,4R)-IV-Aib2-NHMe-M310 
REMARK Energy(ZPE)= -1833.952914 
REMARK #IF = 0 
ATOM  1 C P04 1 -6.0125  1.4475 -0.4733 
ATOM  2 H P04 1 -5.7202  2.2374  0.2178 
ATOM  3 H P04 1 -6.1888  1.9067 -1.4460 
ATOM  4 H P04 1 -6.9351  0.9886 -0.1246 
ATOM  5 C P04 1 -4.8788  0.4746 -0.6042 
ATOM  6 O P04 1 -3.7445  0.8339 -0.9306 
ATOM  7 N P04 1 -5.1467 -0.8179 -0.3258 
ATOM  8 H P04 1 -6.0987 -1.0812 -0.1251 
ATOM  9 C P04 1 -4.1871 -1.8878 -0.5750 
ATOM 10 C P04 1 -3.9495 -2.0711 -2.0677 
ATOM 11 H P04 1 -4.8922 -2.3340 -2.5480 
ATOM 12 H P04 1 -3.5640 -1.1550 -2.5114 
ATOM 13 H P04 1 -3.2299 -2.8696 -2.2383 
ATOM 14 C P04 1 -4.7469 -3.1702  0.0396 
ATOM 15 H P04 1 -4.0382 -3.9859 -0.0970 
ATOM 16 H P04 1 -4.9406 -3.0503  1.1062 
ATOM 17 H P04 1 -5.6780 -3.4422 -0.4601 
ATOM 18 C P04 1 -2.8629 -1.5727  0.1335 
ATOM 19 O P04 1 -1.7829 -1.8896 -0.3636 
ATOM 20 N P04 1 -2.9563 -1.0002  1.3446 
ATOM 21 H P04 1 -3.8755 -0.7703  1.6918 
ATOM 22 C P04 1 -1.8144 -0.7958  2.2266 
ATOM 23 C P04 1 -1.2715 -2.1293  2.7240 
ATOM 24 H P04 1 -2.0563 -2.6499  3.2733 
ATOM 25 H P04 1 -0.9478 -2.7498  1.8896 
ATOM 26 H P04 1 -0.4232 -1.9649  3.3853 
ATOM 27 C P04 1 -2.2852  0.0619  3.4003 
ATOM 28 H P04 1 -1.4502  0.2596  4.0708 
ATOM 29 H P04 1 -2.6909  1.0141  3.0557 
ATOM 30 H P04 1 -3.0555 -0.4693  3.9620 
ATOM 31 C P04 1 -0.7069 -0.0113  1.5099 
ATOM 32 O P04 1  0.4744 -0.1638  1.8289 
ATOM 33 N P04 1 -1.0888  0.8921  0.5949 
ATOM 34 H P04 1 -2.0575  0.9276  0.2940 
ATOM 35 C P04 1 -0.1303  1.7748 -0.0430 
ATOM 36 C P04 1 -0.8792  2.7720 -1.0036 
ATOM 37 H P04 1 -1.2014  2.3100 -1.9355 
ATOM 38 C P04 1  0.5643  2.7467  0.9474 
ATOM 39 H P04 1  0.2481  2.5484  1.9700 
ATOM 40 H P04 1  1.6457  2.6359  0.8856 
ATOM 41 C P04 1 -1.3571  4.2434  0.6939 
ATOM 42 H P04 1 -1.8187  4.7963  1.5016 
ATOM 43 C P04 1 -1.9615  3.4208 -0.1678 
ATOM 44 H P04 1 -3.0080  3.1570 -0.2142 
ATOM 45 C P04 1  0.1263  4.1475  0.4455 
ATOM 46 H P04 1  0.7350  4.9630  0.8310 
ATOM 47 C P04 1  0.1383  3.9149 -1.0687 
ATOM 48 H P04 1  1.1128  3.6134 -1.4496 
ATOM 49 H P04 1 -0.2471  4.7651 -1.6318 
ATOM 50 C P04 1  0.9053  0.9666 -0.8359 
ATOM 51 O P04 1  2.0098  1.4454 -1.1147 
ATOM 52 N P04 1  0.5609 -0.2687 -1.2283 
ATOM 53 H P04 1 -0.3284 -0.6686 -0.9438 
ATOM 54 C P04 1  1.4746 -1.1142 -1.9864 
ATOM 55 C P04 1  1.6584 -0.5858 -3.4028 
ATOM 56 H P04 1  0.6936 -0.5890 -3.9108 
ATOM 57 H P04 1  2.0517  0.4288 -3.3897 
ATOM 58 H P04 1  2.3504 -1.2227 -3.9504 
ATOM 59 C P04 1  0.8880 -2.5252 -2.0257 
ATOM 60 H P04 1  1.5675 -3.1858 -2.5629 
ATOM 61 H P04 1  0.7300 -2.9157 -1.0201 
ATOM 62 H P04 1 -0.0719 -2.5145 -2.5428 
ATOM 63 C P04 1  2.8373 -1.2212 -1.2792 
ATOM 64 O P04 1  3.8627 -1.4211 -1.9269 
ATOM 65 N P04 1  2.8209 -1.1726  0.0662 
ATOM 66 H P04 1  1.9557 -0.9324  0.5388 
ATOM 67 C P04 1  4.0113 -1.3576  0.8859 
ATOM 68 C P04 1  4.5679 -2.7675  0.7317 
ATOM 69 H P04 1  3.8118 -3.4860  1.0505 
ATOM 70 H P04 1  4.8359 -2.9674 -0.3039 
ATOM 71 H P04 1  5.4532 -2.8840  1.3540 
ATOM 72 C P04 1  3.6093 -1.1142  2.3408 
ATOM 73 H P04 1  4.4837 -1.2179  2.9819 
ATOM 74 H P04 1  3.1864 -0.1176  2.4711 
ATOM 75 H P04 1  2.8627 -1.8480  2.6477 
ATOM 76 C P04 1  5.0958 -0.3182  0.5521 
ATOM 77 O P04 1  6.2791 -0.5423  0.8200 
ATOM 78 N P04 1  4.6771  0.8551  0.0672 
ATOM 79 H P04 1  3.7163  0.9581 -0.2388 
ATOM 80 C P04 1  5.6111  1.9146 -0.2257 
ATOM 81 H P04 1  6.2909  1.6382 -1.0350 
ATOM 82 H P04 1  5.0529  2.7992 -0.5218 
ATOM 83 H P04 1  6.2102  2.1508  0.6540 
COMPND Ac-Aib2-(1S,2R,3S,4R)-VIIa-Aib2-NHMe-P310 
REMARK Energy(ZPE)= -2233.38737 
REMARK #IF = 0 
ATOM  1 C P05 1 -6.0818  1.2710 -0.369 
ATOM  2 H P05 1 -5.7213  1.8855 -1.1929 
ATOM  3 H P05 1 -6.9553  0.7087 -0.6915 
ATOM  4 H P05 1 -6.3693  1.9401  0.4422 
ATOM  5 C P05 1 -4.9608  0.3991  0.1097 
ATOM  6 O P05 1 -3.8604  0.8665  0.4196 
ATOM  7 N P05 1 -5.1991 -0.9262  0.1689 
ATOM  8 H P05 1 -6.1296 -1.2526 -0.0404 
ATOM  9 C P05 1 -4.2735 -1.8789  0.7758 
ATOM 10 C P05 1 -4.8000 -3.2847  0.4894 
ATOM 11 H P05 1 -5.7696  -3.422  0.9709 
ATOM 12 H P05 1 -4.9103 -3.4585 -0.5818 
ATOM 13 H P05 1 -4.1124 -4.0258  0.8945 
ATOM 14 C P05 1 -4.1604 -1.6458  2.2764 
ATOM 15 H P05 1 -3.4714 -2.3651  2.7146 
ATOM 16 H P05 1  -3.794  -0.642   2.486 
ATOM 17 H P05 1 -5.1432  -1.771  2.7314 
ATOM 18 C P05 1  -2.889 -1.7608  0.1224 
ATOM 19 O P05 1 -1.8642 -1.9694  0.7707 
ATOM 20 N P05 1 -2.8796 -1.4794 -1.1914 
ATOM 21 H P05 1 -3.7696 -1.3209 -1.6395 
ATOM 22 C P05 1 -1.6831  -1.432 -2.0196 
ATOM 23 C P05 1 -2.0991 -0.9256 -3.4005 
ATOM 24 H P05 1 -2.7843 -1.6375 -3.8635 
ATOM 25 H P05 1 -2.5908  0.0465  -3.337 
ATOM 26 H P05 1 -1.2199 -0.8333 -4.0362 
ATOM 27 C P05 1 -1.0421 -2.8107 -2.1365 
ATOM 28 H P05 1 -0.1545 -2.7522 -2.7634 
ATOM 29 H P05 1 -0.7547 -3.1897 -1.1571 
ATOM 30 H P05 1 -1.7569 -3.4976 -2.5899 
ATOM 31 C P05 1  -0.656 -0.4356 -1.4655 
ATOM 32 O P05 1  0.5302 -0.5357 -1.7844 
ATOM 33 N P05 1 -1.0993  0.5554 -0.6763 
ATOM 34 H P05 1 -2.0787  0.5894 -0.4058 
ATOM 35 C P05 1 -0.1874  1.5637 -0.1625 
ATOM 36 C P05 1  0.4556  2.4546 -1.2662 
ATOM 37 H P05 1  1.3512  2.0029 -1.6848 
ATOM 38 C P05 1 -1.0098  2.6139  0.6748 
ATOM 39 H P05 1 -2.0562  2.3098  0.7142 
ATOM 40 S P05 1 -0.5863  2.7735  2.4397 
ATOM 41 H P05 1  0.7213   3.034  2.2886 
ATOM 42 C P05 1 -1.5708  3.7199 -1.4686 
ATOM 43 H P05 1 -1.7405  4.6831 -1.9515 
ATOM 44 H P05 1  -2.547  3.2515 -1.3207 
ATOM 45 C P05 1 -0.6125  2.8286 -2.2904 
ATOM 46 H P05 1 -1.1056  1.9685  -2.741 
ATOM 47 H P05 1 -0.1436  3.3945 -3.0971 
ATOM 48 C P05 1   -0.83  3.9021 -0.1316 
ATOM 49 H P05 1 -1.1249  4.7885   0.427 
ATOM 50 C P05 1  0.6343  3.7934 -0.5455 
ATOM 51 H P05 1  1.3283  3.7462  0.2929 
ATOM 52 H P05 1  0.9489  4.5853  -1.228 
ATOM 53 C P05 1  0.9194  0.8932  0.6625 
ATOM 54 O P05 1  2.0068  1.4556  0.8241 
ATOM 55 N P05 1  0.6459 -0.3029  1.1936 
ATOM 56 H P05 1 -0.2568 -0.7282  1.0082 
ATOM 57 C P05 1  1.5919 -1.0139  2.0428 
ATOM 58 C P05 1  1.0405 -2.4187  2.2838 
ATOM 59 H P05 1  0.0737 -2.3576  2.7845 
ATOM 60 H P05 1  0.9079 -2.9579   1.345 
ATOM 61 H P05 1   1.729 -2.9761  2.9175 
ATOM 62 C P05 1  1.7808 -0.2867  3.3677 
ATOM 63 H P05 1  2.5122 -0.8129   3.978 
ATOM 64 H P05 1  2.1257  0.7329  3.2014 
ATOM 65 H P05 1  0.8271 -0.2552   3.895 
ATOM 66 C P05 1  2.9458 -1.1798  1.3317 
ATOM 67 O P05 1  3.9843 -1.2755  1.9824 
ATOM 68 N P05 1   2.908 -1.2938 -0.0092 
ATOM 69 H P05 1  2.0303 -1.1265 -0.4912 
ATOM 70 C P05 1  4.0933 -1.5349 -0.8218 
ATOM 71 C P05 1  3.6644 -1.4822 -2.2882 
ATOM 72 H P05 1  2.9352 -2.2684 -2.4898 
ATOM 73 H P05 1   3.211 -0.5212 -2.5328 
ATOM 74 H P05 1  4.5329 -1.6398 -2.9264 
ATOM 75 C P05 1  4.7046 -2.8962 -0.5119 
ATOM 76 H P05 1  5.5891 -3.0488 -1.1275 
ATOM 77 H P05 1  4.9894 -2.9648   0.536 
ATOM 78 H P05 1   3.975  -3.675 -0.7365 
ATOM 79 C P05 1   5.144 -0.4276 -0.6308 
ATOM 80 O P05 1  6.3297 -0.6408 -0.8969 
ATOM 81 N P05 1  4.6947  0.7783 -0.2692 
ATOM 82 H P05 1  3.7342  0.8894 0.0341 
ATOM 83 C P05 1  5.6004  1.8899 -0.1111 
ATOM 84 H P05 1  6.1622  2.0618 -1.0296 
ATOM 85 H P05 1  5.0222  2.7803 0.1224 
ATOM 86 H P05 1  6.3157  1.7105 0.6948 
 
COMPND Ac-Aib2-(1S,2R,3S,4R)-VIIa-Aib2-NHMe-M310 
REMARK Energy(ZPE)= -2233.380876 
REMARK #IF = 0 
ATOM  1 C P05 1 -6.0427  1.3168 -1.0163 
ATOM  2 H P05 1 -5.7297  2.2473 -0.5448 
ATOM  3 H P05 1 -6.2001  1.5185 -2.0762 
ATOM  4 H P05 1 -6.9810  0.9853 -0.5766 
ATOM  5 C P05 1 -4.9395  0.3102 -0.8822 
ATOM  6 O P05 1 -3.7780  0.5656 -1.2095 
ATOM  7 N P05 1 -5.2708 -0.8927 -0.3682 
ATOM  8 H P05 1 -6.2411 -1.0823 -0.1713 
ATOM  9 C P05 1 -4.3393 -2.0149 -0.3430 
ATOM 10 C P05 1 -4.0274 -2.5009 -1.7517 
ATOM 11 H P05 1 -4.9511 -2.8302 -2.2277 
ATOM 12 H P05 1 -3.5817 -1.7038 -2.3441 
ATOM 13 H P05 1 -3.3296 -3.3352 -1.7131 
ATOM 14 C P05 1 -4.9730 -3.1350  0.4816 
ATOM 15 H P05 1 -4.2831 -3.9745  0.5560 
ATOM 16 H P05 1 -5.2220 -2.7977  1.4883 
ATOM 17 H P05 1 -5.8826 -3.4861 -0.0085 
ATOM 18 C P05 1 -3.0454 -1.5957  0.3654 
ATOM 19 O P05 1 -1.9511 -2.0288  0.0073 
ATOM 20 N P05 1 -3.1769 -0.7932  1.4333 
ATOM 21 H P05 1 -4.0997 -0.4692  1.6817 
ATOM 22 C P05 1 -2.0635 -0.4781  2.3177 
ATOM 23 C P05 1 -1.6184 -1.7113  3.0921 
ATOM 24 H P05 1 -2.4530 -2.0760  3.6910 
ATOM 25 H P05 1 -1.2944 -2.4985  2.4131 
ATOM 26 H P05 1 -0.7912 -1.4586  3.7525 
ATOM 27 C P05 1 -2.5274  0.6185  3.2760 
ATOM 28 H P05 1 -1.7095  0.9006  3.9376 
ATOM 29 H P05 1 -2.8590  1.5034  2.7311 
ATOM 30 H P05 1 -3.3509  0.2504  3.8902 
ATOM 31 C P05 1 -0.8866  0.0978  1.5174 
ATOM 32 O P05 1  0.2724 -0.0580  1.8979 
ATOM 33 N P05 1 -1.1951  0.8655  0.4539 
ATOM 34 H P05 1 -2.1390  0.8386  0.0815 
ATOM 35 C P05 1 -0.1800  1.6241 -0.2535 
ATOM 36 C P05 1 -0.8151  2.5559 -1.3285 
ATOM 37 H P05 1 -1.0663  2.0186 -2.2432 
ATOM 38 C P05 1  0.4911  2.6767  0.7100 
ATOM 39 H P05 1 -0.0245  2.6068  1.6679 
ATOM 40 S P05 1  2.2281  2.4744  1.1948 
ATOM 41 H P05 1  2.7738  2.8544  0.0305 
ATOM 42 C P05 1 -1.2939  4.3369  0.2317 
ATOM 43 H P05 1 -1.5046  5.3732 -0.0372 
ATOM 44 H P05 1 -1.6061  4.1977  1.2687 
ATOM 45 C P05 1 -1.9859  3.3519 -0.7352 
ATOM 46 H P05 1 -2.7462  2.7412 -0.2545 
ATOM 47 H P05 1 -2.4818  3.8819 -1.5501 
ATOM 48 C P05 1  0.1932  4.0248  0.0345 
ATOM 49 H P05 1  0.8624  4.8163  0.3670 
ATOM 50 C P05 1  0.2446  3.6558 -1.4469 
ATOM 51 H P05 1  1.2170  3.2921 -1.7748 
ATOM 52 H P05 1 -0.0845  4.4675 -2.0984 
ATOM 53 C P05 1  0.8025  0.6916 -0.9769 
ATOM 54 O P05 1  1.8608  1.1152 -1.4477 
ATOM 55 N P05 1  0.4268 -0.5898 -1.1233 
ATOM 56 H P05 1 -0.4386 -0.9152 -0.7063 
ATOM 57 C P05 1  1.2518 -1.5650 -1.8225 
ATOM 58 C P05 1  1.3839 -1.2251 -3.3020 
ATOM 59 H P05 1  0.3922 -1.2278 -3.7558 
ATOM 60 H P05 1  1.8383 -0.2464 -3.4391 
ATOM 61 H P05 1  2.0015 -1.9723 -3.7966 
ATOM 62 C P05 1  0.5988 -2.9387 -1.6681 
ATOM 63 H P05 1  1.2221 -3.6884 -2.1538 
ATOM 64 H P05 1  0.4740 -3.2045 -0.6183 
ATOM 65 H P05 1 -0.3831 -2.9385 -2.1416 
ATOM 66 C P05 1  2.6407 -1.6718 -1.1744 
ATOM 67 O P05 1  3.6017 -2.0716 -1.8283 
ATOM 68 N P05 1  2.7186 -1.3896  0.1408 
ATOM 69 H P05 1  1.9084 -1.0008  0.6121 
ATOM 70 C P05 1  3.9451 -1.5556  0.9120 
ATOM 71 C P05 1  4.3772 -3.0167  0.9512 
ATOM 72 H P05 1  3.5823 -3.6099  1.4048 
ATOM 73 H P05 1  4.5770 -3.3931 -0.0496 
ATOM 74 H P05 1  5.2792 -3.1171  1.5520 
ATOM 75 C P05 1  3.6663 -1.0626  2.3311 
ATOM 76 H P05 1  4.5758 -1.1341  2.9263 
ATOM 77 H P05 1  3.3204 -0.0289  2.3237 
ATOM 78 H P05 1  2.8987 -1.6854  2.7938 
ATOM 79 C P05 1  5.0774 -0.6826  0.3432 
ATOM 80 O P05 1  6.2583 -0.9615  0.5659 
ATOM 81 N P05 1  4.7096  0.4202 -0.3152 
ATOM 82 H P05 1  3.7293  0.5702 -0.5165 
ATOM 83 C P05 1  5.6856  1.3349 -0.8528 
ATOM 84 H P05 1  6.2632  0.8744 -1.6575 
ATOM 85 H P05 1  5.1690  2.2068 -1.2471 
ATOM 86 H P05 1  6.3807  1.6543 -0.0760 
 
COMPND Ac-Aib2-(1S,2R,3R,4R)-VIIb-Aib2-NHMe-P310 
REMARK Energy(ZPE)= -2233.383227 
REMARK #IF = 0 
ATOM  1 C P06 1 -6.5936  0.1771 -1.2960 
ATOM  2 H P06 1 -6.3441  0.7751 -2.1707 
ATOM  3 H P06 1 -7.1406 -0.7106 -1.6072 
ATOM  4 H P06 1 -7.2392  0.7780 -0.6540 
ATOM  5 C P06 1 -5.3316 -0.1346 -0.5420 
ATOM  6 O P06 1 -4.4817  0.7218 -0.3107 
ATOM  7 N P06 1 -5.1755 -1.4244 -0.1494 
ATOM  8 H P06 1 -5.9344 -2.0607 -0.3368 
ATOM  9 C P06 1 -4.1532 -1.8911  0.7830 
ATOM 10 C P06 1 -4.3144 -3.4061  0.9132 
ATOM 11 H P06 1 -5.2944 -3.6390  1.3331 
ATOM 12 H P06 1 -4.2181 -3.8999 -0.0548 
ATOM 13 H P06 1 -3.5525 -3.7980  1.5849 
ATOM 14 C P06 1 -4.3090 -1.2242  2.1450 
ATOM 15 H P06 1 -3.5241 -1.5680  2.8163 
ATOM 16 H P06 1 -4.2434 -0.1415  2.0516 
ATOM 17 H P06 1 -5.2794 -1.4917  2.5636 
ATOM 18 C P06 1 -2.7338 -1.6538  0.2442 
ATOM 19 O P06 1 -1.7671 -1.6841  1.0080 
ATOM 20 N P06 1 -2.6231 -1.4805 -1.0809 
ATOM 21 H P06 1 -3.4811 -1.4810 -1.6099 
ATOM 22 C P06 1 -1.3798 -1.3992 -1.8288 
ATOM 23 C P06 1 -1.7387 -1.0863 -3.2811 
ATOM 24 H P06 1 -2.3374 -1.8986 -3.6959 
ATOM 25 H P06 1 -2.3039 -0.1560 -3.3580 
ATOM 26 H P06 1 -0.8282 -0.9935 -3.8702 
ATOM 27 C P06 1 -0.6140 -2.7185 -1.7474 
ATOM 28 H P06 1  0.3039 -2.6503 -2.3275 
ATOM 29 H P06 1 -0.3616 -2.9568 -0.7148 
ATOM 30 H P06 1 -1.2372 -3.5152 -2.1539 
ATOM 31 C P06 1 -0.4704 -0.2703 -1.3366 
ATOM 32 O P06 1  0.7120 -0.2633 -1.6911 
ATOM 33 N P06 1 -0.9725  0.6891 -0.5453 
ATOM 34 H P06 1 -1.9485  0.6772 -0.2604 
ATOM 35 C P06 1 -0.0948  1.7203 -0.0297 
ATOM 36 C P06 1  0.2795  2.7928 -1.0873 
ATOM 37 H P06 1  1.1419  2.5066 -1.6848 
ATOM 38 C P06 1 -0.7649  2.6000  1.0932 
ATOM 39 H P06 1 -0.0233  2.7497  1.8783 
ATOM 40 S P06 1 -2.2453  1.9358  1.8968 
ATOM 41 H P06 1 -1.6244  0.9376  2.5447 
ATOM 42 C P06 1 -1.9055  3.7535 -0.8195 
ATOM 43 H P06 1 -2.3099  4.7101 -1.1510 
ATOM 44 H P06 1 -2.7556  3.1085 -0.5790 
ATOM 45 C P06 1 -0.9817  3.1209 -1.8875 
ATOM 46 H P06 1 -1.4252  2.2571 -2.3801 
ATOM 47 H P06 1 -0.7268  3.8460 -2.6620 
ATOM 48 C P06 1 -0.9732  3.9397  0.3896 
ATOM 49 H P06 1 -1.2669  4.7317  1.0767 
ATOM 50 C P06 1  0.4056  4.0739 -0.2592 
ATOM 51 H P06 1  1.2237  4.0566  0.4611 
ATOM 52 H P06 1  0.4961  4.9581 -0.8926 
ATOM 53 C P06 1  1.1263  1.0731  0.6242 
ATOM 54 O P06 1  2.2183  1.6428  0.6408 
ATOM 55 N P06 1  0.8933 -0.0882  1.2615 
ATOM 56 H P06 1 -0.0167 -0.5287  1.1551 
ATOM 57 C P06 1  1.8842 -0.7657  2.0877 
ATOM 58 C P06 1  1.3096 -2.1296  2.4693 
ATOM 59 H P06 1  0.4014 -1.9969  3.0588 
ATOM 60 H P06 1  1.0646 -2.7159  1.5826 
ATOM 61 H P06 1  2.0362 -2.6776  3.0672 
ATOM 62 C P06 1  2.1837  0.0471  3.3413 
ATOM 63 H P06 1  2.9193 -0.4709  3.9533 
ATOM 64 H P06 1  2.5751  1.0294  3.0824 
ATOM 65 H P06 1  1.2638  0.1691  3.9139 
ATOM 66 C P06 1  3.1859 -1.0295  1.3131 
ATOM 67 O P06 1  4.2475 -1.1614  1.9189 
ATOM 68 N P06 1  3.0817 -1.1752 -0.0201 
ATOM 69 H P06 1  2.1953 -0.9717 -0.4704 
ATOM 70 C P06 1  4.2238 -1.4757 -0.8737 
ATOM 71 C P06 1  3.7411 -1.4278 -2.3234 
ATOM 72 H P06 1  2.9678 -2.1811 -2.4818 
ATOM 73 H P06 1  3.3246 -0.4507 -2.5689 
ATOM 74 H P06 1  4.5754 -1.6380 -2.9913 
ATOM 75 C P06 1  4.7941 -2.8541 -0.5636 
ATOM 76 H P06 1  5.6393 -3.0586 -1.2181 
ATOM 77 H P06 1  5.1272 -2.9127  0.4705 
ATOM 78 H P06 1  4.0222 -3.6053 -0.7347 
ATOM 79 C P06 1  5.3174 -0.4019 -0.7376 
ATOM 80 O P06 1  6.4907 -0.6632 -1.0135 
ATOM 81 N P06 1  4.9116  0.8299 -0.4117 
ATOM 82 H P06 1  3.9563  0.9817 -0.1096 
ATOM 83 C P06 1  5.8510  1.9201 -0.3131 
ATOM 84 H P06 1  6.3968  2.0437 -1.2490 
ATOM 85 H P06 1  5.3030  2.8343 -0.0996 




REMARK Energy(ZPE)= -2233.382783 
REMARK #IF = 0 
ATOM  1 C P06 1 -6.1867  0.8444 -0.4855 
ATOM  2 H P06 1 -5.9353  1.7218  0.1093 
ATOM  3 H P06 1 -6.4592  1.1877 -1.4835 
ATOM  4 H P06 1 -7.0402  0.3389 -0.0386 
ATOM  5 C P06 1 -4.9721 -0.0288 -0.5971 
ATOM  6 O P06 1 -3.8962  0.3976 -1.0212 
ATOM  7 N P06 1 -5.1014 -1.3095 -0.1886 
ATOM  8 H P06 1 -6.0117 -1.6399  0.0908 
ATOM  9 C P06 1 -4.0542 -2.3018 -0.3969 
ATOM 10 C P06 1 -3.8600 -2.5926 -1.8788 
ATOM 11 H P06 1 -4.7881 -2.9923 -2.2878 
ATOM 12 H P06 1 -3.5917 -1.6853 -2.4173 
ATOM 13 H P06 1 -3.0665 -3.3251 -2.0150 
ATOM 14 C P06 1 -4.4583 -3.5728  0.3498 
ATOM 15 H P06 1 -3.6799 -4.3273  0.2447 
ATOM 16 H P06 1 -4.6162 -3.3793  1.4116 
ATOM 17 H P06 1 -5.3797 -3.9736 -0.0760 
ATOM 18 C P06 1 -2.7400 -1.8051  0.2189 
ATOM 19 O P06 1 -1.6532 -2.0733 -0.2915 
ATOM 20 N P06 1 -2.8402 -1.1334  1.3775 
ATOM 21 H P06 1 -3.7626 -0.9570  1.7467 
ATOM 22 C P06 1 -1.6897 -0.7982  2.2058 
ATOM 23 C P06 1 -1.0622 -2.0527  2.7991 
ATOM 24 H P06 1 -1.8001 -2.5604  3.4203 
ATOM 25 H P06 1 -0.7314 -2.7280  2.0115 
ATOM 26 H P06 1 -0.2020 -1.7872  3.4108 
ATOM 27 C P06 1 -2.1756  0.1350  3.3139 
ATOM 28 H P06 1 -1.3357  0.4376  3.9375 
ATOM 29 H P06 1 -2.6388  1.0309  2.8986 
ATOM 30 H P06 1 -2.9009 -0.3853  3.9417 
ATOM 31 C P06 1 -0.6426 -0.0306  1.3885 
ATOM 32 O P06 1  0.5564 -0.1468  1.6312 
ATOM 33 N P06 1 -1.1064  0.8302  0.4614 
ATOM 34 H P06 1 -2.0879  0.7867  0.2107 
ATOM 35 C P06 1 -0.2242  1.6662 -0.3240 
ATOM 36 C P06 1 -0.9802  2.3377 -1.5001 
ATOM 37 H P06 1 -1.2410  1.6264 -2.2834 
ATOM 38 C P06 1  0.3692  2.9202  0.4067 
ATOM 39 H P06 1  1.4523  2.8239  0.3981 
ATOM 40 S P06 1 -0.1623  3.0226  2.1489 
ATOM 41 H P06 1  0.5478  4.1267  2.4221 
ATOM 42 C P06 1 -1.5305  4.4040 -0.3480 
ATOM 43 H P06 1 -1.7819  5.3000 -0.9181 
ATOM 44 H P06 1 -1.8329  4.5677  0.6853 
ATOM 45 C P06 1 -2.1770  3.1453 -0.9647 
ATOM 46 H P06 1 -2.7880  2.5978 -0.2493 
ATOM 47 H P06 1 -2.8337  3.3951 -1.7989 
ATOM 48 C P06 1 -0.0412  4.1074 -0.4859 
ATOM 49 H P06 1  0.6061  4.9722 -0.3414 
ATOM 50 C P06 1 -0.0066  3.4588 -1.8719 
ATOM 51 H P06 1  0.9792  3.1103 -2.1735 
ATOM 52 H P06 1 -0.4132  4.1130 -2.6450 
ATOM 53 C P06 1  0.9221  0.8182 -0.9166 
ATOM 54 O P06 1  2.0478  1.2916 -1.0919 
ATOM 55 N P06 1  0.6100 -0.4251 -1.3069 
ATOM 56 H P06 1 -0.2892 -0.8215 -1.0540 
ATOM 57 C P06 1  1.5487 -1.2767 -2.0277 
ATOM 58 C P06 1  1.7775 -0.7436 -3.4365 
ATOM 59 H P06 1  0.8280 -0.7378 -3.9722 
ATOM 60 H P06 1  2.1769  0.2688 -3.4090 
ATOM 61 H P06 1  2.4818 -1.3818 -3.9665 
ATOM 62 C P06 1  0.9529 -2.6830 -2.0899 
ATOM 63 H P06 1  1.6322 -3.3403 -2.6310 
ATOM 64 H P06 1  0.7855 -3.0861 -1.0912 
ATOM 65 H P06 1 -0.0029 -2.6587 -2.6149 
ATOM 66 C P06 1  2.8907 -1.3985 -1.2864 
ATOM 67 O P06 1  3.9248 -1.6275 -1.9112 
ATOM 68 N P06 1  2.8491 -1.3293  0.0563 
ATOM 69 H P06 1  1.9847 -1.0493  0.5077 
ATOM 70 C P06 1  4.0249 -1.5117  0.8978 
ATOM 71 C P06 1  4.5629 -2.9324  0.7846 
ATOM 72 H P06 1  3.7939 -3.6323  1.1136 
ATOM 73 H P06 1  4.8379 -3.1614 -0.2430 
ATOM 74 H P06 1  5.4408 -3.0458  1.4179 
ATOM 75 C P06 1  3.6060 -1.2289  2.3409 
ATOM 76 H P06 1  4.4664 -1.3452  2.9987 
ATOM 77 H P06 1  3.2110 -0.2182  2.4462 
ATOM 78 H P06 1  2.8332 -1.9351  2.6488 
ATOM 79 C P06 1  5.1275 -0.4951  0.5529 
ATOM 80 O P06 1  6.3065 -0.7317  0.8283 
ATOM 81 N P06 1  4.7272  0.6757  0.0468 
ATOM 82 H P06 1  3.7676  0.7869 -0.2596 
ATOM 83 C P06 1  5.6780  1.7138 -0.2679 
ATOM 84 H P06 1  6.2635  1.9790  0.6129 
ATOM 85 H P06 1  6.3695  1.3984 -1.0525 
ATOM 86 H P06 1  5.1353  2.5918 -0.6091 
 
COMPND Ac-Aib2-(1R,2S,4R)-IIIb-Aib2-NHMe-P310 
REMARK Energy(ZPE)= -2023.434992 
REMARK #IF = 0 
ATOM  1 C P07 1 -6.0390  1.7071 -0.4465 
ATOM  2 H P07 1 -5.6581  2.1659 -1.3576 
ATOM  3 H P07 1 -6.9859  1.2144 -0.6564 
ATOM  4 H P07 1 -6.2076  2.5023  0.2802 
ATOM  5 C P07 1 -4.9974  0.7788  0.1010 
ATOM  6 O P07 1 -3.8273  1.1378  0.2653 
ATOM  7 N P07 1 -5.3900 -0.4770  0.3955 
ATOM  8 H P07 1 -6.3672 -0.7070  0.3035 
ATOM  9 C P07 1 -4.5385 -1.4262  1.1069 
ATOM 10 C P07 1 -5.2411 -2.7833  1.0955 
ATOM 11 H P07 1 -6.1841 -2.7165  1.6404 
ATOM 12 H P07 1 -5.4447 -3.1185  0.0779 
ATOM 13 H P07 1 -4.6166 -3.5264  1.5893 
ATOM 14 C P07 1 -4.2881 -0.9657  2.5366 
ATOM 15 H P07 1 -3.6429 -1.6758  3.0501 
ATOM 16 H P07 1 -3.8083  0.0117  2.5482 
ATOM 17 H P07 1 -5.2406 -0.9042  3.0630 
ATOM 18 C P07 1 -3.2036 -1.5906  0.3677 
ATOM 19 O P07 1 -2.1564 -1.7954  0.9801 
ATOM 20 N P07 1 -3.2590 -1.5609 -0.9742 
ATOM 21 H P07 1 -4.1520 -1.3847 -1.4095 
ATOM 22 C P07 1 -2.1119 -1.8235 -1.8321 
ATOM 23 C P07 1 -2.5153 -1.4755 -3.2646 
ATOM 24 H P07 1 -3.3336 -2.1225 -3.5849 
ATOM 25 H P07 1 -2.8344 -0.4355 -3.3452 
ATOM 26 H P07 1 -1.6710 -1.6360 -3.9333 
ATOM 27 C P07 1 -1.6812 -3.2820 -1.7402 
ATOM 28 H P07 1 -0.8173 -3.4531 -2.3796 
ATOM 29 H P07 1 -1.4152 -3.5417 -0.7169 
ATOM 30 H P07 1 -2.5025 -3.9183 -2.0699 
ATOM 31 C P07 1 -0.9381 -0.9099 -1.4611 
ATOM 32 O P07 1  0.2216 -1.2464 -1.7104 
ATOM 33 N P07 1 -1.2293  0.2852 -0.9288 
ATOM 34 H P07 1 -2.1882  0.5200 -0.6865 
ATOM 35 C P07 1 -0.1818  1.2465 -0.6512 
ATOM 36 C P07 1  0.4216  1.8423 -1.9455 
ATOM 37 H P07 1  0.0124  1.3249 -2.8112 
ATOM 38 H P07 1  1.5064  1.7760 -1.9578 
ATOM 39 C P07 1 -0.0880  3.2970 -1.8837 
ATOM 40 H P07 1 -0.2063  3.7979 -2.8397 
ATOM 41 O P07 1 -1.3624  3.1247 -1.2402 
ATOM 42 C P07 1 -0.8703  2.5184 -0.0466 
ATOM 43 H P07 1 -1.6778  2.2985  0.6456 
ATOM 44 C P07 1  0.1868  3.4977  0.3831 
ATOM 45 C P07 1  0.6884  4.0126 -0.8101 
ATOM 46 C P07 1  0.6919  3.8857  1.6075 
ATOM 47 H P07 1  0.3108  3.4755  2.5349 
ATOM 48 C P07 1  1.7218  4.9279 -0.8140 
ATOM 49 H P07 1  2.1269  5.3245 -1.7370 
ATOM 50 C P07 1  1.7184  4.8327  1.6128 
ATOM 51 H P07 1  2.1246  5.1764  2.5559 
ATOM 52 C P07 1  2.2257  5.3431  0.4213 
ATOM 53 H P07 1  3.0199  6.0787  0.4535 
ATOM 54 C P07 1  0.8800  0.6645  0.2822 
ATOM 55 O P07 1  2.0423  1.0717  0.2455 
ATOM 56 N P07 1  0.4670 -0.2660  1.1552 
ATOM 57 H P07 1 -0.4839 -0.6171  1.0961 
ATOM 58 C P07 1  1.3530 -0.8539  2.1521 
ATOM 59 C P07 1  0.6119 -2.0217  2.8020 
ATOM 60 H P07 1 -0.2778 -1.6560  3.3163 
ATOM 61 H P07 1  0.3052 -2.7577  2.0586 
ATOM 62 H P07 1  1.2614 -2.5028  3.5320 
ATOM 63 C P07 1  1.7351  0.1773  3.2069 
ATOM 64 H P07 1  2.3688 -0.2806  3.9638 
ATOM 65 H P07 1  2.2728  1.0112  2.7592 
ATOM 66 H P07 1  0.8272  0.5514  3.6813 
ATOM 67 C P07 1  2.6207 -1.4332  1.5017 
ATOM 68 O P07 1  3.6639 -1.5186  2.1463 
ATOM 69 N P07 1  2.4972 -1.9011  0.2459 
ATOM 70 H P07 1  1.6351 -1.7303 -0.2612 
ATOM 71 C P07 1  3.5897 -2.5471 -0.4712 
ATOM 72 C P07 1  3.1081 -2.8276 -1.8946 
ATOM 73 H P07 1  2.2485 -3.4994 -1.8701 
ATOM 74 H P07 1  2.8124 -1.9087 -2.4011 
ATOM 75 H P07 1  3.9077 -3.3044 -2.4602 
ATOM 76 C P07 1  3.9908 -3.8531  0.2034 
ATOM 77 H P07 1  4.8004 -4.3222 -0.3525 
ATOM 78 H P07 1  4.3201 -3.6779  1.2255 
ATOM 79 H P07 1  3.1324 -4.5259  0.2148 
ATOM 80 C P07 1  4.8072 -1.6138 -0.5940 
ATOM 81 O P07 1  5.9352 -2.0776 -0.7798 
ATOM 82 N P07 1  4.5608 -0.2999 -0.5933 
ATOM 83 H P07 1  3.6393  0.0392 -0.3431 
ATOM 84 C P07 1  5.6281  0.6570 -0.7546 
ATOM 85 H P07 1  6.3399  0.6049  0.0724 
ATOM 86 H P07 1  6.1724  0.4735 -1.6814 
ATOM 87 H P07 1  5.1991  1.6552 -0.7877 
 
COMPND Ac-Aib2-(1R,2S,4R)-IIIb-Aib2-NHMe-M310 
REMARK Energy(ZPE)= -2023.430559 
REMARK #IF = 0 
ATOM  1 C P07 1  6.0159  2.2780  0.0049 
ATOM  2 H P07 1  5.5705  2.8781 -0.7875 
ATOM  3 H P07 1  6.1228  2.9151  0.8828 
ATOM  4 H P07 1  7.0003  1.9380 -0.3096 
ATOM  5 C P07 1  5.0811  1.1562  0.3436 
ATOM  6 O P07 1  3.9043  1.3627  0.6558 
ATOM  7 N P07 1  5.5761 -0.0956  0.2708 
ATOM  8 H P07 1  6.5567 -0.2101  0.0673 
ATOM  9 C P07 1  4.8455 -1.2728  0.7309 
ATOM 10 C P07 1  4.6639 -1.2451  2.2422 
ATOM 11 H P07 1  5.6445 -1.2267  2.7179 
ATOM 12 H P07 1  4.1009 -0.3652  2.5487 
ATOM 13 H P07 1  4.1270 -2.1328  2.5707 
ATOM 14 C P07 1  5.6441 -2.5062  0.3097 
ATOM 15 H P07 1  5.1142 -3.4095  0.6084 
ATOM 16 H P07 1  5.7982 -2.5310 -0.7698 
ATOM 17 H P07 1  6.6163 -2.5028  0.8051 
ATOM 18 C P07 1  3.4772 -1.3505  0.0390 
ATOM 19 O P07 1  2.4984 -1.8212  0.6168 
ATOM 20 N P07 1  3.4340 -0.9355 -1.2376 
ATOM 21 H P07 1  4.2782 -0.5569 -1.6401 
ATOM 22 C P07 1  2.2560 -1.0443 -2.0867 
ATOM 23 C P07 1  1.9416 -2.5022 -2.3994 
ATOM 24 H P07 1  2.7852 -2.9418 -2.9316 
ATOM 25 H P07 1  1.7647 -3.0644 -1.4837 
ATOM 26 H P07 1  1.0531 -2.5644 -3.0246 
ATOM 27 C P07 1  2.5379 -0.2711 -3.3747 
ATOM 28 H P07 1  1.6655 -0.3117 -4.0250 
ATOM 29 H P07 1  2.7720  0.7739 -3.1670 
ATOM 30 H P07 1  3.3788 -0.7250 -3.9014 
ATOM 31 C P07 1  1.0423 -0.3823 -1.4243 
ATOM 32 O P07 1 -0.1010 -0.7275 -1.7310 
ATOM 33 N P07 1  1.2729  0.6157 -0.5563 
ATOM 34 H P07 1  2.2251  0.8591 -0.2990 
ATOM 35 C P07 1  0.1722  1.3623  0.0236 
ATOM 36 C P07 1  0.7233  2.4674  0.9609 
ATOM 37 H P07 1  1.7840  2.3149  1.1518 
ATOM 38 H P07 1  0.1962  2.5006  1.9128 
ATOM 39 C P07 1  0.4786  3.7389  0.1161 
ATOM 40 H P07 1  1.1844  4.5481  0.2772 
ATOM 41 O P07 1  0.5886  3.2226 -1.2178 
ATOM 42 C P07 1 -0.4537  2.2453 -1.1091 
ATOM 43 H P07 1 -0.5935  1.7105 -2.0427 
ATOM 44 C P07 1 -1.5927  3.0909 -0.6081 
ATOM 45 C P07 1 -0.9883  4.0687  0.1777 
ATOM 46 C P07 1 -2.9586  3.0756 -0.8083 
ATOM 47 H P07 1 -3.4335  2.3142 -1.4146 
ATOM 48 C P07 1 -1.7340  5.0389  0.8191 
ATOM 49 H P07 1 -1.2692  5.7928  1.4427 
ATOM 50 C P07 1 -3.7168  4.0701 -0.1906 
ATOM 51 H P07 1 -4.7894  4.0952 -0.3398 
ATOM 52 C P07 1 -3.1156  5.0331  0.6166 
ATOM 53 H P07 1 -3.7276  5.7950  1.0834 
ATOM 54 C P07 1 -0.7847  0.4330  0.7682 
ATOM 55 O P07 1 -1.9597  0.7482  0.9609 
ATOM 56 N P07 1 -0.2542 -0.7051  1.2401 
ATOM 57 H P07 1  0.7127 -0.9267  1.0240 
ATOM 58 C P07 1 -1.0099 -1.6626  2.0368 
ATOM 59 C P07 1 -1.3415 -1.0855  3.4069 
ATOM 60 H P07 1 -0.4126 -0.8512  3.9276 
ATOM 61 H P07 1 -1.9359 -0.1787  3.3116 
ATOM 62 H P07 1 -1.9030 -1.8119  3.9909 
ATOM 63 C P07 1 -0.1510 -2.9182  2.1881 
ATOM 64 H P07 1 -0.6939 -3.6616  2.7702 
ATOM 65 H P07 1  0.1020 -3.3430  1.2161 
ATOM 66 H P07 1  0.7762 -2.6741  2.7078 
ATOM 67 C P07 1 -2.3009 -2.0918  1.3191 
ATOM 68 O P07 1 -3.2710 -2.4807  1.9661 
ATOM 69 N P07 1 -2.2716 -2.0844 -0.0260 
ATOM 70 H P07 1 -1.4575 -1.7042 -0.4969 
ATOM 71 C P07 1 -3.3906 -2.5184 -0.8522 
ATOM 72 C P07 1 -3.6593 -4.0081 -0.6743 
ATOM 73 H P07 1 -2.7660 -4.5663 -0.9572 
ATOM 74 H P07 1 -3.9108 -4.2379  0.3592 
ATOM 75 H P07 1 -4.4849 -4.3144 -1.3139 
ATOM 76 C P07 1 -3.0258 -2.2281 -2.3080 
ATOM 77 H P07 1 -3.8584 -2.5033 -2.9541 
ATOM 78 H P07 1 -2.7947 -1.1724 -2.4542 
ATOM 79 H P07 1 -2.1523 -2.8150 -2.5958 
ATOM 80 C P07 1 -4.6614 -1.7084 -0.5432 
ATOM 81 O P07 1 -5.7755 -2.1702 -0.8028 
ATOM 82 N P07 1 -4.4899 -0.4660 -0.0805 
ATOM 83 H P07 1 -3.5671 -0.1547  0.1997 
ATOM 84 C P07 1 -5.6234  0.3774  0.2102 
ATOM 85 H P07 1 -6.3055 -0.1110  0.9087 
ATOM 86 H P07 1 -5.2649  1.3025  0.6543 
ATOM 87 H P07 1 -6.1811  0.6132 -0.6977 
 
COMPND Ac-Aib2-(1S,2S,3S,4R)-VIIIa-Aib2-NHMe-P310 
REMARK Energy(ZPE)= -1910.359438 
REMARK #IF = 0 
ATOM  1 C P08 1  5.9944  1.6913 -0.2977 
ATOM  2 H P08 1  5.6094  2.4803  0.3463 
ATOM  3 H P08 1  6.9077  1.2853  0.1319 
ATOM  4 H P08 1  6.2258  2.1358 -1.2662 
ATOM  5 C P08 1  4.9242  0.6601 -0.4921 
ATOM  6 O P08 1  3.7753  0.9676 -0.8237 
ATOM  7 N P08 1  5.2660 -0.6255 -0.2717 
ATOM  8 H P08 1  6.2299 -0.8357 -0.0638 
ATOM  9 C P08 1  4.3851 -1.7455 -0.5895 
ATOM 10 C P08 1  5.0252 -3.0160 -0.0313 
ATOM 11 H P08 1  5.9778 -3.2007 -0.5304 
ATOM 12 H P08 1  5.1989 -2.9358  1.0424 
ATOM 13 H P08 1  4.3743 -3.8691 -0.2173 
ATOM 14 C P08 1  4.1800 -1.8657 -2.0937 
ATOM 15 H P08 1  3.5237 -2.7047 -2.3159 
ATOM 16 H P08 1  3.7325 -0.9578 -2.4950 
ATOM 17 H P08 1  5.1453 -2.0326 -2.5719 
ATOM 18 C P08 1  3.0305 -1.5651  0.1100 
ATOM 19 O P08 1  1.9924 -1.9765 -0.4078 
ATOM 20 N P08 1  3.0592 -0.9981  1.3268 
ATOM 21 H P08 1  3.9516 -0.6865  1.6795 
ATOM 22 C P08 1  1.8958 -0.8620  2.1924 
ATOM 23 C P08 1  2.3131 -0.0113  3.3918 
ATOM 24 H P08 1  3.0786 -0.5347  3.9670 
ATOM 25 H P08 1  2.7106  0.9544  3.0754 
ATOM 26 H P08 1  1.4542  0.1572  4.0396 
ATOM 27 C P08 1  1.4044 -2.2275  2.6593 
ATOM 28 H P08 1  0.5435 -2.1087  3.3138 
ATOM 29 H P08 1  1.1171 -2.8472  1.8112 
ATOM 30 H P08 1  2.2049 -2.7234  3.2084 
ATOM 31 C P08 1  0.7565 -0.1170  1.4811 
ATOM 32 O P08 1 -0.4085 -0.2803  1.8472 
ATOM 33 N P08 1  1.0891  0.7448  0.5055 
ATOM 34 H P08 1  2.0554  0.8023  0.1954 
ATOM 35 C P08 1  0.0909  1.5431 -0.1806 
ATOM 36 C P08 1 -0.7133  2.4973  0.7588 
ATOM 37 H P08 1 -1.5789  2.0125  1.2055 
ATOM 38 C P08 1  0.8020  2.5544 -1.1580 
ATOM 39 H P08 1  1.8720  2.3522 -1.1926 
ATOM 40 O P08 1  0.3586  2.4461 -2.4925 
ATOM 41 H P08 1 -0.6052  2.5026 -2.5080 
ATOM 42 C P08 1  1.1795  3.9645  0.8476 
ATOM 43 H P08 1  1.2590  4.9941  1.1970 
ATOM 44 H P08 1  2.1942  3.5600  0.7992 
ATOM 45 C P08 1  0.2584  3.1211  1.7587 
ATOM 46 H P08 1  0.7973  2.3927  2.3617 
ATOM 47 H P08 1 -0.3050  3.7572  2.4434 
ATOM 48 C P08 1  0.4829  3.9030 -0.5225 
ATOM 49 H P08 1  0.7197  4.7323 -1.1880 
ATOM 50 C P08 1 -0.9828  3.7087 -0.1404 
ATOM 51 H P08 1 -1.6408  3.4960 -0.9822 
ATOM 52 H P08 1 -1.3956  4.5473  0.4233 
ATOM 53 C P08 1 -0.8828  0.6577 -0.9582 
ATOM 54 O P08 1 -1.9460  1.1363 -1.3767 
ATOM 55 N P08 1 -0.5597 -0.6231 -1.1516 
ATOM 56 H P08 1  0.3320 -0.9756 -0.8140 
ATOM 57 C P08 1 -1.4772 -1.5613 -1.7873 
ATOM 58 C P08 1 -0.9234 -2.9702 -1.5774 
ATOM 59 H P08 1  0.0404 -3.0696 -2.0771 
ATOM 60 H P08 1 -0.7868 -3.1869 -0.5170 
ATOM 61 H P08 1 -1.6128 -3.6996 -2.0008 
ATOM 62 C P08 1 -1.6207 -1.2663 -3.2739 
ATOM 63 H P08 1 -2.2999 -1.9827 -3.7319 
ATOM 64 H P08 1 -2.0102 -0.2626 -3.4324 
ATOM 65 H P08 1 -0.6428 -1.3505 -3.7490 
ATOM 66 C P08 1 -2.8548 -1.5103 -1.1000 
ATOM 67 O P08 1 -3.8775 -1.7662 -1.7311 
ATOM 68 N P08 1 -2.8565 -1.2516  0.2218 
ATOM 69 H P08 1 -1.9834 -1.0133  0.6814 
ATOM 70 C P08 1 -4.0658 -1.2564  1.0346 
ATOM 71 C P08 1 -3.6758 -0.7948  2.4392 
ATOM 72 H P08 1 -2.9568 -1.4917  2.8726 
ATOM 73 H P08 1 -3.2252  0.1984  2.4186 
ATOM 74 H P08 1 -4.5611 -0.7685  3.0732 
ATOM 75 C P08 1 -4.6796 -2.6493  1.1007 
ATOM 76 H P08 1 -5.5814 -2.6250  1.7097 
ATOM 77 H P08 1 -4.9371 -3.0072  0.1057 
ATOM 78 H P08 1 -3.9619 -3.3347  1.5530 
ATOM 79 C P08 1 -5.1005 -0.2454  0.5107 
ATOM 80 O P08 1 -6.2983 -0.3887  0.7681 
ATOM 81 N P08 1 -4.6272  0.8291 -0.1290 
ATOM 82 H P08 1 -3.6568  0.8580 -0.4200 
ATOM 83 C P08 1 -5.5187  1.8567 -0.6090 
ATOM 84 H P08 1 -6.1241  2.2511  0.2075 
ATOM 85 H P08 1 -4.9254  2.6637 -1.0314 
ATOM 86 H P08 1 -6.1941  1.4740 -1.3776 
 
COMPND Ac-Aib2-(1S,2S,3S,4R)-VIIIa-Aib2-NHMe-M310 
REMARK Energy(ZPE)= -1910.350961 
REMARK #IF = 0 
ATOM  1 C P08 1 -5.8824  1.6065 -1.0531 
ATOM  2 H P08 1 -5.5242  2.5117 -0.5651 
ATOM  3 H P08 1 -6.0147  1.8301 -2.1121 
ATOM  4 H P08 1 -6.8434  1.3223 -0.6297 
ATOM  5 C P08 1 -4.8390  0.5378 -0.9199 
ATOM  6 O P08 1 -3.6573  0.7381 -1.2124 
ATOM  7 N P08 1 -5.2479 -0.6583 -0.4481 
ATOM  8 H P08 1 -6.2321 -0.7985 -0.2812 
ATOM  9 C P08 1 -4.3864 -1.8356 -0.4353 
ATOM 10 C P08 1 -4.0670 -2.2955 -1.8511 
ATOM 11 H P08 1 -4.9944 -2.5631 -2.3575 
ATOM 12 H P08 1 -3.5678 -1.5048 -2.4087 
ATOM 13 H P08 1 -3.4128 -3.1648 -1.8214 
ATOM 14 C P08 1 -5.1108 -2.9377  0.3365 
ATOM 15 H P08 1 -4.4810 -3.8245  0.3921 
ATOM 16 H P08 1 -5.3565 -2.6196  1.3502 
ATOM 17 H P08 1 -6.0322 -3.2075 -0.1821 
ATOM 18 C P08 1 -3.0873 -1.5196  0.3171 
ATOM 19 O P08 1 -2.0159 -2.0233 -0.0184 
ATOM 20 N P08 1 -3.1969 -0.7221  1.3910 
ATOM 21 H P08 1 -4.1032 -0.3372  1.6115 
ATOM 22 C P08 1 -2.0860 -0.4547  2.2936 
ATOM 23 C P08 1 -1.7124 -1.7040  3.0797 
ATOM 24 H P08 1 -2.5748 -2.0296  3.6616 
ATOM 25 H P08 1 -1.4099 -2.5065  2.4086 
ATOM 26 H P08 1 -0.8883 -1.4872  3.7564 
ATOM 27 C P08 1 -2.5159  0.6665  3.2389 
ATOM 28 H P08 1 -1.6983  0.9138  3.9147 
ATOM 29 H P08 1 -2.7949  1.5639  2.6844 
ATOM 30 H P08 1 -3.3674  0.3406  3.8387 
ATOM 31 C P08 1 -0.8692  0.0612  1.5109 
ATOM 32 O P08 1  0.2736 -0.1644  1.9058 
ATOM 33 N P08 1 -1.1229  0.8499  0.4482 
ATOM 34 H P08 1 -2.0614  0.8787  0.0613 
ATOM 35 C P08 1 -0.0670  1.5639 -0.2476 
ATOM 36 C P08 1 -0.6429  2.6339 -1.2211 
ATOM 37 H P08 1 -0.9464  2.2079 -2.1773 
ATOM 38 C P08 1  0.7436  2.4532  0.7649 
ATOM 39 H P08 1  0.3172  2.3114  1.7604 
ATOM 40 O P08 1  2.1093  2.0970  0.7861 
ATOM 41 H P08 1  2.5130  2.5423  1.5364 
ATOM 42 C P08 1 -0.9590  4.2372  0.5505 
ATOM 43 H P08 1 -1.1197  5.3118  0.4567 
ATOM 44 H P08 1 -1.2502  3.9505  1.5641 
ATOM 45 C P08 1 -1.7380  3.4510 -0.5265 
ATOM 46 H P08 1 -2.5543  2.8564 -0.1222 
ATOM 47 H P08 1 -2.1765  4.1254 -1.2643 
ATOM 48 C P08 1  0.5009  3.8746  0.2552 
ATOM 49 H P08 1  1.2291  4.5827  0.6518 
ATOM 50 C P08 1  0.4933  3.6619 -1.2565 
ATOM 51 H P08 1  1.4298  3.2580 -1.6339 
ATOM 52 H P08 1  0.2148  4.5552 -1.8194 
ATOM 53 C P08 1  0.8297  0.6037 -1.0467 
ATOM 54 O P08 1  1.8261  1.0009 -1.6499 
ATOM 55 N P08 1  0.4726 -0.6924 -1.0683 
ATOM 56 H P08 1 -0.3747 -1.0009 -0.6067 
ATOM 57 C P08 1  1.3293 -1.7018 -1.6721 
ATOM 58 C P08 1  1.3894 -1.5640 -3.1876 
ATOM 59 H P08 1  0.3817 -1.6663 -3.5920 
ATOM 60 H P08 1  1.7945 -0.5966 -3.4748 
ATOM 61 H P08 1  2.0178 -2.3478 -3.6071 
ATOM 62 C P08 1  0.7717 -3.0761 -1.3001 
ATOM 63 H P08 1  1.4292 -3.8529 -1.6890 
ATOM 64 H P08 1  0.6909 -3.1897 -0.2182 
ATOM 65 H P08 1 -0.2193 -3.2054 -1.7353 
ATOM 66 C P08 1  2.7396 -1.6203 -1.0631 
ATOM 67 O P08 1  3.7281 -1.9601 -1.7097 
ATOM 68 N P08 1  2.8044 -1.2606  0.2339 
ATOM 69 H P08 1  1.9699 -0.9090  0.6925 
ATOM 70 C P08 1  4.0475 -1.2820  0.9943 
ATOM 71 C P08 1  4.5858 -2.7001  1.1298 
ATOM 72 H P08 1  3.8531 -3.3117  1.6576 
ATOM 73 H P08 1  4.7797 -3.1373  0.1525 
ATOM 74 H P08 1  5.5146 -2.6882  1.6974 
ATOM 75 C P08 1  3.7475 -0.7056  2.3770 
ATOM 76 H P08 1  4.6676 -0.6362  2.9566 
ATOM 77 H P08 1  3.3002  0.2847  2.2932 
ATOM 78 H P08 1  3.0531 -1.3584  2.9083 
ATOM 79 C P08 1  5.1015 -0.3738  0.3366 
ATOM 80 O P08 1  6.3071 -0.6197  0.4333 
ATOM 81 N P08 1  4.6330  0.7261 -0.2563 
ATOM 82 H P08 1  3.6325  0.8695 -0.3229 
ATOM 83 C P08 1  5.5178  1.6918 -0.8575 
ATOM 84 H P08 1  6.2424  2.0622 -0.1306 
ATOM 85 H P08 1  6.0697  1.2580 -1.6942 
ATOM 86 H P08 1  4.9252  2.5266 -1.2230 
 
COMPND Ac-Aib2-(1S,2S,3R,4R)-VIIIb-Aib2-NHMe-P310 
REMARK Energy(ZPE)= -1910.35777 
REMARK #IF = 0 
ATOM  1 C P09 1  6.8066  0.5709  0.5416 
ATOM  2 H P09 1  6.6200  1.4106  1.2087 
ATOM  3 H P09 1  7.3680 -0.1958  1.0721 
ATOM  4 H P09 1  7.4106  0.9345 -0.2907 
ATOM  5 C P09 1  5.4948  0.0796 -0.0022 
ATOM  6 O P09 1  4.6486  0.8438 -0.4583 
ATOM  7 N P09 1  5.2897 -1.2600  0.0555 
ATOM  8 H P09 1  6.0462 -1.8344  0.3921 
ATOM  9 C P09 1  4.1844 -1.9488 -0.6000 
ATOM 10 C P09 1  4.3381 -3.4407 -0.2979 
ATOM 11 H P09 1  5.2718 -3.8083 -0.7265 
ATOM 12 H P09 1  4.3438 -3.6303  0.7767 
ATOM 13 H P09 1  3.5142 -3.9925 -0.7470 
ATOM 14 C P09 1  4.1946 -1.7177 -2.1071 
ATOM 15 H P09 1  3.3690 -2.2576 -2.5667 
ATOM 16 H P09 1  4.0966 -0.6591 -2.3397 
ATOM 17 H P09 1  5.1340 -2.0890 -2.5174 
ATOM 18 C P09 1  2.8269 -1.5335 -0.0161 
ATOM 19 O P09 1  1.7923 -1.7521 -0.6486 
ATOM 20 N P09 1  2.8309 -1.0023  1.2159 
ATOM 21 H P09 1  3.7291 -0.8985  1.6636 
ATOM 22 C P09 1  1.6454 -0.8203  2.0437 
ATOM 23 C P09 1  2.0773 -0.0699  3.3036 
ATOM 24 H P09 1  2.7835 -0.6770  3.8725 
ATOM 25 H P09 1  2.5515  0.8807  3.0554 
ATOM 26 H P09 1  1.2094  0.1227  3.9323 
ATOM 27 C P09 1  1.0393 -2.1710  2.4113 
ATOM 28 H P09 1  0.1700 -2.0302  3.0499 
ATOM 29 H P09 1  0.7331 -2.7131  1.5174 
ATOM 30 H P09 1  1.7846 -2.7596  2.9467 
ATOM 31 C P09 1  0.5868  0.0424  1.3487 
ATOM 32 O P09 1 -0.5944 -0.0445  1.6930 
ATOM 33 N P09 1  0.9853  0.9151  0.4139 
ATOM 34 H P09 1  1.9494  0.9449  0.1007 
ATOM 35 C P09 1  0.0225  1.7610 -0.2588 
ATOM 36 C P09 1 -0.5843  2.8743  0.6373 
ATOM 37 H P09 1 -1.4709  2.5434  1.1721 
ATOM 38 C P09 1  0.7407  2.5978 -1.3772 
ATOM 39 H P09 1  0.1389  2.5486 -2.2912 
ATOM 40 O P09 1  2.0152  2.0591 -1.6128 
ATOM 41 H P09 1  2.4887  2.6158 -2.2371 
ATOM 42 C P09 1  1.4792  4.0929  0.4832 
ATOM 43 H P09 1  1.7138  5.1259  0.7415 
ATOM 44 H P09 1  2.4255  3.5546  0.3976 
ATOM 45 C P09 1  0.5275  3.4452  1.5162 
ATOM 46 H P09 1  1.0163  2.6989  2.1407 
ATOM 47 H P09 1  0.0985  4.1978  2.1802 
ATOM 48 C P09 1  0.6824  4.0207 -0.8262 
ATOM 49 H P09 1  0.9575  4.7684 -1.5704 
ATOM 50 C P09 1 -0.7689  4.0320 -0.3512 
ATOM 51 H P09 1 -1.4871  3.8218 -1.1434 
ATOM 52 H P09 1 -1.0479  4.9584  0.1538 
ATOM 53 C P09 1 -1.0802  0.9134 -0.8992 
ATOM 54 O P09 1 -2.2039  1.3863 -1.0907 
ATOM 55 N P09 1 -0.7517 -0.3275 -1.2844 
ATOM 56 H P09 1  0.1711 -0.6953 -1.0692 
ATOM 57 C P09 1 -1.6890 -1.2059 -1.9718 
ATOM 58 C P09 1 -1.0694 -2.6030 -2.0076 
ATOM 59 H P09 1 -0.1246 -2.5752 -2.5518 
ATOM 60 H P09 1 -0.8736 -2.9724 -1.0003 
ATOM 61 H P09 1 -1.7459 -3.2911 -2.5129 
ATOM 62 C P09 1 -1.9527 -0.7098 -3.3875 
ATOM 63 H P09 1 -2.6556 -1.3706 -3.8908 
ATOM 64 H P09 1 -2.3686  0.2963 -3.3726 
ATOM 65 H P09 1 -1.0136 -0.7001 -3.9414 
ATOM 66 C P09 1 -3.0140 -1.3232 -1.1990 
ATOM 67 O P09 1 -4.0636 -1.5555 -1.7955 
ATOM 68 N P09 1 -2.9403 -1.2445  0.1429 
ATOM 69 H P09 1 -2.0639 -0.9702  0.5746 
ATOM 70 C P09 1 -4.0955 -1.4250  1.0129 
ATOM 71 C P09 1 -3.6428 -1.1387  2.4449 
ATOM 72 H P09 1 -2.8652 -1.8463  2.7368 
ATOM 73 H P09 1 -3.2437 -0.1284  2.5384 
ATOM 74 H P09 1 -4.4881 -1.2515  3.1225 
ATOM 75 C P09 1 -4.6356 -2.8463  0.9173 
ATOM 76 H P09 1 -5.4986 -2.9571  1.5712 
ATOM 77 H P09 1 -4.9342 -3.0791 -0.1026 
ATOM 78 H P09 1 -3.8591 -3.5449  1.2312 
ATOM 79 C P09 1 -5.2065 -0.4097  0.6940 
ATOM 80 O P09 1 -6.3773 -0.6461  1.0029 
ATOM 81 N P09 1 -4.8224  0.7607  0.1746 
ATOM 82 H P09 1 -3.8725  0.8764 -0.1597 
ATOM 83 C P09 1 -5.7843  1.7980 -0.1070 
ATOM 84 H P09 1 -6.3286  2.0744  0.7967 
ATOM 85 H P09 1 -5.2559  2.6708 -0.4821 
ATOM 86 H P09 1 -6.5117  1.4753 -0.8551 
 
COMPND Ac-Aib2-(1S,2S,3R,4R)-VIIIb-Aib2-NHMe-M310 
REMARK Energy(ZPE)= -1910.358165 
REMARK #IF = 0 
ATOM  1 C P09 1 -5.9499  1.2567 -0.8589 
ATOM  2 H P09 1 -6.8626  0.8893 -0.3944 
ATOM  3 H P09 1 -5.6378  2.1777 -0.3690 
ATOM  4 H P09 1 -6.1550  1.4895 -1.9043 
ATOM  5 C P09 1 -4.8212  0.2711 -0.8048 
ATOM  6 O P09 1 -3.6729  0.5732 -1.1397 
ATOM  7 N P09 1 -5.1140 -0.9681 -0.3580 
ATOM  8 H P09 1 -6.0754 -1.1924 -0.1539 
ATOM  9 C P09 1 -4.1598 -2.0692 -0.4242 
ATOM 10 C P09 1 -3.8794 -2.4659 -1.8669 
ATOM 11 H P09 1 -4.8092 -2.7901 -2.3344 
ATOM 12 H P09 1 -3.4704 -1.6257 -2.4253 
ATOM 13 H P09 1 -3.1618 -3.2837 -1.8961 
ATOM 14 C P09 1 -4.7484 -3.2483  0.3502 
ATOM 15 H P09 1 -4.0411 -4.0765  0.3579 
ATOM 16 H P09 1 -4.9774 -2.9747  1.3808 
ATOM 17 H P09 1 -5.6641 -3.5889 -0.1357 
ATOM 18 C P09 1 -2.8540 -1.6634  0.2704 
ATOM 19 O P09 1 -1.7611 -2.0363 -0.1533 
ATOM 20 N P09 1 -2.9735 -0.9423  1.3971 
ATOM 21 H P09 1 -3.8981 -0.6742  1.6993 
ATOM 22 C P09 1 -1.8460 -0.6467  2.2709 
ATOM 23 C P09 1 -1.3157 -1.9134  2.9293 
ATOM 24 H P09 1 -2.1105 -2.3636  3.5241 
ATOM 25 H P09 1 -0.9813 -2.6286  2.1798 
ATOM 26 H P09 1 -0.4779 -1.6728  3.5806 
ATOM 27 C P09 1 -2.3308  0.3441  3.3301 
ATOM 28 H P09 1 -1.5073  0.6140  3.9899 
ATOM 29 H P09 1 -2.7230  1.2520  2.8705 
ATOM 30 H P09 1 -3.1140 -0.1177  3.9335 
ATOM 31 C P09 1 -0.7291  0.0540  1.4888 
ATOM 32 O P09 1  0.4531 -0.0597  1.8367 
ATOM 33 N P09 1 -1.1008  0.8647  0.4908 
ATOM 34 H P09 1 -2.0636  0.8401  0.1710 
ATOM 35 C P09 1 -0.1473  1.6774 -0.2294 
ATOM 36 C P09 1 -0.8501  2.5902 -1.2664 
ATOM 37 H P09 1 -1.1633  2.0515 -2.1611 
ATOM 38 C P09 1  0.6053  2.7429  0.6724 
ATOM 39 H P09 1  1.6763  2.5715  0.5505 
ATOM 40 O P09 1  0.2557  2.7162  2.0315 
ATOM 41 H P09 1  0.5987  1.8908  2.3970 
ATOM 42 C P09 1 -1.2454  4.3755  0.3237 
ATOM 43 H P09 1 -1.4823  5.4068  0.0579 
ATOM 44 H P09 1 -1.4862  4.2382  1.3771 
ATOM 45 C P09 1 -1.9853  3.3739 -0.5902 
ATOM 46 H P09 1 -2.6953  2.7506 -0.0515 
ATOM 47 H P09 1 -2.5523  3.8886 -1.3678 
ATOM 48 C P09 1  0.2272  4.0774  0.0341 
ATOM 49 H P09 1  0.9117  4.8784  0.3128 
ATOM 50 C P09 1  0.1899  3.7015 -1.4470 
ATOM 51 H P09 1  1.1454  3.3515 -1.8344 
ATOM 52 H P09 1 -0.1879  4.5102 -2.0750 
ATOM 53 C P09 1  0.8829  0.7941 -0.9458 
ATOM 54 O P09 1  1.9862  1.2437 -1.2733 
ATOM 55 N P09 1  0.5360 -0.4717 -1.2181 
ATOM 56 H P09 1 -0.3510 -0.8383 -0.8877 
ATOM 57 C P09 1  1.4333 -1.3761 -1.9275 
ATOM 58 C P09 1  1.6015 -0.9435 -3.3783 
ATOM 59 H P09 1  0.6299 -0.9737 -3.8724 
ATOM 60 H P09 1  2.0020  0.0672 -3.4349 
ATOM 61 H P09 1  2.2818 -1.6198 -3.8920 
ATOM 62 C P09 1  0.8388 -2.7821 -1.8631 
ATOM 63 H P09 1  1.5039 -3.4793 -2.3711 
ATOM 64 H P09 1  0.7018 -3.1074 -0.8318 
ATOM 65 H P09 1 -0.1317 -2.7991 -2.3599 
ATOM 66 C P09 1  2.8058 -1.4418 -1.2341 
ATOM 67 O P09 1  3.8189 -1.7053 -1.8779 
ATOM 68 N P09 1  2.8107 -1.2797  0.1023 
ATOM 69 H P09 1  1.9496 -1.0115  0.5644 
ATOM 70 C P09 1  4.0098 -1.3973  0.9221 
ATOM 71 C P09 1  4.5547 -2.8197  0.8913 
ATOM 72 H P09 1  3.7947 -3.5005  1.2764 
ATOM 73 H P09 1  4.8139 -3.1124 -0.1244 
ATOM 74 H P09 1  5.4430 -2.8903  1.5163 
ATOM 75 C P09 1  3.6230 -1.0150  2.3509 
ATOM 76 H P09 1  4.5018 -1.0610  2.9927 
ATOM 77 H P09 1  3.2056 -0.0080  2.3886 
ATOM 78 H P09 1  2.8755 -1.7122  2.7326 
ATOM 79 C P09 1  5.0959 -0.4014  0.4783 
ATOM 80 O P09 1  6.2823 -0.6107  0.7436 
ATOM 81 N P09 1  4.6771  0.7266 -0.1035 
ATOM 82 H P09 1  3.7108  0.8103 -0.3966 
ATOM 83 C P09 1  5.6143  1.7432 -0.5144 
ATOM 84 H P09 1  6.2094  2.0833  0.3337 
ATOM 85 H P09 1  6.2978  1.3697 -1.2801 
ATOM 86 H P09 1  5.0593  2.5862 -0.9179 
 
COMPND Ac-Aib2-(S)-VI-Aib2-NHMe-P310 
REMARK Energy(ZPE)= -2080.946006 
REMARK #IF = 0 
ATOM  1 C P10  5.3822  1.2774  0.1719 
ATOM  2 H P10  5.7746  0.8985  1.1159 
ATOM  3 H P10  5.3528  0.4447 -0.5305 
ATOM  4 H P10  6.0513  2.0468 -0.2075 
ATOM  5 C P10  3.9834  1.7682  0.4009 
ATOM  6 O P10  3.0736  1.0102  0.7446 
ATOM  7 N P10  3.7518  3.0817  0.1949 
ATOM  8 H P10  4.5317  3.6822 -0.0222 
ATOM  9 C P10  2.4837  3.7161  0.5406 
ATOM 10 C P10  2.5034  5.1373 -0.0213 
ATOM 11 H P10  2.6683  5.1383 -1.0994 
ATOM 12 H P10  1.5552  5.6313  0.1867 
ATOM 13 H P10  3.2975  5.7127  0.4572 
ATOM 14 C P10  2.2793  3.7416  2.0489 
ATOM 15 H P10  1.3274  4.2112  2.2900 
ATOM 16 H P10  2.2811  2.7320  2.4560 
ATOM 17 H P10  3.0851  4.3152  2.5072 
ATOM 18 C P10  1.3271  2.9649 -0.1345 
ATOM 19 O P10  0.2344  2.8410  0.4175 
ATOM 20 N P10  1.5603  2.5157 -1.3782 
ATOM 21 H P10  2.4804  2.6537 -1.7686 
ATOM 22 C P10  0.5326  1.9276 -2.2256 
ATOM 23 C P10  1.2288  1.3421 -3.4536 
ATOM 24 H P10  1.9913  0.6167 -3.1659 
ATOM 25 H P10  0.4986  0.8496 -4.0944 
ATOM 26 H P10  1.7017  2.1414 -4.0265 
ATOM 27 C P10 -0.4897  2.9775 -2.6414 
ATOM 28 H P10 -1.2480  2.5310 -3.2813 
ATOM 29 H P10 -0.9785  3.4062 -1.7678 
ATOM 30 H P10  0.0189  3.7695 -3.1915 
ATOM 31 C P10 -0.1694  0.7682 -1.5032 
ATOM 32 O P10 -1.3433  0.4949 -1.7615 
ATOM 33 N P10  0.5729  0.0451 -0.6490 
ATOM 34 H P10  1.5069  0.3641 -0.4070 
ATOM 35 C P10  0.0673 -1.1529  0.0056 
ATOM 36 C P10  1.1507 -1.6756  0.9648 
ATOM 37 H P10  1.5202 -0.8502  1.5792 
ATOM 38 H P10  0.6790 -2.3951  1.6406 
ATOM 39 C P10  2.2617 -2.3010  0.1905 
ATOM 40 C P10  2.1441 -2.6711 -1.1204 
ATOM 41 C P10  0.9167 -2.5309 -1.9427 
ATOM 42 H P10  1.0391 -1.7241 -2.6736 
ATOM 43 H P10  0.7242 -3.4406 -2.5169 
ATOM 44 C P10 -0.2672 -2.2440 -1.0271 
ATOM 45 H P10 -1.1335 -1.9395 -1.6122 
ATOM 46 H P10 -0.5405 -3.1422 -0.4727 
ATOM 47 N P10  3.3374 -3.1836 -1.5640 
ATOM 48 H P10  3.5093 -3.5321 -2.4911 
ATOM 49 C P10  4.2492 -3.1580 -0.5398 
ATOM 50 C P10  5.5819 -3.5628 -0.5063 
ATOM 51 H P10  6.0647 -3.9802 -1.3812 
ATOM 52 C P10  6.2677 -3.4091  0.6880 
ATOM 53 H P10  7.3056 -3.7129  0.7464 
ATOM 54 C P10  5.6419 -2.8688  1.8236 
ATOM 55 H P10  6.2083 -2.7644  2.7409 
ATOM 56 C P10  4.3167 -2.4695  1.7861 
ATOM 57 H P10  3.8429 -2.0505  2.6661 
ATOM 58 C P10  3.5998 -2.6077  0.5923 
ATOM 59 C P10 -1.1809 -0.8534  0.8389 
ATOM 60 O P10 -1.9587 -1.7672  1.1309 
ATOM 61 N P10 -1.3634  0.4067  1.2538 
ATOM 62 H P10 -0.7170  1.1304  0.9530 
ATOM 63 C P10 -2.5070  0.8030  2.0660 
ATOM 64 C P10 -2.5312  2.3300  2.1241 
ATOM 65 H P10 -1.6149  2.6983  2.5868 
ATOM 66 H P10 -2.6116  2.7628  1.1264 
ATOM 67 H P10 -3.3813  2.6583  2.7208 
ATOM 68 C P10 -2.4047  0.2249  3.4709 
ATOM 69 H P10 -3.2676  0.5284  4.0607 
ATOM 70 H P10 -2.3677 -0.8624  3.4401 
ATOM 71 H P10 -1.4982  0.6013  3.9456 
ATOM 72 C P10 -3.8239  0.3580  1.4058 
ATOM 73 O P10 -4.8146  0.1104  2.0897 
ATOM 74 N P10 -3.8391  0.3375  0.0600 
ATOM 75 H P10 -2.9714  0.4950 -0.4423 
ATOM 76 C P10 -5.0295  0.0253 -0.7200 
ATOM 77 C P10 -4.6177 -0.0151 -2.1917 
ATOM 78 H P10 -3.8229 -0.7431 -2.3588 
ATOM 79 H P10 -5.4791 -0.2808 -2.8032 
ATOM 80 H P10 -4.2578  0.9662 -2.5043 
ATOM 81 C P10 -6.1121  1.0777 -0.5137 
ATOM 82 H P10 -6.3999  1.1380  0.5341 
ATOM 83 H P10 -5.7326  2.0478 -0.8366 
ATOM 84 H P10 -6.9893  0.8239 -1.1060 
ATOM 85 C P10 -5.5774 -1.3716 -0.3787 
ATOM 86 O P10 -6.7591 -1.6497 -0.5984 
ATOM 87 N P10 -4.6950 -2.2752  0.0587 
ATOM 88 H P10 -3.7638 -1.9785  0.3262 
ATOM 89 C P10 -5.1016 -3.6259  0.3599 
ATOM 90 H P10 -5.5745 -4.0870 -0.5075 
ATOM 91 H P10 -4.2209 -4.2025  0.6311 
ATOM 92 H P10 -5.8124 -3.6545  1.1889 
 
COMPND Ac-Aib2-(S)-VI-Aib2-NHMe-M310 
REMARK Energy(ZPE)= -2080.945027 
REMARK #IF = 0 
ATOM  1 C P10 5.6352 -1.6465  1.3331 
ATOM  2 H P10 6.4610 -2.1185  0.8052 
ATOM  3 H P10 5.6761 -0.5691  1.1768 
ATOM  4 H P10 5.7441 -1.8307  2.4019 
ATOM  5 C P10 4.2909 -2.1478  0.8979 
ATOM  6 O P10 3.2416 -1.6764  1.3446 
ATOM  7 N P10 4.2744 -3.1295 -0.0263 
ATOM  8 H P10 5.1509 -3.5312 -0.3202 
ATOM  9 C P10 3.0493 -3.8196 -0.4159 
ATOM 10 C P10 2.5101 -4.6642  0.7299 
ATOM 11 H P10 1.5950 -5.1690  0.4262 
ATOM 12 H P10 3.2551 -5.4123  1.0013 
ATOM 13 H P10 2.2932 -4.0433  1.5971 
ATOM 14 C P10 3.3717 -4.6990 -1.6236 
ATOM 15 H P10 4.1050 -5.4566 -1.3429 
ATOM 16 H P10 2.4704 -5.2085 -1.9616 
ATOM 17 H P10 3.7716 -4.1111 -2.4506 
ATOM 18 C P10 1.9965 -2.7944 -0.8575 
ATOM 19 O P10 0.7999 -2.9621 -0.6239 
ATOM 20 N P10 2.4450 -1.7482 -1.5693 
ATOM 21 H P10 3.4379 -1.6663 -1.7293 
ATOM 22 C P10 1.5537 -0.7893 -2.2076 
ATOM 23 C P10 0.8232 -1.4280 -3.3806 
ATOM 24 H P10 0.2324 -2.2800 -3.0476 
ATOM 25 H P10 0.1564 -0.7043 -3.8453 
ATOM 26 H P10 1.5543 -1.7641 -4.1159 
ATOM 27 C P10 2.3996  0.3929 -2.6794 
ATOM 28 H P10 2.9342  0.8521 -1.8468 
ATOM 29 H P10 3.1219  0.0583 -3.4260 
ATOM 30 H P10 1.7597  1.1445 -3.1400 
ATOM 31 C P10 0.5411 -0.2445 -1.1902 
ATOM 32 O P10 0.6017  0.0501 -1.5423 
ATOM 33 N P10 0.9985 -0.0297  0.0561 
ATOM 34 H P10 1.8930 -0.4308  0.3201 
ATOM 35 C P10 0.2147  0.6463  1.0790 
ATOM 36 C P10 0.1168  2.0888  0.6588 
ATOM 37 H P10 0.5668  2.0799 -0.3349 
ATOM 38 H P10 0.8796  2.4611  1.3457 
ATOM 39 C P10 1.1117  2.9284  0.6891 
ATOM 40 C P10 2.2192  2.6086  1.4210 
ATOM 41 C P10 2.3728  1.3925  2.2551 
ATOM 42 H P10 3.1249  0.7261  1.8232 
ATOM 43 H P10 2.7333  1.6436  3.2563 
ATOM 44 C P10 1.0314  0.6683  2.3836 
ATOM 45 H P10 1.2035 -0.3545  2.7250 
ATOM 46 H P10 0.4101  1.1656  3.1303 
ATOM 47 N P10 3.1939  3.5569  1.2271 
ATOM 48 H P10 4.1047  3.5496  1.6525 
ATOM 49 C P10 2.7285  4.5110  0.3591 
ATOM 50 C P10 3.3421  5.6564 -0.1426 
ATOM 51 H P10 4.3512  5.9250  0.1449 
ATOM 52 C P10 2.6155  6.4378 -1.0276 
ATOM 53 H P10 3.0664  7.3333 -1.4370 
ATOM 54 C P10 1.3076  6.0898 -1.4036 
ATOM 55 H P10 0.7699  6.7233 -2.0984 
ATOM 56 C P10 0.6993  4.9530 -0.8989 
ATOM 57 H P10 0.3109  4.6927 -1.1930 
ATOM 58 C P10 1.4091  4.1438 -0.0043 
ATOM 59 C P10 1.0902 -0.1043  1.3767 
ATOM 60 O P10 2.0313  0.4787  1.9241 
ATOM 61 N P10 1.1444 -1.4025  1.0523 
ATOM 62 H P10 0.3691 -1.8290  0.5535 
ATOM 63 C P10 2.3364 -2.2095  1.2829 
ATOM 64 C P10 2.5691 -2.4230  2.7727 
ATOM 65 H P10 2.6967 -1.4701  3.2830 
ATOM 66 H P10 3.4611 -3.0270  2.9272 
ATOM 67 H P10 1.7094 -2.9442  3.1949 
ATOM 68 C P10 2.1353 -3.5521  0.5820 
ATOM 69 H P10 1.2780 -4.0701  1.0134 
ATOM 70 H P10 3.0224 -4.1695  0.7171 
ATOM 71 H P10 1.9521 -3.4177 -0.4844 
ATOM 72 C P10 3.5698 -1.5485  0.6433 
ATOM 73 O P10 4.6922 -1.7416  1.1053 
ATOM 74 N P10 3.3537 -0.8257 -0.4726 
ATOM 75 H P10 2.3998 -0.6637 -0.7815 
ATOM 76 C P10 4.4320 -0.2221 -1.2456 
ATOM 77 C P10 5.3391 -1.2880 -1.8477 
ATOM 78 H P10 5.7876 -1.9009 -1.0682 
ATOM 79 H P10 6.1323 -0.8160 -2.4245 
ATOM 80 H P10 4.7501 -1.9247 -2.5090 
ATOM 81 C P10 3.7949  0.6080 -2.3598 
ATOM 82 H P10 4.5749  1.1131 -2.9282 
ATOM 83 H P10 3.1104  1.3538 -1.9543 
ATOM 84 H P10 3.2377 -0.0418 -3.0361 
ATOM 85 C P10 5.2543  0.7524 -0.3850 
ATOM 86 O P10 6.4159  1.0327 -0.6905 
ATOM 87 N P10 4.6109  1.3441  0.6265 
ATOM 88 H P10 3.6982  1.0007  0.9007 
ATOM 89 C P10 5.2744  2.3052  1.4725 
ATOM 90 H P10 5.6830  3.1223  0.8776 
ATOM 91 H P10 6.0950  1.8480  2.0302 
ATOM 92 H P10 4.5509  2.7079  2.1769 
 COMPND Ac-Aib5 -NHMe-P310 
REMARK Energy(ZPE)= -1680.465008 
REMARK #IF = 0 
ATOM  1 C P11 1 -6.1625 -1.9280  0.3925 
ATOM  2 H P11 1 -5.8385 -2.4901  1.2670 
ATOM  3 H P11 1 -7.0446 -1.3428  0.6439 
ATOM  4 H P11 1 -6.4241 -2.6459 -0.3854 
ATOM  5 C P11 1 -5.0179 -1.0927 -0.0985 
ATOM  6 O P11 1 -3.8992 -1.5737 -0.2979 
ATOM  7 N P11 1 -5.2639  0.2190 -0.2982 
ATOM  8 H P11 1 -6.2083  0.5510 -0.1800 
ATOM  9 C P11 1 -4.3147  1.1192 -0.9456 
ATOM 10 C P11 1 -4.8742  2.5370 -0.8367 
ATOM 11 H P11 1 -5.8163  2.6040 -1.3834 
ATOM 12 H P11 1 -5.0488  2.8167  0.2030 
ATOM 13 H P11 1 -4.1747  3.2459 -1.2772 
ATOM 14 C P11 1 -4.1088  0.7351 -2.4048 
ATOM 15 H P11 1 -3.4073  1.4197 -2.8773 
ATOM 16 H P11 1 -3.7151 -0.2769 -2.4834 
ATOM 17 H P11 1 -5.0650  0.7910 -2.9251 
ATOM 18 C P11 1 -2.9706  1.0943 -0.2057 
ATOM 19 O P11 1 -1.9116  1.2654 -0.8090 
ATOM 20 N P11 1 -3.0225  0.9392  1.1267 
ATOM 21 H P11 1 -3.9257  0.8037  1.5549 
ATOM 22 C P11 1 -1.8501  0.9994  1.9884 
ATOM 23 C P11 1 -2.2715  0.5236  3.3785 
ATOM 24 H P11 1 -3.0224  1.2003  3.7896 
ATOM 25 H P11 1 -2.6847 -0.4854  3.3434 
ATOM 26 H P11 1 -1.4103  0.5252  4.0451 
ATOM 27 C P11 1 -1.2983  2.4177  2.0558 
ATOM 28 H P11 1 -0.4311  2.4513  2.7123 
ATOM 29 H P11 1 -1.0011  2.7636  1.0670 
ATOM 30 H P11 1 -2.0692  3.0801  2.4499 
ATOM 31 C P11 1 -0.7630  0.0365  1.4901 
ATOM 32 O P11 1  0.4264  0.2713  1.7142 
ATOM 33 N P11 1 -1.1711 -1.0822  0.8742 
ATOM 34 H P11 1 -2.1533 -1.1973  0.6409 
ATOM 35 C P11 1 -0.2397 -2.1196  0.4504 
ATOM 36 C P11 1 -1.0097 -3.1158 -0.4158 
ATOM 37 H P11 1 -1.8007 -3.5820  0.1729 
ATOM 38 H P11 1 -1.4665 -2.6231 -1.2744 
ATOM 39 H P11 1 -0.3330 -3.8928 -0.7688 
ATOM 40 C P11 1  0.3674 -2.8274  1.6549 
ATOM 41 H P11 1  1.0585 -3.6006  1.3253 
ATOM 42 H P11 1  0.9064 -2.1232  2.2866 
ATOM 43 H P11 1 -0.4324 -3.2886  2.2344 
ATOM 44 C P11 1  0.8730 -1.5274 -0.4275 
ATOM 45 O P11 1  1.9839 -2.0625 -0.4770 
ATOM 46 N P11 1  0.5491 -0.4612 -1.1726 
ATOM 47 H P11 1 -0.3605 -0.0298 -1.0425 
ATOM 48 C P11 1  1.4639  0.1523 -2.1259 
ATOM 49 C P11 1  0.8348  1.4644 -2.5936 
ATOM 50 H P11 1 -0.1161  1.2640 -3.0891 
ATOM 51 H P11 1  0.6502  2.1348 -1.7537 
ATOM 52 H P11 1  1.5008  1.9561 -3.3014 
ATOM 53 C P11 1  1.7027 -0.7692 -3.3151 
ATOM 54 H P11 1  2.3893 -0.3010 -4.0177 
ATOM 55 H P11 1  2.1275 -1.7182 -2.9919 
ATOM 56 H P11 1  0.7526 -0.9561 -3.8163 
ATOM 57 C P11 1  2.8029  0.5121 -1.4607 
ATOM 58 O P11 1  3.8349  0.5655 -2.1271 
ATOM 59 N P11 1  2.7585  0.8348 -0.1553 
ATOM 60 H P11 1  1.8911  0.7037  0.3560 
ATOM 61 C P11 1  3.9298  1.2753  0.5904 
ATOM 62 C P11 1  3.5195  1.4204  2.0560 
ATOM 63 H P11 1  2.7363  2.1741  2.1498 
ATOM 64 H P11 1  3.1423  0.4789  2.4559 
ATOM 65 H P11 1  4.3802  1.7369  2.6439 
ATOM 66 C P11 1  4.4435  2.6104  0.0660 
ATOM 67 H P11 1  5.3248  2.9128  0.6285 
ATOM 68 H P11 1  4.7050  2.5399 -0.9878 
ATOM 69 H P11 1  3.6660  3.3650  0.1911 
ATOM 70 C P11 1  5.0473  0.2186  0.5513 
ATOM 71 O P11 1  6.2224  0.5429  0.7402 
ATOM 72 N P11 1  4.6674 -1.0558  0.4114 
ATOM 73 H P11 1  3.7091 -1.2719  0.1610 
ATOM 74 C P11 1  5.6397 -2.1215  0.4124 
ATOM 75 H P11 1  6.2176 -2.1150  1.3372 
ATOM 76 H P11 1  5.1169 -3.0708  0.3284 
ATOM 77 H P11 1  6.3370 -2.0254 -0.4228 
 
COMPND Ac-Aib5 -NHMe-M310 
REMARK Energy(ZPE)= -1680.464965  
REMARK #IF = 0 
ATOM  1 C P11 1  6.1621 -1.9282  0.3937 
ATOM  2 H P11 1  5.8375 -2.4910  1.2676 
ATOM  3 H P11 1  6.4247 -2.6456 -0.3844 
ATOM  4 H P11 1  7.0437 -1.3428  0.6463 
ATOM  5 C P11 1  5.0176 -1.0931 -0.0979 
ATOM  6 O P11 1  3.8989 -1.5740 -0.2971 
ATOM  7 N P11 1  5.2638  0.2185 -0.2985 
ATOM  8 H P11 1  6.2083  0.5504 -0.1804 
ATOM  9 C P11 1  4.3148  1.1182 -0.9466 
ATOM 10 C P11 1  4.1088  0.7329 -2.4055 
ATOM 11 H P11 1  5.0650  0.7882 -2.9259 
ATOM 12 H P11 1  3.7149 -0.2791 -2.4832 
ATOM 13 H P11 1  3.4074  1.4172 -2.8786 
ATOM 14 C P11 1  4.8746  2.5361 -0.8390 
ATOM 15 H P11 1  4.1751  3.2447 -1.2800 
ATOM 16 H P11 1  5.0493  2.8166  0.2004 
ATOM 17 H P11 1  5.8166  2.6024 -1.3858 
ATOM 18 C P11 1  2.9707  1.0942 -0.2067 
ATOM 19 O P11 1  1.9117  1.2650 -0.8102 
ATOM 20 N P11 1  3.0226  0.9402  1.1259 
ATOM 21 H P11 1  3.9259  0.8048  1.5541 
ATOM 22 C P11 1  1.8504  1.0015  1.9876 
ATOM 23 C P11 1  1.2987  2.4198  2.0534 
ATOM 24 H P11 1  2.0697  3.0827  2.4466 
ATOM 25 H P11 1  1.0013  2.7646  1.0643 
ATOM 26 H P11 1  0.4317  2.4543  2.7102 
ATOM 27 C P11 1  2.2718  0.5272  3.3782 
ATOM 28 H P11 1  1.4107  0.5296  4.0448 
ATOM 29 H P11 1  2.6851 -0.4818  3.3442 
ATOM 30 H P11 1  3.0229  1.2044  3.7884 
ATOM 31 C P11 1  0.7632  0.0380  1.4905 
ATOM 32 O P11 1 -0.4262  0.2730  1.7146 
ATOM 33 N P11 1  1.1712 -1.0811  0.8754 
ATOM 34 H P11 1  2.1534 -1.1965  0.6422 
ATOM 35 C P11 1  0.2398 -2.1190  0.4527 
ATOM 36 C P11 1 -0.3673 -2.8257  1.6579 
ATOM 37 H P11 1  0.4326 -3.2863  2.2378 
ATOM 38 H P11 1 -0.9063 -2.1210  2.2889 
ATOM 39 H P11 1 -1.0583 -3.5993  1.3290 
ATOM 40 C P11 1  1.0098 -3.1160 -0.4126 
ATOM 41 H P11 1  0.3331 -3.8933 -0.7649 
ATOM 42 H P11 1  1.4667 -2.6241 -1.2716 
ATOM 43 H P11 1  1.8008 -3.5817  0.1765 
ATOM 44 C P11 1 -0.8729 -1.5277 -0.4259 
ATOM 45 O P11 1 -1.9838 -2.0629 -0.4750 
ATOM 46 N P11 1 -0.5490 -0.4621 -1.1718 
ATOM 47 H P11 1  0.3607 -0.0307 -1.0423 
ATOM 48 C P11 1 -1.4638  0.1504 -2.1259 
ATOM 49 C P11 1 -1.7023 -0.7723 -3.3143 
ATOM 50 H P11 1 -0.7521 -0.9592 -3.8153 
ATOM 51 H P11 1 -2.1267 -1.7211 -2.9901 
ATOM 52 H P11 1 -2.3891 -0.3050 -4.0173 
ATOM 53 C P11 1 -0.8349  1.4622 -2.5946 
ATOM 54 H P11 1 -1.5009  1.9531 -3.3031 
ATOM 55 H P11 1 -0.6508  2.1334 -1.7553 
ATOM 56 H P11 1  0.1162  1.2616 -3.0897 
ATOM 57 C P11 1 -2.8029  0.5106 -1.4612 
ATOM 58 O P11 1 -3.8349  0.5630 -2.1277 
ATOM 59 N P11 1 -2.7587  0.8345 -0.1560 
ATOM 60 H P11 1 -1.8913  0.7040  0.3554 
ATOM 61 C P11 1 -3.9301  1.2757  0.5890 
ATOM 62 C P11 1 -4.4435  2.6104  0.0633 
ATOM 63 H P11 1 -3.6660  3.3651  0.1880 
ATOM 64 H P11 1 -4.7048  2.5390 -0.9905 
ATOM 65 H P11 1 -5.3250  2.9133  0.6253 
ATOM 66 C P11 1 -3.5201  1.4222  2.0546 
ATOM 67 H P11 1 -4.3807  1.7396  2.6419 
ATOM 68 H P11 1 -3.1433  0.4810  2.4556 
ATOM 69 H P11 1 -2.7367  2.1757  2.1479 
ATOM 70 C P11 1 -5.0477  0.2191  0.5507 
ATOM 71 O P11 1 -6.2227  0.5437  0.7392 
ATOM 72 N P11 1 -4.6678 -1.0555  0.4121 
ATOM 73 H P11 1 -3.7094 -1.2718  0.1621 
ATOM 74 C P11 1 -5.6400 -2.1212  0.4140 
ATOM 75 H P11 1 -6.2179 -2.1139  1.3387 
ATOM 76 H P11 1 -6.3373 -2.0259 -0.4213 
ATOM 77 H P11 1 -5.1172 -3.0705  0.3308 
 COMPND Ac-Aib2-(1R,2R,4R)-IIIawr-Aib2-NHMe-P310 
REMARK Energy(ZPE)= -1869.877938 
REMARK #IF = 0 
ATOM  1 C P12  6.1406  1.4622 -0.0553 
ATOM  2 H P12  5.7925  2.2323  0.6316 
ATOM  3 H P12  7.0083  0.9627  0.3701 
ATOM  4 H P12  6.4333  1.9529 -0.9837 
ATOM  5 C P12  5.0064  0.5275 -0.3493 
ATOM  6 O P12  3.9071  0.9379 -0.7346 
ATOM  7 N P12  5.2337 -0.7869 -0.1551 
ATOM  8 H P12  6.1637 -1.0765  0.1048 
ATOM  9 C P12  4.2947 -1.8281 -0.5624 
ATOM 10 C P12  4.8080 -3.1584 -0.0125 
ATOM 11 H P12  5.7724 -3.3973 -0.4636 
ATOM 12 H P12  4.9238 -3.1224  1.0713 
ATOM 13 H P12  4.1099 -3.9557 -0.2634 
ATOM 14 C P12  4.1733 -1.8868  -2.079 
ATOM 15 H P12  3.4707 -2.6661 -2.3675 
ATOM 16 H P12  3.8201 -0.9359  -2.475 
ATOM 17 H P12  5.1506 -2.1133 -2.5055 
ATOM 18 C P12  2.9165 -1.5697  0.0635 
ATOM 19 O P12  1.8837 -1.8777 -0.5297 
ATOM 20 N P12  2.9177 -1.0499  1.3023 
ATOM 21 H P12  3.8102 -0.8175  1.7117 
ATOM 22 C P12  1.7209 -0.8435  2.1068 
ATOM 23 C P12  2.1355 -0.0830 3.366 
ATOM 24 H P12  2.8280 -0.6889  3.9523 
ATOM 25 H P12  2.6173  0.8641  3.1183 
ATOM 26 H P12  1.2569  0.1201 3.976 
ATOM 27 C P12  1.0799 -2.1759  2.48 
ATOM 28 H P12  0.1939 -2.0045  3.0881 
ATOM 29 H P12  0.7922 -2.7305  1.5881 
ATOM 30 H P12  1.7960 -2.7663  3.0517 
ATOM 31 C P12  0.7002  0.0305 1.369 
ATOM 32 O P12 -0.4889  0.0083  1.6965 
ATOM 33 N P12  1.1509  0.8452  0.4043 
ATOM 34 H P12  2.1308  0.8297  0.1368 
ATOM 35 C P12  0.2426  1.7113 -0.3139 
ATOM 36 C P12  0.9908  2.5442 -1.3843 
ATOM 37 H P12  2.0405  2.2674 -1.4601 
ATOM 38 H P12  0.5246  2.4341 -2.3626 
ATOM 39 C P12  0.7592  3.9809 -0.8577 
ATOM 40 H P12  0.8600  4.7674 -1.5996 
ATOM 41 O P12 -0.5880  3.8731 -0.4010 
ATOM 42 C P12 -0.3472  2.8675  0.5734 
ATOM 43 H P12 -1.2523  2.6065  1.1098 
ATOM 44 C P12  0.8263  3.4348  1.3372 
ATOM 45 H P12  1.0773  3.2166  2.3645 
ATOM 46 C P12  1.5212  4.1290  0.4369 
ATOM 47 H P12  2.4786  4.6167  0.5491 
ATOM 48 C P12 -0.8963  0.9063 -0.9461 
ATOM 49 O P12 -1.9999  1.4191 -1.1404 
ATOM 50 N P12 -0.6216 -0.3587 -1.2976 
ATOM 51 H P12  0.2857 -0.7578 -1.0757 
ATOM 52 C P12 -1.5939 -1.2074 -1.9743 
ATOM 53 C P12 -1.0421 -2.6325 -1.9825 
ATOM 54 H P12 -0.1137 -2.6686 -2.5537 
ATOM 55 H P12 -0.8413 -2.9834 -0.9696 
ATOM 56 H P12 -1.7636 -3.3002 -2.4520 
ATOM 57 C P12 -1.8282 -0.7242 -3.3998 
ATOM 58 H P12 -2.5504 -1.3668 -3.8992 
ATOM 59 H P12 -2.2077  0.2964 -3.4040 
ATOM 60 H P12 -0.8847 -0.7575 -3.9452 
ATOM 61 C P12 -2.9273 -1.2499 -1.2088 
ATOM 62 O P12 -3.9807 -1.4516 -1.8097 
ATOM 63 N P12 -2.8623 -1.1455  0.1315 
ATOM 64 H P12 -1.9802 -0.8978  0.5671 
ATOM 65 C P12 -4.0335 -1.2651  0.9906 
ATOM 66 C P12 -3.5893 -0.9604  2.4214 
ATOM 67 H P12 -2.8425 -1.6883  2.7421 
ATOM 68 H P12 -3.1550  0.0369  2.4954 
ATOM 69 H P12 -4.4469 -1.0248  3.0899 
ATOM 70 C P12 -4.6213 -2.6687  0.9190 
ATOM 71 H P12 -5.4904 -2.7399  1.5702 
ATOM 72 H P12 -4.9230 -2.9101 -0.0982 
ATOM 73 H P12 -3.8698 -3.3868  1.2494 
ATOM 74 C P12 -5.1031 -0.2191  0.6308 
ATOM 75 O P12 -6.2887 -0.4108  0.9123 
ATOM 76 N P12 -4.6652  0.9297  0.1056 
ATOM 77 H P12 -3.7043  1.0032 -0.2073 
ATOM 78 C P12 -5.5817  1.9944 -0.2215 
ATOM 79 H P12 -6.1467  2.3005  0.6596 
ATOM 80 H P12 -5.0119  2.8442 -0.5887 
ATOM 81 H P12 -6.2936  1.6864 -0.9905 
COMPND Ac-Aib2-(1R,2R,4R)-IIIawr-Aib2-NHMe-M310 
REMARK Energy(ZPE)= -1869.8758 
REMARK #IF = 0 
ATOM  1 C P12 -6.0450  1.4168 -0.3682 
ATOM  2 H P12 -5.7486  2.2051  0.3225 
ATOM  3 H P12 -6.2599  1.8820 -1.3304 
ATOM  4 H P12 -6.9472  0.9345  0.0018 
ATOM  5 C P12 -4.8966  0.4690 -0.5430 
ATOM  6 O P12 -3.7694  0.8603 -0.8599 
ATOM  7 N P12 -5.1431 -0.8372 -0.3174 
ATOM  8 H P12 -6.0903 -1.1211 -0.1218 
ATOM  9 C P12 -4.1703 -1.8843 -0.6099 
ATOM 10 C P12 -3.9316 -2.0030 -2.1090 
ATOM 11 H P12 -4.8720 -2.2551 -2.5993 
ATOM 12 H P12 -3.5553 -1.0654 -2.5148 
ATOM 13 H P12 -3.2047 -2.7869 -2.3128 
ATOM 14 C P12 -4.7130 -3.1972 -0.0466 
ATOM 15 H P12 -3.9939 -3.9975 -0.2157 
ATOM 16 H P12 -4.9069 -3.1217  1.0239 
ATOM 17 H P12 -5.6411 -3.4615 -0.5560 
ATOM 18 C P12 -2.8499 -1.5818  0.1102 
ATOM 19 O P12 -1.7669 -1.8770 -0.3940 
ATOM 20 N P12 -2.9472 -1.0409  1.3355 
ATOM 21 H P12 -3.8674 -0.8247  1.6888 
ATOM 22 C P12 -1.8044 -0.8413  2.2167 
ATOM 23 C P12 -1.2410 -2.1773  2.6839 
ATOM 24 H P12 -2.0155 -2.7185  3.2277 
ATOM 25 H P12 -0.9148 -2.7770  1.8355 
ATOM 26 H P12 -0.3908 -2.0146  3.3432 
ATOM 27 C P12 -2.2788 -0.0137  3.4107 
ATOM 28 H P12 -1.4419  0.1806  4.0798 
ATOM 29 H P12 -2.6991  0.9399  3.0888 
ATOM 30 H P12 -3.0383 -0.5667  3.9659 
ATOM 31 C P12 -0.7117 -0.0284  1.5114 
ATOM 32 O P12  0.4714 -0.1586  1.8293 
ATOM 33 N P12 -1.1084  0.8802  0.6042 
ATOM 34 H P12 -2.0758  0.8943  0.2937 
ATOM 35 C P12 -0.1492  1.7644 -0.0203 
ATOM 36 C P12  0.5186  2.7599  0.9554 
ATOM 37 H P12  0.1756  2.6111  1.9767 
ATOM 38 H P12  1.6004  2.6644  0.9148 
ATOM 39 C P12  0.0734  4.1158  0.3574 
ATOM 40 H P12  0.7146  4.9633  0.5795 
ATOM 41 O P12  0.0900  3.8168 -1.0422 
ATOM 42 C P12 -0.8697  2.7788 -0.9951 
ATOM 43 H P12 -1.0873  2.3858 -1.9845 
ATOM 44 C P12 -1.9998  3.4113 -0.2138 
ATOM 45 H P12 -3.0376  3.1264 -0.2873 
ATOM 46 C P12 -1.4044  4.2558  0.6267 
ATOM 47 H P12 -1.8443  4.8428  1.4197 
ATOM 48 C P12  0.9077  0.9800 -0.8087 
ATOM 49 O P12  2.0090  1.4737 -1.0622 
ATOM 50 N P12  0.5726 -0.2502 -1.2256 
ATOM 51 H P12 -0.3169 -0.6594 -0.9544 
ATOM 52 C P12  1.4944 -1.0786 -1.9927 
ATOM 53 C P12  1.6817 -0.5255 -3.3993 
ATOM 54 H P12  0.7187 -0.5226 -3.9107 
ATOM 55 H P12  2.0724  0.4898 -3.3689 
ATOM 56 H P12  2.3775 -1.1514 -3.9548 
ATOM 57 C P12  0.9137 -2.4910 -2.0582 
ATOM 58 H P12  1.5988 -3.1402 -2.6021 
ATOM 59 H P12  0.7511 -2.8983 -1.0600 
ATOM 60 H P12 -0.0434 -2.4754 -2.5806 
ATOM 61 C P12  2.8549 -1.1912 -1.2827 
ATOM 62 O P12  3.8818 -1.3817 -1.9306 
ATOM 63 N P12  2.8362 -1.1572  0.0631 
ATOM 64 H P12  1.9697 -0.9252  0.5365 
ATOM 65 C P12  4.0265 -1.3446  0.8826 
ATOM 66 C P12  4.5878 -2.7515  0.7174 
ATOM 67 H P12  3.8339 -3.4750  1.0296 
ATOM 68 H P12  4.8573 -2.9418 -0.3197 
ATOM 69 H P12  5.4732 -2.8700  1.3392 
ATOM 70 C P12  3.6215 -1.1136  2.3385 
ATOM 71 H P12  4.4958 -1.2146  2.9801 
ATOM 72 H P12  3.1908 -0.1210  2.4746 
ATOM 73 H P12  2.8804 -1.8552  2.6401 
ATOM 74 C P12  5.1084 -0.2997  0.5569 
ATOM 75 O P12  6.2925 -0.5239  0.8203 
ATOM 76 N P12  4.6864  0.8769  0.0830 
ATOM 77 H P12  3.7243  0.9807 -0.2184 
ATOM 78 C P12  5.6176  1.9399 -0.2059 
ATOM 79 H P12  6.2215  2.1691  0.6724 
ATOM 80 H P12  6.2930  1.6714 -1.0215 
ATOM 81 H P12  5.0568  2.8265 -0.4910 
 
COMPND Ac-Aib2-(1R,2R,4R)-Var-Aib2-NHMe-P310 
REMARK Energy(ZPE)= -1987.511795 
REMARK #IF = 0 
ATOM  1 C P13  6.0431  0.2238 -0.5211 
ATOM  2 H P13  5.8216  1.1795 -0.0486 
ATOM  3 H P13  6.8390 -0.2767  0.0263 
ATOM  4 H P13  6.3862  0.4269 -1.5360 
ATOM  5 C P13  4.7814 -0.5817 -0.6004 
ATOM  6 O P13  3.7360 -0.1088 -1.0559 
ATOM  7 N P13  4.8339 -1.8471 -0.1362 
ATOM  8 H P13  5.7243 -2.2058  0.1719 
ATOM  9 C P13  3.7523 -2.8097 -0.3203 
ATOM 10 C P13  4.0985 -4.0575  0.4919 
ATOM 11 H P13  5.0131 -4.5087 0.104 
ATOM 12 H P13  4.2423 -3.8188  1.5464 
ATOM 13 H P13  3.2961 -4.7888  0.4055 
ATOM 14 C P13  3.5821 -3.1607 -1.7923 
ATOM 15 H P13  2.7751 -3.8802 -1.9147 
ATOM 16 H P13  3.3474 -2.2723 -2.3763 
ATOM 17 H P13  4.5089 -3.5990 -2.1629 
ATOM 18 C P13  2.4382 -2.2469  0.2402 
ATOM 19 O P13  1.3576 -2.5391 -0.2706 
ATOM 20 N P13  2.5443 -1.4847  1.3406 
ATOM 21 H P13  3.4724 -1.2927  1.6867 
ATOM 22 C P13  1.4140 -0.9682  2.1016 
ATOM 23 C P13  1.9744 -0.0763  3.2078 
ATOM 24 H P13  2.5803 -0.6733  3.8914 
ATOM 25 H P13  2.5861  0.7281  2.7973 
ATOM 26 H P13  1.1538  0.3651  3.7714 
ATOM 27 C P13  0.5990 -2.1092 2.704 
ATOM 28 H P13 -0.2278 -1.7051  3.2844 
ATOM 29 H P13  0.1993 -2.7539  1.9221 
ATOM 30 H P13  1.2422 -2.6976  3.3586 
ATOM 31 C P13  0.4954 -0.1019  1.2286 
ATOM 32 O P13 -0.6613  0.1247  1.5937 
ATOM 33 N P13  0.9923  0.3984  0.0901 
ATOM 34 H P13  1.9509  0.1955 -0.1754 
ATOM 35 C P13  0.1774  1.2035 -0.7997 
ATOM 36 C P13  0.9974  1.6022 -2.0623 
ATOM 37 H P13  1.9607  1.0957 -2.0888 
ATOM 38 H P13  0.4509  1.3403 -2.9697 
ATOM 39 C P13  1.1064  3.1378 -1.9515 
ATOM 40 H P13  1.4463  3.6171 -2.8675 
ATOM 41 C P13 -0.3114  3.4631 -1.4667 
ATOM 42 H P13 -1.0887  3.1246 -2.1493 
ATOM 43 H P13 -0.4509  4.5187 -1.2295 
ATOM 44 C P13 -0.2067  2.5992 -0.1985 
ATOM 45 H P13 -1.0651  2.5578  0.4656 
ATOM 46 C P13  1.0726  3.1404  0.3783 
ATOM 47 C P13  1.8956  3.4562 -0.7097 
ATOM 48 C P13  3.1809  3.9276 -0.5114 
ATOM 49 H P13  3.8262  4.1689 -1.3482 
ATOM 50 C P13  3.6274  4.1031  0.8008 
ATOM 51 H P13  4.6227  4.4911  0.9806 
ATOM 52 C P13  2.8071  3.7918 1.881 
ATOM 53 H P13  3.1728  3.9392  2.8899 
ATOM 54 C P13  1.5186  3.2925  1.6776 
ATOM 55 H P13  0.8865  3.0355  2.5202 
ATOM 56 C P13 -1.0808  0.4283 -1.2054 
ATOM 57 O P13 -2.1099  1.0217 -1.5390 
ATOM 58 N P13 -0.9925 -0.9093 -1.2103 
ATOM 59 H P13 -0.1307 -1.3553 -0.9089 
ATOM 60 C P13 -2.0942 -1.7698 -1.6209 
ATOM 61 C P13 -1.7294 -3.2011 -1.2268 
ATOM 62 H P13 -0.8231 -3.5095 -1.7493 
ATOM 63 H P13 -1.5502 -3.2788 -0.1532 
ATOM 64 H P13 -2.5394 -3.8756 -1.5013 
ATOM 65 C P13 -2.3222 -1.6756 -3.1238 
ATOM 66 H P13 -3.1462 -2.3221 -3.4194 
ATOM 67 H P13 -2.5588 -0.6534 -3.4147 
ATOM 68 H P13 -1.4168 -1.9938 -3.6414 
ATOM 69 C P13 -3.3880 -1.4151 -0.8681 
ATOM 70 O P13 -4.4843 -1.6197 -1.3852 
ATOM 71 N P13 -3.2477 -0.9636  0.3922 
ATOM 72 H P13 -2.3186 -0.7414  0.7360 
ATOM 73 C P13 -4.3796 -0.6780  1.2648 
ATOM 74 C P13 -3.8255 -0.0754  2.5560 
ATOM 75 H P13 -3.1809 -0.7993  3.0570 
ATOM 76 H P13 -3.2429  0.8238  2.3538 
ATOM 77 H P13 -4.6494  0.1768  3.2225 
ATOM 78 C P13 -5.1612 -1.9469  1.5821 
ATOM 79 H P13 -5.9953 -1.7125  2.2408 
ATOM 80 H P13 -5.5482 -2.4029  0.6732 
ATOM 81 H P13 -4.5012 -2.6552  2.0842 
ATOM 82 C P13 -5.3098  0.3816  0.6492 
ATOM 83 O P13 -6.4912  0.4570  0.9964 
ATOM 84 N P13 -4.7457  1.2613 -0.1839 
ATOM 85 H P13 -3.8037  1.0974 -0.5205 
ATOM 86 C P13 -5.5179  2.3235 -0.7802 
ATOM 87 H P13 -6.0183  2.9110 -0.0102 
ATOM 88 H P13 -4.8474  2.9707 -1.3401 
ATOM 89 H P13 -6.2807  1.9333 -1.4583 
 
COMPND Ac-Aib2-(1R,2R,4R)-Var-Aib2-NHMe-M310 
REMARK Energy(ZPE)= -1987.5085 
REMARK #IF = 0 
ATOM  1 C P13 -5.8240 -0.3830 -1.0786 
ATOM  2 H P13 -5.9014  0.0311 -2.0824 
ATOM  3 H P13 -6.6776 -1.0295 -0.8855 
ATOM  4 H P13 -5.8485  0.4477 -0.3716 
ATOM  5 C P13 -4.5067 -1.0886 -0.9433 
ATOM  6 O P13 -3.4466 -0.5812 -1.3151 
ATOM  7 N P13 -4.5247 -2.2986 -0.3454 
ATOM  8 H P13 -5.4133 -2.7164 -0.1185 
ATOM  9 C P13 -3.3341 -3.1338 -0.2562 
ATOM 10 C P13 -2.9028 -3.6217 -1.6328 
ATOM 11 H P13 -3.7090 -4.2118 -2.0689 
ATOM 12 H P13 -2.6792 -2.7800 -2.2862 
ATOM 13 H P13 -2.0132 -4.2432 -1.5485 
ATOM 14 C P13 -3.6568 -4.3184  0.6535 
ATOM 15 H P13 -2.7728 -4.9429  0.7748 
ATOM 16 H P13 -3.9890 -3.9868  1.6379 
ATOM 17 H P13 -4.4425 -4.9264  0.2022 
ATOM 18 C P13 -2.1967 -2.3426  0.4020 
ATOM 19 O P13 -1.0259 -2.5086  0.0626 
ATOM 20 N P13 -2.5360 -1.5253  1.4126 
ATOM 21 H P13 -3.5118 -1.4388  1.6545 
ATOM 22 C P13 -1.5471 -0.8961  2.2777 
ATOM 23 C P13 -0.8586 -1.9333  3.1537 
ATOM 24 H P13 -1.6051 -2.4254  3.7774 
ATOM 25 H P13 -0.3542 -2.6793  2.5415 
ATOM 26 H P13 -0.1203 -1.4532  3.7929 
ATOM 27 C P13 -2.2703  0.1397  3.1376 
ATOM 28 H P13 -1.5539  0.6587  3.7732 
ATOM 29 H P13 -2.7877  0.8756  2.5206 
ATOM 30 H P13 -2.9978 -0.3578  3.7811 
ATOM 31 C P13 -0.5057 -0.1456  1.4364 
ATOM 32 O P13  0.6749 -0.0988  1.7835 
ATOM 33 N P13 -0.9606  0.5369  0.3709 
ATOM 34 H P13 -1.9130  0.3982  0.0507 
ATOM 35 C P13 -0.0959  1.4492 -0.3531 
ATOM 36 C P13  0.4671  2.5903  0.5421 
ATOM 37 H P13  0.1435  2.4648  1.5737 
ATOM 38 H P13  1.5551  2.5848  0.5136 
ATOM 39 C P13 -0.0783  3.8798 -0.1082 
ATOM 40 H P13  0.4492  4.7832  0.1917 
ATOM 41 C P13 -0.0225  3.4924 -1.5942 
ATOM 42 H P13  0.9837  3.2606 -1.9369 
ATOM 43 H P13 -0.4844  4.2343 -2.2463 
ATOM 44 C P13 -0.9133  2.2513 -1.4265 
ATOM 45 H P13 -1.1537  1.6701 -2.3155 
ATOM 46 C P13 -2.0870  2.8767 -0.7088 
ATOM 47 C P13 -1.5647  3.8855  0.1086 
ATOM 48 C P13 -2.3915  4.6384  0.9218 
ATOM 49 H P13 -1.9919  5.4174  1.5605 
ATOM 50 C P13 -3.7655  4.3879  0.8837 
ATOM 51 H P13 -4.4352  4.9797  1.4960 
ATOM 52 C P13 -4.2854  3.3976  0.0570 
ATOM 53 H P13 -5.3558  3.2319  0.0312 
ATOM 54 C P13 -3.4455  2.6216 -0.7459 
ATOM 55 H P13 -3.8466  1.8425 -1.3802 
ATOM 56 C P13  1.0566  0.6909 -1.0285 
ATOM 57 O P13  2.0877  1.2814 -1.3661 
ATOM 58 N P13  0.9053 -0.6246 -1.2376 
ATOM 59 H P13  0.0917 -1.1104 -0.8738 
ATOM 60 C P13  1.9627 -1.4208 -1.8500 
ATOM 61 C P13  2.1386 -1.0570 -3.3184 
ATOM 62 H P13  1.2093 -1.2649 -3.8499 
ATOM 63 H P13  2.3877 -0.0037 -3.4308 
ATOM 64 H P13  2.9382 -1.6543 -3.7521 
ATOM 65 C P13  1.5870 -2.8964 -1.7217 
ATOM 66 H P13  2.3606 -3.5054 -2.1878 
ATOM 67 H P13  1.4821 -3.1915 -0.6780 
ATOM 68 H P13  0.6393 -3.0849 -2.2275 
ATOM 69 C P13  3.2914 -1.2372 -1.0955 
ATOM 70 O P13  4.3635 -1.3871 -1.6779 
ATOM 71 N P13  3.2064 -0.9946  0.2268 
ATOM 72 H P13  2.2968 -0.8201  0.6416 
ATOM 73 C P13  4.3737 -0.8891  1.0928 
ATOM 74 C P13  5.1166 -2.2165  1.1777 
ATOM 75 H P13  4.4496 -2.9728  1.5932 
ATOM 76 H P13  5.4514 -2.5373  0.1934 
ATOM 77 H P13  5.9837 -2.1112  1.8273 
ATOM 78 C P13  3.8809 -0.4821  2.4818 
ATOM 79 H P13  4.7324 -0.3762  3.1526 
ATOM 80 H P13  3.3343  0.4608  2.4462 
ATOM 81 H P13  3.2158 -1.2502  2.8794 
ATOM 82 C P13  5.3267  0.2233  0.6226 
ATOM 83 O P13  6.5183  0.1995  0.9404 
ATOM 84 N P13  4.7796  1.2475 -0.0408 
ATOM 85 H P13  3.8268  1.1766 -0.3776 
ATOM 86 C P13  5.5835  2.3628 -0.4777 
ATOM 87 H P13  6.1397  2.7821  0.3607 
ATOM 88 H P13  6.3009  2.0651 -1.2460 
ATOM 89 H P13  4.9277  3.1274 -0.8864 
 
COMPND Ac-Aib2-(1R,2R,4R)-Vdm-Aib2-NHMe-P310 
REMARK Energy(ZPE)= -1912.493059 
REMARK #IF = 0 
ATOM  1 C P14  6.1314  0.6747  0.0912 
ATOM  2 H P14  5.8143  1.5146  0.7076 
ATOM  3 H P14  6.9009  0.1099  0.6131 
ATOM  4 H P14  6.5526  1.0796 -0.8295 
ATOM  5 C P14  4.9283 -0.1479 -0.2596 
ATOM  6 O P14  3.9026  0.3628 -0.7183 
ATOM  7 N P14  5.0062 -1.4760 -0.0363 
ATOM  8 H P14  5.8830 -1.8590  0.2816 
ATOM  9 C P14  3.9869 -2.4151 -0.4947 
ATOM 10 C P14  4.3186 -3.7857  0.0942 
ATOM 11 H P14  5.2775 -4.1332 -0.2937 
ATOM 12 H P14  4.3708 -3.7485  1.1830 
ATOM 13 H P14  3.5547 -4.5061 -0.1948 
ATOM 14 C P14  3.9532 -2.4818 -2.0157 
ATOM 15 H P14  3.2003 -3.1959 -2.3431 
ATOM 16 H P14  3.7168 -1.5077 -2.4405 
ATOM 17 H P14  4.9292 -2.8043 -2.3785 
ATOM 18 C P14  2.6095 -2.0008  0.0446 
ATOM 19 O P14  1.5878 -2.2058 -0.6095 
ATOM 20 N P14  2.5985 -1.4716  1.2792 
ATOM 21 H P14  3.4916 -1.3315  1.7273 
ATOM 22 C P14  1.4012 -1.1316  2.0355 
ATOM 23 C P14  1.8568 -0.5031  3.3505 
ATOM 24 H P14  2.3942 -1.2434  3.9452 
ATOM 25 H P14  2.5132  0.3507  3.1775 
ATOM 26 H P14  0.9891 -0.1704  3.9180 
ATOM 27 C P14  0.5620 -2.3763  2.3165 
ATOM 28 H P14 -0.3144 -2.1018  2.9005 
ATOM 29 H P14  0.2339 -2.8406  1.3876 
ATOM 30 H P14  1.1622 -3.0903  2.8807 
ATOM 31 C P14  0.5251 -0.1093  1.2951 
ATOM 32 O P14 -0.6535  0.0334  1.6342 
ATOM 33 N P14  1.0691  0.6036  0.3020 
ATOM 34 H P14  2.0420  0.4602  0.0491 
ATOM 35 C P14  0.2648  1.4985 -0.5155 
ATOM 36 C P14 -0.1487  2.8243  0.2049 
ATOM 37 H P14 -1.0061  2.7007  0.8624 
ATOM 38 C P14  1.1099  2.0328 -1.7092 
ATOM 39 H P14  2.0985  1.5764 -1.7322 
ATOM 40 H P14  0.6166  1.8167 -2.6588 
ATOM 41 C P14  1.9075  3.7837 -0.1616 
ATOM 42 C P14  3.3075  4.2833 -0.1236 
ATOM 43 H P14  3.3872  5.2705 -0.5872 
ATOM 44 H P14  3.9720  3.6180 -0.6833 
ATOM 45 H P14  3.6879  4.3554  0.8956 
ATOM 46 C P14  1.1191  3.3590  0.8391 
ATOM 47 C P14  1.3764  3.3001  2.3020 
ATOM 48 H P14  1.2314  2.2878  2.6861 
ATOM 49 H P14  0.6737  3.9391  2.8454 
ATOM 50 H P14  2.3875  3.6194  2.5556 
ATOM 51 C P14  1.1463  3.5560 -1.4516 
ATOM 52 H P14  1.4919  4.1325 -2.3094 
ATOM 53 C P14 -0.2912  3.7792 -0.9837 
ATOM 54 H P14 -1.0442  3.4641 -1.7063 
ATOM 55 H P14 -0.4787  4.8040 -0.6604 
ATOM 56 C P14 -0.9658  0.7475 -1.0398 
ATOM 57 O P14 -2.0352  1.3307 -1.2344 
ATOM 58 N P14 -0.8051 -0.5556 -1.3211 
ATOM 59 H P14  0.0789 -1.0109 -1.1095 
ATOM 60 C P14 -1.8531 -1.3561 -1.9415 
ATOM 61 C P14 -1.4133 -2.8192 -1.8946 
ATOM 62 H P14 -0.4895 -2.9486 -2.4595 
ATOM 63 H P14 -1.2402 -3.1458 -0.8686 
ATOM 64 H P14 -2.1847 -3.4463 -2.3399 
ATOM 65 C P14 -2.0810 -0.9222 -3.3838 
ATOM 66 H P14 -2.8678 -1.5243 -3.8339 
ATOM 67 H P14 -2.3746  0.1253 -3.4298 
ATOM 68 H P14 -1.1577 -1.0607 -3.9471 
ATOM 69 C P14 -3.1702 -1.2635 -1.1535 
ATOM 70 O P14 -4.2481 -1.4117 -1.7263 
ATOM 71 N P14 -3.0684 -1.1039  0.1789 
ATOM 72 H P14 -2.1627 -0.8852  0.5815 
ATOM 73 C P14 -4.2246 -1.0924  1.0647 
ATOM 74 C P14 -3.7251 -0.7833  2.4761 
ATOM 75 H P14 -3.0217 -1.5533  2.7975 
ATOM 76 H P14 -3.2195  0.1817  2.5148 
ATOM 77 H P14 -4.5692 -0.7715  3.1644 
ATOM 78 C P14 -4.9362 -2.4401  1.0549 
ATOM 79 H P14 -5.7986 -2.4048  1.7181 
ATOM 80 H P14 -5.2731 -2.6947  0.0519 
ATOM 81 H P14 -4.2476 -3.2092  1.4069 
ATOM 82 C P14 -5.2081  0.0308  0.6927 
ATOM 83 O P14 -6.3911 -0.0349  1.0369 
ATOM 84 N P14 -4.6956  1.1040  0.0819 
ATOM 85 H P14 -3.7453  1.0787 -0.2705 
ATOM 86 C P14 -5.5302  2.2289 -0.2621 
ATOM 87 H P14 -6.0265  2.6255  0.6241 
ATOM 88 H P14 -4.9064  3.0062 -0.6963 
ATOM 89 H P14 -6.3003  1.9484 -0.9842 
 
COMPND Ac-Aib2-(1R,2R,4R)-Vdm-Aib2-NHMe-M310 
REMARK Energy(ZPE)= -1912.4899 
REMARK #IF = 0 
ATOM  1 C P14 -5.7319  0.5957 -1.5142 
ATOM  2 H P14 -5.6748  1.5177 -0.9357 
ATOM  3 H P14 -5.6413  0.8600 -2.5667 
ATOM  4 H P14 -6.7001  0.1311 -1.3403 
ATOM  5 C P14 -4.5783 -0.2879 -1.1411 
ATOM  6 O P14 -3.4098  0.0135 -1.3971 
ATOM  7 N P14 -4.8777 -1.4248 -0.4766 
ATOM  8 H P14 -5.8483 -1.6670 -0.3531 
ATOM  9 C P14 -3.8894 -2.4650 -0.2208 
ATOM 10 C P14 -3.4452 -3.1282 -1.5175 
ATOM 11 H P14 -4.3109 -3.5799 -2.0023 
ATOM 12 H P14 -2.9970 -2.3978 -2.1891 
ATOM 13 H P14 -2.7090 -3.9022 -1.3081 
ATOM 14 C P14 -4.5213 -3.4916  0.7188 
ATOM 15 H P14 -3.7946 -4.2640  0.9671 
ATOM 16 H P14 -4.8668 -3.0266  1.6428 
ATOM 17 H P14 -5.3694 -3.9706  0.2268 
ATOM 18 C P14 -2.6757 -1.8645  0.4955 
ATOM 19 O P14 -1.5335 -2.2433  0.2399 
ATOM 20 N P14 -2.9191 -0.9651  1.4623 
ATOM 21 H P14 -3.8734 -0.6911  1.6435 
ATOM 22 C P14 -1.8651 -0.4887  2.3511 
ATOM 23 C P14 -1.3882 -1.6013  3.2734 
ATOM 24 H P14 -2.2251 -1.9449  3.8817 
ATOM 25 H P14 -0.9958 -2.4377  2.6972 
ATOM 26 H P14 -0.6009 -1.2325  3.9283 
ATOM 27 C P14 -2.4298  0.6759  3.1623 
ATOM 28 H P14 -1.6571  1.0836  3.8131 
ATOM 29 H P14 -2.7924  1.4727  2.5115 
ATOM 30 H P14 -3.2524  0.3275  3.7891 
ATOM 31 C P14 -0.6894  0.0545  1.5223 
ATOM 32 O P14  0.4756 -0.0808  1.8961 
ATOM 33 N P14 -1.0199  0.7690  0.4326 
ATOM 34 H P14 -1.9608  0.6805  0.0638 
ATOM 35 C P14 -0.0371  1.5140 -0.3318 
ATOM 36 C P14 -0.7627  2.4810 -1.3395 
ATOM 37 H P14 -1.1912  1.9623 -2.1974 
ATOM 38 C P14  0.7751  2.5240  0.5297 
ATOM 39 H P14  0.4635  2.4778  1.5721 
ATOM 40 H P14  1.8391  2.2984 0.478 
ATOM 41 C P14 -0.9958  4.1746  0.2051 
ATOM 42 C P14 -1.4113  5.1418  1.2540 
ATOM 43 H P14 -1.0242  6.1418  1.0403 
ATOM 44 H P14 -1.0043  4.8516  2.2279 
ATOM 45 H P14 -2.4946  5.2073  1.3527 
ATOM 46 C P14 -1.7355  3.3235 -0.5230 
ATOM 47 C P14 -3.2136  3.1507 -0.5214 
ATOM 48 H P14 -3.5259  2.2538  0.0209 
ATOM 49 H P14 -3.5984  3.0433 -1.5380 
ATOM 50 H P14 -3.7071  4.0044 -0.0563 
ATOM 51 C P14  0.4515  3.8909 -0.1183 
ATOM 52 H P14  1.1556  4.6799  0.1451 
ATOM 53 C P14  0.3427  3.5095  -1.595 
ATOM 54 H P14  1.2566  3.0844  -2.006 
ATOM 55 H P14 -0.0129  4.3319 -2.2164 
ATOM 56 C P14  0.9336  0.5691 -1.0546 
ATOM 57 O P14  1.9981  0.9924 -1.5201 
ATOM 58 N P14  0.6142 -0.7308 -1.1369 
ATOM 59 H P14 -0.2270 -1.0821 -0.6906 
ATOM 60 C P14  1.5435 -1.6997 -1.7066 
ATOM 61 C P14  1.6881 -1.5054 -3.2101 
ATOM 62 H P14  0.7177 -1.6583 -3.6833 
ATOM 63 H P14  2.0451 -0.5032 -3.4378 
ATOM 64 H P14  2.3964 -2.2297 -3.6081 
ATOM 65 C P14  1.0180 -3.1041 -1.4122 
ATOM 66 H P14  1.7058 -3.8385 -1.83 
ATOM 67 H P14  0.9223 -3.2766 -0.3404 
ATOM 68 H P14  0.0378 -3.2402 -1.8702 
ATOM 69 C P14  2.9181 -1.5899 -1.0226 
ATOM 70 O P14  3.9432 -1.9009 -1.6252 
ATOM 71 N P14  2.9189 -1.2206  0.2734 
ATOM 72 H P14  2.0490 -0.9292  0.7083 
ATOM 73 C P14  4.1302 -1.1575  1.08 
ATOM 74 C P14  4.7428 -2.5411  1.2618 
ATOM 75 H P14  4.0262 -3.1843  1.7738 
ATOM 76 H P14  4.9954 -2.9832  0.2999 
ATOM 77 H P14  5.6469 -2.4663  1.8631 
ATOM 78 C P14  3.7457 -0.5777  2.4411 
ATOM 79 H P14  4.6345 -0.4940 3.065 
ATOM 80 H P14  3.2907  0.4080  2.3354 
ATOM 81 H P14  3.0308 -1.2360  2.9369 
ATOM 82 C P14  5.1662 -0.1964  0.4714 
ATOM 83 O P14  6.3607 -0.3055  0.7601 
ATOM 84 N P14  4.6978  0.8038 -0.2821 
ATOM 85 H P14  3.7319  0.7940 -0.5888 
ATOM 86 C P14  5.5927  1.7767 -0.8596 
ATOM 87 H P14  6.1818  2.2655 -0.0832 
ATOM 88 H P14  6.2835  1.3132 -1.5677 
ATOM 89 H P14  5.0031  2.5263 -1.3811 
 
COMPND Ac-Aib2-(1R,2S,4R)-V-Aib2-NHMe-P310 
REMARK Energy(ZPE)= -1833.953988 
REMARK #IF = 0 
ATOM  1 C P15 -6.0930  1.5259 -0.2947 
ATOM  2 H P15 -5.7344  2.1383 -1.1210 
ATOM  3 H P15 -6.9816  0.9817 -0.6071 
ATOM  4 H P15 -6.3560  2.1956  0.5242 
ATOM  5 C P15 -4.9805  0.6307  0.1624 
ATOM  6 O P15 -3.8713  1.0767  0.4690 
ATOM  7 N P15 -5.2406 -0.6923  0.2046 
ATOM  8 H P15 -6.1789 -1.0005  0.0028 
ATOM  9 C P15 -4.3261 -1.6652  0.7948 
ATOM 10 C P15 -4.8691 -3.0604  0.4877 
ATOM 11 H P15 -5.8403 -3.1936  0.9670 
ATOM 12 H P15 -4.9813 -3.2171 -0.5859 
ATOM 13 H P15 -4.1905 -3.8156  0.8818 
ATOM 14 C P15 -4.2077 -1.4573  2.2985 
ATOM 15 H P15 -3.5218 -2.1875  2.7235 
ATOM 16 H P15 -3.8346 -0.4593  2.5224 
ATOM 17 H P15 -5.1901 -1.5834  2.7542 
ATOM 18 C P15 -2.9420 -1.5524  0.1398 
ATOM 19 O P15 -1.9168 -1.7661  0.7854 
ATOM 20 N P15 -2.9335 -1.2732 -1.1746 
ATOM 21 H P15 -3.8227 -1.1079 -1.6219 
ATOM 22 C P15 -1.7372 -1.2459 -2.0045 
ATOM 23 C P15 -2.1435 -0.7262 -3.3833 
ATOM 24 H P15 -2.8550 -1.4141 -3.8430 
ATOM 25 H P15 -2.5987  0.2632 -3.3168 
ATOM 26 H P15 -1.2648 -0.6645 -4.0235 
ATOM 27 C P15 -1.1226 -2.6359 -2.1244 
ATOM 28 H P15 -0.2373 -2.5939 -2.7557 
ATOM 29 H P15 -0.8366 -3.0198 -1.1463 
ATOM 30 H P15 -1.8518 -3.3101 -2.5741 
ATOM 31 C P15 -0.6954 -0.2673 -1.4486 
ATOM 32 O P15  0.4941 -0.3942 -1.7512 
ATOM 33 N P15 -1.1274  0.7432 -0.6830 
ATOM 34 H P15 -2.1030  0.7932 -0.3999 
ATOM 35 C P15 -0.2018  1.7462 -0.1787 
ATOM 36 C P15  0.3546  2.6519 -1.3055 
ATOM 37 H P15  1.4416  2.6807 -1.2914 
ATOM 38 H P15  0.0234  2.2744 -2.2731 
ATOM 39 C P15 -0.2768  4.0370 -0.9963 
ATOM 40 H P15 -0.2691  4.7223 -1.8414 
ATOM 41 C P15 -1.6403  3.6076 -0.4505 
ATOM 42 H P15 -2.2323  3.0257 -1.1602 
ATOM 43 H P15 -2.2311  4.4400 -0.0676 
ATOM 44 C P15 -1.0337  2.7671  0.6809 
ATOM 45 H P15 -1.7160  2.2734  1.3702 
ATOM 46 C P15 -0.0656  3.7616  1.2712 
ATOM 47 H P15  0.2762  3.7545  2.2970 
ATOM 48 C P15  0.3792  4.5258  0.2705 
ATOM 49 H P15  1.1599  5.2736  0.3175 
ATOM 50 C P15  0.9041  1.0821  0.6432 
ATOM 51 O P15  2.0133  1.6069  0.7674 
ATOM 52 N P15  0.5890 -0.0763  1.2430 
ATOM 53 H P15 -0.3175 -0.4923  1.0550 
ATOM 54 C P15  1.5214 -0.7988  2.0972 
ATOM 55 C P15  0.9227 -2.1753  2.3855 
ATOM 56 H P15 -0.0400 -2.0659  2.8861 
ATOM 57 H P15  0.7693 -2.7393  1.4648 
ATOM 58 H P15  1.5943 -2.7353  3.0350 
ATOM 59 C P15  1.7569 -0.0426  3.3983 
ATOM 60 H P15  2.4552 -0.5903  4.0280 
ATOM 61 H P15  2.1663  0.9467  3.2002 
ATOM 62 H P15  0.8081  0.0616  3.9258 
ATOM 63 C P15  2.8598 -1.0402  1.3780 
ATOM 64 O P15  3.8998 -1.1595  2.0229 
ATOM 65 N P15  2.8059 -1.1963  0.0420 
ATOM 66 H P15  1.9345 -0.9999 -0.4419 
ATOM 67 C P15  3.9749 -1.5181 -0.7658 
ATOM 68 C P15  3.5457 -1.4955 -2.2329 
ATOM 69 H P15  2.7780 -2.2512 -2.4065 
ATOM 70 H P15  3.1392 -0.5229 -2.5111 
ATOM 71 H P15  4.4043 -1.7178 -2.8651 
ATOM 72 C P15  4.5235 -2.8954 -0.4118 
ATOM 73 H P15  5.3902 -3.1177 -1.0315 
ATOM 74 H P15  4.8184 -2.9399  0.6347 
ATOM 75 H P15  3.7524 -3.6439 -0.5984 
ATOM 76 C P15  5.0735 -0.4522 -0.6138 
ATOM 77 O P15  6.2497 -0.7261 -0.8662 
ATOM 78 N P15  4.6740  0.7851 -0.3032 
ATOM 79 H P15  3.7177  0.9458 -0.0077 
ATOM 80 C P15  5.6239  1.8643 -0.1878 
ATOM 81 H P15  6.1962  1.9727 -1.1096 
ATOM 82 H P15  5.0820  2.7872  0.0030 
ATOM 83 H P15  6.3279  1.6917  0.6295 
 
COMPND Ac-Aib2-(1R,2S,4R)-V-Aib2-NHMe-M310 
REMARK Energy(ZPE)= -1833.9511 
REMARK #IF = 0 
ATOM  1 C P15 -6.1969  1.5168  0.2526 
ATOM  2 H P15 -5.8388  2.1862  1.0336 
ATOM  3 H P15 -6.4931  2.1294 -0.5991 
ATOM  4 H P15 -7.0648  0.9700  0.6147 
ATOM  5 C P15 -5.0708  0.6238 -0.1736 
ATOM  6 O P15 -3.9752  1.0771 -0.5174 
ATOM  7 N P15 -5.3011 -0.7046 -0.1452 
ATOM  8 H P15 -6.2289 -1.0235  0.0866 
ATOM  9 C P15 -4.3705 -1.6866 -0.6934 
ATOM 10 C P15 -4.2719 -1.5576 -2.2075 
ATOM 11 H P15 -5.2534 -1.7390 -2.6456 
ATOM 12 H P15 -3.9316 -0.5623 -2.4885 
ATOM 13 H P15 -3.5662 -2.2885 -2.5978 
ATOM 14 C P15 -4.8764 -3.0755 -0.3056 
ATOM 15 H P15 -4.1849 -3.8343 -0.6691 
ATOM 16 H P15 -4.9705 -3.1773  0.7763 
ATOM 17 H P15 -5.8502 -3.2562 -0.7636 
ATOM 18 C P15 -2.9834 -1.5086 -0.0615 
ATOM 19 O P15 -1.9599 -1.7478 -0.7010 
ATOM 20 N P15 -2.9638 -1.1412  1.2300 
ATOM 21 H P15 -3.8487 -0.9583  1.6790 
ATOM 22 C P15 -1.7556 -1.0514  2.0372 
ATOM 23 C P15 -1.1496 -2.4330  2.2593 
ATOM 24 H P15 -1.8794 -3.0635  2.7674 
ATOM 25 H P15 -0.8786 -2.8941  1.3104 
ATOM 26 H P15 -0.2568 -2.3515  2.8756 
ATOM 27 C P15 -2.1371 -0.4162  3.3735 
ATOM 28 H P15 -1.2479 -0.3067  3.9924 
ATOM 29 H P15 -2.5886  0.5666  3.2301 
ATOM 30 H P15 -2.8447 -1.0581  3.9007 
ATOM 31 C P15 -0.7146 -0.1333  1.3839 
ATOM 32 O P15  0.4775 -0.2530  1.6781 
ATOM 33 N P15 -1.1530  0.8102  0.5385 
ATOM 34 H P15 -2.1369  0.8410  0.2884 
ATOM 35 C P15 -0.2385  1.7508 -0.0924 
ATOM 36 C P15 -1.0257  2.6347 -1.1037 
ATOM 37 H P15 -0.5470  2.6559 -2.0819 
ATOM 38 H P15 -2.0382  2.2518 -1.2307 
ATOM 39 C P15 -1.0165  4.0349 -0.4298 
ATOM 40 H P15 -1.8028  4.6957 -0.7893 
ATOM 41 C P15 -1.0426  3.6450  1.0505 
ATOM 42 H P15 -1.9234  3.0680  1.3396 
ATOM 43 H P15 -0.9267  4.5016  1.7145 
ATOM 44 C P15  0.2419  2.8080  0.9555 
ATOM 45 H P15  0.6175  2.3445  1.8644 
ATOM 46 C P15  1.1522  3.7998  0.2705 
ATOM 47 H P15  2.2265  3.8206  0.3732 
ATOM 48 C P15  0.3989  4.5452 -0.5426 
ATOM 49 H P15  0.7370  5.2881 -1.2530 
ATOM 50 C P15  0.8933  0.9886 -0.7826 
ATOM 51 O P15  2.0183  1.4778 -0.9036 
ATOM 52 N P15  0.5860 -0.2140 -1.2960 
ATOM 53 H P15 -0.3302 -0.6182 -1.1217 
ATOM 54 C P15  1.5416 -0.9889 -2.0770 
ATOM 55 C P15  1.8011 -0.3227 -3.4227 
ATOM 56 H P15  0.8637 -0.2613 -3.9763 
ATOM 57 H P15  2.2016  0.6810 -3.2862 
ATOM 58 H P15  2.5169 -0.9084 -3.9963 
ATOM 59 C P15  0.9553 -2.3851 -2.2842 
ATOM 60 H P15  1.6594 -2.9952 -2.8486 
ATOM 61 H P15  0.7509 -2.8733 -1.3305 
ATOM 62 H P15  0.0245 -2.3194 -2.8487 
ATOM 63 C P15  2.8689 -1.1729 -1.3216 
ATOM 64 O P15  3.9187 -1.3285 -1.9427 
ATOM 65 N P15  2.7973 -1.2430  0.0204 
ATOM 66 H P15  1.9234 -1.0022  0.4783 
ATOM 67 C P15  3.9588 -1.4979  0.8631 
ATOM 68 C P15  4.5262 -2.8892  0.6094 
ATOM 69 H P15  3.7664 -3.6340  0.8488 
ATOM 70 H P15  4.8236 -3.0033 -0.4310 
ATOM 71 H P15  5.3956 -3.0504  1.2441 
ATOM 72 C P15  3.5087 -1.3827  2.3196 
ATOM 73 H P15  4.3588 -1.5624  2.9766 
ATOM 74 H P15  3.0981 -0.3949  2.5300 
ATOM 75 H P15  2.7402 -2.1278  2.5306 
ATOM 76 C P15  5.0515 -0.4345  0.6575 
ATOM 77 O P15  6.2253 -0.6803  0.9480 
ATOM 78 N P15  4.6472  0.7749  0.2571 
ATOM 79 H P15  3.6955  0.9056 -0.0669 
ATOM 80 C P15  5.5881  1.8544  0.0853 
ATOM 81 H P15  6.1455  2.0289  1.0061 
ATOM 82 H P15  6.3056  1.6378 -0.7095 
ATOM 83 H P15  5.0392  2.7568 -0.1723 
 
COMPND Ac-Aib2-(1R,2S,4R)-Vdm-Aib2-NHMe-P310 
REMARK Energy(ZPE)= -1912.494595 
REMARK #IF = 0 
ATOM  1 C P16 -6.1199  1.4515 -0.4865 
ATOM  2 H P16 -5.7521  1.9815 -1.3638 
ATOM  3 H P16 -7.0165  0.8939 -0.7494 
ATOM  4 H P16 -6.3746  2.1958  0.2684 
ATOM  5 C P16 -5.0208  0.5857  0.0525 
ATOM  6 O P16 -3.8942  1.0323  0.2842 
ATOM  7 N P16 -5.3130 -0.7156  0.2575 
ATOM  8 H P16 -6.2625 -1.0220  0.1135 
ATOM  9 C P16 -4.4099 -1.6314  0.9471 
ATOM 10 C P16 -4.9971 -3.0376  0.8301 
ATOM 11 H P16 -5.9604 -3.0783  1.3413 
ATOM 12 H P16 -5.1384 -3.3248 -0.2125 
ATOM 13 H P16 -4.3310 -3.7572  1.3039 
ATOM 14 C P16 -4.2501 -1.2400  2.4101 
ATOM 15 H P16 -3.5767 -1.9323  2.9115 
ATOM 16 H P16 -3.8434 -0.2340  2.4975 
ATOM 17 H P16 -5.2249 -1.2773  2.8968 
ATOM 18 C P16 -3.0387 -1.6437  0.2559 
ATOM 19 O P16 -2.0070 -1.8250  0.9015 
ATOM 20 N P16 -3.0460 -1.5133 -1.0807 
ATOM 21 H P16 -3.9347 -1.3570 -1.5320 
ATOM 22 C P16 -1.8613 -1.6280 -1.9209 
ATOM 23 C P16 -2.2663 -1.2427 -3.3433 
ATOM 24 H P16 -3.0132 -1.9442 -3.7185 
ATOM 25 H P16 -2.6795 -0.2335 -3.3777 
ATOM 26 H P16 -1.3967 -1.2869 -3.9970 
ATOM 27 C P16 -1.3127 -3.0503 -1.8931 
ATOM 28 H P16 -0.4390 -3.1249 -2.5375 
ATOM 29 H P16 -1.0275 -3.3363 -0.8818 
ATOM 30 H P16 -2.0812 -3.7340 -2.2543 
ATOM 31 C P16 -0.7716 -0.6410 -1.4811 
ATOM 32 O P16  0.4097 -0.8556 -1.7659 
ATOM 33 N P16 -1.1560  0.4695 -0.8403 
ATOM 34 H P16 -2.1286  0.5906 -0.5708 
ATOM 35 C P16 -0.1928  1.4869 -0.4442 
ATOM 36 C P16  0.3978  2.2427 -1.6594 
ATOM 37 H P16  1.4859  2.2334 -1.6421 
ATOM 38 H P16  0.0566  1.7725 -2.5821 
ATOM 39 C P16 -0.1809  3.6710 -1.5004 
ATOM 40 H P16 -0.1397  4.2661 -2.4123 
ATOM 41 C P16 -1.5622  3.3602 -0.9250 
ATOM 42 H P16 -2.1775  2.7318 -1.5729 
ATOM 43 H P16 -2.1182  4.2525 -0.6364 
ATOM 44 C P16 -0.9867  2.6273  0.2899 
ATOM 45 H P16 -1.6875  2.2372  1.0273 
ATOM 46 C P16  0.0139  3.6466  0.7896 
ATOM 47 C P16  0.4986  4.2778 -0.2907 
ATOM 48 C P16  0.8882  0.8756  0.4513 
ATOM 49 O P16  2.0228  1.3566  0.5069 
ATOM 50 C P16  0.4063  3.7531  2.2194 
ATOM 51 H P16  1.1728  4.5124  2.3749 
ATOM 52 H P16  0.7983  2.8008  2.5869 
ATOM 53 H P16 -0.4537  4.0042  2.8468 
ATOM 54 C P16  1.6097  5.2582 -0.3980 
ATOM 55 H P16  2.4436  4.8315 -0.9649 
ATOM 56 H P16  1.9888  5.5586  0.5788 
ATOM 57 H P16  1.2949  6.1576 -0.9342 
ATOM 58 N P16  0.5246 -0.1839  1.1919 
ATOM 59 H P16 -0.4026 -0.5784  1.0657 
ATOM 60 C P16  1.4287 -0.8586  2.1140 
ATOM 61 C P16  0.7531 -2.1556  2.5584 
ATOM 62 H P16 -0.1790 -1.9297  3.0782 
ATOM 63 H P16  0.5212 -2.7913  1.7033 
ATOM 64 H P16  1.4114 -2.6961  3.2373 
ATOM 65 C P16  1.7277  0.0182  3.3231 
ATOM 66 H P16  2.3682 -0.5158  4.0222 
ATOM 67 H P16  2.2328  0.9337  3.0203 
ATOM 68 H P16  0.7906  0.2722  3.8195 
ATOM 69 C P16  2.7458 -1.2553  1.4253 
ATOM 70 O P16  3.7808 -1.3556  2.0818 
ATOM 71 N P16  2.6822 -1.5558  0.1151 
ATOM 72 H P16  1.8221 -1.3756 -0.3943 
ATOM 73 C P16  3.8388 -2.0189 -0.6412 
ATOM 74 C P16  3.4223 -2.1404 -2.1072 
ATOM 75 H P16  2.6215 -2.8745 -2.2068 
ATOM 76 H P16  3.0689 -1.1869 -2.4998 
ATOM 77 H P16  4.2750 -2.4736 -2.6975 
ATOM 78 C P16  4.3205 -3.3726 -0.1336 
ATOM 79 H P16  5.1911 -3.6898 -0.7046 
ATOM 80 H P16  4.5890 -3.3217  0.9194 
ATOM 81 H P16  3.5237 -4.1060 -0.2641 
ATOM 82 C P16  4.9850 -0.9930 -0.5985 
ATOM 83 O P16  6.1482 -1.3465 -0.8084 
ATOM 84 N P16  4.6429  0.2889 -0.4332 
ATOM 85 H P16  3.6947  0.5285 -0.1657 
ATOM 86 C P16  5.6440  1.3274 -0.4304 
ATOM 87 H P16  6.2162  1.3131 -1.3585 
ATOM 88 H P16  5.1477  2.2901 -0.3357 
ATOM 89 H P16  6.3431  1.2062  0.4001 
 
COMPND Ac-Aib2-(1R,2S,4R)-Vdm-Aib2-NHMe-M310 
REMARK Energy(ZPE)= -1912.4903 
REMARK #IF = 0 
ATOM  1 C P16  6.2209  1.5587 -0.1608 
ATOM  2 H P16  5.8727  2.1997 -0.9695 
ATOM  3 H P16  6.4530  2.1972  0.6918 
ATOM  4 H P16  7.1257  1.0418 -0.4730 
ATOM  5 C P16  5.1130  0.6279  0.2311 
ATOM  6 O P16  3.9855  1.0414  0.5164 
ATOM  7 N P16  5.3977 -0.6905  0.2394 
ATOM  8 H P16  6.3474 -0.9748  0.0570 
ATOM  9 C P16  4.4846 -1.6984  0.7690 
ATOM 10 C P16  4.3112 -1.5403  2.2737 
ATOM 11 H P16  5.2785 -1.6674  2.7601 
ATOM 12 H P16  3.9154 -0.5552  2.5152 
ATOM 13 H P16  3.6207 -2.2932  2.6489 
ATOM 14 C P16  5.0640 -3.0732  0.4377 
ATOM 15 H P16  4.3900 -3.8519  0.7920 
ATOM 16 H P16  5.2077 -3.1966 -0.6364 
ATOM 17 H P16  6.0245 -3.2013  0.9396 
ATOM 18 C P16  3.1207 -1.5947  0.0741 
ATOM 19 O P16  2.0835 -1.8785  0.6726 
ATOM 20 N P16  3.1326 -1.2422 -1.2210 
ATOM 21 H P16  4.0219 -1.0213 -1.6431 
ATOM 22 C P16  1.9442 -1.2138 -2.0620 
ATOM 23 C P16  1.4220 -2.6245 -2.3087 
ATOM 24 H P16  2.1909 -3.2054 -2.8184 
ATOM 25 H P16  1.1706 -3.1128 -1.3682 
ATOM 26 H P16  0.5301 -2.5865 -2.9309 
ATOM 27 C P16  2.3267 -0.5467 -3.3825 
ATOM 28 H P16  1.4514 -0.4823 -4.0271 
ATOM 29 H P16  2.7170  0.4590 -3.2191 
ATOM 30 H P16  3.0849 -1.1424 -3.8935 
ATOM 31 C P16  0.8399 -0.3558 -1.4298 
ATOM 32 O P16 -0.3409 -0.5549 -1.7273 
ATOM 33 N P16  1.2143  0.6322 -0.6054 
ATOM 34 H P16  2.1910  0.7240 -0.3420 
ATOM 35 C P16  0.2398  1.5516 -0.0329 
ATOM 36 C P16  0.9486  2.5020  0.9750 
ATOM 37 H P16  0.4251  2.5387  1.9306 
ATOM 38 H P16  1.9681  2.1635  1.1621 
ATOM 39 C P16  0.9097  3.8672  0.2482 
ATOM 40 H P16  1.6459  4.5790  0.6209 
ATOM 41 C P16  1.0295  3.4271 -1.2117 
ATOM 42 H P16  1.9447  2.8743 -1.4370 
ATOM 43 H P16  0.9159  4.2538 -1.9131 
ATOM 44 C P16 -0.2323  2.5535 -1.1418 
ATOM 45 H P16 -0.5455  2.0410 -2.0498 
ATOM 46 C P16 -1.2151  3.5590 -0.5731 
ATOM 47 C P16 -0.5273  4.3463  0.2681 
ATOM 48 C P16 -0.8531  0.7563  0.6828 
ATOM 49 O P16 -2.0039  1.1819  0.7949 
ATOM 50 C P16 -2.6469  3.6152 -0.9690 
ATOM 51 H P16 -3.2035  4.3458 -0.3810 
ATOM 52 H P16 -3.1226  2.6424 -0.8489 
ATOM 53 H P16 -2.7418  3.8939 -2.0234 
ATOM 54 C P16 -1.0035  5.4272  1.1707 
ATOM 55 H P16 -0.8173  5.1695  2.2184 
ATOM 56 H P16 -2.0713  5.6148  1.0580 
ATOM 57 H P16 -0.4717  6.3640  0.9816 
ATOM 58 N P16 -0.4644 -0.3984  1.2525 
ATOM 59 H P16  0.4701 -0.7563  1.0773 
ATOM 60 C P16 -1.3463 -1.1990  2.0914 
ATOM 61 C P16 -1.6704 -0.4651  3.3876 
ATOM 62 H P16 -0.7426 -0.2745  3.9279 
ATOM 63 H P16 -2.1652  0.4829  3.1821 
ATOM 64 H P16 -2.3246 -1.0744  4.0081 
ATOM 65 C P16 -0.6288 -2.5131  2.3983 
ATOM 66 H P16 -1.2805 -3.1546  2.9901 
ATOM 67 H P16 -0.3497 -3.0335  1.4816 
ATOM 68 H P16  0.2781 -2.3144  2.9708 
ATOM 69 C P16 -2.6479 -1.5630  1.3599 
ATOM 70 O P16 -3.6661 -1.8215  2.0001 
ATOM 71 N P16 -2.5880 -1.6531  0.0192 
ATOM 72 H P16 -1.7432 -1.3540 -0.4578 
ATOM 73 C P16 -3.7345 -2.0309 -0.7960 
ATOM 74 C P16 -4.1429 -3.4750 -0.5316 
ATOM 75 H P16 -3.3051 -4.1306 -0.7716 
ATOM 76 H P16 -4.4177 -3.6151  0.5119 
ATOM 77 H P16 -4.9920 -3.7410 -1.1583 
ATOM 78 C P16 -3.3366 -1.8656 -2.2626 
ATOM 79 H P16 -4.1845 -2.1147 -2.8994 
ATOM 80 H P16 -3.0206 -0.8438 -2.4737 
ATOM 81 H P16 -2.5116 -2.5384 -2.5017 
ATOM 82 C P16 -4.9262 -1.0890 -0.5507 
ATOM 83 O P16 -6.0788 -1.4654 -0.7775 
ATOM 84 N P16 -4.6414  0.1659 -0.1850 
ATOM 85 H P16 -3.6960  0.4099  0.0890 
ATOM 86 C P16 -5.6979  1.1217  0.0428 
ATOM 87 H P16 -6.3606  0.7967  0.8479 
ATOM 88 H P16 -5.2542  2.0758  0.3150 
ATOM 89 H P16 -6.2996  1.2542 -0.8571 
 
COMPND Ac-Aib2-(1R,2S,4R)-IIIbwr-Aib2-NHMe-P310 
REMARK Energy(ZPE)= -1869.877922 
REMARK #IF = 0 
ATOM  1 C P17 -6.1033  1.4892 -0.3267 
ATOM  2 H P17 -5.7550  2.0823 -1.1713 
ATOM  3 H P17 -6.9905  0.9313 -0.6179 
ATOM  4 H P17 -6.3640  2.1782  0.4768 
ATOM  5 C P17 -4.9815  0.6133  0.1443 
ATOM  6 O P17 -3.8746  1.0746  0.4368 
ATOM  7 N P17 -5.2290 -0.7105  0.2153 
ATOM  8 H P17 -6.1649 -1.0318  0.0232 
ATOM  9 C P17 -4.3018 -1.6630  0.8191 
ATOM 10 C P17 -4.8371 -3.0685  0.5477 
ATOM 11 H P17 -5.8023 -3.1980  1.0400 
ATOM 12 H P17 -4.9593 -3.2494 -0.5209 
ATOM 13 H P17 -4.1489 -3.8100  0.9512 
ATOM 14 C P17 -4.1726 -1.4211  2.3169 
ATOM 15 H P17 -3.4796 -2.1383  2.7523 
ATOM 16 H P17 -3.8031 -0.4165  2.5160 
ATOM 17 H P17 -5.1506 -1.5421  2.7831 
ATOM 18 C P17 -2.9234 -1.5547  0.1510 
ATOM 19 O P17 -1.8926 -1.7534  0.7926 
ATOM 20 N P17 -2.9247 -1.2970 -1.1677 
ATOM 21 H P17 -3.8172 -1.1455 -1.6133 
ATOM 22 C P17 -1.7317 -1.2720 -2.0025 
ATOM 23 C P17 -2.1443 -0.7683 -3.3853 
ATOM 24 H P17 -2.8528 -1.4654 -3.8358 
ATOM 25 H P17 -2.6055  0.2188 -3.3283 
ATOM 26 H P17 -1.2680 -0.7081 -4.0287 
ATOM 27 C P17 -1.1091 -2.6595 -2.1097 
ATOM 28 H P17 -0.2269 -2.6197 -2.7456 
ATOM 29 H P17 -0.8163 -3.0304 -1.1287 
ATOM 30 H P17 -1.8365 -3.3426 -2.5486 
ATOM 31 C P17 -0.6952 -0.2835 -1.4552 
ATOM 32 O P17  0.4978 -0.4122 -1.7415 
ATOM 33 N P17 -1.1357  0.7367 -0.7070 
ATOM 34 H P17 -2.1206  0.8132 -0.4650 
ATOM 35 C P17 -0.2145  1.7403 -0.2097 
ATOM 36 C P17  0.3083  2.6639 -1.3314 
ATOM 37 H P17 -0.0162  2.2879 -2.2998 
ATOM 38 H P17  1.3914  2.7533 -1.3174 
ATOM 39 C P17 -0.4051  3.9946 -0.9805 
ATOM 40 H P17 -0.5843  4.6682 -1.8128 
ATOM 41 O P17 -1.6393  3.5164 -0.4358 
ATOM 42 C P17 -1.0600  2.7714  0.6266 
ATOM 43 H P17 -1.8200  2.3135  1.2534 
ATOM 44 C P17 -0.1157  3.7684  1.2501 
ATOM 45 H P17  0.2204  3.7559  2.2758 
ATOM 46 C P17  0.2817  4.5453  0.2451 
ATOM 47 H P17  1.0282  5.3259  0.2481 
ATOM 48 C P17  0.9011  1.0999  0.6164 
ATOM 49 O P17  2.0021  1.6430  0.7273 
ATOM 50 N P17  0.5932 -0.0492  1.2346 
ATOM 51 H P17 -0.3116 -0.4731  1.0523 
ATOM 52 C P17  1.5269 -0.7536  2.1037 
ATOM 53 C P17  0.9274 -2.1232  2.4210 
ATOM 54 H P17 -0.0339 -2.0022  2.9215 
ATOM 55 H P17  0.7713 -2.7054  1.5122 
ATOM 56 H P17  1.6000 -2.6701  3.0803 
ATOM 57 C P17  1.7610  0.0308  3.3883 
ATOM 58 H P17  2.4567 -0.5043  4.0313 
ATOM 59 H P17  2.1726  1.0149  3.1703 
ATOM 60 H P17  0.8113  0.1480  3.9112 
ATOM 61 C P17  2.8654 -1.0100  1.3897 
ATOM 62 O P17  3.9042 -1.1203  2.0377 
ATOM 63 N P17  2.8121 -1.1844  0.0561 
ATOM 64 H P17  1.9396 -1.0019 -0.4309 
ATOM 65 C P17  3.9804 -1.5216 -0.7465 
ATOM 66 C P17  3.5501 -1.5237 -2.2135 
ATOM 67 H P17  2.7839 -2.2838 -2.3739 
ATOM 68 H P17  3.1412 -0.5567 -2.5073 
ATOM 69 H P17  4.4086 -1.7547 -2.8427 
ATOM 70 C P17  4.5279 -2.8932 -0.3693 
ATOM 71 H P17  5.3916 -3.1289 -0.9882 
ATOM 72 H P17  4.8269 -2.9196  0.6766 
ATOM 73 H P17  3.7546 -3.6434 -0.5392 
ATOM 74 C P17  5.0794 -0.4538 -0.6126 
ATOM 75 O P17  6.2555 -0.7327 -0.8588 
ATOM 76 N P17  4.6807  0.7894 -0.3242 
ATOM 77 H P17  3.7238  0.9570 -0.0363 
ATOM 78 C P17  5.6316  1.8700 -0.2300 
ATOM 79 H P17  6.1994  1.9642 -1.1561 
ATOM 80 H P17  5.0910  2.7958 -0.0504 
ATOM 81 H P17  6.3393  1.7091  0.5864 
 
COMPND Ac-Aib2-(1R,2S,4R)-IIIbwr-Aib2-NHMe-M310 
REMARK Energy(ZPE)= -1869.8755 
REMARK #IF = 0 
ATOM  1 C P17 -6.1828  1.5766  0.1175 
ATOM  2 H P17 -5.8301  2.2788  0.8715 
ATOM  3 H P17 -6.4652  2.1510 -0.7650 
ATOM  4 H P17 -7.0582  1.0514  0.4932 
ATOM  5 C P17 -5.0572  0.6587 -0.2534 
ATOM  6 O P17 -3.9522  1.0888 -0.5972 
ATOM  7 N P17 -5.2993 -0.6656 -0.1754 
ATOM  8 H P17 -6.2335 -0.9670  0.0539 
ATOM  9 C P17 -4.3685 -1.6763 -0.6680 
ATOM 10 C P17 -4.2393 -1.6063 -2.1837 
ATOM 11 H P17 -5.2147 -1.7917 -2.6336 
ATOM 12 H P17 -3.8804 -0.6268 -2.4953 
ATOM 13 H P17 -3.5366 -2.3604 -2.5326 
ATOM 14 C P17 -4.8956 -3.0446 -0.2375 
ATOM 15 H P17 -4.2035 -3.8230 -0.5555 
ATOM 16 H P17 -5.0142 -3.1025  0.8451 
ATOM 17 H P17 -5.8608 -3.2349 -0.7095 
ATOM 18 C P17 -2.9919 -1.4873 -0.0166 
ATOM 19 O P17 -1.9592 -1.7605 -0.6276 
ATOM 20 N P17 -2.9912 -1.0718  1.2603 
ATOM 21 H P17 -3.8815 -0.8638  1.6873 
ATOM 22 C P17 -1.7938 -0.9605  2.0818 
ATOM 23 C P17 -1.2047 -2.3362  2.3730 
ATOM 24 H P17 -1.9470 -2.9365  2.8992 
ATOM 25 H P17 -0.9268 -2.8410  1.4490 
ATOM 26 H P17 -0.3184 -2.2362  2.9962 
ATOM 27 C P17 -2.1871 -0.2619  3.3827 
ATOM 28 H P17 -1.3056 -0.1305  4.0081 
ATOM 29 H P17 -2.6293  0.7163  3.1885 
ATOM 30 H P17 -2.9064 -0.8742  3.9290 
ATOM 31 C P17 -0.7379 -0.0836  1.3991 
ATOM 32 O P17  0.4544 -0.2107  1.6884 
ATOM 33 N P17 -1.1635  0.8429  0.5280 
ATOM 34 H P17 -2.1488  0.9005  0.2898 
ATOM 35 C P17 -0.2293  1.7368 -0.1279 
ATOM 36 C P17 -0.9983  2.6562 -1.1100 
ATOM 37 H P17 -2.0251  2.3153 -1.2293 
ATOM 38 H P17 -0.5299  2.7054 -2.0911 
ATOM 39 C P17 -0.9284  4.0126 -0.3588 
ATOM 40 H P17 -1.7539  4.6919 -0.5487 
ATOM 41 O P17 -0.9230  3.5809  1.0040 
ATOM 42 C P17  0.2665  2.7991  0.9129 
ATOM 43 H P17  0.5372  2.3715  1.8731 
ATOM 44 C P17  1.2286  3.7587  0.2566 
ATOM 45 H P17  2.3007  3.7372  0.3634 
ATOM 46 C P17  0.4774  4.5354 -0.5216 
ATOM 47 H P17  0.7876  5.2952 -1.2239 
ATOM 48 C P17  0.8810  0.9510 -0.8219 
ATOM 49 O P17  1.9996  1.4429 -0.9868 
ATOM 50 N P17  0.5608 -0.2692 -1.2761 
ATOM 51 H P17 -0.3560 -0.6589 -1.0738 
ATOM 52 C P17  1.4957 -1.0962 -2.0281 
ATOM 53 C P17  1.7306 -0.5168 -3.4172 
ATOM 54 H P17  0.7830 -0.4875 -3.9558 
ATOM 55 H P17  2.1350  0.4922 -3.3542 
ATOM 56 H P17  2.4339 -1.1399 -3.9661 
ATOM 57 C P17  0.8880 -2.4951 -2.1354 
ATOM 58 H P17  1.5548 -3.1405 -2.7058 
ATOM 59 H P17  0.7296 -2.9325 -1.1488 
ATOM 60 H P17 -0.0739 -2.4435 -2.6471 
ATOM 61 C P17  2.8349 -1.2483 -1.2869 
ATOM 62 O P17  3.8727 -1.4476 -1.9152 
ATOM 63 N P17  2.7849 -1.2373  0.0576 
ATOM 64 H P17  1.9150 -0.9843  0.5154 
ATOM 65 C P17  3.9541 -1.4577  0.8991 
ATOM 66 C P17  4.4998 -2.8689  0.7195 
ATOM 67 H P17  3.7329 -3.5879  1.0101 
ATOM 68 H P17  4.7819 -3.0467 -0.3164 
ATOM 69 H P17  5.3749 -3.0068  1.3519 
ATOM 70 C P17  3.5213 -1.2501  2.3507 
ATOM 71 H P17  4.3766 -1.3949  3.0093 
ATOM 72 H P17  3.1189 -0.2483  2.5033 
ATOM 73 H P17  2.7497 -1.9750  2.6149 
ATOM 74 C P17  5.0572 -0.4227  0.6162 
ATOM 75 O P17  6.2320 -0.6682  0.9020 
ATOM 76 N P17  4.6628  0.7675  0.1524 
ATOM 77 H P17  3.7077  0.8928 -0.1632 
ATOM 78 C P17  5.6161  1.8210 -0.0961 
ATOM 79 H P17  6.2019  2.0269  0.8001 
ATOM 80 H P17  6.3071  1.5553 -0.8994 
ATOM 81 H P17  5.0758  2.7204 -0.3803 
 
COMPND Ac-Aib2-(1R,2S,4R)-IIIbmb-Aib2-NHMe-P310 
REMARK Energy(ZPE)= -1987.512821 
REMARK #IF = 0 
ATOM  1 C P18 -6.0696  1.7257 -0.5413 
ATOM  2 H P18 -5.6755  2.1817 -1.4480 
ATOM  3 H P18 -7.0063  1.2203 -0.7660 
ATOM  4 H P18 -6.2629  2.5243  0.1757 
ATOM  5 C P18 -5.0289  0.8138  0.0359 
ATOM  6 O P18 -3.8621  1.1810  0.2011 
ATOM  7 N P18 -5.4225 -0.4363  0.3561 
ATOM  8 H P18 -6.3992 -0.6678  0.2614 
ATOM  9 C P18 -4.5821 -1.3668  1.1043 
ATOM 10 C P18 -5.2845 -2.7241  1.1155 
ATOM 11 H P18 -6.2352 -2.6446  1.6451 
ATOM 12 H P18 -5.4735 -3.0833  0.1032 
ATOM 13 H P18 -4.6670 -3.4549  1.6358 
ATOM 14 C P18 -4.3543 -0.8712  2.5261 
ATOM 15 H P18 -3.7144 -1.5667  3.0655 
ATOM 16 H P18 -3.8777  0.1079  2.5215 
ATOM 17 H P18 -5.3145 -0.7998  3.0370 
ATOM 18 C P18 -3.2349 -1.5505  0.3919 
ATOM 19 O P18 -2.2024 -1.7522  1.0299 
ATOM 20 N P18 -3.2683 -1.5395 -0.9507 
ATOM 21 H P18 -4.1550 -1.3598 -1.3972 
ATOM 22 C P18 -2.1165 -1.8160 -1.7983 
ATOM 23 C P18 -2.5201 -1.5056 -3.2394 
ATOM 24 H P18 -3.3351 -2.1639 -3.5448 
ATOM 25 H P18 -2.8436 -0.4691 -3.3458 
ATOM 26 H P18 -1.6738 -1.6782 -3.9023 
ATOM 27 C P18 -1.6794 -3.2704 -1.6711 
ATOM 28 H P18 -0.8183 -3.4532 -2.3110 
ATOM 29 H P18 -1.4063 -3.5036 -0.6432 
ATOM 30 H P18 -2.4998 -3.9183 -1.9799 
ATOM 31 C P18 -0.9430 -0.8912 -1.4529 
ATOM 32 O P18  0.2125 -1.2250 -1.7262 
ATOM 33 N P18 -1.2269  0.3017 -0.9127 
ATOM 34 H P18 -2.1785  0.5224 -0.6304 
ATOM 35 C P18 -0.1700  1.2584 -0.6301 
ATOM 36 C P18  0.4622  1.8301 -1.9272 
ATOM 37 H P18  0.0358  1.3187 -2.7901 
ATOM 38 H P18  1.5414  1.6978 -1.9354 
ATOM 39 C P18  0.0455  3.3192 -1.9124 
ATOM 40 H P18  0.1153  3.8068 -2.8828 
ATOM 41 C P18 -1.3474  3.2148 -1.2757 
ATOM 42 H P18 -2.0411  2.5994 -1.8515 
ATOM 43 H P18 -1.8015  4.1839 -1.0664 
ATOM 44 C P18 -0.8377  2.5268  0.0030 
ATOM 45 H P18 -1.5661  2.2793  0.7725 
ATOM 46 C P18  0.2546  3.4822  0.3984 
ATOM 47 C P18  0.8006  3.9775 -0.7897 
ATOM 48 C P18  0.7499  3.8668  1.6299 
ATOM 49 H P18  0.3326  3.4754  2.5505 
ATOM 50 C P18  1.8611  4.8643 -0.7641 
ATOM 51 H P18  2.2948  5.2488 -1.6799 
ATOM 52 C P18  1.8059  4.7804  1.6596 
ATOM 53 H P18  2.2013  5.1133  2.6115 
ATOM 54 C P18  2.3547  5.2702  0.4784 
ATOM 55 H P18  3.1715  5.9805  0.5239 
ATOM 56 C P18  0.8775  0.6454  0.3016 
ATOM 57 O P18  2.0477  1.0327  0.2826 
ATOM 58 N P18  0.4511 -0.2980  1.1555 
ATOM 59 H P18 -0.5052 -0.6329  1.0929 
ATOM 60 C P18  1.3273 -0.9134  2.1430 
ATOM 61 C P18  0.5820 -2.1036  2.7464 
ATOM 62 H P18 -0.3350 -1.7619  3.2284 
ATOM 63 H P18  0.3169 -2.8320  1.9796 
ATOM 64 H P18  1.2107 -2.5874  3.4928 
ATOM 65 C P18  1.6953  0.0861  3.2323 
ATOM 66 H P18  2.3340 -0.3872  3.9755 
ATOM 67 H P18  2.2225  0.9405  2.8112 
ATOM 68 H P18  0.7823  0.4339  3.7169 
ATOM 69 C P18  2.6020 -1.4711  1.4875 
ATOM 70 O P18  3.6426 -1.5665  2.1351 
ATOM 71 N P18  2.4846 -1.9174  0.2229 
ATOM 72 H P18  1.6280 -1.7255 -0.2867 
ATOM 73 C P18  3.5808 -2.5486 -0.5015 
ATOM 74 C P18  3.1033 -2.8085 -1.9303 
ATOM 75 H P18  2.2462 -3.4837 -1.9182 
ATOM 76 H P18  2.8054 -1.8829 -2.4230 
ATOM 77 H P18  3.9060 -3.2733 -2.5014 
ATOM 78 C P18  3.9834 -3.8645  0.1530 
ATOM 79 H P18  4.7920 -4.3251 -0.4115 
ATOM 80 H P18  4.3145 -3.7047  1.1770 
ATOM 81 H P18  3.1252 -4.5376  0.1557 
ATOM 82 C P18  4.7977 -1.6126 -0.6084 
ATOM 83 O P18  5.9253 -2.0727 -0.8069 
ATOM 84 N P18  4.5514 -0.2992 -0.5797 
ATOM 85 H P18  3.6307  0.0350 -0.3182 
ATOM 86 C P18  5.6183  0.6604 -0.7257 
ATOM 87 H P18  6.1646  0.4893 -1.6536 
ATOM 88 H P18  5.1888  1.6590 -0.7466 
ATOM 89 H P18  6.3286  0.5984  0.1020 
 
COMPND Ac-Aib2-(1R,2S,4R)-IIIbmb-Aib2-NHMe-M310 
REMARK Energy(ZPE)= -1987.5071 
REMARK #IF = 0 
ATOM  1 C P18  6.0363  2.2716 -0.1163 
ATOM  2 H P18  5.5934  2.8350 -0.9366 
ATOM  3 H P18  6.1418  2.9484  0.7316 
ATOM  4 H P18  7.0210  1.9167 -0.4124 
ATOM  5 C P18  5.0993  1.1679  0.2720 
ATOM  6 O P18  3.9245  1.3909  0.5795 
ATOM  7 N P18  5.5887 -0.0883  0.2489 
ATOM  8 H P18  6.5677 -0.2172  0.0458 
ATOM  9 C P18  4.8534 -1.2388  0.7657 
ATOM 10 C P18  4.6760 -1.1363  2.2747 
ATOM 11 H P18  5.6579 -1.1067  2.7472 
ATOM 12 H P18  4.1244 -0.2351  2.5378 
ATOM 13 H P18  4.1291 -2.0004  2.6466 
ATOM 14 C P18  5.6433 -2.4955  0.4016 
ATOM 15 H P18  5.1073 -3.3804  0.7417 
ATOM 16 H P18  5.7961 -2.5709 -0.6757 
ATOM 17 H P18  6.6159 -2.4763  0.8959 
ATOM 18 C P18  3.4821 -1.3423  0.0834 
ATOM 19 O P18  2.5077 -1.7932  0.6843 
ATOM 20 N P18  3.4319 -0.9735 -1.2069 
ATOM 21 H P18  4.2742 -0.6065 -1.6241 
ATOM 22 C P18  2.2536 -1.1172 -2.0514 
ATOM 23 C P18  1.9410 -2.5882 -2.2995 
ATOM 24 H P18  2.7947 -3.0540 -2.7919 
ATOM 25 H P18  1.7438 -3.1053 -1.3613 
ATOM 26 H P18  1.0664 -2.6805 -2.9403 
ATOM 27 C P18  2.5409 -0.4026 -3.3714 
ATOM 28 H P18  1.6692 -0.4665 -4.0206 
ATOM 29 H P18  2.7805  0.6493 -3.2088 
ATOM 30 H P18  3.3804 -0.8826 -3.8769 
ATOM 31 C P18  1.0359 -0.4268 -1.4231 
ATOM 32 O P18 -0.1035 -0.7855 -1.7278 
ATOM 33 N P18  1.2636  0.5991 -0.5878 
ATOM 34 H P18  2.2166  0.8258 -0.3177 
ATOM 35 C P18  0.1657  1.3694 -0.0201 
ATOM 36 C P18  0.7284  2.4615  0.9359 
ATOM 37 H P18  1.7924  2.3006  1.1074 
ATOM 38 H P18  0.2239  2.4479  1.9015 
ATOM 39 C P18  0.4744  3.7837  0.1730 
ATOM 40 H P18  1.1133  4.6030  0.4964 
ATOM 41 C P18  0.6097  3.3097 -1.2822 
ATOM 42 H P18  1.5951  2.9068 -1.5215 
ATOM 43 H P18  0.3434  4.0803 -2.0058 
ATOM 44 C P18 -0.4843  2.2306 -1.1521 
ATOM 45 H P18 -0.7241  1.6395 -2.0321 
ATOM 46 C P18 -1.5987  3.0820 -0.6047 
ATOM 47 C P18 -1.0064  4.0473  0.2142 
ATOM 48 C P18 -2.9647  3.0722 -0.8165 
ATOM 49 H P18 -3.4255  2.3282 -1.4557 
ATOM 50 C P18 -1.7748  4.9905  0.8734 
ATOM 51 H P18 -1.3208  5.7342  1.5180 
ATOM 52 C P18 -3.7411  4.0392 -0.1782 
ATOM 53 H P18 -4.8125  4.0602 -0.3388 
ATOM 54 C P18 -3.1555  4.9814  0.6640 
ATOM 55 H P18 -3.7769  5.7238  1.1502 
ATOM 56 C P18 -0.7869  0.4415  0.7360 
ATOM 57 O P18 -1.9669  0.7431  0.9209 
ATOM 58 N P18 -0.2528 -0.6835  1.2385 
ATOM 59 H P18  0.7153 -0.9115  1.0361 
ATOM 60 C P18 -1.0168 -1.6231  2.0475 
ATOM 61 C P18 -1.3401 -1.0269  3.4113 
ATOM 62 H P18 -0.4077 -0.7951  3.9270 
ATOM 63 H P18 -1.9257 -0.1154  3.3056 
ATOM 64 H P18 -1.9075 -1.7398  4.0063 
ATOM 65 C P18 -0.1717 -2.8867  2.2115 
ATOM 66 H P18 -0.7230 -3.6201  2.7986 
ATOM 67 H P18  0.0785 -3.3218  1.2431 
ATOM 68 H P18  0.7570 -2.6482  2.7311 
ATOM 69 C P18 -2.3133 -2.0464  1.3362 
ATOM 70 O P18 -3.2958 -2.3947  1.9881 
ATOM 71 N P18 -2.2741 -2.0887 -0.0082 
ATOM 72 H P18 -1.4539 -1.7312 -0.4866 
ATOM 73 C P18 -3.3923 -2.5401 -0.8260 
ATOM 74 C P18 -3.6793 -4.0187 -0.5935 
ATOM 75 H P18 -2.7906 -4.5976 -0.8478 
ATOM 76 H P18 -3.9407 -4.2055  0.4463 
ATOM 77 H P18 -4.5042 -4.3401 -1.2267 
ATOM 78 C P18 -3.0135 -2.3096 -2.2891 
ATOM 79 H P18 -3.8429 -2.6038 -2.9309 
ATOM 80 H P18 -2.7732 -1.2622 -2.4744 
ATOM 81 H P18 -2.1421 -2.9136 -2.5464 
ATOM 82 C P18 -4.6566 -1.7055 -0.5583 
ATOM 83 O P18 -5.7740 -2.1674 -0.8038 
ATOM 84 N P18 -4.4737 -0.4457 -0.1507 
ATOM 85 H P18 -3.5508 -0.1377  0.1346 
ATOM 86 C P18 -5.5990  0.4210  0.1014 
ATOM 87 H P18 -6.2054  0.5382 -0.7976 
ATOM 88 H P18 -6.2391  0.0216  0.8913 
ATOM 89 H P18 -5.2252  1.3952  0.4059 
ANNEX 7.A. Convergence test for explicit MeOH REMD simulation  
ANNEX 9.A. Correlation between MMPBSA results and available 
experimental data. 
Correlations between MM-PBSA predicted and experimental binding 





Correlations between MM-PBSA predicted and experimental binding 
energies for penicillopepsin. 
Correlations between MM-PBSA predicted and experimental binding energies for avidin. 
 ANNEX 10.A. Scripts used for the automatization of MD/Nwat-MMGBSA protocol on PPIs. 
Script for the selection of interfacial residues. 
from pymol import stored 
  
def interfaceResidues(cmpx, cA='c. A', cB='c. B', cutoff=1.0, 
selName="interface"): 
 """ 




  cmpx 
   The complex containing cA and cB 
  
  cA 
   The first chain in which we search for residues at an 
interface 
   with cB 
  
  cB 
   The second chain in which we search for residues at an 
interface 
   with cA 
  
  cutoff 
   The difference in area OVER which residues are considered 
   interface residues.  Residues whose dASA from the complex 
to 
   a single chain is greater than this cutoff are kept.  Zero 
   keeps all residues. 
  
  selName 
   The name of the selection to return. 
  
 RETURNS 
  * A selection of interface residues is created and named 
   depending on what you passed into selName 
  * An array of values is returned where each value is: 
   ( modelName, residueNumber, dASA ) 
  
 NOTES 
  If you have two chains that are not from the same PDB that you 
want 
  to complex together, use the create command like: 
   create myComplex, pdb1WithChainA or pdb2withChainX 
  then pass myComplex to this script like: 
   interfaceResidues myComlpex, c. A, c. X 
  
  This script calculates the area of the complex as a whole.  
Then, 
  it separates the two chains that you pass in through the 
arguments 
  cA and cB, alone.  Once it has this, it calculates the 
difference 
  and any residues ABOVE the cutoff are called interface residues. 
  
 AUTHOR: 
  Jason Vertrees, 2009.   
 """ 
 # Save user's settings, before setting dot_solvent 
 oldDS = cmd.get("dot_solvent") 
 cmd.set("dot_solvent", 1) 
  
 # set some string names for temporary objects/selections 
 tempC, selName1 = "tempComplex", selName+"1" 
 chA, chB = "chA", "chB" 
  
 # operate on a new object & turn off the original 
 cmd.create(tempC, cmpx) 
 cmd.disable(cmpx) 
  
 # remove cruft and inrrelevant chains 
 cmd.remove(tempC + " and not (polymer and (%s or %s))" % (cA, cB)) 
  
 # get the area of the complete complex 
 cmd.get_area(tempC, load_b=1) 
 # copy the areas from the loaded b to the q, field. 
 cmd.alter(tempC, 'q=b') 
  
 # extract the two chains and calc. the new area 
 # note: the q fields are copied to the new objects 
 # chA and chB 
 cmd.extract(chA, tempC + " and (" + cA + ")") 
 cmd.extract(chB, tempC + " and (" + cB + ")") 
 cmd.get_area(chA, load_b=1) 
 cmd.get_area(chB, load_b=1) 
  
 # update the chain-only objects w/the difference 
 cmd.alter( "%s or %s" % (chA,chB), "b=b-q" ) 
  
 # The calculations are done.  Now, all we need to 
 # do is to determine which residues are over the cutoff 
 # and save them. 
 stored.r, rVal, seen = [], [], [] 




 cmd.select(selName1, None) 
 for (model,resi,diff) in stored.r: 
  key=resi+"-"+model 
  if abs(diff)>=float(cutoff): 
   if key in seen: continue 
   else: seen.append(key) 
   rVal.append( (model,resi,diff) ) 
   # expand the selection here; I chose to iterate over 
stored.r instead of 
   # creating one large selection b/c if there are too many 
residues PyMOL 
   # might crash on a very large selection.  This is pretty 
much guaranteed 
   # not to kill PyMOL; but, it might take a little longer to 
run. 
   cmd.select( selName1, selName1 + " or (%s and i. %s)" % 
(model,resi)) 
  
 # this is how you transfer a selection to another object. 
 cmd.select(selName, cmpx + " in " + selName1) 





 # show the selection 
 cmd.enable(selName) 
  
 # reset users settings 
 cmd.set("dot_solvent", oldDS) 
  




Script for the automatization of Nwat-MMGBSA calculations. 
#!/bin/tcsh  
# 
# Written by I. Maffucci and A. Contini, 2014; based on the work reported 
in J. Chem. Theory Comput., 2013, 9 (6), pp 2706-2717 
# 
# Given a "list" of PDB complexes, this script setup MMPBSA calculations 
including $n explicit water closest to PPI interface. 
# An input file called "complex_features.txt" and containing the 
definitions of "receptor mask", "ligand mask" and "last residue" is also 
required. 
# 
# The script assumes that solvated MD trajectories were previously obtained 
and are stored in $TRAJ/$n.  
# 
# The following standard name are also used: 
# solvated topology file: $z_complex_wat.top 
# solvated trajectory file: $z_complex.prod4.mdcrd 
# with $z = system name 
# 
# AmberTools14 needs to be installed and environment variables correctly 
specified 
# pymol needs to be installed to generate interfaces 
# 
# This scripts assumes that the solvated MD trajectory is made by 1000 
frames. 
# 
#  run as: qsub NWAT_MMPBSA_PyPPIs_2.2_HPC.pbs 
# 
###################################################### 





#PBS -N MMPBSA_PPI 
#PBS -l nodes=1:ppn=6  
#PBS -o MMPBSA_PPI.log 
#PBS -q batch 
#PBS -l walltime=120:0:0 
 
set AMBERV = 14  # amber version 
# 
setenv TRAJ "/home/studenti/giacomo/MMPBSA_ff14SB_TIP3P_4ns" # path to 
trajectories 
# 
setenv INTPATH "/home/studenti/giacomo/Complexes" # path to complexes 
# 
setenv EXTPARAMS "/home/studenti/giacomo/MMPBSA_ff14SB_TIP3P_4ns/2SIC" # 
path to parameters not included in standard ff, if any 
# 
set r = 10   # interval between trajectory frames selected for 
MMGBSA calculation (suggested values for production = 10 or 20) 
# 
set g = 8  # kind of GB model for MMGBSA calculations (i.e. g = 1 for 
igb=1; suggested values = 1, 5, 8) 
#     mind that the correct GB radius (mbondi, mbondi2 or 
mbondi3) need to be set in the solvated prmtop 
set cut = 0.50  # set interface cutoff for pymol interface definition 
# 
set argv = POLAR # flag to set the kind of interface to be selected. 
ALL = all residues; POLAR = polar residues 
# 
source /data/software/amber/amber$AMBERV/amber$AMBERV.csh # modify 
accordingly to your amber installation 
# 
# flag to activate the strip of structural ions; 0 = no stripping; !=0 = 
stripping accordingly to ionmask 
# Note that if you want to strip structural ions such as CA or MG, you need 
to create a modified "complex_features.txt" (complex_features_strip.txt) 
# with updated recmask, ligmask and lastres to be used only in the 
generation of MMGBSA input 
# 
set stripstructions = 0  
if ($stripstructions != 0) then 
 set ionmask = ":CA*" 
else 




# END OF USER MODIFIABLE VARIABLES                  # 
##################################################### 
# 




# option "ALL" or "POLAR" 
# 
if ($argv == ALL | $argv == POLAR) then 
 echo "the interface will consider "$argv" residues" 
   else 
        echo "please specify POLAR or ALL" 
        exit       
endif 
 
if (! -e interface.pymol) then 





@ f = (1000 / $r)  # total number of frames used in MMPBSA 
# 
echo "calculation begun on "`date`  
# 
echo "                     Average Delta          Std. Dev.   Std. Err. of 
Mean" > RESULTS_"$argv".txt 
# 
foreach z (`awk 'f;/name/{f=1}' complex_features.txt | awk '{print $1}'`) 
 echo 'run interface.pymol' > tmp.pml # Generate the input and run 
Pymol 
 echo 'load '$INTPATH'/complex_'$z'_leap.pdb' >> tmp.pml 
 echo 'myInterfaceResidues = interfaceResidues("complex_'$z'_leap", 
cA="c. A", cB="c. B", cutoff='$cut', selName="interface")' >> tmp.pml 
 echo 'save '$z'_interface.pdb, interface' >> tmp.pml 
 echo 'quit' >> tmp.pml 
 pymol -c tmp.pml 
 
 mkdir $z 
        echo "$z" >> RESULTS_$argv.txt 
        if ($argv == ALL) then 
 # the following command create a mask for ALL residues  
  awk '{print $6}' "$z"_interface.pdb | awk '\!x[$0]++' | awk 
'/./' | awk '{print ":"$0","}' | awk '/ key (start|stop) / {next} 
{printf("%s", $0)} END {print ""}' > "$z"_intmask_"$argv".txt 
 
 else if ($argv == POLAR) then 
         awk '/ARG/ || /ASH/ || /ASP/ || /GLH/ || /GLN/ || /GLU/ || /HID/ 
|| /HIE/ || /HIP/ || /LYN/ || /LYS/ || /SER/ || /THR/ || /TRP/ || 
/TYR/{print}' "$z"_interface.pdb | awk '{print $6}' | awk '\!x[$0]++' | awk 
'/./' | awk '{print ":"$0","}' | awk '/ key (start|stop) / {next} 
{printf("%s", $0)} END {print ""}' > "$z"_intmask_"$argv".txt 
 endif 
# 
# set MMPBSA variables 
# 
 set intmask = `cat "$z"_intmask_"$argv".txt`    # set 
PP interface mask  
 if ($stripstructions == 0) then 
  set recmask = `awk "/"$z"/" complex_features.txt | awk '{print 
$2}'` # set receptor mask 
  set ligmask = `awk "/"$z"/" complex_features.txt | awk '{print 
$3}'` # set ligand mask 
  set lastres = `awk "/"$z"/" complex_features.txt | awk '{print 
$4}'` # set last residue number 
 else    
         set recmask = `awk "/"$z"/" complex_features_strip.txt | awk 
'{print $2}'`     # set receptor mask 
  set ligmask = `awk "/"$z"/" complex_features_strip.txt | awk 
'{print $3}'`     # set ligand mask 
  set lastres = `awk "/"$z"/" complex_features_strip.txt | awk 
'{print $4}'`     # set last residue number 
 endif 
# 
# cleanup  
       rm "$z"_interface.pdb 
       rm "$z"_intmask_"$argv".txt      
       rm tmp.pml 
# 
# create a file named nwat.dat containing the nr. of closest water 
molecules to include in top/mdcrd; modify to your needs 
# 
 cd $z 
        printf %"s\n" 0 10 20 30 40 50 60 70 > nwat.dat # for production  
       #printf %"s\n" 10 20 > nwat.dat # for debug 
 
 foreach n (`cat nwat.dat`) 
         
        # set variables for MMPBSA input 
        @ a = $lastres + $n   
 @ w = $lastres + 1 
        @ b = $a + 1 
         
        # create directories named nwatn, where n is nr. of closest water 
molecules  
                mkdir nwat$n  
  cd nwat$n 
  
        # generate ligand topologies 
 cat > lig_gen.cpptraj << EOF 
parmstrip $recmask,:Cl-,:Na+,:WAT,$ionmask 
parmbox nobox 
parmwrite out ligand.top amber 
EOF 
          
 $AMBERHOME/bin/cpptraj -i lig_gen.cpptraj -p 
$TRAJ/$z/"$z"_complex_wat.top > lig_cpptraj.log 
   
        # generate trajectory for nwat > 0  
  if ($n != 0) then 
                 echo "trajin $TRAJ/$z/"$z"_complex_wat.prod4.mdcrd 1 1000 
$r" > cmplx_trj_gen.cpptraj 
   echo "center @CA,C,N mass origin\nimage origin 
center\nstrip :Cl-,:Na+,"$ionmask"\nclosest $n $intmask noimage\ntrajout 
nwat$n.$z.mdcrd nobox" >> cmplx_trj_gen.cpptraj 
                        $AMBERHOME/bin/cpptraj -i cmplx_trj_gen.cpptraj -p 
$TRAJ/$z/"$z"_complex_wat.top > cmplx_trj_cpptraj.log 
                         
 # generate complex pdb for nwat > 0 
   echo "trajin $TRAJ/$z/"$z"_complex_wat.prod4.mdcrd 1 1" > 
cmplx_pdb_gen.cpptraj 
   echo "center @CA,C,N mass origin\nimage origin 
center\nstrip :Cl-,:Na+,"$ionmask"" >> cmplx_pdb_gen.cpptraj 
                        echo "closest $n $intmask noimage\ntrajout 
nwat$n.$z.pdb pdb" >> cmplx_pdb_gen.cpptraj 
   $AMBERHOME/bin/cpptraj -i cmplx_pdb_gen.cpptraj -p 
$TRAJ/$z/"$z"_complex_wat.top > cmplx_pdb_gen_cpptraj.log 
                        
 # generate receptor pdb for nwat > 0 
   echo "trajin $TRAJ/$z/"$z"_complex_wat.prod4.mdcrd 1 1" > 
rec_pdb_gen.cpptraj 
   echo "center @CA,C,N mass origin\nimage origin 
center\nstrip :Cl-,:Na+,"$ionmask"" >> rec_pdb_gen.cpptraj 
                        echo "closest $n $intmask noimage\nstrip 
"$ligmask"\ntrajout nwat$n.$z.rec.pdb pdb" >> rec_pdb_gen.cpptraj 
   $AMBERHOME/bin/cpptraj -i rec_pdb_gen.cpptraj -p 
$TRAJ/$z/"$z"_complex_wat.top > rec_pdb_gen_cpptraj.log 
                        
        # use leap to generate the top 
    echo "source leaprc.ff14SB\nsource 
leaprc.gaff\nloadamberparams frcmod.ionsjc_tip3p\nloadamberparams 
frcmod.ionslm_1264_tip3p" > leap.in 
                        foreach l (`ls $EXTPARAMS/*off`) 
                         echo "loadoff "$l"" >> leap.in  
   end 
   foreach m (`ls $EXTPARAMS/*prep`) 
    echo "loadamberprep "$m"" >> leap.in 
   end 
   foreach o (`ls $EXTPARAMS/*frcmod*`) 
    echo "loadamberparams "$o"" >> leap.in 
   end 
   echo "set default PBRadii mbondi3" >> leap.in 
   echo "cmp=loadpdb nwat"$n"."$z".pdb" >> leap.in  
   echo "rec=loadpdb nwat"$n"."$z".rec.pdb" >> leap.in 
   echo "saveamberparm cmp nwat$n.$z.top nwat$n.$z.crd" >> 
leap.in 
                        echo "saveamberparm rec nwat$n.$z.rec.top 
nwat$n.$z.crd" >> leap.in 
 
   $AMBERHOME/bin/tleap -f leap.in 
 
        # generate MMPBSA input for nwat > 0; change to modify MM-PBSA/GBSA 
protocol. See Amber14 manual for details 
   echo "&general\nreceptor_mask="$recmask":"$w"-"$a", 
ligand_mask="$ligmask", startframe=1, endframe="$f", \ 
interval=1, verbose=1,\n/\n&pb\nistrng=0.15, radiopt=0" > 
mmpbsa_closest_nwat$n.in 
                         
                else      
 # generate trajectory for nwat = 0 
   cat > gen0.cpptraj << EOF 
trajin $TRAJ/$z/$z.complex_wat.prod4.mdcrd 1 1000 $r 
autoimage 
strip :Cl-,:Na+,:WAT,$ionmask 
trajout nwat$n.$z.mdcrd nobox 
EOF 
                        # workaround for heredocs 
                        sed -i 's/'$z'.complex/'$z'_complex/g' gen0.cpptraj  
                         
                        $AMBERHOME/bin/cpptraj -i gen0.cpptraj -p 
$TRAJ/$z/"$z"_complex_wat.top > traj_nwat0_cpptraj.log    
       
 
 # generate receptor and complex topologies for nwat=0 
          cat > topgen0.cpptraj << EOF 
parmstrip :Cl-,:Na+,:WAT,$ionmask 
parmbox nobox 
parmwrite out nwat$n.$z.top amber 
parmstrip $ligmask 
parmwrite out nwat$n.$z.rec.top amber 
EOF 
                         
                        $AMBERHOME/bin/cpptraj -i topgen0.cpptraj -p 
$TRAJ/$z/"$z"_complex_wat.top > top_nwat0_cpptraj.log 
                         
        # generate MMPBSA input for nwat = 0; change to modify MM-PBSA/GBSA 
protocol. See Amber14 manual for details 
                         
   echo "&general\nreceptor_mask="$recmask", 
ligand_mask="$ligmask", startframe=1, endframe="$f", \ 
interval=1, verbose=1,\n/\n&pb\nistrng=0.15, radiopt=0" > 
mmpbsa_closest_nwat$n.in  
 
                         
          endif 
# 
# execute MMPBSA and print results 
# 
  if ($stripstructions == 0) then 
                       $MPI_HOME/bin/mpirun -machinefile $PBS_NODEFILE -np 
$NPROCS $AMBERHOME/bin/MMPBSA.py.MPI -O -i mmpbsa_closest_nwat$n.in -o 
FINAL_RESULTS_CLOSEST$n -cp nwat$n.$z.top -rp nwat$n.$z.rec.top -lp 
ligand.top -y nwat$n.$z.mdcrd > MMPBSA.out 
                       grep "DELTA TOTAL" FINAL_RESULTS_CLOSEST"$n" | sed 
"s/DELTA TOTAL/NWAT="$n"/g" >> $PBS_O_WORKDIR/RESULTS_"$argv".txt 
                else 
                 
                       $MPI_HOME/bin/mpirun -machinefile $PBS_NODEFILE -np 
$NPROCS $AMBERHOME/bin/MMPBSA.py.MPI -O -i mmpbsa_closest_nwat$n.in -o 
FINAL_RESULTS_CLOSEST$n -cp nwat$n.$z.top -rp nwat$n.$z.rec.top -lp 
ligand.top -y nwat$n.$z.mdcrd > MMPBSA.out 
                       grep "DELTA TOTAL" FINAL_RESULTS_CLOSEST"$n" | sed 
"s/DELTA TOTAL/NWAT="$n"/g" >> 
$PBS_O_WORKDIR/RESULTS_strip_"$ionmask"_"$argv".txt 
                endif 
                cd .. 
 end  
 cd .. 
        endif 
end 
# 
# the script terminates 
# 





ANNEX 11.A. Additional information about penicillopesin system 
Correlation between experimental free energy of binding and predicted 
binding energies obtained for penicillopepsin by analyzing the first ns of 







Correlation between experimental free energy of binding and predicted 
binding energies obtained for penicillopepsin by analyzing the 4th ns of 
one of the three MD simulations run on a GPU hardware. 
ANNEX 11.B. Additional information about MDM2 system. 
Correlation between experimental free energy of binding and predicted 
binding energies obtained for MDM2 with Nwat = 0 - 70 by analyzing 
the first ns of a MD simulation run on a CPU hardware. 
 
 
Correlation between experimental free energy of binding and predicted 
binding energies obtained for MDM2 with Nwat = 0 - 70 by analyzing 
the 4th ns of a MD simulation run on a GPU hardware. 
 
 Correlation between experimental free energy of binding and predicted 
binding energies obtained for MDM2 with Nwat = 0 - 70 by analyzing 
the 4th ns of a MD simulation run on a CPU hardware. 
 
ANNEX 11.C. Additional information about BCL-XL system 
Correlation between experimental free energy of binding and predicted 
binding energies obtained for BCL-XL with Nwat = 0 - 50 by analyzing 




Correlation between experimental free energy of binding and predicted 
binding energies obtained for BCL-XL with Nwat = 0 - 50 by analyzing 





Correlation between experimental free energy of binding and predicted 
binding energies obtained for BCL-XL with Nwat = 0 - 50 by analyzing 





 ANNEX 11.D. Additional information about XIAP-BIR2 
Correlation between experimental free energy of binding and predicted 
binding energies obtained for XIAP-BIR2 with Nwat = 0 - 90 by 










Correlation between experimental free energy of binding and predicted 
binding energies obtained for XIAP-BIR2 with Nwat = 0 - 90 by 








 Correlation between experimental free energy of binding and predicted 
binding energies obtained for XIAP-BIR2 with Nwat = 0 - 90 by 









ANNEX 11.E. Additional information about HIV1-protease system. 
Correlation between experimental free energy of binding and predicted 
binding energies obtained for HIV1-protease with Nwat = 0 - 70 by 
analyzing the first ns of a MD simulation run on a CPU hardware. 
 
Correlation between experimental free energy of binding and predicted 
binding energies obtained for HIV1-protease with Nwat = 0 - 70 by 
analyzing the 4th ns of a MD simulation run on a GPU hardware. 
 
Correlation between experimental free energy of binding and predicted 
binding energies obtained for HIV1-protease with Nwat = 0 - 70 by 
analyzing the 4th ns of a MD simulation run on a CPU hardware. 
ANNEX 11.F. Scripts used for the automatization of the MD/Nwat-MMGBSA protocol 
Ligand parametrization. 
#!/bin/tcsh 
# Alessandro Contini 2014 
# Given a multimol2 named multimol2_c1.mol2, the scripts uses antechamber 
and 
# parmchk2 to generate .prep and .frcmods for each ligand 
#  
# usage: tcsh PARAMETERIZE_AC.csh 
# 
# do preliminary setup 
source /usr/local/amber14/amber14.csh 
setenv WORKDIR `pwd` 
if (-e charges.txt) then 
 rm charges.txt 
endif 
if (-e names.txt) then 
 rm names.txt 
endif 
if (! -d BCC) then  
 mkdir BCC 
endif 
if (! -e multimol2_c1.mol2) then 
 echo "multimol2_c1.mol2 must be in the current directory" 
else 
 #edit multimol2s to delete the "Q" before the residue name (I guess 
it is a bug in MOE) 
        sed -i 's/1 Q/1 /g' multimol2*  
        #create list 
        awk '/@<TRIPOS>MOLECULE/{getline; print}' multimol2_c1.mol2 | awk 
'{print substr($0,0,4)}' > list 
 set max = `grep -o "@<TRIPOS>MOLECULE" multimol2_c1.mol2 | wc -l` 
 set  a = 1 
 #split the multimol2, calculate molecule net charge and grab residue 
name 
 foreach n (`cat list`) 
  if ($a <= $max) then 
   awk 
"/^@<TRIPOS>MOLECULE/,/^MOE/{if(++m==1)n++;if(n=="$a")print;if(/^#/)m=0}" 
multimol2_c1.mol2 > ligand_"$n".mol2 
                 babel -imol2 ligand_"$n".mol2 --partialcharge mmff94 -omol2 
tmp 
                 set c = `awk '{print $9}' tmp | awk '{sum+=$1} END {print 
sum}' | awk '{printf "%.0f\n", $1}'` 
                 rm tmp 
                 echo $c >> charges.txt # print charges for debug 
                 set name = `awk '/@<TRIPOS>ATOM/{getline; print}' 
ligand_"$n".mol2 | awk '{print $(NF-1)}' | awk '{print substr( $0, 
length($0) -2,length($0))}'`  
   echo $name >> names.txt 
 #run ac and parmchk 
   antechamber -i ligand_$n.mol2 -fi mol2 -o $name.prep -fo 
prepi -nc $c -c bcc -rn $name -pf y 
                 parmchk2 -i $name.prep -f prepi -o $name.frcmod 
                        mv $name.prep BCC 
                        mv $name.frcmod BCC 
                       @ a ++ 






# Written by I. Maffucci and A. Contini, 2014; based on the work reported 
in J. Chem. Theory Comput., 2013, 9 (6), pp 2706-2717 
# 
# Given a set of PDB complexes, this script setup MMGBSA calculations 
including $n explicit water closest to ligand mask. 
# The sript assumes that solvated .top and MD trajectories are stored in 
$WORKDIR/$n.  
# 
# The following standard name are also used: 
# solvated topology file: $z_complex_wat.top 
# solvated trajectory file: $z_complex.prod$nprod.mdcrd 
# with $z = system name and $nprod = production run number 
# 
# AmberTools14 needs to be installed and environment variables correctly 
specified 
# 
# ATTENTION!  
# Automatic ligand recognition only works if the ligand is a single chain 
(no "TER" inbetween) and is the last residue or set of residues of the 
complex.  
# If ions or cofactors need to be considered as part of the receptor, they 
must be placed "before" the ligand in the original PDB file. 
# 
# run as: tcsh NWAT_MMPBGBSA_5.1_MPI.csh >& NWAT_MMPBGBSA_5.1_MPI.log & 
# 
###################################################### 
# HERE ARE VARIABLES THAT NEED TO BE MODIFIED BY USER# 
###################################################### 
# 
set AMBERV = 14 # modify accordingly to your Amber installation 
# 
set solv = "GB"  # PB = MMPBSA; GB = MMGBSA 
# 
set nproc = 6  # set n° of processors for MMGBSA calculations (max 6 
on born) 
# 
set nprod = 4   # which is the number of production run to be 
analyzed? 
# 
set frames = 1000 # total number of frames in trajectory 
# 
set r = 10   # interval between trajectory frames selected for 
MMGBSA calculation (suggested values for production = 10 or 20) 
# 
set nwat = "0 10 20 30 40 50" # set Nwat walues; typical values for 
screening water effect are 0 10 20 30 40 50; for fixed Nwat run 0 30 
# 
# define residues/ions that are NOT receptor or ligand 
set nonlig = ":Na+,:Cl-,:MG,:ZN,:ATP,:GTP" 
# 
#####################################################  
# END OF USER MODIFIABLE VARIABLES                  # 
##################################################### 
# 
source /usr/local/amber$AMBERV/amber$AMBERV.csh # modify accordingly to 
your amber installation 
# 




echo "MM"$solv"SA calculation begun on "`date`  
# 
echo "                     Average Delta          Std. Dev.   Std. Err. of 
Mean" > $WORKDIR/MM"$solv"SA/RESULTS_$solv.txt 
# 
#foreach z (`cat $WORKDIR/list_debug`) # for debug 
foreach z (`ls */*top | awk -F/ '{print $1F}'`)  
        # check if trajectory exists and is compressed 
 if (-e $WORKDIR/$z/"$z"_complex_wat.prod"$nprod".mdcrd.bz2) then 
  set bz = ".bz2" 
 else if (-e $WORKDIR/$z/"$z"_complex_wat.prod"$nprod".mdcrd.gz) then 
  set bz = ".gz" 
        else if (-e $WORKDIR/$z/"$z"_complex_wat.prod"$nprod".mdcrd) then  
         set bz = "" 
        else  
         echo "I cannot find "$z"_complex_wat.prod"$nprod" trajectory" 
  exit 
        endif 
         
        #see if ligand is a single residue or not 
        # do a pdb file from coordinates 
        cat << EOF | cpptraj -p $WORKDIR/$z/$z\_complex_wat.top 
trajin $WORKDIR/$z/$z\_complex_wat.prod$nprod.mdcrd$bz 1 1 
strip :WAT,$nonlig 
trajout tmp.rst restart  
EOF 
        cat << EOF | cpptraj -p $WORKDIR/$z/$z\_complex_wat.top 
parmstrip :WAT,$nonlig nobox 
parmwrite out tmp1.top amber 
EOF 
ambpdb -p tmp1.top < tmp.rst > tmp 
 #define last receptor residue 
        set y = `tac tmp | awk '/TER/ && ++n ==1 {getline; print$5}'` 
        #define first ligand residue 
        @ f = $y + 1 
        #define last ligand residue  
        set l = `tac tmp | awk 'NR==2 {print$5}'` 
        #rm tmp 
        if ($f == $l) then 
         set x = "$f" 
        else 
  set x = "$f-$l" 
        endif 
        echo ""$z" ligand residue numbers are: "$x""  
         
        #start MM-PBSA/GBSA calculation 
        mkdir MM"$solv"SA/$z 
 echo "$z" >> MM"$solv"SA/RESULTS_$solv.txt 
 cd $WORKDIR/MM"$solv"SA/$z 
  
 if ($solv == GB) then  
        # check the PBRadii set and define the GB model (only if GB method 
is used) 
         set radii = `awk '/FLAG RADIUS_SET/{getline;getline;print $NF}' 
$WORKDIR/$z/"$z"_complex_wat.top | sed 's/(//g' | sed 's/)//g'` 
         if ($radii == mbondi3) then  
          set g = 8 
          else if ($radii == mbondi2) then 
          set g = 5 
          else if ($radii == mbondi) then 
          set g = 1 
         else  
          echo "cannot determine the RADIUS SET from topology" 
                exit 
         endif 
  echo "the radius set is "$radii", setting igb="$g"" 
 endif 
 
 # create a file named nwat.dat containing the nr. of closest water 
molecules to include in top/mdcrd. 
        printf %"s\n" "$nwat" > nwat.dat # for Nwat screen  
   
 foreach n (`cat nwat.dat`) 
                # set variables for MMPB/GBSA input  
                set a = `echo $l+$n | bc`  # last water residue 
  @ w = $l + 1   # first water residue 
                @ b = $a + 1   # first ecluded water 
                mkdir nwat$n # create directories named nwatn, where n is 
nr. of closest water molecules 
  cd nwat$n 
 
 # generate ligand topologies 
  echo "parmstrip :1-"$y","$nonlig",:WAT\nparmbox nobox\nparmwrite 
out ligand.top amber" > lig_gen.cpptraj   
  $AMBERHOME/bin/cpptraj -i lig_gen.cpptraj -p 
"$WORKDIR"/"$z"/"$z"_complex_wat.top > lig_cpptraj.log 
                 
 # generate trajectory  for nwat > 0  
  if ($n != 0) then 
   echo "trajin 
"$WORKDIR"/"$z"/"$z"_complex_wat.prod"$nprod".mdcrd"$bz" 1 $frames "$r"" > 
cmplx_trj_gen.cpptraj 
   echo "center @CA,C,N mass origin\nimage origin 
center\nstrip "$nonlig"\nclosest "$n" :"$x" noimage" >> 
cmplx_trj_gen.cpptraj 
   echo "trajout nwat"$n"."$z".mdcrd nobox" >> 
cmplx_trj_gen.cpptraj 
   $AMBERHOME/bin/cpptraj -i cmplx_trj_gen.cpptraj -p 
"$WORKDIR"/"$z"/"$z"_complex_wat.top > cmplx_trj_gen_cpptraj.log 
 # generate complex topologies for nwat > 0 
   echo "parmstrip "$nonlig"\nparmbox nobox\nparmwrite out 
tmp.top amber" > cmplx_top1_gen.cpptraj  
   $AMBERHOME/bin/cpptraj -i cmplx_top1_gen.cpptraj -p 
"$WORKDIR"/"$z"/"$z"_complex_wat.top > cmplx_top1_nwat_cpptraj.log 
                         
                        #assuming max water number = 60000 
                        echo "parmstrip :"$b"-60000\nparmbox 
nobox\nparmwrite out nwat"$n"."$z".top amber" > cmplx_top2_gen.cpptraj 
   $AMBERHOME/bin/cpptraj -i cmplx_top2_gen.cpptraj -p tmp.top 
> cmplx_top2_nwat_cpptraj.log 
 # generate receptor topologies for nwat > 0 
   echo "parmstrip :"$x"\nparmbox nobox\nparmwrite out 
nwat"$n"."$z"_rec.top amber" > rec_top_gen.cpptraj  
   $AMBERHOME/bin/cpptraj -i rec_top_gen.cpptraj -p 
nwat"$n"."$z".top > rec_top_nwat_cpptraj.log 
                          
        # generate MMPB/GBSA input for nwat > 0; change to modify MM-
PBSA/GBSA protocol. See Amber14 manual for details 
          if ($solv == GB) then 
                         echo "&general\nreceptor_mask=:1-"$y":"$w"-"$a", 
ligand_mask=:"$x", \ 
interval=1, verbose=1,\n/\n&gb\nigb="$g", saltcon=0.15," > 
mmpbsa_closest_nwat$n.in 
                        else if ($solv == PB) then 
                         echo "&general\nreceptor_mask=:1-"$y":"$w"-"$a", 
ligand_mask=:"$x", \ 
interval=1, verbose=1,\n/\n&pb\nistrng=0.150, radiopt=0" > 
mmpbsa_closest_nwat$n.in 
   endif 
  else      
 # generate trajectory for nwat = 0         
                 echo "trajin 
"$WORKDIR"/"$z"/"$z"_complex_wat.prod"$nprod".mdcrd"$bz" 1 $frames "$r"" > 
gen0.cpptraj 
                 echo "autoimage\nstrip "$nonlig",:WAT\ntrajout 
nwat"$n"."$z".mdcrd nobox" >> gen0.cpptraj 
   $AMBERHOME/bin/cpptraj -i gen0.cpptraj -p 
"$WORKDIR"/"$z"/"$z"_complex_wat.top > traj_nwat0_cpptraj.log   
        
 # generate receptor and complex topologies for nwat=0 
                 echo "parmstrip "$nonlig",:WAT\nparmbox nobox\nparmwrite 
out nwat"$n"."$z".top amber" > topgen0.cpptraj  
                 echo "parmstrip :"$x"\nparmwrite out nwat"$n"."$z"_rec.top 
amber" >> topgen0.cpptraj 
   $AMBERHOME/bin/cpptraj -i topgen0.cpptraj -p 
"$WORKDIR"/"$z"/"$z"_complex_wat.top > top_nwat0_cpptraj.log 
                         
       # generate MMPB/GBSA input for nwat = 0; change to modify MM-
PBSA/GBSA protocol. See Amber14 manual for details                
                        if ($solv == GB) then 
                         echo "&general\nreceptor_mask=:1-"$y", 
ligand_mask=:"$x", interval=1, verbose=1,\n/\n&gb\nigb="$g", saltcon=0.15," 
> mmpbsa_closest_nwat$n.in 
   else if ($solv == PB) then 
                         echo "&general\nreceptor_mask=:1-"$y", 
ligand_mask=:"$x", interval=1, verbose=1,\n/\n&pb\nistrng=0.150, radiopt=0" 
> mmpbsa_closest_nwat$n.in   
           endif 
                endif 
# execute MMPB/GBSA and print results 
  $MPI_HOME/bin/mpirun -np $nproc $AMBERHOME/bin/MMPBSA.py.MPI -O 
-i mmpbsa_closest_nwat$n.in -o FINAL_RESULTS_CLOSEST$n \ 
                -cp nwat"$n"."$z".top -rp nwat"$n"."$z"_rec.top -lp 
ligand.top -y nwat$n.$z.mdcrd >& MMPBSA.out                 
                grep "DELTA TOTAL" FINAL_RESULTS_CLOSEST"$n" | sed "s/DELTA 
TOTAL/NWAT="$n"/g" >> $WORKDIR/MM"$solv"SA/RESULTS_$solv.txt   
                cd .. 
 end  
 cd $WORKDIR 
        rm tmp* 
end 
# 
# the script terminates 
# 
echo "MM"$solv"SA calculations ended on "`date` 
